data_2k1g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k1g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 CA--C 1.535 0.381 0 CA-C-O 121.142 0.496 . . . . 63.439999999999998 111.961 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.2 t -58.71 -61.86 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.723 -0.671 . . . . 74.519999999999996 111.713 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.67 -40.36 79.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.828 0.347 . . . . 74.340000000000003 111.195 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.4 t -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.274 -0.421 . . . . 72.340000000000003 111.673 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -35.35 77.91 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.879 0.326 . . . . 74.040000000000006 111.879 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 40' ' ' VAL . 74.7 mt -62.4 -48.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.034 0.445 . . . . 73.329999999999998 111.017 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.524 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 26.7 mmt -67.22 -37.34 83.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.943 0.401 . . . . 72.010000000000005 110.85 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -56.97 -45.24 83.03 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.931 -0.577 . . . . 75.219999999999999 110.624 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.798 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 55.0 tp60 -66.66 -46.25 76.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.294 0.569 . . . . 70.129999999999995 111.271 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HH ' ' HA ' ' A' ' 139' ' ' ILE . 18.3 t80 -56.41 -34.85 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.824 -0.625 . . . . 75.030000000000001 111.221 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.76 12.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.38 0.511 . . . . 73.420000000000002 112.38 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.89 -26.25 21.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.958 0.408 . . . . 62.299999999999997 111.557 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -111.36 12.3 21.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.999 0.74 . . . . 75.129999999999995 112.999 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.56 ' HZ1' ' HB2' ' A' ' 52' ' ' LYS . 10.0 mtmp? -61.95 103.36 0.35 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.074 -0.391 . . . . 74.310000000000002 111.64 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.14 -0.89 26.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.807 -0.711 . . . . 61.530000000000001 114.231 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.03 138.44 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 117.484 0.642 . . . . 75.540000000000006 111.225 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.82 162.44 26.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.145 0.498 . . . . 74.219999999999999 112.229 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 51.7 t80 -84.05 118.41 24.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.053 -0.521 . . . . 75.439999999999998 112.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -137.99 123.61 19.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.661 -0.245 . . . . 72.219999999999999 111.309 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 97.0 mt -70.78 116.49 11.15 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.481 0.549 . . . . 75.040000000000006 112.481 -177.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.36 3.59 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.304 -0.474 . . . . 61.140000000000001 114.065 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.27 67.88 1.79 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.26 -0.495 . . . . 72.150000000000006 113.248 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -69.48 108.65 3.86 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.406 0.521 . . . . 75.230000000000004 112.406 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -166.61 175.38 8.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.123 -0.489 . . . . 73.010000000000005 110.793 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -67.68 -8.26 33.63 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.252 0.464 . . . . 71.200000000000003 112.252 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 64' ' ' LYS . 3.9 mppt? -97.08 7.94 45.57 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.018 0.437 . . . . 73.129999999999995 111.215 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.0 134.63 2.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.359 -0.382 . . . . 63.329999999999998 112.604 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.3 tt -154.53 144.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.427 -0.455 . . . . 72.409999999999997 110.59 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.503 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.5 p-10 -96.99 -174.51 2.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.302 0.572 . . . . 72.510000000000005 112.35 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.7 p -62.68 -50.72 70.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.939 -0.573 . . . . 62.240000000000002 111.488 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.425 ' HA ' HG13 ' A' ' 72' ' ' VAL . 49.1 m -69.09 -35.85 76.94 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.367 -0.379 . . . . 73.340000000000003 111.318 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.04 -44.6 97.55 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.112 -0.565 . . . . 70.209999999999994 112.726 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -66.02 -50.75 63.14 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.54 -0.388 . . . . 74.319999999999993 111.702 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 69' ' ' SER . 11.9 p -61.43 -37.49 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.927 0.394 . . . . 74.340000000000003 110.844 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.474 ' NE2' ' HD3' ' A' ' 86' ' ' ARG . 4.0 tt0 -54.47 -59.34 4.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.1 0.476 . . . . 73.019999999999996 110.693 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.545 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 9.4 mmm180 -52.24 -55.68 19.66 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.847 -0.615 . . . . 73.430000000000007 111.824 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.798 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 72.3 m -48.74 -56.25 9.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.401 0.519 . . . . 74.040000000000006 112.401 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 41.7 m-85 -74.94 -34.89 62.16 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.013 0.746 . . . . 74.25 113.013 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 ptm180 -66.42 -39.67 89.08 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.422 0.527 . . . . 74.409999999999997 112.422 -175.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 15.6 pt-20 -102.34 -23.39 13.97 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.075 0.769 . . . . 71.25 113.075 -174.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 75' ' ' THR . 84.4 mm-40 -87.31 -63.06 1.36 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.984 -0.448 . . . . 62.229999999999997 111.589 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.72 -18.16 30.1 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.004 0.372 . . . . 74.310000000000002 112.004 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 45.14 28.7 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.062 -0.59 . . . . 64.310000000000002 112.592 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 44.4 tp -105.99 136.9 44.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.901 0.381 . . . . 72.030000000000001 111.277 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.83 88.78 4.04 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.818 0.342 . . . . 74.319999999999993 111.645 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.42 138.16 19.46 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.94 0.348 . . . . 62.32 111.94 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HD2' ' OE1' ' A' ' 91' ' ' GLN . 73.4 Cg_endo -74.25 -161.54 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.412 2.741 . . . . 65.329999999999998 113.717 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.474 ' HD3' ' NE2' ' A' ' 73' ' ' GLN . 13.6 mmt180 -102.01 -31.99 10.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.479 1.289 . . . . 75.409999999999997 114.479 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -114.17 148.72 36.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.879 0.696 . . . . 74.540000000000006 112.879 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.2 m -54.38 -42.73 70.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.832 -0.622 . . . . 70.109999999999999 112.478 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -57.37 -29.89 64.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 73.430000000000007 111.488 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.84 -43.67 17.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.075 0.464 . . . . 62.25 110.382 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.473 ' OE1' ' HD2' ' A' ' 85' ' ' PRO . 20.3 mm-40 -54.25 -47.09 72.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.857 -0.61 . . . . 74.329999999999998 112.046 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -61.7 -23.46 66.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.217 0.451 . . . . 74.420000000000002 112.217 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -92.11 2.11 56.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.971 -0.456 . . . . 74.209999999999994 111.972 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 94.3 mmm -85.63 -14.69 44.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.953 0.406 . . . . 63.049999999999997 111.111 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.42 152.54 23.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.154 -0.546 . . . . 53.140000000000001 113.174 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -83.01 150.82 26.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.923 0.392 . . . . 72.340000000000003 111.555 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 86.8 p -76.6 158.43 31.13 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.995 0.739 . . . . 72.340000000000003 112.995 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.407 HG11 ' NE ' ' A' ' 157' ' ' ARG . 1.5 m -145.41 174.06 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.682 -0.69 . . . . 71.319999999999993 111.779 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -111.53 179.67 3.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.783 -0.644 . . . . 75.109999999999999 111.489 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.534 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 32.6 mmt180 -50.09 -32.98 17.08 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.295 0.48 . . . . 72.299999999999997 112.295 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.9 p -77.1 -29.93 55.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.615 0.598 . . . . 73.530000000000001 112.615 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -109.52 20.42 18.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.483 0.549 . . . . 74.140000000000001 112.483 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.52 135.18 57.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.07 0.462 . . . . 72.120000000000005 111.098 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -108.81 148.6 30.31 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.185 -0.322 . . . . 75.510000000000005 111.438 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.412 ' O ' HG12 ' A' ' 40' ' ' VAL . 63.6 m -68.95 110.76 4.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.847 -0.533 . . . . 72.109999999999999 110.078 173.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.07 15.47 30.68 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.419 -0.419 . . . . 72.5 112.266 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.33 152.43 36.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.729 0.411 . . . . 71.400000000000006 110.71 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.4 mt -99.86 108.35 20.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.296 0.569 . . . . 74.409999999999997 111.344 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.16 123.98 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.328 0.585 . . . . 75.310000000000002 111.628 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.9 mt -90.93 135.37 33.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.625 -0.716 . . . . 62.530000000000001 111.945 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 91.0 m-85 -120.22 141.89 49.52 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.166 0.508 . . . . 73.120000000000005 111.962 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -72.48 96.58 1.94 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.709 -0.678 . . . . 75.409999999999997 110.856 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.744 0.307 . . . . 72.109999999999999 111.44 -179.509 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.7 mmt-85 . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 120.898 0.38 . . . . 74.200000000000003 111.537 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 44.5 t60 -102.21 151.5 22.14 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.398 -0.593 . . . . 61.149999999999999 109.398 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.51 137.67 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.258 0.466 . . . . 75.549999999999997 112.258 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 153.34 20.33 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 116.066 -0.516 . . . . 72.129999999999995 112.525 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.1 mt -88.15 103.44 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.975 0.417 . . . . 63.0 111.132 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -64.09 116.39 5.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.08 -0.509 . . . . 74.349999999999994 111.654 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.7 pt -102.76 -28.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.639 0.607 . . . . 63.420000000000002 112.639 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.65 135.37 1.93 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 119.863 -1.161 . . . . 42.340000000000003 114.973 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 65.0 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.071 0.948 . . . . 71.049999999999997 111.403 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.551 HD21 ' HB2' ' A' ' 143' ' ' MET . 22.6 m120 -141.34 -3.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.879 -0.601 . . . . 74.200000000000003 111.493 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -93.29 143.9 25.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.32 0.581 . . . . 74.510000000000005 111.574 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 18.0 p90 -152.61 145.81 24.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.47 -0.786 . . . . 74.0 111.008 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.34 133.83 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 74.030000000000001 110.903 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.49 178.64 8.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.107 0.479 . . . . 75.530000000000001 111.215 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -97.93 110.44 23.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.24 -0.437 . . . . 62.210000000000001 111.187 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 70.3 m -86.08 140.83 29.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.838 0.351 . . . . 73.209999999999994 111.165 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.4 p -47.43 -53.72 13.28 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.453 0.908 . . . . 71.230000000000004 113.453 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 p -90.29 -71.25 0.63 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.537 0.569 . . . . 64.209999999999994 112.537 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 54.2 m -58.71 -26.72 64.17 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.916 0.71 . . . . 70.439999999999998 112.916 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.54 -160.15 18.27 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.895 -0.669 . . . . 45.219999999999999 113.219 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 19.3 t -66.98 109.07 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.03 0.443 . . . . 74.219999999999999 111.909 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.499 ' HA ' ' HH ' ' A' ' 48' ' ' TYR . 38.9 pt -138.37 179.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.999 0.428 . . . . 64.010000000000005 111.754 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.22 110.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 110.599 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.435 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . 55.7 m -101.86 172.84 6.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.904 0.383 . . . . 65.5 111.738 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 138.99 49.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.13 0.49 . . . . 75.239999999999995 111.908 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.551 ' HB2' HD21 ' A' ' 127' ' ' ASN . 65.0 mtt -69.69 -8.17 45.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.389 -0.369 . . . . 71.230000000000004 111.899 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -77.01 -19.43 57.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.978 0.418 . . . . 74.230000000000004 110.612 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.25 124.48 90.88 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.287 -0.415 . . . . 65.25 110.267 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -48.69 -38.5 37.04 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.352 2.701 . . . . 65.049999999999997 114.028 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.437 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 52.3 t80 -63.18 -45.92 89.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.924 0.392 . . . . 74.109999999999999 111.394 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 151' ' ' ARG . 83.8 m95 -80.79 -28.46 36.33 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.055 0.455 . . . . 72.200000000000003 111.392 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.9 -41.82 98.35 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.967 -0.561 . . . . 71.400000000000006 111.58 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -83.82 -21.38 32.11 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.096 0.474 . . . . 71.129999999999995 111.361 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' A' ' 148' ' ' TRP . 0.8 OUTLIER -72.16 -39.09 68.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.341 -0.39 . . . . 72.549999999999997 111.612 177.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.98 104.45 0.14 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.16 0.505 . . . . 72.239999999999995 112.18 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.19 -52.02 5.45 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.925 -0.58 . . . . 74.430000000000007 110.873 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -167.08 171.47 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.251 -0.432 . . . . 74.230000000000004 111.284 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -121.15 154.74 35.81 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.642 -0.254 . . . . 72.120000000000005 110.872 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 79.3 mtt180 -147.93 119.18 7.79 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.076 0.465 . . . . 73.349999999999994 111.742 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.408 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -86.66 109.29 19.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.042 0.448 . . . . 75.5 111.877 -177.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.09 -13.98 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.869 0.366 . . . . 73.430000000000007 111.736 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.469 0.52 0 CA-C-N 116.443 -0.344 . . . . 73.319999999999993 111.205 177.448 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--O 1.235 0.338 0 CA-C-O 121.071 0.462 . . . . 73.200000000000003 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 44' ' ' ILE . 64.8 t -55.54 -51.88 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.109 -0.496 . . . . 75.099999999999994 110.823 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.7 tttt -57.22 -42.26 81.03 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.866 -0.606 . . . . 74.310000000000002 111.757 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.1 t -58.38 -45.44 88.31 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.886 0.374 . . . . 61.530000000000001 111.891 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.428 ' HD3' ' OE1' ' A' ' 79' ' ' GLN . 3.2 mmp_? -66.05 -44.26 85.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 73.439999999999998 111.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.2 mt -57.97 -41.36 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.038 0.447 . . . . 75.120000000000005 111.13 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.529 ' HA ' ' HE3' ' A' ' 45' ' ' MET . 30.7 mmt -67.08 -31.51 72.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 70.540000000000006 111.58 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.77 -41.75 96.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.87 0.367 . . . . 73.120000000000005 110.916 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' ' HD1' ' A' ' 51' ' ' TRP . 71.2 mm-40 -68.37 -55.19 12.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.436 -0.347 . . . . 72.0 111.096 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 28.9 t80 -48.25 -47.06 36.22 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.235 0.457 . . . . 75.329999999999998 112.235 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.62 -32.39 63.09 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.241 0.543 . . . . 71.319999999999993 111.715 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.88 -29.97 35.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.063 -0.517 . . . . 71.510000000000005 111.018 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.457 ' HZ2' HH11 ' A' ' 74' ' ' ARG . 73.9 m95 -96.52 3.17 52.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.103 0.779 . . . . 71.510000000000005 113.103 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 30.7 mtpp -61.45 122.89 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.991 -0.443 . . . . 74.409999999999997 110.797 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.93 -8.3 55.83 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.301 -0.476 . . . . 65.329999999999998 113.299 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -77.07 123.46 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.231 -0.57 . . . . 73.140000000000001 111.519 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -74.75 159.79 31.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 74.319999999999993 112.009 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -79.52 130.12 35.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 110.949 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -136.88 115.15 11.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.915 0.388 . . . . 75.329999999999998 112.023 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.86 123.87 24.26 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.046 0.45 . . . . 74.120000000000005 112.04 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.51 7.41 84.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 114.083 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.34 143.68 15.17 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.975 -0.631 . . . . 71.120000000000005 113.295 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.522 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 t -125.37 100.58 6.56 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.059 0.457 . . . . 72.340000000000003 111.171 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.1 t -170.81 167.95 7.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.274 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -73.96 -13.09 60.83 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.279 0.561 . . . . 73.549999999999997 111.212 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -76.26 -15.63 59.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.245 0.545 . . . . 75.040000000000006 110.55 173.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.33 135.86 1.91 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.847 -0.615 . . . . 64.439999999999998 112.024 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.522 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -151.63 154.11 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.985 0.393 . . . . 74.519999999999996 111.343 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -91.7 176.32 6.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.318 0.58 . . . . 75.420000000000002 111.953 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.8 t -59.11 -51.98 67.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.469 0.544 . . . . 75.120000000000005 112.469 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.6 t -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.279 0.561 . . . . 73.129999999999995 111.16 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 74' ' ' ARG . . . -64.24 -41.58 98.23 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.859 -0.61 . . . . 72.450000000000003 113.002 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.5 -51.01 70.41 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.445 -0.444 . . . . 70.239999999999995 111.795 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.446 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 11.9 p -62.2 -45.3 99.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.66 -0.245 . . . . 71.409999999999997 111.615 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 18.6 pt20 -61.24 -40.02 92.48 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.048 -0.407 . . . . 70.310000000000002 111.804 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.52 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 10.4 mtp-105 -67.85 -45.04 75.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.817 0.342 . . . . 74.329999999999998 111.327 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.7 m -51.98 -46.76 64.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.012 0.434 . . . . 75.049999999999997 111.778 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.0 m-85 -73.78 -42.17 61.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.018 0.747 . . . . 72.340000000000003 113.018 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 13.3 ptm180 -66.45 -34.27 77.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.048 -0.408 . . . . 73.230000000000004 112.065 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -81.16 -39.31 25.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.156 0.428 . . . . 75.349999999999994 112.156 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.428 ' OE1' ' HD3' ' A' ' 43' ' ' ARG . 77.6 mm-40 -86.96 -63.21 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.449 0.537 . . . . 71.040000000000006 112.449 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -90.57 -7.41 52.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.024 0.379 . . . . 75.519999999999996 112.024 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.07 10.15 84.08 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.135 -0.555 . . . . 71.439999999999998 112.519 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 39.0 tp -83.5 112.48 20.01 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.126 0.489 . . . . 73.349999999999994 110.737 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -86.0 92.36 8.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 72.450000000000003 111.456 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 93.3 mt -81.11 145.91 57.53 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.788 0.328 . . . . 73.099999999999994 111.159 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.56 -173.17 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.648 2.232 . . . . 75.140000000000001 113.7 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -94.98 -34.39 12.38 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.494 0.553 . . . . 75.439999999999998 112.494 -170.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.472 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 66.3 m -96.01 136.5 36.37 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.259 -0.276 . . . . 72.129999999999995 111.09 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.517 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 87.5 m -56.58 -39.51 73.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.844 0.313 . . . . 73.349999999999994 111.844 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -55.45 -45.88 76.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.909 0.385 . . . . 73.230000000000004 111.212 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 49.6 mt-10 -59.63 -38.48 81.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.008 0.432 . . . . 73.409999999999997 110.604 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -67.81 -35.59 78.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.251 -0.431 . . . . 72.430000000000007 111.185 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.4 mt-30 -62.14 -37.58 85.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.378 0.609 . . . . 65.329999999999998 110.612 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.98 12.83 10.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.603 -0.726 . . . . 73.540000000000006 112.557 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 90.4 mmm -84.9 -62.6 1.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.893 0.331 . . . . 70.540000000000006 111.893 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.29 -174.57 21.19 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.254 -0.498 . . . . 62.130000000000003 113.942 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.98 159.69 21.18 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.069 0.462 . . . . 74.400000000000006 111.837 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.469 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 61.7 p -91.37 150.59 21.21 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.379 0.609 . . . . 74.540000000000006 112.342 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.403 HG22 ' HB2' ' A' ' 155' ' ' ALA . 1.7 m -138.78 169.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.698 -0.683 . . . . 74.519999999999996 111.416 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -117.16 -179.68 3.78 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.19 -0.459 . . . . 72.319999999999993 111.468 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -47.1 -58.42 4.05 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.919 1.081 . . . . 73.129999999999995 113.919 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.6 m -73.47 -4.73 35.55 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.225 0.454 . . . . 73.129999999999995 112.225 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -99.06 -11.72 21.21 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.891 0.377 . . . . 74.099999999999994 111.28 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.3 114.28 6.63 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.511 0.56 . . . . 70.519999999999996 112.511 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -112.17 -160.91 0.73 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 110.843 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.0 m -82.41 114.84 21.13 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.183 -0.323 . . . . 74.430000000000007 110.984 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.02 -18.69 10.37 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.066 -0.588 . . . . 71.049999999999997 113.098 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.95 130.79 44.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.068 0.461 . . . . 74.109999999999999 111.529 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.55 114.25 24.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.376 -0.375 . . . . 72.540000000000006 110.672 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.27 124.8 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.492 0.663 . . . . 73.109999999999999 111.604 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.8 mt -97.64 126.35 42.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.5 -0.773 . . . . 75.519999999999996 111.776 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -117.41 160.84 20.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.037 0.446 . . . . 71.140000000000001 111.293 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 63.0 mtt85 -91.83 122.2 34.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.14 0.495 . . . . 73.0 111.279 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.415 0 CA-C-N 116.113 -0.494 . . . . 73.409999999999997 111.142 -179.878 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.944 0.402 . . . . 75.120000000000005 111.192 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.55 148.81 50.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.187 -0.46 . . . . 63.509999999999998 109.9 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.481 HG12 ' SG ' ' A' ' 68' ' ' CYS . 9.2 p -135.76 138.93 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.335 0.588 . . . . 74.319999999999993 112.334 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -129.05 144.84 15.74 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.869 -0.605 . . . . 72.150000000000006 112.608 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.8 mt -90.23 107.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.634 -0.333 . . . . 73.310000000000002 111.491 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.497 ' HH ' ' HA ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER -64.35 117.6 7.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.597 0.359 . . . . 75.409999999999997 111.422 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.3 pt -102.13 -32.88 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.362 0.504 . . . . 74.140000000000001 112.362 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.35 133.38 2.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.092 -1.051 . . . . 63.030000000000001 114.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 60.45 -80.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.593 0.757 . . . . 62.149999999999999 112.366 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.497 ' HA ' ' HH ' ' A' ' 123' ' ' TYR . 82.4 m-20 -141.57 1.63 1.56 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.177 0.436 . . . . 73.040000000000006 112.177 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -102.38 146.21 28.39 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.365 0.602 . . . . 71.0 112.051 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.7 p90 -150.73 148.98 29.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.377 -0.829 . . . . 72.230000000000004 111.657 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.87 138.34 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.916 0.389 . . . . 71.040000000000006 111.152 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -163.78 161.65 23.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.995 0.426 . . . . 71.209999999999994 111.847 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -91.2 96.7 10.71 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.207 0.527 . . . . 74.400000000000006 110.641 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.1 p -77.77 150.85 34.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.897 -0.592 . . . . 74.310000000000002 112.569 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.9 p -81.19 8.97 7.59 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.991 -0.55 . . . . 74.230000000000004 111.561 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 t -109.7 -46.55 3.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.855 0.317 . . . . 51.240000000000002 111.855 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.5 t -124.85 -30.16 3.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.385 0.513 . . . . 63.210000000000001 112.385 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.87 -147.65 18.42 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.278 -0.487 . . . . 72.209999999999994 112.005 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.21 101.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 117.141 0.471 . . . . 75.319999999999993 111.626 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.6 pt -136.96 176.6 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 71.409999999999997 112.173 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.12 120.97 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.004 -0.544 . . . . 61.119999999999997 110.846 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.8 p -122.62 178.27 5.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.937 0.399 . . . . 65.310000000000002 111.287 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 t -127.99 153.67 46.47 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.107 0.41 . . . . 65.510000000000005 112.107 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 25.0 mmt -60.07 -20.42 57.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.228 -0.442 . . . . 71.420000000000002 111.348 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.14 -24.3 66.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.287 -0.415 . . . . 74.340000000000003 111.636 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.484 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 29.0 mm-40 -71.47 133.68 84.88 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 120.833 0.349 . . . . 73.530000000000001 111.663 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 93.3 Cg_exo -45.15 -52.85 5.96 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.592 2.861 . . . . 72.049999999999997 115.11 -173.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.1 t80 -61.38 -43.6 98.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.824 0.345 . . . . 75.25 111.777 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.484 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 73.9 m95 -76.13 -38.77 56.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.043 0.449 . . . . 72.25 111.041 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.88 -45.66 71.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.828 -0.624 . . . . 72.420000000000002 112.064 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.5 ptpt -98.38 6.1 47.58 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.798 0.666 . . . . 73.439999999999998 112.798 -175.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 2.5 mpt_? -116.66 7.57 13.59 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 122.193 -0.317 . . . . 74.519999999999996 111.658 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -60.54 104.27 0.32 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.032 0.444 . . . . 74.420000000000002 111.162 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 8.5 t30 -82.15 -49.01 10.63 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.316 -0.402 . . . . 73.319999999999993 111.072 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 153' ' ' ASN . 11.1 pt-20 177.3 -166.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.124 0.57 . . . . 62.439999999999998 109.875 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.403 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -146.69 146.66 30.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.38 0.511 . . . . 73.129999999999995 112.38 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt180 -137.04 126.35 24.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.365 0.666 . . . . 73.299999999999997 110.318 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.37 111.92 24.48 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.439 -0.788 . . . . 74.140000000000001 110.605 175.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.3 m -89.46 -16.74 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.252 -0.885 . . . . 74.209999999999994 112.692 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.415 HD22 HD21 ' A' ' 82' ' ' LEU . 90.6 mt . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.226 0.536 . . . . 72.420000000000002 111.866 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 15.0 t70 . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 120.602 0.239 . . . . 72.150000000000006 110.672 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.73 -57.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.347 0.499 . . . . 73.340000000000003 112.347 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.24 -44.15 95.47 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.666 0.27 . . . . 75.230000000000004 111.651 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 40.3 t -55.13 -47.85 74.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.886 0.374 . . . . 70.129999999999995 111.903 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 39' ' ' ASP . 11.0 mmm180 -59.9 -47.67 84.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.076 0.465 . . . . 74.340000000000003 111.289 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 122' ' ' ILE . 72.5 mt -61.67 -44.85 99.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.167 -0.469 . . . . 73.25 111.571 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.594 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 18.7 mmt -64.15 -29.08 70.22 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.917 0.389 . . . . 71.25 111.403 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.72 -47.76 82.2 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.223 0.535 . . . . 61.409999999999997 110.53 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.496 HE21 ' HB3' ' A' ' 50' ' ' ASP . 25.6 tp60 -66.13 -35.12 79.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 71.230000000000004 111.374 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -54.15 -37.22 64.17 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.463 -0.335 . . . . 73.430000000000007 111.542 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.71 -20.6 57.44 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.336 0.495 . . . . 64.450000000000003 112.336 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.496 ' HB3' HE21 ' A' ' 47' ' ' GLN . 34.9 t70 -90.92 -21.15 21.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.973 0.509 . . . . 71.409999999999997 111.521 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -122.81 30.51 6.4 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.949 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -57.82 -1.45 0.11 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.273 1.582 . . . . 72.239999999999995 115.273 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.54 49.14 0.11 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.246 -0.978 . . . . 72.219999999999999 113.64 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -92.19 137.24 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.784 0.326 . . . . 74.530000000000001 111.004 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -74.34 158.38 34.08 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.021 0.748 . . . . 75.120000000000005 113.021 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -73.09 119.09 16.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.914 -0.585 . . . . 74.329999999999998 111.513 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -137.66 119.14 14.83 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.989 0.423 . . . . 72.310000000000002 111.783 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.11 118.8 10.38 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.248 0.462 . . . . 75.239999999999995 112.248 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.58 -54.33 4.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.187 -0.53 . . . . 62.119999999999997 113.657 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.84 98.47 0.55 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.094 -0.574 . . . . 61.329999999999998 112.246 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.4 p -97.22 119.41 35.68 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 71.530000000000001 111.625 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -176.52 176.97 1.5 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.043 0.537 . . . . 73.299999999999997 110.978 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -16.45 63.7 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.973 -0.454 . . . . 74.219999999999999 110.943 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -85.72 2.75 44.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.295 -0.411 . . . . 73.430000000000007 110.987 175.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.12 142.75 3.62 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.468 -0.396 . . . . 44.210000000000001 112.746 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.1 tt -165.49 138.28 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.941 0.37 . . . . 73.109999999999999 111.105 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.11 171.47 8.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.798 -0.564 . . . . 74.239999999999995 111.319 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 21.0 p -54.52 -39.72 67.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.695 0.628 . . . . 70.519999999999996 112.695 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.433 ' HB2' ' OG1' ' A' ' 88' ' ' THR . 23.9 t -67.47 -47.01 71.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.803 0.335 . . . . 51.119999999999997 111.417 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.5 -36.22 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.01 -0.614 . . . . 73.140000000000001 112.898 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.87 -56.09 20.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.785 0.326 . . . . 74.439999999999998 111.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.9 p -61.32 -38.15 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.757 0.313 . . . . 74.239999999999995 111.536 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 6.0 tt0 -54.0 -58.11 8.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.286 0.565 . . . . 74.219999999999999 111.28 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -60.2 -51.85 67.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.948 -0.569 . . . . 72.409999999999997 111.913 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.403 ' HA ' ' OE1' ' A' ' 79' ' ' GLN . 78.1 m -48.37 -53.63 16.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.389 0.514 . . . . 71.0 112.389 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 45.9 m-85 -68.52 -37.95 80.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.787 0.662 . . . . 73.129999999999995 112.787 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.5 -21.26 45.54 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.889 -0.507 . . . . 72.150000000000006 112.174 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -86.45 -55.09 4.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.925 0.393 . . . . 71.150000000000006 111.492 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.404 ' CD ' ' HB2' ' A' ' 47' ' ' GLN . 1.9 mp0 -67.97 -51.38 48.1 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.336 0.495 . . . . 73.209999999999994 112.336 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -100.52 -36.89 9.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.023 0.44 . . . . 74.420000000000002 112.113 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.55 6.21 41.42 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.714 -0.554 . . . . 63.329999999999998 111.714 -172.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.481 HD23 HD22 ' A' ' 159' ' ' LEU . 29.0 tp -79.4 110.75 14.99 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.081 0.467 . . . . 74.439999999999998 110.669 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -84.3 112.08 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 75.5 111.943 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 84.3 mt -100.92 154.93 36.86 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.915 -0.584 . . . . 75.549999999999997 111.312 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.01 -179.02 1.2 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.45 2.1 . . . . 74.040000000000006 113.592 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -39.86 14.9 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.567 0.58 . . . . 74.140000000000001 112.567 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.7 m -110.59 141.87 43.19 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.143 0.423 . . . . 74.010000000000005 112.143 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.519 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 48.7 m -49.3 -39.06 29.66 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.311 -0.404 . . . . 75.319999999999993 111.8 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -52.98 -47.08 68.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.234 -0.439 . . . . 71.109999999999999 110.989 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -65.22 -36.74 85.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.406 0.622 . . . . 73.540000000000006 110.697 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.96 -28.47 68.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.777 -0.647 . . . . 73.25 111.49 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.0 mt-30 -68.79 -6.58 27.52 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.007 0.373 . . . . 73.530000000000001 112.007 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -98.06 -10.28 24.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.825 0.676 . . . . 70.129999999999995 112.825 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.428 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 25.7 ptm -124.62 162.39 24.2 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.399 0.518 . . . . 71.510000000000005 112.399 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 160.51 36.48 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.319 -0.467 . . . . 74.219999999999999 114.247 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 68.3 mmtt -84.48 125.66 32.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.135 0.493 . . . . 75.430000000000007 111.638 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 64.6 p -81.21 111.98 18.12 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.648 -0.706 . . . . 75.340000000000003 112.841 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 155' ' ' ALA . 2.8 m -106.2 157.58 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.808 -0.633 . . . . 73.439999999999998 111.964 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.439 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 84.0 p -99.59 -179.8 4.31 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.994 -0.548 . . . . 62.100000000000001 111.823 -177.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -53.23 -41.45 65.42 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.988 0.366 . . . . 73.319999999999993 111.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -77.28 -24.76 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 111.985 0.365 . . . . 72.430000000000007 111.985 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.62 -8.1 57.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.194 0.442 . . . . 72.319999999999993 112.194 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.464 HD23 ' HH ' ' A' ' 152' ' ' TYR . 85.3 mt -63.2 133.25 53.99 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.509 0.559 . . . . 74.019999999999996 112.509 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.405 ' O ' ' HD1' ' A' ' 123' ' ' TYR . 51.8 mtt180 -137.49 -122.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.466 -0.334 . . . . 74.420000000000002 110.352 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -106.12 127.04 52.92 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.692 -0.63 . . . . 75.219999999999999 112.134 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.16 13.31 36.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.298 -0.477 . . . . 75.439999999999998 114.178 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 123' ' ' TYR . 1.6 m-20 -81.44 120.09 24.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 122.571 -0.37 . . . . 72.230000000000004 111.5 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.7 mt -76.62 104.04 6.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.972 0.415 . . . . 75.129999999999995 110.195 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.5 m -95.53 118.8 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.512 0.672 . . . . 72.310000000000002 111.995 -173.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.488 HD12 ' HG2' ' A' ' 92' ' ' GLN . 74.7 mt -93.93 117.6 30.32 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.46 -0.791 . . . . 75.129999999999995 112.312 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 77.8 m-85 -107.91 133.36 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 73.230000000000004 110.331 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.62 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 78.4 mtt-85 -82.6 110.44 17.68 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.637 -0.505 . . . . 73.340000000000003 109.637 174.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.93 0.395 . . . . 70.340000000000003 111.664 -173.395 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 118' ' ' ARG . 3.5 ppt_? . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 112.533 0.568 . . . . 73.349999999999994 112.533 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 68.4 t60 -165.67 149.69 8.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.732 -0.667 . . . . 64.310000000000002 109.471 170.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 7.8 p -142.38 137.18 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.288 0.566 . . . . 62.549999999999997 111.969 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.06 154.35 20.5 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.046 -0.597 . . . . 73.400000000000006 112.845 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 44' ' ' ILE . 47.4 mt -92.3 100.33 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 73.319999999999993 110.572 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.443 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 37.4 t80 -71.15 117.68 12.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.141 -0.481 . . . . 74.239999999999995 111.15 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.9 pt -99.08 -30.24 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.16 0.43 . . . . 73.510000000000005 112.16 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.27 163.31 9.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.159 -0.543 . . . . 61.210000000000001 113.202 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 56.76 39.86 29.41 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.674 0.39 . . . . 72.239999999999995 111.909 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.618 ' N ' HD21 ' A' ' 127' ' ' ASN . 0.7 OUTLIER 67.92 4.69 4.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.808 0.443 . . . . 75.400000000000006 111.846 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 141' ' ' SER . 25.8 mt-30 -97.4 140.48 31.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.385 0.612 . . . . 73.450000000000003 112.158 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.443 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.5 p90 -146.54 137.58 24.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.739 . . . . 71.310000000000002 111.215 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.08 126.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.058 0.456 . . . . 71.239999999999995 110.765 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -155.32 150.14 26.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.925 0.393 . . . . 75.040000000000006 111.813 -174.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.81 91.42 4.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.176 0.512 . . . . 74.519999999999996 110.183 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.4 p -78.23 143.94 36.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.815 -0.629 . . . . 74.239999999999995 112.234 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.4 t -77.27 -4.97 47.59 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.383 0.611 . . . . 72.540000000000006 111.369 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -87.94 -35.68 17.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.067 -0.515 . . . . 72.420000000000002 111.729 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 m -138.42 -51.78 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.235 0.54 . . . . 75.239999999999995 111.808 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.86 -153.22 24.52 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.642 -0.708 . . . . 52.43 111.708 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.23 96.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 117.411 0.605 . . . . 72.409999999999997 111.114 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.28 168.47 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.302 -0.408 . . . . 74.329999999999998 111.744 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.12 109.41 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.25 -0.432 . . . . 75.219999999999999 110.666 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 128' ' ' GLN . 48.5 m -107.21 173.81 6.16 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.065 0.395 . . . . 73.099999999999994 112.065 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 29.1 t -119.95 141.16 49.89 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.688 0.625 . . . . 75.299999999999997 112.688 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.5 mtt -76.62 -0.55 23.79 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.859 0.689 . . . . 74.439999999999998 112.859 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -84.95 -10.94 56.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.065 0.459 . . . . 62.210000000000001 110.829 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -76.47 132.91 71.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 110.799 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 72.7 Cg_exo -48.11 -49.4 14.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.224 2.616 . . . . 64.329999999999998 114.554 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 91.9 t80 -61.55 -48.05 82.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.941 0.4 . . . . 73.439999999999998 111.194 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -72.83 -34.94 67.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.782 0.325 . . . . 75.319999999999993 111.665 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.69 -47.58 84.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.898 0.38 . . . . 75.129999999999995 111.319 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 19.0 ptpt -73.24 -32.14 64.54 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.979 0.363 . . . . 75.140000000000001 111.979 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.62 ' HD3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mmp_? -76.82 -23.41 52.77 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.008 -0.433 . . . . 75.019999999999996 111.443 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.464 ' HH ' HD23 ' A' ' 103' ' ' LEU . 25.0 t80 -61.18 108.27 0.88 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.051 0.453 . . . . 73.310000000000002 111.841 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -91.35 -69.1 0.75 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.305 0.574 . . . . 75.230000000000004 111.171 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.49 153.14 38.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.977 -0.556 . . . . 71.310000000000002 110.782 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.487 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -115.48 149.83 37.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.75 -0.204 . . . . 61.210000000000001 110.539 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mtt180 -137.6 122.99 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.365 0.603 . . . . 74.129999999999995 112.437 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -87.91 108.64 19.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.798 -0.637 . . . . 74.430000000000007 110.67 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.0 m -99.31 0.76 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.686 -0.688 . . . . 72.530000000000001 112.546 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.481 HD22 HD23 ' A' ' 82' ' ' LEU . 80.0 mt . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 121.106 0.479 . . . . 75.430000000000007 112.21 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.543 ' HB2' ' HG ' ' A' ' 42' ' ' SER . 14.1 m-20 . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 120.516 0.198 . . . . 74.230000000000004 111.523 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 44' ' ' ILE . 94.1 t -48.74 -41.35 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.486 0.66 . . . . 74.230000000000004 110.322 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 45' ' ' MET . 88.2 tttt -56.48 -45.36 80.97 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.257 -0.883 . . . . 74.120000000000005 112.132 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.543 ' HG ' ' HB2' ' A' ' 39' ' ' ASP . 82.9 p -65.02 -37.78 88.73 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 122.228 -0.295 . . . . 73.109999999999999 111.536 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -70.9 -38.03 73.01 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 75.349999999999994 111.175 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 40' ' ' VAL . 86.2 mt -62.52 -46.08 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.127 0.489 . . . . 75.120000000000005 110.805 174.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 95.8 mmm -67.7 -29.74 69.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.347 -0.388 . . . . 74.239999999999995 111.282 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.46 -44.81 89.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.052 0.453 . . . . 73.319999999999993 110.196 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -65.3 -46.93 78.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.528 -0.76 . . . . 73.420000000000002 111.229 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -53.63 -39.22 64.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 112.136 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.22 68.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.861 0.362 . . . . 71.109999999999999 111.849 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -79.21 -33.79 43.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.248 0.547 . . . . 74.450000000000003 111.081 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.514 ' HZ2' ' NH1' ' A' ' 74' ' ' ARG . 84.9 m95 -99.13 22.75 9.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.438 0.533 . . . . 74.219999999999999 112.438 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.07 120.3 11.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.064 0.459 . . . . 73.409999999999997 112.032 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.03 20.43 75.85 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 114.472 0.549 . . . . 61.310000000000002 114.472 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.3 t -83.6 131.2 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 117.595 0.698 . . . . 74.450000000000003 111.003 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.31 163.46 26.44 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.298 0.571 . . . . 73.120000000000005 112.509 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.411 ' CG ' ' HA ' ' A' ' 134' ' ' THR . 49.9 t80 -89.52 141.59 28.44 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.514 0.673 . . . . 75.329999999999998 112.437 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.618 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 57.2 ttt180 -129.58 131.28 46.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.573 -0.739 . . . . 74.109999999999999 110.462 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.7 mp -76.22 93.54 3.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.969 0.414 . . . . 75.230000000000004 111.374 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 71.71 1.29 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.28 -0.486 . . . . 71.349999999999994 113.285 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' HA3' ' CZ ' ' A' ' 57' ' ' ARG . . . 172.92 139.83 2.97 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.893 -0.67 . . . . 53.329999999999998 113.186 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.558 ' HB2' ' HD2' ' A' ' 74' ' ' ARG . 84.7 p -110.65 101.17 9.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.601 0.593 . . . . 70.209999999999994 112.601 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -153.22 151.78 30.46 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.12 -0.491 . . . . 73.439999999999998 111.137 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.464 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 32.3 ttmt -70.34 -5.56 28.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.05 0.453 . . . . 74.239999999999995 111.827 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -106.29 15.22 26.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.975 0.417 . . . . 74.200000000000003 111.265 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.75 108.11 0.27 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 112.164 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.493 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -138.48 151.76 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 117.342 0.571 . . . . 71.310000000000002 111.894 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.618 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 6.2 p-10 -95.11 -179.13 4.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.185 0.517 . . . . 71.010000000000005 112.238 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.29 -55.76 22.05 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.003 -0.544 . . . . 51.119999999999997 111.954 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.4 ' HA ' HG13 ' A' ' 72' ' ' VAL . 81.5 p -66.21 -29.17 69.38 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.826 0.346 . . . . 73.219999999999999 110.864 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.642 ' HA2' HE21 ' A' ' 73' ' ' GLN . . . -66.1 -44.63 90.9 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.094 -0.503 . . . . 72.099999999999994 112.801 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.07 -51.83 66.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.0 0.428 . . . . 75.409999999999997 111.268 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.434 ' HA ' HD13 ' A' ' 122' ' ' ILE . 7.0 p -62.47 -44.46 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 112.173 0.434 . . . . 54.149999999999999 112.173 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.642 HE21 ' HA2' ' A' ' 70' ' ' GLY . 21.3 pt20 -59.57 -49.98 75.67 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.94 -0.475 . . . . 72.450000000000003 111.443 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.558 ' HD2' ' HB2' ' A' ' 61' ' ' SER . 10.0 mtp-105 -60.13 -41.61 93.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.991 0.424 . . . . 74.319999999999993 111.135 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.4 m -54.53 -52.23 62.68 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.103 -0.499 . . . . 74.129999999999995 111.489 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.6 m-85 -72.27 -37.83 68.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.502 0.556 . . . . 75.239999999999995 112.502 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.469 ' HG3' ' HA ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.77 -20.02 58.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.473 0.546 . . . . 71.439999999999998 112.473 -177.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -97.1 -49.93 4.8 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.166 -0.334 . . . . 73.019999999999996 111.509 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -71.55 -44.93 63.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.112 0.412 . . . . 63.329999999999998 112.112 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.11 -12.75 14.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.677 0.621 . . . . 73.519999999999996 112.677 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 32.32 62.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.127 -0.559 . . . . 62.130000000000003 113.33 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 57.9 tp -92.81 127.21 38.24 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.617 -0.343 . . . . 72.420000000000002 111.596 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.23 79.97 2.35 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.906 0.706 . . . . 73.510000000000005 112.906 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.411 HD23 HG23 ' A' ' 158' ' ' VAL . 64.3 mt -95.82 142.56 24.75 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 121.913 -0.492 . . . . 74.239999999999995 111.777 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.657 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 87.9 Cg_endo -82.1 -174.07 1.98 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.174 2.583 . . . . 63.130000000000003 113.391 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.491 ' HD2' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -105.6 20.64 18.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.44 0.904 . . . . 75.450000000000003 113.44 -169.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.1 m -141.29 132.65 26.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.938 0.399 . . . . 73.030000000000001 111.535 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 34.8 m -51.74 -43.87 63.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.239 -0.437 . . . . 71.129999999999995 111.929 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -58.43 -17.04 17.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.43 0.53 . . . . 74.230000000000004 112.43 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 94' ' ' MET . 35.5 mt-10 -92.35 -53.22 4.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.102 0.477 . . . . 70.120000000000005 110.484 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.612 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 80.6 mt-30 -54.6 -45.97 73.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.964 -0.562 . . . . 73.109999999999999 112.341 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 88' ' ' THR . 18.4 pt20 -53.59 -33.91 56.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.49 0.552 . . . . 61.520000000000003 112.49 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.38 10.9 29.49 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.047 0.758 . . . . 73.420000000000002 113.047 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.657 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 77.6 mtp -79.38 -29.95 42.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.043 0.449 . . . . 75.329999999999998 111.018 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.74 -133.27 6.84 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.37 -0.443 . . . . 74.400000000000006 112.674 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -127.19 174.03 9.25 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.549 -0.383 . . . . 74.420000000000002 111.547 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.6 p -106.81 161.53 14.6 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 112.221 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.402 HG21 ' CB ' ' A' ' 155' ' ' ALA . 0.0 OUTLIER -148.2 160.13 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.604 -0.725 . . . . 73.310000000000002 111.662 177.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 t -95.92 173.22 7.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.976 -0.556 . . . . 74.25 111.441 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -51.19 -33.08 25.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.413 0.894 . . . . 75.209999999999994 113.413 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.8 m -82.71 -22.43 34.48 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.811 0.671 . . . . 70.25 112.811 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -96.53 14.71 23.76 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.349 0.5 . . . . 74.299999999999997 112.349 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.37 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.96 0.355 . . . . 73.219999999999999 111.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -124.68 -174.63 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.152 0.501 . . . . 75.129999999999995 111.014 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.3 m -76.19 107.22 8.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.255 -0.43 . . . . 74.349999999999994 111.173 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.78 -19.64 6.54 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.253 -0.499 . . . . 70.540000000000006 112.885 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.3 134.43 51.56 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.396 0.617 . . . . 64.239999999999995 111.693 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.0 mt -91.58 120.14 32.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.087 -0.506 . . . . 72.430000000000007 111.069 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.3 m -96.21 134.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.899 0.38 . . . . 73.430000000000007 111.564 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.34 125.9 51.57 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.921 0.391 . . . . 71.420000000000002 111.964 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB3' ' HB3' ' A' ' 151' ' ' ARG . 90.6 m-85 -114.95 136.76 52.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.292 -0.413 . . . . 74.420000000000002 111.019 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.557 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 57.4 mtp180 -79.02 77.82 5.48 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.227 0.537 . . . . 73.340000000000003 110.903 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 CA-C-N 116.051 -0.522 . . . . 72.329999999999998 112.173 -173.454 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.072 0.463 . . . . 73.219999999999999 110.31 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -84.04 118.9 24.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 110.683 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 10.9 p -105.07 136.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.287 0.565 . . . . 74.299999999999997 112.408 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.18 148.02 19.19 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.995 -0.548 . . . . 75.310000000000002 112.689 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 72' ' ' VAL . 37.1 mt -87.68 110.22 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.492 -0.416 . . . . 72.349999999999994 111.029 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.491 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 20.8 t80 -68.13 109.39 3.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.767 0.317 . . . . 75.129999999999995 111.173 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.11 -32.48 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.072 0.397 . . . . 75.340000000000003 112.072 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 149.25 132.94 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.705 -0.76 . . . . 73.230000000000004 113.757 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 t30 55.34 78.33 0.19 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.746 0.647 . . . . 74.540000000000006 112.746 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 70.2 -41.04 0.48 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.777 1.029 . . . . 72.510000000000005 113.777 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -81.03 146.15 30.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.612 0.72 . . . . 74.120000000000005 112.64 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.491 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.85 154.65 35.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.349 -0.841 . . . . 73.129999999999995 111.153 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 139.49 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.888 0.375 . . . . 74.040000000000006 111.3 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -160.53 177.04 10.93 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.019 0.437 . . . . 72.209999999999994 111.733 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.93 103.47 10.64 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 111.393 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 70.8 m -81.38 149.38 28.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.871 0.367 . . . . 73.310000000000002 111.439 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 56' ' ' TYR . 71.3 p -56.05 -43.77 78.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.98 0.733 . . . . 74.439999999999998 112.98 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.4 m -100.18 -42.07 6.85 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.13 0.418 . . . . 71.409999999999997 112.13 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 55.0 m -76.63 -25.71 54.14 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.825 0.676 . . . . 52.409999999999997 112.825 -176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.68 32.8 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.024 -0.608 . . . . 72.099999999999994 112.841 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.47 102.57 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.967 0.413 . . . . 75.450000000000003 111.666 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.1 pt -135.99 179.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.582 0.706 . . . . 70.319999999999993 112.541 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.66 135.81 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.507 -0.769 . . . . 65.420000000000002 110.785 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -132.12 176.1 8.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.441 0.163 . . . . 73.409999999999997 110.903 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.2 t -137.31 145.37 43.36 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.786 0.662 . . . . 74.230000000000004 112.786 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.49 -20.3 66.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.924 0.712 . . . . 71.340000000000003 112.924 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -75.82 -18.67 59.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.717 0.294 . . . . 71.329999999999998 111.694 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.47 130.66 91.98 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 116.668 -0.242 . . . . 75.140000000000001 111.061 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.86 -46.6 26.92 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.338 2.692 . . . . 71.409999999999997 113.838 -173.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -61.14 -46.31 91.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.709 0.29 . . . . 74.5 111.659 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -73.71 -39.74 64.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.904 0.383 . . . . 74.310000000000002 111.029 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.74 -44.83 70.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 75.209999999999994 111.629 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -78.63 -32.34 47.33 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.8 0.296 . . . . 74.319999999999993 111.8 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 20.0 mmt180 -70.11 -18.89 63.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.89 0.33 . . . . 71.010000000000005 111.89 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.15 111.57 0.99 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.33 0.586 . . . . 73.430000000000007 111.972 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.557 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -89.17 -57.0 3.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 70.230000000000004 110.08 177.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -171.87 176.75 3.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 74.099999999999994 110.523 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.402 ' CB ' HG21 ' A' ' 98' ' ' VAL . . . -125.67 153.93 43.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.234 0.54 . . . . 72.019999999999996 111.729 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -140.88 167.01 23.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.947 -0.569 . . . . 74.420000000000002 110.141 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.8 136.06 13.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.127 0.489 . . . . 74.439999999999998 111.287 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.411 HG23 HD23 ' A' ' 84' ' ' LEU . 13.4 m -104.15 3.85 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.785 -0.643 . . . . 72.120000000000005 112.314 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.911 0.386 . . . . 75.430000000000007 111.629 179.083 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 120.707 0.289 . . . . 71.409999999999997 110.859 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.9 t -55.14 -62.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.307 -0.406 . . . . 74.0 111.818 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.562 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 86.7 tttt -53.58 -45.86 70.11 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 74.239999999999995 111.66 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.1 m -63.78 -39.29 93.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.058 -0.519 . . . . 74.049999999999997 112.204 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -35.53 75.3 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.814 0.301 . . . . 71.319999999999993 111.814 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 40' ' ' VAL . 63.8 mt -64.61 -44.2 96.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.053 0.454 . . . . 73.150000000000006 110.567 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.562 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 26.9 mmt -64.24 -35.7 81.66 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.028 0.442 . . . . 73.200000000000003 110.892 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.72 -36.85 74.94 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.959 -0.564 . . . . 75.049999999999997 111.184 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.439 ' NE2' ' HE1' ' A' ' 51' ' ' TRP . 7.7 tp60 -76.04 -44.31 39.76 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.293 0.568 . . . . 74.439999999999998 111.216 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -55.37 -40.63 71.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 111.627 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.54 -21.57 65.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.032 0.382 . . . . 74.230000000000004 112.032 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -84.52 -42.75 15.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.061 0.457 . . . . 73.239999999999995 111.579 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.439 ' HE1' ' NE2' ' A' ' 47' ' ' GLN . 64.9 m95 -82.45 -50.42 8.88 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.43 -0.35 . . . . 64.319999999999993 111.708 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HB3' ' HE3' ' A' ' 52' ' ' LYS . 21.2 mmmt 46.46 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.446 1.276 . . . . 75.439999999999998 114.446 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.11 38.36 96.0 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.301 0.88 . . . . 72.340000000000003 115.301 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.62 131.33 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.635 0.717 . . . . 72.450000000000003 110.291 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.34 155.4 28.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.935 0.717 . . . . 75.030000000000001 112.935 -174.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -67.83 119.94 13.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.705 -0.68 . . . . 74.430000000000007 111.837 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 57' ' ' ARG . 20.6 ttm-85 -137.08 123.75 21.08 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.463 0.305 . . . . 74.450000000000003 110.721 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.3 mp -69.97 113.94 7.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.079 0.466 . . . . 74.319999999999993 112.162 -175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.26 -56.23 5.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 114.137 0.415 . . . . 51.409999999999997 114.137 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.7 82.34 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.224 -0.513 . . . . 72.310000000000002 113.226 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.483 ' OG ' ' HD2' ' A' ' 74' ' ' ARG . 83.8 p -76.61 110.58 11.3 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.096 0.474 . . . . 73.549999999999997 111.841 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -167.47 173.51 8.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.04 0.448 . . . . 73.519999999999996 111.524 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -69.41 -7.0 33.72 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.112 0.482 . . . . 71.310000000000002 111.42 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -93.42 8.23 41.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.113 0.482 . . . . 71.230000000000004 110.934 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.1 144.1 4.23 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.175 -0.466 . . . . 63.109999999999999 112.687 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 tt -163.52 135.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.582 -0.364 . . . . 75.420000000000002 110.844 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -85.42 177.03 7.92 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.351 0.596 . . . . 75.120000000000005 112.406 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.52 ' SG ' HG12 ' A' ' 120' ' ' VAL . 27.5 t -52.6 -57.24 10.64 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.694 -0.685 . . . . 71.310000000000002 111.933 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -65.53 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.161 0.505 . . . . 74.409999999999997 110.954 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.776 ' HA2' HE21 ' A' ' 73' ' ' GLN . . . -61.16 -45.78 95.84 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.946 -0.57 . . . . 65.230000000000004 113.107 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.34 -48.92 73.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.521 -0.4 . . . . 75.239999999999995 111.743 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.532 ' HA ' HD13 ' A' ' 122' ' ' ILE . 7.3 p -60.34 -50.48 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.11 0.411 . . . . 64.5 112.11 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.776 HE21 ' HA2' ' A' ' 70' ' ' GLY . 28.4 pt20 -57.98 -40.95 81.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.093 0.473 . . . . 73.420000000000002 111.269 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.623 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.9 mtp180 -71.75 -48.63 45.57 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.725 -0.39 . . . . 73.230000000000004 111.868 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.9 m -46.35 -46.3 18.21 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.039 0.447 . . . . 64.209999999999994 111.611 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.621 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 55.0 m-85 -67.81 -44.32 77.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.655 0.613 . . . . 75.010000000000005 112.655 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.623 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 1.2 ptm180 -73.53 -43.19 60.56 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.757 -0.589 . . . . 75.530000000000001 112.284 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 58.2 mm-40 -60.79 -37.73 82.92 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.922 0.392 . . . . 72.510000000000005 111.06 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -94.9 -69.34 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.196 0.443 . . . . 73.030000000000001 112.196 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -81.14 -22.06 39.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.792 0.664 . . . . 74.329999999999998 112.792 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.51 40.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.908 -0.663 . . . . 72.209999999999994 112.407 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.621 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.3 tp -103.24 117.35 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.698 -0.295 . . . . 74.540000000000006 110.864 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 129.59 39.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.184 0.438 . . . . 73.239999999999995 112.184 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.3 mt -121.58 159.93 48.47 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.232 -0.44 . . . . 75.430000000000007 110.73 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.16 160.87 48.15 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.639 2.226 . . . . 73.109999999999999 113.581 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 86' ' ' ARG . 61.8 mtt-85 -88.44 24.86 1.81 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.402 0.89 . . . . 73.340000000000003 113.402 -169.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -154.91 142.9 20.12 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.838 -0.539 . . . . 75.420000000000002 112.183 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 118' ' ' ARG . 37.9 p -51.96 -50.05 62.01 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.127 -0.488 . . . . 70.099999999999994 111.598 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -53.27 -37.63 62.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.578 -0.737 . . . . 72.239999999999995 111.359 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.7 -44.56 63.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 65.340000000000003 110.756 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.02 -20.98 66.36 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.03 -0.532 . . . . 75.5 112.028 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.4 mt-30 -56.46 -28.04 58.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.963 0.411 . . . . 74.340000000000003 111.477 174.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -89.95 -19.46 24.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.216 -0.447 . . . . 75.340000000000003 111.737 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.2 mmm -76.1 140.36 41.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.956 0.408 . . . . 73.409999999999997 111.847 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.77 -166.87 46.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.173 -0.537 . . . . 43.340000000000003 113.454 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -110.34 148.1 32.62 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.296 0.569 . . . . 63.450000000000003 111.865 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.7 p -79.5 133.55 36.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.409 -0.814 . . . . 71.099999999999994 112.11 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.565 HG13 ' CZ ' ' A' ' 157' ' ' ARG . 3.8 m -146.07 167.31 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.93 0.715 . . . . 74.099999999999994 112.93 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.2 t -116.83 -171.43 2.02 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.374 -0.83 . . . . 74.129999999999995 110.985 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 -49.91 -56.47 10.41 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.058 0.762 . . . . 73.129999999999995 113.058 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 m -65.79 -11.72 48.36 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.734 0.642 . . . . 74.510000000000005 112.734 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.547 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.6 m120 -106.7 -4.31 19.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.073 0.398 . . . . 72.329999999999998 112.073 -174.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.484 HD21 ' HH ' ' A' ' 152' ' ' TYR . 86.0 mt -62.88 147.38 50.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.985 0.735 . . . . 75.319999999999993 112.985 -176.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -118.12 -159.01 0.73 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.654 -0.703 . . . . 73.510000000000005 109.297 173.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.8 m -102.01 102.75 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.03 -0.419 . . . . 74.200000000000003 110.662 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.06 6.94 5.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.214 -0.517 . . . . 38.460000000000001 113.649 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.12 134.69 44.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.261 0.553 . . . . 64.239999999999995 112.086 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.432 HD23 HG22 ' A' ' 72' ' ' VAL . 37.9 mt -79.59 110.7 15.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.913 -0.585 . . . . 61.520000000000003 110.044 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.44 118.91 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.261 0.553 . . . . 73.019999999999996 111.744 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.4 mt -90.28 123.83 34.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.743 -0.662 . . . . 75.329999999999998 111.593 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.66 140.99 45.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.182 0.515 . . . . 64.219999999999999 111.483 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.583 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 77.1 mtp180 -92.44 97.89 11.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.906 -0.588 . . . . 75.209999999999994 111.031 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.18 0.514 . . . . 72.099999999999994 111.391 -176.194 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.459 ' O ' HG23 ' A' ' 88' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.671 0.272 . . . . 72.400000000000006 110.632 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -115.5 149.89 37.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.245 -0.434 . . . . 74.109999999999999 110.556 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.52 HG12 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -134.84 146.17 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.203 0.525 . . . . 72.140000000000001 112.389 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.4 155.99 22.18 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.333 -0.46 . . . . 74.109999999999999 112.676 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 72' ' ' VAL . 47.8 mt -90.87 103.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.423 -0.457 . . . . 72.409999999999997 111.16 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t80 -69.47 101.11 1.51 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.241 0.543 . . . . 71.120000000000005 111.405 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.562 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.6 pt -82.15 -21.87 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.93 -0.577 . . . . 72.349999999999994 111.711 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.69 170.9 13.11 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 116.281 -0.418 . . . . 54.409999999999997 112.641 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 60.84 27.43 17.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.626 0.37 . . . . 74.019999999999996 111.675 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 63.81 23.66 13.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.418 0.287 . . . . 73.099999999999994 111.441 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -114.99 150.05 36.42 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.247 0.546 . . . . 71.420000000000002 111.55 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 13.5 p90 -156.54 148.68 23.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.88 -0.6 . . . . 75.329999999999998 111.992 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.33 141.09 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.793 -0.639 . . . . 75.510000000000005 110.952 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -158.96 162.1 36.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.94 0.4 . . . . 75.409999999999997 111.517 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -101.76 93.75 5.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.191 0.519 . . . . 73.109999999999999 110.892 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 41.1 t -76.78 166.07 23.86 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.169 0.509 . . . . 75.239999999999995 111.692 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.7 p -66.4 -66.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.082 0.467 . . . . 72.409999999999997 112.067 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 83.5 p -89.63 8.66 30.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.293 0.479 . . . . 71.099999999999994 112.293 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.617 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 48.5 m -125.84 -29.26 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.736 0.643 . . . . 73.209999999999994 112.736 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.86 -154.56 43.54 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.984 -0.627 . . . . 71.400000000000006 112.986 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.39 95.77 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.167 0.432 . . . . 74.140000000000001 112.167 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.23 -178.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.098 0.475 . . . . 73.430000000000007 112.263 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.51 139.44 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 72.109999999999999 111.255 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.8 p -143.87 163.94 31.97 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.748 0.308 . . . . 52.409999999999997 110.822 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.5 m -113.73 143.87 43.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.907 0.706 . . . . 75.219999999999999 112.907 -174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 91.4 mmm -58.86 -30.42 67.71 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.906 -0.588 . . . . 74.219999999999999 111.266 174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -68.71 -19.62 64.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 112.164 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -64.98 113.65 11.87 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 117.027 -0.079 . . . . 74.519999999999996 110.952 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -43.71 -38.54 9.49 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.248 2.632 . . . . 72.329999999999998 113.818 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.619 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 71.7 t80 -57.62 -50.49 72.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.764 0.316 . . . . 72.450000000000003 111.629 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -82.53 -36.31 26.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.015 0.436 . . . . 72.200000000000003 111.455 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.5 -36.97 64.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.862 -0.608 . . . . 73.400000000000006 111.983 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -83.6 -15.21 49.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.886 0.328 . . . . 75.319999999999993 111.886 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 20.6 mmt180 -89.74 -17.15 28.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.993 0.368 . . . . 75.319999999999993 111.993 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.484 ' HH ' HD21 ' A' ' 103' ' ' LEU . 68.3 t80 -59.26 116.49 3.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.538 . . . . 73.510000000000005 112.454 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -92.57 -60.8 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.977 -0.556 . . . . 71.510000000000005 110.889 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -173.34 170.73 4.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.38 0.272 . . . . 74.040000000000006 110.503 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.485 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -119.98 169.41 10.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.267 0.84 . . . . 53.109999999999999 113.267 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -137.75 113.51 9.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.538 -0.755 . . . . 71.140000000000001 111.838 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.565 ' CZ ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.72 105.98 9.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.934 0.397 . . . . 75.040000000000006 110.55 171.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.44 -0.69 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.738 0.644 . . . . 73.430000000000007 112.738 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.411 HD23 HD23 ' A' ' 82' ' ' LEU . 81.9 mt . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.917 0.389 . . . . 71.019999999999996 111.913 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.599 ' HB2' ' HG ' ' A' ' 42' ' ' SER . 10.2 m-20 . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.72 0.295 . . . . 74.200000000000003 111.438 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.1 t -46.53 -49.76 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.22 0.533 . . . . 74.420000000000002 111.118 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 82.9 tttt -54.78 -48.29 72.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.655 -0.702 . . . . 74.420000000000002 112.33 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.599 ' HG ' ' HB2' ' A' ' 39' ' ' ASP . 24.2 p -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.935 0.398 . . . . 73.310000000000002 111.766 -174.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.31 -36.89 85.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.473 -0.33 . . . . 72.200000000000003 111.592 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.3 mt -63.07 -36.64 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.959 0.409 . . . . 74.209999999999994 110.641 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.535 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 28.8 mmt -70.2 -36.5 74.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.454 -0.339 . . . . 74.530000000000001 111.316 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.78 -42.54 99.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.214 0.531 . . . . 73.299999999999997 110.526 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.615 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 56.8 tp60 -64.03 -48.01 77.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.013 -0.54 . . . . 74.299999999999997 110.515 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -53.59 -39.56 64.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.797 -0.638 . . . . 73.409999999999997 111.499 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . . . -54.99 -34.42 63.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.018 0.437 . . . . 62.009999999999998 111.843 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.17 -24.46 51.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.088 0.471 . . . . 73.099999999999994 111.459 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -114.84 18.32 16.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.783 0.66 . . . . 75.349999999999994 112.783 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.627 ' HB2' ' HZ2' ' A' ' 52' ' ' LYS . 10.2 mtmp? -59.09 109.08 0.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.144 0.497 . . . . 75.109999999999999 112.245 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.03 4.53 68.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 114.793 0.677 . . . . 61.030000000000001 114.793 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.49 127.68 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.839 0.82 . . . . 72.329999999999998 110.806 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 157.51 38.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.97 0.73 . . . . 72.120000000000005 112.97 -176.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -77.2 126.03 30.28 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.347 -0.842 . . . . 74.329999999999998 111.775 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -138.04 110.37 7.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.476 -0.329 . . . . 74.150000000000006 111.68 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.32 121.25 15.88 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.984 0.421 . . . . 74.120000000000005 111.894 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.79 69.34 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.098 -0.572 . . . . 42.420000000000002 113.9 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -138.5 137.86 9.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.33 -0.462 . . . . 63.140000000000001 112.365 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.7 m -125.86 99.49 5.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.001 0.401 . . . . 73.540000000000006 111.541 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.0 t -177.28 177.69 1.18 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.251 -0.432 . . . . 75.239999999999995 111.115 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -71.17 -11.49 60.97 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.082 0.468 . . . . 74.209999999999994 110.87 178.32 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -74.81 -11.83 60.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.213 0.53 . . . . 74.200000000000003 110.703 170.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.23 148.11 4.76 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.119 -0.491 . . . . 64.129999999999995 112.75 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 19.8 tt -154.98 144.81 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.861 0.331 . . . . 74.349999999999994 111.436 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.16 179.91 4.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.201 0.524 . . . . 54.409999999999997 112.349 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.7 t -58.82 -61.25 2.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.416 0.525 . . . . 74.439999999999998 112.416 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -59.01 -36.86 75.67 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.974 0.416 . . . . 75.319999999999993 111.533 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.91 95.06 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 121.057 -0.592 . . . . 74.549999999999997 113.219 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.26 -54.73 28.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.895 0.332 . . . . 73.420000000000002 111.895 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.445 HG22 HD21 ' A' ' 108' ' ' LEU . 7.4 p -57.0 -41.91 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.956 0.408 . . . . 73.299999999999997 111.216 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -50.85 -62.67 1.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.312 0.577 . . . . 71.319999999999993 111.315 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HA ' ' CG ' ' A' ' 77' ' ' ARG . 10.3 mtp180 -63.66 -34.91 78.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.888 -0.596 . . . . 74.299999999999997 112.457 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.615 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 95.7 m -55.93 -54.58 42.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.083 0.468 . . . . 64.299999999999997 111.555 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.1 m-85 -65.84 -37.81 87.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.829 0.677 . . . . 74.120000000000005 112.829 -177.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.431 ' HA ' ' H ' ' A' ' 82' ' ' LEU . 3.0 ptm180 -75.15 -43.46 52.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.773 -0.579 . . . . 72.340000000000003 112.265 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.41 -18.49 64.45 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 122.098 -0.376 . . . . 74.299999999999997 111.756 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -108.39 -68.22 0.92 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.121 0.415 . . . . 75.109999999999999 112.121 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.63 0.45 57.38 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.579 0.585 . . . . 71.5 112.579 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.64 44.27 98.03 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 61.039999999999999 113.095 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.3 tp -104.68 122.39 45.57 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.087 0.47 . . . . 72.310000000000002 111.785 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.71 96.93 2.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 112.037 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.52 135.69 21.06 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.153 -0.476 . . . . 72.200000000000003 110.513 173.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.03 -175.62 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.463 2.109 . . . . 74.340000000000003 112.301 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -109.25 6.21 24.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.855 -0.528 . . . . 73.209999999999994 111.663 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.7 m -108.71 128.05 54.52 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.447 -0.342 . . . . 64.209999999999994 110.619 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.8 m -56.76 -46.52 81.37 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.383 0.512 . . . . 52.450000000000003 112.383 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.567 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 33.3 m-85 -59.69 -36.46 76.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 111.872 0.323 . . . . 74.409999999999997 111.872 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.63 -36.02 60.32 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.974 0.416 . . . . 53.329999999999998 111.471 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.21 -43.87 93.68 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.91 0.386 . . . . 72.239999999999995 111.499 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 17.0 pt20 -62.88 -26.87 68.99 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.965 0.412 . . . . 75.209999999999994 111.392 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -86.19 -10.08 55.37 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.23 0.455 . . . . 73.239999999999995 112.23 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.5 mmm -66.39 -37.51 85.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.162 0.506 . . . . 74.219999999999999 110.86 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.35 166.56 12.2 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 116.0 -0.546 . . . . 65.109999999999999 112.11 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -86.96 160.34 18.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.36 -0.494 . . . . 73.200000000000003 111.221 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.531 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 36.5 t -78.62 135.02 37.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.602 0.593 . . . . 74.0 112.602 -174.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 155' ' ' ALA . 15.5 m -127.89 142.99 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 74.120000000000005 110.633 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.6 t -88.66 177.12 6.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.99 0.424 . . . . 74.230000000000004 111.26 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -49.68 -29.19 6.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.153 0.581 . . . . 71.400000000000006 112.142 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m -84.4 -21.14 30.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.884 0.698 . . . . 72.409999999999997 112.884 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.0 m120 -108.16 11.35 27.57 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.002 0.741 . . . . 72.120000000000005 113.002 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.454 HD21 ' HH ' ' A' ' 152' ' ' TYR . 96.5 mt -57.0 151.84 14.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.911 0.708 . . . . 73.230000000000004 112.911 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -140.35 143.78 35.94 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.096 -0.502 . . . . 74.209999999999994 111.18 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.9 m -58.47 96.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.833 0.349 . . . . 72.209999999999994 110.948 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 123.62 14.17 3.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.171 -0.538 . . . . 71.439999999999998 113.818 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.24 167.87 13.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.94 0.87 . . . . 72.040000000000006 111.123 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.445 HD21 HG22 ' A' ' 72' ' ' VAL . 47.1 mt -102.85 113.87 27.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.097 -0.501 . . . . 74.530000000000001 110.549 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -94.92 122.66 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.401 0.62 . . . . 74.219999999999999 111.43 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 92' ' ' GLN . 67.0 mt -100.4 124.48 45.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.579 -0.737 . . . . 74.239999999999995 111.785 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -116.02 138.41 51.24 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.205 -0.452 . . . . 74.349999999999994 110.982 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -74.22 94.64 2.5 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.899 0.381 . . . . 73.310000000000002 110.715 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 120.759 0.314 . . . . 74.519999999999996 111.627 -178.463 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 121.002 0.43 . . . . 74.400000000000006 110.218 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -91.17 126.9 36.4 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.196 -0.456 . . . . 70.129999999999995 110.459 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -111.6 132.03 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.529 0.681 . . . . 74.329999999999998 112.288 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -124.45 160.69 19.03 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.58 -0.736 . . . . 74.540000000000006 112.074 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.3 mt -97.04 112.8 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.091 0.446 . . . . 73.420000000000002 111.019 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.461 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 51.7 t80 -75.83 113.71 13.62 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.107 0.48 . . . . 75.349999999999994 111.904 -175.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.405 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.2 pt -99.06 -7.95 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.155 0.428 . . . . 72.030000000000001 112.155 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.68 164.37 13.21 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.111 -0.566 . . . . 74.140000000000001 113.348 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 58.61 31.08 20.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.762 0.425 . . . . 73.310000000000002 112.021 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.461 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 80.1 m-20 67.19 13.16 9.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.987 -0.551 . . . . 62.119999999999997 112.367 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -101.32 144.62 29.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.318 0.58 . . . . 65.450000000000003 111.493 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -152.91 146.38 24.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.77 -0.65 . . . . 74.129999999999995 111.584 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.69 138.76 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.729 0.299 . . . . 71.109999999999999 111.008 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -158.78 175.04 14.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.976 0.417 . . . . 75.120000000000005 111.631 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.21 103.44 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.195 -0.457 . . . . 62.210000000000001 111.045 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 36.9 t -89.17 162.5 15.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.789 0.328 . . . . 72.209999999999994 111.421 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -55.12 -61.55 2.24 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.034 0.753 . . . . 74.450000000000003 113.034 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m -93.69 -36.28 12.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.888 -0.508 . . . . 64.409999999999997 111.453 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.614 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 14.4 m -66.97 -29.62 69.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.242 -0.435 . . . . 73.140000000000001 112.118 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.69 34.75 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.97 -0.633 . . . . 63.100000000000001 112.565 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.46 102.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 117.127 0.464 . . . . 74.319999999999993 111.761 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.62 -179.01 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.13 0.49 . . . . 70.209999999999994 111.608 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.17 144.3 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.957 0.408 . . . . 73.129999999999995 110.72 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.7 m -137.08 169.41 17.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.199 -0.313 . . . . 73.200000000000003 111.396 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.2 m -130.52 139.89 50.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.911 0.386 . . . . 74.219999999999999 111.769 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.46 ' HB2' ' HB3' ' A' ' 127' ' ' ASN . 67.1 mtt -65.37 -9.63 26.5 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.439 0.533 . . . . 72.340000000000003 112.439 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.67 -4.89 45.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.949 0.404 . . . . 73.329999999999998 111.452 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 25.8 mm-40 -83.56 127.08 69.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.244 -0.434 . . . . 73.530000000000001 109.962 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.436 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 84.9 Cg_exo -46.75 -39.0 23.49 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.704 2.269 . . . . 63.340000000000003 113.691 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 73.6 t80 -60.22 -51.31 70.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.651 0.263 . . . . 74.519999999999996 111.623 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.401 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 86.6 m95 -73.26 -33.35 65.21 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.899 0.38 . . . . 74.540000000000006 111.431 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 143' ' ' MET . 37.9 ttpt -68.54 -39.85 80.96 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.07 0.396 . . . . 75.129999999999995 112.07 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 19.3 ptpt -79.56 -28.13 41.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.738 0.304 . . . . 74.310000000000002 111.812 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 9.6 mmm180 -91.13 -4.88 55.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 111.886 0.328 . . . . 75.150000000000006 111.886 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.454 ' HH ' HD21 ' A' ' 103' ' ' LEU . 28.3 t80 -59.07 111.59 1.38 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.006 0.431 . . . . 74.109999999999999 111.41 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -92.26 -50.65 5.55 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.251 -0.431 . . . . 75.209999999999994 111.844 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -177.57 -173.02 0.39 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.329 -0.396 . . . . 72.340000000000003 110.901 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.509 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -140.42 159.87 41.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.89 0.376 . . . . 63.32 111.366 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt85 -139.42 109.54 6.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.473 0.309 . . . . 75.219999999999999 111.432 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 108.05 17.81 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.617 0.722 . . . . 74.239999999999995 111.42 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.71 -27.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.856 -0.611 . . . . 70.319999999999993 112.437 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 111.919 0.34 . . . . 73.219999999999999 111.919 -179.217 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 120.972 0.415 . . . . 72.129999999999995 111.528 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 44' ' ' ILE . 83.5 t -50.69 -54.23 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.174 -0.466 . . . . 71.420000000000002 111.557 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.5 ' HB2' HG22 ' A' ' 105' ' ' THR . 87.2 tttt -53.9 -50.51 66.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.232 -0.44 . . . . 74.140000000000001 111.613 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 t -59.21 -44.35 92.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.425 -0.352 . . . . 51.109999999999999 111.879 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -63.68 -39.84 95.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.274 0.559 . . . . 75.230000000000004 111.303 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 40' ' ' VAL . 76.4 mt -61.37 -40.33 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.056 0.455 . . . . 74.109999999999999 110.6 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.532 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 30.3 mmt -63.54 -34.93 78.87 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.104 -0.498 . . . . 64.540000000000006 111.583 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.95 -45.4 86.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.912 0.387 . . . . 54.450000000000003 110.934 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.43 ' O ' ' HD1' ' A' ' 51' ' ' TRP . 15.7 mm100 -62.53 -52.37 63.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.974 0.416 . . . . 74.409999999999997 111.044 174.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -55.37 -38.42 68.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.106 0.409 . . . . 71.209999999999994 112.106 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.92 -30.92 71.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.471 . . . . 74.049999999999997 111.396 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.427 ' CG ' ' HZ2' ' A' ' 63' ' ' LYS . 32.8 t70 -76.28 -31.95 58.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.134 -0.485 . . . . 74.340000000000003 111.126 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.43 ' HD1' ' O ' ' A' ' 47' ' ' GLN . 77.7 m95 -99.77 16.55 23.25 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.596 0.591 . . . . 74.140000000000001 112.596 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.81 109.83 1.02 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.836 0.31 . . . . 73.430000000000007 111.836 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.15 15.31 54.22 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.916 -0.659 . . . . 72.129999999999995 114.146 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -78.56 132.88 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 117.318 0.559 . . . . 72.319999999999993 111.951 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -73.84 152.44 40.24 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.201 0.524 . . . . 74.510000000000005 111.907 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.426 ' CE1' ' HA ' ' A' ' 67' ' ' ASP . 72.4 t80 -83.7 148.18 27.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.034 0.445 . . . . 75.25 111.856 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.527 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 58.0 ttm-85 -137.69 148.73 45.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.039 -0.528 . . . . 72.239999999999995 110.611 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.02 93.59 8.42 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.973 -0.454 . . . . 74.319999999999993 110.701 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.37 61.32 1.25 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.216 -0.447 . . . . 53.100000000000001 113.361 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -176.37 150.82 10.83 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.16 -0.543 . . . . 73.510000000000005 112.685 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.534 ' HA ' HG13 ' A' ' 66' ' ' ILE . 80.7 p -128.0 99.93 5.69 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.554 0.575 . . . . 74.450000000000003 112.554 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 t -170.46 167.54 8.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.41 0.284 . . . . 74.040000000000006 111.439 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HZ2' ' CG ' ' A' ' 50' ' ' ASP . 1.4 mptm? -66.35 -22.82 66.27 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.015 0.435 . . . . 73.219999999999999 111.206 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -91.14 21.14 4.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.077 0.465 . . . . 72.310000000000002 111.364 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.503 ' HA3' ' HE ' ' A' ' 57' ' ' ARG . . . 142.88 112.76 0.9 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.223 -0.513 . . . . 64.230000000000004 113.199 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 20.5 tt -137.34 144.79 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 117.067 0.434 . . . . 72.409999999999997 111.558 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.527 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.0 p30 -97.89 174.13 6.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.451 0.644 . . . . 62.130000000000003 111.98 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.6 t -58.92 -44.53 91.34 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.925 0.713 . . . . 50.329999999999998 112.925 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.6 p -74.39 -39.05 62.94 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.738 0.304 . . . . 62.350000000000001 110.471 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.63 91.5 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.372 -0.442 . . . . 72.109999999999999 112.928 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.02 -53.23 41.15 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.769 0.318 . . . . 75.129999999999995 111.633 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.96 -48.04 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 111.909 0.337 . . . . 71.420000000000002 111.909 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.562 HE22 ' HG2' ' A' ' 86' ' ' ARG . 13.8 pt20 -59.47 -43.82 93.15 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.15 -0.343 . . . . 72.5 111.463 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.533 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 55.8 mtp180 -64.98 -47.61 76.95 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.12 -0.232 . . . . 74.340000000000003 111.53 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -50.57 -44.39 56.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.966 0.413 . . . . 71.239999999999995 111.777 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.569 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 59.0 m-85 -75.66 -44.46 42.37 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.999 0.74 . . . . 73.430000000000007 112.999 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.533 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 9.0 ptm180 -62.0 -32.19 72.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.436 -0.79 . . . . 75.129999999999995 111.512 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 33.7 mm-40 -73.24 -72.99 0.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.94 0.4 . . . . 74.129999999999995 111.929 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -87.11 -5.96 58.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.212 0.819 . . . . 73.040000000000006 113.212 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -127.41 -7.33 5.8 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 62.219999999999999 112.086 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.84 37.78 79.94 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.228 -0.511 . . . . 75.420000000000002 113.18 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 34.9 tp -104.9 144.38 31.86 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.892 0.377 . . . . 72.349999999999994 111.151 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -95.49 125.96 40.46 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.936 0.398 . . . . 74.209999999999994 111.834 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 73' ' ' GLN . 88.2 mt -135.12 133.47 20.82 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.472 -0.331 . . . . 74.120000000000005 110.929 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.71 155.93 61.85 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.788 2.325 . . . . 61.5 113.275 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.562 ' HG2' HE22 ' A' ' 73' ' ' GLN . 67.2 mtt85 -82.66 48.8 1.37 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.965 0.728 . . . . 71.030000000000001 112.965 -172.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.478 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 20.3 t -169.09 135.54 1.73 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 111.276 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.628 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 25.5 m -53.19 -46.35 68.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.374 -0.376 . . . . 73.150000000000006 111.036 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -39.4 75.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.078 0.466 . . . . 71.219999999999999 111.696 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 14.5 mm-40 -75.93 -35.57 59.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.996 -0.547 . . . . 75.349999999999994 111.115 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.94 -30.13 70.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.912 0.387 . . . . 70.319999999999993 111.775 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 88' ' ' THR . 20.0 mt-30 -62.72 -21.01 65.47 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.734 0.302 . . . . 74.150000000000006 111.749 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.01 16.42 1.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.667 0.617 . . . . 64.200000000000003 112.667 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptp -142.52 -178.58 5.83 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 122.186 -0.321 . . . . 71.239999999999995 111.067 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.3 50.89 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.13 -0.557 . . . . 73.439999999999998 113.141 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.6 mmtp -127.75 139.17 52.84 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.416 -0.461 . . . . 74.340000000000003 111.952 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.533 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 75.5 p -76.32 127.84 33.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.761 -0.654 . . . . 75.239999999999995 111.905 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.58 HG13 ' CZ ' ' A' ' 157' ' ' ARG . 5.7 m -136.93 157.72 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.307 0.575 . . . . 75.150000000000006 112.532 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 t -109.62 -177.31 3.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.786 -0.643 . . . . 74.049999999999997 112.353 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.647 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 24.3 mmm180 -41.04 -50.28 3.36 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.26 1.208 . . . . 73.239999999999995 114.26 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -84.34 -14.4 49.72 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.566 0.58 . . . . 70.239999999999995 112.566 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.8 m120 -89.75 -12.23 39.94 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.977 0.362 . . . . 75.010000000000005 111.977 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -57.77 131.88 51.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.979 0.733 . . . . 74.129999999999995 112.979 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -111.96 -162.33 0.79 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.788 -0.642 . . . . 75.010000000000005 110.381 171.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 41' ' ' LYS . 91.7 m -92.9 108.35 19.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.708 0.289 . . . . 74.140000000000001 110.849 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.66 -10.36 7.58 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.598 -0.334 . . . . 74.310000000000002 112.753 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' OD2' ' HD2' ' A' ' 157' ' ' ARG . 0.8 OUTLIER -60.9 127.05 29.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.115 0.413 . . . . 75.439999999999998 112.115 177.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 39.4 mt -82.87 108.07 15.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.892 0.377 . . . . 71.549999999999997 110.754 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.27 124.86 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.284 0.564 . . . . 74.109999999999999 111.965 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 73.8 mt -93.96 136.16 34.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.831 -0.622 . . . . 74.530000000000001 112.002 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 96.0 m-85 -124.22 139.99 53.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 72.349999999999994 111.666 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -81.05 98.32 7.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.601 -0.272 . . . . 74.120000000000005 111.141 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 121.145 0.498 . . . . 64.329999999999998 111.743 179.593 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 109.457 -0.572 . . . . 74.099999999999994 109.457 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 69.0 t60 -84.24 149.32 26.2 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.816 -0.629 . . . . 71.340000000000003 111.277 -172.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 7.6 p -142.6 119.04 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.461 0.648 . . . . 75.319999999999993 111.948 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -114.33 152.85 17.93 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.204 -0.522 . . . . 73.430000000000007 112.854 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.4 mt -88.39 106.92 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 122.51 -0.406 . . . . 73.340000000000003 110.706 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -68.51 116.73 9.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.045 0.45 . . . . 72.209999999999994 111.338 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.1 pt -103.04 -14.44 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.361 0.504 . . . . 64.540000000000006 112.361 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.13 164.67 11.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.11 -0.567 . . . . 70.299999999999997 112.991 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 127' ' ' ASN . 13.4 m120 61.58 27.35 16.84 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.002 0.401 . . . . 71.299999999999997 111.891 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 126' ' ' ASN . 47.6 m-80 67.12 7.61 5.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.328 0.251 . . . . 75.439999999999998 111.509 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.7 144.17 26.2 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.595 0.712 . . . . 64.099999999999994 111.253 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -149.29 138.43 21.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 73.25 111.056 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.92 133.43 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.031 0.443 . . . . 71.109999999999999 110.7 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -157.73 172.2 18.93 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.257 0.551 . . . . 73.439999999999998 111.723 -173.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -105.12 93.04 4.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.0 -0.546 . . . . 71.450000000000003 110.154 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.7 p -67.39 140.04 57.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.952 0.406 . . . . 75.099999999999994 111.531 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -57.6 -30.33 65.22 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.914 0.709 . . . . 72.040000000000006 112.914 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.9 t -102.18 -53.82 2.83 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.564 0.579 . . . . 74.230000000000004 112.564 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 t -81.0 -33.59 33.55 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.601 0.593 . . . . 71.329999999999998 112.601 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.44 -153.09 17.01 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.164 -0.541 . . . . 62.420000000000002 112.635 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.58 106.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.211 0.506 . . . . 73.409999999999997 111.499 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.5 178.21 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.299 0.571 . . . . 72.420000000000002 112.033 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.03 138.17 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.944 -0.571 . . . . 73.430000000000007 109.957 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.4 m -132.06 171.7 13.29 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.312 -0.243 . . . . 74.209999999999994 111.152 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.6 m -127.66 138.24 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.873 0.323 . . . . 72.310000000000002 111.873 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.647 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 66.3 mtt -64.78 -12.18 44.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.97 0.414 . . . . 75.5 111.866 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 144' ' ' ASN . 0.9 OUTLIER -66.1 -28.28 68.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.83 0.348 . . . . 75.329999999999998 111.204 173.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.56 125.54 92.04 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.573 -0.285 . . . . 73.129999999999995 110.63 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 82.3 Cg_exo -46.39 -41.88 22.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.968 2.445 . . . . 74.239999999999995 113.723 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -59.63 -41.5 90.61 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.223 0.453 . . . . 74.099999999999994 112.223 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.03 -36.44 19.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.011 0.375 . . . . 74.530000000000001 112.011 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -54.81 -50.93 67.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.074 0.464 . . . . 74.030000000000001 111.612 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 18.4 ptpt -82.35 1.17 38.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.975 0.417 . . . . 73.299999999999997 111.88 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.18 -28.69 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.531 0.332 . . . . 75.150000000000006 110.959 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -58.51 115.4 2.99 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.179 -0.464 . . . . 73.310000000000002 112.097 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -98.07 -62.43 1.25 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.059 -0.519 . . . . 72.340000000000003 111.447 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -158.44 164.73 35.95 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.231 -0.293 . . . . 74.120000000000005 110.482 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -126.24 149.22 49.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.551 0.215 . . . . 63.149999999999999 111.523 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.533 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 89.5 mtt180 -143.99 112.72 6.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.611 0.243 . . . . 75.540000000000006 110.987 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.58 ' CZ ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -85.4 129.31 34.84 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.16 0.505 . . . . 74.109999999999999 110.84 176.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.436 HG23 HD22 ' A' ' 84' ' ' LEU . 27.8 m -107.13 7.89 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.895 0.702 . . . . 73.420000000000002 112.895 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.177 0.513 . . . . 74.239999999999995 112.235 -179.895 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.913 0.387 . . . . 73.209999999999994 111.566 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 44' ' ' ILE . 86.6 t -48.66 -46.08 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 72.25 111.215 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 45' ' ' MET . 58.9 tttm -54.89 -46.3 74.79 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.576 0.584 . . . . 75.230000000000004 112.576 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.7 p -60.61 -44.03 96.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.801 0.334 . . . . 75.219999999999999 111.868 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -73.93 -30.03 62.35 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.445 0.535 . . . . 73.239999999999995 112.445 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 40' ' ' VAL . 75.4 mt -63.69 -43.85 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.265 0.555 . . . . 75.420000000000002 110.135 173.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 87.4 mmm -66.63 -37.1 84.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.064 -0.516 . . . . 74.319999999999993 110.848 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.06 -43.45 70.25 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.169 0.509 . . . . 74.439999999999998 111.475 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.43 ' NE2' HE22 ' A' ' 79' ' ' GLN . 5.3 tp-100 -69.8 -54.51 13.26 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.273 -0.421 . . . . 75.140000000000001 110.617 174.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.432 ' OH ' ' NZ ' ' A' ' 52' ' ' LYS . 16.4 t80 -49.01 -39.68 27.78 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.088 0.773 . . . . 74.0 113.088 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.45 -33.81 55.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.115 0.484 . . . . 71.120000000000005 111.884 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.79 -23.41 55.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.038 -0.528 . . . . 74.129999999999995 112.413 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.431 ' HB3' HG22 ' A' ' 138' ' ' VAL . 82.8 m95 -97.2 -0.31 47.01 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.587 0.588 . . . . 74.25 112.587 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.432 ' NZ ' ' OH ' ' A' ' 48' ' ' TYR . 29.5 mtpp -64.85 95.37 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.992 0.425 . . . . 75.219999999999999 111.269 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.81 -12.47 7.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.444 -0.407 . . . . 73.540000000000006 112.725 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.6 t -74.18 124.9 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 64.430000000000007 111.187 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -86.2 160.64 19.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.563 0.697 . . . . 74.409999999999997 112.39 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 47.3 t80 -74.72 127.51 33.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.412 -0.813 . . . . 73.040000000000006 112.125 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -136.93 121.53 18.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.712 0.291 . . . . 74.430000000000007 111.599 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.86 121.63 22.91 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.201 0.445 . . . . 74.430000000000007 112.201 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.4 50.82 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.946 -0.645 . . . . 61.140000000000001 113.689 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -151.7 135.63 5.13 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.09 -0.576 . . . . 61.240000000000002 112.438 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.532 ' HA ' HG13 ' A' ' 66' ' ' ILE . 29.0 p -125.44 98.98 5.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.315 0.579 . . . . 71.040000000000006 111.691 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.1 t -159.84 161.88 34.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.065 -0.516 . . . . 71.430000000000007 110.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -67.88 -3.36 9.49 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.061 0.458 . . . . 74.129999999999995 111.738 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -92.55 -19.37 22.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.983 0.421 . . . . 74.430000000000007 111.269 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 136.52 2.23 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.59 -0.604 . . . . 60.109999999999999 111.59 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.4 tt -157.45 150.96 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 117.702 0.751 . . . . 64.129999999999995 112.496 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.15 -179.36 4.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.273 0.558 . . . . 71.040000000000006 112.186 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.4 t -58.15 -56.64 19.48 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.593 0.59 . . . . 73.319999999999993 112.593 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 75.2 p -60.46 -36.2 77.68 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.939 0.399 . . . . 74.530000000000001 111.608 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.66 85.09 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.039 -0.528 . . . . 74.010000000000005 113.17 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.73 -50.92 70.48 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.587 -0.361 . . . . 74.450000000000003 111.72 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.495 ' HA ' HD13 ' A' ' 122' ' ' ILE . 11.0 p -65.14 -43.79 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 111.987 0.366 . . . . 73.329999999999998 111.987 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.558 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 21.1 pt20 -62.18 -38.93 90.96 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.162 -0.336 . . . . 64.239999999999995 111.592 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 74' ' ' ARG . 14.4 mtp180 -67.12 -55.54 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.715 0.293 . . . . 72.439999999999998 111.579 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.4 m -47.46 -42.35 22.42 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.284 0.475 . . . . 74.409999999999997 112.284 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 49.9 m-85 -75.02 -41.55 59.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.717 0.636 . . . . 70.239999999999995 112.717 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 13.7 ptm180 -76.92 -26.68 54.37 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.812 -0.555 . . . . 74.150000000000006 112.355 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.0 -37.67 16.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.122 0.415 . . . . 55.420000000000002 112.122 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.43 HE22 ' NE2' ' A' ' 47' ' ' GLN . 19.2 mp0 -93.48 -48.43 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.9 0.704 . . . . 71.420000000000002 112.9 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.426 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 58.4 m-85 -101.55 -5.58 24.97 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.42 0.526 . . . . 75.109999999999999 112.42 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.59 13.62 74.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.089 -0.577 . . . . 73.349999999999994 113.066 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -90.82 111.51 22.94 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.671 -0.311 . . . . 71.230000000000004 110.674 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.48 95.85 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.177 0.513 . . . . 70.549999999999997 112.149 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 91.4 mt -82.69 143.6 47.3 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 110.195 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 43.9 Cg_endo -67.45 -172.67 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.53 2.153 . . . . 73.049999999999997 113.522 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -95.62 -33.09 12.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.864 0.69 . . . . 74.400000000000006 112.864 -172.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 19.9 m -96.43 141.74 29.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.69 0.255 . . . . 74.319999999999993 111.69 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.49 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 59.8 m -52.13 -50.35 61.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.905 0.335 . . . . 75.150000000000006 111.905 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.457 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 24.9 m-85 -54.11 -44.0 70.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.534 0.207 . . . . 73.239999999999995 111.437 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 45.3 mt-10 -58.91 -47.5 84.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.552 . . . . 70.530000000000001 110.87 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -63.37 -30.71 71.79 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.147 -0.479 . . . . 73.400000000000006 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.7 mt-30 -71.34 -21.05 62.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.465 -0.334 . . . . 75.400000000000006 111.495 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 89' ' ' TYR . 41.6 mt-10 -79.48 -5.23 54.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.852 0.358 . . . . 74.340000000000003 111.132 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.417 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 75.0 mtp -106.28 131.83 53.04 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.368 -0.378 . . . . 64.200000000000003 110.936 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.24 134.78 1.07 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.465 -0.397 . . . . 73.030000000000001 113.715 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 96' ' ' LYS . 70.3 mmtt -88.31 162.53 16.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.587 . . . . 72.299999999999997 112.025 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 29.6 m -75.38 155.19 36.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.208 1.188 . . . . 42.420000000000002 114.208 -167.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 155' ' ' ALA . 0.9 OUTLIER -144.04 149.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.017 -0.992 . . . . 73.209999999999994 110.864 171.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 t -100.57 -173.49 2.42 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.367 -0.379 . . . . 73.420000000000002 111.355 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.447 HH11 ' HE2' ' A' ' 152' ' ' TYR . 1.1 mpp_? -59.87 -38.56 82.53 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.978 1.103 . . . . 73.019999999999996 113.978 -169.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.9 p -79.86 -5.68 55.96 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.744 -0.598 . . . . 70.450000000000003 111.67 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -116.73 11.11 14.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.843 0.312 . . . . 62.409999999999997 111.843 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 78.1 mt -72.44 129.56 38.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.109 0.48 . . . . 71.329999999999998 111.588 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -138.8 172.23 13.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.02 0.528 . . . . 73.510000000000005 111.08 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.3 m -64.94 114.93 4.88 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.184 0.516 . . . . 72.030000000000001 111.969 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.86 -3.36 24.36 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.296 -0.478 . . . . 72.120000000000005 113.696 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -79.99 134.16 36.22 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.304 0.573 . . . . 70.140000000000001 111.125 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 77.3 mt -89.36 119.37 29.77 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.477 -0.328 . . . . 74.420000000000002 111.482 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 155' ' ' ALA . 12.5 m -95.62 129.24 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.978 0.418 . . . . 70.430000000000007 111.721 -177.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.61 140.7 33.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.308 -0.405 . . . . 55.210000000000001 111.58 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.41 140.09 51.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.794 0.33 . . . . 75.439999999999998 111.407 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -86.72 90.13 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.917 0.389 . . . . 75.340000000000003 110.229 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 112.372 0.508 . . . . 61.149999999999999 112.372 -173.898 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 88' ' ' THR . 2.7 mpt_? . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 121.232 0.539 . . . . 65.239999999999995 110.552 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -92.63 143.01 26.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.919 -0.582 . . . . 75.129999999999995 110.613 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.93 137.58 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.263 0.554 . . . . 74.209999999999994 112.346 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.26 20.65 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.044 -0.525 . . . . 72.25 112.874 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 72' ' ' VAL . 47.0 mt -90.27 109.42 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.801 0.3 . . . . 74.329999999999998 111.038 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.537 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 63.8 t80 -75.46 113.78 13.27 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.954 0.407 . . . . 63.130000000000003 111.358 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.436 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 27.7 pt -95.51 -32.96 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.107 0.41 . . . . 74.040000000000006 112.107 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.38 165.36 11.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.187 -0.53 . . . . 71.120000000000005 113.2 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.402 ' O ' ' HG3' ' A' ' 128' ' ' GLN . 10.0 t30 59.39 42.49 17.89 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.219 0.533 . . . . 74.25 110.788 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.537 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 4.2 p30 51.53 17.18 0.52 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.066 0.947 . . . . 62.340000000000003 112.725 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 126' ' ' ASN . 28.0 mt-30 -108.56 145.51 34.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.371 0.605 . . . . 73.310000000000002 111.702 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 8.0 p90 -148.97 150.43 32.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.648 -0.706 . . . . 74.310000000000002 111.659 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.49 140.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.014 0.435 . . . . 75.310000000000002 111.326 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -161.72 -166.37 1.46 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.474 -0.33 . . . . 71.150000000000006 111.236 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.96 106.46 8.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.76 0.314 . . . . 74.239999999999995 111.615 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.6 m -81.89 155.19 25.44 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.892 0.377 . . . . 71.329999999999998 111.987 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 67.8 p -52.84 -46.56 67.84 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.216 1.191 . . . . 73.430000000000007 114.216 -172.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -100.56 -44.74 5.75 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.904 -0.497 . . . . 74.239999999999995 112.07 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.0 m -65.77 -38.71 89.8 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.938 0.718 . . . . 53.409999999999997 112.938 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.66 -146.4 18.25 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.937 -0.649 . . . . 74.129999999999995 112.212 -173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 51' ' ' TRP . 61.0 t -69.38 111.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 117.201 0.5 . . . . 64.540000000000006 111.67 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.2 pt -141.16 -179.98 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.165 0.507 . . . . 75.109999999999999 111.663 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.47 137.08 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.192 -0.458 . . . . 72.299999999999997 110.42 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.5 m -130.44 159.08 38.13 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.938 0.399 . . . . 75.010000000000005 111.68 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.6 m -115.2 148.4 39.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.366 -0.379 . . . . 72.519999999999996 111.586 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.506 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 91.8 mmm -67.54 -22.53 65.41 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.14 0.495 . . . . 75.030000000000001 110.863 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.33 -20.6 66.13 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.098 -0.501 . . . . 71.040000000000006 111.615 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -67.1 132.25 93.64 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.546 0.212 . . . . 72.439999999999998 110.96 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.584 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 14.1 Cg_endo -54.49 -48.79 19.53 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.747 2.298 . . . . 73.420000000000002 113.299 -174.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -56.54 -48.47 77.21 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.129 0.418 . . . . 75.099999999999994 112.129 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.9 -40.07 61.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 111.424 -174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -53.56 -55.95 21.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.162 -0.472 . . . . 65.099999999999994 111.834 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 19.1 ptpt -74.06 -28.74 61.54 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.803 0.668 . . . . 63.25 112.803 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.571 ' HD2' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -86.89 -7.5 58.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.478 0.547 . . . . 74.400000000000006 112.478 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.447 ' HE2' HH11 ' A' ' 100' ' ' ARG . 63.3 t80 -60.0 121.44 11.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.114 0.483 . . . . 75.129999999999995 111.778 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -94.65 -69.59 0.75 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.851 -0.613 . . . . 71.510000000000005 111.234 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.65 144.15 7.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.507 -0.315 . . . . 72.120000000000005 111.627 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -99.82 162.88 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.417 -0.177 . . . . 74.310000000000002 111.172 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -141.81 141.46 33.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.037 0.446 . . . . 74.239999999999995 111.899 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.45 95.29 7.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.29 0.567 . . . . 75.209999999999994 111.677 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.78 -15.18 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.004 -0.544 . . . . 74.400000000000006 112.175 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.462 HD22 HD23 ' A' ' 82' ' ' LEU . 96.0 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.683 0.278 . . . . 75.409999999999997 111.371 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.139 0.495 . . . . 63.409999999999997 110.938 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 44' ' ' ILE . 60.0 t -52.13 -46.64 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.751 -0.659 . . . . 73.230000000000004 112.087 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -59.01 -44.51 91.7 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.942 0.401 . . . . 75.430000000000007 111.086 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.5 m -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.466 -0.334 . . . . 73.340000000000003 111.287 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -65.37 -38.82 91.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 71.049999999999997 112.309 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 40' ' ' VAL . 81.6 mt -64.29 -52.61 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.077 0.465 . . . . 74.230000000000004 111.23 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.577 ' HA ' ' HE3' ' A' ' 45' ' ' MET . 28.9 mmt -63.6 -27.73 69.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.967 0.413 . . . . 72.400000000000006 111.219 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -59.52 -48.4 81.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.917 -0.583 . . . . 63.020000000000003 111.284 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -76.64 -36.27 57.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 70.219999999999999 111.106 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.514 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 27.2 t80 -53.58 -37.65 63.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.765 0.317 . . . . 74.340000000000003 110.651 174.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.527 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . . . -53.34 -25.35 14.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.206 0.447 . . . . 63.350000000000001 112.206 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -86.4 -38.05 17.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.135 0.493 . . . . 75.329999999999998 111.124 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -88.07 -2.63 58.72 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.924 0.713 . . . . 75.530000000000001 112.924 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HE3' ' HA ' ' A' ' 49' ' ' ALA . 98.6 mttt -53.0 106.07 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.552 0.575 . . . . 75.5 112.552 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.14 -8.25 25.06 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.982 -0.628 . . . . 74.219999999999999 114.386 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.66 123.22 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 117.49 0.645 . . . . 73.129999999999995 111.031 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.97 169.69 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.424 0.63 . . . . 74.409999999999997 112.568 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -83.93 128.42 34.53 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.808 -0.633 . . . . 72.299999999999997 111.679 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -136.87 118.61 15.05 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.53 -0.305 . . . . 75.549999999999997 111.024 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 58' ' ' LEU . 5.0 mp -74.3 102.59 4.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.999 0.37 . . . . 74.420000000000002 111.999 -173.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.28 33.7 31.4 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.068 -0.587 . . . . 64.239999999999995 113.241 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.15 102.93 0.27 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.905 -0.478 . . . . 74.010000000000005 111.905 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.529 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 p -94.81 100.84 12.66 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.504 0.557 . . . . 72.439999999999998 112.504 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -158.93 173.09 17.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.161 -0.472 . . . . 62.200000000000003 111.791 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -74.75 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.431 . . . . 74.239999999999995 111.32 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 3.1 mptp? -90.98 0.73 57.46 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.205 -0.452 . . . . 62.5 111.001 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.11 145.99 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.059 -0.417 . . . . 73.209999999999994 112.059 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.529 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.5 tt -165.02 148.09 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 117.551 0.676 . . . . 74.120000000000005 112.001 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.84 0.352 . . . . 70.129999999999995 111.473 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 25.0 p -59.94 -47.66 84.87 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.285 0.476 . . . . 72.340000000000003 112.285 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.3 m -63.97 -41.5 97.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.976 0.417 . . . . 72.129999999999995 111.225 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.81 -40.27 95.52 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.973 -0.632 . . . . 62.409999999999997 112.605 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -60.24 -54.24 48.19 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.976 0.362 . . . . 74.040000000000006 111.976 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.66 -38.04 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.058 0.456 . . . . 65.25 111.038 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -53.79 -57.78 9.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.293 0.568 . . . . 64.530000000000001 111.642 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 18.5 mmt180 -64.8 -48.1 75.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.951 -0.568 . . . . 73.530000000000001 111.844 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 m -52.68 -51.1 61.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.093 0.473 . . . . 65.310000000000002 111.865 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 35.3 m-85 -70.05 -38.66 75.87 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.773 0.657 . . . . 75.319999999999993 112.773 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 4.7 ptm180 -69.24 -33.71 73.69 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.89 -0.507 . . . . 73.319999999999993 111.542 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.12 -36.85 64.23 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 111.902 0.334 . . . . 72.409999999999997 111.902 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -97.48 -58.4 2.01 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.578 0.585 . . . . 73.150000000000006 112.578 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.33 -1.74 53.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.421 0.526 . . . . 74.540000000000006 112.421 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.68 22.43 76.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.182 -0.533 . . . . 72.010000000000005 112.889 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -100.34 113.02 25.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 75.219999999999999 111.192 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.994 0.426 . . . . 74.420000000000002 111.575 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.01 153.83 37.75 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.325 -0.398 . . . . 75.540000000000006 111.361 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.86 168.21 19.31 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.443 2.096 . . . . 55.030000000000001 113.208 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -81.32 3.58 23.69 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.559 0.577 . . . . 70.530000000000001 112.559 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 30.8 t -122.17 133.44 54.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.343 0.498 . . . . 73.400000000000006 112.343 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.573 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 2.5 m -56.21 -45.21 79.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.854 -0.612 . . . . 75.310000000000002 111.026 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.6 -44.31 85.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.571 -0.741 . . . . 72.329999999999998 111.438 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 19.2 mm-40 -70.52 -33.99 71.79 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.153 0.501 . . . . 75.420000000000002 111.214 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -66.29 -20.36 66.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.528 -0.305 . . . . 70.420000000000002 111.74 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 88' ' ' THR . 22.9 mt-30 -72.08 -22.53 61.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.983 0.42 . . . . 71.129999999999995 111.819 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -87.46 -2.66 58.77 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.342 -0.39 . . . . 71.219999999999999 111.484 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.2 mmm -97.25 -75.83 0.53 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.865 0.364 . . . . 71.239999999999995 111.561 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.65 151.87 48.48 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.369 -0.443 . . . . 75.510000000000005 113.634 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 29.8 mmtp -89.29 153.94 20.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.998 0.427 . . . . 73.109999999999999 111.533 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.9 p -85.61 152.86 22.8 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.223 0.823 . . . . 75.510000000000005 113.223 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.498 HG13 ' NE ' ' A' ' 157' ' ' ARG . 1.1 m -152.25 171.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.861 -0.609 . . . . 74.519999999999996 112.161 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.2 t -116.26 -178.63 3.46 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.727 -0.67 . . . . 50.210000000000001 111.053 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.421 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -55.74 -46.09 77.88 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.287 0.477 . . . . 74.430000000000007 112.287 -177.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -69.48 -3.3 14.0 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.22 0.452 . . . . 70.430000000000007 112.22 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 5.6 m120 -116.08 -7.5 11.89 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.948 -0.47 . . . . 72.040000000000006 111.96 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.27 135.06 57.62 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.897 0.703 . . . . 72.549999999999997 112.897 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 104' ' ' ARG . 14.2 mmt180 -115.42 -152.02 0.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.491 -0.777 . . . . 73.349999999999994 109.855 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.9 m -102.83 105.02 15.34 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.791 -0.568 . . . . 75.0 111.505 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 122.91 -3.78 9.87 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.842 -0.694 . . . . 61.140000000000001 114.604 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.86 134.24 56.89 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.373 0.586 . . . . 75.549999999999997 111.759 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.4 mt -85.38 113.19 21.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.026 0.441 . . . . 72.530000000000001 111.26 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.2 m -95.4 134.78 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.031 0.443 . . . . 74.530000000000001 111.438 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 87.8 mt -104.62 138.57 40.75 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.245 0.461 . . . . 72.340000000000003 112.245 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -123.4 141.28 52.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.933 -0.576 . . . . 75.019999999999996 111.505 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 48.2 mtt180 -82.87 82.01 8.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.956 0.408 . . . . 74.510000000000005 110.027 173.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 112.002 0.371 . . . . 74.200000000000003 112.002 -173.49 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.028 0.442 . . . . 71.439999999999998 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.429 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 52.5 t60 -95.94 154.64 17.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.342 -0.39 . . . . 74.510000000000005 110.555 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.57 142.94 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.172 0.51 . . . . 75.439999999999998 112.308 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.38 160.89 26.93 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.979 -0.555 . . . . 51.340000000000003 112.625 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -97.01 109.65 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.532 -0.393 . . . . 75.319999999999993 111.32 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -68.03 108.65 3.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.928 0.394 . . . . 74.25 111.231 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 pt -109.43 -32.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.458 0.54 . . . . 71.5 112.458 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.51 -175.72 14.13 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.201 -0.523 . . . . 73.150000000000006 113.038 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -43.02 -58.0 2.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.858 0.688 . . . . 72.450000000000003 112.858 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -122.11 -10.35 8.58 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.17 -0.331 . . . . 72.329999999999998 111.525 174.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -84.36 137.17 33.56 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.348 0.594 . . . . 75.049999999999997 112.459 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.69 142.57 27.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.594 -0.73 . . . . 73.230000000000004 110.965 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -97.41 136.33 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.869 0.366 . . . . 71.030000000000001 111.251 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -165.19 168.69 16.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 73.0 111.181 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.86 91.25 7.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.145 0.498 . . . . 73.319999999999993 110.515 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.8 p -65.14 146.02 55.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.868 -0.606 . . . . 45.210000000000001 112.086 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.2 p -64.48 -25.13 67.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.147 0.499 . . . . 63.329999999999998 111.303 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -73.17 -70.59 0.35 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.089 -0.505 . . . . 54.409999999999997 112.276 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.0 m -102.83 -35.75 8.51 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.124 0.416 . . . . 70.120000000000005 112.124 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.63 -141.29 13.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.078 -0.582 . . . . 71.25 112.567 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.9 92.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.321 0.582 . . . . 74.540000000000006 111.948 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.415 ' HA ' ' HH ' ' A' ' 48' ' ' TYR . 35.7 pt -136.88 -176.69 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.059 -0.519 . . . . 74.120000000000005 111.024 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.28 116.36 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.543 -0.299 . . . . 64.510000000000005 110.656 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.2 m -104.3 -177.99 3.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.767 0.318 . . . . 74.109999999999999 110.758 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.3 m -143.59 145.27 32.38 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.154 0.502 . . . . 65.439999999999998 112.342 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.81 -27.57 69.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.687 0.625 . . . . 71.540000000000006 112.687 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -72.85 -3.63 26.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.929 0.344 . . . . 72.319999999999993 111.929 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -74.8 122.25 87.07 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 110.423 -0.214 . . . . 72.329999999999998 110.423 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.14 -39.36 11.58 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.418 2.745 . . . . 72.329999999999998 114.421 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 85.7 t80 -61.72 -51.46 68.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.862 0.363 . . . . 75.019999999999996 111.28 176.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -76.84 -27.97 55.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.434 -0.348 . . . . 75.319999999999993 111.203 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.91 -34.56 74.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.203 -0.453 . . . . 65.150000000000006 111.234 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -102.6 0.99 34.19 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.362 -0.381 . . . . 71.439999999999998 111.521 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -103.41 -30.64 10.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 111.905 0.335 . . . . 74.349999999999994 111.905 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.421 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 70.6 t80 -56.64 135.28 54.96 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.886 0.374 . . . . 74.409999999999997 111.498 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -123.0 -51.33 1.9 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.932 0.345 . . . . 73.319999999999993 111.932 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.69 -179.04 7.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.079 0.4 . . . . 71.400000000000006 112.079 -173.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -144.73 149.47 35.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.516 -0.311 . . . . 74.439999999999998 111.374 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.6 mtm-85 -137.46 118.2 14.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.68 0.252 . . . . 74.439999999999998 111.68 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.498 ' NE ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.21 109.42 11.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.138 0.494 . . . . 75.25 110.981 174.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 82' ' ' LEU . 16.8 m -84.13 -29.73 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.14 0.495 . . . . 54.340000000000003 111.201 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 CA--C 1.535 0.383 0 CA-C-N 116.267 -0.424 . . . . 75.150000000000006 110.177 174.33 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 12.2 t70 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 110.272 -0.27 . . . . 74.409999999999997 110.272 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.1 t -56.21 -53.87 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.831 0.348 . . . . 63.43 111.411 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.528 ' HB2' HG22 ' A' ' 105' ' ' THR . 87.7 tttt -61.4 -43.19 99.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.307 -0.406 . . . . 70.120000000000005 111.238 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.4 m -57.17 -42.73 81.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.099 -0.5 . . . . 43.109999999999999 111.331 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.462 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -72.01 -42.36 66.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.259 0.466 . . . . 75.430000000000007 112.259 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 40' ' ' VAL . 78.9 mt -58.35 -48.69 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 64.519999999999996 110.897 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 92.7 mmm -63.88 -36.23 83.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.039 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.35 -43.62 83.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.912 -0.585 . . . . 73.319999999999993 111.37 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -71.24 -45.61 62.87 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.998 0.428 . . . . 72.230000000000004 111.145 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -54.44 -41.22 69.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.445 -0.343 . . . . 74.239999999999995 111.831 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.82 -20.85 9.52 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.321 0.489 . . . . 74.120000000000005 112.321 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.1 -25.54 17.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.087 0.47 . . . . 73.040000000000006 111.47 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.409 ' CZ3' HD11 ' A' ' 66' ' ' ILE . 81.4 m95 -105.14 3.27 30.09 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.101 0.778 . . . . 74.5 113.101 -175.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -54.84 101.71 0.05 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.844 0.354 . . . . 74.340000000000003 111.916 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.45 21.4 22.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.015 -0.612 . . . . 64.340000000000003 114.412 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.7 t -80.5 132.05 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 117.851 0.826 . . . . 73.329999999999998 110.992 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -63.27 163.3 10.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.938 0.718 . . . . 74.430000000000007 112.938 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -92.94 140.17 29.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.096 -0.502 . . . . 73.430000000000007 111.602 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -137.08 139.47 41.31 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.869 0.366 . . . . 65.450000000000003 110.969 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 58' ' ' LEU . 6.7 mp -74.72 97.4 3.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 72.239999999999995 112.193 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.43 6.76 88.05 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.051 -0.522 . . . . 65.299999999999997 114.329 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.77 77.85 0.3 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 117.497 0.648 . . . . 70.430000000000007 113.128 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.495 ' H ' ' NH2' ' A' ' 86' ' ' ARG . 48.3 t -68.41 107.69 2.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.396 0.887 . . . . 73.230000000000004 113.396 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.8 t -166.14 172.58 11.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.724 0.409 . . . . 73.040000000000006 111.576 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -65.01 -21.35 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.953 -0.467 . . . . 75.230000000000004 111.572 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.01 9.25 20.18 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.392 0.615 . . . . 71.040000000000006 111.021 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.52 136.05 3.08 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.863 -0.895 . . . . 73.109999999999999 110.863 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 71' ' ' PHE . 19.7 tt -144.58 146.4 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.232 1.016 . . . . 65.129999999999995 112.828 -175.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.12 160.04 15.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.005 -0.543 . . . . 74.530000000000001 111.502 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 28.2 p -57.36 -54.46 46.6 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.841 0.353 . . . . 54.530000000000001 111.553 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.401 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 8.2 p -58.95 -42.86 90.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.193 -0.458 . . . . 74.519999999999996 111.18 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.63 -33.84 68.31 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.322 -0.399 . . . . 63.439999999999998 113.654 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.532 ' HA ' HD12 ' A' ' 66' ' ' ILE . 74.6 t80 -72.04 -48.46 44.32 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.48 -0.423 . . . . 74.109999999999999 111.612 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.558 HG12 HE22 ' A' ' 91' ' ' GLN . 7.1 p -63.1 -44.18 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.576 -0.284 . . . . 72.129999999999995 111.443 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.611 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.1 pp0? -61.14 -44.85 96.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.036 -0.415 . . . . 74.010000000000005 111.336 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -57.62 -50.5 72.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.041 0.386 . . . . 74.230000000000004 112.041 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.4 m -53.43 -45.83 69.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.833 0.349 . . . . 74.400000000000006 111.816 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 65.8 m-85 -72.86 -38.39 67.06 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.061 0.763 . . . . 72.530000000000001 113.061 -177.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -76.88 -42.77 38.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.572 -0.705 . . . . 75.450000000000003 112.287 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -73.43 -26.49 60.97 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.274 0.472 . . . . 74.209999999999994 112.274 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -96.0 -61.25 1.48 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.843 0.354 . . . . 74.219999999999999 111.866 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.406 ' HD2' ' HA ' ' A' ' 76' ' ' PHE . 63.9 m-85 -90.08 -28.5 18.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.42 0.526 . . . . 75.540000000000006 112.42 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.1 27.29 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.191 -0.528 . . . . 74.519999999999996 112.512 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 37.4 tp -83.15 160.09 21.92 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.311 0.577 . . . . 74.310000000000002 111.865 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.63 114.57 27.1 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.058 0.456 . . . . 73.439999999999998 111.895 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.77 145.01 41.15 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 122.274 -0.267 . . . . 74.439999999999998 111.033 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.575 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 63.1 Cg_endo -85.73 -171.47 0.9 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.979 2.453 . . . . 74.019999999999996 113.881 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.495 ' NH2' ' H ' ' A' ' 61' ' ' SER . 11.0 mmm180 -88.44 -19.43 26.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.473 0.546 . . . . 74.329999999999998 112.473 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -106.31 126.63 52.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.756 0.65 . . . . 74.109999999999999 112.756 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 44.1 m -52.0 -41.8 62.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.89 -0.595 . . . . 74.340000000000003 111.665 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -54.76 -32.53 60.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.85 -0.614 . . . . 73.129999999999995 112.306 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.08 -38.61 31.38 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.18 0.514 . . . . 75.019999999999996 110.961 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.575 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 44.9 mt-30 -61.85 -33.64 74.55 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.192 -0.458 . . . . 73.239999999999995 111.595 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.492 ' HG2' HD11 ' A' ' 110' ' ' LEU . 18.7 mt-30 -52.01 -37.72 54.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.241 0.543 . . . . 75.340000000000003 111.596 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -90.48 -9.81 45.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.015 -0.539 . . . . 74.219999999999999 112.126 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.484 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 81.1 mtp -87.25 -37.18 17.45 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.872 0.367 . . . . 70.329999999999998 111.374 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.76 150.93 21.41 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.946 -0.645 . . . . 64.409999999999997 113.388 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 31.2 mmmt -70.88 141.32 51.22 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.161 0.505 . . . . 74.120000000000005 112.007 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 m -77.47 127.54 32.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.656 -0.702 . . . . 75.400000000000006 112.106 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.498 HG13 ' CZ ' ' A' ' 157' ' ' ARG . 7.1 m -145.5 164.65 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.382 0.61 . . . . 71.010000000000005 112.417 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 t -116.7 -177.71 3.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.689 -0.687 . . . . 73.0 110.776 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.491 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -56.14 -36.69 68.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.455 0.539 . . . . 74.400000000000006 112.455 -175.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.0 p -64.88 -29.14 70.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.03 0.443 . . . . 74.420000000000002 112.141 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -100.68 -6.89 24.46 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.173 0.805 . . . . 75.209999999999994 113.173 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.14 131.05 48.77 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.419 0.896 . . . . 74.109999999999999 113.419 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -125.07 175.79 7.12 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.743 -0.662 . . . . 70.109999999999999 110.33 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.528 HG22 ' HB2' ' A' ' 41' ' ' LYS . 62.9 m -68.44 111.35 4.63 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.98 -0.45 . . . . 65.319999999999993 111.1 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.33 -12.93 7.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.388 -0.434 . . . . 72.200000000000003 112.711 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.18 130.45 43.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.022 0.439 . . . . 75.519999999999996 111.581 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.8 mt -87.95 112.32 22.43 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.95 0.405 . . . . 75.019999999999996 110.56 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -96.65 128.1 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.375 0.607 . . . . 74.239999999999995 111.577 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' A' ' 92' ' ' GLN . 79.3 mt -98.84 143.44 29.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 111.917 -175.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -131.14 132.19 44.61 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.39 -0.368 . . . . 74.310000000000002 111.266 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -81.22 84.79 6.49 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.242 0.544 . . . . 74.120000000000005 110.666 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 CA-C-N 115.873 -0.603 . . . . 54.149999999999999 112.138 -173.405 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 74.510000000000005 110.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -87.78 151.63 22.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.005 -0.543 . . . . 72.140000000000001 110.236 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.5 139.07 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.092 0.472 . . . . 72.120000000000005 112.242 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 131' ' ' HIS . . . -132.15 149.85 19.49 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 116.177 -0.465 . . . . 73.409999999999997 112.525 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 72' ' ' VAL . 43.6 mt -89.39 106.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 122.476 -0.426 . . . . 74.200000000000003 111.031 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.67 115.05 5.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.387 -0.37 . . . . 73.129999999999995 111.314 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.1 pt -103.04 -33.75 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.893 0.701 . . . . 73.150000000000006 112.893 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.45 123.24 0.83 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 119.777 -1.201 . . . . 41.520000000000003 115.139 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.69 -78.25 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.24 1.016 . . . . 74.019999999999996 111.696 171.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 142' ' ' SER . 53.8 m-80 -133.57 -7.4 2.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.449 -0.342 . . . . 73.200000000000003 111.342 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -86.68 140.42 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.285 0.564 . . . . 74.310000000000002 112.287 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -151.41 140.68 21.36 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.524 -0.762 . . . . 75.540000000000006 111.041 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.44 137.44 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.994 0.426 . . . . 61.200000000000003 111.394 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.506 ' CE1' ' HB2' ' A' ' 133' ' ' SER . 5.0 p80 -162.9 162.21 26.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.988 0.366 . . . . 64.540000000000006 111.988 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -88.23 92.06 9.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.951 0.405 . . . . 75.430000000000007 110.391 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.506 ' HB2' ' CE1' ' A' ' 131' ' ' HIS . 37.5 t -86.78 126.39 34.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.424 -0.353 . . . . 72.120000000000005 111.886 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -59.3 -17.76 31.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.44 0.533 . . . . 72.099999999999994 112.44 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.1 p -65.95 -41.3 91.45 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.91 0.386 . . . . 53.25 111.503 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.1 m -138.79 -39.22 0.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.048 0.388 . . . . 72.109999999999999 112.048 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.48 24.62 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.792 -0.523 . . . . 72.109999999999999 111.792 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 57.5 t -65.72 103.01 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.179 0.49 . . . . 64.239999999999995 111.237 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.72 169.84 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.106 -0.497 . . . . 71.340000000000003 111.399 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.48 114.55 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.591 -0.277 . . . . 75.420000000000002 110.687 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.5 m -104.57 178.56 4.52 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.965 0.412 . . . . 74.209999999999994 111.054 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 66.4 m -141.65 140.43 33.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.006 0.431 . . . . 75.540000000000006 112.106 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.02 -6.01 7.67 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.366 0.506 . . . . 74.219999999999999 112.366 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -73.0 -19.68 61.16 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 70.209999999999994 110.628 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.77 134.05 69.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.051 -0.522 . . . . 72.030000000000001 110.768 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.539 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 78.4 Cg_exo -51.25 -46.21 32.55 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.757 2.305 . . . . 71.200000000000003 113.489 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.79 -45.42 86.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.197 0.443 . . . . 74.310000000000002 112.197 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -80.33 -34.46 36.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.984 0.421 . . . . 64.5 111.641 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -60.5 -54.59 43.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.114 -0.493 . . . . 75.230000000000004 112.066 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 51.7 pttt -86.06 -14.78 43.33 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.173 0.805 . . . . 74.239999999999995 113.173 -174.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -92.95 -4.59 52.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.0 -0.438 . . . . 74.430000000000007 111.702 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.491 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 77.0 t80 -55.2 135.62 49.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.582 . . . . 74.109999999999999 112.234 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -104.81 -71.0 0.75 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.907 -0.588 . . . . 74.439999999999998 111.258 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.468 ' HG3' HD13 ' A' ' 110' ' ' LEU . 9.6 pt-20 -163.45 -174.11 3.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.17 -0.468 . . . . 73.019999999999996 111.057 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -142.11 137.63 31.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.611 0.597 . . . . 63.409999999999997 112.611 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 14.0 mmt180 -137.45 114.79 10.99 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.955 -0.566 . . . . 75.519999999999996 110.325 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.498 ' CZ ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -95.07 122.6 37.9 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.086 -1.009 . . . . 74.310000000000002 111.687 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.48 1.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.669 -0.696 . . . . 74.400000000000006 112.766 -176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 112.165 0.432 . . . . 71.219999999999999 112.165 -179.533 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 110.302 -0.258 . . . . 74.299999999999997 110.302 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 44' ' ' ILE . 46.6 t -56.5 -57.08 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.561 -0.291 . . . . 74.420000000000002 111.545 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.51 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 85.1 tttt -55.7 -42.31 75.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.901 0.381 . . . . 72.030000000000001 111.475 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -58.89 -43.66 91.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.218 -0.446 . . . . 74.319999999999993 111.583 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -74.29 -33.28 63.19 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.19 0.441 . . . . 65.049999999999997 112.19 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 40' ' ' VAL . 87.5 mt -60.06 -50.25 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.156 0.503 . . . . 73.400000000000006 110.649 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.564 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 27.6 mmt -67.83 -34.01 75.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 71.420000000000002 111.136 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -55.41 -43.65 75.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.262 -0.426 . . . . 73.409999999999997 110.93 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.437 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 60.7 tp60 -78.87 -35.92 43.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.539 -0.3 . . . . 74.340000000000003 111.322 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.35 -32.77 39.89 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.82 0.343 . . . . 74.030000000000001 111.564 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.73 -34.44 52.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.358 -0.383 . . . . 44.509999999999998 111.812 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -19.8 42.24 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.38 0.511 . . . . 72.439999999999998 112.38 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.512 ' CZ3' ' HA ' ' A' ' 63' ' ' LYS . 99.3 m95 -100.91 -4.33 27.92 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.281 0.845 . . . . 73.230000000000004 113.281 -174.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.526 ' HB2' ' HZ2' ' A' ' 52' ' ' LYS . 10.1 mtmp? -65.18 127.57 32.23 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.877 -0.514 . . . . 75.319999999999993 111.272 178.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.27 -1.47 67.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.312 -0.47 . . . . 71.340000000000003 113.785 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.3 134.1 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 117.299 0.55 . . . . 63.420000000000002 111.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -83.56 161.07 21.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.403 0.52 . . . . 65.349999999999994 112.403 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -78.4 116.34 18.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.88 -0.6 . . . . 75.400000000000006 111.404 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -127.25 97.48 4.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.166 0.508 . . . . 74.329999999999998 110.638 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 40.7 tp -70.85 104.94 3.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.095 -0.502 . . . . 72.420000000000002 111.648 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.17 -63.61 0.56 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.362 -0.447 . . . . 74.530000000000001 112.781 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.92 99.35 2.11 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.221 -0.514 . . . . 60.229999999999997 112.532 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.55 ' HA ' HG13 ' A' ' 66' ' ' ILE . 76.4 p -84.09 105.9 15.32 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.068 0.395 . . . . 74.319999999999993 112.068 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -156.89 163.21 39.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.129 0.49 . . . . 71.319999999999993 112.167 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 39.2 ttmt -67.04 -11.76 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.272 0.558 . . . . 74.420000000000002 111.502 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -94.95 11.46 31.77 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.221 0.534 . . . . 75.109999999999999 110.748 177.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.5 123.25 1.57 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.159 -0.776 . . . . 71.129999999999995 111.159 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.55 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.8 tt -155.72 152.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 117.953 0.876 . . . . 73.439999999999998 112.706 -171.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.549 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -93.21 179.31 5.46 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.994 0.426 . . . . 73.310000000000002 111.509 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.53 -54.35 41.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.554 0.576 . . . . 63.219999999999999 112.554 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.5 p -62.13 -34.39 76.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.108 0.48 . . . . 71.109999999999999 111.71 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.67 -44.19 72.17 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.832 -0.699 . . . . 71.439999999999998 112.292 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -56.96 -52.31 65.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.866 0.365 . . . . 73.420000000000002 111.851 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.8 p -59.82 -41.92 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 74.319999999999993 111.386 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 5.7 tt0 -55.24 -54.82 38.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.363 0.601 . . . . 75.310000000000002 111.169 174.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -56.33 -54.38 46.17 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.44 -0.8 . . . . 74.239999999999995 111.73 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.437 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 66.1 m -52.87 -48.06 67.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.054 0.39 . . . . 71.129999999999995 112.054 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 38.3 m-85 -70.18 -35.23 73.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.983 0.735 . . . . 74.040000000000006 112.983 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -80.31 -33.52 37.5 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.722 -0.611 . . . . 74.129999999999995 111.806 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -72.64 -33.61 66.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.978 0.418 . . . . 72.400000000000006 111.53 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -102.35 -56.7 2.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.803 0.668 . . . . 74.129999999999995 112.803 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.54 -3.59 54.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.403 0.52 . . . . 75.540000000000006 112.403 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.49 22.79 66.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.429 -0.415 . . . . 74.510000000000005 113.012 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.508 HD23 HD23 ' A' ' 159' ' ' LEU . 46.4 tp -86.94 130.21 34.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.196 0.522 . . . . 74.310000000000002 111.97 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.67 101.38 10.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 111.496 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 73' ' ' GLN . 83.9 mt -111.99 139.83 22.78 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.292 . . . . 73.109999999999999 111.242 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.61 148.92 54.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.351 2.034 . . . . 71.120000000000005 112.751 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -83.37 65.22 8.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.352 0.596 . . . . 74.040000000000006 110.177 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 13.2 t -171.0 120.24 0.52 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.688 -0.687 . . . . 74.549999999999997 111.029 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.56 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 53.5 m -52.06 -41.62 62.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.946 0.403 . . . . 73.219999999999999 111.001 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -60.83 -46.53 90.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.181 -0.463 . . . . 70.450000000000003 111.322 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.99 -37.66 88.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.934 0.397 . . . . 74.019999999999996 111.322 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 87' ' ' SER . 95.2 mt-30 -67.07 -36.12 81.33 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.027 0.38 . . . . 74.329999999999998 112.027 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 88' ' ' THR . 23.6 mt-30 -52.89 -55.15 25.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.307 0.575 . . . . 74.230000000000004 111.545 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.08 0.9 17.12 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.598 0.592 . . . . 73.230000000000004 112.598 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 88.0 mmm -91.88 -13.43 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.682 0.277 . . . . 73.0 111.369 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.427 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -135.52 156.1 22.55 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.077 -0.583 . . . . 55.340000000000003 113.535 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 34.1 mmtp -94.37 152.84 18.32 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.482 -0.422 . . . . 74.450000000000003 111.367 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 79.3 p -84.44 157.26 21.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.149 0.796 . . . . 73.150000000000006 113.149 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.34 158.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 115.28 -0.873 . . . . 73.140000000000001 111.536 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.6 t -94.41 178.27 5.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.168 0.433 . . . . 73.430000000000007 112.168 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -51.3 -54.91 21.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.854 0.687 . . . . 73.140000000000001 112.854 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -74.17 -8.25 55.53 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.606 0.595 . . . . 72.439999999999998 112.606 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -107.45 3.67 25.38 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.205 0.446 . . . . 64.129999999999995 112.205 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.06 122.93 16.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.797 0.332 . . . . 73.340000000000003 111.843 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -105.72 154.36 20.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.372 -0.376 . . . . 74.140000000000001 110.602 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.3 m -66.35 119.52 11.71 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.916 -0.49 . . . . 75.530000000000001 110.855 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.47 -11.18 23.8 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.361 -0.447 . . . . 74.209999999999994 112.626 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.57 138.41 53.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.228 0.537 . . . . 74.510000000000005 111.412 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 72' ' ' VAL . 23.5 mt -86.62 117.04 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.8 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -95.23 118.87 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.433 0.635 . . . . 72.140000000000001 111.418 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 70.1 mt -93.1 127.02 38.48 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.613 -0.721 . . . . 73.409999999999997 111.867 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.67 133.58 55.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.328 -0.396 . . . . 73.420000000000002 111.126 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -75.87 92.06 3.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.904 0.383 . . . . 74.409999999999997 110.832 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 112.21 0.448 . . . . 63.450000000000003 112.21 -175.783 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 8.2 mpt_? . . . . . 0 N--CA 1.468 0.425 0 CA-C-O 121.009 0.433 . . . . 75.450000000000003 111.223 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -102.4 151.89 21.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.474 -0.33 . . . . 72.340000000000003 110.213 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.71 137.77 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.149 0.499 . . . . 62.009999999999998 112.279 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.18 159.29 23.97 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.082 -0.508 . . . . 73.329999999999998 112.598 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 72' ' ' VAL . 45.0 mt -92.22 106.57 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.536 -0.391 . . . . 75.329999999999998 111.418 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -65.74 120.79 13.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.818 0.342 . . . . 64.439999999999998 111.32 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.51 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.9 pt -102.98 -37.61 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.348 0.499 . . . . 65.209999999999994 112.348 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.27 142.05 4.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.381 -0.914 . . . . 38.240000000000002 114.086 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.52 -79.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.453 0.701 . . . . 70.530000000000001 111.822 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.508 ' OD1' ' HB3' ' A' ' 142' ' ' SER . 7.8 p30 -150.8 9.08 0.59 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.134 -0.484 . . . . 75.319999999999993 110.92 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -89.28 143.01 27.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.112 0.482 . . . . 74.340000000000003 111.22 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 19.1 p90 -153.92 145.15 22.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 64.530000000000001 111.325 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.13 129.95 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.188 0.518 . . . . 75.299999999999997 110.86 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -150.65 -178.52 6.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.349 -0.387 . . . . 73.109999999999999 111.394 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -110.73 99.6 8.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.986 0.422 . . . . 64.099999999999994 111.482 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.9 t -66.25 136.23 55.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.126 -0.488 . . . . 74.409999999999997 111.452 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -57.28 -25.73 59.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.237 0.458 . . . . 73.349999999999994 112.237 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.8 t -99.56 -60.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.14 0.422 . . . . 52.409999999999997 112.14 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.8 m -73.32 -52.82 12.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.587 0.588 . . . . 75.319999999999993 112.587 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 -146.9 16.61 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.489 -0.386 . . . . 73.299999999999997 112.279 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.75 106.58 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 117.373 0.587 . . . . 74.010000000000005 112.001 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.24 174.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 120.988 0.423 . . . . 72.319999999999993 111.568 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.5 mt -105.41 123.26 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.526 -0.306 . . . . 73.239999999999995 111.213 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -116.37 173.58 6.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.658 0.266 . . . . 53.329999999999998 111.287 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.508 ' HB3' ' OD1' ' A' ' 127' ' ' ASN . 67.6 m -137.82 139.48 39.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.554 0.576 . . . . 75.109999999999999 112.554 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.504 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 67.7 mtm -78.65 8.74 4.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.954 0.724 . . . . 64.530000000000001 112.954 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.444 ' ND2' ' HB3' ' A' ' 142' ' ' SER . 10.4 p30 -78.6 -21.13 48.99 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.62 -0.675 . . . . 75.030000000000001 109.685 166.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.54 126.01 92.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.626 -0.716 . . . . 75.25 110.423 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.414 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 86.8 Cg_exo -43.7 -48.46 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.134 2.556 . . . . 72.310000000000002 114.298 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.539 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.6 t80 -57.4 -48.74 78.28 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.865 0.32 . . . . 75.329999999999998 111.865 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -73.97 -39.48 63.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.021 0.439 . . . . 71.5 111.405 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -55.0 -44.33 74.4 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.847 -0.615 . . . . 74.109999999999999 112.159 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.7 ptpt -91.21 -19.65 22.81 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.444 0.535 . . . . 71.120000000000005 112.444 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -83.21 -16.84 44.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.074 -0.391 . . . . 74.140000000000001 111.33 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -58.73 111.9 1.44 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.054 0.455 . . . . 74.349999999999994 111.898 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -85.85 -58.5 2.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.37 -0.377 . . . . 74.310000000000002 110.794 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -166.46 152.14 8.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.798 0.332 . . . . 74.0 111.211 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -105.57 145.16 31.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.521 -0.309 . . . . 73.120000000000005 110.637 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 63.5 mtt180 -134.59 118.82 17.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.893 0.377 . . . . 74.319999999999993 111.42 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.457 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -80.8 125.69 30.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.094 0.473 . . . . 75.430000000000007 111.473 -178.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.21 -10.49 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.364 -0.38 . . . . 55.310000000000002 112.012 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.508 HD23 HD23 ' A' ' 82' ' ' LEU . 91.1 mt . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.936 0.398 . . . . 72.409999999999997 111.545 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 24.7 m-20 . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.542 0.211 . . . . 74.329999999999998 110.522 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.7 t -50.07 -50.93 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.286 . . . . 72.209999999999994 111.34 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.26 -44.6 75.74 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.814 0.34 . . . . 71.430000000000007 111.578 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 35.3 t -59.74 -39.96 86.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.931 0.396 . . . . 73.319999999999993 111.011 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.528 ' HA ' ' HE ' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -67.39 -42.05 83.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.349 -0.387 . . . . 74.209999999999994 111.826 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 40' ' ' VAL . 48.7 mt -64.31 -45.13 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.006 0.431 . . . . 73.120000000000005 111.089 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.497 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 29.9 mmt -65.76 -36.31 83.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.902 0.382 . . . . 72.409999999999997 110.871 176.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -47.72 74.29 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.209999999999994 110.958 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.512 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 8.0 tp60 -66.04 -47.86 72.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.947 -0.57 . . . . 72.209999999999994 110.894 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.502 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 17.0 t80 -55.8 -32.66 63.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.141 -0.481 . . . . 75.329999999999998 111.382 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.41 -33.07 58.65 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.049 0.452 . . . . 71.129999999999995 111.632 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.32 -20.96 31.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.231 0.456 . . . . 74.519999999999996 112.231 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -113.75 17.84 17.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.693 0.627 . . . . 74.409999999999997 112.693 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.1 mtmt -62.68 110.41 1.71 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.144 0.497 . . . . 73.439999999999998 112.33 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 21.77 41.84 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.407 0.523 . . . . 75.439999999999998 114.407 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.95 118.67 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 117.577 0.689 . . . . 74.010000000000005 110.967 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -71.73 163.64 27.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.742 0.645 . . . . 74.230000000000004 112.742 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 50.2 t80 -77.85 126.65 31.18 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.701 . . . . 75.420000000000002 111.833 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -138.39 103.08 4.8 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.056 -0.52 . . . . 75.349999999999994 110.156 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 tp -72.04 132.28 44.03 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.96 0.409 . . . . 74.420000000000002 111.716 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 -44.2 3.22 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.203 -0.522 . . . . 73.230000000000004 113.175 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.75 60.54 2.41 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 122.509 -0.407 . . . . 73.409999999999997 112.749 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' HG13 ' A' ' 66' ' ' ILE . 99.1 p -67.26 113.62 5.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.053 0.454 . . . . 52.119999999999997 112.161 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 2.6 t -164.74 171.57 14.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.991 -0.55 . . . . 74.299999999999997 110.89 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.658 ' HB2' ' HZ3' ' A' ' 63' ' ' LYS . 4.1 ttmp? -69.96 -14.4 62.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.658 -0.651 . . . . 75.530000000000001 111.32 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.67 2.38 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.948 0.404 . . . . 75.519999999999996 110.958 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.23 121.37 0.97 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.178 -0.769 . . . . 63.310000000000002 111.178 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.5 tt -149.54 158.6 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 74.519999999999996 112.421 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.93 174.39 6.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.039 0.447 . . . . 71.530000000000001 111.621 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.8 p -65.09 -53.29 47.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.576 0.584 . . . . 71.019999999999996 112.576 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 12.2 p -59.04 -39.62 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.978 0.362 . . . . 72.349999999999994 111.978 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.98 -37.91 92.44 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.021 -0.609 . . . . 72.409999999999997 112.821 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -63.17 -53.97 44.91 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.641 0.258 . . . . 71.319999999999993 111.367 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.53 -43.93 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 112.249 0.463 . . . . 74.219999999999999 112.249 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.8 -37.04 80.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.924 0.392 . . . . 74.310000000000002 110.912 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 84.1 mtt85 -69.53 -50.05 48.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.993 0.368 . . . . 75.439999999999998 111.993 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -52.71 -48.16 66.81 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.096 0.474 . . . . 63.32 111.582 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.8 m-85 -69.72 -36.38 75.83 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.698 . . . . 75.310000000000002 112.886 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 6.4 ptm180 -68.42 -32.06 71.84 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.949 -0.469 . . . . 71.400000000000006 111.201 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.488 ' HG3' HE22 ' A' ' 47' ' ' GLN . 27.2 mm-40 -74.47 -62.18 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.166 0.508 . . . . 72.450000000000003 111.225 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.512 ' OE1' ' HB2' ' A' ' 47' ' ' GLN . 3.0 mp0 -72.1 -44.76 62.71 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.758 0.651 . . . . 74.140000000000001 112.758 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -110.81 -3.6 15.65 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.066 0.765 . . . . 72.129999999999995 113.066 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 22.44 68.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.824 -0.703 . . . . 60.350000000000001 113.068 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.1 tp -95.47 121.52 37.24 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 75.230000000000004 111.31 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.59 110.34 22.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.952 0.406 . . . . 63.340000000000003 111.769 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.9 mt -97.29 152.71 38.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.472 -0.331 . . . . 73.200000000000003 111.221 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.5 175.67 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.433 2.089 . . . . 74.329999999999998 112.963 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 86' ' ' ARG . 34.6 mmt-85 -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.873 1.064 . . . . 74.5 113.873 -167.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 84.4 p -130.6 147.05 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.806 -0.559 . . . . 70.450000000000003 111.882 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.587 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.4 m -53.32 -40.13 64.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.271 -0.422 . . . . 73.329999999999998 111.274 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -49.65 -43.49 46.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.022 -0.535 . . . . 71.430000000000007 111.104 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.62 -40.96 32.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.769 -0.65 . . . . 73.439999999999998 111.355 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 87' ' ' SER . 91.6 mt-30 -57.58 -31.16 65.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.197 0.443 . . . . 73.040000000000006 112.197 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 88' ' ' THR . 37.7 mt-30 -58.45 -33.58 69.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.0 0.37 . . . . 74.450000000000003 112.0 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.92 -25.24 62.67 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.932 0.345 . . . . 74.409999999999997 111.932 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 92.4 mmm -69.32 -43.82 72.95 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.552 0.575 . . . . 72.230000000000004 112.552 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -102.42 160.28 17.46 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.803 -0.713 . . . . 75.150000000000006 114.305 -172.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 75.1 mmtt -91.26 147.31 23.14 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.807 0.337 . . . . 73.439999999999998 111.524 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 41.0 m -76.01 150.72 37.34 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.343 0.868 . . . . 74.129999999999995 113.343 -172.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.5 137.95 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.677 -0.692 . . . . 72.230000000000004 111.739 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.7 t -80.13 176.21 9.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.957 -0.565 . . . . 72.310000000000002 111.789 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.421 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -54.49 -50.31 68.07 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.754 0.65 . . . . 74.319999999999993 112.754 -175.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -70.11 -14.91 62.87 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.23 0.456 . . . . 73.340000000000003 112.23 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -102.31 4.52 39.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.302 0.482 . . . . 73.549999999999997 112.302 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.19 138.74 49.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.961 0.41 . . . . 74.040000000000006 111.591 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -134.08 174.48 10.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.948 0.404 . . . . 75.129999999999995 110.852 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.6 m -71.7 103.72 3.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.692 0.282 . . . . 63.329999999999998 111.39 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 133.13 -12.99 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.282 -0.485 . . . . 53.240000000000002 113.467 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 157' ' ' ARG . 7.4 m-20 -71.15 147.31 48.51 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.237 0.542 . . . . 64.329999999999998 111.599 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 mt -94.28 123.11 37.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.347 -0.388 . . . . 72.430000000000007 110.769 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 m -96.35 116.06 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.251 0.548 . . . . 71.439999999999998 111.245 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.2 mt -92.41 121.85 34.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.593 -0.731 . . . . 75.329999999999998 111.4 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -114.3 166.41 11.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.598 0.713 . . . . 71.430000000000007 112.188 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 68.1 mtp180 -103.8 109.79 21.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.28 -0.873 . . . . 73.209999999999994 109.474 172.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.596 0 O-C-N 122.126 -0.359 . . . . 63.450000000000003 111.599 -172.412 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.118 0.485 . . . . 74.340000000000003 111.526 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -113.32 156.21 23.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.076 -0.511 . . . . 71.129999999999995 110.096 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.88 137.94 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.387 0.613 . . . . 64.129999999999995 112.254 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.77 155.91 21.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.747 -0.66 . . . . 64.140000000000001 112.205 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.4 mt -92.37 110.32 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.32 -0.518 . . . . 73.409999999999997 110.972 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.427 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 61.1 t80 -73.77 114.89 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.048 0.451 . . . . 75.019999999999996 111.9 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 pt -95.56 -32.61 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.404 -0.362 . . . . 74.540000000000006 111.801 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 148.11 159.73 8.6 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.9 -0.667 . . . . 73.510000000000005 113.654 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 53.96 46.81 24.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.988 0.515 . . . . 73.230000000000004 112.267 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 142' ' ' SER . 44.2 m-80 67.18 -1.11 1.55 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.446 0.536 . . . . 74.209999999999994 112.446 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.22 141.99 28.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.353 0.597 . . . . 74.200000000000003 112.127 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -155.42 146.59 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.438 -0.801 . . . . 74.150000000000006 111.271 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.43 133.86 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.936 0.398 . . . . 65.420000000000002 111.089 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 9.3 p80 -158.72 165.28 34.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.513 -0.312 . . . . 72.310000000000002 111.404 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.35 95.75 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.038 0.447 . . . . 72.420000000000002 111.407 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 32.7 t -70.19 142.37 52.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.327 -0.397 . . . . 63.140000000000001 111.719 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -53.28 -41.37 65.5 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.658 0.614 . . . . 71.319999999999993 112.658 -176.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.1 t -108.16 -44.21 4.21 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.842 0.353 . . . . 72.329999999999998 111.802 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.1 m -76.57 -19.14 58.21 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.824 0.675 . . . . 65.400000000000006 112.824 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.73 -164.61 45.1 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.065 -0.588 . . . . 70.439999999999998 113.497 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 60.4 t -65.06 96.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.308 0.575 . . . . 75.430000000000007 111.192 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.8 pt -129.19 174.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.564 . . . . 73.439999999999998 111.648 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.1 mt -107.84 104.34 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.108 -0.496 . . . . 74.519999999999996 110.575 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.5 m -96.91 -173.39 2.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.807 0.337 . . . . 72.439999999999998 111.099 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 19.7 m -148.19 135.8 20.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.995 0.369 . . . . 73.109999999999999 111.995 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 59.3 mtm -74.46 5.19 4.93 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.015 0.376 . . . . 71.239999999999995 112.015 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -85.18 -6.96 59.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.02 0.438 . . . . 63.420000000000002 110.175 170.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -78.5 137.12 59.45 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.285 171.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 10.2 Cg_endo -51.83 -46.44 32.15 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.328 2.019 . . . . 71.329999999999998 113.259 -177.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.428 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 80.3 t80 -60.88 -47.7 85.17 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.809 0.3 . . . . 64.150000000000006 111.809 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -71.75 -37.07 70.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.915 0.388 . . . . 75.510000000000005 111.333 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.46 -42.99 93.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.076 0.465 . . . . 73.010000000000005 111.582 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.0 ptpt -88.09 1.74 53.59 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.051 0.389 . . . . 73.319999999999993 112.051 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 2.6 mpt_? -109.04 -16.87 14.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.555 0.206 . . . . 75.409999999999997 111.555 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.421 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 53.3 t80 -57.57 109.71 0.75 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.059 0.456 . . . . 63.350000000000001 111.548 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -85.65 -55.01 4.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.136 0.493 . . . . 74.209999999999994 110.331 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -173.24 169.65 4.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.938 -0.574 . . . . 63.43 110.42 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.62 146.68 47.23 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.229 -0.295 . . . . 72.420000000000002 111.311 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 91.3 mtt180 -142.69 135.05 27.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.932 0.396 . . . . 75.540000000000006 111.997 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.468 ' HB3' ' OD2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -95.56 117.0 29.62 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.172 0.51 . . . . 74.409999999999997 111.255 176.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.72 0.65 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.95 -0.568 . . . . 70.010000000000005 112.041 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 82' ' ' LEU . 79.1 mt . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 112.693 0.627 . . . . 70.340000000000003 112.693 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 120.678 0.275 . . . . 74.420000000000002 110.565 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.67 -48.09 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.149 0.5 . . . . 75.439999999999998 111.463 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 105' ' ' THR . 88.3 tttt -55.02 -46.93 75.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.791 -0.641 . . . . 73.319999999999993 111.593 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t -58.61 -45.18 89.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.842 0.312 . . . . 60.409999999999997 111.842 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -62.67 -39.08 92.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.868 0.366 . . . . 74.519999999999996 111.314 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.35 -46.74 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.922 0.391 . . . . 72.219999999999999 111.35 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 94.3 mmm -62.23 -37.93 87.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.912 0.387 . . . . 73.329999999999998 111.158 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.1 -45.27 93.52 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 72.299999999999997 110.796 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.718 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 59.0 tp60 -62.01 -46.77 87.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.156 -0.474 . . . . 65.109999999999999 111.132 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.446 ' HH ' ' HA ' ' A' ' 139' ' ' ILE . 20.0 t80 -58.16 -37.95 75.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.427 -0.351 . . . . 74.209999999999994 111.208 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.95 -32.65 47.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.027 0.442 . . . . 75.120000000000005 111.596 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.63 -42.06 61.96 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.001 0.429 . . . . 70.099999999999994 111.348 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.08 4.65 52.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.767 0.654 . . . . 73.239999999999995 112.767 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 50.5 mttm -54.32 112.15 0.93 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.724 0.297 . . . . 75.310000000000002 111.328 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.07 55.15 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.09 -0.576 . . . . 61.420000000000002 114.401 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.66 137.39 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.818 0.809 . . . . 75.200000000000003 111.462 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -76.04 166.89 22.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.128 0.489 . . . . 75.319999999999993 111.724 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -91.32 140.05 30.15 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.481 0.658 . . . . 75.129999999999995 112.567 -173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 65.8 ttt180 -131.57 176.87 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.611 -0.722 . . . . 73.400000000000006 109.944 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.4 mt -129.43 94.94 3.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.983 0.42 . . . . 74.040000000000006 111.407 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.38 55.01 2.68 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.362 -0.447 . . . . 44.219999999999999 113.357 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.436 ' HA3' ' NH1' ' A' ' 57' ' ' ARG . . . -177.51 104.47 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.928 -0.653 . . . . 72.510000000000005 113.474 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.8 p -78.64 115.05 18.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.935 0.398 . . . . 74.430000000000007 111.901 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -169.97 160.85 8.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.449 -0.342 . . . . 74.019999999999996 111.335 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.34 -6.99 44.21 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 73.439999999999998 111.002 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.58 -10.71 59.37 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.519999999999996 110.919 172.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.97 141.72 3.21 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.322 -0.399 . . . . 53.530000000000001 112.561 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.5 tp -141.31 143.44 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 122.446 -0.443 . . . . 71.409999999999997 111.65 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -93.91 166.48 12.15 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.259 0.552 . . . . 74.209999999999994 112.421 177.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 29.9 t -51.74 -54.34 29.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.615 -0.72 . . . . 62.240000000000002 112.319 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.1 p -67.6 -44.98 76.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.505 -0.316 . . . . 74.329999999999998 111.249 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.78 -40.02 56.13 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.435 -0.412 . . . . 75.209999999999994 113.767 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -61.09 -57.78 11.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.591 -0.358 . . . . 72.219999999999999 111.532 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HA ' HD12 ' A' ' 122' ' ' ILE . 7.1 p -59.59 -36.49 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.917 0.389 . . . . 74.239999999999995 111.24 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 20.3 mt-30 -55.67 -61.17 2.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.385 -0.37 . . . . 71.109999999999999 111.673 175.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -60.02 -35.46 75.14 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.129 0.418 . . . . 75.200000000000003 112.129 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.718 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 99.7 m -56.12 -54.87 39.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 73.120000000000005 111.84 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.8 m-85 -75.03 -31.22 61.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.238 0.829 . . . . 71.530000000000001 113.238 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -76.05 -43.93 41.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.571 0.582 . . . . 74.549999999999997 112.571 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.04 -33.42 59.61 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.596 0.591 . . . . 73.200000000000003 112.596 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -87.28 -56.41 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.417 0.525 . . . . 75.420000000000002 112.417 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.08 -15.71 18.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.691 0.626 . . . . 74.209999999999994 112.691 -173.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.96 47.74 11.03 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.817 -0.706 . . . . 64.099999999999994 112.6 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 51.1 tp -104.86 137.71 42.22 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.14 0.495 . . . . 64.420000000000002 111.791 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.31 115.84 24.1 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.28 0.562 . . . . 73.420000000000002 111.438 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 73' ' ' GLN . 93.5 mt -127.37 151.41 74.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 122.137 -0.352 . . . . 71.519999999999996 111.625 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.98 -154.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.142 2.561 . . . . 74.319999999999993 112.902 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -110.06 -25.97 9.94 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.915 0.709 . . . . 74.430000000000007 112.915 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -120.72 148.66 43.66 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.828 -0.545 . . . . 73.409999999999997 112.305 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 26.2 m -52.54 -46.17 66.65 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.95 -0.568 . . . . 74.209999999999994 111.904 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -52.14 -32.35 35.22 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.075 -0.511 . . . . 73.349999999999994 111.545 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.22 -37.41 28.64 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.978 -0.556 . . . . 70.400000000000006 111.033 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.437 ' NE2' ' HG3' ' A' ' 73' ' ' GLN . 85.8 mt-30 -61.61 -32.61 72.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.238 -0.437 . . . . 64.400000000000006 111.384 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 88' ' ' THR . 17.1 mt-30 -52.71 -41.63 64.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.164 0.506 . . . . 74.319999999999993 111.547 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -77.73 -11.4 59.87 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.333 0.494 . . . . 75.540000000000006 112.333 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.4 mmm -80.91 -4.66 55.68 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.431 0.53 . . . . 74.510000000000005 112.431 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' A' ' 156' ' ' ARG . . . -151.8 163.25 29.99 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.86 -0.686 . . . . 45.549999999999997 113.091 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 92.1 mttt -86.21 172.27 10.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 75.329999999999998 111.793 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 77.9 p -95.59 141.43 29.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.843 -0.617 . . . . 71.329999999999998 112.624 -171.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 155' ' ' ALA . 5.1 m -131.98 158.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.796 -0.638 . . . . 40.119999999999997 111.282 175.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.8 t -100.13 176.55 5.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.376 -0.375 . . . . 61.530000000000001 111.833 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -47.53 -48.24 27.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.097 0.475 . . . . 75.019999999999996 112.176 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.2 m -69.11 -28.53 66.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.244 -0.434 . . . . 74.430000000000007 111.88 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 13.4 m120 -87.06 -13.86 43.13 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.112 0.412 . . . . 71.439999999999998 112.112 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -51.95 128.01 22.93 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.863 0.363 . . . . 74.450000000000003 111.688 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 102' ' ' ASN . 50.7 mtp85 -129.01 173.18 10.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.224 -0.444 . . . . 71.319999999999993 111.571 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 41' ' ' LYS . 36.7 m -69.49 122.28 18.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.279 -0.418 . . . . 72.400000000000006 111.631 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.27 11.34 52.4 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.241 -0.504 . . . . 75.129999999999995 113.177 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.402 ' OD1' ' HB1' ' A' ' 155' ' ' ALA . 9.5 t70 -84.44 152.84 23.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.824 0.345 . . . . 65.510000000000005 110.875 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 72' ' ' VAL . 44.0 mt -96.37 103.51 15.42 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 110.66 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -95.56 122.88 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.492 0.663 . . . . 73.120000000000005 111.376 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 154' ' ' GLU . 72.1 mt -96.73 120.37 36.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.463 -0.789 . . . . 73.0 111.735 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -114.15 152.24 31.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.386 0.612 . . . . 75.040000000000006 111.749 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -91.2 106.57 18.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.653 -0.703 . . . . 75.329999999999998 111.09 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.967 0.413 . . . . 74.420000000000002 111.955 -178.725 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.944 0.402 . . . . 75.430000000000007 110.479 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -98.17 141.11 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.18 -0.463 . . . . 75.439999999999998 110.392 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 88' ' ' THR . 14.9 p -119.48 139.8 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 63.130000000000003 111.999 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 151.79 19.79 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.981 -0.554 . . . . 73.400000000000006 112.151 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 72' ' ' VAL . 48.5 mt -88.22 107.62 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.51 -0.406 . . . . 73.510000000000005 110.827 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.22 105.71 1.16 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.77 0.319 . . . . 64.239999999999995 110.914 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.7 pt -91.47 -26.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.476 0.547 . . . . 74.140000000000001 112.476 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 160.94 122.17 0.62 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.154 -1.022 . . . . 75.219999999999999 114.193 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 45.99 81.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.88 0.872 . . . . 70.239999999999995 112.9 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.2 m120 68.21 -19.17 0.15 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.728 1.01 . . . . 70.239999999999995 113.728 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -86.57 141.45 29.01 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.163 0.506 . . . . 74.519999999999996 111.851 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.04 150.8 27.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.983 -0.553 . . . . 71.030000000000001 111.222 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.67 138.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.869 0.366 . . . . 71.219999999999999 111.159 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -157.25 173.58 16.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.226 0.536 . . . . 72.420000000000002 111.734 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -103.65 122.92 46.02 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.078 -0.51 . . . . 75.109999999999999 110.978 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -114.53 159.62 20.18 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.008 0.432 . . . . 75.420000000000002 111.644 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -53.17 -65.82 0.49 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.767 1.025 . . . . 74.219999999999999 113.767 -171.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.8 t -87.06 -36.47 18.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.987 0.422 . . . . 72.120000000000005 112.028 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 m -77.88 -8.97 58.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.745 0.646 . . . . 70.310000000000002 112.745 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.78 -93.93 0.96 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.856 -0.687 . . . . 73.319999999999993 112.855 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 17.7 t -133.73 113.41 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.468 -0.43 . . . . 74.140000000000001 111.024 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.446 ' HA ' ' HH ' ' A' ' 48' ' ' TYR . 37.6 pt -138.24 173.58 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.84 0.681 . . . . 75.230000000000004 112.84 -173.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.5 127.13 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.639 -0.709 . . . . 72.329999999999998 110.388 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 m -119.06 178.18 4.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.981 0.419 . . . . 50.399999999999999 111.202 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.4 m -144.45 139.23 28.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.841 0.353 . . . . 71.319999999999993 111.627 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 75.5 mtm -69.13 3.68 2.0 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.72 0.295 . . . . 71.430000000000007 111.768 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -72.24 -28.8 63.38 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.323 0.582 . . . . 71.140000000000001 109.861 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 37.1 mt-10 -71.61 127.79 90.58 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.737 -0.665 . . . . 74.409999999999997 110.474 176.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 6.2 Cg_endo -47.88 -41.35 32.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.117 2.545 . . . . 74.329999999999998 113.833 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 90.9 t80 -53.6 -53.75 47.35 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.969 0.414 . . . . 73.230000000000004 111.546 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.401 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 88.5 m95 -75.95 -35.35 59.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 73.010000000000005 111.073 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -56.09 -32.63 64.32 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.028 -0.533 . . . . 75.120000000000005 112.129 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.723 ' HB3' ' HZ3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -97.41 -9.07 28.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.46 0.541 . . . . 74.150000000000006 112.46 -178.266 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 30.6 mmt180 -103.79 -3.02 25.47 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.998 0.74 . . . . 74.439999999999998 112.998 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.43 107.32 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.96 0.409 . . . . 73.349999999999994 111.186 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.37 -66.56 0.89 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.25 0.548 . . . . 71.450000000000003 110.346 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.497 ' HG3' HD13 ' A' ' 110' ' ' LEU . 14.2 pt-20 -160.86 -175.65 5.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 64.510000000000005 110.383 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.492 ' HB2' HG21 ' A' ' 98' ' ' VAL . . . -140.22 157.21 45.95 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.616 0.246 . . . . 63.439999999999998 111.507 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 15.3 mmt180 -139.55 109.54 6.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.933 0.346 . . . . 75.150000000000006 111.933 -174.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -88.94 104.24 16.77 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.785 0.802 . . . . 74.329999999999998 111.1 177.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 113.101 0.778 . . . . 73.450000000000003 113.101 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 112.351 0.5 . . . . 74.420000000000002 112.351 -176.274 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 120.662 0.268 . . . . 73.340000000000003 111.399 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.7 t -51.62 -47.94 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.958 0.409 . . . . 74.409999999999997 111.187 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -56.5 -48.54 76.96 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.083 -0.508 . . . . 74.230000000000004 111.722 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -69.05 -32.85 72.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.632 -0.258 . . . . 73.019999999999996 111.674 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -43.68 85.79 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.846 0.355 . . . . 75.200000000000003 111.238 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 40' ' ' VAL . 64.4 mt -65.02 -37.33 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.752 0.311 . . . . 74.439999999999998 110.759 176.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.5 mmt -64.44 -43.66 93.59 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.915 0.388 . . . . 74.329999999999998 111.368 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.0 -42.03 89.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.229 -0.441 . . . . 74.0 111.111 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -51.16 60.07 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.085 0.469 . . . . 71.5 110.036 175.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.5 -34.56 58.52 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.031 -0.532 . . . . 72.319999999999993 111.47 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.51 -33.08 53.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.861 0.362 . . . . 71.319999999999993 111.722 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -31.73 62.95 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.1 0.407 . . . . 73.329999999999998 112.1 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -106.07 12.88 29.85 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.644 0.609 . . . . 71.510000000000005 112.644 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -58.91 95.85 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.121 0.415 . . . . 62.450000000000003 112.121 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.47 27.3 10.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.088 -0.577 . . . . 74.129999999999995 113.898 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.5 t -77.67 127.09 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 122.25 -0.559 . . . . 74.230000000000004 110.796 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 55' ' ' ARG . 7.0 ptp180 -62.77 160.81 13.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.341 0.591 . . . . 75.140000000000001 112.281 -177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 39.8 t80 -84.83 123.26 30.26 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.141 -0.481 . . . . 75.319999999999993 111.97 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -136.97 130.38 31.43 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.423 -0.353 . . . . 74.409999999999997 110.531 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.488 HD11 ' N ' ' A' ' 58' ' ' LEU . 4.5 mp -80.96 112.74 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.615 0.245 . . . . 74.329999999999998 111.434 -175.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.53 3.47 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.035 -0.602 . . . . 65.420000000000002 114.151 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.21 72.57 0.58 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.957 -0.64 . . . . 74.430000000000007 112.778 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 t -69.72 100.81 1.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.301 0.482 . . . . 72.439999999999998 112.301 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 t -152.69 166.5 31.97 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.926 -0.579 . . . . 74.439999999999998 111.305 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.46 -6.49 36.26 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.441 . . . . 61.520000000000003 112.192 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.23 12.54 33.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.18 0.514 . . . . 74.319999999999993 111.006 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.42 126.9 0.93 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.937 -0.574 . . . . 64.129999999999995 112.253 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 18.5 tt -158.59 154.54 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 117.545 0.672 . . . . 70.400000000000006 111.854 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.0 178.19 4.63 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.243 0.544 . . . . 75.140000000000001 112.299 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 12.3 t -58.17 -52.78 64.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.799 -0.637 . . . . 64.230000000000004 112.677 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 t -69.31 -43.32 74.0 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.214 0.53 . . . . 75.319999999999993 110.676 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.43 75.05 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.835 -0.621 . . . . 52.310000000000002 113.157 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -68.5 -48.88 63.28 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 122.395 -0.473 . . . . 74.510000000000005 112.147 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' HD11 ' A' ' 122' ' ' ILE . 12.1 p -61.88 -43.77 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 111.808 0.299 . . . . 73.099999999999994 111.808 -177.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 20.6 pt20 -63.93 -37.72 88.44 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.165 -0.335 . . . . 75.530000000000001 111.484 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 36.0 mmt180 -59.8 -65.92 0.6 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.747 0.308 . . . . 73.349999999999994 111.315 173.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.9 m -44.52 -46.14 9.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.919 0.711 . . . . 75.120000000000005 112.919 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 39.5 m-85 -68.06 -43.22 79.14 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.729 0.64 . . . . 73.540000000000006 112.729 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 8.6 ptp180 -71.91 -30.25 65.17 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.594 -0.691 . . . . 73.230000000000004 111.559 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 mm-40 -68.33 -50.67 51.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 73.430000000000007 111.377 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -87.94 -61.55 1.69 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.451 0.537 . . . . 74.310000000000002 112.451 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.429 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 67.0 m-85 -92.67 -3.19 55.31 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.547 0.573 . . . . 71.519999999999996 112.547 -171.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.49 23.56 72.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.982 -0.627 . . . . 70.120000000000005 112.817 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 38.0 tp -95.12 115.82 27.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.895 0.378 . . . . 74.530000000000001 110.899 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.83 103.87 16.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.211 0.529 . . . . 73.299999999999997 112.179 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.93 146.93 37.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.898 -0.592 . . . . 74.109999999999999 110.521 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.2 172.39 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.546 2.164 . . . . 72.409999999999997 113.641 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -67.8 -48.58 65.88 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.159 0.8 . . . . 74.530000000000001 113.159 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -108.48 144.16 36.48 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.865 -0.522 . . . . 74.400000000000006 112.013 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 32.8 p -46.04 -43.61 14.59 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.827 0.677 . . . . 74.010000000000005 112.827 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.416 ' HA ' HE21 ' A' ' 92' ' ' GLN . 59.2 m-85 -54.08 -35.66 62.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.109 0.48 . . . . 74.400000000000006 111.342 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.76 -38.96 62.08 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.671 -0.695 . . . . 74.209999999999994 110.733 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -63.12 -31.22 72.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.668 -0.696 . . . . 73.140000000000001 111.55 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' A' ' 89' ' ' TYR . 32.5 mt-30 -59.84 -34.87 73.66 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.143 0.497 . . . . 74.099999999999994 110.83 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 8.56 8.88 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.127 -0.488 . . . . 74.519999999999996 112.044 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.6 mmm -97.9 -68.17 0.81 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.928 0.394 . . . . 74.109999999999999 111.635 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.47 164.52 34.76 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.078 -0.582 . . . . 74.430000000000007 113.485 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.439 ' HB2' ' NH1' ' A' ' 157' ' ' ARG . 14.3 mmmm -91.12 150.99 21.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 111.551 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 78.2 p -76.47 115.67 16.44 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.878 0.696 . . . . 74.239999999999995 112.878 -174.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 10.2 m -104.12 152.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.879 -0.601 . . . . 71.230000000000004 111.152 173.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.0 t -97.65 -176.98 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.185 -0.322 . . . . 70.310000000000002 110.826 175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 100' ' ' ARG . 1.4 mpp_? -59.82 -35.47 74.78 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.336 0.495 . . . . 75.150000000000006 112.336 -175.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.2 m -75.69 -12.5 60.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.946 0.35 . . . . 65.209999999999994 111.946 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.2 m120 -103.86 -5.06 22.73 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.204 0.446 . . . . 71.540000000000006 112.204 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.09 125.93 24.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.344 0.498 . . . . 75.340000000000003 112.344 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -141.79 134.69 28.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.639 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.0 m -38.67 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.964 0.727 . . . . 70.340000000000003 112.964 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 159' ' ' LEU . . . 135.51 -0.01 3.38 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.034 -0.603 . . . . 72.420000000000002 114.054 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 4.1 p30 -90.04 158.98 17.08 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 117.706 0.753 . . . . 72.120000000000005 111.436 176.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.7 mt -104.76 120.79 42.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 73.319999999999993 111.165 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 m -94.75 112.98 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.583 0.706 . . . . 60.340000000000003 111.443 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.21 119.51 31.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.641 -0.709 . . . . 73.019999999999996 111.681 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.437 ' HZ ' ' SD ' ' A' ' 143' ' ' MET . 92.2 m-85 -109.4 153.5 23.89 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.415 0.626 . . . . 75.329999999999998 111.922 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -88.39 113.85 24.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.707 -0.679 . . . . 74.420000000000002 109.352 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.372 0 O-C-N 122.095 -0.378 . . . . 74.140000000000001 111.868 -171.654 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.637 0.256 . . . . 73.540000000000006 111.631 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -99.6 124.27 44.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.88 -0.415 . . . . 75.430000000000007 109.88 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.435 HG13 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -110.18 145.04 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.659 0.614 . . . . 74.409999999999997 112.659 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.87 148.73 19.16 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.948 -0.569 . . . . 72.099999999999994 112.147 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.487 HD11 ' HA ' ' A' ' 72' ' ' VAL . 42.4 mt -89.86 106.6 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.168 0.484 . . . . 74.510000000000005 111.183 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 61.3 t80 -71.29 111.34 6.55 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.233 0.54 . . . . 75.230000000000004 111.622 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.7 pt -95.57 -16.81 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.251 -0.431 . . . . 65.129999999999995 111.874 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.21 164.62 11.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.111 -0.566 . . . . 64.340000000000003 112.998 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.8 m120 58.08 32.6 22.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.818 0.342 . . . . 73.329999999999998 111.863 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 142' ' ' SER . 41.2 m-80 65.55 11.29 7.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.367 0.506 . . . . 64.120000000000005 112.367 -177.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -100.34 143.63 30.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.104 0.478 . . . . 73.230000000000004 111.232 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.72 151.96 31.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.901 -0.59 . . . . 71.239999999999995 111.553 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -103.21 141.99 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.244 -0.434 . . . . 72.109999999999999 110.949 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.39 -170.73 3.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.844 0.354 . . . . 73.019999999999996 111.072 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -132.98 108.26 8.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.53 -0.304 . . . . 72.239999999999995 111.017 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.6 p -91.42 155.26 18.59 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.071 0.462 . . . . 74.310000000000002 111.32 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.4 p -66.66 -2.38 4.84 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.632 0.605 . . . . 74.420000000000002 112.632 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.9 t -97.46 -67.47 0.85 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.053 0.39 . . . . 64.200000000000003 112.053 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.4 m -104.72 -6.41 20.39 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.688 0.625 . . . . 54.310000000000002 112.688 -175.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 132' ' ' ALA . . . 84.28 -133.45 11.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.521 -0.847 . . . . 72.099999999999994 112.614 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.06 108.72 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.216 0.45 . . . . 75.030000000000001 112.216 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.8 pt -143.43 179.19 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.228 0.537 . . . . 75.430000000000007 112.155 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.0 mm -106.81 149.9 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 116.176 -0.465 . . . . 73.530000000000001 110.917 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.1 m -148.97 172.19 15.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.77 0.319 . . . . 72.310000000000002 111.421 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.441 ' HB2' ' HG3' ' A' ' 145' ' ' GLU . 50.6 m -129.31 142.91 50.7 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.289 0.566 . . . . 74.239999999999995 112.376 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.437 ' SD ' ' HZ ' ' A' ' 111' ' ' PHE . 86.3 mmm -59.84 -27.11 66.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.717 -0.674 . . . . 74.200000000000003 112.539 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -85.96 3.65 41.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.593 0.59 . . . . 73.549999999999997 112.593 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 142' ' ' SER . 58.7 mt-10 -81.36 125.97 77.65 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 122.236 -0.29 . . . . 70.549999999999997 110.309 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -38.15 -50.11 2.18 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.946 3.098 . . . . 74.519999999999996 115.232 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.38 -43.04 97.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.009 0.374 . . . . 74.219999999999999 112.009 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -81.35 -42.39 20.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.187 0.518 . . . . 75.340000000000003 111.07 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -54.17 -55.55 26.74 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.609 -0.723 . . . . 74.010000000000005 112.751 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -80.33 -11.69 59.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.059 0.392 . . . . 75.099999999999994 112.059 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -99.83 -2.21 35.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.176 0.436 . . . . 74.230000000000004 112.176 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.416 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 68.5 t80 -58.29 126.49 27.77 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.148 0.499 . . . . 71.129999999999995 111.73 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -101.8 -59.5 1.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.482 -0.326 . . . . 72.530000000000001 110.991 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -169.22 145.62 3.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.487 -0.324 . . . . 72.420000000000002 111.456 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.411 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -100.43 146.68 26.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.675 -0.239 . . . . 71.219999999999999 110.404 172.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 45.5 mtp85 -142.62 115.71 8.86 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.25 -0.281 . . . . 75.120000000000005 110.969 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -81.43 122.23 27.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.213 0.53 . . . . 73.040000000000006 111.976 -176.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.96 -20.14 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.561 0.578 . . . . 74.310000000000002 112.561 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.49 HD11 ' HA3' ' A' ' 106' ' ' GLY . 43.8 mt . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.213 0.53 . . . . 74.120000000000005 111.917 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 120.488 0.185 . . . . 71.439999999999998 110.511 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.33 -45.54 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.0 0.429 . . . . 74.0 111.203 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 76.0 tttt -53.38 -50.79 64.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.065 -0.516 . . . . 71.349999999999994 111.46 175.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.5 t -59.36 -44.0 92.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.356 -0.384 . . . . 72.310000000000002 111.59 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -57.17 -53.93 52.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.029 0.442 . . . . 74.239999999999995 110.871 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.02 -39.28 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.98 0.419 . . . . 73.340000000000003 111.791 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.581 ' HA ' ' HE2' ' A' ' 45' ' ' MET . 31.1 mmt -66.24 -28.23 68.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.876 0.324 . . . . 74.040000000000006 111.876 177.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -63.62 -46.63 84.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.18 0.514 . . . . 72.230000000000004 110.044 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.427 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.6 tp60 -63.89 -44.97 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.718 -0.673 . . . . 72.099999999999994 110.385 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.17 -42.09 76.52 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.999 -0.546 . . . . 64.400000000000006 111.333 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.98 -33.22 66.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.034 0.445 . . . . 74.230000000000004 111.617 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -81.96 -26.09 34.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.21 0.529 . . . . 71.319999999999993 111.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -108.25 20.66 18.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.814 0.672 . . . . 75.109999999999999 112.814 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -59.42 101.56 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.901 0.704 . . . . 73.430000000000007 112.901 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.43 38.86 16.36 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.69 -0.687 . . . . 74.219999999999999 114.66 174.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.15 144.19 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 117.547 0.674 . . . . 74.239999999999995 111.081 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -56.54 142.77 38.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.545 0.338 . . . . 73.549999999999997 111.752 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 20.1 t80 -83.64 116.64 22.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.922 -0.399 . . . . 63.329999999999998 109.922 172.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -122.34 105.86 10.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.388 . . . . 62.32 110.49 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.86 116.86 12.74 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.934 0.397 . . . . 73.340000000000003 110.481 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 26.29 35.9 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.967 -0.635 . . . . 72.150000000000006 113.052 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.02 106.71 0.29 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.334 -0.46 . . . . 64.099999999999994 112.409 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.529 ' HA ' HG13 ' A' ' 66' ' ' ILE . 64.6 p -97.32 112.41 24.24 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.486 0.55 . . . . 64.530000000000001 112.486 -175.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.4 t -171.76 172.91 4.73 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.913 0.387 . . . . 74.519999999999996 111.651 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.64 -14.97 61.71 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 122.04 -0.412 . . . . 75.340000000000003 111.502 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -83.03 4.54 25.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.074 0.464 . . . . 75.409999999999997 110.602 172.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.64 132.47 2.61 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.603 -0.599 . . . . 75.120000000000005 111.603 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.529 HG13 ' HA ' ' A' ' 61' ' ' SER . 21.0 tt -151.22 153.09 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 117.391 0.595 . . . . 72.239999999999995 111.912 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -91.9 177.24 6.24 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.326 0.584 . . . . 72.200000000000003 111.985 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.528 ' HA ' ' HB1' ' A' ' 132' ' ' ALA . 32.4 t -62.09 -48.31 80.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.545 0.572 . . . . 71.430000000000007 112.545 -176.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 88' ' ' THR . 17.7 p -78.11 -27.58 48.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.918 0.389 . . . . 53.420000000000002 111.742 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.12 98.98 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.116 -0.564 . . . . 74.239999999999995 112.634 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -59.92 -50.66 72.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.928 0.344 . . . . 74.420000000000002 111.928 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.519 ' HA ' HD13 ' A' ' 122' ' ' ILE . 6.1 p -59.74 -52.82 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.294 0.479 . . . . 71.140000000000001 112.294 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' A' ' 86' ' ' ARG . 4.4 pp0? -65.99 -26.71 67.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.15 0.426 . . . . 72.5 112.15 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.541 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.3 mtp180 -69.31 -53.92 17.23 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.137 -0.352 . . . . 75.129999999999995 111.068 171.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -46.4 -49.61 17.75 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.257 0.551 . . . . 74.200000000000003 111.792 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 67.2 m-85 -68.44 -39.2 81.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.746 0.647 . . . . 73.310000000000002 112.746 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.541 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 11.8 ptp180 -76.75 -25.62 53.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.641 -0.662 . . . . 73.209999999999994 112.159 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.25 -28.27 34.84 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.979 0.362 . . . . 74.140000000000001 111.979 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 85.6 mt-30 -109.05 -61.44 1.62 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.587 0.588 . . . . 74.409999999999997 112.587 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -83.81 -11.67 56.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.928 0.344 . . . . 72.019999999999996 111.928 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.9 71.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.346 -0.454 . . . . 44.420000000000002 113.173 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.4 tp -73.37 123.3 23.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 74.530000000000001 111.53 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -74.29 85.17 1.93 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.401 0.62 . . . . 73.120000000000005 112.434 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.7 mt -106.28 135.2 19.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 122.126 -0.359 . . . . 72.299999999999997 111.215 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.596 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 58.7 Cg_endo -71.27 156.87 58.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.774 2.316 . . . . 75.209999999999994 113.111 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HA ' ' HG2' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -57.0 -43.35 81.65 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.811 1.041 . . . . 75.209999999999994 113.811 -174.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.423 ' N ' ' HG2' ' A' ' 86' ' ' ARG . 73.9 m -102.61 152.4 21.23 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.841 1.052 . . . . 64.230000000000004 113.841 -170.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 69' ' ' SER . 51.4 p -51.45 -58.91 4.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.971 -1.013 . . . . 61.130000000000003 112.969 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -47.24 -35.56 7.85 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.004 -0.543 . . . . 73.450000000000003 112.287 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.66 -42.59 28.23 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.052 -0.522 . . . . 74.040000000000006 111.162 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.16 -22.15 65.65 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.938 0.399 . . . . 72.510000000000005 111.461 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HG2' HD11 ' A' ' 110' ' ' LEU . 27.1 mt-30 -66.44 -34.46 77.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 112.171 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -84.22 -10.84 57.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.457 0.539 . . . . 61.509999999999998 112.457 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.596 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 62.4 mtp -94.78 -70.18 0.72 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.589 0.233 . . . . 75.319999999999993 111.525 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.4 130.31 28.99 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.388 -0.91 . . . . 73.430000000000007 112.277 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -85.27 143.57 28.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.406 0.622 . . . . 71.540000000000006 112.363 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 18.4 m -64.84 144.29 57.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.883 -1.053 . . . . 45.420000000000002 113.354 -170.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.428 ' CG2' ' HD3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -132.44 163.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.838 -0.619 . . . . 75.319999999999993 111.516 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.7 t -116.57 171.68 7.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.402 -0.363 . . . . 72.140000000000001 111.132 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -43.98 -57.64 3.23 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.217 1.191 . . . . 74.049999999999997 114.217 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -69.39 -9.25 52.67 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.981 0.734 . . . . 63.329999999999998 112.981 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -114.97 5.06 14.92 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.502 0.556 . . . . 73.409999999999997 112.502 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.35 133.04 55.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.77 0.319 . . . . 72.409999999999997 111.757 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 104' ' ' ARG . 54.2 mtt180 -108.28 169.44 8.63 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.436 0.636 . . . . 73.129999999999995 112.247 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.7 m -79.85 118.43 21.62 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.192 -0.458 . . . . 75.540000000000006 110.524 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 18.93 33.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.046 -0.597 . . . . 72.25 112.004 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -77.51 159.71 29.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.922 0.489 . . . . 73.530000000000001 110.291 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.0 mt -114.06 109.27 18.18 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.64 -0.663 . . . . 71.530000000000001 111.826 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.59 126.19 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.408 0.623 . . . . 74.010000000000005 111.913 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.425 HD11 ' HG2' ' A' ' 92' ' ' GLN . 83.0 mt -97.97 138.96 34.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.744 -0.662 . . . . 65.430000000000007 111.649 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -124.48 137.99 54.38 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.216 0.532 . . . . 73.230000000000004 111.929 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 33.6 mtp85 -72.56 84.01 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.976 -0.556 . . . . 74.129999999999995 110.533 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 112.381 0.512 . . . . 51.329999999999998 112.381 -174.604 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 111.864 0.32 . . . . 74.030000000000001 111.864 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -115.64 149.22 38.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.413 -0.358 . . . . 72.439999999999998 110.178 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.61 135.34 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.154 0.502 . . . . 74.340000000000003 112.147 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -123.3 148.57 16.79 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.21 -0.519 . . . . 72.129999999999995 113.226 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 72' ' ' VAL . 40.2 mt -82.47 107.51 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.796 0.332 . . . . 73.310000000000002 110.797 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.7 104.35 2.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.119 -0.491 . . . . 73.239999999999995 111.616 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.411 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 38.2 pt -102.18 -17.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.743 0.645 . . . . 75.120000000000005 112.743 -176.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.69 -170.31 16.35 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.524 -0.846 . . . . 44.450000000000003 113.9 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -58.31 -32.77 68.78 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.68 0.392 . . . . 73.019999999999996 111.884 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -137.52 -26.46 0.98 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.226 -0.443 . . . . 74.239999999999995 112.153 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -85.26 140.87 30.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.03 0.752 . . . . 74.310000000000002 113.03 -175.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -148.38 142.95 26.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.461 -0.79 . . . . 72.129999999999995 110.982 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.82 137.2 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.975 0.416 . . . . 75.200000000000003 111.558 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -155.92 163.55 39.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.989 0.424 . . . . 74.430000000000007 111.74 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 68' ' ' CYS . . . -94.54 97.85 10.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.019 0.438 . . . . 61.420000000000002 110.832 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 80.9 p -81.7 142.06 33.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.175 0.512 . . . . 72.340000000000003 111.714 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.0 t -69.24 -7.04 33.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.233 -0.44 . . . . 72.439999999999998 112.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.3 p -101.52 -59.74 1.65 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.842 0.353 . . . . 44.520000000000003 111.834 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.463 ' HB2' HD12 ' A' ' 139' ' ' ILE . 68.6 m -109.5 13.79 23.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.399 0.518 . . . . 65.420000000000002 112.399 -175.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.65 -152.5 52.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.0 -0.619 . . . . 65.319999999999993 112.883 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 53.6 t -64.74 106.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.458 -0.436 . . . . 64.019999999999996 111.764 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 136' ' ' SER . 35.9 pt -136.82 -175.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.101 0.477 . . . . 73.329999999999998 111.703 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.28 129.11 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.428 -0.351 . . . . 74.439999999999998 110.965 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.7 m -118.53 174.44 6.25 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.876 0.37 . . . . 71.200000000000003 111.809 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.8 t -124.53 142.34 51.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.297 0.48 . . . . 75.420000000000002 112.297 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 85.0 mmm -63.39 -17.16 62.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.156 -0.474 . . . . 61.049999999999997 111.284 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -74.0 -18.04 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.324 -0.398 . . . . 71.439999999999998 111.617 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.09 130.22 93.82 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.786 -0.188 . . . . 73.439999999999998 111.118 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.484 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 85.2 Cg_exo -47.93 -51.97 8.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.907 2.404 . . . . 65.030000000000001 114.059 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.422 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 94.4 t80 -58.42 -47.07 85.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.784 0.326 . . . . 71.310000000000002 111.718 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -72.3 -40.14 67.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.784 0.326 . . . . 75.340000000000003 111.591 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.13 -52.64 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.003 0.43 . . . . 73.230000000000004 111.925 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.0 ptpt -78.12 -14.84 59.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.889 0.376 . . . . 72.209999999999994 111.988 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.536 ' HA ' ' HE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -91.83 -12.07 34.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.19 -0.318 . . . . 74.349999999999994 111.789 175.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.47 105.57 0.16 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.319 0.581 . . . . 74.430000000000007 111.176 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -90.46 -51.56 5.35 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.993 -0.548 . . . . 74.109999999999999 111.54 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -172.76 147.39 1.74 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.865 0.364 . . . . 75.329999999999998 111.204 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -103.01 161.62 13.61 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.356 -0.215 . . . . 73.200000000000003 110.659 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.8 mtm-85 -146.84 113.01 5.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.829 0.347 . . . . 74.219999999999999 111.806 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.428 ' HD3' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.76 96.89 4.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.289 0.566 . . . . 63.140000000000001 111.361 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.4 m -77.21 -29.79 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.953 -0.467 . . . . 65.439999999999998 111.62 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.613 -0.267 . . . . 74.25 110.427 174.995 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.869 0.366 . . . . 74.340000000000003 111.215 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 44' ' ' ILE . 88.9 t -61.84 -49.58 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.211 -0.45 . . . . 75.019999999999996 111.815 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.532 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 87.2 tttt -57.3 -44.88 84.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.34 -0.391 . . . . 75.450000000000003 111.496 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -60.1 -45.18 93.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.264 -0.425 . . . . 74.299999999999997 111.536 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mmm-85 -61.19 -43.57 98.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.073 0.463 . . . . 75.319999999999993 111.111 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 40' ' ' VAL . 73.1 mt -63.09 -47.79 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.021 0.439 . . . . 74.129999999999995 111.372 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.555 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 29.7 mmt -62.86 -29.4 70.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.394 -0.366 . . . . 75.230000000000004 111.522 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.43 -38.84 81.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.651 0.262 . . . . 72.319999999999993 111.166 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -77.54 -31.82 53.54 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.575 0.226 . . . . 73.420000000000002 111.506 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -53.45 -37.53 62.71 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.82 0.343 . . . . 74.510000000000005 111.286 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -24.31 64.47 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.127 0.417 . . . . 71.329999999999998 112.127 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -47.12 24.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.085 0.469 . . . . 72.409999999999997 111.513 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -85.55 16.01 4.17 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.073 0.768 . . . . 75.329999999999998 113.073 -172.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.535 ' HZ1' ' HB3' ' A' ' 52' ' ' LYS . 2.8 mmmp? -68.87 118.33 11.68 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.141 -0.349 . . . . 75.340000000000003 110.952 176.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.64 46.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.302 -0.475 . . . . 75.540000000000006 113.494 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.83 128.94 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.062 0.458 . . . . 75.219999999999999 111.729 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -88.19 179.31 6.4 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.912 -0.586 . . . . 75.140000000000001 111.599 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -91.66 133.02 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.091 0.472 . . . . 75.209999999999994 111.208 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -134.23 113.54 12.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.11 -0.496 . . . . 72.040000000000006 110.192 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.1 mp -57.93 115.2 2.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.924 0.393 . . . . 74.230000000000004 111.717 -175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.39 19.67 74.61 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.122 -0.49 . . . . 54.25 113.665 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.94 143.98 17.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.458 -0.401 . . . . 65.329999999999998 112.886 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.542 ' HA ' HG13 ' A' ' 66' ' ' ILE . 62.0 p -126.76 99.53 5.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.451 -0.441 . . . . 64.430000000000007 111.21 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 t -174.99 165.62 3.49 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.807 0.337 . . . . 73.200000000000003 111.635 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.38 -9.85 59.0 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.107 0.479 . . . . 75.400000000000006 110.909 176.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.11 -1.51 56.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.112 -0.494 . . . . 70.329999999999998 111.281 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.34 124.11 1.57 Allowed Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.248 -0.433 . . . . 74.239999999999995 112.053 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.5 tt -134.03 149.62 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.21 -0.583 . . . . 65.030000000000001 111.922 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.65 160.75 26.22 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.958 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 132' ' ' ALA . 29.4 p -58.86 -53.6 56.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.152 0.501 . . . . 75.310000000000002 110.895 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.428 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 87.6 p -63.8 -33.78 76.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.235 0.541 . . . . 63.409999999999997 110.822 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.525 ' O ' ' HG2' ' A' ' 73' ' ' GLN . . . -67.76 -31.6 76.22 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.817 -0.629 . . . . 74.0 112.954 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -66.13 -47.25 74.7 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.501 -0.411 . . . . 75.109999999999999 111.342 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 122' ' ' ILE . 11.2 p -67.9 -40.02 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 111.977 0.362 . . . . 74.239999999999995 111.977 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 22.0 pt20 -58.69 -41.91 87.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.062 0.458 . . . . 75.230000000000004 110.427 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.649 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 11.5 mmm180 -66.64 -67.0 0.48 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.248 -0.433 . . . . 74.109999999999999 110.929 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 m -40.75 -46.65 2.7 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.441 0.534 . . . . 72.099999999999994 112.441 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 14.0 m-30 -68.88 -39.39 79.82 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.432 0.53 . . . . 71.200000000000003 112.432 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 10.9 ptm180 -79.68 -19.29 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.701 -0.624 . . . . 72.329999999999998 111.846 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.649 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.7 mm-40 -72.28 -47.68 48.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.464 0.649 . . . . 63.43 110.162 175.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -95.12 -53.38 3.83 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.59 -0.732 . . . . 74.209999999999994 112.791 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -93.78 -23.76 18.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.278 0.474 . . . . 74.430000000000007 112.278 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.71 36.32 22.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.053 -0.594 . . . . 74.150000000000006 112.973 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 40.4 tp -95.19 119.22 33.32 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.76 0.314 . . . . 75.25 111.23 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.54 84.19 7.16 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.22 0.452 . . . . 72.040000000000006 112.22 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.67 145.63 30.74 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.5 -0.318 . . . . 73.230000000000004 111.301 176.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 150.11 62.41 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.721 2.28 . . . . 74.439999999999998 112.837 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.82 42.44 0.79 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.214 0.53 . . . . 73.510000000000005 112.205 -176.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.5 m -153.16 117.67 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.116 -0.365 . . . . 72.329999999999998 111.034 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.499 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 17.2 m -48.46 -44.36 35.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.506 0.558 . . . . 74.010000000000005 112.506 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -54.98 -46.42 75.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.76 0.314 . . . . 70.129999999999995 111.751 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -62.78 -42.77 99.85 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.429 0.633 . . . . 75.230000000000004 110.534 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -62.9 -30.55 71.62 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.875 -0.602 . . . . 74.409999999999997 111.755 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 88' ' ' THR . 26.1 mt-30 -63.03 -16.08 58.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.815 0.34 . . . . 72.109999999999999 111.692 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.81 -3.47 26.3 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.77 0.319 . . . . 60.310000000000002 111.438 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.3 mmm -95.18 -13.33 25.08 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.885 0.698 . . . . 73.549999999999997 112.885 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -141.58 154.97 25.05 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.858 -0.687 . . . . 72.239999999999995 113.725 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -96.11 153.35 17.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.04 0.448 . . . . 75.109999999999999 111.495 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 92.9 p -77.69 157.26 30.21 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.937 1.088 . . . . 72.299999999999997 113.937 -170.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.42 147.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 114.893 -1.049 . . . . 75.400000000000006 110.202 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -83.29 164.28 20.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 111.309 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -49.08 -29.89 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.858 0.688 . . . . 72.420000000000002 112.858 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -82.7 -23.19 34.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.887 0.699 . . . . 72.439999999999998 112.887 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -103.5 20.6 17.58 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.496 0.554 . . . . 74.400000000000006 112.496 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.0 mt -69.84 126.09 28.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.025 0.441 . . . . 71.109999999999999 111.918 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -101.72 -164.6 1.11 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.061 0.457 . . . . 74.340000000000003 111.132 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.468 HG23 ' HB2' ' A' ' 41' ' ' LYS . 58.7 m -97.44 109.06 21.89 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.426 -0.352 . . . . 73.430000000000007 110.83 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.54 25.33 6.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.404 -0.427 . . . . 72.219999999999999 113.687 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -94.47 146.28 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.444 -0.445 . . . . 72.230000000000004 111.302 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.1 mt -78.03 108.4 11.27 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.369 -0.378 . . . . 74.340000000000003 111.788 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.6 m -96.81 112.48 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.452 0.644 . . . . 70.430000000000007 111.433 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.37 120.64 28.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.649 -0.705 . . . . 74.430000000000007 111.956 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.6 157.81 20.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.31 0.576 . . . . 74.040000000000006 111.766 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.556 ' HB2' ' HG3' ' A' ' 151' ' ' ARG . 19.6 mtp180 -90.45 103.52 16.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.048 -0.524 . . . . 73.349999999999994 110.832 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . . . . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 71.150000000000006 111.791 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 . . . . . 0 CA--C 1.536 0.421 0 CA-C-O 120.965 0.412 . . . . 75.319999999999993 110.613 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 59.6 t60 -92.93 148.71 21.78 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.277 -0.42 . . . . 74.230000000000004 111.283 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.93 128.98 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.226 0.536 . . . . 74.540000000000006 111.281 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.72 154.44 16.5 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.208 -0.52 . . . . 70.129999999999995 112.93 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 72' ' ' VAL . 49.5 mt -89.65 102.66 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 122.549 -0.383 . . . . 73.439999999999998 110.584 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.414 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 37.2 t80 -73.7 105.24 4.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 75.409999999999997 111.762 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.532 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.0 pt -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.954 0.407 . . . . 61.100000000000001 111.735 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.97 178.71 19.17 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.501 -0.38 . . . . 60.450000000000003 113.032 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 62.67 21.36 12.67 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.689 0.28 . . . . 75.239999999999995 111.139 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 142' ' ' SER . 0.9 OUTLIER 65.12 12.54 8.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.93 0.395 . . . . 65.510000000000005 111.503 -171.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -103.81 145.24 30.39 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.376 0.608 . . . . 72.25 111.235 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 10.5 p90 -150.07 140.73 22.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.953 -0.567 . . . . 70.420000000000002 111.39 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.75 133.12 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.965 0.412 . . . . 70.519999999999996 110.718 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -157.04 154.72 30.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.199 0.523 . . . . 73.230000000000004 111.88 -173.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 68' ' ' CYS . . . -84.41 91.04 7.71 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.952 0.406 . . . . 75.409999999999997 110.155 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -67.47 146.04 54.38 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.108 0.48 . . . . 73.329999999999998 111.628 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.6 p -49.55 -47.91 48.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.606 -0.725 . . . . 71.099999999999994 112.855 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.0 m -98.9 -51.07 3.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.683 0.623 . . . . 71.400000000000006 112.683 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.6 m -80.75 -15.14 57.25 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.259 0.837 . . . . 65.310000000000002 113.259 -170.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.61 -154.93 30.18 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.01 -0.614 . . . . 71.310000000000002 113.036 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.38 102.68 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.864 0.364 . . . . 75.319999999999993 111.958 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.9 pt -140.13 178.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.093 0.473 . . . . 74.140000000000001 111.773 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.19 134.93 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.418 -0.355 . . . . 74.519999999999996 110.76 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.9 m -128.47 172.56 11.02 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 122.267 -0.271 . . . . 73.340000000000003 111.538 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 65.5 m -125.43 141.42 52.07 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.056 0.391 . . . . 65.349999999999994 112.056 -177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.3 mtt -67.4 -15.06 63.47 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.372 0.508 . . . . 73.109999999999999 112.372 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.965 0.412 . . . . 71.450000000000003 111.241 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -71.79 135.59 83.19 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.548 -0.296 . . . . 72.349999999999994 110.734 175.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.27 -48.03 21.68 Favored 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 122.91 2.406 . . . . 70.400000000000006 113.672 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 78.9 t80 -59.39 -50.85 72.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.833 0.349 . . . . 74.409999999999997 111.562 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -71.84 -36.92 70.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.576 -0.284 . . . . 64.219999999999999 111.701 -172.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -53.32 -54.87 30.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.08 0.467 . . . . 75.019999999999996 111.777 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -80.82 -18.86 46.11 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.94 0.348 . . . . 75.439999999999998 111.94 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.556 ' HG3' ' HB2' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -84.68 -15.36 45.56 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.958 -0.464 . . . . 73.310000000000002 111.884 177.531 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -61.26 92.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.296 0.569 . . . . 73.540000000000006 110.301 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -79.08 -46.01 18.93 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.966 -0.561 . . . . 74.329999999999998 111.379 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -172.9 163.58 4.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.979 -0.555 . . . . 72.230000000000004 110.978 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -128.15 149.3 50.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.766 -0.197 . . . . 65.329999999999998 110.718 176.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 95' ' ' GLY . 50.8 mtt180 -138.61 125.92 21.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.184 0.516 . . . . 74.519999999999996 112.016 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.71 120.67 27.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.034 -0.53 . . . . 75.129999999999995 111.242 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.55 -19.53 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.732 0.641 . . . . 70.439999999999998 112.732 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.477 HD23 HD23 ' A' ' 82' ' ' LEU . 91.7 mt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.129 0.49 . . . . 73.200000000000003 112.079 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.403 ' OD2' ' HB3' ' A' ' 41' ' ' LYS . 30.9 t70 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.732 0.301 . . . . 72.5 110.888 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.2 -48.38 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.406 -0.361 . . . . 74.25 111.531 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.9 tttt -60.04 -44.03 94.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.342 -0.39 . . . . 74.420000000000002 111.372 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.7 t -53.19 -49.79 65.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.181 0.437 . . . . 75.340000000000003 112.181 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -63.5 -44.2 95.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.964 0.412 . . . . 74.409999999999997 111.572 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.475 HD13 HG21 ' A' ' 122' ' ' ILE . 67.5 mt -64.36 -36.88 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.957 0.408 . . . . 73.099999999999994 111.365 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 96.0 mmm -65.74 -37.29 85.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.912 0.387 . . . . 72.439999999999998 110.715 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.75 -37.17 78.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.252 0.549 . . . . 54.210000000000001 110.198 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.549 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 7.6 tp60 -62.74 -53.65 51.13 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.013 -0.54 . . . . 75.209999999999994 110.451 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.419 ' HH ' ' HA ' ' A' ' 139' ' ' ILE . 32.0 t80 -51.1 -39.44 56.15 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.053 -0.521 . . . . 74.510000000000005 111.293 177.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.93 71.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.366 . . . . 74.010000000000005 111.685 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.02 -26.91 61.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 75.299999999999997 111.47 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -107.01 11.78 29.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.064 0.764 . . . . 75.519999999999996 113.064 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.78 128.43 35.88 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.959 -0.463 . . . . 72.310000000000002 111.325 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.05 -18.13 58.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.254 -0.498 . . . . 75.409999999999997 113.665 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.58 131.63 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.42 . . . . 74.230000000000004 111.837 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -82.3 178.39 8.27 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.228 0.455 . . . . 71.209999999999994 112.228 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -85.39 121.46 28.15 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.896 0.379 . . . . 71.349999999999994 111.661 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -137.57 115.46 11.5 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 74.510000000000005 110.65 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 21.7 tp -72.87 116.85 13.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.004 0.43 . . . . 72.340000000000003 112.102 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.91 -53.25 3.97 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.369 -0.443 . . . . 73.439999999999998 113.339 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.92 71.48 0.93 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.114 -0.565 . . . . 64.430000000000007 113.236 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.2 p -69.6 106.97 3.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.252 0.549 . . . . 74.0 112.132 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 t -160.94 172.46 16.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.906 -0.588 . . . . 74.099999999999994 111.026 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.5 -14.11 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.911 0.386 . . . . 75.25 111.433 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.73 -16.28 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.887 0.375 . . . . 70.450000000000003 110.903 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.22 144.38 4.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.157 -0.474 . . . . 54.310000000000002 112.222 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.6 tt -155.58 148.21 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 117.444 0.622 . . . . 71.319999999999993 111.506 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 6.4 p-10 -96.08 -171.37 2.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.185 0.517 . . . . 72.400000000000006 112.063 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 24.4 p -70.97 -50.16 37.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.073 -0.512 . . . . 71.109999999999999 112.023 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.443 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 50.5 p -66.76 -40.95 88.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.818 0.342 . . . . 71.420000000000002 110.836 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.29 -40.73 99.4 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.333 -0.461 . . . . 64.150000000000006 113.093 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -65.32 -55.99 15.14 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.666 0.269 . . . . 72.340000000000003 111.553 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.06 -42.23 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.915 0.388 . . . . 63.409999999999997 111.054 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.8 tt0 -52.86 -61.28 2.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 75.310000000000002 111.719 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -56.96 -46.53 82.07 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.544 -0.298 . . . . 75.420000000000002 111.783 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.2 m -49.85 -50.18 46.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.272 0.471 . . . . 71.140000000000001 112.272 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.482 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 85.0 m-85 -80.4 -42.46 22.75 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.849 0.685 . . . . 60.25 112.849 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 14.7 ptm180 -66.66 -33.56 75.93 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.94 -0.475 . . . . 75.329999999999998 111.996 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.446 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 5.0 mm-40 -86.71 -45.93 10.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.961 0.356 . . . . 64.430000000000007 111.961 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.549 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 29.8 mt-30 -83.26 -51.7 7.22 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.613 0.597 . . . . 75.239999999999995 112.613 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -97.15 -6.17 35.51 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.391 0.515 . . . . 71.25 112.391 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.03 43.64 98.88 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.032 -0.604 . . . . 71.310000000000002 112.663 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 52.7 tp -108.89 138.85 44.58 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 73.150000000000006 111.742 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.6 118.06 12.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.551 0.575 . . . . 75.299999999999997 112.551 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 158' ' ' VAL . 60.5 mt -136.72 134.78 19.59 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.83 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.489 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 81.3 Cg_endo -77.35 173.7 13.89 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.726 2.284 . . . . 73.209999999999994 113.409 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -95.55 16.03 18.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 73.230000000000004 112.985 -173.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.0 m -143.06 127.88 18.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.652 0.263 . . . . 70.200000000000003 111.675 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 69' ' ' SER . 26.9 m -51.28 -37.33 46.78 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.073 0.463 . . . . 72.420000000000002 111.75 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.47 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 72.9 m-85 -57.86 -32.02 67.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.089 -0.505 . . . . 74.109999999999999 111.631 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -83.1 -38.58 22.27 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.385 0.612 . . . . 70.530000000000001 110.456 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.86 -25.46 67.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.052 -0.522 . . . . 73.329999999999998 111.845 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 26.5 pt20 -78.28 -15.51 58.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.443 0.534 . . . . 64.409999999999997 112.443 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -110.99 -21.61 11.92 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.797 0.665 . . . . 70.349999999999994 112.797 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.489 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 25.5 ptm -75.03 -15.95 60.62 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.912 0.708 . . . . 72.129999999999995 112.912 -176.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.63 170.19 13.36 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.048 -0.596 . . . . 71.439999999999998 113.642 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 74.2 mmtt -90.87 133.59 35.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.186 0.517 . . . . 75.109999999999999 111.772 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -78.38 132.7 37.48 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.512 -0.767 . . . . 75.340000000000003 112.797 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.535 HG13 ' CZ ' ' A' ' 157' ' ' ARG . 2.4 m -134.15 161.6 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.971 0.508 . . . . 73.430000000000007 111.488 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -116.95 -175.68 2.83 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.835 -0.62 . . . . 65.319999999999993 112.068 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.545 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 25.8 mmm180 -40.54 -61.49 0.92 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 75.430000000000007 113.855 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -69.03 -16.93 63.83 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.999 0.74 . . . . 54.219999999999999 112.999 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -94.12 -13.8 26.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.518 0.562 . . . . 73.25 112.518 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.22 148.89 43.33 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.439 0.903 . . . . 73.219999999999999 113.439 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -133.25 -163.01 1.3 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.062 -0.972 . . . . 65.019999999999996 109.917 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 41' ' ' LYS . 36.0 m -86.52 108.42 18.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.883 -0.511 . . . . 73.319999999999993 110.907 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.54 -13.48 6.92 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.952 -0.642 . . . . 62.340000000000003 113.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 120.98 13.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.338 0.569 . . . . 64.109999999999999 111.362 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 35.8 mt -76.49 110.98 11.48 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.302 -0.408 . . . . 73.319999999999993 111.282 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 155' ' ' ALA . 27.7 m -95.36 139.98 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.046 0.45 . . . . 72.239999999999995 112.081 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.424 ' HG ' HH12 ' A' ' 156' ' ' ARG . 96.4 mt -106.56 134.76 49.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.15 -0.477 . . . . 72.430000000000007 111.879 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.58 133.92 52.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 72.230000000000004 110.459 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 112' ' ' ARG . 24.5 mtp180 -74.1 91.47 2.09 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.186 0.517 . . . . 75.430000000000007 110.397 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.715 0.635 . . . . 71.519999999999996 112.715 -170.014 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 10.4 mpt_? . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.835 0.35 . . . . 72.530000000000001 110.536 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -105.09 141.68 36.23 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.465 -0.334 . . . . 74.329999999999998 110.799 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.17 137.78 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.199 0.523 . . . . 75.319999999999993 111.92 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.28 159.84 23.95 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 116.054 -0.521 . . . . 73.140000000000001 112.635 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.475 HG21 HD13 ' A' ' 44' ' ' ILE . 56.8 mt -93.33 110.3 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 122.603 -0.351 . . . . 74.430000000000007 110.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -69.32 115.7 8.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.928 0.394 . . . . 75.140000000000001 111.611 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.9 pt -106.58 14.27 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.12 0.415 . . . . 73.420000000000002 112.12 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.57 162.62 33.95 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.309 -0.472 . . . . 70.540000000000006 114.071 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 59.07 35.56 23.91 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.831 0.452 . . . . 72.150000000000006 111.996 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 143' ' ' MET . 48.4 m-80 62.18 14.49 6.7 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.126 0.417 . . . . 65.25 112.126 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -103.35 145.7 29.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.111 0.482 . . . . 73.019999999999996 111.139 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.03 139.87 19.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.115 -0.493 . . . . 75.420000000000002 111.844 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.49 133.62 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.091 0.472 . . . . 74.349999999999994 110.977 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -163.67 168.71 19.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.299 -0.41 . . . . 74.010000000000005 111.184 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.13 93.4 8.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.009 0.433 . . . . 71.049999999999997 110.814 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.1 t -79.54 130.39 35.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.309 -0.405 . . . . 73.120000000000005 111.993 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.8 p -63.36 -11.85 25.74 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.063 -0.517 . . . . 71.409999999999997 112.359 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 m -79.72 -32.39 41.23 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.976 0.362 . . . . 55.009999999999998 111.976 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.4 t -139.65 -48.45 0.47 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.04 0.448 . . . . 73.450000000000003 112.069 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.1 -148.28 19.95 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.713 -0.555 . . . . 74.439999999999998 111.713 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.2 99.5 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 117.321 0.561 . . . . 64.409999999999997 111.175 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.419 ' HA ' ' HH ' ' A' ' 48' ' ' TYR . 41.0 pt -138.23 -177.54 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.118 0.485 . . . . 73.420000000000002 111.824 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.79 129.03 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.251 -0.431 . . . . 72.400000000000006 110.565 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.5 m -119.8 172.94 7.35 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.942 0.401 . . . . 63.32 111.599 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 47.2 m -128.78 144.83 51.26 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.993 0.425 . . . . 61.509999999999998 112.085 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.545 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 65.8 mtt -75.2 0.87 14.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.675 0.62 . . . . 75.239999999999995 112.675 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -86.95 -11.86 49.32 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.936 -0.477 . . . . 65.319999999999993 111.287 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.46 130.6 92.04 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.486 -0.325 . . . . 75.030000000000001 110.699 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.34 -31.02 75.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.876 2.384 . . . . 71.209999999999994 113.442 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.19 -45.0 62.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.705 0.288 . . . . 71.400000000000006 111.74 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -83.79 -37.54 22.45 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.183 0.438 . . . . 72.230000000000004 112.183 -174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -53.51 -51.41 62.91 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.43 0.53 . . . . 73.349999999999994 112.43 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.22 -7.86 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.955 0.354 . . . . 71.099999999999994 111.955 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -95.94 -10.87 27.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.119 0.414 . . . . 73.420000000000002 112.119 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.86 114.63 2.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.946 0.403 . . . . 74.150000000000006 111.474 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -96.26 -55.5 2.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.296 -0.411 . . . . 74.420000000000002 111.255 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -168.74 -179.69 3.87 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.871 0.367 . . . . 74.439999999999998 111.398 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -140.33 160.4 40.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.28 -0.418 . . . . 74.299999999999997 111.162 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.4 mtm-85 -144.33 121.22 11.31 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.321 -0.237 . . . . 73.439999999999998 111.584 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.535 ' CZ ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -94.08 98.92 11.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.755 0.788 . . . . 75.019999999999996 111.242 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.525 HG23 HD21 ' A' ' 84' ' ' LEU . 15.9 m -83.18 -1.01 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.515 -0.766 . . . . 75.219999999999999 112.592 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.477 HD22 HD23 ' A' ' 82' ' ' LEU . 90.9 mt . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.866 0.365 . . . . 74.040000000000006 111.974 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.301 0.572 . . . . 74.329999999999998 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.75 -38.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.854 -0.612 . . . . 71.200000000000003 112.117 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.47 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.7 tttt -63.08 -55.31 26.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.638 0.606 . . . . 74.129999999999995 112.638 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 t -57.41 -42.99 83.38 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.95 0.352 . . . . 61.32 111.95 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -59.14 -45.19 91.59 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.022 0.439 . . . . 74.049999999999997 111.446 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.466 HD11 HG21 ' A' ' 122' ' ' ILE . 86.8 mt -69.17 -44.54 80.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.828 0.347 . . . . 72.230000000000004 111.722 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.58 ' HA ' ' HE2' ' A' ' 45' ' ' MET . 28.1 mmt -61.56 -32.04 72.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.889 0.376 . . . . 74.150000000000006 111.051 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.09 -53.12 61.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.995 -0.548 . . . . 73.209999999999994 110.765 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 51.6 tp60 -65.25 -36.33 83.79 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.02 -0.536 . . . . 72.0 111.812 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 34.0 t80 -55.21 -39.68 69.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.868 0.366 . . . . 63.539999999999999 111.273 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.452 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . . . -59.37 -18.4 38.19 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.454 0.538 . . . . 75.140000000000001 112.454 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -92.5 -22.63 19.46 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.058 0.456 . . . . 71.439999999999998 111.776 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.454 ' CZ2' ' HG2' ' A' ' 63' ' ' LYS . 35.5 m95 -113.56 13.0 18.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.06 0.763 . . . . 72.140000000000001 113.06 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.6 mtmt -63.57 105.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.229 0.538 . . . . 73.450000000000003 112.027 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.96 19.33 9.14 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.94 -0.648 . . . . 71.409999999999997 114.375 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.32 130.3 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.619 0.709 . . . . 72.25 110.738 174.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 55' ' ' ARG . 16.5 ptt180 -79.46 163.27 24.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.408 0.521 . . . . 74.340000000000003 112.408 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -81.25 125.48 30.37 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.174 0.511 . . . . 74.5 112.242 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.408 HH11 HG21 ' A' ' 62' ' ' THR . 53.0 ttt180 -137.0 111.47 8.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.794 -0.639 . . . . 75.239999999999995 110.263 176.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 1.1 pt? -92.82 113.06 25.23 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.324 0.583 . . . . 72.430000000000007 112.026 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.08 -7.26 27.17 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.848 -0.615 . . . . 52.350000000000001 113.267 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.01 110.8 0.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.455 -0.403 . . . . 45.210000000000001 112.314 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.527 ' HA ' HG13 ' A' ' 66' ' ' ILE . 48.8 m -92.09 104.23 16.64 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.557 0.577 . . . . 63.210000000000001 112.557 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.408 HG21 HH11 ' A' ' 57' ' ' ARG . 2.9 t -151.87 157.18 41.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 73.409999999999997 111.222 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HG2' ' CZ2' ' A' ' 51' ' ' TRP . 43.8 mtpt -65.69 -15.86 63.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 73.319999999999993 111.708 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -92.41 11.12 27.21 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.061 0.458 . . . . 74.219999999999999 111.015 178.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.44 116.39 0.67 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.747 -0.541 . . . . 52.340000000000003 111.747 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.527 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.9 tt -150.19 151.85 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 117.263 0.531 . . . . 64.519999999999996 111.882 -173.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.573 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -91.05 177.48 6.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.284 0.564 . . . . 71.239999999999995 112.084 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.42 ' O ' HG13 ' A' ' 72' ' ' VAL . 23.0 p -61.31 -43.9 98.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.1 -0.5 . . . . 73.340000000000003 111.749 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.557 ' HG ' ' NE2' ' A' ' 91' ' ' GLN . 40.3 t -61.13 -46.29 91.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.156 0.503 . . . . 72.329999999999998 111.221 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.551 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -60.67 -45.85 95.59 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.045 -0.598 . . . . 71.319999999999993 112.797 177.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.22 -53.7 55.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.804 0.335 . . . . 75.540000000000006 111.902 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.513 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.7 p -59.76 -40.41 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.934 0.397 . . . . 70.200000000000003 110.676 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.475 ' HA ' HD12 ' A' ' 84' ' ' LEU . 20.3 tt0 -55.62 -48.64 74.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.153 -0.476 . . . . 75.209999999999994 111.406 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.574 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 15.7 mmm180 -60.75 -49.03 79.12 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.937 0.347 . . . . 70.049999999999997 111.937 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.567 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 86.6 m -57.81 -54.19 49.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.049 0.452 . . . . 70.030000000000001 112.045 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 68.7 m-85 -64.11 -33.96 76.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.494 0.553 . . . . 65.129999999999995 112.494 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.7 -29.18 58.89 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.019 -0.425 . . . . 75.420000000000002 111.679 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 78.6 mm-40 -71.18 -64.08 0.98 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.105 0.479 . . . . 73.420000000000002 111.417 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -72.5 -59.42 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.81 0.67 . . . . 73.129999999999995 112.81 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -88.78 -12.87 40.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.524 0.565 . . . . 74.420000000000002 112.524 -173.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.03 31.2 77.27 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.793 -0.718 . . . . 37.68 112.492 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 56.4 tp -90.8 132.34 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.675 0.39 . . . . 74.430000000000007 111.236 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.83 131.07 35.95 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.199 0.523 . . . . 74.109999999999999 112.117 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 73' ' ' GLN . 95.0 mt -136.0 150.96 72.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.224 -0.443 . . . . 73.209999999999994 111.079 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.09 156.92 55.22 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.551 2.167 . . . . 75.010000000000005 112.927 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.46 6.19 10.89 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.728 0.64 . . . . 75.019999999999996 112.728 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.3 m -131.25 129.11 41.17 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.663 0.268 . . . . 73.409999999999997 111.642 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.541 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 89.0 m -54.74 -43.38 72.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.897 0.379 . . . . 75.209999999999994 111.357 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -51.51 -32.39 27.53 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.729 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.15 -40.77 14.31 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.328 -0.397 . . . . 74.019999999999996 111.393 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.557 ' NE2' ' HG ' ' A' ' 69' ' ' SER . 70.2 mt-30 -56.41 -30.2 62.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.885 0.374 . . . . 72.140000000000001 111.411 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 88' ' ' THR . 21.7 mt-30 -52.94 -38.45 61.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.057 -0.52 . . . . 63.43 111.93 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.41 22.97 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.111 0.411 . . . . 75.430000000000007 112.111 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.0 mmm -98.31 -35.43 10.33 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.085 0.772 . . . . 64.150000000000006 113.085 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.0 -175.89 14.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.641 -0.79 . . . . 63.049999999999997 114.755 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.0 mmmt -86.21 149.03 25.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.687 0.395 . . . . 75.209999999999994 111.875 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -90.28 153.22 20.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.343 0.592 . . . . 72.400000000000006 112.563 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.99 159.76 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.676 -0.693 . . . . 74.109999999999999 111.502 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.4 t -87.66 157.76 19.02 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.286 -0.415 . . . . 65.099999999999994 111.514 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -52.18 -32.68 37.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.191 0.52 . . . . 74.239999999999995 111.413 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.5 p -74.57 -28.88 61.12 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.579 0.585 . . . . 61.039999999999999 112.579 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -96.05 -0.85 49.88 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.867 0.691 . . . . 74.439999999999998 112.867 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.475 HD23 ' HH ' ' A' ' 152' ' ' TYR . 50.4 mt -59.94 123.49 17.23 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.599 0.592 . . . . 74.299999999999997 112.599 -177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -128.05 -178.84 4.69 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.012 -0.54 . . . . 75.310000000000002 110.771 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.47 HG21 ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -64.33 108.11 1.52 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.819 0.342 . . . . 74.430000000000007 111.893 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.73 -18.61 5.11 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.905 -0.664 . . . . 74.430000000000007 113.452 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.431 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 66.8 m-20 -74.15 129.73 38.39 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.047 0.451 . . . . 73.329999999999998 111.331 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.26 115.77 23.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.679 0.276 . . . . 75.349999999999994 110.595 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 155' ' ' ALA . 16.5 m -95.67 128.58 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.143 0.497 . . . . 74.129999999999995 111.908 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.4 mt -97.67 129.19 44.76 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.937 -0.574 . . . . 74.209999999999994 111.714 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.11 140.31 49.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.536 0.684 . . . . 75.219999999999999 112.376 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -83.95 100.35 10.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.459 -0.791 . . . . 72.109999999999999 110.932 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 120.847 0.356 . . . . 64.019999999999996 111.85 -178.761 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.123 0.487 . . . . 71.430000000000007 111.761 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -98.51 148.06 24.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.057 -0.52 . . . . 75.120000000000005 110.643 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.5 141.9 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.069 0.461 . . . . 75.120000000000005 111.969 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.62 155.59 21.84 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.322 -0.466 . . . . 55.119999999999997 112.556 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 72' ' ' VAL . 20.1 mt -95.25 106.26 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.482 -0.422 . . . . 73.400000000000006 111.018 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.488 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 33.8 t80 -64.43 113.49 3.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.329 . . . . 74.549999999999997 111.186 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.41 -27.47 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.303 0.483 . . . . 74.010000000000005 112.303 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.33 144.95 4.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.441 -0.885 . . . . 64.209999999999994 114.23 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.21 53.37 12.54 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.107 0.563 . . . . 65.420000000000002 112.393 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 142' ' ' SER . 40.6 m-80 66.93 -4.98 0.72 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.173 0.805 . . . . 73.140000000000001 113.173 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.484 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 25.1 mt-30 -87.45 143.73 27.08 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.26 0.553 . . . . 74.450000000000003 111.061 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.561 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 25.2 p90 -156.32 148.95 23.75 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.77 -0.65 . . . . 74.129999999999995 111.519 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 137.54 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.104 -0.498 . . . . 73.349999999999994 110.835 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -166.45 162.29 16.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.114 0.483 . . . . 65.340000000000003 111.85 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -88.78 86.99 7.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.111 0.482 . . . . 75.409999999999997 110.309 172.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.2 t -58.22 134.71 56.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.783 -0.644 . . . . 74.200000000000003 112.498 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.9 p -57.18 -35.67 69.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.109 0.481 . . . . 74.109999999999999 111.82 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.7 t -85.94 -50.74 6.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.715 0.635 . . . . 72.340000000000003 112.715 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.8 m -98.9 -34.63 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.202 0.816 . . . . 64.329999999999998 113.202 -173.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.61 -158.67 14.4 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.05 -0.595 . . . . 71.439999999999998 112.369 -172.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 99.2 t -63.08 102.5 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.318 0.58 . . . . 72.0 111.793 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.76 -178.81 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.817 -0.629 . . . . 73.530000000000001 111.642 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.42 109.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.167 -0.469 . . . . 70.510000000000005 110.9 172.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 92.7 p -107.88 -171.46 1.87 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.584 0.23 . . . . 64.230000000000004 110.818 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.616 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 43.9 m -146.86 136.54 23.06 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.339 0.496 . . . . 71.230000000000004 112.339 -174.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.561 ' HG3' ' CE1' ' A' ' 129' ' ' PHE . 72.9 mtm -78.21 3.93 13.98 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.334 0.864 . . . . 73.109999999999999 113.334 -177.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.616 ' OD1' ' HB3' ' A' ' 142' ' ' SER . 1.0 OUTLIER -83.2 -12.85 56.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.867 0.365 . . . . 75.030000000000001 110.544 170.154 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -71.54 136.93 83.37 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 116.532 -0.304 . . . . 74.0 110.427 169.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -52.98 -43.0 60.44 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.722 2.281 . . . . 75.530000000000001 113.522 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.409 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 80.5 t80 -59.45 -47.66 84.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.705 0.288 . . . . 73.420000000000002 111.689 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -78.89 -33.62 45.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.835 0.35 . . . . 75.140000000000001 111.623 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -56.81 -38.43 72.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.257 -0.429 . . . . 74.329999999999998 111.382 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -93.52 -12.32 29.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.788 0.328 . . . . 71.329999999999998 111.801 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -79.32 -32.48 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.836 0.35 . . . . 73.430000000000007 111.079 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.475 ' HH ' HD23 ' A' ' 103' ' ' LEU . 91.9 t80 -58.04 126.59 28.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.845 -0.616 . . . . 74.420000000000002 112.405 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -101.38 -63.9 1.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.177 0.513 . . . . 65.019999999999996 110.344 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.27 172.46 18.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 71.439999999999998 110.032 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB3' HG12 ' A' ' 109' ' ' VAL . . . -131.23 145.63 52.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.999 0.428 . . . . 63.450000000000003 111.934 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 97.1 mtt180 -140.6 124.96 17.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.332 -0.395 . . . . 74.209999999999994 110.8 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -98.29 137.19 37.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.325 0.583 . . . . 74.209999999999994 111.767 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.2 m -104.83 14.29 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.661 -0.7 . . . . 73.530000000000001 112.753 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 112.439 0.533 . . . . 75.340000000000003 112.439 -177.737 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 120.745 0.307 . . . . 51.219999999999999 111.384 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.9 t -51.22 -44.59 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.162 -0.472 . . . . 63.149999999999999 111.582 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.49 -37.76 79.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.431 -0.349 . . . . 74.299999999999997 111.62 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.8 m -64.14 -10.87 25.46 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.235 0.457 . . . . 64.400000000000006 112.235 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.521 ' HA ' ' HE ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -101.01 -49.1 4.22 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.023 0.44 . . . . 74.530000000000001 110.512 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.503 ' HA ' HE22 ' A' ' 79' ' ' GLN . 59.2 mt -52.41 -43.98 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.117 0.484 . . . . 74.5 111.027 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.516 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 31.1 mmt -71.07 -22.49 62.11 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 111.801 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.78 -46.47 78.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.69 0.281 . . . . 63.530000000000001 110.673 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.02 -42.23 69.84 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.707 0.289 . . . . 73.129999999999995 110.938 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.576 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 36.6 t80 -50.44 -36.68 34.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.638 0.256 . . . . 73.439999999999998 111.183 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.24 80.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.451 -0.341 . . . . 75.430000000000007 111.665 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.1 -29.66 60.67 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.831 0.348 . . . . 73.299999999999997 111.713 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -92.09 5.9 48.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.163 0.431 . . . . 74.409999999999997 112.163 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 23.6 mmmt -58.69 101.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.483 . . . . 73.150000000000006 111.915 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.34 -0.45 37.56 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.049 -0.596 . . . . 64.549999999999997 113.949 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.5 134.54 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 117.319 0.559 . . . . 73.400000000000006 111.323 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -85.58 171.67 11.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.481 0.658 . . . . 74.319999999999993 112.427 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -102.18 137.81 39.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.732 -0.667 . . . . 74.230000000000004 110.666 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -132.63 121.83 23.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.01 0.433 . . . . 74.409999999999997 111.676 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.67 103.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 74.310000000000002 111.275 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.57 28.96 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.184 -0.532 . . . . 75.409999999999997 113.401 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 134.71 7.61 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.394 -0.432 . . . . 72.129999999999995 112.503 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.534 ' HA ' HD11 ' A' ' 66' ' ' ILE . 11.7 m -125.01 98.28 5.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.255 0.527 . . . . 64.219999999999999 111.4 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 t 177.99 172.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.867 0.365 . . . . 73.129999999999995 111.659 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -66.68 -18.6 65.45 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.881 0.372 . . . . 72.409999999999997 111.719 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -78.64 -11.79 59.99 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.107 0.479 . . . . 71.329999999999998 110.883 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.92 111.21 0.25 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.595 -0.602 . . . . 72.129999999999995 111.595 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 61' ' ' SER . 11.2 tp -112.2 154.33 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.999 0.399 . . . . 72.450000000000003 111.658 -173.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.26 178.7 4.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.984 0.421 . . . . 63.329999999999998 111.15 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.8 p -60.27 -52.9 63.29 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.309 -0.405 . . . . 61.450000000000003 112.013 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -69.42 -36.7 76.95 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.956 0.408 . . . . 74.209999999999994 111.129 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -58.68 -48.95 82.1 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.941 -0.572 . . . . 73.299999999999997 113.774 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.69 -56.16 25.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.184 0.492 . . . . 71.310000000000002 111.912 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' HD11 ' A' ' 122' ' ' ILE . 10.8 p -60.02 -39.41 80.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.872 0.368 . . . . 73.040000000000006 111.266 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.577 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 tt0 -56.68 -57.18 13.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.166 -0.47 . . . . 72.219999999999999 111.39 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 25.2 mmt180 -55.28 -49.46 72.02 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.904 0.383 . . . . 75.219999999999999 111.24 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.466 HG22 ' NE2' ' A' ' 79' ' ' GLN . 97.9 m -49.72 -61.96 1.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.013 -0.54 . . . . 73.129999999999995 112.452 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 69.5 m-85 -68.09 -37.38 81.15 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.202 0.815 . . . . 71.510000000000005 113.202 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -71.36 -36.72 71.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.879 -0.513 . . . . 64.200000000000003 112.172 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -78.08 -23.89 47.82 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.092 -0.38 . . . . 75.299999999999997 111.774 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.503 HE22 ' HA ' ' A' ' 44' ' ' ILE . 77.1 mt-30 -92.32 -70.31 0.7 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.178 0.513 . . . . 73.409999999999997 112.127 178.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -89.96 -9.78 47.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.043 -0.526 . . . . 72.510000000000005 112.042 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.51 77.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.918 -0.658 . . . . 64.319999999999993 112.33 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.8 tp -73.55 111.38 8.63 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.037 0.446 . . . . 72.120000000000005 110.533 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.35 78.59 4.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.437 0.637 . . . . 72.400000000000006 112.558 -173.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.13 143.32 69.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.064 -0.516 . . . . 73.549999999999997 111.571 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.51 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 89.9 Cg_endo -79.73 -179.43 5.32 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.019 2.479 . . . . 74.209999999999994 113.505 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -11.63 43.12 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.277 0.843 . . . . 75.129999999999995 113.277 -173.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 39.1 t -115.62 137.56 51.95 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.897 -0.502 . . . . 74.329999999999998 111.851 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.47 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 6.2 m -56.87 -39.59 74.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.134 0.492 . . . . 74.439999999999998 111.476 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -64.08 -33.72 76.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.327 -0.397 . . . . 74.439999999999998 111.781 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.476 ' HG3' ' HB3' ' A' ' 87' ' ' SER . 43.0 mt-10 -68.21 -38.34 81.81 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.274 0.559 . . . . 73.209999999999994 110.627 175.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.51 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 84.1 mt-30 -64.93 -30.58 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.697 -0.683 . . . . 73.540000000000006 110.912 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.4 mt-30 -64.98 -8.74 17.11 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.652 0.612 . . . . 75.450000000000003 112.652 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -99.16 -1.89 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.52 0.563 . . . . 71.540000000000006 112.52 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.2 ptp -114.04 154.95 26.8 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.062 -0.399 . . . . 74.409999999999997 110.863 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.27 177.22 29.63 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.777 -0.725 . . . . 72.340000000000003 112.756 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -118.46 149.75 40.74 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.325 -0.515 . . . . 75.230000000000004 111.611 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.49 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 89.0 p -76.91 154.53 33.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.237 0.829 . . . . 75.239999999999995 113.237 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 1.5 m -145.44 150.16 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.235 -0.893 . . . . 73.019999999999996 111.63 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.5 t -95.79 -179.52 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.884 0.373 . . . . 65.129999999999995 111.571 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -51.52 -44.09 62.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.317 0.488 . . . . 73.319999999999993 112.317 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.5 t -83.51 10.12 9.7 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.246 -0.434 . . . . 62.43 112.06 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.471 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.3 m120 -120.45 -8.55 9.57 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.126 -0.359 . . . . 74.129999999999995 111.832 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.64 144.19 57.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.101 0.778 . . . . 62.43 113.101 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -130.28 -156.44 0.76 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.717 -0.674 . . . . 71.409999999999997 110.599 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.9 m -101.14 126.97 47.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.548 -0.296 . . . . 74.510000000000005 110.325 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.06 -4.07 31.74 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.08 -0.581 . . . . 65.140000000000001 113.291 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 123' ' ' TYR . 2.2 m-20 -75.84 142.09 42.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.054 0.454 . . . . 64.219999999999999 111.128 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.43 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.535 -0.302 . . . . 74.450000000000003 110.331 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.22 126.46 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.473 0.654 . . . . 74.549999999999997 111.508 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 77.4 mt -105.71 115.1 29.66 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.488 -0.778 . . . . 73.310000000000002 111.823 -173.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -107.07 151.61 25.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.179 -0.464 . . . . 75.0 111.245 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.588 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 93.4 mtt180 -87.6 101.28 13.49 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.445 -0.343 . . . . 74.219999999999999 111.022 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.506 0 O-C-N 122.173 -0.329 . . . . 75.239999999999995 111.516 -178.317 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.727 ' HD2' ' HB3' ' A' ' 110' ' ' LEU . 2.1 tpp180 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.886 0.374 . . . . 73.519999999999996 111.004 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -118.05 124.92 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.147 -0.316 . . . . 74.099999999999994 110.147 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.82 138.58 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.24 0.459 . . . . 72.230000000000004 112.24 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -127.9 147.56 17.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.261 -0.427 . . . . 74.25 112.56 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 72' ' ' VAL . 40.3 mt -87.46 108.58 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.519 -0.4 . . . . 63.32 110.917 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.518 ' HD1' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -66.28 109.82 2.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.048 0.452 . . . . 73.420000000000002 111.901 -175.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.4 pt -105.23 11.49 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.01 0.434 . . . . 71.150000000000006 111.605 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.42 37.94 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.294 -0.412 . . . . 64.510000000000005 112.581 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -67.62 -16.21 64.05 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.281 0.475 . . . . 71.430000000000007 112.281 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.476 ' HA ' ' OH ' ' A' ' 123' ' ' TYR . 9.9 p30 -150.96 -13.42 0.22 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.668 0.618 . . . . 72.099999999999994 112.668 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -89.3 143.44 26.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.331 0.586 . . . . 73.349999999999994 111.869 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.518 ' HB3' ' HD1' ' A' ' 123' ' ' TYR . 27.6 p90 -153.1 146.46 24.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.647 -0.706 . . . . 73.349999999999994 111.462 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.7 p -99.19 136.84 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.055 0.455 . . . . 75.129999999999995 111.062 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -156.09 -166.28 2.14 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.246 -0.434 . . . . 74.439999999999998 110.736 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.4 114.41 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.707 0.289 . . . . 63.399999999999999 111.696 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 67.5 m -91.06 145.97 24.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.852 0.358 . . . . 72.319999999999993 111.272 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p -50.55 -48.91 57.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.58 0.955 . . . . 71.439999999999998 113.58 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.7 p -106.83 19.54 20.33 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.773 0.657 . . . . 60.310000000000002 112.773 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 133' ' ' SER . 67.6 m -133.05 -23.5 1.96 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.321 0.489 . . . . 74.549999999999997 112.321 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.29 -151.94 31.95 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.966 -0.635 . . . . 71.109999999999999 112.705 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.0 t -75.63 111.77 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.947 0.403 . . . . 61.240000000000002 111.993 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.36 -178.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 120.962 0.41 . . . . 64.340000000000003 111.491 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.41 143.13 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.738 0.304 . . . . 73.120000000000005 110.783 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.8 t -138.43 179.47 6.44 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.806 0.336 . . . . 74.140000000000001 111.657 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 69.7 m -137.7 138.71 39.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.341 -0.39 . . . . 70.040000000000006 111.258 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.488 ' HE2' ' OH ' ' A' ' 123' ' ' TYR . 27.0 mtm -69.97 -9.67 55.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.426 0.528 . . . . 75.010000000000005 112.426 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -78.52 -9.44 59.34 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.092 -0.38 . . . . 72.219999999999999 111.38 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.92 136.18 82.65 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 110.167 -0.309 . . . . 73.400000000000006 110.167 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -49.98 -45.85 30.75 Favored 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 123.029 2.486 . . . . 72.530000000000001 114.157 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.514 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 56.3 t80 -65.11 -44.14 89.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.912 0.387 . . . . 75.140000000000001 111.757 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -77.53 -35.56 53.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.832 0.308 . . . . 75.340000000000003 111.832 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -53.72 -38.98 64.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.237 0.542 . . . . 73.340000000000003 111.565 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -92.59 0.47 57.43 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.525 0.565 . . . . 74.140000000000001 112.525 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.588 ' HD2' ' O ' ' A' ' 112' ' ' ARG . 33.4 mmt180 -100.83 -17.94 16.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.109 0.411 . . . . 74.540000000000006 112.109 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.41 130.07 44.65 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.373 0.508 . . . . 74.430000000000007 112.373 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -112.89 -54.66 2.6 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 72.5 111.102 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -165.86 167.46 16.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.425 -0.352 . . . . 74.329999999999998 110.914 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -133.91 145.41 49.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.165 0.186 . . . . 72.519999999999996 110.864 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 57.5 mtt180 -141.0 121.14 13.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.743 0.306 . . . . 72.040000000000006 111.422 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.43 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -85.06 121.94 28.55 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.409 0.623 . . . . 72.420000000000002 110.864 175.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.48 4.91 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.026 -0.534 . . . . 72.239999999999995 112.329 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 120.874 0.368 . . . . 73.109999999999999 111.315 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 111.435 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -55.31 -48.71 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.581 0.585 . . . . 74.329999999999998 112.581 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.505 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.1 tttt -61.86 -56.95 14.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.863 0.32 . . . . 73.450000000000003 111.863 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.6 m -59.83 -38.83 83.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.597 0.237 . . . . 61.229999999999997 111.563 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -52.9 -52.05 59.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.331 0.586 . . . . 73.409999999999997 111.2 176.412 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.464 HD13 HG21 ' A' ' 122' ' ' ILE . 72.8 mt -69.16 -42.8 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.829 -0.623 . . . . 72.109999999999999 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.586 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 17.7 mmt -62.66 -37.28 85.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.022 0.439 . . . . 71.299999999999997 111.328 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.87 -46.05 92.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.317 -0.401 . . . . 71.040000000000006 110.605 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -68.02 -36.82 80.6 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.399 -0.364 . . . . 64.120000000000005 111.523 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -54.07 -39.39 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.831 0.308 . . . . 74.25 111.831 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.36 -23.24 9.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 74.420000000000002 112.234 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.65 -44.41 11.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.12 0.486 . . . . 61.030000000000001 111.024 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -80.92 -2.27 46.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.139 0.792 . . . . 74.239999999999995 113.139 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -50.04 117.75 2.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.678 0.621 . . . . 73.439999999999998 112.678 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.41 -6.35 77.95 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 114.75 0.66 . . . . 72.340000000000003 114.75 172.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.0 t -59.72 130.21 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 117.827 0.814 . . . . 73.25 111.599 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.02 171.15 13.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.094 -0.503 . . . . 75.420000000000002 112.315 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 32.3 t80 -98.28 123.01 42.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.236 0.458 . . . . 72.010000000000005 112.236 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -138.17 133.08 32.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.653 0.381 . . . . 75.329999999999998 110.623 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 5.3 mp -84.0 121.25 27.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.058 0.392 . . . . 73.219999999999999 112.058 -175.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.43 -50.82 3.87 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.03 -0.605 . . . . 74.049999999999997 113.006 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.21 60.19 1.86 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.342 -0.456 . . . . 73.349999999999994 112.305 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.3 m -67.61 103.47 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.814 0.446 . . . . 64.140000000000001 111.919 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.6 t -158.74 172.87 17.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.128 0.49 . . . . 75.010000000000005 111.909 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.39 -1.1 14.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.616 0.599 . . . . 70.040000000000006 112.616 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -105.17 10.84 33.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 74.430000000000007 110.803 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.87 118.55 0.91 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.714 -0.554 . . . . 61.130000000000003 111.714 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.2 tt -147.6 147.5 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.775 0.788 . . . . 75.129999999999995 112.331 -175.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.547 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.2 p-10 -92.44 176.22 6.55 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.168 0.509 . . . . 73.129999999999995 112.37 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.433 ' SG ' ' N ' ' A' ' 69' ' ' SER . 26.1 p -59.02 -59.88 4.77 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.893 -0.594 . . . . 53.340000000000003 111.643 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.433 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 16.7 p -62.61 -37.3 85.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.267 -0.424 . . . . 70.450000000000003 111.362 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.65 -43.29 99.18 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.346 -0.454 . . . . 73.219999999999999 113.286 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -61.26 -52.69 63.66 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 122.57 -0.371 . . . . 62.549999999999997 111.774 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.531 ' HA ' HD11 ' A' ' 122' ' ' ILE . 4.9 p -61.42 -49.27 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 112.252 0.464 . . . . 73.420000000000002 112.252 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -60.8 -33.9 73.69 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.092 -0.38 . . . . 74.329999999999998 111.791 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.512 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 78.2 mtt-85 -72.0 -52.11 18.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.086 -0.384 . . . . 72.409999999999997 111.497 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -49.66 -40.69 40.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.99 0.424 . . . . 72.019999999999996 111.892 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 47.0 m-85 -73.47 -40.91 63.79 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.582 0.586 . . . . 75.310000000000002 112.582 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.512 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 12.1 ptp180 -70.43 -24.73 62.96 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.757 -0.589 . . . . 71.129999999999995 111.223 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 20.6 mm-40 -69.48 -62.07 1.53 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.266 0.555 . . . . 74.349999999999994 111.345 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 43' ' ' ARG . 85.9 mm-40 -88.26 -32.17 18.64 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.555 0.946 . . . . 75.439999999999998 113.555 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.25 -13.05 13.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 75.310000000000002 112.357 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.99 17.61 77.17 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.867 -0.682 . . . . 52.130000000000003 112.814 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.5 tp -83.63 115.06 21.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.919 0.39 . . . . 74.510000000000005 111.147 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.94 96.68 8.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.843 0.354 . . . . 51.229999999999997 111.377 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 97.2 mt -98.64 142.37 24.48 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.459 -0.337 . . . . 71.400000000000006 110.889 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.23 163.79 9.59 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.84 2.36 . . . . 72.430000000000007 113.31 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 3.5 mpt_? -78.81 -25.27 44.21 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.689 0.626 . . . . 75.430000000000007 112.689 -173.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.416 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 36.3 t -98.95 140.22 33.43 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.375 0.509 . . . . 72.230000000000004 112.375 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 92.8 m -55.05 -42.52 72.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.844 -0.616 . . . . 74.450000000000003 111.321 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.38 -44.75 95.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.97 -0.559 . . . . 74.439999999999998 111.33 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 40.2 mm-40 -64.44 -36.73 85.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.08 0.467 . . . . 71.140000000000001 110.649 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.92 -27.42 66.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.18 -0.464 . . . . 72.420000000000002 111.617 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.537 ' HA ' ' NE ' ' A' ' 156' ' ' ARG . 28.4 mt-30 -59.94 -49.58 77.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 71.120000000000005 110.838 175.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.93 -6.21 43.71 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.06 -0.518 . . . . 75.319999999999993 112.247 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mmm -110.72 21.46 16.51 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.875 0.369 . . . . 75.120000000000005 111.95 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.38 133.66 5.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.275 -0.488 . . . . 53.219999999999999 112.272 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 43.6 mmtm -88.43 140.92 28.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.162 0.506 . . . . 72.409999999999997 112.085 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 t -74.71 136.98 41.81 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.631 0.974 . . . . 73.430000000000007 113.631 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.25 139.6 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.521 -0.763 . . . . 74.310000000000002 110.656 172.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.1 t -92.72 -179.98 5.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.533 0.568 . . . . 73.120000000000005 112.533 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -41.23 -53.72 3.11 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.125 1.157 . . . . 75.510000000000005 114.125 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -82.72 -14.5 54.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.515 0.561 . . . . 74.430000000000007 112.515 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -99.07 6.85 46.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.543 0.571 . . . . 71.5 112.543 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.28 138.36 58.51 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.785 0.326 . . . . 73.430000000000007 111.542 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -145.5 134.21 22.26 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.579 -0.282 . . . . 75.430000000000007 111.118 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 41' ' ' LYS . 83.4 m -44.69 102.0 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.047 0.451 . . . . 74.140000000000001 111.792 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.09 -8.12 3.23 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.964 -0.562 . . . . 73.420000000000002 113.178 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 3.4 p30 -88.12 160.25 17.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.467 0.651 . . . . 72.200000000000003 111.603 176.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 mt -106.34 117.43 34.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 75.040000000000006 110.709 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 m -94.15 119.18 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.425 0.631 . . . . 74.530000000000001 111.553 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.457 HD12 ' HG2' ' A' ' 92' ' ' GLN . 95.6 mt -91.21 132.0 36.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.642 -0.708 . . . . 75.329999999999998 111.436 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -122.16 134.11 54.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.408 -0.36 . . . . 75.540000000000006 110.993 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 80.2 mtp180 -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.673 -0.491 . . . . 74.439999999999998 109.673 174.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 121.074 0.464 . . . . 74.340000000000003 111.633 -175.22 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 120.917 0.389 . . . . 71.299999999999997 111.383 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -127.52 160.46 31.45 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.322 -0.399 . . . . 75.349999999999994 110.107 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.83 141.18 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.148 0.499 . . . . 72.409999999999997 112.317 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.66 160.76 24.62 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.108 -0.497 . . . . 71.239999999999995 112.437 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.531 HD11 ' HA ' ' A' ' 72' ' ' VAL . 34.1 mt -94.62 112.27 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.464 -0.433 . . . . 74.439999999999998 111.084 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.12 113.65 4.1 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.762 0.315 . . . . 73.430000000000007 111.64 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.446 ' HA ' HG22 ' A' ' 105' ' ' THR . 31.2 pt -98.64 -20.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.201 0.445 . . . . 74.549999999999997 112.201 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.95 148.04 5.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.931 -0.652 . . . . 70.140000000000001 113.782 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.4 m120 58.47 40.02 24.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.277 0.473 . . . . 74.439999999999998 112.277 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 68.6 3.59 3.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.859 -0.61 . . . . 72.340000000000003 112.397 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.554 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 25.1 mt-30 -90.14 147.53 23.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.039 0.447 . . . . 72.510000000000005 110.759 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -155.35 151.76 28.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 72.209999999999994 111.979 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.34 135.91 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.071 -0.513 . . . . 75.140000000000001 110.448 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.91 173.33 16.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.034 0.445 . . . . 75.310000000000002 111.746 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -102.03 96.81 7.27 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.005 -0.543 . . . . 63.439999999999998 110.909 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.4 t -68.69 135.47 51.39 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.063 -0.517 . . . . 73.409999999999997 111.84 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.6 p -65.22 -20.66 66.54 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 75.129999999999995 111.56 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.9 m -97.07 -52.4 3.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.416 -0.356 . . . . 55.43 111.913 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.422 ' HB2' HD13 ' A' ' 139' ' ' ILE . 49.8 m -101.48 -16.45 16.81 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.073 0.768 . . . . 63.219999999999999 113.073 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.1 -154.27 24.3 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.853 -0.689 . . . . 72.430000000000007 112.884 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.37 104.39 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.019 0.438 . . . . 65.129999999999995 111.999 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.422 HD13 ' HB2' ' A' ' 136' ' ' SER . 41.6 pt -140.77 178.48 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.113 0.482 . . . . 65.010000000000005 111.704 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.7 mm -101.15 141.83 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.467 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -144.56 165.4 28.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.773 0.321 . . . . 75.530000000000001 110.541 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.554 ' OG ' ' HG2' ' A' ' 128' ' ' GLN . 15.8 m -138.48 142.88 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.975 0.361 . . . . 74.129999999999995 111.975 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.2 mtm -72.57 -3.09 22.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.369 0.604 . . . . 62.420000000000002 110.626 171.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.98 -16.29 61.08 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.864 -0.607 . . . . 75.349999999999994 110.089 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 19.5 mm-40 -85.76 135.01 38.45 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.784 -0.644 . . . . 75.409999999999997 110.317 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -48.92 -44.87 30.77 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.183 2.589 . . . . 75.230000000000004 114.303 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 50.5 t80 -64.56 -44.16 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.946 -0.471 . . . . 73.430000000000007 111.759 -177.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -77.47 -32.75 54.54 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.184 0.516 . . . . 72.239999999999995 111.392 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -56.2 -48.71 75.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.401 0.68 . . . . 72.040000000000006 112.232 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -84.36 -13.92 50.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.853 0.686 . . . . 71.120000000000005 112.853 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 17.2 mmm180 -100.3 -3.39 31.43 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.72 0.637 . . . . 75.400000000000006 112.72 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -54.11 123.03 11.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.094 0.405 . . . . 62.210000000000001 112.094 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.429 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 7.0 t30 -98.4 -66.61 0.89 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.382 -0.372 . . . . 73.109999999999999 111.248 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -164.48 144.71 7.76 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.603 0.24 . . . . 63.219999999999999 110.829 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -102.57 146.49 28.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.781 0.324 . . . . 62.329999999999998 111.357 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.537 ' NE ' ' HA ' ' A' ' 92' ' ' GLN . 11.8 mtm-85 -136.89 111.37 8.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.607 0.225 . . . . 75.340000000000003 111.607 -176.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -75.02 124.99 27.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.04 0.448 . . . . 75.540000000000006 111.143 176.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.23 -19.51 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.037 -0.529 . . . . 74.329999999999998 112.105 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 121.148 0.499 . . . . 74.409999999999997 111.718 177.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 111.644 0.239 . . . . 74.150000000000006 111.644 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -64.96 149.92 48.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.921 0.391 . . . . 73.540000000000006 111.808 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.2 t -68.29 82.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.309 0.576 . . . . 74.230000000000004 110.356 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -75.12 136.58 41.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.016 -0.538 . . . . 63.439999999999998 111.961 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.2 t -58.71 -61.86 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.723 -0.671 . . . . 74.519999999999996 111.713 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.67 -40.36 79.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.828 0.347 . . . . 74.340000000000003 111.195 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.4 t -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.274 -0.421 . . . . 72.340000000000003 111.673 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -35.35 77.91 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.879 0.326 . . . . 74.040000000000006 111.879 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 40' ' ' VAL . 74.7 mt -62.4 -48.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.034 0.445 . . . . 73.329999999999998 111.017 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.524 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 26.7 mmt -67.22 -37.34 83.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.943 0.401 . . . . 72.010000000000005 110.85 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -56.97 -45.24 83.03 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.931 -0.577 . . . . 75.219999999999999 110.624 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.798 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 55.0 tp60 -66.66 -46.25 76.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.294 0.569 . . . . 70.129999999999995 111.271 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HH ' ' HA ' ' A' ' 139' ' ' ILE . 18.3 t80 -56.41 -34.85 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.824 -0.625 . . . . 75.030000000000001 111.221 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.76 12.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.38 0.511 . . . . 73.420000000000002 112.38 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.89 -26.25 21.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.958 0.408 . . . . 62.299999999999997 111.557 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -111.36 12.3 21.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.999 0.74 . . . . 75.129999999999995 112.999 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.56 ' HZ1' ' HB2' ' A' ' 52' ' ' LYS . 10.0 mtmp? -61.95 103.36 0.35 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.074 -0.391 . . . . 74.310000000000002 111.64 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.14 -0.89 26.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.807 -0.711 . . . . 61.530000000000001 114.231 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.03 138.44 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 117.484 0.642 . . . . 75.540000000000006 111.225 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.82 162.44 26.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.145 0.498 . . . . 74.219999999999999 112.229 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 51.7 t80 -84.05 118.41 24.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.053 -0.521 . . . . 75.439999999999998 112.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -137.99 123.61 19.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.661 -0.245 . . . . 72.219999999999999 111.309 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 97.0 mt -70.78 116.49 11.15 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.481 0.549 . . . . 75.040000000000006 112.481 -177.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.36 3.59 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.304 -0.474 . . . . 61.140000000000001 114.065 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.27 67.88 1.79 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.26 -0.495 . . . . 72.150000000000006 113.248 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -69.48 108.65 3.86 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.406 0.521 . . . . 75.230000000000004 112.406 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -166.61 175.38 8.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.123 -0.489 . . . . 73.010000000000005 110.793 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -67.68 -8.26 33.63 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.252 0.464 . . . . 71.200000000000003 112.252 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 64' ' ' LYS . 3.9 mppt? -97.08 7.94 45.57 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.018 0.437 . . . . 73.129999999999995 111.215 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.0 134.63 2.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.359 -0.382 . . . . 63.329999999999998 112.604 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.3 tt -154.53 144.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.427 -0.455 . . . . 72.409999999999997 110.59 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.503 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.5 p-10 -96.99 -174.51 2.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.302 0.572 . . . . 72.510000000000005 112.35 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.7 p -62.68 -50.72 70.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.939 -0.573 . . . . 62.240000000000002 111.488 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.425 ' HA ' HG13 ' A' ' 72' ' ' VAL . 49.1 m -69.09 -35.85 76.94 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.367 -0.379 . . . . 73.340000000000003 111.318 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.04 -44.6 97.55 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.112 -0.565 . . . . 70.209999999999994 112.726 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -66.02 -50.75 63.14 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.54 -0.388 . . . . 74.319999999999993 111.702 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 69' ' ' SER . 11.9 p -61.43 -37.49 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.927 0.394 . . . . 74.340000000000003 110.844 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.474 ' NE2' ' HD3' ' A' ' 86' ' ' ARG . 4.0 tt0 -54.47 -59.34 4.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.1 0.476 . . . . 73.019999999999996 110.693 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.545 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 9.4 mmm180 -52.24 -55.68 19.66 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.847 -0.615 . . . . 73.430000000000007 111.824 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.798 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 72.3 m -48.74 -56.25 9.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.401 0.519 . . . . 74.040000000000006 112.401 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 41.7 m-85 -74.94 -34.89 62.16 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.013 0.746 . . . . 74.25 113.013 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 ptm180 -66.42 -39.67 89.08 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.422 0.527 . . . . 74.409999999999997 112.422 -175.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 15.6 pt-20 -102.34 -23.39 13.97 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.075 0.769 . . . . 71.25 113.075 -174.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 75' ' ' THR . 84.4 mm-40 -87.31 -63.06 1.36 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.984 -0.448 . . . . 62.229999999999997 111.589 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.72 -18.16 30.1 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.004 0.372 . . . . 74.310000000000002 112.004 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 45.14 28.7 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.062 -0.59 . . . . 64.310000000000002 112.592 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 44.4 tp -105.99 136.9 44.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.901 0.381 . . . . 72.030000000000001 111.277 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.83 88.78 4.04 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.818 0.342 . . . . 74.319999999999993 111.645 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.42 138.16 19.46 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.94 0.348 . . . . 62.32 111.94 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HD2' ' OE1' ' A' ' 91' ' ' GLN . 73.4 Cg_endo -74.25 -161.54 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.412 2.741 . . . . 65.329999999999998 113.717 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.474 ' HD3' ' NE2' ' A' ' 73' ' ' GLN . 13.6 mmt180 -102.01 -31.99 10.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.479 1.289 . . . . 75.409999999999997 114.479 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -114.17 148.72 36.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.879 0.696 . . . . 74.540000000000006 112.879 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.2 m -54.38 -42.73 70.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.832 -0.622 . . . . 70.109999999999999 112.478 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -57.37 -29.89 64.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 73.430000000000007 111.488 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.84 -43.67 17.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.075 0.464 . . . . 62.25 110.382 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.473 ' OE1' ' HD2' ' A' ' 85' ' ' PRO . 20.3 mm-40 -54.25 -47.09 72.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.857 -0.61 . . . . 74.329999999999998 112.046 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -61.7 -23.46 66.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.217 0.451 . . . . 74.420000000000002 112.217 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -92.11 2.11 56.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.971 -0.456 . . . . 74.209999999999994 111.972 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 94.3 mmm -85.63 -14.69 44.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.953 0.406 . . . . 63.049999999999997 111.111 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.42 152.54 23.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.154 -0.546 . . . . 53.140000000000001 113.174 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -83.01 150.82 26.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.923 0.392 . . . . 72.340000000000003 111.555 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 86.8 p -76.6 158.43 31.13 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.995 0.739 . . . . 72.340000000000003 112.995 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.407 HG11 ' NE ' ' A' ' 157' ' ' ARG . 1.5 m -145.41 174.06 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.682 -0.69 . . . . 71.319999999999993 111.779 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -111.53 179.67 3.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.783 -0.644 . . . . 75.109999999999999 111.489 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.534 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 32.6 mmt180 -50.09 -32.98 17.08 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.295 0.48 . . . . 72.299999999999997 112.295 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.9 p -77.1 -29.93 55.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.615 0.598 . . . . 73.530000000000001 112.615 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -109.52 20.42 18.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.483 0.549 . . . . 74.140000000000001 112.483 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.52 135.18 57.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.07 0.462 . . . . 72.120000000000005 111.098 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -108.81 148.6 30.31 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.185 -0.322 . . . . 75.510000000000005 111.438 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.412 ' O ' HG12 ' A' ' 40' ' ' VAL . 63.6 m -68.95 110.76 4.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.847 -0.533 . . . . 72.109999999999999 110.078 173.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.07 15.47 30.68 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.419 -0.419 . . . . 72.5 112.266 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.33 152.43 36.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.729 0.411 . . . . 71.400000000000006 110.71 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.4 mt -99.86 108.35 20.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.296 0.569 . . . . 74.409999999999997 111.344 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.16 123.98 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.328 0.585 . . . . 75.310000000000002 111.628 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.9 mt -90.93 135.37 33.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.625 -0.716 . . . . 62.530000000000001 111.945 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 91.0 m-85 -120.22 141.89 49.52 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.166 0.508 . . . . 73.120000000000005 111.962 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -72.48 96.58 1.94 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.709 -0.678 . . . . 75.409999999999997 110.856 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -126.9 106.9 9.63 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.744 0.307 . . . . 72.109999999999999 111.44 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.37 -28.9 51.86 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 114.034 0.374 . . . . 54.240000000000002 114.034 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -61.09 -32.97 72.63 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.285 0.476 . . . . 74.140000000000001 112.285 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.3 p -130.25 -0.72 4.56 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.091 0.404 . . . . 71.209999999999994 112.091 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.2 -57.02 3.65 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.296 -0.478 . . . . 42.299999999999997 112.257 -174.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.7 mmt-85 -126.65 117.64 23.16 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.898 0.38 . . . . 74.200000000000003 111.537 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 44.5 t60 -102.21 151.5 22.14 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.398 -0.593 . . . . 61.149999999999999 109.398 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.51 137.67 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.258 0.466 . . . . 75.549999999999997 112.258 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 153.34 20.33 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 116.066 -0.516 . . . . 72.129999999999995 112.525 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.1 mt -88.15 103.44 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.975 0.417 . . . . 63.0 111.132 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -64.09 116.39 5.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.08 -0.509 . . . . 74.349999999999994 111.654 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.7 pt -102.76 -28.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.639 0.607 . . . . 63.420000000000002 112.639 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.65 135.37 1.93 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 119.863 -1.161 . . . . 42.340000000000003 114.973 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 65.0 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.071 0.948 . . . . 71.049999999999997 111.403 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.551 HD21 ' HB2' ' A' ' 143' ' ' MET . 22.6 m120 -141.34 -3.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.879 -0.601 . . . . 74.200000000000003 111.493 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -93.29 143.9 25.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.32 0.581 . . . . 74.510000000000005 111.574 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 18.0 p90 -152.61 145.81 24.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.47 -0.786 . . . . 74.0 111.008 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.34 133.83 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 74.030000000000001 110.903 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.49 178.64 8.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.107 0.479 . . . . 75.530000000000001 111.215 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -97.93 110.44 23.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.24 -0.437 . . . . 62.210000000000001 111.187 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 70.3 m -86.08 140.83 29.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.838 0.351 . . . . 73.209999999999994 111.165 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.4 p -47.43 -53.72 13.28 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.453 0.908 . . . . 71.230000000000004 113.453 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 p -90.29 -71.25 0.63 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.537 0.569 . . . . 64.209999999999994 112.537 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 54.2 m -58.71 -26.72 64.17 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.916 0.71 . . . . 70.439999999999998 112.916 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.54 -160.15 18.27 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.895 -0.669 . . . . 45.219999999999999 113.219 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 19.3 t -66.98 109.07 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.03 0.443 . . . . 74.219999999999999 111.909 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.499 ' HA ' ' HH ' ' A' ' 48' ' ' TYR . 38.9 pt -138.37 179.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.999 0.428 . . . . 64.010000000000005 111.754 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.22 110.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 110.599 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.435 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . 55.7 m -101.86 172.84 6.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.904 0.383 . . . . 65.5 111.738 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 138.99 49.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.13 0.49 . . . . 75.239999999999995 111.908 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.551 ' HB2' HD21 ' A' ' 127' ' ' ASN . 65.0 mtt -69.69 -8.17 45.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.389 -0.369 . . . . 71.230000000000004 111.899 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -77.01 -19.43 57.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.978 0.418 . . . . 74.230000000000004 110.612 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.25 124.48 90.88 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.287 -0.415 . . . . 65.25 110.267 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -48.69 -38.5 37.04 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.352 2.701 . . . . 65.049999999999997 114.028 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.437 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 52.3 t80 -63.18 -45.92 89.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.924 0.392 . . . . 74.109999999999999 111.394 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 151' ' ' ARG . 83.8 m95 -80.79 -28.46 36.33 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.055 0.455 . . . . 72.200000000000003 111.392 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.9 -41.82 98.35 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.967 -0.561 . . . . 71.400000000000006 111.58 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -83.82 -21.38 32.11 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.096 0.474 . . . . 71.129999999999995 111.361 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' A' ' 148' ' ' TRP . 0.8 OUTLIER -72.16 -39.09 68.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.341 -0.39 . . . . 72.549999999999997 111.612 177.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.98 104.45 0.14 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.16 0.505 . . . . 72.239999999999995 112.18 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.19 -52.02 5.45 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.925 -0.58 . . . . 74.430000000000007 110.873 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -167.08 171.47 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.251 -0.432 . . . . 74.230000000000004 111.284 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -121.15 154.74 35.81 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.642 -0.254 . . . . 72.120000000000005 110.872 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 79.3 mtt180 -147.93 119.18 7.79 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.076 0.465 . . . . 73.349999999999994 111.742 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.408 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -86.66 109.29 19.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.042 0.448 . . . . 75.5 111.877 -177.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.09 -13.98 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.869 0.366 . . . . 73.430000000000007 111.736 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.69 130.6 34.52 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.443 -0.344 . . . . 73.319999999999993 111.205 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.9 t -77.5 112.26 14.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.918 0.389 . . . . 75.409999999999997 110.903 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -66.81 -28.93 68.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.836 0.35 . . . . 71.510000000000005 111.625 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.1 m -88.97 138.91 30.98 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.893 0.378 . . . . 61.020000000000003 111.467 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 163' ' ' LEU . 1.9 pt? -134.28 154.96 51.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.913 0.387 . . . . 65.239999999999995 111.043 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.684 -0.674 . . . . 74.310000000000002 112.065 -177.132 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.64 ' N ' ' SD ' ' A' ' 36' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.666 0.27 . . . . 72.400000000000006 110.753 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.92 101.7 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.956 0.407 . . . . 74.299999999999997 111.233 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.74 99.48 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.358 -0.383 . . . . 74.099999999999994 111.087 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -80.89 134.6 35.77 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.071 0.462 . . . . 73.200000000000003 111.851 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 44' ' ' ILE . 64.8 t -55.54 -51.88 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.109 -0.496 . . . . 75.099999999999994 110.823 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.7 tttt -57.22 -42.26 81.03 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.866 -0.606 . . . . 74.310000000000002 111.757 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.1 t -58.38 -45.44 88.31 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.886 0.374 . . . . 61.530000000000001 111.891 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.428 ' HD3' ' OE1' ' A' ' 79' ' ' GLN . 3.2 mmp_? -66.05 -44.26 85.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 73.439999999999998 111.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.2 mt -57.97 -41.36 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.038 0.447 . . . . 75.120000000000005 111.13 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.529 ' HA ' ' HE3' ' A' ' 45' ' ' MET . 30.7 mmt -67.08 -31.51 72.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 70.540000000000006 111.58 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.77 -41.75 96.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.87 0.367 . . . . 73.120000000000005 110.916 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' ' HD1' ' A' ' 51' ' ' TRP . 71.2 mm-40 -68.37 -55.19 12.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.436 -0.347 . . . . 72.0 111.096 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 28.9 t80 -48.25 -47.06 36.22 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.235 0.457 . . . . 75.329999999999998 112.235 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.62 -32.39 63.09 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.241 0.543 . . . . 71.319999999999993 111.715 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.88 -29.97 35.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.063 -0.517 . . . . 71.510000000000005 111.018 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.457 ' HZ2' HH11 ' A' ' 74' ' ' ARG . 73.9 m95 -96.52 3.17 52.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.103 0.779 . . . . 71.510000000000005 113.103 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 30.7 mtpp -61.45 122.89 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.991 -0.443 . . . . 74.409999999999997 110.797 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.93 -8.3 55.83 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.301 -0.476 . . . . 65.329999999999998 113.299 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -77.07 123.46 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.231 -0.57 . . . . 73.140000000000001 111.519 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -74.75 159.79 31.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 74.319999999999993 112.009 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -79.52 130.12 35.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 110.949 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -136.88 115.15 11.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.915 0.388 . . . . 75.329999999999998 112.023 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.86 123.87 24.26 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.046 0.45 . . . . 74.120000000000005 112.04 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.51 7.41 84.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 114.083 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.34 143.68 15.17 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.975 -0.631 . . . . 71.120000000000005 113.295 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.522 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 t -125.37 100.58 6.56 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.059 0.457 . . . . 72.340000000000003 111.171 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.1 t -170.81 167.95 7.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.274 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -73.96 -13.09 60.83 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.279 0.561 . . . . 73.549999999999997 111.212 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -76.26 -15.63 59.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.245 0.545 . . . . 75.040000000000006 110.55 173.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.33 135.86 1.91 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.847 -0.615 . . . . 64.439999999999998 112.024 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.522 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -151.63 154.11 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.985 0.393 . . . . 74.519999999999996 111.343 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -91.7 176.32 6.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.318 0.58 . . . . 75.420000000000002 111.953 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.8 t -59.11 -51.98 67.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.469 0.544 . . . . 75.120000000000005 112.469 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.6 t -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.279 0.561 . . . . 73.129999999999995 111.16 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 74' ' ' ARG . . . -64.24 -41.58 98.23 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.859 -0.61 . . . . 72.450000000000003 113.002 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.5 -51.01 70.41 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.445 -0.444 . . . . 70.239999999999995 111.795 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.446 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 11.9 p -62.2 -45.3 99.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.66 -0.245 . . . . 71.409999999999997 111.615 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 18.6 pt20 -61.24 -40.02 92.48 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.048 -0.407 . . . . 70.310000000000002 111.804 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.52 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 10.4 mtp-105 -67.85 -45.04 75.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.817 0.342 . . . . 74.329999999999998 111.327 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.7 m -51.98 -46.76 64.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.012 0.434 . . . . 75.049999999999997 111.778 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.0 m-85 -73.78 -42.17 61.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.018 0.747 . . . . 72.340000000000003 113.018 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 13.3 ptm180 -66.45 -34.27 77.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.048 -0.408 . . . . 73.230000000000004 112.065 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -81.16 -39.31 25.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.156 0.428 . . . . 75.349999999999994 112.156 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.428 ' OE1' ' HD3' ' A' ' 43' ' ' ARG . 77.6 mm-40 -86.96 -63.21 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.449 0.537 . . . . 71.040000000000006 112.449 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -90.57 -7.41 52.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.024 0.379 . . . . 75.519999999999996 112.024 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.07 10.15 84.08 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.135 -0.555 . . . . 71.439999999999998 112.519 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 39.0 tp -83.5 112.48 20.01 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.126 0.489 . . . . 73.349999999999994 110.737 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -86.0 92.36 8.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 72.450000000000003 111.456 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 93.3 mt -81.11 145.91 57.53 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.788 0.328 . . . . 73.099999999999994 111.159 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.56 -173.17 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.648 2.232 . . . . 75.140000000000001 113.7 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -94.98 -34.39 12.38 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.494 0.553 . . . . 75.439999999999998 112.494 -170.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.472 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 66.3 m -96.01 136.5 36.37 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.259 -0.276 . . . . 72.129999999999995 111.09 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.517 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 87.5 m -56.58 -39.51 73.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.844 0.313 . . . . 73.349999999999994 111.844 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -55.45 -45.88 76.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.909 0.385 . . . . 73.230000000000004 111.212 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 49.6 mt-10 -59.63 -38.48 81.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.008 0.432 . . . . 73.409999999999997 110.604 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -67.81 -35.59 78.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.251 -0.431 . . . . 72.430000000000007 111.185 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.4 mt-30 -62.14 -37.58 85.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.378 0.609 . . . . 65.329999999999998 110.612 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.98 12.83 10.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.603 -0.726 . . . . 73.540000000000006 112.557 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 90.4 mmm -84.9 -62.6 1.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.893 0.331 . . . . 70.540000000000006 111.893 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.29 -174.57 21.19 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.254 -0.498 . . . . 62.130000000000003 113.942 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.98 159.69 21.18 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.069 0.462 . . . . 74.400000000000006 111.837 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.469 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 61.7 p -91.37 150.59 21.21 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.379 0.609 . . . . 74.540000000000006 112.342 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.403 HG22 ' HB2' ' A' ' 155' ' ' ALA . 1.7 m -138.78 169.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.698 -0.683 . . . . 74.519999999999996 111.416 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -117.16 -179.68 3.78 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.19 -0.459 . . . . 72.319999999999993 111.468 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -47.1 -58.42 4.05 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.919 1.081 . . . . 73.129999999999995 113.919 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.6 m -73.47 -4.73 35.55 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.225 0.454 . . . . 73.129999999999995 112.225 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -99.06 -11.72 21.21 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.891 0.377 . . . . 74.099999999999994 111.28 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.3 114.28 6.63 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.511 0.56 . . . . 70.519999999999996 112.511 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -112.17 -160.91 0.73 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 110.843 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.0 m -82.41 114.84 21.13 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.183 -0.323 . . . . 74.430000000000007 110.984 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.02 -18.69 10.37 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.066 -0.588 . . . . 71.049999999999997 113.098 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.95 130.79 44.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.068 0.461 . . . . 74.109999999999999 111.529 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.55 114.25 24.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.376 -0.375 . . . . 72.540000000000006 110.672 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.27 124.8 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.492 0.663 . . . . 73.109999999999999 111.604 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.8 mt -97.64 126.35 42.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.5 -0.773 . . . . 75.519999999999996 111.776 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -117.41 160.84 20.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.037 0.446 . . . . 71.140000000000001 111.293 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 63.0 mtt85 -91.83 122.2 34.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.14 0.495 . . . . 73.0 111.279 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.87 163.04 17.49 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.113 -0.494 . . . . 73.409999999999997 111.142 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.34 -67.92 1.54 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.959 -0.639 . . . . 71.140000000000001 113.35 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.1 t -58.73 -52.23 66.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.136 0.421 . . . . 72.120000000000005 112.136 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 77.6 p -85.92 -23.42 27.0 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.666 0.617 . . . . 71.430000000000007 112.666 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.33 -48.17 3.76 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.901 -0.666 . . . . 61.350000000000001 112.598 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -118.08 134.97 54.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.944 0.402 . . . . 75.120000000000005 111.192 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.55 148.81 50.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.187 -0.46 . . . . 63.509999999999998 109.9 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.481 HG12 ' SG ' ' A' ' 68' ' ' CYS . 9.2 p -135.76 138.93 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.335 0.588 . . . . 74.319999999999993 112.334 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -129.05 144.84 15.74 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.869 -0.605 . . . . 72.150000000000006 112.608 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.8 mt -90.23 107.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.634 -0.333 . . . . 73.310000000000002 111.491 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.497 ' HH ' ' HA ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER -64.35 117.6 7.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.597 0.359 . . . . 75.409999999999997 111.422 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.3 pt -102.13 -32.88 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.362 0.504 . . . . 74.140000000000001 112.362 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.35 133.38 2.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.092 -1.051 . . . . 63.030000000000001 114.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 60.45 -80.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.593 0.757 . . . . 62.149999999999999 112.366 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.497 ' HA ' ' HH ' ' A' ' 123' ' ' TYR . 82.4 m-20 -141.57 1.63 1.56 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.177 0.436 . . . . 73.040000000000006 112.177 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -102.38 146.21 28.39 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.365 0.602 . . . . 71.0 112.051 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.7 p90 -150.73 148.98 29.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.377 -0.829 . . . . 72.230000000000004 111.657 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.87 138.34 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.916 0.389 . . . . 71.040000000000006 111.152 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -163.78 161.65 23.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.995 0.426 . . . . 71.209999999999994 111.847 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -91.2 96.7 10.71 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.207 0.527 . . . . 74.400000000000006 110.641 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.1 p -77.77 150.85 34.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.897 -0.592 . . . . 74.310000000000002 112.569 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.9 p -81.19 8.97 7.59 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.991 -0.55 . . . . 74.230000000000004 111.561 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 t -109.7 -46.55 3.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.855 0.317 . . . . 51.240000000000002 111.855 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.5 t -124.85 -30.16 3.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.385 0.513 . . . . 63.210000000000001 112.385 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.87 -147.65 18.42 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.278 -0.487 . . . . 72.209999999999994 112.005 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.21 101.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 117.141 0.471 . . . . 75.319999999999993 111.626 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.6 pt -136.96 176.6 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 71.409999999999997 112.173 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.12 120.97 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.004 -0.544 . . . . 61.119999999999997 110.846 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.8 p -122.62 178.27 5.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.937 0.399 . . . . 65.310000000000002 111.287 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 t -127.99 153.67 46.47 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.107 0.41 . . . . 65.510000000000005 112.107 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 25.0 mmt -60.07 -20.42 57.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.228 -0.442 . . . . 71.420000000000002 111.348 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.14 -24.3 66.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.287 -0.415 . . . . 74.340000000000003 111.636 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.484 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 29.0 mm-40 -71.47 133.68 84.88 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 120.833 0.349 . . . . 73.530000000000001 111.663 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 93.3 Cg_exo -45.15 -52.85 5.96 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.592 2.861 . . . . 72.049999999999997 115.11 -173.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.1 t80 -61.38 -43.6 98.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.824 0.345 . . . . 75.25 111.777 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.484 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 73.9 m95 -76.13 -38.77 56.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.043 0.449 . . . . 72.25 111.041 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.88 -45.66 71.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.828 -0.624 . . . . 72.420000000000002 112.064 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.5 ptpt -98.38 6.1 47.58 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.798 0.666 . . . . 73.439999999999998 112.798 -175.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 2.5 mpt_? -116.66 7.57 13.59 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 122.193 -0.317 . . . . 74.519999999999996 111.658 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -60.54 104.27 0.32 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.032 0.444 . . . . 74.420000000000002 111.162 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 8.5 t30 -82.15 -49.01 10.63 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.316 -0.402 . . . . 73.319999999999993 111.072 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 153' ' ' ASN . 11.1 pt-20 177.3 -166.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.124 0.57 . . . . 62.439999999999998 109.875 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.403 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -146.69 146.66 30.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.38 0.511 . . . . 73.129999999999995 112.38 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt180 -137.04 126.35 24.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.365 0.666 . . . . 73.299999999999997 110.318 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.37 111.92 24.48 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.439 -0.788 . . . . 74.140000000000001 110.605 175.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.3 m -89.46 -16.74 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.252 -0.885 . . . . 74.209999999999994 112.692 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.415 HD22 HD21 ' A' ' 82' ' ' LEU . 90.6 mt -69.75 153.57 43.18 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.226 0.536 . . . . 72.420000000000002 111.866 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.4 m -82.74 120.0 25.05 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.158 -0.473 . . . . 74.549999999999997 110.361 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -60.99 94.31 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.727 0.299 . . . . 75.409999999999997 110.253 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.1 m -64.84 132.44 49.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.46 -0.336 . . . . 75.200000000000003 111.604 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 163' ' ' LEU . 2.3 mm? -98.13 -168.74 1.7 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 110.174 -0.306 . . . . 71.239999999999995 110.174 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.779 -0.629 . . . . 72.109999999999999 111.202 175.265 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.853 0.359 . . . . 64.049999999999997 111.19 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -153.99 133.35 12.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.047 0.451 . . . . 71.450000000000003 111.364 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.9 t -76.51 118.18 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.172 -0.467 . . . . 70.430000000000007 111.623 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 15.0 t70 -99.11 122.29 42.13 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.602 0.239 . . . . 72.150000000000006 110.672 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.73 -57.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.347 0.499 . . . . 73.340000000000003 112.347 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.24 -44.15 95.47 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.666 0.27 . . . . 75.230000000000004 111.651 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 40.3 t -55.13 -47.85 74.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.886 0.374 . . . . 70.129999999999995 111.903 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 39' ' ' ASP . 11.0 mmm180 -59.9 -47.67 84.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.076 0.465 . . . . 74.340000000000003 111.289 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 122' ' ' ILE . 72.5 mt -61.67 -44.85 99.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.167 -0.469 . . . . 73.25 111.571 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.594 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 18.7 mmt -64.15 -29.08 70.22 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.917 0.389 . . . . 71.25 111.403 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.72 -47.76 82.2 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.223 0.535 . . . . 61.409999999999997 110.53 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.496 HE21 ' HB3' ' A' ' 50' ' ' ASP . 25.6 tp60 -66.13 -35.12 79.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 71.230000000000004 111.374 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -54.15 -37.22 64.17 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.463 -0.335 . . . . 73.430000000000007 111.542 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.71 -20.6 57.44 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.336 0.495 . . . . 64.450000000000003 112.336 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.496 ' HB3' HE21 ' A' ' 47' ' ' GLN . 34.9 t70 -90.92 -21.15 21.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.973 0.509 . . . . 71.409999999999997 111.521 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -122.81 30.51 6.4 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.949 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -57.82 -1.45 0.11 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.273 1.582 . . . . 72.239999999999995 115.273 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.54 49.14 0.11 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.246 -0.978 . . . . 72.219999999999999 113.64 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -92.19 137.24 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.784 0.326 . . . . 74.530000000000001 111.004 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -74.34 158.38 34.08 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.021 0.748 . . . . 75.120000000000005 113.021 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -73.09 119.09 16.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.914 -0.585 . . . . 74.329999999999998 111.513 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -137.66 119.14 14.83 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.989 0.423 . . . . 72.310000000000002 111.783 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.11 118.8 10.38 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.248 0.462 . . . . 75.239999999999995 112.248 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.58 -54.33 4.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.187 -0.53 . . . . 62.119999999999997 113.657 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.84 98.47 0.55 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.094 -0.574 . . . . 61.329999999999998 112.246 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.4 p -97.22 119.41 35.68 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 71.530000000000001 111.625 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -176.52 176.97 1.5 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.043 0.537 . . . . 73.299999999999997 110.978 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -16.45 63.7 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.973 -0.454 . . . . 74.219999999999999 110.943 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -85.72 2.75 44.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.295 -0.411 . . . . 73.430000000000007 110.987 175.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.12 142.75 3.62 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.468 -0.396 . . . . 44.210000000000001 112.746 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.1 tt -165.49 138.28 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.941 0.37 . . . . 73.109999999999999 111.105 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.11 171.47 8.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.798 -0.564 . . . . 74.239999999999995 111.319 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 21.0 p -54.52 -39.72 67.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.695 0.628 . . . . 70.519999999999996 112.695 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.433 ' HB2' ' OG1' ' A' ' 88' ' ' THR . 23.9 t -67.47 -47.01 71.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.803 0.335 . . . . 51.119999999999997 111.417 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.5 -36.22 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.01 -0.614 . . . . 73.140000000000001 112.898 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.87 -56.09 20.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.785 0.326 . . . . 74.439999999999998 111.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.9 p -61.32 -38.15 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.757 0.313 . . . . 74.239999999999995 111.536 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 6.0 tt0 -54.0 -58.11 8.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.286 0.565 . . . . 74.219999999999999 111.28 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -60.2 -51.85 67.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.948 -0.569 . . . . 72.409999999999997 111.913 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.403 ' HA ' ' OE1' ' A' ' 79' ' ' GLN . 78.1 m -48.37 -53.63 16.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.389 0.514 . . . . 71.0 112.389 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 45.9 m-85 -68.52 -37.95 80.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.787 0.662 . . . . 73.129999999999995 112.787 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.5 -21.26 45.54 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.889 -0.507 . . . . 72.150000000000006 112.174 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -86.45 -55.09 4.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.925 0.393 . . . . 71.150000000000006 111.492 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.404 ' CD ' ' HB2' ' A' ' 47' ' ' GLN . 1.9 mp0 -67.97 -51.38 48.1 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.336 0.495 . . . . 73.209999999999994 112.336 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -100.52 -36.89 9.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.023 0.44 . . . . 74.420000000000002 112.113 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.55 6.21 41.42 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.714 -0.554 . . . . 63.329999999999998 111.714 -172.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.481 HD23 HD22 ' A' ' 159' ' ' LEU . 29.0 tp -79.4 110.75 14.99 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.081 0.467 . . . . 74.439999999999998 110.669 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -84.3 112.08 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 75.5 111.943 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 84.3 mt -100.92 154.93 36.86 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.915 -0.584 . . . . 75.549999999999997 111.312 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.01 -179.02 1.2 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.45 2.1 . . . . 74.040000000000006 113.592 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -39.86 14.9 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.567 0.58 . . . . 74.140000000000001 112.567 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.7 m -110.59 141.87 43.19 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.143 0.423 . . . . 74.010000000000005 112.143 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.519 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 48.7 m -49.3 -39.06 29.66 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.311 -0.404 . . . . 75.319999999999993 111.8 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -52.98 -47.08 68.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.234 -0.439 . . . . 71.109999999999999 110.989 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -65.22 -36.74 85.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.406 0.622 . . . . 73.540000000000006 110.697 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.96 -28.47 68.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.777 -0.647 . . . . 73.25 111.49 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.0 mt-30 -68.79 -6.58 27.52 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.007 0.373 . . . . 73.530000000000001 112.007 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -98.06 -10.28 24.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.825 0.676 . . . . 70.129999999999995 112.825 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.428 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 25.7 ptm -124.62 162.39 24.2 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.399 0.518 . . . . 71.510000000000005 112.399 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 160.51 36.48 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.319 -0.467 . . . . 74.219999999999999 114.247 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 68.3 mmtt -84.48 125.66 32.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.135 0.493 . . . . 75.430000000000007 111.638 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 64.6 p -81.21 111.98 18.12 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.648 -0.706 . . . . 75.340000000000003 112.841 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 155' ' ' ALA . 2.8 m -106.2 157.58 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.808 -0.633 . . . . 73.439999999999998 111.964 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.439 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 84.0 p -99.59 -179.8 4.31 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.994 -0.548 . . . . 62.100000000000001 111.823 -177.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -53.23 -41.45 65.42 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.988 0.366 . . . . 73.319999999999993 111.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -77.28 -24.76 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 111.985 0.365 . . . . 72.430000000000007 111.985 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.62 -8.1 57.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.194 0.442 . . . . 72.319999999999993 112.194 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.464 HD23 ' HH ' ' A' ' 152' ' ' TYR . 85.3 mt -63.2 133.25 53.99 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.509 0.559 . . . . 74.019999999999996 112.509 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.405 ' O ' ' HD1' ' A' ' 123' ' ' TYR . 51.8 mtt180 -137.49 -122.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.466 -0.334 . . . . 74.420000000000002 110.352 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -106.12 127.04 52.92 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.692 -0.63 . . . . 75.219999999999999 112.134 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.16 13.31 36.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.298 -0.477 . . . . 75.439999999999998 114.178 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 123' ' ' TYR . 1.6 m-20 -81.44 120.09 24.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 122.571 -0.37 . . . . 72.230000000000004 111.5 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.7 mt -76.62 104.04 6.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.972 0.415 . . . . 75.129999999999995 110.195 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.5 m -95.53 118.8 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.512 0.672 . . . . 72.310000000000002 111.995 -173.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.488 HD12 ' HG2' ' A' ' 92' ' ' GLN . 74.7 mt -93.93 117.6 30.32 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.46 -0.791 . . . . 75.129999999999995 112.312 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 77.8 m-85 -107.91 133.36 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 73.230000000000004 110.331 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.62 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 78.4 mtt-85 -82.6 110.44 17.68 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.637 -0.505 . . . . 73.340000000000003 109.637 174.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.14 156.15 18.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.93 0.395 . . . . 70.340000000000003 111.664 -173.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.92 -95.2 0.33 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.211 -0.518 . . . . 65.239999999999995 112.03 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -116.81 -59.79 1.92 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.242 0.544 . . . . 73.319999999999993 109.78 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 112' ' ' ARG . 8.2 p -145.47 45.44 1.3 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.667 -0.697 . . . . 60.310000000000002 110.883 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.72 -127.72 0.77 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.309 -0.472 . . . . 65.239999999999995 112.994 176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 118' ' ' ARG . 3.5 ppt_? -148.27 149.77 32.47 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 122.066 -0.667 . . . . 73.349999999999994 112.533 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 68.4 t60 -165.67 149.69 8.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.732 -0.667 . . . . 64.310000000000002 109.471 170.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 7.8 p -142.38 137.18 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.288 0.566 . . . . 62.549999999999997 111.969 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.06 154.35 20.5 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.046 -0.597 . . . . 73.400000000000006 112.845 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 44' ' ' ILE . 47.4 mt -92.3 100.33 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 73.319999999999993 110.572 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.443 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 37.4 t80 -71.15 117.68 12.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.141 -0.481 . . . . 74.239999999999995 111.15 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.9 pt -99.08 -30.24 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.16 0.43 . . . . 73.510000000000005 112.16 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.27 163.31 9.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.159 -0.543 . . . . 61.210000000000001 113.202 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 56.76 39.86 29.41 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.674 0.39 . . . . 72.239999999999995 111.909 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.618 ' N ' HD21 ' A' ' 127' ' ' ASN . 0.7 OUTLIER 67.92 4.69 4.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.808 0.443 . . . . 75.400000000000006 111.846 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 141' ' ' SER . 25.8 mt-30 -97.4 140.48 31.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.385 0.612 . . . . 73.450000000000003 112.158 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.443 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.5 p90 -146.54 137.58 24.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.739 . . . . 71.310000000000002 111.215 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.08 126.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.058 0.456 . . . . 71.239999999999995 110.765 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -155.32 150.14 26.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.925 0.393 . . . . 75.040000000000006 111.813 -174.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.81 91.42 4.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.176 0.512 . . . . 74.519999999999996 110.183 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.4 p -78.23 143.94 36.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.815 -0.629 . . . . 74.239999999999995 112.234 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.4 t -77.27 -4.97 47.59 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.383 0.611 . . . . 72.540000000000006 111.369 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -87.94 -35.68 17.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.067 -0.515 . . . . 72.420000000000002 111.729 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 m -138.42 -51.78 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.235 0.54 . . . . 75.239999999999995 111.808 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.86 -153.22 24.52 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.642 -0.708 . . . . 52.43 111.708 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.23 96.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 117.411 0.605 . . . . 72.409999999999997 111.114 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.28 168.47 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.302 -0.408 . . . . 74.329999999999998 111.744 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.12 109.41 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.25 -0.432 . . . . 75.219999999999999 110.666 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 128' ' ' GLN . 48.5 m -107.21 173.81 6.16 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.065 0.395 . . . . 73.099999999999994 112.065 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 29.1 t -119.95 141.16 49.89 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.688 0.625 . . . . 75.299999999999997 112.688 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.5 mtt -76.62 -0.55 23.79 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.859 0.689 . . . . 74.439999999999998 112.859 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -84.95 -10.94 56.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.065 0.459 . . . . 62.210000000000001 110.829 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -76.47 132.91 71.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 110.799 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 72.7 Cg_exo -48.11 -49.4 14.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.224 2.616 . . . . 64.329999999999998 114.554 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 91.9 t80 -61.55 -48.05 82.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.941 0.4 . . . . 73.439999999999998 111.194 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -72.83 -34.94 67.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.782 0.325 . . . . 75.319999999999993 111.665 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.69 -47.58 84.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.898 0.38 . . . . 75.129999999999995 111.319 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 19.0 ptpt -73.24 -32.14 64.54 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.979 0.363 . . . . 75.140000000000001 111.979 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.62 ' HD3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mmp_? -76.82 -23.41 52.77 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.008 -0.433 . . . . 75.019999999999996 111.443 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.464 ' HH ' HD23 ' A' ' 103' ' ' LEU . 25.0 t80 -61.18 108.27 0.88 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.051 0.453 . . . . 73.310000000000002 111.841 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -91.35 -69.1 0.75 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.305 0.574 . . . . 75.230000000000004 111.171 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.49 153.14 38.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.977 -0.556 . . . . 71.310000000000002 110.782 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.487 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -115.48 149.83 37.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.75 -0.204 . . . . 61.210000000000001 110.539 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mtt180 -137.6 122.99 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.365 0.603 . . . . 74.129999999999995 112.437 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -87.91 108.64 19.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.798 -0.637 . . . . 74.430000000000007 110.67 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.0 m -99.31 0.76 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.686 -0.688 . . . . 72.530000000000001 112.546 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.481 HD22 HD23 ' A' ' 82' ' ' LEU . 80.0 mt -67.36 99.36 0.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.106 0.479 . . . . 75.430000000000007 112.21 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.5 t -89.69 -174.53 4.34 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.019 -0.537 . . . . 72.099999999999994 110.53 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -142.11 105.54 4.65 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.155 0.502 . . . . 73.530000000000001 111.682 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 m -82.68 -169.77 2.64 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.95 -0.568 . . . . 72.129999999999995 110.843 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 164' ' ' GLU . 4.8 tt -72.35 132.62 44.21 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 110.156 -0.313 . . . . 73.5 110.156 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.486 ' N ' HD23 ' A' ' 163' ' ' LEU . 76.9 mm-40 . . . . . 0 C--O 1.252 1.207 0 N-CA-C 113.26 0.837 . . . . 72.409999999999997 113.26 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.633 0.254 . . . . 72.450000000000003 111.307 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -70.86 96.27 1.25 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.827 0.346 . . . . 53.049999999999997 110.408 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.38 97.15 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.964 0.411 . . . . 73.200000000000003 111.275 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.543 ' HB2' ' HG ' ' A' ' 42' ' ' SER . 14.1 m-20 -58.04 105.34 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.187 -0.461 . . . . 74.230000000000004 111.523 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 44' ' ' ILE . 94.1 t -48.74 -41.35 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.486 0.66 . . . . 74.230000000000004 110.322 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 45' ' ' MET . 88.2 tttt -56.48 -45.36 80.97 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.257 -0.883 . . . . 74.120000000000005 112.132 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.543 ' HG ' ' HB2' ' A' ' 39' ' ' ASP . 82.9 p -65.02 -37.78 88.73 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 122.228 -0.295 . . . . 73.109999999999999 111.536 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -70.9 -38.03 73.01 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 75.349999999999994 111.175 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 40' ' ' VAL . 86.2 mt -62.52 -46.08 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.127 0.489 . . . . 75.120000000000005 110.805 174.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 95.8 mmm -67.7 -29.74 69.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.347 -0.388 . . . . 74.239999999999995 111.282 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.46 -44.81 89.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.052 0.453 . . . . 73.319999999999993 110.196 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -65.3 -46.93 78.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.528 -0.76 . . . . 73.420000000000002 111.229 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -53.63 -39.22 64.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 112.136 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.22 68.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.861 0.362 . . . . 71.109999999999999 111.849 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -79.21 -33.79 43.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.248 0.547 . . . . 74.450000000000003 111.081 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.514 ' HZ2' ' NH1' ' A' ' 74' ' ' ARG . 84.9 m95 -99.13 22.75 9.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.438 0.533 . . . . 74.219999999999999 112.438 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.07 120.3 11.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.064 0.459 . . . . 73.409999999999997 112.032 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.03 20.43 75.85 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 114.472 0.549 . . . . 61.310000000000002 114.472 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.3 t -83.6 131.2 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 117.595 0.698 . . . . 74.450000000000003 111.003 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.31 163.46 26.44 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.298 0.571 . . . . 73.120000000000005 112.509 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.411 ' CG ' ' HA ' ' A' ' 134' ' ' THR . 49.9 t80 -89.52 141.59 28.44 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.514 0.673 . . . . 75.329999999999998 112.437 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.618 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 57.2 ttt180 -129.58 131.28 46.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.573 -0.739 . . . . 74.109999999999999 110.462 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.7 mp -76.22 93.54 3.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.969 0.414 . . . . 75.230000000000004 111.374 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 71.71 1.29 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.28 -0.486 . . . . 71.349999999999994 113.285 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' HA3' ' CZ ' ' A' ' 57' ' ' ARG . . . 172.92 139.83 2.97 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.893 -0.67 . . . . 53.329999999999998 113.186 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.558 ' HB2' ' HD2' ' A' ' 74' ' ' ARG . 84.7 p -110.65 101.17 9.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.601 0.593 . . . . 70.209999999999994 112.601 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -153.22 151.78 30.46 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.12 -0.491 . . . . 73.439999999999998 111.137 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.464 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 32.3 ttmt -70.34 -5.56 28.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.05 0.453 . . . . 74.239999999999995 111.827 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -106.29 15.22 26.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.975 0.417 . . . . 74.200000000000003 111.265 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.75 108.11 0.27 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 112.164 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.493 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -138.48 151.76 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 117.342 0.571 . . . . 71.310000000000002 111.894 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.618 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 6.2 p-10 -95.11 -179.13 4.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.185 0.517 . . . . 71.010000000000005 112.238 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.29 -55.76 22.05 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.003 -0.544 . . . . 51.119999999999997 111.954 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.4 ' HA ' HG13 ' A' ' 72' ' ' VAL . 81.5 p -66.21 -29.17 69.38 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.826 0.346 . . . . 73.219999999999999 110.864 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.642 ' HA2' HE21 ' A' ' 73' ' ' GLN . . . -66.1 -44.63 90.9 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.094 -0.503 . . . . 72.099999999999994 112.801 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.07 -51.83 66.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.0 0.428 . . . . 75.409999999999997 111.268 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 ' HA ' HD13 ' A' ' 122' ' ' ILE . 7.0 p -62.47 -44.46 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 112.173 0.434 . . . . 54.149999999999999 112.173 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.642 HE21 ' HA2' ' A' ' 70' ' ' GLY . 21.3 pt20 -59.57 -49.98 75.67 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.94 -0.475 . . . . 72.450000000000003 111.443 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.558 ' HD2' ' HB2' ' A' ' 61' ' ' SER . 10.0 mtp-105 -60.13 -41.61 93.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.991 0.424 . . . . 74.319999999999993 111.135 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.4 m -54.53 -52.23 62.68 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.103 -0.499 . . . . 74.129999999999995 111.489 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.6 m-85 -72.27 -37.83 68.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.502 0.556 . . . . 75.239999999999995 112.502 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.469 ' HG3' ' HA ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.77 -20.02 58.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.473 0.546 . . . . 71.439999999999998 112.473 -177.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -97.1 -49.93 4.8 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.166 -0.334 . . . . 73.019999999999996 111.509 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -71.55 -44.93 63.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.112 0.412 . . . . 63.329999999999998 112.112 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.11 -12.75 14.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.677 0.621 . . . . 73.519999999999996 112.677 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 32.32 62.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.127 -0.559 . . . . 62.130000000000003 113.33 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 57.9 tp -92.81 127.21 38.24 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.617 -0.343 . . . . 72.420000000000002 111.596 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.23 79.97 2.35 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.906 0.706 . . . . 73.510000000000005 112.906 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.411 HD23 HG23 ' A' ' 158' ' ' VAL . 64.3 mt -95.82 142.56 24.75 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 121.913 -0.492 . . . . 74.239999999999995 111.777 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.657 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 87.9 Cg_endo -82.1 -174.07 1.98 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.174 2.583 . . . . 63.130000000000003 113.391 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.491 ' HD2' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -105.6 20.64 18.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.44 0.904 . . . . 75.450000000000003 113.44 -169.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.1 m -141.29 132.65 26.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.938 0.399 . . . . 73.030000000000001 111.535 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 34.8 m -51.74 -43.87 63.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.239 -0.437 . . . . 71.129999999999995 111.929 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -58.43 -17.04 17.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.43 0.53 . . . . 74.230000000000004 112.43 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 94' ' ' MET . 35.5 mt-10 -92.35 -53.22 4.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.102 0.477 . . . . 70.120000000000005 110.484 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.612 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 80.6 mt-30 -54.6 -45.97 73.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.964 -0.562 . . . . 73.109999999999999 112.341 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 88' ' ' THR . 18.4 pt20 -53.59 -33.91 56.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.49 0.552 . . . . 61.520000000000003 112.49 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.38 10.9 29.49 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.047 0.758 . . . . 73.420000000000002 113.047 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.657 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 77.6 mtp -79.38 -29.95 42.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.043 0.449 . . . . 75.329999999999998 111.018 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.74 -133.27 6.84 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.37 -0.443 . . . . 74.400000000000006 112.674 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -127.19 174.03 9.25 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.549 -0.383 . . . . 74.420000000000002 111.547 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.6 p -106.81 161.53 14.6 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 112.221 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.402 HG21 ' CB ' ' A' ' 155' ' ' ALA . 0.0 OUTLIER -148.2 160.13 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.604 -0.725 . . . . 73.310000000000002 111.662 177.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 t -95.92 173.22 7.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.976 -0.556 . . . . 74.25 111.441 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -51.19 -33.08 25.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.413 0.894 . . . . 75.209999999999994 113.413 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.8 m -82.71 -22.43 34.48 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.811 0.671 . . . . 70.25 112.811 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -96.53 14.71 23.76 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.349 0.5 . . . . 74.299999999999997 112.349 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.37 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.96 0.355 . . . . 73.219999999999999 111.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -124.68 -174.63 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.152 0.501 . . . . 75.129999999999995 111.014 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.3 m -76.19 107.22 8.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.255 -0.43 . . . . 74.349999999999994 111.173 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.78 -19.64 6.54 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.253 -0.499 . . . . 70.540000000000006 112.885 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.3 134.43 51.56 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.396 0.617 . . . . 64.239999999999995 111.693 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.0 mt -91.58 120.14 32.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.087 -0.506 . . . . 72.430000000000007 111.069 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.3 m -96.21 134.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.899 0.38 . . . . 73.430000000000007 111.564 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.34 125.9 51.57 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.921 0.391 . . . . 71.420000000000002 111.964 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB3' ' HB3' ' A' ' 151' ' ' ARG . 90.6 m-85 -114.95 136.76 52.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.292 -0.413 . . . . 74.420000000000002 111.019 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.557 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 57.4 mtp180 -79.02 77.82 5.48 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.227 0.537 . . . . 73.340000000000003 110.903 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.91 123.36 36.11 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.051 -0.522 . . . . 72.329999999999998 112.173 -173.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.29 -25.22 66.39 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 121.113 -0.565 . . . . 74.319999999999993 113.945 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.6 m -82.03 -8.13 59.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.38 0.511 . . . . 72.530000000000001 112.38 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.7 p -141.02 -59.12 0.5 Allowed 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.376 0.608 . . . . 70.310000000000002 112.071 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 130.47 -98.82 0.42 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.151 -0.779 . . . . 65.329999999999998 111.151 -175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -94.7 90.8 6.23 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.072 0.463 . . . . 73.219999999999999 110.31 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -84.04 118.9 24.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 110.683 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 10.9 p -105.07 136.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.287 0.565 . . . . 74.299999999999997 112.408 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.18 148.02 19.19 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.995 -0.548 . . . . 75.310000000000002 112.689 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 72' ' ' VAL . 37.1 mt -87.68 110.22 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.492 -0.416 . . . . 72.349999999999994 111.029 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.491 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 20.8 t80 -68.13 109.39 3.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.767 0.317 . . . . 75.129999999999995 111.173 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.11 -32.48 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.072 0.397 . . . . 75.340000000000003 112.072 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 149.25 132.94 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.705 -0.76 . . . . 73.230000000000004 113.757 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 t30 55.34 78.33 0.19 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.746 0.647 . . . . 74.540000000000006 112.746 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 70.2 -41.04 0.48 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.777 1.029 . . . . 72.510000000000005 113.777 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -81.03 146.15 30.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.612 0.72 . . . . 74.120000000000005 112.64 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.491 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.85 154.65 35.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.349 -0.841 . . . . 73.129999999999995 111.153 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 139.49 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.888 0.375 . . . . 74.040000000000006 111.3 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -160.53 177.04 10.93 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.019 0.437 . . . . 72.209999999999994 111.733 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.93 103.47 10.64 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 111.393 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 70.8 m -81.38 149.38 28.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.871 0.367 . . . . 73.310000000000002 111.439 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 56' ' ' TYR . 71.3 p -56.05 -43.77 78.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.98 0.733 . . . . 74.439999999999998 112.98 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.4 m -100.18 -42.07 6.85 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.13 0.418 . . . . 71.409999999999997 112.13 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 55.0 m -76.63 -25.71 54.14 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.825 0.676 . . . . 52.409999999999997 112.825 -176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.68 32.8 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.024 -0.608 . . . . 72.099999999999994 112.841 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.47 102.57 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.967 0.413 . . . . 75.450000000000003 111.666 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.1 pt -135.99 179.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.582 0.706 . . . . 70.319999999999993 112.541 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.66 135.81 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.507 -0.769 . . . . 65.420000000000002 110.785 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -132.12 176.1 8.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.441 0.163 . . . . 73.409999999999997 110.903 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.2 t -137.31 145.37 43.36 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.786 0.662 . . . . 74.230000000000004 112.786 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.49 -20.3 66.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.924 0.712 . . . . 71.340000000000003 112.924 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -75.82 -18.67 59.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.717 0.294 . . . . 71.329999999999998 111.694 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.47 130.66 91.98 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 116.668 -0.242 . . . . 75.140000000000001 111.061 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.86 -46.6 26.92 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.338 2.692 . . . . 71.409999999999997 113.838 -173.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -61.14 -46.31 91.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.709 0.29 . . . . 74.5 111.659 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -73.71 -39.74 64.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.904 0.383 . . . . 74.310000000000002 111.029 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.74 -44.83 70.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 75.209999999999994 111.629 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -78.63 -32.34 47.33 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.8 0.296 . . . . 74.319999999999993 111.8 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 20.0 mmt180 -70.11 -18.89 63.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.89 0.33 . . . . 71.010000000000005 111.89 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.15 111.57 0.99 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.33 0.586 . . . . 73.430000000000007 111.972 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.557 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -89.17 -57.0 3.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 70.230000000000004 110.08 177.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -171.87 176.75 3.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 74.099999999999994 110.523 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.402 ' CB ' HG21 ' A' ' 98' ' ' VAL . . . -125.67 153.93 43.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.234 0.54 . . . . 72.019999999999996 111.729 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -140.88 167.01 23.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.947 -0.569 . . . . 74.420000000000002 110.141 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.8 136.06 13.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.127 0.489 . . . . 74.439999999999998 111.287 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.411 HG23 HD23 ' A' ' 84' ' ' LEU . 13.4 m -104.15 3.85 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.785 -0.643 . . . . 72.120000000000005 112.314 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.21 156.96 18.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.911 0.386 . . . . 75.430000000000007 111.629 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.9 t -122.93 178.96 4.82 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.442 -0.345 . . . . 72.329999999999998 110.864 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -118.33 124.15 47.07 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.039 0.447 . . . . 75.510000000000005 112.076 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.9 m -78.81 142.56 36.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.05 -0.523 . . . . 72.230000000000004 110.984 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.436 ' N ' HD21 ' A' ' 163' ' ' LEU . 2.9 mm? -93.92 171.11 9.06 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.756 0.312 . . . . 74.409999999999997 110.904 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.266 -0.874 . . . . 73.510000000000005 112.263 -178.667 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.743 0.306 . . . . 65.420000000000002 111.16 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -67.23 89.08 0.19 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.124 0.488 . . . . 73.200000000000003 111.267 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -72.78 82.21 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.304 0.573 . . . . 65.219999999999999 111.039 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.71 132.36 35.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.031 -0.531 . . . . 71.409999999999997 110.859 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.9 t -55.14 -62.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.307 -0.406 . . . . 74.0 111.818 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.562 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 86.7 tttt -53.58 -45.86 70.11 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 74.239999999999995 111.66 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.1 m -63.78 -39.29 93.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.058 -0.519 . . . . 74.049999999999997 112.204 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -35.53 75.3 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.814 0.301 . . . . 71.319999999999993 111.814 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 40' ' ' VAL . 63.8 mt -64.61 -44.2 96.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.053 0.454 . . . . 73.150000000000006 110.567 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.562 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 26.9 mmt -64.24 -35.7 81.66 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.028 0.442 . . . . 73.200000000000003 110.892 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.72 -36.85 74.94 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.959 -0.564 . . . . 75.049999999999997 111.184 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.439 ' NE2' ' HE1' ' A' ' 51' ' ' TRP . 7.7 tp60 -76.04 -44.31 39.76 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.293 0.568 . . . . 74.439999999999998 111.216 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -55.37 -40.63 71.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 111.627 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.54 -21.57 65.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.032 0.382 . . . . 74.230000000000004 112.032 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -84.52 -42.75 15.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.061 0.457 . . . . 73.239999999999995 111.579 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.439 ' HE1' ' NE2' ' A' ' 47' ' ' GLN . 64.9 m95 -82.45 -50.42 8.88 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.43 -0.35 . . . . 64.319999999999993 111.708 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HB3' ' HE3' ' A' ' 52' ' ' LYS . 21.2 mmmt 46.46 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.446 1.276 . . . . 75.439999999999998 114.446 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.11 38.36 96.0 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.301 0.88 . . . . 72.340000000000003 115.301 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.62 131.33 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.635 0.717 . . . . 72.450000000000003 110.291 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.34 155.4 28.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.935 0.717 . . . . 75.030000000000001 112.935 -174.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -67.83 119.94 13.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.705 -0.68 . . . . 74.430000000000007 111.837 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 57' ' ' ARG . 20.6 ttm-85 -137.08 123.75 21.08 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.463 0.305 . . . . 74.450000000000003 110.721 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.3 mp -69.97 113.94 7.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.079 0.466 . . . . 74.319999999999993 112.162 -175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.26 -56.23 5.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 114.137 0.415 . . . . 51.409999999999997 114.137 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.7 82.34 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.224 -0.513 . . . . 72.310000000000002 113.226 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.483 ' OG ' ' HD2' ' A' ' 74' ' ' ARG . 83.8 p -76.61 110.58 11.3 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.096 0.474 . . . . 73.549999999999997 111.841 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -167.47 173.51 8.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.04 0.448 . . . . 73.519999999999996 111.524 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -69.41 -7.0 33.72 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.112 0.482 . . . . 71.310000000000002 111.42 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -93.42 8.23 41.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.113 0.482 . . . . 71.230000000000004 110.934 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.1 144.1 4.23 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.175 -0.466 . . . . 63.109999999999999 112.687 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 tt -163.52 135.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.582 -0.364 . . . . 75.420000000000002 110.844 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -85.42 177.03 7.92 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.351 0.596 . . . . 75.120000000000005 112.406 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.52 ' SG ' HG12 ' A' ' 120' ' ' VAL . 27.5 t -52.6 -57.24 10.64 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.694 -0.685 . . . . 71.310000000000002 111.933 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -65.53 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.161 0.505 . . . . 74.409999999999997 110.954 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.776 ' HA2' HE21 ' A' ' 73' ' ' GLN . . . -61.16 -45.78 95.84 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.946 -0.57 . . . . 65.230000000000004 113.107 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.34 -48.92 73.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.521 -0.4 . . . . 75.239999999999995 111.743 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.532 ' HA ' HD13 ' A' ' 122' ' ' ILE . 7.3 p -60.34 -50.48 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.11 0.411 . . . . 64.5 112.11 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.776 HE21 ' HA2' ' A' ' 70' ' ' GLY . 28.4 pt20 -57.98 -40.95 81.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.093 0.473 . . . . 73.420000000000002 111.269 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.623 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.9 mtp180 -71.75 -48.63 45.57 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.725 -0.39 . . . . 73.230000000000004 111.868 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.9 m -46.35 -46.3 18.21 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.039 0.447 . . . . 64.209999999999994 111.611 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.621 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 55.0 m-85 -67.81 -44.32 77.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.655 0.613 . . . . 75.010000000000005 112.655 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.623 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 1.2 ptm180 -73.53 -43.19 60.56 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.757 -0.589 . . . . 75.530000000000001 112.284 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 58.2 mm-40 -60.79 -37.73 82.92 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.922 0.392 . . . . 72.510000000000005 111.06 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -94.9 -69.34 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.196 0.443 . . . . 73.030000000000001 112.196 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -81.14 -22.06 39.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.792 0.664 . . . . 74.329999999999998 112.792 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.51 40.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.908 -0.663 . . . . 72.209999999999994 112.407 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.621 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.3 tp -103.24 117.35 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.698 -0.295 . . . . 74.540000000000006 110.864 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 129.59 39.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.184 0.438 . . . . 73.239999999999995 112.184 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.3 mt -121.58 159.93 48.47 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.232 -0.44 . . . . 75.430000000000007 110.73 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.16 160.87 48.15 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.639 2.226 . . . . 73.109999999999999 113.581 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 86' ' ' ARG . 61.8 mtt-85 -88.44 24.86 1.81 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.402 0.89 . . . . 73.340000000000003 113.402 -169.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -154.91 142.9 20.12 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.838 -0.539 . . . . 75.420000000000002 112.183 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 118' ' ' ARG . 37.9 p -51.96 -50.05 62.01 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.127 -0.488 . . . . 70.099999999999994 111.598 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -53.27 -37.63 62.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.578 -0.737 . . . . 72.239999999999995 111.359 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.7 -44.56 63.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 65.340000000000003 110.756 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.02 -20.98 66.36 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.03 -0.532 . . . . 75.5 112.028 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.4 mt-30 -56.46 -28.04 58.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.963 0.411 . . . . 74.340000000000003 111.477 174.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -89.95 -19.46 24.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.216 -0.447 . . . . 75.340000000000003 111.737 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.2 mmm -76.1 140.36 41.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.956 0.408 . . . . 73.409999999999997 111.847 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.77 -166.87 46.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.173 -0.537 . . . . 43.340000000000003 113.454 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -110.34 148.1 32.62 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.296 0.569 . . . . 63.450000000000003 111.865 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.7 p -79.5 133.55 36.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.409 -0.814 . . . . 71.099999999999994 112.11 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.565 HG13 ' CZ ' ' A' ' 157' ' ' ARG . 3.8 m -146.07 167.31 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.93 0.715 . . . . 74.099999999999994 112.93 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.2 t -116.83 -171.43 2.02 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.374 -0.83 . . . . 74.129999999999995 110.985 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 -49.91 -56.47 10.41 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.058 0.762 . . . . 73.129999999999995 113.058 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 m -65.79 -11.72 48.36 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.734 0.642 . . . . 74.510000000000005 112.734 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.547 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.6 m120 -106.7 -4.31 19.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.073 0.398 . . . . 72.329999999999998 112.073 -174.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.484 HD21 ' HH ' ' A' ' 152' ' ' TYR . 86.0 mt -62.88 147.38 50.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.985 0.735 . . . . 75.319999999999993 112.985 -176.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -118.12 -159.01 0.73 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.654 -0.703 . . . . 73.510000000000005 109.297 173.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.8 m -102.01 102.75 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.03 -0.419 . . . . 74.200000000000003 110.662 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.06 6.94 5.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.214 -0.517 . . . . 38.460000000000001 113.649 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.12 134.69 44.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.261 0.553 . . . . 64.239999999999995 112.086 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.432 HD23 HG22 ' A' ' 72' ' ' VAL . 37.9 mt -79.59 110.7 15.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.913 -0.585 . . . . 61.520000000000003 110.044 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.44 118.91 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.261 0.553 . . . . 73.019999999999996 111.744 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.4 mt -90.28 123.83 34.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.743 -0.662 . . . . 75.329999999999998 111.593 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.66 140.99 45.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.182 0.515 . . . . 64.219999999999999 111.483 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.583 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 77.1 mtp180 -92.44 97.89 11.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.906 -0.588 . . . . 75.209999999999994 111.031 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.86 122.58 34.52 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.18 0.514 . . . . 72.099999999999994 111.391 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.52 -84.49 0.06 OUTLIER Glycine 0 CA--C 1.527 0.789 0 CA-C-N 116.099 -0.5 . . . . 61.43 112.43 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.0 m -165.23 -42.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.953 0.501 . . . . 74.400000000000006 110.604 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 p -100.7 5.39 43.71 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.311 0.485 . . . . 75.400000000000006 112.311 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -102.49 107.55 3.15 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.12 -0.562 . . . . 64.219999999999999 113.718 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.459 ' O ' HG23 ' A' ' 88' ' ' THR . 0.7 OUTLIER -90.53 111.29 22.52 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.474 -0.427 . . . . 72.400000000000006 110.632 173.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -115.5 149.89 37.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.245 -0.434 . . . . 74.109999999999999 110.556 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.52 HG12 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -134.84 146.17 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.203 0.525 . . . . 72.140000000000001 112.389 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.4 155.99 22.18 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.333 -0.46 . . . . 74.109999999999999 112.676 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 72' ' ' VAL . 47.8 mt -90.87 103.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.423 -0.457 . . . . 72.409999999999997 111.16 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t80 -69.47 101.11 1.51 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.241 0.543 . . . . 71.120000000000005 111.405 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.562 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.6 pt -82.15 -21.87 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.93 -0.577 . . . . 72.349999999999994 111.711 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.69 170.9 13.11 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 116.281 -0.418 . . . . 54.409999999999997 112.641 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 60.84 27.43 17.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.626 0.37 . . . . 74.019999999999996 111.675 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 63.81 23.66 13.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.418 0.287 . . . . 73.099999999999994 111.441 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -114.99 150.05 36.42 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.247 0.546 . . . . 71.420000000000002 111.55 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 13.5 p90 -156.54 148.68 23.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.88 -0.6 . . . . 75.329999999999998 111.992 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.33 141.09 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.793 -0.639 . . . . 75.510000000000005 110.952 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -158.96 162.1 36.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.94 0.4 . . . . 75.409999999999997 111.517 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -101.76 93.75 5.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.191 0.519 . . . . 73.109999999999999 110.892 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 41.1 t -76.78 166.07 23.86 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.169 0.509 . . . . 75.239999999999995 111.692 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.7 p -66.4 -66.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.082 0.467 . . . . 72.409999999999997 112.067 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 83.5 p -89.63 8.66 30.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.293 0.479 . . . . 71.099999999999994 112.293 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.617 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 48.5 m -125.84 -29.26 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.736 0.643 . . . . 73.209999999999994 112.736 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.86 -154.56 43.54 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.984 -0.627 . . . . 71.400000000000006 112.986 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.39 95.77 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.167 0.432 . . . . 74.140000000000001 112.167 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.23 -178.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.098 0.475 . . . . 73.430000000000007 112.263 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.51 139.44 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 72.109999999999999 111.255 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.8 p -143.87 163.94 31.97 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.748 0.308 . . . . 52.409999999999997 110.822 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.5 m -113.73 143.87 43.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.907 0.706 . . . . 75.219999999999999 112.907 -174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 91.4 mmm -58.86 -30.42 67.71 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.906 -0.588 . . . . 74.219999999999999 111.266 174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -68.71 -19.62 64.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 112.164 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -64.98 113.65 11.87 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 117.027 -0.079 . . . . 74.519999999999996 110.952 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -43.71 -38.54 9.49 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.248 2.632 . . . . 72.329999999999998 113.818 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.619 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 71.7 t80 -57.62 -50.49 72.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.764 0.316 . . . . 72.450000000000003 111.629 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -82.53 -36.31 26.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.015 0.436 . . . . 72.200000000000003 111.455 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.5 -36.97 64.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.862 -0.608 . . . . 73.400000000000006 111.983 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -83.6 -15.21 49.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.886 0.328 . . . . 75.319999999999993 111.886 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 20.6 mmt180 -89.74 -17.15 28.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.993 0.368 . . . . 75.319999999999993 111.993 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.484 ' HH ' HD21 ' A' ' 103' ' ' LEU . 68.3 t80 -59.26 116.49 3.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.538 . . . . 73.510000000000005 112.454 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -92.57 -60.8 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.977 -0.556 . . . . 71.510000000000005 110.889 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -173.34 170.73 4.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.38 0.272 . . . . 74.040000000000006 110.503 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.485 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -119.98 169.41 10.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.267 0.84 . . . . 53.109999999999999 113.267 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -137.75 113.51 9.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.538 -0.755 . . . . 71.140000000000001 111.838 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.565 ' CZ ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.72 105.98 9.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.934 0.397 . . . . 75.040000000000006 110.55 171.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.44 -0.69 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.738 0.644 . . . . 73.430000000000007 112.738 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.411 HD23 HD23 ' A' ' 82' ' ' LEU . 81.9 mt -87.56 110.7 20.55 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.917 0.389 . . . . 71.019999999999996 111.913 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 65.5 m -74.26 90.83 2.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.336 -0.393 . . . . 62.039999999999999 111.418 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -67.02 123.63 20.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.29 -0.414 . . . . 73.0 111.998 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 58.0 m -83.62 9.78 10.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.992 0.425 . . . . 72.140000000000001 111.983 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.0 tp -95.57 143.76 26.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.699 0.285 . . . . 74.150000000000006 111.16 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.453 -0.784 . . . . 73.239999999999995 112.005 179.465 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 47.6 ttp . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.639 0.257 . . . . 70.200000000000003 111.676 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -109.39 153.84 23.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.769 0.318 . . . . 71.329999999999998 110.505 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.61 91.6 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.129 0.49 . . . . 73.129999999999995 111.021 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.599 ' HB2' ' HG ' ' A' ' 42' ' ' SER . 10.2 m-20 -56.93 97.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.196 -0.456 . . . . 74.200000000000003 111.438 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.1 t -46.53 -49.76 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.22 0.533 . . . . 74.420000000000002 111.118 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 82.9 tttt -54.78 -48.29 72.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.655 -0.702 . . . . 74.420000000000002 112.33 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.599 ' HG ' ' HB2' ' A' ' 39' ' ' ASP . 24.2 p -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.935 0.398 . . . . 73.310000000000002 111.766 -174.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.31 -36.89 85.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.473 -0.33 . . . . 72.200000000000003 111.592 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.3 mt -63.07 -36.64 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.959 0.409 . . . . 74.209999999999994 110.641 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.535 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 28.8 mmt -70.2 -36.5 74.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.454 -0.339 . . . . 74.530000000000001 111.316 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.78 -42.54 99.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.214 0.531 . . . . 73.299999999999997 110.526 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.615 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 56.8 tp60 -64.03 -48.01 77.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.013 -0.54 . . . . 74.299999999999997 110.515 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -53.59 -39.56 64.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.797 -0.638 . . . . 73.409999999999997 111.499 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . . . -54.99 -34.42 63.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.018 0.437 . . . . 62.009999999999998 111.843 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.17 -24.46 51.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.088 0.471 . . . . 73.099999999999994 111.459 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -114.84 18.32 16.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.783 0.66 . . . . 75.349999999999994 112.783 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.627 ' HB2' ' HZ2' ' A' ' 52' ' ' LYS . 10.2 mtmp? -59.09 109.08 0.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.144 0.497 . . . . 75.109999999999999 112.245 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.03 4.53 68.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 114.793 0.677 . . . . 61.030000000000001 114.793 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.49 127.68 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.839 0.82 . . . . 72.329999999999998 110.806 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 157.51 38.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.97 0.73 . . . . 72.120000000000005 112.97 -176.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -77.2 126.03 30.28 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.347 -0.842 . . . . 74.329999999999998 111.775 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -138.04 110.37 7.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.476 -0.329 . . . . 74.150000000000006 111.68 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.32 121.25 15.88 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.984 0.421 . . . . 74.120000000000005 111.894 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.79 69.34 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.098 -0.572 . . . . 42.420000000000002 113.9 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -138.5 137.86 9.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.33 -0.462 . . . . 63.140000000000001 112.365 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.7 m -125.86 99.49 5.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.001 0.401 . . . . 73.540000000000006 111.541 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.0 t -177.28 177.69 1.18 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.251 -0.432 . . . . 75.239999999999995 111.115 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -71.17 -11.49 60.97 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.082 0.468 . . . . 74.209999999999994 110.87 178.32 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -74.81 -11.83 60.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.213 0.53 . . . . 74.200000000000003 110.703 170.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.23 148.11 4.76 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.119 -0.491 . . . . 64.129999999999995 112.75 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 19.8 tt -154.98 144.81 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.861 0.331 . . . . 74.349999999999994 111.436 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.16 179.91 4.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.201 0.524 . . . . 54.409999999999997 112.349 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.7 t -58.82 -61.25 2.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.416 0.525 . . . . 74.439999999999998 112.416 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -59.01 -36.86 75.67 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.974 0.416 . . . . 75.319999999999993 111.533 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.91 95.06 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 121.057 -0.592 . . . . 74.549999999999997 113.219 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.26 -54.73 28.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.895 0.332 . . . . 73.420000000000002 111.895 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.445 HG22 HD21 ' A' ' 108' ' ' LEU . 7.4 p -57.0 -41.91 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.956 0.408 . . . . 73.299999999999997 111.216 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -50.85 -62.67 1.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.312 0.577 . . . . 71.319999999999993 111.315 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HA ' ' CG ' ' A' ' 77' ' ' ARG . 10.3 mtp180 -63.66 -34.91 78.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.888 -0.596 . . . . 74.299999999999997 112.457 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.615 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 95.7 m -55.93 -54.58 42.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.083 0.468 . . . . 64.299999999999997 111.555 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.1 m-85 -65.84 -37.81 87.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.829 0.677 . . . . 74.120000000000005 112.829 -177.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.431 ' HA ' ' H ' ' A' ' 82' ' ' LEU . 3.0 ptm180 -75.15 -43.46 52.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.773 -0.579 . . . . 72.340000000000003 112.265 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.41 -18.49 64.45 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 122.098 -0.376 . . . . 74.299999999999997 111.756 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -108.39 -68.22 0.92 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.121 0.415 . . . . 75.109999999999999 112.121 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.63 0.45 57.38 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.579 0.585 . . . . 71.5 112.579 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.64 44.27 98.03 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 61.039999999999999 113.095 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.3 tp -104.68 122.39 45.57 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.087 0.47 . . . . 72.310000000000002 111.785 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.71 96.93 2.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 112.037 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.52 135.69 21.06 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.153 -0.476 . . . . 72.200000000000003 110.513 173.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.03 -175.62 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.463 2.109 . . . . 74.340000000000003 112.301 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -109.25 6.21 24.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.855 -0.528 . . . . 73.209999999999994 111.663 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.7 m -108.71 128.05 54.52 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.447 -0.342 . . . . 64.209999999999994 110.619 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.8 m -56.76 -46.52 81.37 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.383 0.512 . . . . 52.450000000000003 112.383 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.567 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 33.3 m-85 -59.69 -36.46 76.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 111.872 0.323 . . . . 74.409999999999997 111.872 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.63 -36.02 60.32 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.974 0.416 . . . . 53.329999999999998 111.471 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.21 -43.87 93.68 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.91 0.386 . . . . 72.239999999999995 111.499 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 17.0 pt20 -62.88 -26.87 68.99 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.965 0.412 . . . . 75.209999999999994 111.392 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -86.19 -10.08 55.37 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.23 0.455 . . . . 73.239999999999995 112.23 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.5 mmm -66.39 -37.51 85.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.162 0.506 . . . . 74.219999999999999 110.86 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.35 166.56 12.2 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 116.0 -0.546 . . . . 65.109999999999999 112.11 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -86.96 160.34 18.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.36 -0.494 . . . . 73.200000000000003 111.221 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.531 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 36.5 t -78.62 135.02 37.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.602 0.593 . . . . 74.0 112.602 -174.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 155' ' ' ALA . 15.5 m -127.89 142.99 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 74.120000000000005 110.633 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.6 t -88.66 177.12 6.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.99 0.424 . . . . 74.230000000000004 111.26 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -49.68 -29.19 6.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.153 0.581 . . . . 71.400000000000006 112.142 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m -84.4 -21.14 30.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.884 0.698 . . . . 72.409999999999997 112.884 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.0 m120 -108.16 11.35 27.57 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.002 0.741 . . . . 72.120000000000005 113.002 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.454 HD21 ' HH ' ' A' ' 152' ' ' TYR . 96.5 mt -57.0 151.84 14.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.911 0.708 . . . . 73.230000000000004 112.911 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -140.35 143.78 35.94 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.096 -0.502 . . . . 74.209999999999994 111.18 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.9 m -58.47 96.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.833 0.349 . . . . 72.209999999999994 110.948 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 123.62 14.17 3.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.171 -0.538 . . . . 71.439999999999998 113.818 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.24 167.87 13.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.94 0.87 . . . . 72.040000000000006 111.123 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.445 HD21 HG22 ' A' ' 72' ' ' VAL . 47.1 mt -102.85 113.87 27.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.097 -0.501 . . . . 74.530000000000001 110.549 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -94.92 122.66 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.401 0.62 . . . . 74.219999999999999 111.43 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 92' ' ' GLN . 67.0 mt -100.4 124.48 45.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.579 -0.737 . . . . 74.239999999999995 111.785 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -116.02 138.41 51.24 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.205 -0.452 . . . . 74.349999999999994 110.982 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -74.22 94.64 2.5 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.899 0.381 . . . . 73.310000000000002 110.715 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.5 157.36 16.24 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.759 0.314 . . . . 74.519999999999996 111.627 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.58 -43.8 8.99 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.001 -0.619 . . . . 64.219999999999999 112.747 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 53.7 m -83.57 -39.69 20.05 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.329 0.492 . . . . 70.010000000000005 112.329 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 67.8 p -101.51 -10.88 19.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.014 0.746 . . . . 74.129999999999995 113.014 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.46 -76.96 0.62 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.036 -0.602 . . . . 52.149999999999999 113.029 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -107.57 92.95 4.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.002 0.43 . . . . 74.400000000000006 110.218 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -91.17 126.9 36.4 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.196 -0.456 . . . . 70.129999999999995 110.459 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -111.6 132.03 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.529 0.681 . . . . 74.329999999999998 112.288 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -124.45 160.69 19.03 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.58 -0.736 . . . . 74.540000000000006 112.074 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.3 mt -97.04 112.8 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.091 0.446 . . . . 73.420000000000002 111.019 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.461 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 51.7 t80 -75.83 113.71 13.62 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.107 0.48 . . . . 75.349999999999994 111.904 -175.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.405 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.2 pt -99.06 -7.95 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.155 0.428 . . . . 72.030000000000001 112.155 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.68 164.37 13.21 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.111 -0.566 . . . . 74.140000000000001 113.348 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 58.61 31.08 20.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.762 0.425 . . . . 73.310000000000002 112.021 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.461 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 80.1 m-20 67.19 13.16 9.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.987 -0.551 . . . . 62.119999999999997 112.367 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -101.32 144.62 29.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.318 0.58 . . . . 65.450000000000003 111.493 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -152.91 146.38 24.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.77 -0.65 . . . . 74.129999999999995 111.584 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.69 138.76 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.729 0.299 . . . . 71.109999999999999 111.008 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -158.78 175.04 14.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.976 0.417 . . . . 75.120000000000005 111.631 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.21 103.44 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.195 -0.457 . . . . 62.210000000000001 111.045 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 36.9 t -89.17 162.5 15.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.789 0.328 . . . . 72.209999999999994 111.421 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -55.12 -61.55 2.24 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.034 0.753 . . . . 74.450000000000003 113.034 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m -93.69 -36.28 12.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.888 -0.508 . . . . 64.409999999999997 111.453 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.614 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 14.4 m -66.97 -29.62 69.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.242 -0.435 . . . . 73.140000000000001 112.118 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.69 34.75 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.97 -0.633 . . . . 63.100000000000001 112.565 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.46 102.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 117.127 0.464 . . . . 74.319999999999993 111.761 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.62 -179.01 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.13 0.49 . . . . 70.209999999999994 111.608 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.17 144.3 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.957 0.408 . . . . 73.129999999999995 110.72 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.7 m -137.08 169.41 17.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.199 -0.313 . . . . 73.200000000000003 111.396 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.2 m -130.52 139.89 50.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.911 0.386 . . . . 74.219999999999999 111.769 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.46 ' HB2' ' HB3' ' A' ' 127' ' ' ASN . 67.1 mtt -65.37 -9.63 26.5 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.439 0.533 . . . . 72.340000000000003 112.439 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.67 -4.89 45.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.949 0.404 . . . . 73.329999999999998 111.452 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 25.8 mm-40 -83.56 127.08 69.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.244 -0.434 . . . . 73.530000000000001 109.962 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.436 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 84.9 Cg_exo -46.75 -39.0 23.49 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.704 2.269 . . . . 63.340000000000003 113.691 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 73.6 t80 -60.22 -51.31 70.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.651 0.263 . . . . 74.519999999999996 111.623 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.401 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 86.6 m95 -73.26 -33.35 65.21 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.899 0.38 . . . . 74.540000000000006 111.431 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 143' ' ' MET . 37.9 ttpt -68.54 -39.85 80.96 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.07 0.396 . . . . 75.129999999999995 112.07 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 19.3 ptpt -79.56 -28.13 41.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.738 0.304 . . . . 74.310000000000002 111.812 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 9.6 mmm180 -91.13 -4.88 55.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 111.886 0.328 . . . . 75.150000000000006 111.886 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.454 ' HH ' HD21 ' A' ' 103' ' ' LEU . 28.3 t80 -59.07 111.59 1.38 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.006 0.431 . . . . 74.109999999999999 111.41 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -92.26 -50.65 5.55 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.251 -0.431 . . . . 75.209999999999994 111.844 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -177.57 -173.02 0.39 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.329 -0.396 . . . . 72.340000000000003 110.901 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.509 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -140.42 159.87 41.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.89 0.376 . . . . 63.32 111.366 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt85 -139.42 109.54 6.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.473 0.309 . . . . 75.219999999999999 111.432 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 108.05 17.81 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.617 0.722 . . . . 74.239999999999995 111.42 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.71 -27.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.856 -0.611 . . . . 70.319999999999993 112.437 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.2 mt -73.3 109.36 6.76 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 111.919 0.34 . . . . 73.219999999999999 111.919 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.3 t -79.41 141.48 36.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.882 0.373 . . . . 71.519999999999996 111.117 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -80.28 99.29 7.79 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.802 0.334 . . . . 73.519999999999996 110.871 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 27.6 t -99.72 -6.48 27.01 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.792 0.329 . . . . 75.099999999999994 111.887 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 163' ' ' LEU . 6.9 mp -97.91 174.66 6.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.725 0.298 . . . . 72.150000000000006 111.096 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.365 -0.826 . . . . 63.329999999999998 112.291 -179.722 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.076 0.465 . . . . 72.109999999999999 111.5 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -76.3 121.76 23.43 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.352 -0.385 . . . . 73.219999999999999 111.261 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.76 109.93 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.959 0.409 . . . . 75.439999999999998 111.281 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.64 84.41 0.63 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.972 0.415 . . . . 72.129999999999995 111.528 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 44' ' ' ILE . 83.5 t -50.69 -54.23 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.174 -0.466 . . . . 71.420000000000002 111.557 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.5 ' HB2' HG22 ' A' ' 105' ' ' THR . 87.2 tttt -53.9 -50.51 66.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.232 -0.44 . . . . 74.140000000000001 111.613 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 t -59.21 -44.35 92.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.425 -0.352 . . . . 51.109999999999999 111.879 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -63.68 -39.84 95.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.274 0.559 . . . . 75.230000000000004 111.303 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 40' ' ' VAL . 76.4 mt -61.37 -40.33 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.056 0.455 . . . . 74.109999999999999 110.6 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.532 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 30.3 mmt -63.54 -34.93 78.87 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.104 -0.498 . . . . 64.540000000000006 111.583 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.95 -45.4 86.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.912 0.387 . . . . 54.450000000000003 110.934 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.43 ' O ' ' HD1' ' A' ' 51' ' ' TRP . 15.7 mm100 -62.53 -52.37 63.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.974 0.416 . . . . 74.409999999999997 111.044 174.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -55.37 -38.42 68.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.106 0.409 . . . . 71.209999999999994 112.106 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.92 -30.92 71.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.471 . . . . 74.049999999999997 111.396 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.427 ' CG ' ' HZ2' ' A' ' 63' ' ' LYS . 32.8 t70 -76.28 -31.95 58.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.134 -0.485 . . . . 74.340000000000003 111.126 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.43 ' HD1' ' O ' ' A' ' 47' ' ' GLN . 77.7 m95 -99.77 16.55 23.25 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.596 0.591 . . . . 74.140000000000001 112.596 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.81 109.83 1.02 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.836 0.31 . . . . 73.430000000000007 111.836 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.15 15.31 54.22 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.916 -0.659 . . . . 72.129999999999995 114.146 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -78.56 132.88 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 117.318 0.559 . . . . 72.319999999999993 111.951 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -73.84 152.44 40.24 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.201 0.524 . . . . 74.510000000000005 111.907 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.426 ' CE1' ' HA ' ' A' ' 67' ' ' ASP . 72.4 t80 -83.7 148.18 27.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.034 0.445 . . . . 75.25 111.856 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.527 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 58.0 ttm-85 -137.69 148.73 45.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.039 -0.528 . . . . 72.239999999999995 110.611 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.02 93.59 8.42 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.973 -0.454 . . . . 74.319999999999993 110.701 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.37 61.32 1.25 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.216 -0.447 . . . . 53.100000000000001 113.361 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -176.37 150.82 10.83 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.16 -0.543 . . . . 73.510000000000005 112.685 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.534 ' HA ' HG13 ' A' ' 66' ' ' ILE . 80.7 p -128.0 99.93 5.69 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.554 0.575 . . . . 74.450000000000003 112.554 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 t -170.46 167.54 8.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.41 0.284 . . . . 74.040000000000006 111.439 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HZ2' ' CG ' ' A' ' 50' ' ' ASP . 1.4 mptm? -66.35 -22.82 66.27 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.015 0.435 . . . . 73.219999999999999 111.206 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -91.14 21.14 4.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.077 0.465 . . . . 72.310000000000002 111.364 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.503 ' HA3' ' HE ' ' A' ' 57' ' ' ARG . . . 142.88 112.76 0.9 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.223 -0.513 . . . . 64.230000000000004 113.199 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 20.5 tt -137.34 144.79 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 117.067 0.434 . . . . 72.409999999999997 111.558 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.527 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.0 p30 -97.89 174.13 6.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.451 0.644 . . . . 62.130000000000003 111.98 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.6 t -58.92 -44.53 91.34 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.925 0.713 . . . . 50.329999999999998 112.925 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.6 p -74.39 -39.05 62.94 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.738 0.304 . . . . 62.350000000000001 110.471 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.63 91.5 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.372 -0.442 . . . . 72.109999999999999 112.928 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.02 -53.23 41.15 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.769 0.318 . . . . 75.129999999999995 111.633 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.96 -48.04 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 111.909 0.337 . . . . 71.420000000000002 111.909 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.562 HE22 ' HG2' ' A' ' 86' ' ' ARG . 13.8 pt20 -59.47 -43.82 93.15 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.15 -0.343 . . . . 72.5 111.463 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.533 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 55.8 mtp180 -64.98 -47.61 76.95 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.12 -0.232 . . . . 74.340000000000003 111.53 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -50.57 -44.39 56.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.966 0.413 . . . . 71.239999999999995 111.777 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.569 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 59.0 m-85 -75.66 -44.46 42.37 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.999 0.74 . . . . 73.430000000000007 112.999 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.533 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 9.0 ptm180 -62.0 -32.19 72.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.436 -0.79 . . . . 75.129999999999995 111.512 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 33.7 mm-40 -73.24 -72.99 0.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.94 0.4 . . . . 74.129999999999995 111.929 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -87.11 -5.96 58.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.212 0.819 . . . . 73.040000000000006 113.212 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -127.41 -7.33 5.8 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 62.219999999999999 112.086 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.84 37.78 79.94 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.228 -0.511 . . . . 75.420000000000002 113.18 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 34.9 tp -104.9 144.38 31.86 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.892 0.377 . . . . 72.349999999999994 111.151 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -95.49 125.96 40.46 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.936 0.398 . . . . 74.209999999999994 111.834 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 73' ' ' GLN . 88.2 mt -135.12 133.47 20.82 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.472 -0.331 . . . . 74.120000000000005 110.929 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.71 155.93 61.85 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.788 2.325 . . . . 61.5 113.275 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.562 ' HG2' HE22 ' A' ' 73' ' ' GLN . 67.2 mtt85 -82.66 48.8 1.37 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.965 0.728 . . . . 71.030000000000001 112.965 -172.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.478 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 20.3 t -169.09 135.54 1.73 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 111.276 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.628 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 25.5 m -53.19 -46.35 68.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.374 -0.376 . . . . 73.150000000000006 111.036 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -39.4 75.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.078 0.466 . . . . 71.219999999999999 111.696 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.478 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 14.5 mm-40 -75.93 -35.57 59.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.996 -0.547 . . . . 75.349999999999994 111.115 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.94 -30.13 70.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.912 0.387 . . . . 70.319999999999993 111.775 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 88' ' ' THR . 20.0 mt-30 -62.72 -21.01 65.47 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.734 0.302 . . . . 74.150000000000006 111.749 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.01 16.42 1.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.667 0.617 . . . . 64.200000000000003 112.667 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptp -142.52 -178.58 5.83 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 122.186 -0.321 . . . . 71.239999999999995 111.067 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.3 50.89 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.13 -0.557 . . . . 73.439999999999998 113.141 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.6 mmtp -127.75 139.17 52.84 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.416 -0.461 . . . . 74.340000000000003 111.952 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.533 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 75.5 p -76.32 127.84 33.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.761 -0.654 . . . . 75.239999999999995 111.905 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.58 HG13 ' CZ ' ' A' ' 157' ' ' ARG . 5.7 m -136.93 157.72 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.307 0.575 . . . . 75.150000000000006 112.532 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 t -109.62 -177.31 3.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.786 -0.643 . . . . 74.049999999999997 112.353 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.647 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 24.3 mmm180 -41.04 -50.28 3.36 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.26 1.208 . . . . 73.239999999999995 114.26 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -84.34 -14.4 49.72 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.566 0.58 . . . . 70.239999999999995 112.566 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.8 m120 -89.75 -12.23 39.94 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.977 0.362 . . . . 75.010000000000005 111.977 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -57.77 131.88 51.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.979 0.733 . . . . 74.129999999999995 112.979 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -111.96 -162.33 0.79 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.788 -0.642 . . . . 75.010000000000005 110.381 171.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 41' ' ' LYS . 91.7 m -92.9 108.35 19.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.708 0.289 . . . . 74.140000000000001 110.849 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.66 -10.36 7.58 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.598 -0.334 . . . . 74.310000000000002 112.753 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' OD2' ' HD2' ' A' ' 157' ' ' ARG . 0.8 OUTLIER -60.9 127.05 29.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.115 0.413 . . . . 75.439999999999998 112.115 177.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 39.4 mt -82.87 108.07 15.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.892 0.377 . . . . 71.549999999999997 110.754 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.27 124.86 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.284 0.564 . . . . 74.109999999999999 111.965 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 73.8 mt -93.96 136.16 34.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.831 -0.622 . . . . 74.530000000000001 112.002 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 96.0 m-85 -124.22 139.99 53.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 72.349999999999994 111.666 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -81.05 98.32 7.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.601 -0.272 . . . . 74.120000000000005 111.141 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.89 100.11 10.39 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.145 0.498 . . . . 64.329999999999998 111.743 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.01 -88.33 0.48 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.293 -0.479 . . . . 75.099999999999994 113.603 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.3 t -151.81 -59.62 0.16 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.174 0.511 . . . . 72.010000000000005 111.534 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.7 p -84.85 -18.67 34.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.86 -0.609 . . . . 74.120000000000005 111.356 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.99 85.05 0.57 Allowed Glycine 0 CA--C 1.526 0.74 0 CA-C-N 116.005 -0.543 . . . . 55.43 113.962 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -86.16 89.71 7.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.457 -0.572 . . . . 74.099999999999994 109.457 170.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 69.0 t60 -84.24 149.32 26.2 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.816 -0.629 . . . . 71.340000000000003 111.277 -172.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 7.6 p -142.6 119.04 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.461 0.648 . . . . 75.319999999999993 111.948 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -114.33 152.85 17.93 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.204 -0.522 . . . . 73.430000000000007 112.854 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.4 mt -88.39 106.92 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 122.51 -0.406 . . . . 73.340000000000003 110.706 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -68.51 116.73 9.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.045 0.45 . . . . 72.209999999999994 111.338 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.1 pt -103.04 -14.44 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.361 0.504 . . . . 64.540000000000006 112.361 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.13 164.67 11.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.11 -0.567 . . . . 70.299999999999997 112.991 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 127' ' ' ASN . 13.4 m120 61.58 27.35 16.84 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.002 0.401 . . . . 71.299999999999997 111.891 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 126' ' ' ASN . 47.6 m-80 67.12 7.61 5.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.328 0.251 . . . . 75.439999999999998 111.509 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.7 144.17 26.2 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.595 0.712 . . . . 64.099999999999994 111.253 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -149.29 138.43 21.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 73.25 111.056 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.92 133.43 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.031 0.443 . . . . 71.109999999999999 110.7 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -157.73 172.2 18.93 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.257 0.551 . . . . 73.439999999999998 111.723 -173.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -105.12 93.04 4.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.0 -0.546 . . . . 71.450000000000003 110.154 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.7 p -67.39 140.04 57.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.952 0.406 . . . . 75.099999999999994 111.531 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -57.6 -30.33 65.22 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.914 0.709 . . . . 72.040000000000006 112.914 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.9 t -102.18 -53.82 2.83 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.564 0.579 . . . . 74.230000000000004 112.564 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 t -81.0 -33.59 33.55 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.601 0.593 . . . . 71.329999999999998 112.601 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.44 -153.09 17.01 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.164 -0.541 . . . . 62.420000000000002 112.635 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.58 106.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.211 0.506 . . . . 73.409999999999997 111.499 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.5 178.21 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.299 0.571 . . . . 72.420000000000002 112.033 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.03 138.17 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.944 -0.571 . . . . 73.430000000000007 109.957 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.4 m -132.06 171.7 13.29 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.312 -0.243 . . . . 74.209999999999994 111.152 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.6 m -127.66 138.24 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.873 0.323 . . . . 72.310000000000002 111.873 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.647 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 66.3 mtt -64.78 -12.18 44.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.97 0.414 . . . . 75.5 111.866 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 144' ' ' ASN . 0.9 OUTLIER -66.1 -28.28 68.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.83 0.348 . . . . 75.329999999999998 111.204 173.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.56 125.54 92.04 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.573 -0.285 . . . . 73.129999999999995 110.63 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 82.3 Cg_exo -46.39 -41.88 22.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.968 2.445 . . . . 74.239999999999995 113.723 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -59.63 -41.5 90.61 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.223 0.453 . . . . 74.099999999999994 112.223 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.03 -36.44 19.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.011 0.375 . . . . 74.530000000000001 112.011 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -54.81 -50.93 67.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.074 0.464 . . . . 74.030000000000001 111.612 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 18.4 ptpt -82.35 1.17 38.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.975 0.417 . . . . 73.299999999999997 111.88 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.18 -28.69 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.531 0.332 . . . . 75.150000000000006 110.959 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -58.51 115.4 2.99 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.179 -0.464 . . . . 73.310000000000002 112.097 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -98.07 -62.43 1.25 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.059 -0.519 . . . . 72.340000000000003 111.447 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -158.44 164.73 35.95 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.231 -0.293 . . . . 74.120000000000005 110.482 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -126.24 149.22 49.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.551 0.215 . . . . 63.149999999999999 111.523 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.533 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 89.5 mtt180 -143.99 112.72 6.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.611 0.243 . . . . 75.540000000000006 110.987 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.58 ' CZ ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -85.4 129.31 34.84 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.16 0.505 . . . . 74.109999999999999 110.84 176.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.436 HG23 HD22 ' A' ' 84' ' ' LEU . 27.8 m -107.13 7.89 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.895 0.702 . . . . 73.420000000000002 112.895 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 69.3 mt -68.05 141.73 56.09 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.177 0.513 . . . . 74.239999999999995 112.235 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.0 t -98.43 -61.58 1.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.932 -0.576 . . . . 74.129999999999995 111.894 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -67.89 142.48 56.06 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.83 0.347 . . . . 74.219999999999999 111.824 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.4 t -120.17 173.42 7.12 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.873 0.368 . . . . 71.230000000000004 111.281 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -74.68 149.28 39.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.746 0.307 . . . . 70.340000000000003 111.261 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.624 -0.703 . . . . 55.210000000000001 111.227 179.139 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.732 ' HA ' ' HE3' ' A' ' 36' ' ' MET . 5.4 mmt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 112.058 0.392 . . . . 73.209999999999994 112.058 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -50.8 125.19 12.72 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.361 0.874 . . . . 63.420000000000002 113.361 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.94 93.9 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.022 -0.535 . . . . 74.430000000000007 109.964 169.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.52 105.04 0.58 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.913 0.387 . . . . 73.209999999999994 111.566 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 44' ' ' ILE . 86.6 t -48.66 -46.08 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 72.25 111.215 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 45' ' ' MET . 58.9 tttm -54.89 -46.3 74.79 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.576 0.584 . . . . 75.230000000000004 112.576 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.7 p -60.61 -44.03 96.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.801 0.334 . . . . 75.219999999999999 111.868 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -73.93 -30.03 62.35 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.445 0.535 . . . . 73.239999999999995 112.445 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 40' ' ' VAL . 75.4 mt -63.69 -43.85 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.265 0.555 . . . . 75.420000000000002 110.135 173.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 87.4 mmm -66.63 -37.1 84.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.064 -0.516 . . . . 74.319999999999993 110.848 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.06 -43.45 70.25 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.169 0.509 . . . . 74.439999999999998 111.475 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.43 ' NE2' HE22 ' A' ' 79' ' ' GLN . 5.3 tp-100 -69.8 -54.51 13.26 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.273 -0.421 . . . . 75.140000000000001 110.617 174.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.432 ' OH ' ' NZ ' ' A' ' 52' ' ' LYS . 16.4 t80 -49.01 -39.68 27.78 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.088 0.773 . . . . 74.0 113.088 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.45 -33.81 55.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.115 0.484 . . . . 71.120000000000005 111.884 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.79 -23.41 55.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.038 -0.528 . . . . 74.129999999999995 112.413 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.431 ' HB3' HG22 ' A' ' 138' ' ' VAL . 82.8 m95 -97.2 -0.31 47.01 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.587 0.588 . . . . 74.25 112.587 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' NZ ' ' OH ' ' A' ' 48' ' ' TYR . 29.5 mtpp -64.85 95.37 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.992 0.425 . . . . 75.219999999999999 111.269 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.81 -12.47 7.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.444 -0.407 . . . . 73.540000000000006 112.725 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.6 t -74.18 124.9 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 64.430000000000007 111.187 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -86.2 160.64 19.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.563 0.697 . . . . 74.409999999999997 112.39 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 47.3 t80 -74.72 127.51 33.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.412 -0.813 . . . . 73.040000000000006 112.125 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -136.93 121.53 18.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.712 0.291 . . . . 74.430000000000007 111.599 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.86 121.63 22.91 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.201 0.445 . . . . 74.430000000000007 112.201 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.4 50.82 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.946 -0.645 . . . . 61.140000000000001 113.689 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -151.7 135.63 5.13 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.09 -0.576 . . . . 61.240000000000002 112.438 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.532 ' HA ' HG13 ' A' ' 66' ' ' ILE . 29.0 p -125.44 98.98 5.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.315 0.579 . . . . 71.040000000000006 111.691 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.1 t -159.84 161.88 34.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.065 -0.516 . . . . 71.430000000000007 110.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -67.88 -3.36 9.49 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.061 0.458 . . . . 74.129999999999995 111.738 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -92.55 -19.37 22.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.983 0.421 . . . . 74.430000000000007 111.269 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 136.52 2.23 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.59 -0.604 . . . . 60.109999999999999 111.59 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.4 tt -157.45 150.96 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 117.702 0.751 . . . . 64.129999999999995 112.496 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.15 -179.36 4.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.273 0.558 . . . . 71.040000000000006 112.186 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.4 t -58.15 -56.64 19.48 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.593 0.59 . . . . 73.319999999999993 112.593 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 75.2 p -60.46 -36.2 77.68 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.939 0.399 . . . . 74.530000000000001 111.608 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.66 85.09 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.039 -0.528 . . . . 74.010000000000005 113.17 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.73 -50.92 70.48 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.587 -0.361 . . . . 74.450000000000003 111.72 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.495 ' HA ' HD13 ' A' ' 122' ' ' ILE . 11.0 p -65.14 -43.79 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 111.987 0.366 . . . . 73.329999999999998 111.987 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.558 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 21.1 pt20 -62.18 -38.93 90.96 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.162 -0.336 . . . . 64.239999999999995 111.592 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 74' ' ' ARG . 14.4 mtp180 -67.12 -55.54 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.715 0.293 . . . . 72.439999999999998 111.579 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.4 m -47.46 -42.35 22.42 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.284 0.475 . . . . 74.409999999999997 112.284 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 49.9 m-85 -75.02 -41.55 59.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.717 0.636 . . . . 70.239999999999995 112.717 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 13.7 ptm180 -76.92 -26.68 54.37 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.812 -0.555 . . . . 74.150000000000006 112.355 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.0 -37.67 16.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.122 0.415 . . . . 55.420000000000002 112.122 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.43 HE22 ' NE2' ' A' ' 47' ' ' GLN . 19.2 mp0 -93.48 -48.43 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.9 0.704 . . . . 71.420000000000002 112.9 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.426 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 58.4 m-85 -101.55 -5.58 24.97 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.42 0.526 . . . . 75.109999999999999 112.42 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.59 13.62 74.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.089 -0.577 . . . . 73.349999999999994 113.066 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -90.82 111.51 22.94 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.671 -0.311 . . . . 71.230000000000004 110.674 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.48 95.85 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.177 0.513 . . . . 70.549999999999997 112.149 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 91.4 mt -82.69 143.6 47.3 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 110.195 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 43.9 Cg_endo -67.45 -172.67 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.53 2.153 . . . . 73.049999999999997 113.522 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -95.62 -33.09 12.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.864 0.69 . . . . 74.400000000000006 112.864 -172.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 19.9 m -96.43 141.74 29.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.69 0.255 . . . . 74.319999999999993 111.69 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.49 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 59.8 m -52.13 -50.35 61.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.905 0.335 . . . . 75.150000000000006 111.905 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.457 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 24.9 m-85 -54.11 -44.0 70.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.534 0.207 . . . . 73.239999999999995 111.437 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 45.3 mt-10 -58.91 -47.5 84.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.552 . . . . 70.530000000000001 110.87 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -63.37 -30.71 71.79 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.147 -0.479 . . . . 73.400000000000006 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.7 mt-30 -71.34 -21.05 62.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.465 -0.334 . . . . 75.400000000000006 111.495 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 89' ' ' TYR . 41.6 mt-10 -79.48 -5.23 54.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.852 0.358 . . . . 74.340000000000003 111.132 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.417 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 75.0 mtp -106.28 131.83 53.04 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.368 -0.378 . . . . 64.200000000000003 110.936 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.24 134.78 1.07 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.465 -0.397 . . . . 73.030000000000001 113.715 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 96' ' ' LYS . 70.3 mmtt -88.31 162.53 16.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.587 . . . . 72.299999999999997 112.025 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 29.6 m -75.38 155.19 36.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.208 1.188 . . . . 42.420000000000002 114.208 -167.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 155' ' ' ALA . 0.9 OUTLIER -144.04 149.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.017 -0.992 . . . . 73.209999999999994 110.864 171.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 t -100.57 -173.49 2.42 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.367 -0.379 . . . . 73.420000000000002 111.355 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.447 HH11 ' HE2' ' A' ' 152' ' ' TYR . 1.1 mpp_? -59.87 -38.56 82.53 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.978 1.103 . . . . 73.019999999999996 113.978 -169.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.9 p -79.86 -5.68 55.96 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.744 -0.598 . . . . 70.450000000000003 111.67 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -116.73 11.11 14.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.843 0.312 . . . . 62.409999999999997 111.843 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 78.1 mt -72.44 129.56 38.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.109 0.48 . . . . 71.329999999999998 111.588 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -138.8 172.23 13.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.02 0.528 . . . . 73.510000000000005 111.08 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.3 m -64.94 114.93 4.88 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.184 0.516 . . . . 72.030000000000001 111.969 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.86 -3.36 24.36 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.296 -0.478 . . . . 72.120000000000005 113.696 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -79.99 134.16 36.22 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.304 0.573 . . . . 70.140000000000001 111.125 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 77.3 mt -89.36 119.37 29.77 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.477 -0.328 . . . . 74.420000000000002 111.482 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 155' ' ' ALA . 12.5 m -95.62 129.24 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.978 0.418 . . . . 70.430000000000007 111.721 -177.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.61 140.7 33.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.308 -0.405 . . . . 55.210000000000001 111.58 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.41 140.09 51.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.794 0.33 . . . . 75.439999999999998 111.407 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -86.72 90.13 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.917 0.389 . . . . 75.340000000000003 110.229 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.36 135.04 48.55 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.372 0.508 . . . . 61.149999999999999 112.372 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.78 26.43 1.69 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 121.467 -0.397 . . . . 74.409999999999997 113.778 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.5 m -132.86 -38.42 0.99 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.933 0.397 . . . . 74.420000000000002 111.216 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.0 p -118.91 1.03 11.47 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.224 0.453 . . . . 74.040000000000006 112.224 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.12 -87.48 0.39 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.084 -0.579 . . . . 75.200000000000003 112.549 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 88' ' ' THR . 2.7 mpt_? -107.56 100.0 9.45 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.232 0.539 . . . . 65.239999999999995 110.552 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -92.63 143.01 26.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.919 -0.582 . . . . 75.129999999999995 110.613 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.93 137.58 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.263 0.554 . . . . 74.209999999999994 112.346 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.26 20.65 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.044 -0.525 . . . . 72.25 112.874 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 72' ' ' VAL . 47.0 mt -90.27 109.42 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.801 0.3 . . . . 74.329999999999998 111.038 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.537 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 63.8 t80 -75.46 113.78 13.27 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.954 0.407 . . . . 63.130000000000003 111.358 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.436 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 27.7 pt -95.51 -32.96 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.107 0.41 . . . . 74.040000000000006 112.107 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.38 165.36 11.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.187 -0.53 . . . . 71.120000000000005 113.2 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.402 ' O ' ' HG3' ' A' ' 128' ' ' GLN . 10.0 t30 59.39 42.49 17.89 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.219 0.533 . . . . 74.25 110.788 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.537 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 4.2 p30 51.53 17.18 0.52 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.066 0.947 . . . . 62.340000000000003 112.725 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 126' ' ' ASN . 28.0 mt-30 -108.56 145.51 34.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.371 0.605 . . . . 73.310000000000002 111.702 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 8.0 p90 -148.97 150.43 32.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.648 -0.706 . . . . 74.310000000000002 111.659 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.49 140.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.014 0.435 . . . . 75.310000000000002 111.326 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -161.72 -166.37 1.46 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.474 -0.33 . . . . 71.150000000000006 111.236 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.96 106.46 8.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.76 0.314 . . . . 74.239999999999995 111.615 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.6 m -81.89 155.19 25.44 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.892 0.377 . . . . 71.329999999999998 111.987 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 67.8 p -52.84 -46.56 67.84 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.216 1.191 . . . . 73.430000000000007 114.216 -172.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -100.56 -44.74 5.75 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.904 -0.497 . . . . 74.239999999999995 112.07 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.0 m -65.77 -38.71 89.8 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.938 0.718 . . . . 53.409999999999997 112.938 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.66 -146.4 18.25 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.937 -0.649 . . . . 74.129999999999995 112.212 -173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 51' ' ' TRP . 61.0 t -69.38 111.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 117.201 0.5 . . . . 64.540000000000006 111.67 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.2 pt -141.16 -179.98 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.165 0.507 . . . . 75.109999999999999 111.663 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.47 137.08 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.192 -0.458 . . . . 72.299999999999997 110.42 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.5 m -130.44 159.08 38.13 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.938 0.399 . . . . 75.010000000000005 111.68 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.6 m -115.2 148.4 39.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.366 -0.379 . . . . 72.519999999999996 111.586 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.506 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 91.8 mmm -67.54 -22.53 65.41 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.14 0.495 . . . . 75.030000000000001 110.863 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.33 -20.6 66.13 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.098 -0.501 . . . . 71.040000000000006 111.615 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -67.1 132.25 93.64 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.546 0.212 . . . . 72.439999999999998 110.96 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.584 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 14.1 Cg_endo -54.49 -48.79 19.53 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.747 2.298 . . . . 73.420000000000002 113.299 -174.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -56.54 -48.47 77.21 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.129 0.418 . . . . 75.099999999999994 112.129 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.9 -40.07 61.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 111.424 -174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -53.56 -55.95 21.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.162 -0.472 . . . . 65.099999999999994 111.834 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 19.1 ptpt -74.06 -28.74 61.54 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.803 0.668 . . . . 63.25 112.803 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.571 ' HD2' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -86.89 -7.5 58.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.478 0.547 . . . . 74.400000000000006 112.478 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.447 ' HE2' HH11 ' A' ' 100' ' ' ARG . 63.3 t80 -60.0 121.44 11.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.114 0.483 . . . . 75.129999999999995 111.778 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -94.65 -69.59 0.75 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.851 -0.613 . . . . 71.510000000000005 111.234 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.65 144.15 7.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.507 -0.315 . . . . 72.120000000000005 111.627 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -99.82 162.88 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.417 -0.177 . . . . 74.310000000000002 111.172 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -141.81 141.46 33.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.037 0.446 . . . . 74.239999999999995 111.899 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.45 95.29 7.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.29 0.567 . . . . 75.209999999999994 111.677 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.78 -15.18 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.004 -0.544 . . . . 74.400000000000006 112.175 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.462 HD22 HD23 ' A' ' 82' ' ' LEU . 96.0 mt -94.33 128.33 40.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.683 0.278 . . . . 75.409999999999997 111.371 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.8 t -66.98 86.1 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.058 0.456 . . . . 73.140000000000001 111.164 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.3 ppt_? -160.94 160.34 30.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.054 -0.521 . . . . 75.510000000000005 111.556 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.2 t 65.63 27.57 11.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.261 0.553 . . . . 74.329999999999998 110.867 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.6 mt -133.79 -171.33 2.7 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.785 -0.643 . . . . 74.140000000000001 111.324 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.256 1.405 0 CA-C-O 118.484 -0.77 . . . . 74.409999999999997 112.835 -178.044 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.774 0.321 . . . . 74.030000000000001 110.609 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -129.63 173.48 10.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.16 0.505 . . . . 72.409999999999997 111.649 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.6 t -69.67 108.65 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.084 -0.507 . . . . 71.329999999999998 110.42 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.06 106.78 12.33 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.139 0.495 . . . . 63.409999999999997 110.938 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 44' ' ' ILE . 60.0 t -52.13 -46.64 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.751 -0.659 . . . . 73.230000000000004 112.087 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -59.01 -44.51 91.7 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.942 0.401 . . . . 75.430000000000007 111.086 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.5 m -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.466 -0.334 . . . . 73.340000000000003 111.287 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -65.37 -38.82 91.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 71.049999999999997 112.309 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 40' ' ' VAL . 81.6 mt -64.29 -52.61 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.077 0.465 . . . . 74.230000000000004 111.23 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.577 ' HA ' ' HE3' ' A' ' 45' ' ' MET . 28.9 mmt -63.6 -27.73 69.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.967 0.413 . . . . 72.400000000000006 111.219 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -59.52 -48.4 81.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.917 -0.583 . . . . 63.020000000000003 111.284 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -76.64 -36.27 57.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 70.219999999999999 111.106 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.514 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 27.2 t80 -53.58 -37.65 63.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.765 0.317 . . . . 74.340000000000003 110.651 174.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.527 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . . . -53.34 -25.35 14.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.206 0.447 . . . . 63.350000000000001 112.206 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -86.4 -38.05 17.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.135 0.493 . . . . 75.329999999999998 111.124 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -88.07 -2.63 58.72 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.924 0.713 . . . . 75.530000000000001 112.924 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HE3' ' HA ' ' A' ' 49' ' ' ALA . 98.6 mttt -53.0 106.07 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.552 0.575 . . . . 75.5 112.552 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.14 -8.25 25.06 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.982 -0.628 . . . . 74.219999999999999 114.386 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.66 123.22 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 117.49 0.645 . . . . 73.129999999999995 111.031 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.97 169.69 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.424 0.63 . . . . 74.409999999999997 112.568 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -83.93 128.42 34.53 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.808 -0.633 . . . . 72.299999999999997 111.679 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -136.87 118.61 15.05 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.53 -0.305 . . . . 75.549999999999997 111.024 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 58' ' ' LEU . 5.0 mp -74.3 102.59 4.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.999 0.37 . . . . 74.420000000000002 111.999 -173.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.28 33.7 31.4 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.068 -0.587 . . . . 64.239999999999995 113.241 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.15 102.93 0.27 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.905 -0.478 . . . . 74.010000000000005 111.905 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.529 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 p -94.81 100.84 12.66 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.504 0.557 . . . . 72.439999999999998 112.504 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -158.93 173.09 17.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.161 -0.472 . . . . 62.200000000000003 111.791 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -74.75 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.431 . . . . 74.239999999999995 111.32 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 3.1 mptp? -90.98 0.73 57.46 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.205 -0.452 . . . . 62.5 111.001 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.11 145.99 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.059 -0.417 . . . . 73.209999999999994 112.059 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.529 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.5 tt -165.02 148.09 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 117.551 0.676 . . . . 74.120000000000005 112.001 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.84 0.352 . . . . 70.129999999999995 111.473 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 25.0 p -59.94 -47.66 84.87 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.285 0.476 . . . . 72.340000000000003 112.285 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.3 m -63.97 -41.5 97.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.976 0.417 . . . . 72.129999999999995 111.225 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.81 -40.27 95.52 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.973 -0.632 . . . . 62.409999999999997 112.605 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -60.24 -54.24 48.19 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.976 0.362 . . . . 74.040000000000006 111.976 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.66 -38.04 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.058 0.456 . . . . 65.25 111.038 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -53.79 -57.78 9.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.293 0.568 . . . . 64.530000000000001 111.642 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 18.5 mmt180 -64.8 -48.1 75.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.951 -0.568 . . . . 73.530000000000001 111.844 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 m -52.68 -51.1 61.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.093 0.473 . . . . 65.310000000000002 111.865 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 35.3 m-85 -70.05 -38.66 75.87 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.773 0.657 . . . . 75.319999999999993 112.773 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 4.7 ptm180 -69.24 -33.71 73.69 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.89 -0.507 . . . . 73.319999999999993 111.542 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.12 -36.85 64.23 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 111.902 0.334 . . . . 72.409999999999997 111.902 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -97.48 -58.4 2.01 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.578 0.585 . . . . 73.150000000000006 112.578 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.33 -1.74 53.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.421 0.526 . . . . 74.540000000000006 112.421 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.68 22.43 76.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.182 -0.533 . . . . 72.010000000000005 112.889 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -100.34 113.02 25.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 75.219999999999999 111.192 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.994 0.426 . . . . 74.420000000000002 111.575 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.01 153.83 37.75 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.325 -0.398 . . . . 75.540000000000006 111.361 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.86 168.21 19.31 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.443 2.096 . . . . 55.030000000000001 113.208 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -81.32 3.58 23.69 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.559 0.577 . . . . 70.530000000000001 112.559 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 30.8 t -122.17 133.44 54.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.343 0.498 . . . . 73.400000000000006 112.343 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.573 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 2.5 m -56.21 -45.21 79.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.854 -0.612 . . . . 75.310000000000002 111.026 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.6 -44.31 85.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.571 -0.741 . . . . 72.329999999999998 111.438 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 19.2 mm-40 -70.52 -33.99 71.79 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.153 0.501 . . . . 75.420000000000002 111.214 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -66.29 -20.36 66.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.528 -0.305 . . . . 70.420000000000002 111.74 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 88' ' ' THR . 22.9 mt-30 -72.08 -22.53 61.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.983 0.42 . . . . 71.129999999999995 111.819 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -87.46 -2.66 58.77 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.342 -0.39 . . . . 71.219999999999999 111.484 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.2 mmm -97.25 -75.83 0.53 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.865 0.364 . . . . 71.239999999999995 111.561 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.65 151.87 48.48 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.369 -0.443 . . . . 75.510000000000005 113.634 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 29.8 mmtp -89.29 153.94 20.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.998 0.427 . . . . 73.109999999999999 111.533 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.9 p -85.61 152.86 22.8 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.223 0.823 . . . . 75.510000000000005 113.223 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.498 HG13 ' NE ' ' A' ' 157' ' ' ARG . 1.1 m -152.25 171.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.861 -0.609 . . . . 74.519999999999996 112.161 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.2 t -116.26 -178.63 3.46 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.727 -0.67 . . . . 50.210000000000001 111.053 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.421 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -55.74 -46.09 77.88 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.287 0.477 . . . . 74.430000000000007 112.287 -177.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -69.48 -3.3 14.0 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.22 0.452 . . . . 70.430000000000007 112.22 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 5.6 m120 -116.08 -7.5 11.89 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.948 -0.47 . . . . 72.040000000000006 111.96 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.27 135.06 57.62 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.897 0.703 . . . . 72.549999999999997 112.897 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 104' ' ' ARG . 14.2 mmt180 -115.42 -152.02 0.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.491 -0.777 . . . . 73.349999999999994 109.855 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.9 m -102.83 105.02 15.34 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.791 -0.568 . . . . 75.0 111.505 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 122.91 -3.78 9.87 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.842 -0.694 . . . . 61.140000000000001 114.604 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.86 134.24 56.89 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.373 0.586 . . . . 75.549999999999997 111.759 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.4 mt -85.38 113.19 21.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.026 0.441 . . . . 72.530000000000001 111.26 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.2 m -95.4 134.78 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.031 0.443 . . . . 74.530000000000001 111.438 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 87.8 mt -104.62 138.57 40.75 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.245 0.461 . . . . 72.340000000000003 112.245 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -123.4 141.28 52.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.933 -0.576 . . . . 75.019999999999996 111.505 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 48.2 mtt180 -82.87 82.01 8.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.956 0.408 . . . . 74.510000000000005 110.027 173.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.22 134.07 35.79 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.002 0.371 . . . . 74.200000000000003 112.002 -173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.17 50.36 1.96 Allowed Glycine 0 CA--C 1.529 0.941 0 CA-C-N 116.51 -0.314 . . . . 74.319999999999993 113.586 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.1 m -154.62 -57.39 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.277 0.56 . . . . 74.319999999999993 109.769 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.6 p -103.17 -10.76 18.54 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.071 -0.513 . . . . 74.439999999999998 111.829 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.68 -61.01 4.31 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.242 -0.504 . . . . 44.420000000000002 112.798 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -117.08 97.75 6.1 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.028 0.442 . . . . 71.439999999999998 110.598 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.429 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 52.5 t60 -95.94 154.64 17.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.342 -0.39 . . . . 74.510000000000005 110.555 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.57 142.94 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.172 0.51 . . . . 75.439999999999998 112.308 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.38 160.89 26.93 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.979 -0.555 . . . . 51.340000000000003 112.625 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -97.01 109.65 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.532 -0.393 . . . . 75.319999999999993 111.32 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -68.03 108.65 3.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.928 0.394 . . . . 74.25 111.231 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 pt -109.43 -32.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.458 0.54 . . . . 71.5 112.458 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.51 -175.72 14.13 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.201 -0.523 . . . . 73.150000000000006 113.038 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -43.02 -58.0 2.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.858 0.688 . . . . 72.450000000000003 112.858 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -122.11 -10.35 8.58 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.17 -0.331 . . . . 72.329999999999998 111.525 174.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -84.36 137.17 33.56 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.348 0.594 . . . . 75.049999999999997 112.459 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.69 142.57 27.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.594 -0.73 . . . . 73.230000000000004 110.965 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -97.41 136.33 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.869 0.366 . . . . 71.030000000000001 111.251 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -165.19 168.69 16.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 73.0 111.181 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.86 91.25 7.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.145 0.498 . . . . 73.319999999999993 110.515 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.8 p -65.14 146.02 55.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.868 -0.606 . . . . 45.210000000000001 112.086 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.2 p -64.48 -25.13 67.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.147 0.499 . . . . 63.329999999999998 111.303 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -73.17 -70.59 0.35 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.089 -0.505 . . . . 54.409999999999997 112.276 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.0 m -102.83 -35.75 8.51 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.124 0.416 . . . . 70.120000000000005 112.124 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.63 -141.29 13.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.078 -0.582 . . . . 71.25 112.567 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.9 92.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.321 0.582 . . . . 74.540000000000006 111.948 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.415 ' HA ' ' HH ' ' A' ' 48' ' ' TYR . 35.7 pt -136.88 -176.69 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.059 -0.519 . . . . 74.120000000000005 111.024 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.28 116.36 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.543 -0.299 . . . . 64.510000000000005 110.656 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.2 m -104.3 -177.99 3.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.767 0.318 . . . . 74.109999999999999 110.758 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.3 m -143.59 145.27 32.38 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.154 0.502 . . . . 65.439999999999998 112.342 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.81 -27.57 69.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.687 0.625 . . . . 71.540000000000006 112.687 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -72.85 -3.63 26.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.929 0.344 . . . . 72.319999999999993 111.929 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -74.8 122.25 87.07 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 110.423 -0.214 . . . . 72.329999999999998 110.423 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.14 -39.36 11.58 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.418 2.745 . . . . 72.329999999999998 114.421 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 85.7 t80 -61.72 -51.46 68.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.862 0.363 . . . . 75.019999999999996 111.28 176.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -76.84 -27.97 55.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.434 -0.348 . . . . 75.319999999999993 111.203 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.91 -34.56 74.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.203 -0.453 . . . . 65.150000000000006 111.234 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -102.6 0.99 34.19 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.362 -0.381 . . . . 71.439999999999998 111.521 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -103.41 -30.64 10.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 111.905 0.335 . . . . 74.349999999999994 111.905 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.421 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 70.6 t80 -56.64 135.28 54.96 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.886 0.374 . . . . 74.409999999999997 111.498 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -123.0 -51.33 1.9 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.932 0.345 . . . . 73.319999999999993 111.932 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.69 -179.04 7.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.079 0.4 . . . . 71.400000000000006 112.079 -173.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -144.73 149.47 35.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.516 -0.311 . . . . 74.439999999999998 111.374 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.6 mtm-85 -137.46 118.2 14.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.68 0.252 . . . . 74.439999999999998 111.68 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.498 ' NE ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.21 109.42 11.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.138 0.494 . . . . 75.25 110.981 174.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 82' ' ' LEU . 16.8 m -84.13 -29.73 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.14 0.495 . . . . 54.340000000000003 111.201 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.48 94.72 5.63 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.267 -0.424 . . . . 75.150000000000006 110.177 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -64.32 117.22 6.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.299 0.481 . . . . 73.439999999999998 112.299 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 161' ' ' ARG . 9.2 tpt180 -138.63 111.74 7.93 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.104 -0.498 . . . . 74.25 110.465 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 58.7 m -110.18 131.04 55.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.05 0.452 . . . . 73.25 112.124 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -76.96 -178.01 4.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.332 -0.395 . . . . 71.239999999999995 110.624 173.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.509 -0.758 . . . . 70.109999999999999 112.083 177.732 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 111.276 0.102 . . . . 73.129999999999995 111.276 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -42.14 138.35 1.65 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.244 0.831 . . . . 70.219999999999999 113.244 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.95 89.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.513 0.673 . . . . 75.319999999999993 112.192 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 12.2 t70 -96.02 140.91 30.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.772 -0.649 . . . . 74.409999999999997 110.272 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.1 t -56.21 -53.87 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.831 0.348 . . . . 63.43 111.411 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.528 ' HB2' HG22 ' A' ' 105' ' ' THR . 87.7 tttt -61.4 -43.19 99.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.307 -0.406 . . . . 70.120000000000005 111.238 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.4 m -57.17 -42.73 81.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.099 -0.5 . . . . 43.109999999999999 111.331 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.462 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -72.01 -42.36 66.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.259 0.466 . . . . 75.430000000000007 112.259 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 40' ' ' VAL . 78.9 mt -58.35 -48.69 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 64.519999999999996 110.897 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 92.7 mmm -63.88 -36.23 83.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.039 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.35 -43.62 83.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.912 -0.585 . . . . 73.319999999999993 111.37 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -71.24 -45.61 62.87 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.998 0.428 . . . . 72.230000000000004 111.145 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -54.44 -41.22 69.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.445 -0.343 . . . . 74.239999999999995 111.831 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.82 -20.85 9.52 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.321 0.489 . . . . 74.120000000000005 112.321 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.1 -25.54 17.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.087 0.47 . . . . 73.040000000000006 111.47 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.409 ' CZ3' HD11 ' A' ' 66' ' ' ILE . 81.4 m95 -105.14 3.27 30.09 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.101 0.778 . . . . 74.5 113.101 -175.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -54.84 101.71 0.05 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.844 0.354 . . . . 74.340000000000003 111.916 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.45 21.4 22.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.015 -0.612 . . . . 64.340000000000003 114.412 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.7 t -80.5 132.05 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 117.851 0.826 . . . . 73.329999999999998 110.992 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -63.27 163.3 10.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.938 0.718 . . . . 74.430000000000007 112.938 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -92.94 140.17 29.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.096 -0.502 . . . . 73.430000000000007 111.602 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -137.08 139.47 41.31 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.869 0.366 . . . . 65.450000000000003 110.969 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 58' ' ' LEU . 6.7 mp -74.72 97.4 3.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 72.239999999999995 112.193 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.43 6.76 88.05 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.051 -0.522 . . . . 65.299999999999997 114.329 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.77 77.85 0.3 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 117.497 0.648 . . . . 70.430000000000007 113.128 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.495 ' H ' ' NH2' ' A' ' 86' ' ' ARG . 48.3 t -68.41 107.69 2.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.396 0.887 . . . . 73.230000000000004 113.396 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.8 t -166.14 172.58 11.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.724 0.409 . . . . 73.040000000000006 111.576 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -65.01 -21.35 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.953 -0.467 . . . . 75.230000000000004 111.572 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.01 9.25 20.18 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.392 0.615 . . . . 71.040000000000006 111.021 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.52 136.05 3.08 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.863 -0.895 . . . . 73.109999999999999 110.863 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 71' ' ' PHE . 19.7 tt -144.58 146.4 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.232 1.016 . . . . 65.129999999999995 112.828 -175.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.12 160.04 15.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.005 -0.543 . . . . 74.530000000000001 111.502 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 28.2 p -57.36 -54.46 46.6 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.841 0.353 . . . . 54.530000000000001 111.553 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.401 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 8.2 p -58.95 -42.86 90.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.193 -0.458 . . . . 74.519999999999996 111.18 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.63 -33.84 68.31 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.322 -0.399 . . . . 63.439999999999998 113.654 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.532 ' HA ' HD12 ' A' ' 66' ' ' ILE . 74.6 t80 -72.04 -48.46 44.32 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.48 -0.423 . . . . 74.109999999999999 111.612 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.558 HG12 HE22 ' A' ' 91' ' ' GLN . 7.1 p -63.1 -44.18 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.576 -0.284 . . . . 72.129999999999995 111.443 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.611 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.1 pp0? -61.14 -44.85 96.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.036 -0.415 . . . . 74.010000000000005 111.336 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -57.62 -50.5 72.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.041 0.386 . . . . 74.230000000000004 112.041 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.4 m -53.43 -45.83 69.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.833 0.349 . . . . 74.400000000000006 111.816 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 65.8 m-85 -72.86 -38.39 67.06 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.061 0.763 . . . . 72.530000000000001 113.061 -177.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -76.88 -42.77 38.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.572 -0.705 . . . . 75.450000000000003 112.287 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -73.43 -26.49 60.97 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.274 0.472 . . . . 74.209999999999994 112.274 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -96.0 -61.25 1.48 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.843 0.354 . . . . 74.219999999999999 111.866 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.406 ' HD2' ' HA ' ' A' ' 76' ' ' PHE . 63.9 m-85 -90.08 -28.5 18.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.42 0.526 . . . . 75.540000000000006 112.42 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.1 27.29 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.191 -0.528 . . . . 74.519999999999996 112.512 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 37.4 tp -83.15 160.09 21.92 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.311 0.577 . . . . 74.310000000000002 111.865 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.63 114.57 27.1 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.058 0.456 . . . . 73.439999999999998 111.895 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.77 145.01 41.15 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 122.274 -0.267 . . . . 74.439999999999998 111.033 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.575 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 63.1 Cg_endo -85.73 -171.47 0.9 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.979 2.453 . . . . 74.019999999999996 113.881 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.495 ' NH2' ' H ' ' A' ' 61' ' ' SER . 11.0 mmm180 -88.44 -19.43 26.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.473 0.546 . . . . 74.329999999999998 112.473 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -106.31 126.63 52.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.756 0.65 . . . . 74.109999999999999 112.756 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 44.1 m -52.0 -41.8 62.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.89 -0.595 . . . . 74.340000000000003 111.665 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -54.76 -32.53 60.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.85 -0.614 . . . . 73.129999999999995 112.306 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.08 -38.61 31.38 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.18 0.514 . . . . 75.019999999999996 110.961 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.575 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 44.9 mt-30 -61.85 -33.64 74.55 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.192 -0.458 . . . . 73.239999999999995 111.595 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.492 ' HG2' HD11 ' A' ' 110' ' ' LEU . 18.7 mt-30 -52.01 -37.72 54.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.241 0.543 . . . . 75.340000000000003 111.596 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -90.48 -9.81 45.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.015 -0.539 . . . . 74.219999999999999 112.126 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.484 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 81.1 mtp -87.25 -37.18 17.45 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.872 0.367 . . . . 70.329999999999998 111.374 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.76 150.93 21.41 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.946 -0.645 . . . . 64.409999999999997 113.388 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 31.2 mmmt -70.88 141.32 51.22 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.161 0.505 . . . . 74.120000000000005 112.007 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 m -77.47 127.54 32.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.656 -0.702 . . . . 75.400000000000006 112.106 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.498 HG13 ' CZ ' ' A' ' 157' ' ' ARG . 7.1 m -145.5 164.65 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.382 0.61 . . . . 71.010000000000005 112.417 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 t -116.7 -177.71 3.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.689 -0.687 . . . . 73.0 110.776 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.491 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -56.14 -36.69 68.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.455 0.539 . . . . 74.400000000000006 112.455 -175.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.0 p -64.88 -29.14 70.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.03 0.443 . . . . 74.420000000000002 112.141 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -100.68 -6.89 24.46 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.173 0.805 . . . . 75.209999999999994 113.173 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.14 131.05 48.77 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.419 0.896 . . . . 74.109999999999999 113.419 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -125.07 175.79 7.12 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.743 -0.662 . . . . 70.109999999999999 110.33 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.528 HG22 ' HB2' ' A' ' 41' ' ' LYS . 62.9 m -68.44 111.35 4.63 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.98 -0.45 . . . . 65.319999999999993 111.1 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.33 -12.93 7.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.388 -0.434 . . . . 72.200000000000003 112.711 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.18 130.45 43.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.022 0.439 . . . . 75.519999999999996 111.581 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.8 mt -87.95 112.32 22.43 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.95 0.405 . . . . 75.019999999999996 110.56 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -96.65 128.1 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.375 0.607 . . . . 74.239999999999995 111.577 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' A' ' 92' ' ' GLN . 79.3 mt -98.84 143.44 29.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 111.917 -175.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -131.14 132.19 44.61 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.39 -0.368 . . . . 74.310000000000002 111.266 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -81.22 84.79 6.49 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.242 0.544 . . . . 74.120000000000005 110.666 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.03 125.01 47.62 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.873 -0.603 . . . . 54.149999999999999 112.138 -173.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.99 1.27 8.54 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 121.116 -0.564 . . . . 74.310000000000002 113.981 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.8 m -105.61 -23.53 12.75 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 122.476 -0.426 . . . . 73.219999999999999 112.1 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 p -134.37 -1.04 2.9 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.54 0.57 . . . . 50.039999999999999 112.54 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.25 -100.69 1.41 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.117 -0.563 . . . . 72.349999999999994 112.546 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -102.98 94.85 5.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 74.510000000000005 110.469 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -87.78 151.63 22.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.005 -0.543 . . . . 72.140000000000001 110.236 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.5 139.07 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.092 0.472 . . . . 72.120000000000005 112.242 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 131' ' ' HIS . . . -132.15 149.85 19.49 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 116.177 -0.465 . . . . 73.409999999999997 112.525 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 72' ' ' VAL . 43.6 mt -89.39 106.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 122.476 -0.426 . . . . 74.200000000000003 111.031 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.67 115.05 5.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.387 -0.37 . . . . 73.129999999999995 111.314 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.1 pt -103.04 -33.75 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.893 0.701 . . . . 73.150000000000006 112.893 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.45 123.24 0.83 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 119.777 -1.201 . . . . 41.520000000000003 115.139 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.69 -78.25 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.24 1.016 . . . . 74.019999999999996 111.696 171.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 142' ' ' SER . 53.8 m-80 -133.57 -7.4 2.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.449 -0.342 . . . . 73.200000000000003 111.342 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -86.68 140.42 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.285 0.564 . . . . 74.310000000000002 112.287 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -151.41 140.68 21.36 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.524 -0.762 . . . . 75.540000000000006 111.041 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.44 137.44 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.994 0.426 . . . . 61.200000000000003 111.394 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.506 ' CE1' ' HB2' ' A' ' 133' ' ' SER . 5.0 p80 -162.9 162.21 26.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.988 0.366 . . . . 64.540000000000006 111.988 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -88.23 92.06 9.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.951 0.405 . . . . 75.430000000000007 110.391 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.506 ' HB2' ' CE1' ' A' ' 131' ' ' HIS . 37.5 t -86.78 126.39 34.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.424 -0.353 . . . . 72.120000000000005 111.886 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -59.3 -17.76 31.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.44 0.533 . . . . 72.099999999999994 112.44 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.1 p -65.95 -41.3 91.45 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.91 0.386 . . . . 53.25 111.503 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.1 m -138.79 -39.22 0.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.048 0.388 . . . . 72.109999999999999 112.048 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.48 24.62 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.792 -0.523 . . . . 72.109999999999999 111.792 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 57.5 t -65.72 103.01 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.179 0.49 . . . . 64.239999999999995 111.237 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.72 169.84 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.106 -0.497 . . . . 71.340000000000003 111.399 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.48 114.55 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.591 -0.277 . . . . 75.420000000000002 110.687 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.5 m -104.57 178.56 4.52 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.965 0.412 . . . . 74.209999999999994 111.054 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 66.4 m -141.65 140.43 33.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.006 0.431 . . . . 75.540000000000006 112.106 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.02 -6.01 7.67 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.366 0.506 . . . . 74.219999999999999 112.366 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -73.0 -19.68 61.16 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 70.209999999999994 110.628 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.77 134.05 69.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.051 -0.522 . . . . 72.030000000000001 110.768 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.539 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 78.4 Cg_exo -51.25 -46.21 32.55 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.757 2.305 . . . . 71.200000000000003 113.489 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.79 -45.42 86.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.197 0.443 . . . . 74.310000000000002 112.197 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -80.33 -34.46 36.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.984 0.421 . . . . 64.5 111.641 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -60.5 -54.59 43.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.114 -0.493 . . . . 75.230000000000004 112.066 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 51.7 pttt -86.06 -14.78 43.33 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.173 0.805 . . . . 74.239999999999995 113.173 -174.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -92.95 -4.59 52.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.0 -0.438 . . . . 74.430000000000007 111.702 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.491 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 77.0 t80 -55.2 135.62 49.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.582 . . . . 74.109999999999999 112.234 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -104.81 -71.0 0.75 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.907 -0.588 . . . . 74.439999999999998 111.258 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.468 ' HG3' HD13 ' A' ' 110' ' ' LEU . 9.6 pt-20 -163.45 -174.11 3.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.17 -0.468 . . . . 73.019999999999996 111.057 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -142.11 137.63 31.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.611 0.597 . . . . 63.409999999999997 112.611 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 14.0 mmt180 -137.45 114.79 10.99 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.955 -0.566 . . . . 75.519999999999996 110.325 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.498 ' CZ ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -95.07 122.6 37.9 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.086 -1.009 . . . . 74.310000000000002 111.687 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.48 1.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.669 -0.696 . . . . 74.400000000000006 112.766 -176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.2 mt -95.2 132.92 39.63 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.165 0.432 . . . . 71.219999999999999 112.165 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.9 m -82.24 102.89 11.45 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.497 -0.319 . . . . 71.239999999999995 110.297 172.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 161' ' ' ARG . 4.9 ppt_? -80.08 148.19 31.12 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.578 0.584 . . . . 73.439999999999998 112.578 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.5 m -94.56 151.75 19.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.161 -0.472 . . . . 72.230000000000004 111.132 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.429 ' N ' HD13 ' A' ' 163' ' ' LEU . 6.3 mp -92.27 -169.15 2.16 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.935 0.398 . . . . 61.210000000000001 110.637 176.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.611 -0.709 . . . . 73.420000000000002 110.944 176.898 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 36' ' ' MET . 3.3 mpp? . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 111.798 0.296 . . . . 72.209999999999994 111.798 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -79.46 141.88 36.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.537 0.208 . . . . 74.219999999999999 111.174 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.2 t -78.67 106.1 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.123 0.487 . . . . 74.439999999999998 111.175 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -116.91 139.55 50.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.928 -0.578 . . . . 74.299999999999997 110.302 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 44' ' ' ILE . 46.6 t -56.5 -57.08 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.561 -0.291 . . . . 74.420000000000002 111.545 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.51 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 85.1 tttt -55.7 -42.31 75.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.901 0.381 . . . . 72.030000000000001 111.475 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -58.89 -43.66 91.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.218 -0.446 . . . . 74.319999999999993 111.583 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -74.29 -33.28 63.19 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.19 0.441 . . . . 65.049999999999997 112.19 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 40' ' ' VAL . 87.5 mt -60.06 -50.25 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.156 0.503 . . . . 73.400000000000006 110.649 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.564 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 27.6 mmt -67.83 -34.01 75.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 71.420000000000002 111.136 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -55.41 -43.65 75.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.262 -0.426 . . . . 73.409999999999997 110.93 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.437 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 60.7 tp60 -78.87 -35.92 43.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.539 -0.3 . . . . 74.340000000000003 111.322 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.35 -32.77 39.89 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.82 0.343 . . . . 74.030000000000001 111.564 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.73 -34.44 52.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.358 -0.383 . . . . 44.509999999999998 111.812 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -19.8 42.24 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.38 0.511 . . . . 72.439999999999998 112.38 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.512 ' CZ3' ' HA ' ' A' ' 63' ' ' LYS . 99.3 m95 -100.91 -4.33 27.92 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.281 0.845 . . . . 73.230000000000004 113.281 -174.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.526 ' HB2' ' HZ2' ' A' ' 52' ' ' LYS . 10.1 mtmp? -65.18 127.57 32.23 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.877 -0.514 . . . . 75.319999999999993 111.272 178.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.27 -1.47 67.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.312 -0.47 . . . . 71.340000000000003 113.785 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.3 134.1 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 117.299 0.55 . . . . 63.420000000000002 111.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -83.56 161.07 21.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.403 0.52 . . . . 65.349999999999994 112.403 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -78.4 116.34 18.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.88 -0.6 . . . . 75.400000000000006 111.404 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -127.25 97.48 4.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.166 0.508 . . . . 74.329999999999998 110.638 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 40.7 tp -70.85 104.94 3.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.095 -0.502 . . . . 72.420000000000002 111.648 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.17 -63.61 0.56 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.362 -0.447 . . . . 74.530000000000001 112.781 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.92 99.35 2.11 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.221 -0.514 . . . . 60.229999999999997 112.532 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.55 ' HA ' HG13 ' A' ' 66' ' ' ILE . 76.4 p -84.09 105.9 15.32 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.068 0.395 . . . . 74.319999999999993 112.068 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -156.89 163.21 39.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.129 0.49 . . . . 71.319999999999993 112.167 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 39.2 ttmt -67.04 -11.76 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.272 0.558 . . . . 74.420000000000002 111.502 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -94.95 11.46 31.77 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.221 0.534 . . . . 75.109999999999999 110.748 177.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.5 123.25 1.57 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.159 -0.776 . . . . 71.129999999999995 111.159 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.55 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.8 tt -155.72 152.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 117.953 0.876 . . . . 73.439999999999998 112.706 -171.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.549 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -93.21 179.31 5.46 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.994 0.426 . . . . 73.310000000000002 111.509 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.53 -54.35 41.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.554 0.576 . . . . 63.219999999999999 112.554 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.5 p -62.13 -34.39 76.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.108 0.48 . . . . 71.109999999999999 111.71 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.67 -44.19 72.17 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.832 -0.699 . . . . 71.439999999999998 112.292 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -56.96 -52.31 65.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.866 0.365 . . . . 73.420000000000002 111.851 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.8 p -59.82 -41.92 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 74.319999999999993 111.386 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 5.7 tt0 -55.24 -54.82 38.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.363 0.601 . . . . 75.310000000000002 111.169 174.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -56.33 -54.38 46.17 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.44 -0.8 . . . . 74.239999999999995 111.73 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.437 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 66.1 m -52.87 -48.06 67.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.054 0.39 . . . . 71.129999999999995 112.054 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 38.3 m-85 -70.18 -35.23 73.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.983 0.735 . . . . 74.040000000000006 112.983 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -80.31 -33.52 37.5 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.722 -0.611 . . . . 74.129999999999995 111.806 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -72.64 -33.61 66.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.978 0.418 . . . . 72.400000000000006 111.53 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -102.35 -56.7 2.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.803 0.668 . . . . 74.129999999999995 112.803 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.54 -3.59 54.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.403 0.52 . . . . 75.540000000000006 112.403 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.49 22.79 66.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.429 -0.415 . . . . 74.510000000000005 113.012 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.508 HD23 HD23 ' A' ' 159' ' ' LEU . 46.4 tp -86.94 130.21 34.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.196 0.522 . . . . 74.310000000000002 111.97 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.67 101.38 10.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 111.496 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 73' ' ' GLN . 83.9 mt -111.99 139.83 22.78 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.292 . . . . 73.109999999999999 111.242 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.61 148.92 54.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.351 2.034 . . . . 71.120000000000005 112.751 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -83.37 65.22 8.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.352 0.596 . . . . 74.040000000000006 110.177 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 13.2 t -171.0 120.24 0.52 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.688 -0.687 . . . . 74.549999999999997 111.029 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.56 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 53.5 m -52.06 -41.62 62.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.946 0.403 . . . . 73.219999999999999 111.001 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -60.83 -46.53 90.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.181 -0.463 . . . . 70.450000000000003 111.322 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.99 -37.66 88.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.934 0.397 . . . . 74.019999999999996 111.322 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 87' ' ' SER . 95.2 mt-30 -67.07 -36.12 81.33 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.027 0.38 . . . . 74.329999999999998 112.027 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 88' ' ' THR . 23.6 mt-30 -52.89 -55.15 25.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.307 0.575 . . . . 74.230000000000004 111.545 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.08 0.9 17.12 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.598 0.592 . . . . 73.230000000000004 112.598 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 88.0 mmm -91.88 -13.43 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.682 0.277 . . . . 73.0 111.369 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.427 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -135.52 156.1 22.55 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.077 -0.583 . . . . 55.340000000000003 113.535 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 34.1 mmtp -94.37 152.84 18.32 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.482 -0.422 . . . . 74.450000000000003 111.367 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 79.3 p -84.44 157.26 21.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.149 0.796 . . . . 73.150000000000006 113.149 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.34 158.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 115.28 -0.873 . . . . 73.140000000000001 111.536 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.6 t -94.41 178.27 5.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.168 0.433 . . . . 73.430000000000007 112.168 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -51.3 -54.91 21.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.854 0.687 . . . . 73.140000000000001 112.854 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -74.17 -8.25 55.53 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.606 0.595 . . . . 72.439999999999998 112.606 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -107.45 3.67 25.38 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.205 0.446 . . . . 64.129999999999995 112.205 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.06 122.93 16.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.797 0.332 . . . . 73.340000000000003 111.843 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -105.72 154.36 20.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.372 -0.376 . . . . 74.140000000000001 110.602 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.3 m -66.35 119.52 11.71 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.916 -0.49 . . . . 75.530000000000001 110.855 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.47 -11.18 23.8 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.361 -0.447 . . . . 74.209999999999994 112.626 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.57 138.41 53.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.228 0.537 . . . . 74.510000000000005 111.412 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 72' ' ' VAL . 23.5 mt -86.62 117.04 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.8 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -95.23 118.87 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.433 0.635 . . . . 72.140000000000001 111.418 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 70.1 mt -93.1 127.02 38.48 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.613 -0.721 . . . . 73.409999999999997 111.867 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.67 133.58 55.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.328 -0.396 . . . . 73.420000000000002 111.126 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -75.87 92.06 3.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.904 0.383 . . . . 74.409999999999997 110.832 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.23 133.66 37.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.21 0.448 . . . . 63.450000000000003 112.21 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.69 60.34 4.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.385 -0.436 . . . . 72.219999999999999 113.455 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.6 t -172.52 -69.52 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.225 0.536 . . . . 72.150000000000006 110.744 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.5 p -81.88 -12.72 58.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.097 0.475 . . . . 74.209999999999994 111.12 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.19 -76.08 2.1 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.375 -0.44 . . . . 52.340000000000003 112.155 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 8.2 mpt_? -110.15 116.51 31.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.009 0.433 . . . . 75.450000000000003 111.223 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -102.4 151.89 21.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.474 -0.33 . . . . 72.340000000000003 110.213 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.71 137.77 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.149 0.499 . . . . 62.009999999999998 112.279 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.18 159.29 23.97 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.082 -0.508 . . . . 73.329999999999998 112.598 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 72' ' ' VAL . 45.0 mt -92.22 106.57 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.536 -0.391 . . . . 75.329999999999998 111.418 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -65.74 120.79 13.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.818 0.342 . . . . 64.439999999999998 111.32 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.51 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.9 pt -102.98 -37.61 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.348 0.499 . . . . 65.209999999999994 112.348 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.27 142.05 4.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.381 -0.914 . . . . 38.240000000000002 114.086 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.52 -79.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.453 0.701 . . . . 70.530000000000001 111.822 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.508 ' OD1' ' HB3' ' A' ' 142' ' ' SER . 7.8 p30 -150.8 9.08 0.59 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.134 -0.484 . . . . 75.319999999999993 110.92 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -89.28 143.01 27.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.112 0.482 . . . . 74.340000000000003 111.22 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 19.1 p90 -153.92 145.15 22.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 64.530000000000001 111.325 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.13 129.95 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.188 0.518 . . . . 75.299999999999997 110.86 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -150.65 -178.52 6.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.349 -0.387 . . . . 73.109999999999999 111.394 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -110.73 99.6 8.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.986 0.422 . . . . 64.099999999999994 111.482 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.9 t -66.25 136.23 55.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.126 -0.488 . . . . 74.409999999999997 111.452 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -57.28 -25.73 59.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.237 0.458 . . . . 73.349999999999994 112.237 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.8 t -99.56 -60.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.14 0.422 . . . . 52.409999999999997 112.14 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.8 m -73.32 -52.82 12.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.587 0.588 . . . . 75.319999999999993 112.587 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 -146.9 16.61 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.489 -0.386 . . . . 73.299999999999997 112.279 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.75 106.58 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 117.373 0.587 . . . . 74.010000000000005 112.001 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.24 174.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 120.988 0.423 . . . . 72.319999999999993 111.568 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.5 mt -105.41 123.26 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.526 -0.306 . . . . 73.239999999999995 111.213 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -116.37 173.58 6.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.658 0.266 . . . . 53.329999999999998 111.287 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.508 ' HB3' ' OD1' ' A' ' 127' ' ' ASN . 67.6 m -137.82 139.48 39.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.554 0.576 . . . . 75.109999999999999 112.554 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.504 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 67.7 mtm -78.65 8.74 4.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.954 0.724 . . . . 64.530000000000001 112.954 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.444 ' ND2' ' HB3' ' A' ' 142' ' ' SER . 10.4 p30 -78.6 -21.13 48.99 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.62 -0.675 . . . . 75.030000000000001 109.685 166.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.54 126.01 92.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.626 -0.716 . . . . 75.25 110.423 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.414 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 86.8 Cg_exo -43.7 -48.46 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.134 2.556 . . . . 72.310000000000002 114.298 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.539 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.6 t80 -57.4 -48.74 78.28 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.865 0.32 . . . . 75.329999999999998 111.865 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -73.97 -39.48 63.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.021 0.439 . . . . 71.5 111.405 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -55.0 -44.33 74.4 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.847 -0.615 . . . . 74.109999999999999 112.159 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.7 ptpt -91.21 -19.65 22.81 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.444 0.535 . . . . 71.120000000000005 112.444 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -83.21 -16.84 44.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.074 -0.391 . . . . 74.140000000000001 111.33 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -58.73 111.9 1.44 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.054 0.455 . . . . 74.349999999999994 111.898 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -85.85 -58.5 2.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.37 -0.377 . . . . 74.310000000000002 110.794 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -166.46 152.14 8.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.798 0.332 . . . . 74.0 111.211 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -105.57 145.16 31.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.521 -0.309 . . . . 73.120000000000005 110.637 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 63.5 mtt180 -134.59 118.82 17.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.893 0.377 . . . . 74.319999999999993 111.42 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.457 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -80.8 125.69 30.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.094 0.473 . . . . 75.430000000000007 111.473 -178.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.21 -10.49 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.364 -0.38 . . . . 55.310000000000002 112.012 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.508 HD23 HD23 ' A' ' 82' ' ' LEU . 91.1 mt -84.64 108.74 17.53 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.936 0.398 . . . . 72.409999999999997 111.545 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 55.1 p -75.91 92.55 3.11 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.227 0.537 . . . . 71.530000000000001 111.099 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.532 ' HA ' ' HE ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -106.36 177.38 4.87 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.018 0.437 . . . . 73.319999999999993 112.085 -177.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.7 t -53.08 136.67 35.09 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.752 -0.658 . . . . 64.310000000000002 112.45 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 163' ' ' LEU . 2.9 mm? -81.71 -167.02 1.34 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.051 -0.522 . . . . 74.299999999999997 111.084 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.926 -0.559 . . . . 71.230000000000004 111.876 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 112.664 0.616 . . . . 73.329999999999998 112.664 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -69.65 169.85 11.98 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.074 -0.391 . . . . 70.200000000000003 110.797 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.1 t -92.96 92.07 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.078 0.466 . . . . 73.510000000000005 111.485 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 24.7 m-20 -82.87 112.8 20.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.548 -0.296 . . . . 74.329999999999998 110.522 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.7 t -50.07 -50.93 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.286 . . . . 72.209999999999994 111.34 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.26 -44.6 75.74 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.814 0.34 . . . . 71.430000000000007 111.578 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 35.3 t -59.74 -39.96 86.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.931 0.396 . . . . 73.319999999999993 111.011 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.528 ' HA ' ' HE ' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -67.39 -42.05 83.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.349 -0.387 . . . . 74.209999999999994 111.826 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 40' ' ' VAL . 48.7 mt -64.31 -45.13 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.006 0.431 . . . . 73.120000000000005 111.089 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.497 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 29.9 mmt -65.76 -36.31 83.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.902 0.382 . . . . 72.409999999999997 110.871 176.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -47.72 74.29 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.209999999999994 110.958 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.512 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 8.0 tp60 -66.04 -47.86 72.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.947 -0.57 . . . . 72.209999999999994 110.894 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 17.0 t80 -55.8 -32.66 63.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.141 -0.481 . . . . 75.329999999999998 111.382 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.41 -33.07 58.65 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.049 0.452 . . . . 71.129999999999995 111.632 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.32 -20.96 31.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.231 0.456 . . . . 74.519999999999996 112.231 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -113.75 17.84 17.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.693 0.627 . . . . 74.409999999999997 112.693 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.1 mtmt -62.68 110.41 1.71 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.144 0.497 . . . . 73.439999999999998 112.33 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 21.77 41.84 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.407 0.523 . . . . 75.439999999999998 114.407 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.95 118.67 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 117.577 0.689 . . . . 74.010000000000005 110.967 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -71.73 163.64 27.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.742 0.645 . . . . 74.230000000000004 112.742 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 50.2 t80 -77.85 126.65 31.18 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.701 . . . . 75.420000000000002 111.833 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -138.39 103.08 4.8 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.056 -0.52 . . . . 75.349999999999994 110.156 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 tp -72.04 132.28 44.03 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.96 0.409 . . . . 74.420000000000002 111.716 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 -44.2 3.22 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.203 -0.522 . . . . 73.230000000000004 113.175 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.75 60.54 2.41 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 122.509 -0.407 . . . . 73.409999999999997 112.749 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' HG13 ' A' ' 66' ' ' ILE . 99.1 p -67.26 113.62 5.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.053 0.454 . . . . 52.119999999999997 112.161 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 2.6 t -164.74 171.57 14.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.991 -0.55 . . . . 74.299999999999997 110.89 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.658 ' HB2' ' HZ3' ' A' ' 63' ' ' LYS . 4.1 ttmp? -69.96 -14.4 62.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.658 -0.651 . . . . 75.530000000000001 111.32 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.67 2.38 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.948 0.404 . . . . 75.519999999999996 110.958 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.23 121.37 0.97 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.178 -0.769 . . . . 63.310000000000002 111.178 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.5 tt -149.54 158.6 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 74.519999999999996 112.421 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.93 174.39 6.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.039 0.447 . . . . 71.530000000000001 111.621 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.8 p -65.09 -53.29 47.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.576 0.584 . . . . 71.019999999999996 112.576 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 12.2 p -59.04 -39.62 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.978 0.362 . . . . 72.349999999999994 111.978 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.98 -37.91 92.44 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.021 -0.609 . . . . 72.409999999999997 112.821 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -63.17 -53.97 44.91 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.641 0.258 . . . . 71.319999999999993 111.367 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.53 -43.93 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 112.249 0.463 . . . . 74.219999999999999 112.249 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.8 -37.04 80.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.924 0.392 . . . . 74.310000000000002 110.912 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 84.1 mtt85 -69.53 -50.05 48.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.993 0.368 . . . . 75.439999999999998 111.993 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -52.71 -48.16 66.81 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.096 0.474 . . . . 63.32 111.582 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.8 m-85 -69.72 -36.38 75.83 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.698 . . . . 75.310000000000002 112.886 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 6.4 ptm180 -68.42 -32.06 71.84 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.949 -0.469 . . . . 71.400000000000006 111.201 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.488 ' HG3' HE22 ' A' ' 47' ' ' GLN . 27.2 mm-40 -74.47 -62.18 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.166 0.508 . . . . 72.450000000000003 111.225 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.512 ' OE1' ' HB2' ' A' ' 47' ' ' GLN . 3.0 mp0 -72.1 -44.76 62.71 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.758 0.651 . . . . 74.140000000000001 112.758 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -110.81 -3.6 15.65 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.066 0.765 . . . . 72.129999999999995 113.066 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 22.44 68.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.824 -0.703 . . . . 60.350000000000001 113.068 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.1 tp -95.47 121.52 37.24 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 75.230000000000004 111.31 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.59 110.34 22.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.952 0.406 . . . . 63.340000000000003 111.769 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.9 mt -97.29 152.71 38.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.472 -0.331 . . . . 73.200000000000003 111.221 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.5 175.67 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.433 2.089 . . . . 74.329999999999998 112.963 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 86' ' ' ARG . 34.6 mmt-85 -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.873 1.064 . . . . 74.5 113.873 -167.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 84.4 p -130.6 147.05 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.806 -0.559 . . . . 70.450000000000003 111.882 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.587 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.4 m -53.32 -40.13 64.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.271 -0.422 . . . . 73.329999999999998 111.274 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -49.65 -43.49 46.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.022 -0.535 . . . . 71.430000000000007 111.104 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.62 -40.96 32.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.769 -0.65 . . . . 73.439999999999998 111.355 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 87' ' ' SER . 91.6 mt-30 -57.58 -31.16 65.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.197 0.443 . . . . 73.040000000000006 112.197 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 88' ' ' THR . 37.7 mt-30 -58.45 -33.58 69.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.0 0.37 . . . . 74.450000000000003 112.0 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.92 -25.24 62.67 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.932 0.345 . . . . 74.409999999999997 111.932 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 92.4 mmm -69.32 -43.82 72.95 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.552 0.575 . . . . 72.230000000000004 112.552 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -102.42 160.28 17.46 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.803 -0.713 . . . . 75.150000000000006 114.305 -172.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 75.1 mmtt -91.26 147.31 23.14 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.807 0.337 . . . . 73.439999999999998 111.524 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 41.0 m -76.01 150.72 37.34 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.343 0.868 . . . . 74.129999999999995 113.343 -172.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.5 137.95 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.677 -0.692 . . . . 72.230000000000004 111.739 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.7 t -80.13 176.21 9.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.957 -0.565 . . . . 72.310000000000002 111.789 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.421 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -54.49 -50.31 68.07 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.754 0.65 . . . . 74.319999999999993 112.754 -175.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -70.11 -14.91 62.87 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.23 0.456 . . . . 73.340000000000003 112.23 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -102.31 4.52 39.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.302 0.482 . . . . 73.549999999999997 112.302 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.19 138.74 49.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.961 0.41 . . . . 74.040000000000006 111.591 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -134.08 174.48 10.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.948 0.404 . . . . 75.129999999999995 110.852 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.6 m -71.7 103.72 3.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.692 0.282 . . . . 63.329999999999998 111.39 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 133.13 -12.99 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.282 -0.485 . . . . 53.240000000000002 113.467 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 157' ' ' ARG . 7.4 m-20 -71.15 147.31 48.51 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.237 0.542 . . . . 64.329999999999998 111.599 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 mt -94.28 123.11 37.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.347 -0.388 . . . . 72.430000000000007 110.769 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 m -96.35 116.06 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.251 0.548 . . . . 71.439999999999998 111.245 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.2 mt -92.41 121.85 34.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.593 -0.731 . . . . 75.329999999999998 111.4 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -114.3 166.41 11.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.598 0.713 . . . . 71.430000000000007 112.188 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 68.1 mtp180 -103.8 109.79 21.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.28 -0.873 . . . . 73.209999999999994 109.474 172.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.2 124.38 35.37 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.126 -0.359 . . . . 63.450000000000003 111.599 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.25 -73.7 0.71 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.138 -0.553 . . . . 74.340000000000003 111.906 -173.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.7 m -167.78 -51.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.532 0.733 . . . . 74.120000000000005 110.269 174.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 p -107.68 93.84 4.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.986 0.422 . . . . 74.519999999999996 111.541 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 162.18 140.48 2.89 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.973 -0.632 . . . . 45.329999999999998 113.26 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -96.08 122.63 39.13 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.118 0.485 . . . . 74.340000000000003 111.526 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -113.32 156.21 23.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.076 -0.511 . . . . 71.129999999999995 110.096 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.88 137.94 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.387 0.613 . . . . 64.129999999999995 112.254 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.77 155.91 21.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.747 -0.66 . . . . 64.140000000000001 112.205 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.4 mt -92.37 110.32 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.32 -0.518 . . . . 73.409999999999997 110.972 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.427 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 61.1 t80 -73.77 114.89 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.048 0.451 . . . . 75.019999999999996 111.9 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 pt -95.56 -32.61 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.404 -0.362 . . . . 74.540000000000006 111.801 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 148.11 159.73 8.6 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.9 -0.667 . . . . 73.510000000000005 113.654 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 53.96 46.81 24.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.988 0.515 . . . . 73.230000000000004 112.267 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 142' ' ' SER . 44.2 m-80 67.18 -1.11 1.55 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.446 0.536 . . . . 74.209999999999994 112.446 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.22 141.99 28.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.353 0.597 . . . . 74.200000000000003 112.127 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -155.42 146.59 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.438 -0.801 . . . . 74.150000000000006 111.271 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.43 133.86 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.936 0.398 . . . . 65.420000000000002 111.089 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 9.3 p80 -158.72 165.28 34.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.513 -0.312 . . . . 72.310000000000002 111.404 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.35 95.75 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.038 0.447 . . . . 72.420000000000002 111.407 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 32.7 t -70.19 142.37 52.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.327 -0.397 . . . . 63.140000000000001 111.719 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -53.28 -41.37 65.5 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.658 0.614 . . . . 71.319999999999993 112.658 -176.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.1 t -108.16 -44.21 4.21 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.842 0.353 . . . . 72.329999999999998 111.802 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.1 m -76.57 -19.14 58.21 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.824 0.675 . . . . 65.400000000000006 112.824 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.73 -164.61 45.1 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.065 -0.588 . . . . 70.439999999999998 113.497 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 60.4 t -65.06 96.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.308 0.575 . . . . 75.430000000000007 111.192 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.8 pt -129.19 174.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.564 . . . . 73.439999999999998 111.648 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.1 mt -107.84 104.34 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.108 -0.496 . . . . 74.519999999999996 110.575 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.5 m -96.91 -173.39 2.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.807 0.337 . . . . 72.439999999999998 111.099 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 19.7 m -148.19 135.8 20.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.995 0.369 . . . . 73.109999999999999 111.995 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 59.3 mtm -74.46 5.19 4.93 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.015 0.376 . . . . 71.239999999999995 112.015 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -85.18 -6.96 59.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.02 0.438 . . . . 63.420000000000002 110.175 170.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -78.5 137.12 59.45 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.285 171.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 10.2 Cg_endo -51.83 -46.44 32.15 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.328 2.019 . . . . 71.329999999999998 113.259 -177.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.428 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 80.3 t80 -60.88 -47.7 85.17 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.809 0.3 . . . . 64.150000000000006 111.809 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -71.75 -37.07 70.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.915 0.388 . . . . 75.510000000000005 111.333 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.46 -42.99 93.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.076 0.465 . . . . 73.010000000000005 111.582 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.0 ptpt -88.09 1.74 53.59 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.051 0.389 . . . . 73.319999999999993 112.051 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 2.6 mpt_? -109.04 -16.87 14.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.555 0.206 . . . . 75.409999999999997 111.555 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.421 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 53.3 t80 -57.57 109.71 0.75 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.059 0.456 . . . . 63.350000000000001 111.548 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -85.65 -55.01 4.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.136 0.493 . . . . 74.209999999999994 110.331 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -173.24 169.65 4.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.938 -0.574 . . . . 63.43 110.42 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.62 146.68 47.23 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.229 -0.295 . . . . 72.420000000000002 111.311 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 91.3 mtt180 -142.69 135.05 27.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.932 0.396 . . . . 75.540000000000006 111.997 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.468 ' HB3' ' OD2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -95.56 117.0 29.62 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.172 0.51 . . . . 74.409999999999997 111.255 176.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.72 0.65 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.95 -0.568 . . . . 70.010000000000005 112.041 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 82' ' ' LEU . 79.1 mt -79.31 109.51 13.73 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.693 0.627 . . . . 70.340000000000003 112.693 -176.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 68.9 m -78.01 78.46 4.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.174 0.512 . . . . 64.420000000000002 109.621 168.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -63.78 161.6 14.96 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.365 1.246 . . . . 74.209999999999994 114.365 -170.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 47.6 t -109.09 12.67 25.0 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.537 -0.756 . . . . 70.349999999999994 111.688 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.493 ' O ' ' HD2' ' A' ' 161' ' ' ARG . 2.1 pt? -136.0 -167.05 1.97 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.487 -0.324 . . . . 74.120000000000005 110.739 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.861 -0.59 . . . . 73.209999999999994 111.783 -179.894 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 111.778 0.288 . . . . 71.129999999999995 111.778 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -58.18 126.59 28.13 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.444 0.535 . . . . 60.140000000000001 112.444 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.1 t -96.03 101.13 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.501 -0.318 . . . . 64.150000000000006 111.524 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -89.87 114.08 25.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.678 0.275 . . . . 74.420000000000002 110.565 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.67 -48.09 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.149 0.5 . . . . 75.439999999999998 111.463 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 105' ' ' THR . 88.3 tttt -55.02 -46.93 75.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.791 -0.641 . . . . 73.319999999999993 111.593 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t -58.61 -45.18 89.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.842 0.312 . . . . 60.409999999999997 111.842 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -62.67 -39.08 92.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.868 0.366 . . . . 74.519999999999996 111.314 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.35 -46.74 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.922 0.391 . . . . 72.219999999999999 111.35 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 94.3 mmm -62.23 -37.93 87.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.912 0.387 . . . . 73.329999999999998 111.158 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.1 -45.27 93.52 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 72.299999999999997 110.796 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.718 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 59.0 tp60 -62.01 -46.77 87.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.156 -0.474 . . . . 65.109999999999999 111.132 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.446 ' HH ' ' HA ' ' A' ' 139' ' ' ILE . 20.0 t80 -58.16 -37.95 75.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.427 -0.351 . . . . 74.209999999999994 111.208 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.95 -32.65 47.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.027 0.442 . . . . 75.120000000000005 111.596 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.63 -42.06 61.96 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.001 0.429 . . . . 70.099999999999994 111.348 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.08 4.65 52.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.767 0.654 . . . . 73.239999999999995 112.767 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 50.5 mttm -54.32 112.15 0.93 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.724 0.297 . . . . 75.310000000000002 111.328 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.07 55.15 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.09 -0.576 . . . . 61.420000000000002 114.401 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.66 137.39 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.818 0.809 . . . . 75.200000000000003 111.462 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -76.04 166.89 22.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.128 0.489 . . . . 75.319999999999993 111.724 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -91.32 140.05 30.15 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.481 0.658 . . . . 75.129999999999995 112.567 -173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 65.8 ttt180 -131.57 176.87 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.611 -0.722 . . . . 73.400000000000006 109.944 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.4 mt -129.43 94.94 3.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.983 0.42 . . . . 74.040000000000006 111.407 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.38 55.01 2.68 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.362 -0.447 . . . . 44.219999999999999 113.357 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.436 ' HA3' ' NH1' ' A' ' 57' ' ' ARG . . . -177.51 104.47 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.928 -0.653 . . . . 72.510000000000005 113.474 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.8 p -78.64 115.05 18.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.935 0.398 . . . . 74.430000000000007 111.901 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -169.97 160.85 8.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.449 -0.342 . . . . 74.019999999999996 111.335 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.34 -6.99 44.21 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 73.439999999999998 111.002 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.58 -10.71 59.37 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.519999999999996 110.919 172.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.97 141.72 3.21 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.322 -0.399 . . . . 53.530000000000001 112.561 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.5 tp -141.31 143.44 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 122.446 -0.443 . . . . 71.409999999999997 111.65 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -93.91 166.48 12.15 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.259 0.552 . . . . 74.209999999999994 112.421 177.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 29.9 t -51.74 -54.34 29.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.615 -0.72 . . . . 62.240000000000002 112.319 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.1 p -67.6 -44.98 76.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.505 -0.316 . . . . 74.329999999999998 111.249 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.78 -40.02 56.13 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.435 -0.412 . . . . 75.209999999999994 113.767 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -61.09 -57.78 11.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.591 -0.358 . . . . 72.219999999999999 111.532 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HA ' HD12 ' A' ' 122' ' ' ILE . 7.1 p -59.59 -36.49 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.917 0.389 . . . . 74.239999999999995 111.24 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 20.3 mt-30 -55.67 -61.17 2.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.385 -0.37 . . . . 71.109999999999999 111.673 175.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -60.02 -35.46 75.14 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.129 0.418 . . . . 75.200000000000003 112.129 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.718 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 99.7 m -56.12 -54.87 39.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 73.120000000000005 111.84 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.8 m-85 -75.03 -31.22 61.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.238 0.829 . . . . 71.530000000000001 113.238 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -76.05 -43.93 41.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.571 0.582 . . . . 74.549999999999997 112.571 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.04 -33.42 59.61 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.596 0.591 . . . . 73.200000000000003 112.596 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -87.28 -56.41 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.417 0.525 . . . . 75.420000000000002 112.417 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.08 -15.71 18.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.691 0.626 . . . . 74.209999999999994 112.691 -173.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.96 47.74 11.03 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.817 -0.706 . . . . 64.099999999999994 112.6 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 51.1 tp -104.86 137.71 42.22 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.14 0.495 . . . . 64.420000000000002 111.791 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.31 115.84 24.1 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.28 0.562 . . . . 73.420000000000002 111.438 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 73' ' ' GLN . 93.5 mt -127.37 151.41 74.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 122.137 -0.352 . . . . 71.519999999999996 111.625 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.98 -154.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.142 2.561 . . . . 74.319999999999993 112.902 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -110.06 -25.97 9.94 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.915 0.709 . . . . 74.430000000000007 112.915 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -120.72 148.66 43.66 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.828 -0.545 . . . . 73.409999999999997 112.305 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 26.2 m -52.54 -46.17 66.65 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.95 -0.568 . . . . 74.209999999999994 111.904 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -52.14 -32.35 35.22 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.075 -0.511 . . . . 73.349999999999994 111.545 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.22 -37.41 28.64 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.978 -0.556 . . . . 70.400000000000006 111.033 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.437 ' NE2' ' HG3' ' A' ' 73' ' ' GLN . 85.8 mt-30 -61.61 -32.61 72.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.238 -0.437 . . . . 64.400000000000006 111.384 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 88' ' ' THR . 17.1 mt-30 -52.71 -41.63 64.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.164 0.506 . . . . 74.319999999999993 111.547 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -77.73 -11.4 59.87 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.333 0.494 . . . . 75.540000000000006 112.333 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.4 mmm -80.91 -4.66 55.68 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.431 0.53 . . . . 74.510000000000005 112.431 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' A' ' 156' ' ' ARG . . . -151.8 163.25 29.99 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.86 -0.686 . . . . 45.549999999999997 113.091 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 92.1 mttt -86.21 172.27 10.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 75.329999999999998 111.793 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 77.9 p -95.59 141.43 29.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.843 -0.617 . . . . 71.329999999999998 112.624 -171.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 155' ' ' ALA . 5.1 m -131.98 158.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.796 -0.638 . . . . 40.119999999999997 111.282 175.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.8 t -100.13 176.55 5.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.376 -0.375 . . . . 61.530000000000001 111.833 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -47.53 -48.24 27.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.097 0.475 . . . . 75.019999999999996 112.176 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.2 m -69.11 -28.53 66.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.244 -0.434 . . . . 74.430000000000007 111.88 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 13.4 m120 -87.06 -13.86 43.13 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.112 0.412 . . . . 71.439999999999998 112.112 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -51.95 128.01 22.93 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.863 0.363 . . . . 74.450000000000003 111.688 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 102' ' ' ASN . 50.7 mtp85 -129.01 173.18 10.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.224 -0.444 . . . . 71.319999999999993 111.571 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 41' ' ' LYS . 36.7 m -69.49 122.28 18.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.279 -0.418 . . . . 72.400000000000006 111.631 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.27 11.34 52.4 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.241 -0.504 . . . . 75.129999999999995 113.177 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.402 ' OD1' ' HB1' ' A' ' 155' ' ' ALA . 9.5 t70 -84.44 152.84 23.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.824 0.345 . . . . 65.510000000000005 110.875 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 72' ' ' VAL . 44.0 mt -96.37 103.51 15.42 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 110.66 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -95.56 122.88 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.492 0.663 . . . . 73.120000000000005 111.376 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 154' ' ' GLU . 72.1 mt -96.73 120.37 36.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.463 -0.789 . . . . 73.0 111.735 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -114.15 152.24 31.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.386 0.612 . . . . 75.040000000000006 111.749 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -91.2 106.57 18.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.653 -0.703 . . . . 75.329999999999998 111.09 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -103.48 139.26 39.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.967 0.413 . . . . 74.420000000000002 111.955 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -22.73 74.17 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.034 -0.603 . . . . 63.340000000000003 112.73 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.4 t -86.8 -74.27 0.44 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.859 0.361 . . . . 61.210000000000001 111.532 177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.1 p -73.86 -35.82 64.8 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.961 0.726 . . . . 71.430000000000007 112.961 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.06 -89.16 0.83 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.153 -0.546 . . . . 70.299999999999997 111.941 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -91.26 94.18 9.42 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.5 -0.412 . . . . 75.430000000000007 110.479 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -98.17 141.11 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.18 -0.463 . . . . 75.439999999999998 110.392 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 88' ' ' THR . 14.9 p -119.48 139.8 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 63.130000000000003 111.999 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 151.79 19.79 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.981 -0.554 . . . . 73.400000000000006 112.151 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 72' ' ' VAL . 48.5 mt -88.22 107.62 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.51 -0.406 . . . . 73.510000000000005 110.827 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.22 105.71 1.16 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.77 0.319 . . . . 64.239999999999995 110.914 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.7 pt -91.47 -26.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.476 0.547 . . . . 74.140000000000001 112.476 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 160.94 122.17 0.62 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.154 -1.022 . . . . 75.219999999999999 114.193 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 45.99 81.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.88 0.872 . . . . 70.239999999999995 112.9 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.2 m120 68.21 -19.17 0.15 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.728 1.01 . . . . 70.239999999999995 113.728 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -86.57 141.45 29.01 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.163 0.506 . . . . 74.519999999999996 111.851 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.04 150.8 27.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.983 -0.553 . . . . 71.030000000000001 111.222 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.67 138.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.869 0.366 . . . . 71.219999999999999 111.159 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -157.25 173.58 16.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.226 0.536 . . . . 72.420000000000002 111.734 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -103.65 122.92 46.02 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.078 -0.51 . . . . 75.109999999999999 110.978 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -114.53 159.62 20.18 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.008 0.432 . . . . 75.420000000000002 111.644 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -53.17 -65.82 0.49 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.767 1.025 . . . . 74.219999999999999 113.767 -171.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.8 t -87.06 -36.47 18.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.987 0.422 . . . . 72.120000000000005 112.028 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 m -77.88 -8.97 58.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.745 0.646 . . . . 70.310000000000002 112.745 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.78 -93.93 0.96 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.856 -0.687 . . . . 73.319999999999993 112.855 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 17.7 t -133.73 113.41 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.468 -0.43 . . . . 74.140000000000001 111.024 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.446 ' HA ' ' HH ' ' A' ' 48' ' ' TYR . 37.6 pt -138.24 173.58 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.84 0.681 . . . . 75.230000000000004 112.84 -173.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.5 127.13 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.639 -0.709 . . . . 72.329999999999998 110.388 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 m -119.06 178.18 4.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.981 0.419 . . . . 50.399999999999999 111.202 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.4 m -144.45 139.23 28.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.841 0.353 . . . . 71.319999999999993 111.627 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 75.5 mtm -69.13 3.68 2.0 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.72 0.295 . . . . 71.430000000000007 111.768 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -72.24 -28.8 63.38 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.323 0.582 . . . . 71.140000000000001 109.861 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 37.1 mt-10 -71.61 127.79 90.58 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.737 -0.665 . . . . 74.409999999999997 110.474 176.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 6.2 Cg_endo -47.88 -41.35 32.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.117 2.545 . . . . 74.329999999999998 113.833 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 90.9 t80 -53.6 -53.75 47.35 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.969 0.414 . . . . 73.230000000000004 111.546 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.401 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 88.5 m95 -75.95 -35.35 59.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 73.010000000000005 111.073 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -56.09 -32.63 64.32 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.028 -0.533 . . . . 75.120000000000005 112.129 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.723 ' HB3' ' HZ3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -97.41 -9.07 28.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.46 0.541 . . . . 74.150000000000006 112.46 -178.266 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 30.6 mmt180 -103.79 -3.02 25.47 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.998 0.74 . . . . 74.439999999999998 112.998 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.43 107.32 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.96 0.409 . . . . 73.349999999999994 111.186 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.37 -66.56 0.89 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.25 0.548 . . . . 71.450000000000003 110.346 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.497 ' HG3' HD13 ' A' ' 110' ' ' LEU . 14.2 pt-20 -160.86 -175.65 5.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 64.510000000000005 110.383 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.492 ' HB2' HG21 ' A' ' 98' ' ' VAL . . . -140.22 157.21 45.95 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.616 0.246 . . . . 63.439999999999998 111.507 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 15.3 mmt180 -139.55 109.54 6.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.933 0.346 . . . . 75.150000000000006 111.933 -174.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -88.94 104.24 16.77 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.785 0.802 . . . . 74.329999999999998 111.1 177.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 113.101 0.778 . . . . 73.450000000000003 113.101 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.93 128.43 36.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.351 0.5 . . . . 74.420000000000002 112.351 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.5 p -79.0 128.93 33.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.275 -0.421 . . . . 75.230000000000004 111.084 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -76.15 145.39 39.97 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.64 0.607 . . . . 74.219999999999999 112.64 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.9 m -130.13 -168.21 1.93 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.849 -0.614 . . . . 74.109999999999999 109.761 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.3 tp -61.7 110.28 1.46 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.169 -0.332 . . . . 74.319999999999993 110.243 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.712 -0.661 . . . . 75.010000000000005 111.853 -176.579 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.99 0.424 . . . . 74.049999999999997 111.886 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -78.23 128.85 34.34 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.238 -0.289 . . . . 72.209999999999994 110.45 173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.07 106.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.083 0.468 . . . . 73.049999999999997 111.51 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.11 90.98 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.276 -0.42 . . . . 73.340000000000003 111.399 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.7 t -51.62 -47.94 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.958 0.409 . . . . 74.409999999999997 111.187 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -56.5 -48.54 76.96 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.083 -0.508 . . . . 74.230000000000004 111.722 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -69.05 -32.85 72.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.632 -0.258 . . . . 73.019999999999996 111.674 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -43.68 85.79 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.846 0.355 . . . . 75.200000000000003 111.238 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 40' ' ' VAL . 64.4 mt -65.02 -37.33 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.752 0.311 . . . . 74.439999999999998 110.759 176.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.5 mmt -64.44 -43.66 93.59 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.915 0.388 . . . . 74.329999999999998 111.368 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.0 -42.03 89.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.229 -0.441 . . . . 74.0 111.111 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -51.16 60.07 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.085 0.469 . . . . 71.5 110.036 175.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.5 -34.56 58.52 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.031 -0.532 . . . . 72.319999999999993 111.47 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.51 -33.08 53.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.861 0.362 . . . . 71.319999999999993 111.722 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -31.73 62.95 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.1 0.407 . . . . 73.329999999999998 112.1 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -106.07 12.88 29.85 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.644 0.609 . . . . 71.510000000000005 112.644 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -58.91 95.85 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.121 0.415 . . . . 62.450000000000003 112.121 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.47 27.3 10.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.088 -0.577 . . . . 74.129999999999995 113.898 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.5 t -77.67 127.09 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 122.25 -0.559 . . . . 74.230000000000004 110.796 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 55' ' ' ARG . 7.0 ptp180 -62.77 160.81 13.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.341 0.591 . . . . 75.140000000000001 112.281 -177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 39.8 t80 -84.83 123.26 30.26 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.141 -0.481 . . . . 75.319999999999993 111.97 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -136.97 130.38 31.43 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.423 -0.353 . . . . 74.409999999999997 110.531 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.488 HD11 ' N ' ' A' ' 58' ' ' LEU . 4.5 mp -80.96 112.74 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.615 0.245 . . . . 74.329999999999998 111.434 -175.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.53 3.47 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.035 -0.602 . . . . 65.420000000000002 114.151 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.21 72.57 0.58 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.957 -0.64 . . . . 74.430000000000007 112.778 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 t -69.72 100.81 1.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.301 0.482 . . . . 72.439999999999998 112.301 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 t -152.69 166.5 31.97 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.926 -0.579 . . . . 74.439999999999998 111.305 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.46 -6.49 36.26 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.441 . . . . 61.520000000000003 112.192 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.23 12.54 33.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.18 0.514 . . . . 74.319999999999993 111.006 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.42 126.9 0.93 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.937 -0.574 . . . . 64.129999999999995 112.253 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 18.5 tt -158.59 154.54 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 117.545 0.672 . . . . 70.400000000000006 111.854 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.0 178.19 4.63 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.243 0.544 . . . . 75.140000000000001 112.299 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 12.3 t -58.17 -52.78 64.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.799 -0.637 . . . . 64.230000000000004 112.677 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 t -69.31 -43.32 74.0 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.214 0.53 . . . . 75.319999999999993 110.676 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.43 75.05 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.835 -0.621 . . . . 52.310000000000002 113.157 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -68.5 -48.88 63.28 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 122.395 -0.473 . . . . 74.510000000000005 112.147 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' HD11 ' A' ' 122' ' ' ILE . 12.1 p -61.88 -43.77 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 111.808 0.299 . . . . 73.099999999999994 111.808 -177.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 20.6 pt20 -63.93 -37.72 88.44 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.165 -0.335 . . . . 75.530000000000001 111.484 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 36.0 mmt180 -59.8 -65.92 0.6 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.747 0.308 . . . . 73.349999999999994 111.315 173.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.9 m -44.52 -46.14 9.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.919 0.711 . . . . 75.120000000000005 112.919 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 39.5 m-85 -68.06 -43.22 79.14 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.729 0.64 . . . . 73.540000000000006 112.729 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 8.6 ptp180 -71.91 -30.25 65.17 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.594 -0.691 . . . . 73.230000000000004 111.559 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 mm-40 -68.33 -50.67 51.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 73.430000000000007 111.377 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -87.94 -61.55 1.69 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.451 0.537 . . . . 74.310000000000002 112.451 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.429 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 67.0 m-85 -92.67 -3.19 55.31 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.547 0.573 . . . . 71.519999999999996 112.547 -171.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.49 23.56 72.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.982 -0.627 . . . . 70.120000000000005 112.817 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 38.0 tp -95.12 115.82 27.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.895 0.378 . . . . 74.530000000000001 110.899 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.83 103.87 16.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.211 0.529 . . . . 73.299999999999997 112.179 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.93 146.93 37.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.898 -0.592 . . . . 74.109999999999999 110.521 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.2 172.39 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.546 2.164 . . . . 72.409999999999997 113.641 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -67.8 -48.58 65.88 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.159 0.8 . . . . 74.530000000000001 113.159 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -108.48 144.16 36.48 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.865 -0.522 . . . . 74.400000000000006 112.013 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 32.8 p -46.04 -43.61 14.59 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.827 0.677 . . . . 74.010000000000005 112.827 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.464 ' OH ' ' HA2' ' A' ' 117' ' ' GLY . 59.2 m-85 -54.08 -35.66 62.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.109 0.48 . . . . 74.400000000000006 111.342 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.76 -38.96 62.08 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.671 -0.695 . . . . 74.209999999999994 110.733 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -63.12 -31.22 72.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.668 -0.696 . . . . 73.140000000000001 111.55 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' A' ' 89' ' ' TYR . 32.5 mt-30 -59.84 -34.87 73.66 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.143 0.497 . . . . 74.099999999999994 110.83 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 8.56 8.88 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.127 -0.488 . . . . 74.519999999999996 112.044 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.6 mmm -97.9 -68.17 0.81 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.928 0.394 . . . . 74.109999999999999 111.635 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.47 164.52 34.76 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.078 -0.582 . . . . 74.430000000000007 113.485 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.439 ' HB2' ' NH1' ' A' ' 157' ' ' ARG . 14.3 mmmm -91.12 150.99 21.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 111.551 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 78.2 p -76.47 115.67 16.44 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.878 0.696 . . . . 74.239999999999995 112.878 -174.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 10.2 m -104.12 152.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.879 -0.601 . . . . 71.230000000000004 111.152 173.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.0 t -97.65 -176.98 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.185 -0.322 . . . . 70.310000000000002 110.826 175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 100' ' ' ARG . 1.4 mpp_? -59.82 -35.47 74.78 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.336 0.495 . . . . 75.150000000000006 112.336 -175.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.2 m -75.69 -12.5 60.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.946 0.35 . . . . 65.209999999999994 111.946 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.2 m120 -103.86 -5.06 22.73 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.204 0.446 . . . . 71.540000000000006 112.204 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.09 125.93 24.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.344 0.498 . . . . 75.340000000000003 112.344 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -141.79 134.69 28.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.639 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.0 m -38.67 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.964 0.727 . . . . 70.340000000000003 112.964 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 159' ' ' LEU . . . 135.51 -0.01 3.38 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.034 -0.603 . . . . 72.420000000000002 114.054 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 4.1 p30 -90.04 158.98 17.08 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 117.706 0.753 . . . . 72.120000000000005 111.436 176.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.7 mt -104.76 120.79 42.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 73.319999999999993 111.165 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 m -94.75 112.98 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.583 0.706 . . . . 60.340000000000003 111.443 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.21 119.51 31.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.641 -0.709 . . . . 73.019999999999996 111.681 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.437 ' HZ ' ' SD ' ' A' ' 143' ' ' MET . 92.2 m-85 -109.4 153.5 23.89 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.415 0.626 . . . . 75.329999999999998 111.922 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -88.39 113.85 24.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.707 -0.679 . . . . 74.420000000000002 109.352 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.36 168.74 11.65 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 122.095 -0.378 . . . . 74.140000000000001 111.868 -171.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.87 -38.83 46.78 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.351 -0.452 . . . . 75.319999999999993 113.472 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -101.22 165.32 11.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.702 0.287 . . . . 75.400000000000006 110.844 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 p -62.2 103.17 0.36 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.901 0.381 . . . . 75.5 111.953 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.464 ' HA2' ' OH ' ' A' ' 89' ' ' TYR . . . 167.04 163.7 21.35 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.258 -0.496 . . . . 74.010000000000005 113.668 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -98.65 119.85 38.07 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.758 -0.26 . . . . 73.540000000000006 111.631 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -99.6 124.27 44.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.88 -0.415 . . . . 75.430000000000007 109.88 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.435 HG13 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -110.18 145.04 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.659 0.614 . . . . 74.409999999999997 112.659 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.87 148.73 19.16 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.948 -0.569 . . . . 72.099999999999994 112.147 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.487 HD11 ' HA ' ' A' ' 72' ' ' VAL . 42.4 mt -89.86 106.6 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.168 0.484 . . . . 74.510000000000005 111.183 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 61.3 t80 -71.29 111.34 6.55 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.233 0.54 . . . . 75.230000000000004 111.622 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.7 pt -95.57 -16.81 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.251 -0.431 . . . . 65.129999999999995 111.874 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.21 164.62 11.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.111 -0.566 . . . . 64.340000000000003 112.998 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.8 m120 58.08 32.6 22.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.818 0.342 . . . . 73.329999999999998 111.863 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 142' ' ' SER . 41.2 m-80 65.55 11.29 7.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.367 0.506 . . . . 64.120000000000005 112.367 -177.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -100.34 143.63 30.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.104 0.478 . . . . 73.230000000000004 111.232 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.72 151.96 31.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.901 -0.59 . . . . 71.239999999999995 111.553 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -103.21 141.99 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.244 -0.434 . . . . 72.109999999999999 110.949 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.39 -170.73 3.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.844 0.354 . . . . 73.019999999999996 111.072 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -132.98 108.26 8.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.53 -0.304 . . . . 72.239999999999995 111.017 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.6 p -91.42 155.26 18.59 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.071 0.462 . . . . 74.310000000000002 111.32 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.4 p -66.66 -2.38 4.84 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.632 0.605 . . . . 74.420000000000002 112.632 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.9 t -97.46 -67.47 0.85 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.053 0.39 . . . . 64.200000000000003 112.053 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.4 m -104.72 -6.41 20.39 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.688 0.625 . . . . 54.310000000000002 112.688 -175.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 132' ' ' ALA . . . 84.28 -133.45 11.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.521 -0.847 . . . . 72.099999999999994 112.614 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.06 108.72 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.216 0.45 . . . . 75.030000000000001 112.216 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.8 pt -143.43 179.19 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.228 0.537 . . . . 75.430000000000007 112.155 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.0 mm -106.81 149.9 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 116.176 -0.465 . . . . 73.530000000000001 110.917 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.1 m -148.97 172.19 15.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.77 0.319 . . . . 72.310000000000002 111.421 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.441 ' HB2' ' HG3' ' A' ' 145' ' ' GLU . 50.6 m -129.31 142.91 50.7 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.289 0.566 . . . . 74.239999999999995 112.376 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.437 ' SD ' ' HZ ' ' A' ' 111' ' ' PHE . 86.3 mmm -59.84 -27.11 66.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.717 -0.674 . . . . 74.200000000000003 112.539 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -85.96 3.65 41.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.593 0.59 . . . . 73.549999999999997 112.593 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 142' ' ' SER . 58.7 mt-10 -81.36 125.97 77.65 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 122.236 -0.29 . . . . 70.549999999999997 110.309 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -38.15 -50.11 2.18 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.946 3.098 . . . . 74.519999999999996 115.232 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.38 -43.04 97.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.009 0.374 . . . . 74.219999999999999 112.009 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -81.35 -42.39 20.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.187 0.518 . . . . 75.340000000000003 111.07 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -54.17 -55.55 26.74 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.609 -0.723 . . . . 74.010000000000005 112.751 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -80.33 -11.69 59.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.059 0.392 . . . . 75.099999999999994 112.059 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -99.83 -2.21 35.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.176 0.436 . . . . 74.230000000000004 112.176 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.416 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 68.5 t80 -58.29 126.49 27.77 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.148 0.499 . . . . 71.129999999999995 111.73 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -101.8 -59.5 1.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.482 -0.326 . . . . 72.530000000000001 110.991 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -169.22 145.62 3.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.487 -0.324 . . . . 72.420000000000002 111.456 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.411 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -100.43 146.68 26.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.675 -0.239 . . . . 71.219999999999999 110.404 172.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 45.5 mtp85 -142.62 115.71 8.86 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.25 -0.281 . . . . 75.120000000000005 110.969 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -81.43 122.23 27.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.213 0.53 . . . . 73.040000000000006 111.976 -176.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.96 -20.14 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.561 0.578 . . . . 74.310000000000002 112.561 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.49 HD11 ' HA3' ' A' ' 106' ' ' GLY . 43.8 mt -68.17 104.97 1.94 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.213 0.53 . . . . 74.120000000000005 111.917 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 82.4 p -68.83 -19.46 64.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.803 -0.635 . . . . 72.129999999999995 111.6 176.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -69.81 126.84 30.91 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.437 0.532 . . . . 75.549999999999997 112.437 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 79.2 p -128.62 170.74 12.89 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.871 -0.604 . . . . 62.130000000000003 110.339 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -68.92 178.27 2.27 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.977 0.418 . . . . 74.230000000000004 111.493 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--O 1.254 1.33 0 CA-C-O 118.233 -0.889 . . . . 73.319999999999993 112.59 -177.81 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 55.2 ttm . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.593 0.235 . . . . 74.329999999999998 111.119 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -142.93 160.93 39.41 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.916 0.388 . . . . 74.109999999999999 111.468 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -104.03 105.92 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.141 0.496 . . . . 70.439999999999998 111.86 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -83.04 107.04 15.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.202 -0.454 . . . . 71.439999999999998 110.511 175.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.33 -45.54 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.0 0.429 . . . . 74.0 111.203 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 76.0 tttt -53.38 -50.79 64.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.065 -0.516 . . . . 71.349999999999994 111.46 175.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.5 t -59.36 -44.0 92.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.356 -0.384 . . . . 72.310000000000002 111.59 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -57.17 -53.93 52.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.029 0.442 . . . . 74.239999999999995 110.871 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.02 -39.28 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.98 0.419 . . . . 73.340000000000003 111.791 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.581 ' HA ' ' HE2' ' A' ' 45' ' ' MET . 31.1 mmt -66.24 -28.23 68.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.876 0.324 . . . . 74.040000000000006 111.876 177.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -63.62 -46.63 84.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.18 0.514 . . . . 72.230000000000004 110.044 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.427 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.6 tp60 -63.89 -44.97 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.718 -0.673 . . . . 72.099999999999994 110.385 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.17 -42.09 76.52 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.999 -0.546 . . . . 64.400000000000006 111.333 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.98 -33.22 66.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.034 0.445 . . . . 74.230000000000004 111.617 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -81.96 -26.09 34.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.21 0.529 . . . . 71.319999999999993 111.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -108.25 20.66 18.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.814 0.672 . . . . 75.109999999999999 112.814 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -59.42 101.56 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.901 0.704 . . . . 73.430000000000007 112.901 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.43 38.86 16.36 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.69 -0.687 . . . . 74.219999999999999 114.66 174.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.15 144.19 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 117.547 0.674 . . . . 74.239999999999995 111.081 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -56.54 142.77 38.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.545 0.338 . . . . 73.549999999999997 111.752 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 20.1 t80 -83.64 116.64 22.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.922 -0.399 . . . . 63.329999999999998 109.922 172.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -122.34 105.86 10.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.388 . . . . 62.32 110.49 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.86 116.86 12.74 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.934 0.397 . . . . 73.340000000000003 110.481 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 26.29 35.9 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.967 -0.635 . . . . 72.150000000000006 113.052 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.02 106.71 0.29 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.334 -0.46 . . . . 64.099999999999994 112.409 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.529 ' HA ' HG13 ' A' ' 66' ' ' ILE . 64.6 p -97.32 112.41 24.24 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.486 0.55 . . . . 64.530000000000001 112.486 -175.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.4 t -171.76 172.91 4.73 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.913 0.387 . . . . 74.519999999999996 111.651 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.64 -14.97 61.71 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 122.04 -0.412 . . . . 75.340000000000003 111.502 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -83.03 4.54 25.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.074 0.464 . . . . 75.409999999999997 110.602 172.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.64 132.47 2.61 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.603 -0.599 . . . . 75.120000000000005 111.603 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.529 HG13 ' HA ' ' A' ' 61' ' ' SER . 21.0 tt -151.22 153.09 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 117.391 0.595 . . . . 72.239999999999995 111.912 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -91.9 177.24 6.24 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.326 0.584 . . . . 72.200000000000003 111.985 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.528 ' HA ' ' HB1' ' A' ' 132' ' ' ALA . 32.4 t -62.09 -48.31 80.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.545 0.572 . . . . 71.430000000000007 112.545 -176.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 88' ' ' THR . 17.7 p -78.11 -27.58 48.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.918 0.389 . . . . 53.420000000000002 111.742 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.12 98.98 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.116 -0.564 . . . . 74.239999999999995 112.634 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -59.92 -50.66 72.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.928 0.344 . . . . 74.420000000000002 111.928 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.519 ' HA ' HD13 ' A' ' 122' ' ' ILE . 6.1 p -59.74 -52.82 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.294 0.479 . . . . 71.140000000000001 112.294 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' A' ' 86' ' ' ARG . 4.4 pp0? -65.99 -26.71 67.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.15 0.426 . . . . 72.5 112.15 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.541 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.3 mtp180 -69.31 -53.92 17.23 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.137 -0.352 . . . . 75.129999999999995 111.068 171.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -46.4 -49.61 17.75 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.257 0.551 . . . . 74.200000000000003 111.792 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 67.2 m-85 -68.44 -39.2 81.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.746 0.647 . . . . 73.310000000000002 112.746 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.541 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 11.8 ptp180 -76.75 -25.62 53.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.641 -0.662 . . . . 73.209999999999994 112.159 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.25 -28.27 34.84 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.979 0.362 . . . . 74.140000000000001 111.979 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 85.6 mt-30 -109.05 -61.44 1.62 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.587 0.588 . . . . 74.409999999999997 112.587 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -83.81 -11.67 56.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.928 0.344 . . . . 72.019999999999996 111.928 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.9 71.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.346 -0.454 . . . . 44.420000000000002 113.173 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.4 tp -73.37 123.3 23.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 74.530000000000001 111.53 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -74.29 85.17 1.93 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.401 0.62 . . . . 73.120000000000005 112.434 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.7 mt -106.28 135.2 19.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 122.126 -0.359 . . . . 72.299999999999997 111.215 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.596 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 58.7 Cg_endo -71.27 156.87 58.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.774 2.316 . . . . 75.209999999999994 113.111 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HA ' ' HG2' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -57.0 -43.35 81.65 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.811 1.041 . . . . 75.209999999999994 113.811 -174.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.423 ' N ' ' HG2' ' A' ' 86' ' ' ARG . 73.9 m -102.61 152.4 21.23 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.841 1.052 . . . . 64.230000000000004 113.841 -170.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 69' ' ' SER . 51.4 p -51.45 -58.91 4.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.971 -1.013 . . . . 61.130000000000003 112.969 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -47.24 -35.56 7.85 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.004 -0.543 . . . . 73.450000000000003 112.287 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.66 -42.59 28.23 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.052 -0.522 . . . . 74.040000000000006 111.162 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.16 -22.15 65.65 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.938 0.399 . . . . 72.510000000000005 111.461 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HG2' HD11 ' A' ' 110' ' ' LEU . 27.1 mt-30 -66.44 -34.46 77.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 112.171 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -84.22 -10.84 57.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.457 0.539 . . . . 61.509999999999998 112.457 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.596 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 62.4 mtp -94.78 -70.18 0.72 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.589 0.233 . . . . 75.319999999999993 111.525 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.4 130.31 28.99 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.388 -0.91 . . . . 73.430000000000007 112.277 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -85.27 143.57 28.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.406 0.622 . . . . 71.540000000000006 112.363 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 18.4 m -64.84 144.29 57.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.883 -1.053 . . . . 45.420000000000002 113.354 -170.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.428 ' CG2' ' HD3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -132.44 163.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.838 -0.619 . . . . 75.319999999999993 111.516 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.7 t -116.57 171.68 7.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.402 -0.363 . . . . 72.140000000000001 111.132 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -43.98 -57.64 3.23 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.217 1.191 . . . . 74.049999999999997 114.217 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -69.39 -9.25 52.67 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.981 0.734 . . . . 63.329999999999998 112.981 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -114.97 5.06 14.92 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.502 0.556 . . . . 73.409999999999997 112.502 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.35 133.04 55.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.77 0.319 . . . . 72.409999999999997 111.757 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 104' ' ' ARG . 54.2 mtt180 -108.28 169.44 8.63 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.436 0.636 . . . . 73.129999999999995 112.247 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.7 m -79.85 118.43 21.62 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.192 -0.458 . . . . 75.540000000000006 110.524 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 18.93 33.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.046 -0.597 . . . . 72.25 112.004 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -77.51 159.71 29.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.922 0.489 . . . . 73.530000000000001 110.291 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.0 mt -114.06 109.27 18.18 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.64 -0.663 . . . . 71.530000000000001 111.826 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.59 126.19 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.408 0.623 . . . . 74.010000000000005 111.913 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.425 HD11 ' HG2' ' A' ' 92' ' ' GLN . 83.0 mt -97.97 138.96 34.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.744 -0.662 . . . . 65.430000000000007 111.649 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -124.48 137.99 54.38 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.216 0.532 . . . . 73.230000000000004 111.929 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 33.6 mtp85 -72.56 84.01 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.976 -0.556 . . . . 74.129999999999995 110.533 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.36 139.95 30.11 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.381 0.512 . . . . 51.329999999999998 112.381 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.56 -41.81 83.07 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.781 -0.723 . . . . 53.140000000000001 111.55 173.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 m -78.22 128.35 33.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.377 0.271 . . . . 71.230000000000004 110.857 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 74.3 p 57.81 9.13 0.81 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.647 0.98 . . . . 75.400000000000006 113.647 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.31 -87.01 0.8 Allowed Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.418 0.527 . . . . 64.430000000000007 114.418 174.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -93.59 122.1 35.69 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.291 -0.534 . . . . 74.030000000000001 111.864 -176.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -115.64 149.22 38.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.413 -0.358 . . . . 72.439999999999998 110.178 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.61 135.34 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.154 0.502 . . . . 74.340000000000003 112.147 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -123.3 148.57 16.79 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.21 -0.519 . . . . 72.129999999999995 113.226 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 72' ' ' VAL . 40.2 mt -82.47 107.51 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.796 0.332 . . . . 73.310000000000002 110.797 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.7 104.35 2.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.119 -0.491 . . . . 73.239999999999995 111.616 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.411 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 38.2 pt -102.18 -17.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.743 0.645 . . . . 75.120000000000005 112.743 -176.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.69 -170.31 16.35 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.524 -0.846 . . . . 44.450000000000003 113.9 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -58.31 -32.77 68.78 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.68 0.392 . . . . 73.019999999999996 111.884 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -137.52 -26.46 0.98 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.226 -0.443 . . . . 74.239999999999995 112.153 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -85.26 140.87 30.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.03 0.752 . . . . 74.310000000000002 113.03 -175.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -148.38 142.95 26.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.461 -0.79 . . . . 72.129999999999995 110.982 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.82 137.2 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.975 0.416 . . . . 75.200000000000003 111.558 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -155.92 163.55 39.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.989 0.424 . . . . 74.430000000000007 111.74 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 68' ' ' CYS . . . -94.54 97.85 10.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.019 0.438 . . . . 61.420000000000002 110.832 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 80.9 p -81.7 142.06 33.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.175 0.512 . . . . 72.340000000000003 111.714 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.0 t -69.24 -7.04 33.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.233 -0.44 . . . . 72.439999999999998 112.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.3 p -101.52 -59.74 1.65 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.842 0.353 . . . . 44.520000000000003 111.834 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.463 ' HB2' HD12 ' A' ' 139' ' ' ILE . 68.6 m -109.5 13.79 23.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.399 0.518 . . . . 65.420000000000002 112.399 -175.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.65 -152.5 52.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.0 -0.619 . . . . 65.319999999999993 112.883 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 53.6 t -64.74 106.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.458 -0.436 . . . . 64.019999999999996 111.764 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 136' ' ' SER . 35.9 pt -136.82 -175.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.101 0.477 . . . . 73.329999999999998 111.703 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.28 129.11 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.428 -0.351 . . . . 74.439999999999998 110.965 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.7 m -118.53 174.44 6.25 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.876 0.37 . . . . 71.200000000000003 111.809 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.8 t -124.53 142.34 51.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.297 0.48 . . . . 75.420000000000002 112.297 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 85.0 mmm -63.39 -17.16 62.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.156 -0.474 . . . . 61.049999999999997 111.284 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -74.0 -18.04 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.324 -0.398 . . . . 71.439999999999998 111.617 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.09 130.22 93.82 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.786 -0.188 . . . . 73.439999999999998 111.118 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.484 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 85.2 Cg_exo -47.93 -51.97 8.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.907 2.404 . . . . 65.030000000000001 114.059 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.422 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 94.4 t80 -58.42 -47.07 85.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.784 0.326 . . . . 71.310000000000002 111.718 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -72.3 -40.14 67.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.784 0.326 . . . . 75.340000000000003 111.591 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.13 -52.64 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.003 0.43 . . . . 73.230000000000004 111.925 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.0 ptpt -78.12 -14.84 59.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.889 0.376 . . . . 72.209999999999994 111.988 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.536 ' HA ' ' HE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -91.83 -12.07 34.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.19 -0.318 . . . . 74.349999999999994 111.789 175.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.47 105.57 0.16 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.319 0.581 . . . . 74.430000000000007 111.176 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -90.46 -51.56 5.35 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.993 -0.548 . . . . 74.109999999999999 111.54 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -172.76 147.39 1.74 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.865 0.364 . . . . 75.329999999999998 111.204 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -103.01 161.62 13.61 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.356 -0.215 . . . . 73.200000000000003 110.659 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.8 mtm-85 -146.84 113.01 5.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.829 0.347 . . . . 74.219999999999999 111.806 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.428 ' HD3' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.76 96.89 4.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.289 0.566 . . . . 63.140000000000001 111.361 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.4 m -77.21 -29.79 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.953 -0.467 . . . . 65.439999999999998 111.62 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.26 142.77 35.91 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.613 -0.267 . . . . 74.25 110.427 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.1 t 66.41 23.25 10.63 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.174 0.511 . . . . 71.200000000000003 111.582 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -67.56 119.72 12.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.099 -0.5 . . . . 75.099999999999994 111.109 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.1 p -66.62 150.2 49.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.889 0.376 . . . . 72.430000000000007 111.36 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 163' ' ' LEU . 7.2 mp -69.87 170.16 11.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.432 0.634 . . . . 71.120000000000005 112.365 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.648 -0.691 . . . . 75.329999999999998 111.627 -178.764 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 112.163 0.431 . . . . 73.219999999999999 112.163 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -154.04 149.99 27.76 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.957 0.408 . . . . 74.109999999999999 111.723 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.91 124.68 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.391 -0.368 . . . . 74.140000000000001 111.259 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -97.06 132.68 42.61 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.869 0.366 . . . . 74.340000000000003 111.215 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 44' ' ' ILE . 88.9 t -61.84 -49.58 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.211 -0.45 . . . . 75.019999999999996 111.815 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.532 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 87.2 tttt -57.3 -44.88 84.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.34 -0.391 . . . . 75.450000000000003 111.496 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -60.1 -45.18 93.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.264 -0.425 . . . . 74.299999999999997 111.536 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mmm-85 -61.19 -43.57 98.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.073 0.463 . . . . 75.319999999999993 111.111 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 40' ' ' VAL . 73.1 mt -63.09 -47.79 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.021 0.439 . . . . 74.129999999999995 111.372 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.555 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 29.7 mmt -62.86 -29.4 70.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.394 -0.366 . . . . 75.230000000000004 111.522 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.43 -38.84 81.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.651 0.262 . . . . 72.319999999999993 111.166 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -77.54 -31.82 53.54 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.575 0.226 . . . . 73.420000000000002 111.506 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -53.45 -37.53 62.71 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.82 0.343 . . . . 74.510000000000005 111.286 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -24.31 64.47 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.127 0.417 . . . . 71.329999999999998 112.127 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -47.12 24.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.085 0.469 . . . . 72.409999999999997 111.513 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -85.55 16.01 4.17 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.073 0.768 . . . . 75.329999999999998 113.073 -172.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.535 ' HZ1' ' HB3' ' A' ' 52' ' ' LYS . 2.8 mmmp? -68.87 118.33 11.68 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.141 -0.349 . . . . 75.340000000000003 110.952 176.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.64 46.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.302 -0.475 . . . . 75.540000000000006 113.494 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.83 128.94 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.062 0.458 . . . . 75.219999999999999 111.729 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -88.19 179.31 6.4 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.912 -0.586 . . . . 75.140000000000001 111.599 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -91.66 133.02 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.091 0.472 . . . . 75.209999999999994 111.208 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -134.23 113.54 12.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.11 -0.496 . . . . 72.040000000000006 110.192 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.1 mp -57.93 115.2 2.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.924 0.393 . . . . 74.230000000000004 111.717 -175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.39 19.67 74.61 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.122 -0.49 . . . . 54.25 113.665 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.94 143.98 17.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.458 -0.401 . . . . 65.329999999999998 112.886 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.542 ' HA ' HG13 ' A' ' 66' ' ' ILE . 62.0 p -126.76 99.53 5.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.451 -0.441 . . . . 64.430000000000007 111.21 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 t -174.99 165.62 3.49 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.807 0.337 . . . . 73.200000000000003 111.635 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.38 -9.85 59.0 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.107 0.479 . . . . 75.400000000000006 110.909 176.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.11 -1.51 56.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.112 -0.494 . . . . 70.329999999999998 111.281 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.34 124.11 1.57 Allowed Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.248 -0.433 . . . . 74.239999999999995 112.053 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.5 tt -134.03 149.62 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.21 -0.583 . . . . 65.030000000000001 111.922 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.65 160.75 26.22 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.958 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 132' ' ' ALA . 29.4 p -58.86 -53.6 56.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.152 0.501 . . . . 75.310000000000002 110.895 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.428 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 87.6 p -63.8 -33.78 76.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.235 0.541 . . . . 63.409999999999997 110.822 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.525 ' O ' ' HG2' ' A' ' 73' ' ' GLN . . . -67.76 -31.6 76.22 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.817 -0.629 . . . . 74.0 112.954 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -66.13 -47.25 74.7 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.501 -0.411 . . . . 75.109999999999999 111.342 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 122' ' ' ILE . 11.2 p -67.9 -40.02 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 111.977 0.362 . . . . 74.239999999999995 111.977 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 22.0 pt20 -58.69 -41.91 87.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.062 0.458 . . . . 75.230000000000004 110.427 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.649 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 11.5 mmm180 -66.64 -67.0 0.48 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.248 -0.433 . . . . 74.109999999999999 110.929 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 m -40.75 -46.65 2.7 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.441 0.534 . . . . 72.099999999999994 112.441 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 14.0 m-30 -68.88 -39.39 79.82 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.432 0.53 . . . . 71.200000000000003 112.432 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 10.9 ptm180 -79.68 -19.29 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.701 -0.624 . . . . 72.329999999999998 111.846 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.649 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.7 mm-40 -72.28 -47.68 48.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.464 0.649 . . . . 63.43 110.162 175.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -95.12 -53.38 3.83 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.59 -0.732 . . . . 74.209999999999994 112.791 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -93.78 -23.76 18.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.278 0.474 . . . . 74.430000000000007 112.278 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.71 36.32 22.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.053 -0.594 . . . . 74.150000000000006 112.973 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 40.4 tp -95.19 119.22 33.32 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.76 0.314 . . . . 75.25 111.23 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.54 84.19 7.16 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.22 0.452 . . . . 72.040000000000006 112.22 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.67 145.63 30.74 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.5 -0.318 . . . . 73.230000000000004 111.301 176.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 150.11 62.41 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.721 2.28 . . . . 74.439999999999998 112.837 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.82 42.44 0.79 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.214 0.53 . . . . 73.510000000000005 112.205 -176.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.5 m -153.16 117.67 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.116 -0.365 . . . . 72.329999999999998 111.034 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.499 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 17.2 m -48.46 -44.36 35.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.506 0.558 . . . . 74.010000000000005 112.506 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -54.98 -46.42 75.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.76 0.314 . . . . 70.129999999999995 111.751 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -62.78 -42.77 99.85 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.429 0.633 . . . . 75.230000000000004 110.534 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -62.9 -30.55 71.62 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.875 -0.602 . . . . 74.409999999999997 111.755 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 88' ' ' THR . 26.1 mt-30 -63.03 -16.08 58.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.815 0.34 . . . . 72.109999999999999 111.692 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.81 -3.47 26.3 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.77 0.319 . . . . 60.310000000000002 111.438 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.3 mmm -95.18 -13.33 25.08 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.885 0.698 . . . . 73.549999999999997 112.885 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -141.58 154.97 25.05 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.858 -0.687 . . . . 72.239999999999995 113.725 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -96.11 153.35 17.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.04 0.448 . . . . 75.109999999999999 111.495 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 92.9 p -77.69 157.26 30.21 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.937 1.088 . . . . 72.299999999999997 113.937 -170.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.42 147.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 114.893 -1.049 . . . . 75.400000000000006 110.202 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -83.29 164.28 20.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 111.309 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -49.08 -29.89 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.858 0.688 . . . . 72.420000000000002 112.858 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -82.7 -23.19 34.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.887 0.699 . . . . 72.439999999999998 112.887 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -103.5 20.6 17.58 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.496 0.554 . . . . 74.400000000000006 112.496 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.0 mt -69.84 126.09 28.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.025 0.441 . . . . 71.109999999999999 111.918 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -101.72 -164.6 1.11 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.061 0.457 . . . . 74.340000000000003 111.132 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.468 HG23 ' HB2' ' A' ' 41' ' ' LYS . 58.7 m -97.44 109.06 21.89 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.426 -0.352 . . . . 73.430000000000007 110.83 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.54 25.33 6.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.404 -0.427 . . . . 72.219999999999999 113.687 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -94.47 146.28 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.444 -0.445 . . . . 72.230000000000004 111.302 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.1 mt -78.03 108.4 11.27 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.369 -0.378 . . . . 74.340000000000003 111.788 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.6 m -96.81 112.48 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.452 0.644 . . . . 70.430000000000007 111.433 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.37 120.64 28.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.649 -0.705 . . . . 74.430000000000007 111.956 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.6 157.81 20.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.31 0.576 . . . . 74.040000000000006 111.766 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.556 ' HB2' ' HG3' ' A' ' 151' ' ' ARG . 19.6 mtp180 -90.45 103.52 16.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.048 -0.524 . . . . 73.349999999999994 110.832 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . . . -93.84 121.13 34.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 71.150000000000006 111.791 -176.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.28 -71.76 0.61 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.199 -0.455 . . . . 62.450000000000003 113.396 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.7 p -163.58 -64.14 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.89 0.376 . . . . 74.209999999999994 110.875 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.2 p -95.19 -17.03 22.1 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.285 -0.416 . . . . 75.5 112.079 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.66 121.23 24.48 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 114.345 0.498 . . . . 74.030000000000001 114.345 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -91.1 97.53 11.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.965 0.412 . . . . 75.319999999999993 110.613 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 59.6 t60 -92.93 148.71 21.78 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.277 -0.42 . . . . 74.230000000000004 111.283 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.93 128.98 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.226 0.536 . . . . 74.540000000000006 111.281 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.72 154.44 16.5 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.208 -0.52 . . . . 70.129999999999995 112.93 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 72' ' ' VAL . 49.5 mt -89.65 102.66 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 122.549 -0.383 . . . . 73.439999999999998 110.584 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.414 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 37.2 t80 -73.7 105.24 4.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 75.409999999999997 111.762 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.532 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.0 pt -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.954 0.407 . . . . 61.100000000000001 111.735 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.97 178.71 19.17 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.501 -0.38 . . . . 60.450000000000003 113.032 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 62.67 21.36 12.67 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.689 0.28 . . . . 75.239999999999995 111.139 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 142' ' ' SER . 0.9 OUTLIER 65.12 12.54 8.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.93 0.395 . . . . 65.510000000000005 111.503 -171.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -103.81 145.24 30.39 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.376 0.608 . . . . 72.25 111.235 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 10.5 p90 -150.07 140.73 22.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.953 -0.567 . . . . 70.420000000000002 111.39 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.75 133.12 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.965 0.412 . . . . 70.519999999999996 110.718 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -157.04 154.72 30.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.199 0.523 . . . . 73.230000000000004 111.88 -173.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 68' ' ' CYS . . . -84.41 91.04 7.71 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.952 0.406 . . . . 75.409999999999997 110.155 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -67.47 146.04 54.38 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.108 0.48 . . . . 73.329999999999998 111.628 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.6 p -49.55 -47.91 48.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.606 -0.725 . . . . 71.099999999999994 112.855 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.0 m -98.9 -51.07 3.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.683 0.623 . . . . 71.400000000000006 112.683 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.6 m -80.75 -15.14 57.25 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.259 0.837 . . . . 65.310000000000002 113.259 -170.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.61 -154.93 30.18 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.01 -0.614 . . . . 71.310000000000002 113.036 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.38 102.68 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.864 0.364 . . . . 75.319999999999993 111.958 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.9 pt -140.13 178.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.093 0.473 . . . . 74.140000000000001 111.773 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.19 134.93 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.418 -0.355 . . . . 74.519999999999996 110.76 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.9 m -128.47 172.56 11.02 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 122.267 -0.271 . . . . 73.340000000000003 111.538 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 65.5 m -125.43 141.42 52.07 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.056 0.391 . . . . 65.349999999999994 112.056 -177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.3 mtt -67.4 -15.06 63.47 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.372 0.508 . . . . 73.109999999999999 112.372 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.965 0.412 . . . . 71.450000000000003 111.241 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -71.79 135.59 83.19 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.548 -0.296 . . . . 72.349999999999994 110.734 175.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.27 -48.03 21.68 Favored 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 122.91 2.406 . . . . 70.400000000000006 113.672 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 78.9 t80 -59.39 -50.85 72.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.833 0.349 . . . . 74.409999999999997 111.562 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -71.84 -36.92 70.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.576 -0.284 . . . . 64.219999999999999 111.701 -172.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -53.32 -54.87 30.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.08 0.467 . . . . 75.019999999999996 111.777 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -80.82 -18.86 46.11 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.94 0.348 . . . . 75.439999999999998 111.94 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.556 ' HG3' ' HB2' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -84.68 -15.36 45.56 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.958 -0.464 . . . . 73.310000000000002 111.884 177.531 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -61.26 92.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.296 0.569 . . . . 73.540000000000006 110.301 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -79.08 -46.01 18.93 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.966 -0.561 . . . . 74.329999999999998 111.379 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -172.9 163.58 4.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.979 -0.555 . . . . 72.230000000000004 110.978 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -128.15 149.3 50.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.766 -0.197 . . . . 65.329999999999998 110.718 176.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 95' ' ' GLY . 50.8 mtt180 -138.61 125.92 21.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.184 0.516 . . . . 74.519999999999996 112.016 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.71 120.67 27.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.034 -0.53 . . . . 75.129999999999995 111.242 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.55 -19.53 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.732 0.641 . . . . 70.439999999999998 112.732 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.477 HD23 HD23 ' A' ' 82' ' ' LEU . 91.7 mt -75.33 144.0 42.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.129 0.49 . . . . 73.200000000000003 112.079 -176.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 87.0 p -74.67 137.64 42.32 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.055 -0.521 . . . . 72.209999999999994 111.647 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.477 ' HD2' ' H ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -88.31 15.19 8.04 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.043 0.449 . . . . 72.420000000000002 111.517 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.0 m -83.18 -171.71 3.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.02 0.438 . . . . 72.099999999999994 112.031 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.4 ' HB2' ' H ' ' A' ' 164' ' ' GLU . 1.2 pp -83.5 -166.25 1.33 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.802 0.667 . . . . 74.540000000000006 112.802 -178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' A' ' 163' ' ' LEU . 2.5 mp0 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 123.501 0.72 . . . . 75.010000000000005 112.912 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 112.083 0.401 . . . . 74.319999999999993 112.083 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -130.93 -176.6 4.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.086 0.47 . . . . 71.099999999999994 111.462 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.3 t -102.44 129.14 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.892 0.377 . . . . 71.200000000000003 111.375 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.403 ' OD2' ' HB3' ' A' ' 41' ' ' LYS . 30.9 t70 -101.36 134.57 44.23 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.463 -0.335 . . . . 72.5 110.888 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.2 -48.38 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.406 -0.361 . . . . 74.25 111.531 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.9 tttt -60.04 -44.03 94.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.342 -0.39 . . . . 74.420000000000002 111.372 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.7 t -53.19 -49.79 65.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.181 0.437 . . . . 75.340000000000003 112.181 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -63.5 -44.2 95.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.964 0.412 . . . . 74.409999999999997 111.572 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.475 HD13 HG21 ' A' ' 122' ' ' ILE . 67.5 mt -64.36 -36.88 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.957 0.408 . . . . 73.099999999999994 111.365 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 96.0 mmm -65.74 -37.29 85.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.912 0.387 . . . . 72.439999999999998 110.715 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.75 -37.17 78.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.252 0.549 . . . . 54.210000000000001 110.198 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.549 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 7.6 tp60 -62.74 -53.65 51.13 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.013 -0.54 . . . . 75.209999999999994 110.451 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.419 ' HH ' ' HA ' ' A' ' 139' ' ' ILE . 32.0 t80 -51.1 -39.44 56.15 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.053 -0.521 . . . . 74.510000000000005 111.293 177.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.93 71.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.366 . . . . 74.010000000000005 111.685 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.02 -26.91 61.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 75.299999999999997 111.47 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -107.01 11.78 29.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.064 0.764 . . . . 75.519999999999996 113.064 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.78 128.43 35.88 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.959 -0.463 . . . . 72.310000000000002 111.325 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.05 -18.13 58.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.254 -0.498 . . . . 75.409999999999997 113.665 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.58 131.63 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.42 . . . . 74.230000000000004 111.837 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -82.3 178.39 8.27 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.228 0.455 . . . . 71.209999999999994 112.228 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -85.39 121.46 28.15 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.896 0.379 . . . . 71.349999999999994 111.661 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -137.57 115.46 11.5 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 74.510000000000005 110.65 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 21.7 tp -72.87 116.85 13.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.004 0.43 . . . . 72.340000000000003 112.102 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.91 -53.25 3.97 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.369 -0.443 . . . . 73.439999999999998 113.339 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.92 71.48 0.93 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.114 -0.565 . . . . 64.430000000000007 113.236 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.2 p -69.6 106.97 3.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.252 0.549 . . . . 74.0 112.132 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 t -160.94 172.46 16.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.906 -0.588 . . . . 74.099999999999994 111.026 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.5 -14.11 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.911 0.386 . . . . 75.25 111.433 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.73 -16.28 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.887 0.375 . . . . 70.450000000000003 110.903 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.22 144.38 4.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.157 -0.474 . . . . 54.310000000000002 112.222 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.6 tt -155.58 148.21 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 117.444 0.622 . . . . 71.319999999999993 111.506 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 6.4 p-10 -96.08 -171.37 2.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.185 0.517 . . . . 72.400000000000006 112.063 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 24.4 p -70.97 -50.16 37.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.073 -0.512 . . . . 71.109999999999999 112.023 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.443 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 50.5 p -66.76 -40.95 88.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.818 0.342 . . . . 71.420000000000002 110.836 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.29 -40.73 99.4 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.333 -0.461 . . . . 64.150000000000006 113.093 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -65.32 -55.99 15.14 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.666 0.269 . . . . 72.340000000000003 111.553 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.06 -42.23 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.915 0.388 . . . . 63.409999999999997 111.054 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.8 tt0 -52.86 -61.28 2.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 75.310000000000002 111.719 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -56.96 -46.53 82.07 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.544 -0.298 . . . . 75.420000000000002 111.783 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.2 m -49.85 -50.18 46.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.272 0.471 . . . . 71.140000000000001 112.272 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.482 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 85.0 m-85 -80.4 -42.46 22.75 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.849 0.685 . . . . 60.25 112.849 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 14.7 ptm180 -66.66 -33.56 75.93 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.94 -0.475 . . . . 75.329999999999998 111.996 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.446 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 5.0 mm-40 -86.71 -45.93 10.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.961 0.356 . . . . 64.430000000000007 111.961 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.549 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 29.8 mt-30 -83.26 -51.7 7.22 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.613 0.597 . . . . 75.239999999999995 112.613 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -97.15 -6.17 35.51 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.391 0.515 . . . . 71.25 112.391 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.03 43.64 98.88 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.032 -0.604 . . . . 71.310000000000002 112.663 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 52.7 tp -108.89 138.85 44.58 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 73.150000000000006 111.742 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.6 118.06 12.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.551 0.575 . . . . 75.299999999999997 112.551 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 158' ' ' VAL . 60.5 mt -136.72 134.78 19.59 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.83 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.489 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 81.3 Cg_endo -77.35 173.7 13.89 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.726 2.284 . . . . 73.209999999999994 113.409 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -95.55 16.03 18.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 73.230000000000004 112.985 -173.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.0 m -143.06 127.88 18.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.652 0.263 . . . . 70.200000000000003 111.675 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 69' ' ' SER . 26.9 m -51.28 -37.33 46.78 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.073 0.463 . . . . 72.420000000000002 111.75 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.47 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 72.9 m-85 -57.86 -32.02 67.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.089 -0.505 . . . . 74.109999999999999 111.631 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -83.1 -38.58 22.27 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.385 0.612 . . . . 70.530000000000001 110.456 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.86 -25.46 67.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.052 -0.522 . . . . 73.329999999999998 111.845 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 26.5 pt20 -78.28 -15.51 58.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.443 0.534 . . . . 64.409999999999997 112.443 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -110.99 -21.61 11.92 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.797 0.665 . . . . 70.349999999999994 112.797 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.489 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 25.5 ptm -75.03 -15.95 60.62 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.912 0.708 . . . . 72.129999999999995 112.912 -176.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.63 170.19 13.36 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.048 -0.596 . . . . 71.439999999999998 113.642 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 74.2 mmtt -90.87 133.59 35.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.186 0.517 . . . . 75.109999999999999 111.772 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -78.38 132.7 37.48 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.512 -0.767 . . . . 75.340000000000003 112.797 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.535 HG13 ' CZ ' ' A' ' 157' ' ' ARG . 2.4 m -134.15 161.6 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.971 0.508 . . . . 73.430000000000007 111.488 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -116.95 -175.68 2.83 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.835 -0.62 . . . . 65.319999999999993 112.068 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.545 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 25.8 mmm180 -40.54 -61.49 0.92 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 75.430000000000007 113.855 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -69.03 -16.93 63.83 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.999 0.74 . . . . 54.219999999999999 112.999 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -94.12 -13.8 26.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.518 0.562 . . . . 73.25 112.518 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.22 148.89 43.33 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.439 0.903 . . . . 73.219999999999999 113.439 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -133.25 -163.01 1.3 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.062 -0.972 . . . . 65.019999999999996 109.917 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 41' ' ' LYS . 36.0 m -86.52 108.42 18.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.883 -0.511 . . . . 73.319999999999993 110.907 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.54 -13.48 6.92 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.952 -0.642 . . . . 62.340000000000003 113.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 120.98 13.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.338 0.569 . . . . 64.109999999999999 111.362 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 35.8 mt -76.49 110.98 11.48 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.302 -0.408 . . . . 73.319999999999993 111.282 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 155' ' ' ALA . 27.7 m -95.36 139.98 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.046 0.45 . . . . 72.239999999999995 112.081 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.424 ' HG ' HH12 ' A' ' 156' ' ' ARG . 96.4 mt -106.56 134.76 49.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.15 -0.477 . . . . 72.430000000000007 111.879 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.58 133.92 52.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 72.230000000000004 110.459 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 112' ' ' ARG . 24.5 mtp180 -74.1 91.47 2.09 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.186 0.517 . . . . 75.430000000000007 110.397 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.54 133.01 35.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.715 0.635 . . . . 71.519999999999996 112.715 -170.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.19 -25.8 69.96 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.816 -0.629 . . . . 64.099999999999994 113.513 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.7 m -78.74 -53.94 6.61 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.046 0.45 . . . . 64.25 111.666 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.6 p -102.89 -48.81 3.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.253 0.549 . . . . 75.439999999999998 112.451 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 118.97 -82.4 0.34 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.731 -0.548 . . . . 63.140000000000001 111.731 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 10.4 mpt_? -92.91 96.13 9.92 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.582 -0.364 . . . . 72.530000000000001 110.536 173.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -105.09 141.68 36.23 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.465 -0.334 . . . . 74.329999999999998 110.799 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.17 137.78 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.199 0.523 . . . . 75.319999999999993 111.92 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.28 159.84 23.95 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 116.054 -0.521 . . . . 73.140000000000001 112.635 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.475 HG21 HD13 ' A' ' 44' ' ' ILE . 56.8 mt -93.33 110.3 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 122.603 -0.351 . . . . 74.430000000000007 110.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -69.32 115.7 8.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.928 0.394 . . . . 75.140000000000001 111.611 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.9 pt -106.58 14.27 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.12 0.415 . . . . 73.420000000000002 112.12 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.57 162.62 33.95 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.309 -0.472 . . . . 70.540000000000006 114.071 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 59.07 35.56 23.91 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.831 0.452 . . . . 72.150000000000006 111.996 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 143' ' ' MET . 48.4 m-80 62.18 14.49 6.7 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.126 0.417 . . . . 65.25 112.126 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -103.35 145.7 29.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.111 0.482 . . . . 73.019999999999996 111.139 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.03 139.87 19.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.115 -0.493 . . . . 75.420000000000002 111.844 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.49 133.62 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.091 0.472 . . . . 74.349999999999994 110.977 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -163.67 168.71 19.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.299 -0.41 . . . . 74.010000000000005 111.184 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.13 93.4 8.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.009 0.433 . . . . 71.049999999999997 110.814 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.1 t -79.54 130.39 35.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.309 -0.405 . . . . 73.120000000000005 111.993 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.8 p -63.36 -11.85 25.74 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.063 -0.517 . . . . 71.409999999999997 112.359 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 m -79.72 -32.39 41.23 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.976 0.362 . . . . 55.009999999999998 111.976 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.4 t -139.65 -48.45 0.47 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.04 0.448 . . . . 73.450000000000003 112.069 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.1 -148.28 19.95 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.713 -0.555 . . . . 74.439999999999998 111.713 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.2 99.5 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 117.321 0.561 . . . . 64.409999999999997 111.175 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.419 ' HA ' ' HH ' ' A' ' 48' ' ' TYR . 41.0 pt -138.23 -177.54 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.118 0.485 . . . . 73.420000000000002 111.824 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.79 129.03 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.251 -0.431 . . . . 72.400000000000006 110.565 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.5 m -119.8 172.94 7.35 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.942 0.401 . . . . 63.32 111.599 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 47.2 m -128.78 144.83 51.26 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.993 0.425 . . . . 61.509999999999998 112.085 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.545 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 65.8 mtt -75.2 0.87 14.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.675 0.62 . . . . 75.239999999999995 112.675 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -86.95 -11.86 49.32 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.936 -0.477 . . . . 65.319999999999993 111.287 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.46 130.6 92.04 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.486 -0.325 . . . . 75.030000000000001 110.699 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.34 -31.02 75.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.876 2.384 . . . . 71.209999999999994 113.442 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.19 -45.0 62.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.705 0.288 . . . . 71.400000000000006 111.74 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -83.79 -37.54 22.45 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.183 0.438 . . . . 72.230000000000004 112.183 -174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -53.51 -51.41 62.91 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.43 0.53 . . . . 73.349999999999994 112.43 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.22 -7.86 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.955 0.354 . . . . 71.099999999999994 111.955 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -95.94 -10.87 27.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.119 0.414 . . . . 73.420000000000002 112.119 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.86 114.63 2.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.946 0.403 . . . . 74.150000000000006 111.474 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -96.26 -55.5 2.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.296 -0.411 . . . . 74.420000000000002 111.255 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -168.74 -179.69 3.87 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.871 0.367 . . . . 74.439999999999998 111.398 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 98' ' ' VAL . . . -140.33 160.4 40.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.28 -0.418 . . . . 74.299999999999997 111.162 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.4 mtm-85 -144.33 121.22 11.31 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.321 -0.237 . . . . 73.439999999999998 111.584 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.535 ' CZ ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -94.08 98.92 11.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.755 0.788 . . . . 75.019999999999996 111.242 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.525 HG23 HD21 ' A' ' 84' ' ' LEU . 15.9 m -83.18 -1.01 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.515 -0.766 . . . . 75.219999999999999 112.592 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.477 HD22 HD23 ' A' ' 82' ' ' LEU . 90.9 mt -69.48 166.42 18.85 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.866 0.365 . . . . 74.040000000000006 111.974 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 31.8 t -47.79 135.05 12.44 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.037 -0.529 . . . . 54.329999999999998 111.87 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -64.11 101.91 0.45 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.065 0.459 . . . . 75.540000000000006 111.441 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -85.28 -25.63 27.11 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.029 -0.532 . . . . 74.349999999999994 111.044 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.61 -170.63 1.89 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.81 -0.632 . . . . 73.319999999999993 111.315 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 C--O 1.253 1.245 0 CA-C-N 115.979 -0.555 . . . . 63.439999999999998 110.989 178.426 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 81.4 mtp . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.685 0.279 . . . . 72.219999999999999 111.314 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -144.13 107.4 4.55 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.197 0.522 . . . . 55.329999999999998 111.648 175.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.64 112.11 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.211 -0.449 . . . . 74.209999999999994 111.301 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -93.1 150.05 20.79 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.301 0.572 . . . . 74.329999999999998 111.133 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.75 -38.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.854 -0.612 . . . . 71.200000000000003 112.117 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.47 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.7 tttt -63.08 -55.31 26.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.638 0.606 . . . . 74.129999999999995 112.638 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 t -57.41 -42.99 83.38 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.95 0.352 . . . . 61.32 111.95 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -59.14 -45.19 91.59 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.022 0.439 . . . . 74.049999999999997 111.446 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.466 HD11 HG21 ' A' ' 122' ' ' ILE . 86.8 mt -69.17 -44.54 80.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.828 0.347 . . . . 72.230000000000004 111.722 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.58 ' HA ' ' HE2' ' A' ' 45' ' ' MET . 28.1 mmt -61.56 -32.04 72.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.889 0.376 . . . . 74.150000000000006 111.051 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.09 -53.12 61.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.995 -0.548 . . . . 73.209999999999994 110.765 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 51.6 tp60 -65.25 -36.33 83.79 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.02 -0.536 . . . . 72.0 111.812 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 34.0 t80 -55.21 -39.68 69.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.868 0.366 . . . . 63.539999999999999 111.273 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.452 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . . . -59.37 -18.4 38.19 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.454 0.538 . . . . 75.140000000000001 112.454 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -92.5 -22.63 19.46 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.058 0.456 . . . . 71.439999999999998 111.776 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.454 ' CZ2' ' HG2' ' A' ' 63' ' ' LYS . 35.5 m95 -113.56 13.0 18.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.06 0.763 . . . . 72.140000000000001 113.06 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.6 mtmt -63.57 105.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.229 0.538 . . . . 73.450000000000003 112.027 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.96 19.33 9.14 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.94 -0.648 . . . . 71.409999999999997 114.375 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.32 130.3 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.619 0.709 . . . . 72.25 110.738 174.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 55' ' ' ARG . 16.5 ptt180 -79.46 163.27 24.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.408 0.521 . . . . 74.340000000000003 112.408 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -81.25 125.48 30.37 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.174 0.511 . . . . 74.5 112.242 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.408 HH11 HG21 ' A' ' 62' ' ' THR . 53.0 ttt180 -137.0 111.47 8.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.794 -0.639 . . . . 75.239999999999995 110.263 176.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 1.1 pt? -92.82 113.06 25.23 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.324 0.583 . . . . 72.430000000000007 112.026 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.08 -7.26 27.17 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.848 -0.615 . . . . 52.350000000000001 113.267 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.01 110.8 0.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.455 -0.403 . . . . 45.210000000000001 112.314 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.527 ' HA ' HG13 ' A' ' 66' ' ' ILE . 48.8 m -92.09 104.23 16.64 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.557 0.577 . . . . 63.210000000000001 112.557 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.408 HG21 HH11 ' A' ' 57' ' ' ARG . 2.9 t -151.87 157.18 41.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 73.409999999999997 111.222 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HG2' ' CZ2' ' A' ' 51' ' ' TRP . 43.8 mtpt -65.69 -15.86 63.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 73.319999999999993 111.708 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -92.41 11.12 27.21 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.061 0.458 . . . . 74.219999999999999 111.015 178.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.44 116.39 0.67 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.747 -0.541 . . . . 52.340000000000003 111.747 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.527 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.9 tt -150.19 151.85 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 117.263 0.531 . . . . 64.519999999999996 111.882 -173.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.573 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -91.05 177.48 6.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.284 0.564 . . . . 71.239999999999995 112.084 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.42 ' O ' HG13 ' A' ' 72' ' ' VAL . 23.0 p -61.31 -43.9 98.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.1 -0.5 . . . . 73.340000000000003 111.749 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.557 ' HG ' ' NE2' ' A' ' 91' ' ' GLN . 40.3 t -61.13 -46.29 91.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.156 0.503 . . . . 72.329999999999998 111.221 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.551 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -60.67 -45.85 95.59 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.045 -0.598 . . . . 71.319999999999993 112.797 177.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.22 -53.7 55.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.804 0.335 . . . . 75.540000000000006 111.902 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.513 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.7 p -59.76 -40.41 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.934 0.397 . . . . 70.200000000000003 110.676 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.475 ' HA ' HD12 ' A' ' 84' ' ' LEU . 20.3 tt0 -55.62 -48.64 74.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.153 -0.476 . . . . 75.209999999999994 111.406 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.574 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 15.7 mmm180 -60.75 -49.03 79.12 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.937 0.347 . . . . 70.049999999999997 111.937 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.567 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 86.6 m -57.81 -54.19 49.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.049 0.452 . . . . 70.030000000000001 112.045 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 68.7 m-85 -64.11 -33.96 76.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.494 0.553 . . . . 65.129999999999995 112.494 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.7 -29.18 58.89 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.019 -0.425 . . . . 75.420000000000002 111.679 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 78.6 mm-40 -71.18 -64.08 0.98 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.105 0.479 . . . . 73.420000000000002 111.417 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -72.5 -59.42 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.81 0.67 . . . . 73.129999999999995 112.81 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -88.78 -12.87 40.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.524 0.565 . . . . 74.420000000000002 112.524 -173.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.03 31.2 77.27 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.793 -0.718 . . . . 37.68 112.492 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 56.4 tp -90.8 132.34 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.675 0.39 . . . . 74.430000000000007 111.236 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.83 131.07 35.95 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.199 0.523 . . . . 74.109999999999999 112.117 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 73' ' ' GLN . 95.0 mt -136.0 150.96 72.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.224 -0.443 . . . . 73.209999999999994 111.079 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.09 156.92 55.22 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.551 2.167 . . . . 75.010000000000005 112.927 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.46 6.19 10.89 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.728 0.64 . . . . 75.019999999999996 112.728 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.3 m -131.25 129.11 41.17 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.663 0.268 . . . . 73.409999999999997 111.642 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.541 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 89.0 m -54.74 -43.38 72.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.897 0.379 . . . . 75.209999999999994 111.357 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -51.51 -32.39 27.53 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.729 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.15 -40.77 14.31 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.328 -0.397 . . . . 74.019999999999996 111.393 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.557 ' NE2' ' HG ' ' A' ' 69' ' ' SER . 70.2 mt-30 -56.41 -30.2 62.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.885 0.374 . . . . 72.140000000000001 111.411 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 88' ' ' THR . 21.7 mt-30 -52.94 -38.45 61.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.057 -0.52 . . . . 63.43 111.93 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.41 22.97 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.111 0.411 . . . . 75.430000000000007 112.111 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.0 mmm -98.31 -35.43 10.33 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.085 0.772 . . . . 64.150000000000006 113.085 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.0 -175.89 14.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.641 -0.79 . . . . 63.049999999999997 114.755 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.0 mmmt -86.21 149.03 25.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.687 0.395 . . . . 75.209999999999994 111.875 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -90.28 153.22 20.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.343 0.592 . . . . 72.400000000000006 112.563 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.99 159.76 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.676 -0.693 . . . . 74.109999999999999 111.502 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.4 t -87.66 157.76 19.02 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.286 -0.415 . . . . 65.099999999999994 111.514 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -52.18 -32.68 37.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.191 0.52 . . . . 74.239999999999995 111.413 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.5 p -74.57 -28.88 61.12 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.579 0.585 . . . . 61.039999999999999 112.579 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -96.05 -0.85 49.88 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.867 0.691 . . . . 74.439999999999998 112.867 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.475 HD23 ' HH ' ' A' ' 152' ' ' TYR . 50.4 mt -59.94 123.49 17.23 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.599 0.592 . . . . 74.299999999999997 112.599 -177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -128.05 -178.84 4.69 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.012 -0.54 . . . . 75.310000000000002 110.771 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.47 HG21 ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -64.33 108.11 1.52 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.819 0.342 . . . . 74.430000000000007 111.893 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.73 -18.61 5.11 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.905 -0.664 . . . . 74.430000000000007 113.452 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.431 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 66.8 m-20 -74.15 129.73 38.39 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.047 0.451 . . . . 73.329999999999998 111.331 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.26 115.77 23.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.679 0.276 . . . . 75.349999999999994 110.595 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 155' ' ' ALA . 16.5 m -95.67 128.58 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.143 0.497 . . . . 74.129999999999995 111.908 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.4 mt -97.67 129.19 44.76 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.937 -0.574 . . . . 74.209999999999994 111.714 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.11 140.31 49.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.536 0.684 . . . . 75.219999999999999 112.376 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -83.95 100.35 10.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.459 -0.791 . . . . 72.109999999999999 110.932 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.32 147.99 27.54 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.847 0.356 . . . . 64.019999999999996 111.85 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 56.53 -99.98 0.1 OUTLIER Glycine 0 CA--C 1.529 0.961 0 CA-C-N 116.265 -0.425 . . . . 53.409999999999997 113.806 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 63.9 m -153.6 -50.76 0.1 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.129 0.49 . . . . 61.409999999999997 110.181 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -115.4 79.19 1.25 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.193 0.52 . . . . 73.409999999999997 110.215 172.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.53 119.94 0.91 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.138 -0.553 . . . . 75.219999999999999 113.235 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -97.55 108.45 21.18 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.123 0.487 . . . . 71.430000000000007 111.761 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -98.51 148.06 24.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.057 -0.52 . . . . 75.120000000000005 110.643 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.5 141.9 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.069 0.461 . . . . 75.120000000000005 111.969 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.62 155.59 21.84 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.322 -0.466 . . . . 55.119999999999997 112.556 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 72' ' ' VAL . 20.1 mt -95.25 106.26 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.482 -0.422 . . . . 73.400000000000006 111.018 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.488 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 33.8 t80 -64.43 113.49 3.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.329 . . . . 74.549999999999997 111.186 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.41 -27.47 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.303 0.483 . . . . 74.010000000000005 112.303 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.33 144.95 4.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.441 -0.885 . . . . 64.209999999999994 114.23 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.21 53.37 12.54 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.107 0.563 . . . . 65.420000000000002 112.393 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 142' ' ' SER . 40.6 m-80 66.93 -4.98 0.72 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.173 0.805 . . . . 73.140000000000001 113.173 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.484 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 25.1 mt-30 -87.45 143.73 27.08 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.26 0.553 . . . . 74.450000000000003 111.061 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.561 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 25.2 p90 -156.32 148.95 23.75 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.77 -0.65 . . . . 74.129999999999995 111.519 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 137.54 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.104 -0.498 . . . . 73.349999999999994 110.835 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -166.45 162.29 16.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.114 0.483 . . . . 65.340000000000003 111.85 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -88.78 86.99 7.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.111 0.482 . . . . 75.409999999999997 110.309 172.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.2 t -58.22 134.71 56.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.783 -0.644 . . . . 74.200000000000003 112.498 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.9 p -57.18 -35.67 69.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.109 0.481 . . . . 74.109999999999999 111.82 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.7 t -85.94 -50.74 6.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.715 0.635 . . . . 72.340000000000003 112.715 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.8 m -98.9 -34.63 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.202 0.816 . . . . 64.329999999999998 113.202 -173.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.61 -158.67 14.4 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.05 -0.595 . . . . 71.439999999999998 112.369 -172.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 99.2 t -63.08 102.5 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.318 0.58 . . . . 72.0 111.793 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.76 -178.81 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.817 -0.629 . . . . 73.530000000000001 111.642 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.42 109.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.167 -0.469 . . . . 70.510000000000005 110.9 172.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 92.7 p -107.88 -171.46 1.87 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.584 0.23 . . . . 64.230000000000004 110.818 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.616 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 43.9 m -146.86 136.54 23.06 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.339 0.496 . . . . 71.230000000000004 112.339 -174.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.561 ' HG3' ' CE1' ' A' ' 129' ' ' PHE . 72.9 mtm -78.21 3.93 13.98 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.334 0.864 . . . . 73.109999999999999 113.334 -177.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.616 ' OD1' ' HB3' ' A' ' 142' ' ' SER . 1.0 OUTLIER -83.2 -12.85 56.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.867 0.365 . . . . 75.030000000000001 110.544 170.154 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -71.54 136.93 83.37 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 116.532 -0.304 . . . . 74.0 110.427 169.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -52.98 -43.0 60.44 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.722 2.281 . . . . 75.530000000000001 113.522 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.409 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 80.5 t80 -59.45 -47.66 84.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.705 0.288 . . . . 73.420000000000002 111.689 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -78.89 -33.62 45.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.835 0.35 . . . . 75.140000000000001 111.623 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -56.81 -38.43 72.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.257 -0.429 . . . . 74.329999999999998 111.382 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -93.52 -12.32 29.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.788 0.328 . . . . 71.329999999999998 111.801 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -79.32 -32.48 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.836 0.35 . . . . 73.430000000000007 111.079 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.475 ' HH ' HD23 ' A' ' 103' ' ' LEU . 91.9 t80 -58.04 126.59 28.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.845 -0.616 . . . . 74.420000000000002 112.405 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -101.38 -63.9 1.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.177 0.513 . . . . 65.019999999999996 110.344 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.27 172.46 18.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 71.439999999999998 110.032 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB3' HG12 ' A' ' 109' ' ' VAL . . . -131.23 145.63 52.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.999 0.428 . . . . 63.450000000000003 111.934 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 97.1 mtt180 -140.6 124.96 17.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.332 -0.395 . . . . 74.209999999999994 110.8 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -98.29 137.19 37.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.325 0.583 . . . . 74.209999999999994 111.767 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.2 m -104.83 14.29 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.661 -0.7 . . . . 73.530000000000001 112.753 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.42 154.85 19.36 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.439 0.533 . . . . 75.340000000000003 112.439 -177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.5 m -139.91 125.53 19.26 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.911 -0.586 . . . . 75.329999999999998 111.122 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -119.15 -172.62 2.34 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.015 0.376 . . . . 74.200000000000003 112.015 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.2 t -125.7 157.29 37.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.665 -0.243 . . . . 72.230000000000004 110.765 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.454 ' N ' HD11 ' A' ' 163' ' ' LEU . 6.7 mp -91.53 155.22 18.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.945 0.402 . . . . 73.409999999999997 111.792 -176.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.823 -0.608 . . . . 75.540000000000006 111.489 177.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.476 ' C ' ' SD ' ' A' ' 36' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.825 0.345 . . . . 72.150000000000006 110.919 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -74.16 127.58 33.31 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.836 0.351 . . . . 61.329999999999998 111.827 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.89 101.87 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.834 0.35 . . . . 74.409999999999997 111.202 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -57.1 122.51 12.56 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.745 0.307 . . . . 51.219999999999999 111.384 175.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.9 t -51.22 -44.59 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.162 -0.472 . . . . 63.149999999999999 111.582 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.49 -37.76 79.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.431 -0.349 . . . . 74.299999999999997 111.62 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.8 m -64.14 -10.87 25.46 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.235 0.457 . . . . 64.400000000000006 112.235 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.521 ' HA ' ' HE ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -101.01 -49.1 4.22 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.023 0.44 . . . . 74.530000000000001 110.512 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.503 ' HA ' HE22 ' A' ' 79' ' ' GLN . 59.2 mt -52.41 -43.98 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.117 0.484 . . . . 74.5 111.027 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.516 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 31.1 mmt -71.07 -22.49 62.11 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 111.801 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.78 -46.47 78.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.69 0.281 . . . . 63.530000000000001 110.673 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.02 -42.23 69.84 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.707 0.289 . . . . 73.129999999999995 110.938 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.576 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 36.6 t80 -50.44 -36.68 34.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.638 0.256 . . . . 73.439999999999998 111.183 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.24 80.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.451 -0.341 . . . . 75.430000000000007 111.665 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.1 -29.66 60.67 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.831 0.348 . . . . 73.299999999999997 111.713 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -92.09 5.9 48.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.163 0.431 . . . . 74.409999999999997 112.163 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 23.6 mmmt -58.69 101.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.483 . . . . 73.150000000000006 111.915 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.34 -0.45 37.56 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.049 -0.596 . . . . 64.549999999999997 113.949 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.5 134.54 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 117.319 0.559 . . . . 73.400000000000006 111.323 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -85.58 171.67 11.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.481 0.658 . . . . 74.319999999999993 112.427 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -102.18 137.81 39.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.732 -0.667 . . . . 74.230000000000004 110.666 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -132.63 121.83 23.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.01 0.433 . . . . 74.409999999999997 111.676 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.67 103.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 74.310000000000002 111.275 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.57 28.96 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.184 -0.532 . . . . 75.409999999999997 113.401 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 134.71 7.61 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.394 -0.432 . . . . 72.129999999999995 112.503 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.534 ' HA ' HD11 ' A' ' 66' ' ' ILE . 11.7 m -125.01 98.28 5.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.255 0.527 . . . . 64.219999999999999 111.4 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 t 177.99 172.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.867 0.365 . . . . 73.129999999999995 111.659 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -66.68 -18.6 65.45 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.881 0.372 . . . . 72.409999999999997 111.719 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -78.64 -11.79 59.99 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.107 0.479 . . . . 71.329999999999998 110.883 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.92 111.21 0.25 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.595 -0.602 . . . . 72.129999999999995 111.595 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 61' ' ' SER . 11.2 tp -112.2 154.33 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.999 0.399 . . . . 72.450000000000003 111.658 -173.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.26 178.7 4.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.984 0.421 . . . . 63.329999999999998 111.15 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.8 p -60.27 -52.9 63.29 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.309 -0.405 . . . . 61.450000000000003 112.013 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -69.42 -36.7 76.95 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.956 0.408 . . . . 74.209999999999994 111.129 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -58.68 -48.95 82.1 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.941 -0.572 . . . . 73.299999999999997 113.774 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.69 -56.16 25.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.184 0.492 . . . . 71.310000000000002 111.912 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' HD11 ' A' ' 122' ' ' ILE . 10.8 p -60.02 -39.41 80.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.872 0.368 . . . . 73.040000000000006 111.266 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.577 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 tt0 -56.68 -57.18 13.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.166 -0.47 . . . . 72.219999999999999 111.39 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 25.2 mmt180 -55.28 -49.46 72.02 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.904 0.383 . . . . 75.219999999999999 111.24 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.466 HG22 ' NE2' ' A' ' 79' ' ' GLN . 97.9 m -49.72 -61.96 1.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.013 -0.54 . . . . 73.129999999999995 112.452 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 69.5 m-85 -68.09 -37.38 81.15 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.202 0.815 . . . . 71.510000000000005 113.202 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -71.36 -36.72 71.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.879 -0.513 . . . . 64.200000000000003 112.172 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -78.08 -23.89 47.82 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.092 -0.38 . . . . 75.299999999999997 111.774 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.503 HE22 ' HA ' ' A' ' 44' ' ' ILE . 77.1 mt-30 -92.32 -70.31 0.7 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.178 0.513 . . . . 73.409999999999997 112.127 178.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -89.96 -9.78 47.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.043 -0.526 . . . . 72.510000000000005 112.042 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.51 77.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.918 -0.658 . . . . 64.319999999999993 112.33 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.8 tp -73.55 111.38 8.63 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.037 0.446 . . . . 72.120000000000005 110.533 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.35 78.59 4.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.437 0.637 . . . . 72.400000000000006 112.558 -173.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.13 143.32 69.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.064 -0.516 . . . . 73.549999999999997 111.571 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.51 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 89.9 Cg_endo -79.73 -179.43 5.32 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.019 2.479 . . . . 74.209999999999994 113.505 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -11.63 43.12 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.277 0.843 . . . . 75.129999999999995 113.277 -173.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 39.1 t -115.62 137.56 51.95 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.897 -0.502 . . . . 74.329999999999998 111.851 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.47 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 6.2 m -56.87 -39.59 74.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.134 0.492 . . . . 74.439999999999998 111.476 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -64.08 -33.72 76.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.327 -0.397 . . . . 74.439999999999998 111.781 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.476 ' HG3' ' HB3' ' A' ' 87' ' ' SER . 43.0 mt-10 -68.21 -38.34 81.81 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.274 0.559 . . . . 73.209999999999994 110.627 175.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.51 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 84.1 mt-30 -64.93 -30.58 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.697 -0.683 . . . . 73.540000000000006 110.912 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.4 mt-30 -64.98 -8.74 17.11 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.652 0.612 . . . . 75.450000000000003 112.652 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -99.16 -1.89 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.52 0.563 . . . . 71.540000000000006 112.52 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.2 ptp -114.04 154.95 26.8 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.062 -0.399 . . . . 74.409999999999997 110.863 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.27 177.22 29.63 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.777 -0.725 . . . . 72.340000000000003 112.756 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -118.46 149.75 40.74 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.325 -0.515 . . . . 75.230000000000004 111.611 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.49 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 89.0 p -76.91 154.53 33.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.237 0.829 . . . . 75.239999999999995 113.237 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 1.5 m -145.44 150.16 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.235 -0.893 . . . . 73.019999999999996 111.63 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.5 t -95.79 -179.52 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.884 0.373 . . . . 65.129999999999995 111.571 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -51.52 -44.09 62.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.317 0.488 . . . . 73.319999999999993 112.317 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.5 t -83.51 10.12 9.7 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.246 -0.434 . . . . 62.43 112.06 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.471 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.3 m120 -120.45 -8.55 9.57 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.126 -0.359 . . . . 74.129999999999995 111.832 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.64 144.19 57.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.101 0.778 . . . . 62.43 113.101 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -130.28 -156.44 0.76 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.717 -0.674 . . . . 71.409999999999997 110.599 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.9 m -101.14 126.97 47.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.548 -0.296 . . . . 74.510000000000005 110.325 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.06 -4.07 31.74 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.08 -0.581 . . . . 65.140000000000001 113.291 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 123' ' ' TYR . 2.2 m-20 -75.84 142.09 42.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.054 0.454 . . . . 64.219999999999999 111.128 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.43 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.535 -0.302 . . . . 74.450000000000003 110.331 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.22 126.46 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.473 0.654 . . . . 74.549999999999997 111.508 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 77.4 mt -105.71 115.1 29.66 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.488 -0.778 . . . . 73.310000000000002 111.823 -173.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -107.07 151.61 25.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.179 -0.464 . . . . 75.0 111.245 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.588 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 93.4 mtt180 -87.6 101.28 13.49 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.445 -0.343 . . . . 74.219999999999999 111.022 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.57 152.97 18.68 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.173 -0.329 . . . . 75.239999999999995 111.516 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.87 -22.8 58.96 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.122 -0.561 . . . . 37.710000000000001 113.71 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.9 t -99.01 -55.52 2.68 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 122.406 -0.467 . . . . 73.409999999999997 112.098 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.4 p -86.85 -3.12 59.03 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.591 0.589 . . . . 74.049999999999997 112.591 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.53 -65.57 2.78 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.033 -0.603 . . . . 62.299999999999997 112.189 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.727 ' HD2' ' HB3' ' A' ' 110' ' ' LEU . 2.1 tpp180 -119.46 128.37 53.94 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.371 -0.488 . . . . 73.519999999999996 111.004 176.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -118.05 124.92 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.147 -0.316 . . . . 74.099999999999994 110.147 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.82 138.58 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.24 0.459 . . . . 72.230000000000004 112.24 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -127.9 147.56 17.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.261 -0.427 . . . . 74.25 112.56 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 72' ' ' VAL . 40.3 mt -87.46 108.58 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.519 -0.4 . . . . 63.32 110.917 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.518 ' HD1' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -66.28 109.82 2.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.048 0.452 . . . . 73.420000000000002 111.901 -175.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.4 pt -105.23 11.49 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.01 0.434 . . . . 71.150000000000006 111.605 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.42 37.94 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.294 -0.412 . . . . 64.510000000000005 112.581 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -67.62 -16.21 64.05 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.281 0.475 . . . . 71.430000000000007 112.281 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.476 ' HA ' ' OH ' ' A' ' 123' ' ' TYR . 9.9 p30 -150.96 -13.42 0.22 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.668 0.618 . . . . 72.099999999999994 112.668 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -89.3 143.44 26.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.331 0.586 . . . . 73.349999999999994 111.869 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.518 ' HB3' ' HD1' ' A' ' 123' ' ' TYR . 27.6 p90 -153.1 146.46 24.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.647 -0.706 . . . . 73.349999999999994 111.462 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.7 p -99.19 136.84 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.055 0.455 . . . . 75.129999999999995 111.062 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -156.09 -166.28 2.14 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.246 -0.434 . . . . 74.439999999999998 110.736 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.4 114.41 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.707 0.289 . . . . 63.399999999999999 111.696 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 67.5 m -91.06 145.97 24.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.852 0.358 . . . . 72.319999999999993 111.272 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p -50.55 -48.91 57.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.58 0.955 . . . . 71.439999999999998 113.58 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.7 p -106.83 19.54 20.33 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.773 0.657 . . . . 60.310000000000002 112.773 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 133' ' ' SER . 67.6 m -133.05 -23.5 1.96 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.321 0.489 . . . . 74.549999999999997 112.321 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.29 -151.94 31.95 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.966 -0.635 . . . . 71.109999999999999 112.705 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.0 t -75.63 111.77 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.947 0.403 . . . . 61.240000000000002 111.993 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.36 -178.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 120.962 0.41 . . . . 64.340000000000003 111.491 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.41 143.13 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.738 0.304 . . . . 73.120000000000005 110.783 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.8 t -138.43 179.47 6.44 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.806 0.336 . . . . 74.140000000000001 111.657 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 69.7 m -137.7 138.71 39.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.341 -0.39 . . . . 70.040000000000006 111.258 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.488 ' HE2' ' OH ' ' A' ' 123' ' ' TYR . 27.0 mtm -69.97 -9.67 55.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.426 0.528 . . . . 75.010000000000005 112.426 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -78.52 -9.44 59.34 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.092 -0.38 . . . . 72.219999999999999 111.38 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.92 136.18 82.65 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 110.167 -0.309 . . . . 73.400000000000006 110.167 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -49.98 -45.85 30.75 Favored 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 123.029 2.486 . . . . 72.530000000000001 114.157 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.514 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 56.3 t80 -65.11 -44.14 89.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.912 0.387 . . . . 75.140000000000001 111.757 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -77.53 -35.56 53.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.832 0.308 . . . . 75.340000000000003 111.832 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -53.72 -38.98 64.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.237 0.542 . . . . 73.340000000000003 111.565 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -92.59 0.47 57.43 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.525 0.565 . . . . 74.140000000000001 112.525 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.588 ' HD2' ' O ' ' A' ' 112' ' ' ARG . 33.4 mmt180 -100.83 -17.94 16.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.109 0.411 . . . . 74.540000000000006 112.109 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.41 130.07 44.65 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.373 0.508 . . . . 74.430000000000007 112.373 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -112.89 -54.66 2.6 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 72.5 111.102 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -165.86 167.46 16.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.425 -0.352 . . . . 74.329999999999998 110.914 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -133.91 145.41 49.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.165 0.186 . . . . 72.519999999999996 110.864 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 57.5 mtt180 -141.0 121.14 13.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.743 0.306 . . . . 72.040000000000006 111.422 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.43 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -85.06 121.94 28.55 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.409 0.623 . . . . 72.420000000000002 110.864 175.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.48 4.91 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.026 -0.534 . . . . 72.239999999999995 112.329 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.88 110.99 22.35 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.874 0.368 . . . . 73.109999999999999 111.315 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.5 t -82.38 -174.1 4.96 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.136 0.493 . . . . 72.209999999999994 111.903 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -106.06 123.06 47.41 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.118 0.485 . . . . 75.400000000000006 112.091 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 96.1 p -109.7 133.5 53.06 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.63 -0.507 . . . . 71.019999999999996 109.63 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 163' ' ' LEU . 2.0 pt? -144.35 179.09 7.47 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 122.118 -0.364 . . . . 75.239999999999995 111.847 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.252 1.185 0 N-CA-C 113.064 0.765 . . . . 73.439999999999998 113.064 -177.535 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.815 0.34 . . . . 74.150000000000006 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.8 167.18 10.7 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.561 0.219 . . . . 75.019999999999996 110.765 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.43 79.22 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.136 0.493 . . . . 64.540000000000006 110.565 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER -69.44 95.19 0.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 111.435 177.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -55.31 -48.71 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.581 0.585 . . . . 74.329999999999998 112.581 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.505 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.1 tttt -61.86 -56.95 14.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.863 0.32 . . . . 73.450000000000003 111.863 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.6 m -59.83 -38.83 83.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.597 0.237 . . . . 61.229999999999997 111.563 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -52.9 -52.05 59.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.331 0.586 . . . . 73.409999999999997 111.2 176.412 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.464 HD13 HG21 ' A' ' 122' ' ' ILE . 72.8 mt -69.16 -42.8 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.829 -0.623 . . . . 72.109999999999999 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.586 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 17.7 mmt -62.66 -37.28 85.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.022 0.439 . . . . 71.299999999999997 111.328 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.87 -46.05 92.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.317 -0.401 . . . . 71.040000000000006 110.605 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -68.02 -36.82 80.6 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.399 -0.364 . . . . 64.120000000000005 111.523 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -54.07 -39.39 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.831 0.308 . . . . 74.25 111.831 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.36 -23.24 9.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 74.420000000000002 112.234 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.65 -44.41 11.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.12 0.486 . . . . 61.030000000000001 111.024 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -80.92 -2.27 46.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.139 0.792 . . . . 74.239999999999995 113.139 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -50.04 117.75 2.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.678 0.621 . . . . 73.439999999999998 112.678 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.41 -6.35 77.95 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 114.75 0.66 . . . . 72.340000000000003 114.75 172.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.0 t -59.72 130.21 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 117.827 0.814 . . . . 73.25 111.599 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.02 171.15 13.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.094 -0.503 . . . . 75.420000000000002 112.315 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 32.3 t80 -98.28 123.01 42.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.236 0.458 . . . . 72.010000000000005 112.236 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -138.17 133.08 32.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.653 0.381 . . . . 75.329999999999998 110.623 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 5.3 mp -84.0 121.25 27.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.058 0.392 . . . . 73.219999999999999 112.058 -175.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.43 -50.82 3.87 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.03 -0.605 . . . . 74.049999999999997 113.006 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.21 60.19 1.86 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.342 -0.456 . . . . 73.349999999999994 112.305 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.3 m -67.61 103.47 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.814 0.446 . . . . 64.140000000000001 111.919 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.6 t -158.74 172.87 17.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.128 0.49 . . . . 75.010000000000005 111.909 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.39 -1.1 14.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.616 0.599 . . . . 70.040000000000006 112.616 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -105.17 10.84 33.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 74.430000000000007 110.803 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.87 118.55 0.91 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.714 -0.554 . . . . 61.130000000000003 111.714 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.2 tt -147.6 147.5 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.775 0.788 . . . . 75.129999999999995 112.331 -175.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.547 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.2 p-10 -92.44 176.22 6.55 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.168 0.509 . . . . 73.129999999999995 112.37 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.433 ' SG ' ' N ' ' A' ' 69' ' ' SER . 26.1 p -59.02 -59.88 4.77 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.893 -0.594 . . . . 53.340000000000003 111.643 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.433 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 16.7 p -62.61 -37.3 85.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.267 -0.424 . . . . 70.450000000000003 111.362 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.65 -43.29 99.18 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.346 -0.454 . . . . 73.219999999999999 113.286 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -61.26 -52.69 63.66 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 122.57 -0.371 . . . . 62.549999999999997 111.774 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.531 ' HA ' HD11 ' A' ' 122' ' ' ILE . 4.9 p -61.42 -49.27 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 112.252 0.464 . . . . 73.420000000000002 112.252 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -60.8 -33.9 73.69 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.092 -0.38 . . . . 74.329999999999998 111.791 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.512 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 78.2 mtt-85 -72.0 -52.11 18.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.086 -0.384 . . . . 72.409999999999997 111.497 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -49.66 -40.69 40.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.99 0.424 . . . . 72.019999999999996 111.892 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 47.0 m-85 -73.47 -40.91 63.79 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.582 0.586 . . . . 75.310000000000002 112.582 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.512 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 12.1 ptp180 -70.43 -24.73 62.96 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.757 -0.589 . . . . 71.129999999999995 111.223 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 20.6 mm-40 -69.48 -62.07 1.53 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.266 0.555 . . . . 74.349999999999994 111.345 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 43' ' ' ARG . 85.9 mm-40 -88.26 -32.17 18.64 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.555 0.946 . . . . 75.439999999999998 113.555 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.25 -13.05 13.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 75.310000000000002 112.357 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.99 17.61 77.17 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.867 -0.682 . . . . 52.130000000000003 112.814 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.5 tp -83.63 115.06 21.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.919 0.39 . . . . 74.510000000000005 111.147 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.94 96.68 8.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.843 0.354 . . . . 51.229999999999997 111.377 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 97.2 mt -98.64 142.37 24.48 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.459 -0.337 . . . . 71.400000000000006 110.889 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.23 163.79 9.59 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.84 2.36 . . . . 72.430000000000007 113.31 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 3.5 mpt_? -78.81 -25.27 44.21 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.689 0.626 . . . . 75.430000000000007 112.689 -173.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.416 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 36.3 t -98.95 140.22 33.43 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.375 0.509 . . . . 72.230000000000004 112.375 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 92.8 m -55.05 -42.52 72.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.844 -0.616 . . . . 74.450000000000003 111.321 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.38 -44.75 95.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.97 -0.559 . . . . 74.439999999999998 111.33 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 40.2 mm-40 -64.44 -36.73 85.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.08 0.467 . . . . 71.140000000000001 110.649 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.92 -27.42 66.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.18 -0.464 . . . . 72.420000000000002 111.617 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.537 ' HA ' ' NE ' ' A' ' 156' ' ' ARG . 28.4 mt-30 -59.94 -49.58 77.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 71.120000000000005 110.838 175.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.93 -6.21 43.71 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.06 -0.518 . . . . 75.319999999999993 112.247 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mmm -110.72 21.46 16.51 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.875 0.369 . . . . 75.120000000000005 111.95 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.38 133.66 5.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.275 -0.488 . . . . 53.219999999999999 112.272 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 43.6 mmtm -88.43 140.92 28.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.162 0.506 . . . . 72.409999999999997 112.085 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 t -74.71 136.98 41.81 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.631 0.974 . . . . 73.430000000000007 113.631 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.25 139.6 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.521 -0.763 . . . . 74.310000000000002 110.656 172.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.1 t -92.72 -179.98 5.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.533 0.568 . . . . 73.120000000000005 112.533 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -41.23 -53.72 3.11 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.125 1.157 . . . . 75.510000000000005 114.125 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -82.72 -14.5 54.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.515 0.561 . . . . 74.430000000000007 112.515 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -99.07 6.85 46.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.543 0.571 . . . . 71.5 112.543 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.28 138.36 58.51 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.785 0.326 . . . . 73.430000000000007 111.542 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -145.5 134.21 22.26 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.579 -0.282 . . . . 75.430000000000007 111.118 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 41' ' ' LYS . 83.4 m -44.69 102.0 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.047 0.451 . . . . 74.140000000000001 111.792 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.09 -8.12 3.23 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.964 -0.562 . . . . 73.420000000000002 113.178 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 3.4 p30 -88.12 160.25 17.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.467 0.651 . . . . 72.200000000000003 111.603 176.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 mt -106.34 117.43 34.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 75.040000000000006 110.709 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 m -94.15 119.18 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.425 0.631 . . . . 74.530000000000001 111.553 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.457 HD12 ' HG2' ' A' ' 92' ' ' GLN . 95.6 mt -91.21 132.0 36.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.642 -0.708 . . . . 75.329999999999998 111.436 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -122.16 134.11 54.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.408 -0.36 . . . . 75.540000000000006 110.993 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 80.2 mtp180 -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.673 -0.491 . . . . 74.439999999999998 109.673 174.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.547 ' HB1' ' OG1' ' A' ' 116' ' ' THR . . . -92.2 143.05 26.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.074 0.464 . . . . 74.340000000000003 111.633 -175.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.49 -37.21 73.81 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.171 -0.468 . . . . 64.530000000000001 114.159 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -103.5 7.6 37.82 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.926 0.713 . . . . 74.549999999999997 112.926 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.547 ' OG1' ' HB1' ' A' ' 113' ' ' ALA . 43.5 p -132.7 -24.58 1.95 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.555 0.576 . . . . 72.239999999999995 112.555 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.62 -58.33 4.47 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.07 -0.586 . . . . 71.109999999999999 112.468 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -130.89 122.55 27.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.917 0.389 . . . . 71.299999999999997 111.383 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -127.52 160.46 31.45 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.322 -0.399 . . . . 75.349999999999994 110.107 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.83 141.18 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.148 0.499 . . . . 72.409999999999997 112.317 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.66 160.76 24.62 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.108 -0.497 . . . . 71.239999999999995 112.437 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.531 HD11 ' HA ' ' A' ' 72' ' ' VAL . 34.1 mt -94.62 112.27 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.464 -0.433 . . . . 74.439999999999998 111.084 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.12 113.65 4.1 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.762 0.315 . . . . 73.430000000000007 111.64 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.446 ' HA ' HG22 ' A' ' 105' ' ' THR . 31.2 pt -98.64 -20.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.201 0.445 . . . . 74.549999999999997 112.201 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.95 148.04 5.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.931 -0.652 . . . . 70.140000000000001 113.782 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.4 m120 58.47 40.02 24.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.277 0.473 . . . . 74.439999999999998 112.277 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 68.6 3.59 3.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.859 -0.61 . . . . 72.340000000000003 112.397 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.554 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 25.1 mt-30 -90.14 147.53 23.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.039 0.447 . . . . 72.510000000000005 110.759 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -155.35 151.76 28.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 72.209999999999994 111.979 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.34 135.91 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.071 -0.513 . . . . 75.140000000000001 110.448 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.91 173.33 16.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.034 0.445 . . . . 75.310000000000002 111.746 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -102.03 96.81 7.27 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.005 -0.543 . . . . 63.439999999999998 110.909 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.4 t -68.69 135.47 51.39 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.063 -0.517 . . . . 73.409999999999997 111.84 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.6 p -65.22 -20.66 66.54 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 75.129999999999995 111.56 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.9 m -97.07 -52.4 3.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.416 -0.356 . . . . 55.43 111.913 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.422 ' HB2' HD13 ' A' ' 139' ' ' ILE . 49.8 m -101.48 -16.45 16.81 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.073 0.768 . . . . 63.219999999999999 113.073 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.1 -154.27 24.3 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.853 -0.689 . . . . 72.430000000000007 112.884 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.37 104.39 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.019 0.438 . . . . 65.129999999999995 111.999 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.422 HD13 ' HB2' ' A' ' 136' ' ' SER . 41.6 pt -140.77 178.48 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.113 0.482 . . . . 65.010000000000005 111.704 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.7 mm -101.15 141.83 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.467 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -144.56 165.4 28.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.773 0.321 . . . . 75.530000000000001 110.541 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.554 ' OG ' ' HG2' ' A' ' 128' ' ' GLN . 15.8 m -138.48 142.88 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.975 0.361 . . . . 74.129999999999995 111.975 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.2 mtm -72.57 -3.09 22.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.369 0.604 . . . . 62.420000000000002 110.626 171.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.98 -16.29 61.08 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.864 -0.607 . . . . 75.349999999999994 110.089 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 19.5 mm-40 -85.76 135.01 38.45 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.784 -0.644 . . . . 75.409999999999997 110.317 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -48.92 -44.87 30.77 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.183 2.589 . . . . 75.230000000000004 114.303 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 50.5 t80 -64.56 -44.16 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.946 -0.471 . . . . 73.430000000000007 111.759 -177.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -77.47 -32.75 54.54 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.184 0.516 . . . . 72.239999999999995 111.392 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -56.2 -48.71 75.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.401 0.68 . . . . 72.040000000000006 112.232 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -84.36 -13.92 50.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.853 0.686 . . . . 71.120000000000005 112.853 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 17.2 mmm180 -100.3 -3.39 31.43 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.72 0.637 . . . . 75.400000000000006 112.72 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -54.11 123.03 11.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.094 0.405 . . . . 62.210000000000001 112.094 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.429 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 7.0 t30 -98.4 -66.61 0.89 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.382 -0.372 . . . . 73.109999999999999 111.248 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -164.48 144.71 7.76 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.603 0.24 . . . . 63.219999999999999 110.829 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -102.57 146.49 28.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.781 0.324 . . . . 62.329999999999998 111.357 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.537 ' NE ' ' HA ' ' A' ' 92' ' ' GLN . 11.8 mtm-85 -136.89 111.37 8.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.607 0.225 . . . . 75.340000000000003 111.607 -176.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -75.02 124.99 27.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.04 0.448 . . . . 75.540000000000006 111.143 176.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.23 -19.51 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.037 -0.529 . . . . 74.329999999999998 112.105 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.89 149.09 34.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.148 0.499 . . . . 74.409999999999997 111.718 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.8 m -87.39 104.79 16.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.087 -0.506 . . . . 65.430000000000007 112.126 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -93.78 1.26 56.52 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.065 0.46 . . . . 73.239999999999995 110.985 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.3 m -108.23 -168.37 1.36 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.005 -0.543 . . . . 71.099999999999994 110.738 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 164' ' ' GLU . 6.7 tt -62.39 137.23 58.22 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.63 0.252 . . . . 74.129999999999995 110.372 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.507 ' N ' HD23 ' A' ' 163' ' ' LEU . 42.2 mt-10 . . . . . 0 C--O 1.253 1.279 0 CA-C-O 119.145 -0.455 . . . . 71.209999999999994 112.048 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 36.8 t70 . . . . . 0 CA--C 1.535 0.381 0 CA-C-O 121.142 0.496 . . . . 63.439999999999998 111.961 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.2 t -58.71 -61.86 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.723 -0.671 . . . . 50.109999999999999 111.713 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.67 -40.36 79.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.828 0.347 . . . . 72.120000000000005 111.195 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 28.4 t -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.274 -0.421 . . . . 64.299999999999997 111.673 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -35.35 77.91 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.879 0.326 . . . . 74.040000000000006 111.879 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 40' ' ' VAL . 74.7 mt -62.4 -48.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.034 0.445 . . . . 53.409999999999997 111.017 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.7 mmt -67.22 -37.34 83.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.943 0.401 . . . . 63.329999999999998 110.85 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -56.97 -45.24 83.03 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.931 -0.577 . . . . 75.219999999999999 110.624 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.798 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 55.0 tp60 -66.66 -46.25 76.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.294 0.569 . . . . 51.439999999999998 111.271 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 18.3 t80 -56.41 -34.85 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.824 -0.625 . . . . 75.030000000000001 111.221 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.76 12.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.38 0.511 . . . . 73.420000000000002 112.38 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.89 -26.25 21.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.958 0.408 . . . . 62.299999999999997 111.557 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -111.36 12.3 21.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.999 0.74 . . . . 74.510000000000005 112.999 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 10.0 mtmp? -61.95 103.36 0.35 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.074 -0.391 . . . . 74.310000000000002 111.64 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.14 -0.89 26.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.807 -0.711 . . . . 54.119999999999997 114.231 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.03 138.44 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 117.484 0.642 . . . . 54.119999999999997 111.225 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.82 162.44 26.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.145 0.498 . . . . 74.219999999999999 112.229 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 51.7 t80 -84.05 118.41 24.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.053 -0.521 . . . . 74.319999999999993 112.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -137.99 123.61 19.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.661 -0.245 . . . . 62.439999999999998 111.309 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.53 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 97.0 mt -70.78 116.49 11.15 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.481 0.549 . . . . 74.109999999999999 112.481 -177.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.36 3.59 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.304 -0.474 . . . . 61.140000000000001 114.065 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.27 67.88 1.79 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.26 -0.495 . . . . 72.150000000000006 113.248 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -69.48 108.65 3.86 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.406 0.521 . . . . 75.230000000000004 112.406 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -166.61 175.38 8.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.123 -0.489 . . . . 73.010000000000005 110.793 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -67.68 -8.26 33.63 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.252 0.464 . . . . 71.200000000000003 112.252 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 64' ' ' LYS . 3.9 mppt? -97.08 7.94 45.57 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.018 0.437 . . . . 63.329999999999998 111.215 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.0 134.63 2.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.359 -0.382 . . . . 63.329999999999998 112.604 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.3 tt -154.53 144.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.427 -0.455 . . . . 70.209999999999994 110.59 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.53 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.5 p-10 -96.99 -174.51 2.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.302 0.572 . . . . 72.510000000000005 112.35 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.7 p -62.68 -50.72 70.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.939 -0.573 . . . . 62.240000000000002 111.488 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 72' ' ' VAL . 49.1 m -69.09 -35.85 76.94 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.367 -0.379 . . . . 64.430000000000007 111.318 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.04 -44.6 97.55 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.112 -0.565 . . . . 70.209999999999994 112.726 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -66.02 -50.75 63.14 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.54 -0.388 . . . . 71.439999999999998 111.702 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 69' ' ' SER . 11.9 p -61.43 -37.49 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.927 0.394 . . . . 74.019999999999996 110.844 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -54.47 -59.34 4.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.1 0.476 . . . . 73.019999999999996 110.693 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.549 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 9.4 mmm180 -52.24 -55.68 19.66 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.847 -0.615 . . . . 72.150000000000006 111.824 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.798 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 72.3 m -48.74 -56.25 9.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.401 0.519 . . . . 73.219999999999999 112.401 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 41.7 m-85 -74.94 -34.89 62.16 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.013 0.746 . . . . 74.25 113.013 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 ptm180 -66.42 -39.67 89.08 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.422 0.527 . . . . 74.409999999999997 112.422 -175.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 15.6 pt-20 -102.34 -23.39 13.97 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.075 0.769 . . . . 65.519999999999996 113.075 -174.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.468 ' HG3' ' HB2' ' A' ' 47' ' ' GLN . 84.4 mm-40 -87.31 -63.06 1.36 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.984 -0.448 . . . . 62.229999999999997 111.589 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.72 -18.16 30.1 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.004 0.372 . . . . 71.540000000000006 112.004 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 45.14 28.7 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.062 -0.59 . . . . 64.310000000000002 112.592 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 44.4 tp -105.99 136.9 44.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.901 0.381 . . . . 61.420000000000002 111.277 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.83 88.78 4.04 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.818 0.342 . . . . 74.319999999999993 111.645 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.42 138.16 19.46 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.94 0.348 . . . . 62.130000000000003 111.94 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HD2' ' OE1' ' A' ' 91' ' ' GLN . 73.4 Cg_endo -74.25 -161.54 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.412 2.741 . . . . 65.329999999999998 113.717 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -102.01 -31.99 10.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.479 1.289 . . . . 71.430000000000007 114.479 -172.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -114.17 148.72 36.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.879 0.696 . . . . 74.540000000000006 112.879 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.2 m -54.38 -42.73 70.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.832 -0.622 . . . . 70.109999999999999 112.478 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -57.37 -29.89 64.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 73.430000000000007 111.488 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.84 -43.67 17.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.075 0.464 . . . . 62.25 110.382 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.463 ' OE1' ' HD2' ' A' ' 85' ' ' PRO . 20.3 mm-40 -54.25 -47.09 72.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.857 -0.61 . . . . 74.329999999999998 112.046 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -61.7 -23.46 66.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.217 0.451 . . . . 63.520000000000003 112.217 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -92.11 2.11 56.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.971 -0.456 . . . . 74.209999999999994 111.972 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 94.3 mmm -85.63 -14.69 44.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.953 0.406 . . . . 60.130000000000003 111.111 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.42 152.54 23.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.154 -0.546 . . . . 52.119999999999997 113.174 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -83.01 150.82 26.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.923 0.392 . . . . 72.340000000000003 111.555 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 86.8 p -76.6 158.43 31.13 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.995 0.739 . . . . 72.340000000000003 112.995 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.404 HG13 ' NE ' ' A' ' 157' ' ' ARG . 1.5 m -145.41 174.06 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.682 -0.69 . . . . 52.350000000000001 111.779 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -111.53 179.67 3.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.783 -0.644 . . . . 75.109999999999999 111.489 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.534 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 32.6 mmt180 -50.09 -32.98 17.08 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.295 0.48 . . . . 72.299999999999997 112.295 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.9 p -77.1 -29.93 55.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.615 0.598 . . . . 73.530000000000001 112.615 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -109.52 20.42 18.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.483 0.549 . . . . 74.140000000000001 112.483 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.52 135.18 57.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.07 0.462 . . . . 60.219999999999999 111.098 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -108.81 148.6 30.31 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.185 -0.322 . . . . 75.510000000000005 111.438 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.427 ' O ' HG11 ' A' ' 40' ' ' VAL . 63.6 m -68.95 110.76 4.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.847 -0.533 . . . . 72.109999999999999 110.078 173.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.07 15.47 30.68 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.419 -0.419 . . . . 72.5 112.266 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.403 ' OD1' ' HB1' ' A' ' 155' ' ' ALA . 9.0 t70 -76.33 152.43 36.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.729 0.411 . . . . 71.400000000000006 110.71 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.4 mt -99.86 108.35 20.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.296 0.569 . . . . 71.329999999999998 111.344 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.16 123.98 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.328 0.585 . . . . 63.350000000000001 111.628 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.9 mt -90.93 135.37 33.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.625 -0.716 . . . . 61.140000000000001 111.945 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 91.0 m-85 -120.22 141.89 49.52 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.166 0.508 . . . . 73.120000000000005 111.962 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -72.48 96.58 1.94 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.709 -0.678 . . . . 75.409999999999997 110.856 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.744 0.307 . . . . 62.210000000000001 111.44 -179.509 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.7 mmt-85 . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 120.898 0.38 . . . . 73.420000000000002 111.537 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 44.5 t60 -102.21 151.5 22.14 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.398 -0.593 . . . . 51.409999999999997 109.398 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.51 137.67 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.258 0.466 . . . . 75.549999999999997 112.258 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 153.34 20.33 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 116.066 -0.516 . . . . 64.109999999999999 112.525 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 72' ' ' VAL . 48.1 mt -88.15 103.44 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.975 0.417 . . . . 55.450000000000003 111.132 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -64.09 116.39 5.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.08 -0.509 . . . . 74.349999999999994 111.654 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.7 pt -102.76 -28.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.639 0.607 . . . . 55.43 112.639 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.65 135.37 1.93 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 119.863 -1.161 . . . . 41.100000000000001 114.973 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 65.0 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.071 0.948 . . . . 51.439999999999998 111.403 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -141.34 -3.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.879 -0.601 . . . . 74.200000000000003 111.493 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -93.29 143.9 25.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.32 0.581 . . . . 74.510000000000005 111.574 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 18.0 p90 -152.61 145.81 24.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.47 -0.786 . . . . 62.5 111.008 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.34 133.83 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 64.049999999999997 110.903 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.49 178.64 8.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.107 0.479 . . . . 75.530000000000001 111.215 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -97.93 110.44 23.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.24 -0.437 . . . . 62.210000000000001 111.187 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 70.3 m -86.08 140.83 29.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.838 0.351 . . . . 71.129999999999995 111.165 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.4 p -47.43 -53.72 13.28 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.453 0.908 . . . . 65.409999999999997 113.453 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 p -90.29 -71.25 0.63 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.537 0.569 . . . . 64.209999999999994 112.537 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 54.2 m -58.71 -26.72 64.17 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.916 0.71 . . . . 54.140000000000001 112.916 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.54 -160.15 18.27 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.895 -0.669 . . . . 45.219999999999999 113.219 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 19.3 t -66.98 109.07 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.03 0.443 . . . . 62.439999999999998 111.909 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.9 pt -138.37 179.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.999 0.428 . . . . 52.149999999999999 111.754 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.22 110.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 110.599 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.451 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . 55.7 m -101.86 172.84 6.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.904 0.383 . . . . 44.030000000000001 111.738 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 138.99 49.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.13 0.49 . . . . 62.420000000000002 111.908 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.534 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 65.0 mtt -69.69 -8.17 45.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.389 -0.369 . . . . 71.230000000000004 111.899 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -77.01 -19.43 57.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.978 0.418 . . . . 55.450000000000003 110.612 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.25 124.48 90.88 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.287 -0.415 . . . . 64.540000000000006 110.267 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -48.69 -38.5 37.04 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.352 2.701 . . . . 65.049999999999997 114.028 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.443 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 52.3 t80 -63.18 -45.92 89.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.924 0.392 . . . . 53.43 111.394 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.535 ' HA ' ' HB2' ' A' ' 151' ' ' ARG . 83.8 m95 -80.79 -28.46 36.33 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.055 0.455 . . . . 72.200000000000003 111.392 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.9 -41.82 98.35 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.967 -0.561 . . . . 71.400000000000006 111.58 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -83.82 -21.38 32.11 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.096 0.474 . . . . 63.420000000000002 111.361 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 148' ' ' TRP . 0.8 OUTLIER -72.16 -39.09 68.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.341 -0.39 . . . . 62.32 111.612 177.402 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.98 104.45 0.14 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.16 0.505 . . . . 63.399999999999999 112.18 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.19 -52.02 5.45 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.925 -0.58 . . . . 74.430000000000007 110.873 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -167.08 171.47 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.251 -0.432 . . . . 74.230000000000004 111.284 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -121.15 154.74 35.81 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.642 -0.254 . . . . 72.120000000000005 110.872 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 79.3 mtt180 -147.93 119.18 7.79 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.076 0.465 . . . . 73.349999999999994 111.742 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.467 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -86.66 109.29 19.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.042 0.448 . . . . 75.5 111.877 -177.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.09 -13.98 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.869 0.366 . . . . 73.430000000000007 111.736 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.469 0.52 0 CA-C-N 116.443 -0.344 . . . . 73.319999999999993 111.205 177.448 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--O 1.235 0.338 0 CA-C-O 121.071 0.462 . . . . 73.200000000000003 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 44' ' ' ILE . 64.8 t -55.54 -51.88 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.109 -0.496 . . . . 75.099999999999994 110.823 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.7 tttt -57.22 -42.26 81.03 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.866 -0.606 . . . . 74.310000000000002 111.757 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.1 t -58.38 -45.44 88.31 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.886 0.374 . . . . 51.109999999999999 111.891 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.423 ' HD3' ' OE1' ' A' ' 79' ' ' GLN . 3.2 mmp_? -66.05 -44.26 85.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 73.439999999999998 111.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.2 mt -57.97 -41.36 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.038 0.447 . . . . 73.209999999999994 111.13 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 30.7 mmt -67.08 -31.51 72.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 70.540000000000006 111.58 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.77 -41.75 96.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.87 0.367 . . . . 73.120000000000005 110.916 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HG2' HE21 ' A' ' 79' ' ' GLN . 71.2 mm-40 -68.37 -55.19 12.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.436 -0.347 . . . . 72.0 111.096 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.481 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 28.9 t80 -48.25 -47.06 36.22 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.235 0.457 . . . . 75.329999999999998 112.235 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.62 -32.39 63.09 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.241 0.543 . . . . 71.319999999999993 111.715 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.88 -29.97 35.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.063 -0.517 . . . . 51.350000000000001 111.018 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.46 ' HZ2' HH11 ' A' ' 74' ' ' ARG . 73.9 m95 -96.52 3.17 52.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.103 0.779 . . . . 71.510000000000005 113.103 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 30.7 mtpp -61.45 122.89 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.991 -0.443 . . . . 74.409999999999997 110.797 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.93 -8.3 55.83 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.301 -0.476 . . . . 65.329999999999998 113.299 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -77.07 123.46 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.231 -0.57 . . . . 73.140000000000001 111.519 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -74.75 159.79 31.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 72.030000000000001 112.009 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -79.52 130.12 35.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 110.949 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 57' ' ' ARG . 38.9 ttt180 -136.88 115.15 11.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.915 0.388 . . . . 75.329999999999998 112.023 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.86 123.87 24.26 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.046 0.45 . . . . 74.120000000000005 112.04 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.51 7.41 84.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.281 -0.418 . . . . 63.43 114.083 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.34 143.68 15.17 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.975 -0.631 . . . . 71.120000000000005 113.295 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.518 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 t -125.37 100.58 6.56 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.059 0.457 . . . . 72.340000000000003 111.171 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.1 t -170.81 167.95 7.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.274 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -73.96 -13.09 60.83 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.279 0.561 . . . . 51.450000000000003 111.212 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -76.26 -15.63 59.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.245 0.545 . . . . 75.040000000000006 110.55 173.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.33 135.86 1.91 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.847 -0.615 . . . . 40.32 112.024 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.518 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -151.63 154.11 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.985 0.393 . . . . 74.519999999999996 111.343 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -91.7 176.32 6.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.318 0.58 . . . . 75.420000000000002 111.953 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.8 t -59.11 -51.98 67.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.469 0.544 . . . . 71.25 112.469 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.6 t -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.279 0.561 . . . . 73.129999999999995 111.16 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 74' ' ' ARG . . . -64.24 -41.58 98.23 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.859 -0.61 . . . . 72.450000000000003 113.002 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.5 -51.01 70.41 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.445 -0.444 . . . . 61.310000000000002 111.795 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 11.9 p -62.2 -45.3 99.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.66 -0.245 . . . . 54.340000000000003 111.615 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 18.6 pt20 -61.24 -40.02 92.48 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.048 -0.407 . . . . 63.32 111.804 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 10.4 mtp-105 -67.85 -45.04 75.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.817 0.342 . . . . 74.329999999999998 111.327 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.7 m -51.98 -46.76 64.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.012 0.434 . . . . 54.100000000000001 111.778 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.0 m-85 -73.78 -42.17 61.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.018 0.747 . . . . 64.299999999999997 113.018 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 13.3 ptm180 -66.45 -34.27 77.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.048 -0.408 . . . . 73.230000000000004 112.065 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -81.16 -39.31 25.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.156 0.428 . . . . 75.349999999999994 112.156 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.442 HE21 ' HG2' ' A' ' 47' ' ' GLN . 77.6 mm-40 -86.96 -63.21 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.449 0.537 . . . . 42.530000000000001 112.449 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -90.57 -7.41 52.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.024 0.379 . . . . 74.010000000000005 112.024 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.07 10.15 84.08 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.135 -0.555 . . . . 65.209999999999994 112.519 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 39.0 tp -83.5 112.48 20.01 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.126 0.489 . . . . 73.349999999999994 110.737 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -86.0 92.36 8.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 71.200000000000003 111.456 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 93.3 mt -81.11 145.91 57.53 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.788 0.328 . . . . 73.099999999999994 111.159 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.56 -173.17 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.648 2.232 . . . . 73.439999999999998 113.7 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -94.98 -34.39 12.38 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.494 0.553 . . . . 75.439999999999998 112.494 -170.406 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.477 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 66.3 m -96.01 136.5 36.37 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.259 -0.276 . . . . 70.140000000000001 111.09 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 87.5 m -56.58 -39.51 73.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.844 0.313 . . . . 65.540000000000006 111.844 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -55.45 -45.88 76.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.909 0.385 . . . . 73.230000000000004 111.212 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 49.6 mt-10 -59.63 -38.48 81.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.008 0.432 . . . . 73.409999999999997 110.604 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -67.81 -35.59 78.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.251 -0.431 . . . . 61.219999999999999 111.185 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.4 mt-30 -62.14 -37.58 85.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.378 0.609 . . . . 52.0 110.612 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.98 12.83 10.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.603 -0.726 . . . . 72.200000000000003 112.557 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 90.4 mmm -84.9 -62.6 1.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.893 0.331 . . . . 52.509999999999998 111.893 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.29 -174.57 21.19 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.254 -0.498 . . . . 62.130000000000003 113.942 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.98 159.69 21.18 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.069 0.462 . . . . 74.400000000000006 111.837 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 61.7 p -91.37 150.59 21.21 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.379 0.609 . . . . 74.540000000000006 112.342 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.78 169.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.698 -0.683 . . . . 74.519999999999996 111.416 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -117.16 -179.68 3.78 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.19 -0.459 . . . . 72.319999999999993 111.468 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -47.1 -58.42 4.05 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.919 1.081 . . . . 72.510000000000005 113.919 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.6 m -73.47 -4.73 35.55 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.225 0.454 . . . . 65.340000000000003 112.225 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -99.06 -11.72 21.21 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.891 0.377 . . . . 74.099999999999994 111.28 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.3 114.28 6.63 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.511 0.56 . . . . 70.519999999999996 112.511 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -112.17 -160.91 0.73 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 110.843 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.0 m -82.41 114.84 21.13 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.183 -0.323 . . . . 72.430000000000007 110.984 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.02 -18.69 10.37 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.066 -0.588 . . . . 71.049999999999997 113.098 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.95 130.79 44.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.068 0.461 . . . . 74.109999999999999 111.529 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.55 114.25 24.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.376 -0.375 . . . . 72.540000000000006 110.672 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.27 124.8 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.492 0.663 . . . . 70.219999999999999 111.604 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.8 mt -97.64 126.35 42.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.5 -0.773 . . . . 72.319999999999993 111.776 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -117.41 160.84 20.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.037 0.446 . . . . 71.140000000000001 111.293 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.45 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 63.0 mtt85 -91.83 122.2 34.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.14 0.495 . . . . 73.0 111.279 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.415 0 CA-C-N 116.113 -0.494 . . . . 73.409999999999997 111.142 -179.878 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.944 0.402 . . . . 70.519999999999996 111.192 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.55 148.81 50.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.187 -0.46 . . . . 63.509999999999998 109.9 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.466 HG12 ' SG ' ' A' ' 68' ' ' CYS . 9.2 p -135.76 138.93 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.335 0.588 . . . . 73.010000000000005 112.334 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -129.05 144.84 15.74 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.869 -0.605 . . . . 72.150000000000006 112.608 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.8 mt -90.23 107.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.634 -0.333 . . . . 73.310000000000002 111.491 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER -64.35 117.6 7.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.597 0.359 . . . . 71.519999999999996 111.422 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.3 pt -102.13 -32.88 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.362 0.504 . . . . 74.140000000000001 112.362 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.35 133.38 2.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.092 -1.051 . . . . 63.030000000000001 114.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 60.45 -80.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.593 0.757 . . . . 62.149999999999999 112.366 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.45 ' HA ' ' OH ' ' A' ' 123' ' ' TYR . 82.4 m-20 -141.57 1.63 1.56 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.177 0.436 . . . . 71.040000000000006 112.177 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -102.38 146.21 28.39 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.365 0.602 . . . . 62.299999999999997 112.051 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.7 p90 -150.73 148.98 29.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.377 -0.829 . . . . 72.230000000000004 111.657 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.87 138.34 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.916 0.389 . . . . 71.040000000000006 111.152 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -163.78 161.65 23.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.995 0.426 . . . . 63.509999999999998 111.847 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -91.2 96.7 10.71 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.207 0.527 . . . . 74.400000000000006 110.641 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.1 p -77.77 150.85 34.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.897 -0.592 . . . . 71.420000000000002 112.569 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.9 p -81.19 8.97 7.59 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.991 -0.55 . . . . 74.230000000000004 111.561 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 t -109.7 -46.55 3.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.855 0.317 . . . . 43.100000000000001 111.855 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.5 t -124.85 -30.16 3.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.385 0.513 . . . . 63.210000000000001 112.385 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.87 -147.65 18.42 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.278 -0.487 . . . . 72.209999999999994 112.005 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.21 101.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 117.141 0.471 . . . . 64.219999999999999 111.626 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.6 pt -136.96 176.6 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 61.310000000000002 112.173 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.12 120.97 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.004 -0.544 . . . . 55.140000000000001 110.846 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.8 p -122.62 178.27 5.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.937 0.399 . . . . 65.310000000000002 111.287 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 t -127.99 153.67 46.47 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.107 0.41 . . . . 65.510000000000005 112.107 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 25.0 mmt -60.07 -20.42 57.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.228 -0.442 . . . . 54.310000000000002 111.348 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.14 -24.3 66.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.287 -0.415 . . . . 65.099999999999994 111.636 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.509 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 29.0 mm-40 -71.47 133.68 84.88 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 120.833 0.349 . . . . 73.530000000000001 111.663 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.47 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 93.3 Cg_exo -45.15 -52.85 5.96 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.592 2.861 . . . . 72.049999999999997 115.11 -173.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.1 t80 -61.38 -43.6 98.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.824 0.345 . . . . 75.25 111.777 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.509 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 73.9 m95 -76.13 -38.77 56.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.043 0.449 . . . . 72.25 111.041 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.88 -45.66 71.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.828 -0.624 . . . . 42.509999999999998 112.064 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.5 ptpt -98.38 6.1 47.58 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.798 0.666 . . . . 73.439999999999998 112.798 -175.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 2.5 mpt_? -116.66 7.57 13.59 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 122.193 -0.317 . . . . 70.510000000000005 111.658 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -60.54 104.27 0.32 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.032 0.444 . . . . 71.409999999999997 111.162 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.463 HD22 ' HG2' ' A' ' 154' ' ' GLU . 8.5 t30 -82.15 -49.01 10.63 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.316 -0.402 . . . . 73.030000000000001 111.072 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.463 ' HG2' HD22 ' A' ' 153' ' ' ASN . 11.1 pt-20 177.3 -166.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.124 0.57 . . . . 60.530000000000001 109.875 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -146.69 146.66 30.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.38 0.511 . . . . 51.399999999999999 112.38 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt180 -137.04 126.35 24.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.365 0.666 . . . . 73.299999999999997 110.318 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.404 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -107.37 111.92 24.48 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.439 -0.788 . . . . 74.140000000000001 110.605 175.416 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.3 m -89.46 -16.74 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.252 -0.885 . . . . 62.130000000000003 112.692 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.428 HD23 HD22 ' A' ' 82' ' ' LEU . 90.6 mt . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.226 0.536 . . . . 70.109999999999999 111.866 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 15.0 t70 . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 120.602 0.239 . . . . 72.150000000000006 110.672 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.73 -57.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.347 0.499 . . . . 73.340000000000003 112.347 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.24 -44.15 95.47 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.666 0.27 . . . . 75.230000000000004 111.651 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 40.3 t -55.13 -47.85 74.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.886 0.374 . . . . 62.149999999999999 111.903 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 39' ' ' ASP . 11.0 mmm180 -59.9 -47.67 84.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.076 0.465 . . . . 65.0 111.289 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 122' ' ' ILE . 72.5 mt -61.67 -44.85 99.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.167 -0.469 . . . . 55.539999999999999 111.571 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 18.7 mmt -64.15 -29.08 70.22 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.917 0.389 . . . . 71.25 111.403 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.72 -47.76 82.2 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.223 0.535 . . . . 61.409999999999997 110.53 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 50' ' ' ASP . 25.6 tp60 -66.13 -35.12 79.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 60.210000000000001 111.374 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -54.15 -37.22 64.17 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.463 -0.335 . . . . 73.430000000000007 111.542 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.71 -20.6 57.44 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.336 0.495 . . . . 64.450000000000003 112.336 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.558 ' HB3' HE21 ' A' ' 47' ' ' GLN . 34.9 t70 -90.92 -21.15 21.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.973 0.509 . . . . 70.530000000000001 111.521 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -122.81 30.51 6.4 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.161 -0.472 . . . . 73.239999999999995 111.949 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -57.82 -1.45 0.11 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.273 1.582 . . . . 72.239999999999995 115.273 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.54 49.14 0.11 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.246 -0.978 . . . . 72.219999999999999 113.64 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -92.19 137.24 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.784 0.326 . . . . 74.530000000000001 111.004 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -74.34 158.38 34.08 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.021 0.748 . . . . 75.120000000000005 113.021 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -73.09 119.09 16.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.914 -0.585 . . . . 54.420000000000002 111.513 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -137.66 119.14 14.83 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.989 0.423 . . . . 72.310000000000002 111.783 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.11 118.8 10.38 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.248 0.462 . . . . 75.239999999999995 112.248 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.58 -54.33 4.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.187 -0.53 . . . . 62.119999999999997 113.657 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.84 98.47 0.55 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.094 -0.574 . . . . 60.340000000000003 112.246 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.4 p -97.22 119.41 35.68 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 71.530000000000001 111.625 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -176.52 176.97 1.5 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.043 0.537 . . . . 73.299999999999997 110.978 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -16.45 63.7 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.973 -0.454 . . . . 71.239999999999995 110.943 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -85.72 2.75 44.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.295 -0.411 . . . . 61.310000000000002 110.987 175.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.12 142.75 3.62 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.468 -0.396 . . . . 44.210000000000001 112.746 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.1 tt -165.49 138.28 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.941 0.37 . . . . 73.109999999999999 111.105 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.11 171.47 8.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.798 -0.564 . . . . 74.239999999999995 111.319 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 21.0 p -54.52 -39.72 67.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.695 0.628 . . . . 70.519999999999996 112.695 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.432 ' HB2' ' OG1' ' A' ' 88' ' ' THR . 23.9 t -67.47 -47.01 71.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.803 0.335 . . . . 51.119999999999997 111.417 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.5 -36.22 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.01 -0.614 . . . . 73.140000000000001 112.898 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.87 -56.09 20.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.785 0.326 . . . . 74.439999999999998 111.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.408 HG21 HD22 ' A' ' 108' ' ' LEU . 12.9 p -61.32 -38.15 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.757 0.313 . . . . 74.239999999999995 111.536 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 36.5 tt0 -54.0 -58.11 8.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.286 0.565 . . . . 74.219999999999999 111.28 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -60.2 -51.85 67.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.948 -0.569 . . . . 72.409999999999997 111.913 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 78.1 m -48.37 -53.63 16.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.389 0.514 . . . . 60.310000000000002 112.389 -176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 45.9 m-85 -68.52 -37.95 80.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.787 0.662 . . . . 73.010000000000005 112.787 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.5 -21.26 45.54 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.889 -0.507 . . . . 72.150000000000006 112.174 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -86.45 -55.09 4.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.925 0.393 . . . . 71.030000000000001 111.492 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.409 ' CD ' ' HB2' ' A' ' 47' ' ' GLN . 1.9 mp0 -67.97 -51.38 48.1 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.336 0.495 . . . . 73.209999999999994 112.336 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -100.52 -36.89 9.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.023 0.44 . . . . 74.420000000000002 112.113 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.55 6.21 41.42 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.714 -0.554 . . . . 44.039999999999999 111.714 -172.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.503 HD22 HD23 ' A' ' 159' ' ' LEU . 29.0 tp -79.4 110.75 14.99 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.081 0.467 . . . . 73.409999999999997 110.669 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -84.3 112.08 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 75.5 111.943 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 84.3 mt -100.92 154.93 36.86 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.915 -0.584 . . . . 75.549999999999997 111.312 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.01 -179.02 1.2 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.45 2.1 . . . . 65.349999999999994 113.592 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -39.86 14.9 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.567 0.58 . . . . 71.209999999999994 112.567 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.7 m -110.59 141.87 43.19 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.143 0.423 . . . . 74.010000000000005 112.143 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.522 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 48.7 m -49.3 -39.06 29.66 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.311 -0.404 . . . . 75.319999999999993 111.8 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -52.98 -47.08 68.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.234 -0.439 . . . . 71.109999999999999 110.989 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -65.22 -36.74 85.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.406 0.622 . . . . 72.219999999999999 110.697 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.96 -28.47 68.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.777 -0.647 . . . . 50.409999999999997 111.49 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 88' ' ' THR . 95.8 mt-30 -68.79 -6.58 27.52 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.007 0.373 . . . . 71.430000000000007 112.007 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -98.06 -10.28 24.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.825 0.676 . . . . 70.129999999999995 112.825 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.45 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 25.7 ptm -124.62 162.39 24.2 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.399 0.518 . . . . 54.399999999999999 112.399 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 160.51 36.48 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.319 -0.467 . . . . 74.109999999999999 114.247 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 68.3 mmtt -84.48 125.66 32.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.135 0.493 . . . . 75.430000000000007 111.638 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 64.6 p -81.21 111.98 18.12 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.648 -0.706 . . . . 75.340000000000003 112.841 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.427 HG23 ' HB3' ' A' ' 155' ' ' ALA . 2.8 m -106.2 157.58 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.808 -0.633 . . . . 73.439999999999998 111.964 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.448 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 84.0 p -99.59 -179.8 4.31 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.994 -0.548 . . . . 62.100000000000001 111.823 -177.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -53.23 -41.45 65.42 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.988 0.366 . . . . 71.209999999999994 111.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -77.28 -24.76 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 111.985 0.365 . . . . 72.430000000000007 111.985 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.62 -8.1 57.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.194 0.442 . . . . 72.319999999999993 112.194 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 99' ' ' SER . 85.3 mt -63.2 133.25 53.99 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.509 0.559 . . . . 74.019999999999996 112.509 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.411 ' O ' ' HD1' ' A' ' 123' ' ' TYR . 51.8 mtt180 -137.49 -122.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.466 -0.334 . . . . 74.420000000000002 110.352 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -106.12 127.04 52.92 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.692 -0.63 . . . . 53.530000000000001 112.134 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.16 13.31 36.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.298 -0.477 . . . . 75.439999999999998 114.178 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' A' ' 123' ' ' TYR . 1.6 m-20 -81.44 120.09 24.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 122.571 -0.37 . . . . 62.399999999999999 111.5 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.408 HD22 HG21 ' A' ' 72' ' ' VAL . 27.7 mt -76.62 104.04 6.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.972 0.415 . . . . 75.129999999999995 110.195 173.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 155' ' ' ALA . 27.5 m -95.53 118.8 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.512 0.672 . . . . 72.310000000000002 111.995 -173.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.484 HD13 ' HG2' ' A' ' 92' ' ' GLN . 74.7 mt -93.93 117.6 30.32 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.46 -0.791 . . . . 72.219999999999999 112.312 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 77.8 m-85 -107.91 133.36 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 73.230000000000004 110.331 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.628 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 78.4 mtt-85 -82.6 110.44 17.68 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.637 -0.505 . . . . 72.140000000000001 109.637 174.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.93 0.395 . . . . 70.340000000000003 111.664 -173.395 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 118' ' ' ARG . 3.5 ppt_? . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 112.533 0.568 . . . . 73.349999999999994 112.533 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 68.4 t60 -165.67 149.69 8.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.732 -0.667 . . . . 64.310000000000002 109.471 170.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 7.8 p -142.38 137.18 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.288 0.566 . . . . 62.549999999999997 111.969 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 109' ' ' VAL . . . -130.06 154.35 20.5 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.046 -0.597 . . . . 73.400000000000006 112.845 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 44' ' ' ILE . 47.4 mt -92.3 100.33 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 73.319999999999993 110.572 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 37.4 t80 -71.15 117.68 12.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.141 -0.481 . . . . 71.450000000000003 111.15 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.9 pt -99.08 -30.24 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.16 0.43 . . . . 73.510000000000005 112.16 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.27 163.31 9.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.159 -0.543 . . . . 61.210000000000001 113.202 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 56.76 39.86 29.41 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.674 0.39 . . . . 72.239999999999995 111.909 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.637 ' N ' HD22 ' A' ' 127' ' ' ASN . 0.7 OUTLIER 67.92 4.69 4.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.808 0.443 . . . . 75.400000000000006 111.846 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 141' ' ' SER . 99.1 mt-30 -97.4 140.48 31.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.385 0.612 . . . . 73.450000000000003 112.158 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.456 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.5 p90 -146.54 137.58 24.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.739 . . . . 70.109999999999999 111.215 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.08 126.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.058 0.456 . . . . 70.540000000000006 110.765 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -155.32 150.14 26.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.925 0.393 . . . . 75.040000000000006 111.813 -174.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.81 91.42 4.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.176 0.512 . . . . 74.519999999999996 110.183 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.4 p -78.23 143.94 36.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.815 -0.629 . . . . 74.239999999999995 112.234 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.4 t -77.27 -4.97 47.59 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.383 0.611 . . . . 61.240000000000002 111.369 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -87.94 -35.68 17.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.067 -0.515 . . . . 72.420000000000002 111.729 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 m -138.42 -51.78 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.235 0.54 . . . . 62.039999999999999 111.808 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.86 -153.22 24.52 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.642 -0.708 . . . . 52.140000000000001 111.708 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.23 96.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 117.411 0.605 . . . . 72.409999999999997 111.114 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.28 168.47 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.302 -0.408 . . . . 74.329999999999998 111.744 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.12 109.41 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.25 -0.432 . . . . 73.420000000000002 110.666 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 128' ' ' GLN . 48.5 m -107.21 173.81 6.16 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.065 0.395 . . . . 73.099999999999994 112.065 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 29.1 t -119.95 141.16 49.89 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.688 0.625 . . . . 75.299999999999997 112.688 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.5 mtt -76.62 -0.55 23.79 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.859 0.689 . . . . 74.439999999999998 112.859 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -84.95 -10.94 56.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.065 0.459 . . . . 62.210000000000001 110.829 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -76.47 132.91 71.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 110.799 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.11 -49.4 14.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.224 2.616 . . . . 64.329999999999998 114.554 -172.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.567 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 91.9 t80 -61.55 -48.05 82.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.941 0.4 . . . . 61.530000000000001 111.194 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -72.83 -34.94 67.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.782 0.325 . . . . 74.219999999999999 111.665 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.69 -47.58 84.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.898 0.38 . . . . 72.200000000000003 111.319 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -73.24 -32.14 64.54 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.979 0.363 . . . . 75.140000000000001 111.979 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.628 ' HD3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mmp_? -76.82 -23.41 52.77 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.008 -0.433 . . . . 73.319999999999993 111.443 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -61.18 108.27 0.88 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.051 0.453 . . . . 73.310000000000002 111.841 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -91.35 -69.1 0.75 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.305 0.574 . . . . 75.230000000000004 111.171 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG3' HD12 ' A' ' 110' ' ' LEU . 10.9 pt-20 -148.49 153.14 38.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.977 -0.556 . . . . 71.310000000000002 110.782 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -115.48 149.83 37.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.75 -0.204 . . . . 51.140000000000001 110.539 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mtt180 -137.6 122.99 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.365 0.603 . . . . 54.539999999999999 112.437 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 157' ' ' ARG . 2.9 mtp180 -87.91 108.64 19.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.798 -0.637 . . . . 64.109999999999999 110.67 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.0 m -99.31 0.76 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.686 -0.688 . . . . 72.530000000000001 112.546 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.503 HD23 HD22 ' A' ' 82' ' ' LEU . 80.0 mt . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 121.106 0.479 . . . . 75.430000000000007 112.21 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 120.516 0.198 . . . . 72.420000000000002 111.523 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 44' ' ' ILE . 94.1 t -48.74 -41.35 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.486 0.66 . . . . 55.020000000000003 110.322 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 45' ' ' MET . 88.2 tttt -56.48 -45.36 80.97 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.257 -0.883 . . . . 74.120000000000005 112.132 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.9 p -65.02 -37.78 88.73 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 122.228 -0.295 . . . . 72.219999999999999 111.536 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -70.9 -38.03 73.01 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 75.349999999999994 111.175 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 40' ' ' VAL . 86.2 mt -62.52 -46.08 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.127 0.489 . . . . 63.310000000000002 110.805 174.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 95.8 mmm -67.7 -29.74 69.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.347 -0.388 . . . . 54.310000000000002 111.282 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.46 -44.81 89.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.052 0.453 . . . . 64.049999999999997 110.196 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -65.3 -46.93 78.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.528 -0.76 . . . . 73.420000000000002 111.229 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -53.63 -39.22 64.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 112.136 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.22 68.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.861 0.362 . . . . 53.329999999999998 111.849 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -79.21 -33.79 43.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.248 0.547 . . . . 73.120000000000005 111.081 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.516 ' HZ2' ' NH1' ' A' ' 74' ' ' ARG . 84.9 m95 -99.13 22.75 9.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.438 0.533 . . . . 73.040000000000006 112.438 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.07 120.3 11.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.064 0.459 . . . . 73.239999999999995 112.032 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.03 20.43 75.85 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 114.472 0.549 . . . . 61.310000000000002 114.472 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.3 t -83.6 131.2 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 117.595 0.698 . . . . 74.450000000000003 111.003 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.31 163.46 26.44 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.298 0.571 . . . . 51.240000000000002 112.509 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 134' ' ' THR . 49.9 t80 -89.52 141.59 28.44 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.514 0.673 . . . . 75.329999999999998 112.437 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.624 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 57.2 ttt180 -129.58 131.28 46.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.573 -0.739 . . . . 73.430000000000007 110.462 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.7 mp -76.22 93.54 3.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.969 0.414 . . . . 60.43 111.374 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 71.71 1.29 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.28 -0.486 . . . . 71.349999999999994 113.285 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' ' 57' ' ' ARG . . . 172.92 139.83 2.97 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.893 -0.67 . . . . 25.23 113.186 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.577 ' HB2' ' HD2' ' A' ' 74' ' ' ARG . 84.7 p -110.65 101.17 9.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.601 0.593 . . . . 70.209999999999994 112.601 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -153.22 151.78 30.46 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.12 -0.491 . . . . 73.329999999999998 111.137 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.46 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 32.3 ttmt -70.34 -5.56 28.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.05 0.453 . . . . 72.319999999999993 111.827 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -106.29 15.22 26.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.975 0.417 . . . . 74.200000000000003 111.265 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.75 108.11 0.27 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 112.164 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.493 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -138.48 151.76 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 117.342 0.571 . . . . 71.310000000000002 111.894 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.624 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 6.2 p-10 -95.11 -179.13 4.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.185 0.517 . . . . 71.010000000000005 112.238 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.29 -55.76 22.05 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.003 -0.544 . . . . 45.109999999999999 111.954 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 81.5 p -66.21 -29.17 69.38 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.826 0.346 . . . . 62.530000000000001 110.864 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 74' ' ' ARG . . . -66.1 -44.63 90.9 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.094 -0.503 . . . . 72.099999999999994 112.801 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.07 -51.83 66.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.0 0.428 . . . . 75.409999999999997 111.268 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.45 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.0 p -62.47 -44.46 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 112.173 0.434 . . . . 42.140000000000001 112.173 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.542 ' HG3' ' N ' ' A' ' 74' ' ' ARG . 2.3 pt20 -59.57 -49.98 75.67 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.94 -0.475 . . . . 71.219999999999999 111.443 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.577 ' HD2' ' HB2' ' A' ' 61' ' ' SER . 10.0 mtp-105 -60.13 -41.61 93.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.991 0.424 . . . . 74.319999999999993 111.135 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.4 m -54.53 -52.23 62.68 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.103 -0.499 . . . . 74.129999999999995 111.489 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.6 m-85 -72.27 -37.83 68.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.502 0.556 . . . . 75.239999999999995 112.502 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.493 ' HG3' ' HA ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.77 -20.02 58.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.473 0.546 . . . . 64.329999999999998 112.473 -177.13 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -97.1 -49.93 4.8 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.166 -0.334 . . . . 73.019999999999996 111.509 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -71.55 -44.93 63.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.112 0.412 . . . . 63.329999999999998 112.112 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.11 -12.75 14.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.677 0.621 . . . . 72.200000000000003 112.677 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 32.32 62.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.127 -0.559 . . . . 53.130000000000003 113.33 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 57.9 tp -92.81 127.21 38.24 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.617 -0.343 . . . . 72.420000000000002 111.596 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.23 79.97 2.35 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.906 0.706 . . . . 73.510000000000005 112.906 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.439 HD21 HG21 ' A' ' 158' ' ' VAL . 64.3 mt -95.82 142.56 24.75 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 121.913 -0.492 . . . . 70.540000000000006 111.777 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.679 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 87.9 Cg_endo -82.1 -174.07 1.98 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.174 2.583 . . . . 63.130000000000003 113.391 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.571 ' HD2' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -105.6 20.64 18.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.44 0.904 . . . . 75.450000000000003 113.44 -169.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.1 m -141.29 132.65 26.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.938 0.399 . . . . 73.030000000000001 111.535 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 34.8 m -51.74 -43.87 63.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.239 -0.437 . . . . 41.240000000000002 111.929 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -58.43 -17.04 17.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.43 0.53 . . . . 63.049999999999997 112.43 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 94' ' ' MET . 35.5 mt-10 -92.35 -53.22 4.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.102 0.477 . . . . 70.120000000000005 110.484 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.641 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 80.6 mt-30 -54.6 -45.97 73.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.964 -0.562 . . . . 64.319999999999993 112.341 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 88' ' ' THR . 18.4 pt20 -53.59 -33.91 56.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.49 0.552 . . . . 61.520000000000003 112.49 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.38 10.9 29.49 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.047 0.758 . . . . 60.200000000000003 113.047 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.679 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 77.6 mtp -79.38 -29.95 42.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.043 0.449 . . . . 75.329999999999998 111.018 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.74 -133.27 6.84 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.37 -0.443 . . . . 74.400000000000006 112.674 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -127.19 174.03 9.25 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.549 -0.383 . . . . 65.319999999999993 111.547 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.6 p -106.81 161.53 14.6 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 112.221 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.413 HG23 ' CB ' ' A' ' 155' ' ' ALA . 0.0 OUTLIER -148.2 160.13 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.604 -0.725 . . . . 73.310000000000002 111.662 177.027 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 t -95.92 173.22 7.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.976 -0.556 . . . . 73.430000000000007 111.441 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -51.19 -33.08 25.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.413 0.894 . . . . 75.209999999999994 113.413 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.8 m -82.71 -22.43 34.48 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.811 0.671 . . . . 70.25 112.811 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -96.53 14.71 23.76 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.349 0.5 . . . . 74.299999999999997 112.349 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.37 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.96 0.355 . . . . 71.25 111.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -124.68 -174.63 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.152 0.501 . . . . 72.540000000000006 111.014 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.3 m -76.19 107.22 8.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.255 -0.43 . . . . 72.5 111.173 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.78 -19.64 6.54 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.253 -0.499 . . . . 65.319999999999993 112.885 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.3 134.43 51.56 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.396 0.617 . . . . 64.239999999999995 111.693 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.0 mt -91.58 120.14 32.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.087 -0.506 . . . . 44.109999999999999 111.069 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.3 m -96.21 134.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.899 0.38 . . . . 72.329999999999998 111.564 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.34 125.9 51.57 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.921 0.391 . . . . 61.399999999999999 111.964 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 151' ' ' ARG . 90.6 m-85 -114.95 136.76 52.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.292 -0.413 . . . . 70.230000000000004 111.019 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 57.4 mtp180 -79.02 77.82 5.48 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.227 0.537 . . . . 73.340000000000003 110.903 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 CA-C-N 116.051 -0.522 . . . . 64.129999999999995 112.173 -173.454 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.072 0.463 . . . . 62.43 110.31 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -84.04 118.9 24.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 110.683 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 10.9 p -105.07 136.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.287 0.565 . . . . 72.409999999999997 112.408 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.18 148.02 19.19 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.995 -0.548 . . . . 75.310000000000002 112.689 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 72' ' ' VAL . 37.1 mt -87.68 110.22 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.492 -0.416 . . . . 72.129999999999995 111.029 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 20.8 t80 -68.13 109.39 3.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.767 0.317 . . . . 74.109999999999999 111.173 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.11 -32.48 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.072 0.397 . . . . 73.349999999999994 112.072 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 149.25 132.94 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.705 -0.76 . . . . 45.329999999999998 113.757 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 t30 55.34 78.33 0.19 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.746 0.647 . . . . 74.540000000000006 112.746 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 70.2 -41.04 0.48 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.777 1.029 . . . . 72.510000000000005 113.777 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -81.03 146.15 30.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.612 0.72 . . . . 74.120000000000005 112.64 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.85 154.65 35.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.349 -0.841 . . . . 73.129999999999995 111.153 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 139.49 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.888 0.375 . . . . 73.25 111.3 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -160.53 177.04 10.93 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.019 0.437 . . . . 72.209999999999994 111.733 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.93 103.47 10.64 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 111.393 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 70.8 m -81.38 149.38 28.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.871 0.367 . . . . 70.420000000000002 111.439 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.433 ' HA ' ' CG ' ' A' ' 56' ' ' TYR . 71.3 p -56.05 -43.77 78.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.98 0.733 . . . . 74.439999999999998 112.98 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.4 m -100.18 -42.07 6.85 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.13 0.418 . . . . 71.409999999999997 112.13 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 133' ' ' SER . 55.0 m -76.63 -25.71 54.14 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.825 0.676 . . . . 51.020000000000003 112.825 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.68 32.8 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.024 -0.608 . . . . 72.099999999999994 112.841 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.47 102.57 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.967 0.413 . . . . 74.129999999999995 111.666 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 136' ' ' SER . 47.1 pt -135.99 179.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.582 0.706 . . . . 70.319999999999993 112.541 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.66 135.81 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.507 -0.769 . . . . 65.420000000000002 110.785 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -132.12 176.1 8.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.441 0.163 . . . . 73.409999999999997 110.903 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.2 t -137.31 145.37 43.36 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.786 0.662 . . . . 74.230000000000004 112.786 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.49 -20.3 66.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.924 0.712 . . . . 71.340000000000003 112.924 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -75.82 -18.67 59.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.717 0.294 . . . . 71.329999999999998 111.694 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.4 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 35.7 mt-10 -68.47 130.66 91.98 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 116.668 -0.242 . . . . 75.140000000000001 111.061 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.86 -46.6 26.92 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.338 2.692 . . . . 71.409999999999997 113.838 -173.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -61.14 -46.31 91.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.709 0.29 . . . . 74.5 111.659 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.4 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 96.1 m95 -73.71 -39.74 64.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.904 0.383 . . . . 74.310000000000002 111.029 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.74 -44.83 70.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 75.209999999999994 111.629 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -78.63 -32.34 47.33 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.8 0.296 . . . . 63.329999999999998 111.8 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 20.0 mmt180 -70.11 -18.89 63.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.89 0.33 . . . . 71.010000000000005 111.89 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.15 111.57 0.99 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.33 0.586 . . . . 73.430000000000007 111.972 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.576 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -89.17 -57.0 3.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 70.0 110.08 177.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -171.87 176.75 3.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 73.510000000000005 110.523 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.413 ' CB ' HG23 ' A' ' 98' ' ' VAL . . . -125.67 153.93 43.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.234 0.54 . . . . 71.439999999999998 111.729 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -140.88 167.01 23.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.947 -0.569 . . . . 74.420000000000002 110.141 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.8 136.06 13.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.127 0.489 . . . . 71.329999999999998 111.287 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.439 HG21 HD21 ' A' ' 84' ' ' LEU . 13.4 m -104.15 3.85 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.785 -0.643 . . . . 72.120000000000005 112.314 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.911 0.386 . . . . 63.420000000000002 111.629 179.083 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 120.707 0.289 . . . . 71.409999999999997 110.859 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.9 t -55.14 -62.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.307 -0.406 . . . . 72.219999999999999 111.818 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.583 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 86.7 tttt -53.58 -45.86 70.11 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 74.239999999999995 111.66 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.1 m -63.78 -39.29 93.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.058 -0.519 . . . . 74.049999999999997 112.204 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -35.53 75.3 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.814 0.301 . . . . 71.319999999999993 111.814 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 40' ' ' VAL . 63.8 mt -64.61 -44.2 96.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.053 0.454 . . . . 73.150000000000006 110.567 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.9 mmt -64.24 -35.7 81.66 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.028 0.442 . . . . 65.329999999999998 110.892 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.72 -36.85 74.94 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.959 -0.564 . . . . 74.439999999999998 111.184 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' NE2' ' HE1' ' A' ' 51' ' ' TRP . 7.7 tp60 -76.04 -44.31 39.76 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.293 0.568 . . . . 74.439999999999998 111.216 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -55.37 -40.63 71.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.274 -0.421 . . . . 64.319999999999993 111.627 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.54 -21.57 65.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.032 0.382 . . . . 74.230000000000004 112.032 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -84.52 -42.75 15.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.061 0.457 . . . . 72.519999999999996 111.579 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.469 ' HE1' ' NE2' ' A' ' 47' ' ' GLN . 64.9 m95 -82.45 -50.42 8.88 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.43 -0.35 . . . . 64.319999999999993 111.708 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HB3' ' HE3' ' A' ' 52' ' ' LYS . 21.2 mmmt 46.46 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.446 1.276 . . . . 75.439999999999998 114.446 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.11 38.36 96.0 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.301 0.88 . . . . 72.340000000000003 115.301 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.62 131.33 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.635 0.717 . . . . 71.120000000000005 110.291 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.34 155.4 28.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.935 0.717 . . . . 72.530000000000001 112.935 -174.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -67.83 119.94 13.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.705 -0.68 . . . . 71.150000000000006 111.837 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 57' ' ' ARG . 20.6 ttm-85 -137.08 123.75 21.08 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.463 0.305 . . . . 74.450000000000003 110.721 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.3 mp -69.97 113.94 7.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.079 0.466 . . . . 71.140000000000001 112.162 -175.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.26 -56.23 5.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 114.137 0.415 . . . . 51.409999999999997 114.137 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.7 82.34 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.224 -0.513 . . . . 72.310000000000002 113.226 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.497 ' OG ' ' HD2' ' A' ' 74' ' ' ARG . 83.8 p -76.61 110.58 11.3 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.096 0.474 . . . . 73.549999999999997 111.841 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -167.47 173.51 8.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.04 0.448 . . . . 63.420000000000002 111.524 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -69.41 -7.0 33.72 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.112 0.482 . . . . 54.509999999999998 111.42 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -93.42 8.23 41.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.113 0.482 . . . . 61.210000000000001 110.934 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.411 ' HA3' ' HE ' ' A' ' 57' ' ' ARG . . . 143.1 144.1 4.23 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.175 -0.466 . . . . 63.109999999999999 112.687 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 tt -163.52 135.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.582 -0.364 . . . . 74.340000000000003 110.844 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -85.42 177.03 7.92 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.351 0.596 . . . . 75.120000000000005 112.406 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' ' 120' ' ' VAL . 27.5 t -52.6 -57.24 10.64 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.694 -0.685 . . . . 71.310000000000002 111.933 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -65.53 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.161 0.505 . . . . 74.409999999999997 110.954 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.16 -45.78 95.84 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.946 -0.57 . . . . 65.230000000000004 113.107 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.34 -48.92 73.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.521 -0.4 . . . . 73.299999999999997 111.743 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.55 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.3 p -60.34 -50.48 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.11 0.411 . . . . 64.5 112.11 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.739 HE22 ' HG2' ' A' ' 86' ' ' ARG . 3.3 pt20 -57.98 -40.95 81.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.093 0.473 . . . . 53.119999999999997 111.269 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.651 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.9 mtp180 -71.75 -48.63 45.57 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.725 -0.39 . . . . 72.329999999999998 111.868 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.9 m -46.35 -46.3 18.21 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.039 0.447 . . . . 62.130000000000003 111.611 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.646 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 55.0 m-85 -67.81 -44.32 77.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.655 0.613 . . . . 75.010000000000005 112.655 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.651 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 1.2 ptm180 -73.53 -43.19 60.56 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.757 -0.589 . . . . 75.530000000000001 112.284 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 58.2 mm-40 -60.79 -37.73 82.92 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.922 0.392 . . . . 72.510000000000005 111.06 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -94.9 -69.34 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.196 0.443 . . . . 64.409999999999997 112.196 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -81.14 -22.06 39.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.792 0.664 . . . . 65.450000000000003 112.792 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.51 40.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.908 -0.663 . . . . 72.209999999999994 112.407 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.3 tp -103.24 117.35 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.698 -0.295 . . . . 74.540000000000006 110.864 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 129.59 39.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.184 0.438 . . . . 73.239999999999995 112.184 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.3 mt -121.58 159.93 48.47 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.232 -0.44 . . . . 62.399999999999999 110.73 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.16 160.87 48.15 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.639 2.226 . . . . 73.109999999999999 113.581 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.739 ' HG2' HE22 ' A' ' 73' ' ' GLN . 61.8 mtt-85 -88.44 24.86 1.81 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.402 0.89 . . . . 73.340000000000003 113.402 -169.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -154.91 142.9 20.12 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.838 -0.539 . . . . 72.430000000000007 112.183 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 118' ' ' ARG . 37.9 p -51.96 -50.05 62.01 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.127 -0.488 . . . . 70.099999999999994 111.598 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -53.27 -37.63 62.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.578 -0.737 . . . . 53.310000000000002 111.359 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.7 -44.56 63.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 65.340000000000003 110.756 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.02 -20.98 66.36 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.03 -0.532 . . . . 75.5 112.028 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 88' ' ' THR . 98.6 mt-30 -56.46 -28.04 58.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.963 0.411 . . . . 74.340000000000003 111.477 174.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -89.95 -19.46 24.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.216 -0.447 . . . . 75.299999999999997 111.737 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.2 mmm -76.1 140.36 41.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.956 0.408 . . . . 73.409999999999997 111.847 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.77 -166.87 46.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.173 -0.537 . . . . 43.340000000000003 113.454 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -110.34 148.1 32.62 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.296 0.569 . . . . 63.420000000000002 111.865 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.7 p -79.5 133.55 36.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.409 -0.814 . . . . 63.329999999999998 112.11 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.578 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 3.8 m -146.07 167.31 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.93 0.715 . . . . 74.099999999999994 112.93 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.2 t -116.83 -171.43 2.02 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.374 -0.83 . . . . 74.129999999999995 110.985 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 -49.91 -56.47 10.41 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.058 0.762 . . . . 73.129999999999995 113.058 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 m -65.79 -11.72 48.36 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.734 0.642 . . . . 72.349999999999994 112.734 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.576 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.6 m120 -106.7 -4.31 19.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.073 0.398 . . . . 72.329999999999998 112.073 -174.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.88 147.38 50.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.985 0.735 . . . . 31.52 112.985 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -118.12 -159.01 0.73 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.654 -0.703 . . . . 72.200000000000003 109.297 173.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.8 m -102.01 102.75 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.03 -0.419 . . . . 72.109999999999999 110.662 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.06 6.94 5.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.214 -0.517 . . . . 35.229999999999997 113.649 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.12 134.69 44.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.261 0.553 . . . . 51.409999999999997 112.086 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.46 HD22 HG21 ' A' ' 72' ' ' VAL . 37.9 mt -79.59 110.7 15.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.913 -0.585 . . . . 61.520000000000003 110.044 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.44 118.91 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.261 0.553 . . . . 73.019999999999996 111.744 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.4 mt -90.28 123.83 34.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.743 -0.662 . . . . 75.329999999999998 111.593 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.66 140.99 45.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.182 0.515 . . . . 64.219999999999999 111.483 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.593 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 77.1 mtp180 -92.44 97.89 11.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.906 -0.588 . . . . 75.209999999999994 111.031 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.18 0.514 . . . . 72.099999999999994 111.391 -176.194 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.475 ' O ' HG21 ' A' ' 88' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.671 0.272 . . . . 72.400000000000006 110.632 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -115.5 149.89 37.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.245 -0.434 . . . . 74.109999999999999 110.556 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -134.84 146.17 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.203 0.525 . . . . 72.140000000000001 112.389 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.4 155.99 22.18 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.333 -0.46 . . . . 74.109999999999999 112.676 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 72' ' ' VAL . 47.8 mt -90.87 103.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.423 -0.457 . . . . 72.099999999999994 111.16 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t80 -69.47 101.11 1.51 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.241 0.543 . . . . 71.120000000000005 111.405 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.583 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.6 pt -82.15 -21.87 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.93 -0.577 . . . . 55.25 111.711 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.69 170.9 13.11 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 116.281 -0.418 . . . . 34.219999999999999 112.641 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 60.84 27.43 17.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.626 0.37 . . . . 54.329999999999998 111.675 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.1 m120 63.81 23.66 13.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.418 0.287 . . . . 64.200000000000003 111.441 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -114.99 150.05 36.42 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.247 0.546 . . . . 71.420000000000002 111.55 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 13.5 p90 -156.54 148.68 23.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.88 -0.6 . . . . 75.329999999999998 111.992 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.33 141.09 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.793 -0.639 . . . . 73.129999999999995 110.952 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.405 ' CE1' HD11 ' A' ' 139' ' ' ILE . 8.1 p80 -158.96 162.1 36.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.94 0.4 . . . . 75.409999999999997 111.517 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -101.76 93.75 5.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.191 0.519 . . . . 73.109999999999999 110.892 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.63 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 41.1 t -76.78 166.07 23.86 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.169 0.509 . . . . 73.319999999999993 111.692 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.7 p -66.4 -66.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.082 0.467 . . . . 61.439999999999998 112.067 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 83.5 p -89.63 8.66 30.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.293 0.479 . . . . 63.219999999999999 112.293 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 48.5 m -125.84 -29.26 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.736 0.643 . . . . 73.209999999999994 112.736 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.86 -154.56 43.54 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.984 -0.627 . . . . 71.400000000000006 112.986 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.39 95.77 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.167 0.432 . . . . 74.140000000000001 112.167 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -131.23 -178.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.098 0.475 . . . . 72.299999999999997 112.263 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.51 139.44 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 72.109999999999999 111.255 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.8 p -143.87 163.94 31.97 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.748 0.308 . . . . 52.409999999999997 110.822 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.418 ' HB2' ' HG2' ' A' ' 145' ' ' GLU . 45.5 m -113.73 143.87 43.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.907 0.706 . . . . 75.219999999999999 112.907 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 91.4 mmm -58.86 -30.42 67.71 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.906 -0.588 . . . . 73.140000000000001 111.266 174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -68.71 -19.62 64.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 112.164 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 41.4 mm-40 -64.98 113.65 11.87 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 117.027 -0.079 . . . . 74.519999999999996 110.952 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -43.71 -38.54 9.49 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.248 2.632 . . . . 55.299999999999997 113.818 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.641 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 71.7 t80 -57.62 -50.49 72.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.764 0.316 . . . . 72.450000000000003 111.629 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -82.53 -36.31 26.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.015 0.436 . . . . 72.200000000000003 111.455 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.5 -36.97 64.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.862 -0.608 . . . . 73.400000000000006 111.983 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -83.6 -15.21 49.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.886 0.328 . . . . 75.319999999999993 111.886 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 20.6 mmt180 -89.74 -17.15 28.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.993 0.368 . . . . 71.310000000000002 111.993 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.26 116.49 3.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.538 . . . . 72.230000000000004 112.454 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -92.57 -60.8 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.977 -0.556 . . . . 55.210000000000001 110.889 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -173.34 170.73 4.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.38 0.272 . . . . 74.040000000000006 110.503 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -119.98 169.41 10.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.267 0.84 . . . . 53.109999999999999 113.267 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -137.75 113.51 9.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.538 -0.755 . . . . 61.119999999999997 111.838 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.578 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.72 105.98 9.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.934 0.397 . . . . 75.040000000000006 110.55 171.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.44 -0.69 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.738 0.644 . . . . 73.409999999999997 112.738 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 82' ' ' LEU . 81.9 mt . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.917 0.389 . . . . 71.019999999999996 111.913 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.72 0.295 . . . . 74.200000000000003 111.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.1 t -46.53 -49.76 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.22 0.533 . . . . 61.530000000000001 111.118 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 82.9 tttt -54.78 -48.29 72.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.655 -0.702 . . . . 72.239999999999995 112.33 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.2 p -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.935 0.398 . . . . 72.540000000000006 111.766 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.31 -36.89 85.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.473 -0.33 . . . . 70.430000000000007 111.592 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.3 mt -63.07 -36.64 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.959 0.409 . . . . 74.209999999999994 110.641 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 28.8 mmt -70.2 -36.5 74.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.454 -0.339 . . . . 54.140000000000001 111.316 175.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.78 -42.54 99.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.214 0.531 . . . . 73.299999999999997 110.526 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.61 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 56.8 tp60 -64.03 -48.01 77.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.013 -0.54 . . . . 71.319999999999993 110.515 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -53.59 -39.56 64.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.797 -0.638 . . . . 73.409999999999997 111.499 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . . . -54.99 -34.42 63.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.018 0.437 . . . . 43.43 111.843 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.17 -24.46 51.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.088 0.471 . . . . 73.099999999999994 111.459 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -114.84 18.32 16.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.783 0.66 . . . . 75.349999999999994 112.783 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' A' ' 49' ' ' ALA . 10.2 mtmp? -59.09 109.08 0.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.144 0.497 . . . . 52.520000000000003 112.245 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.03 4.53 68.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 114.793 0.677 . . . . 61.030000000000001 114.793 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.49 127.68 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.839 0.82 . . . . 72.329999999999998 110.806 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -71.08 157.51 38.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.97 0.73 . . . . 72.120000000000005 112.97 -176.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -77.2 126.03 30.28 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.347 -0.842 . . . . 74.329999999999998 111.775 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -138.04 110.37 7.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.476 -0.329 . . . . 74.150000000000006 111.68 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.32 121.25 15.88 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.984 0.421 . . . . 74.120000000000005 111.894 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.79 69.34 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.098 -0.572 . . . . 42.420000000000002 113.9 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -138.5 137.86 9.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.33 -0.462 . . . . 63.140000000000001 112.365 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.7 m -125.86 99.49 5.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.001 0.401 . . . . 53.240000000000002 111.541 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 64' ' ' LYS . 4.0 t -177.28 177.69 1.18 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.251 -0.432 . . . . 75.239999999999995 111.115 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -71.17 -11.49 60.97 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.082 0.468 . . . . 62.210000000000001 110.87 178.32 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' HB2' HG23 ' A' ' 62' ' ' THR . 30.2 mmmt -74.81 -11.83 60.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.213 0.53 . . . . 74.200000000000003 110.703 170.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 55' ' ' ARG . . . 145.23 148.11 4.76 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.119 -0.491 . . . . 64.129999999999995 112.75 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 19.8 tt -154.98 144.81 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.861 0.331 . . . . 71.540000000000006 111.436 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.16 179.91 4.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.201 0.524 . . . . 54.229999999999997 112.349 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.7 t -58.82 -61.25 2.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.416 0.525 . . . . 71.120000000000005 112.416 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -59.01 -36.86 75.67 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.974 0.416 . . . . 72.219999999999999 111.533 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.91 95.06 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 121.057 -0.592 . . . . 74.549999999999997 113.219 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.26 -54.73 28.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.895 0.332 . . . . 73.420000000000002 111.895 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG21 HD22 ' A' ' 108' ' ' LEU . 7.4 p -57.0 -41.91 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.956 0.408 . . . . 71.349999999999994 111.216 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -50.85 -62.67 1.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.312 0.577 . . . . 71.319999999999993 111.315 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HA ' ' CG ' ' A' ' 77' ' ' ARG . 10.3 mtp180 -63.66 -34.91 78.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.888 -0.596 . . . . 74.299999999999997 112.457 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.61 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 95.7 m -55.93 -54.58 42.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.083 0.468 . . . . 64.299999999999997 111.555 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.492 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.1 m-85 -65.84 -37.81 87.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.829 0.677 . . . . 73.519999999999996 112.829 -177.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HA ' ' H ' ' A' ' 82' ' ' LEU . 3.0 ptm180 -75.15 -43.46 52.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.773 -0.579 . . . . 72.340000000000003 112.265 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.41 -18.49 64.45 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 122.098 -0.376 . . . . 74.299999999999997 111.756 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -108.39 -68.22 0.92 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.121 0.415 . . . . 75.109999999999999 112.121 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.63 0.45 57.38 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.579 0.585 . . . . 63.119999999999997 112.579 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.64 44.27 98.03 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 61.039999999999999 113.095 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.3 tp -104.68 122.39 45.57 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.087 0.47 . . . . 72.310000000000002 111.785 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.71 96.93 2.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.206 0.527 . . . . 72.120000000000005 112.037 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.52 135.69 21.06 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.153 -0.476 . . . . 64.120000000000005 110.513 173.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.03 -175.62 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.463 2.109 . . . . 74.340000000000003 112.301 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -109.25 6.21 24.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.855 -0.528 . . . . 73.209999999999994 111.663 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.7 m -108.71 128.05 54.52 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.447 -0.342 . . . . 64.209999999999994 110.619 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 118' ' ' ARG . 4.8 m -56.76 -46.52 81.37 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.383 0.512 . . . . 52.240000000000002 112.383 -173.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.578 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 33.3 m-85 -59.69 -36.46 76.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 111.872 0.323 . . . . 74.409999999999997 111.872 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.63 -36.02 60.32 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.974 0.416 . . . . 53.329999999999998 111.471 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.21 -43.87 93.68 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.91 0.386 . . . . 70.230000000000004 111.499 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 17.0 pt20 -62.88 -26.87 68.99 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.965 0.412 . . . . 74.409999999999997 111.392 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -86.19 -10.08 55.37 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.23 0.455 . . . . 65.430000000000007 112.23 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.5 mmm -66.39 -37.51 85.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.162 0.506 . . . . 71.239999999999995 110.86 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.35 166.56 12.2 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 116.0 -0.546 . . . . 55.32 112.11 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -86.96 160.34 18.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.36 -0.494 . . . . 54.399999999999999 111.221 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.537 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 36.5 t -78.62 135.02 37.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.602 0.593 . . . . 74.0 112.602 -174.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.55 HG23 ' HB3' ' A' ' 155' ' ' ALA . 15.5 m -127.89 142.99 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 54.509999999999998 110.633 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.6 t -88.66 177.12 6.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.99 0.424 . . . . 73.310000000000002 111.26 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -49.68 -29.19 6.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.153 0.581 . . . . 62.25 112.142 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m -84.4 -21.14 30.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.884 0.698 . . . . 64.120000000000005 112.884 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.0 m120 -108.16 11.35 27.57 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.002 0.741 . . . . 72.120000000000005 113.002 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.0 151.84 14.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.911 0.708 . . . . 65.109999999999999 112.911 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -140.35 143.78 35.94 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.096 -0.502 . . . . 74.209999999999994 111.18 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.9 m -58.47 96.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.833 0.349 . . . . 61.43 110.948 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 123.62 14.17 3.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.171 -0.538 . . . . 54.310000000000002 113.818 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.24 167.87 13.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.94 0.87 . . . . 72.040000000000006 111.123 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.465 HD22 HG21 ' A' ' 72' ' ' VAL . 47.1 mt -102.85 113.87 27.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.097 -0.501 . . . . 62.450000000000003 110.549 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -94.92 122.66 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.401 0.62 . . . . 74.219999999999999 111.43 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 92' ' ' GLN . 67.0 mt -100.4 124.48 45.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.579 -0.737 . . . . 73.319999999999993 111.785 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -116.02 138.41 51.24 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.205 -0.452 . . . . 74.319999999999993 110.982 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -74.22 94.64 2.5 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.899 0.381 . . . . 73.310000000000002 110.715 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 120.759 0.314 . . . . 74.519999999999996 111.627 -178.463 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.403 ' O ' HG21 ' A' ' 88' ' ' THR . 13.8 mmm180 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 121.002 0.43 . . . . 74.400000000000006 110.218 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -91.17 126.9 36.4 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.196 -0.456 . . . . 70.129999999999995 110.459 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -111.6 132.03 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.529 0.681 . . . . 74.329999999999998 112.288 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -124.45 160.69 19.03 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.58 -0.736 . . . . 74.540000000000006 112.074 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.3 mt -97.04 112.8 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.091 0.446 . . . . 71.150000000000006 111.019 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.476 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 51.7 t80 -75.83 113.71 13.62 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.107 0.48 . . . . 73.140000000000001 111.904 -175.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.402 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.2 pt -99.06 -7.95 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.155 0.428 . . . . 71.349999999999994 112.155 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.68 164.37 13.21 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.111 -0.566 . . . . 72.030000000000001 113.348 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 58.61 31.08 20.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.762 0.425 . . . . 73.310000000000002 112.021 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.476 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 80.1 m-20 67.19 13.16 9.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.987 -0.551 . . . . 42.100000000000001 112.367 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -101.32 144.62 29.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.318 0.58 . . . . 62.439999999999998 111.493 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -152.91 146.38 24.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.77 -0.65 . . . . 62.130000000000003 111.584 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.69 138.76 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.729 0.299 . . . . 64.519999999999996 111.008 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -158.78 175.04 14.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.976 0.417 . . . . 75.120000000000005 111.631 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.21 103.44 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.195 -0.457 . . . . 62.210000000000001 111.045 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 36.9 t -89.17 162.5 15.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.789 0.328 . . . . 72.209999999999994 111.421 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -55.12 -61.55 2.24 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.034 0.753 . . . . 63.549999999999997 113.034 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m -93.69 -36.28 12.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.888 -0.508 . . . . 62.420000000000002 111.453 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 14.4 m -66.97 -29.62 69.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.242 -0.435 . . . . 71.120000000000005 112.118 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.69 34.75 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.97 -0.633 . . . . 61.130000000000003 112.565 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.46 102.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 117.127 0.464 . . . . 74.319999999999993 111.761 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.499 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -139.62 -179.01 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.13 0.49 . . . . 70.209999999999994 111.608 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.17 144.3 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.957 0.408 . . . . 73.129999999999995 110.72 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.7 m -137.08 169.41 17.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.199 -0.313 . . . . 71.129999999999995 111.396 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.2 m -130.52 139.89 50.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.911 0.386 . . . . 74.219999999999999 111.769 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 127' ' ' ASN . 67.1 mtt -65.37 -9.63 26.5 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.439 0.533 . . . . 72.340000000000003 112.439 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.67 -4.89 45.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.949 0.404 . . . . 64.209999999999994 111.452 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.41 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 25.8 mm-40 -83.56 127.08 69.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.244 -0.434 . . . . 73.530000000000001 109.962 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.432 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 84.9 Cg_exo -46.75 -39.0 23.49 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.704 2.269 . . . . 61.240000000000002 113.691 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.545 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 73.6 t80 -60.22 -51.31 70.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.651 0.263 . . . . 74.030000000000001 111.623 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.41 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 86.6 m95 -73.26 -33.35 65.21 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.899 0.38 . . . . 74.540000000000006 111.431 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 143' ' ' MET . 37.9 ttpt -68.54 -39.85 80.96 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.07 0.396 . . . . 75.129999999999995 112.07 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 19.3 ptpt -79.56 -28.13 41.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.738 0.304 . . . . 70.319999999999993 111.812 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 9.6 mmm180 -91.13 -4.88 55.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 111.886 0.328 . . . . 71.129999999999995 111.886 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -59.07 111.59 1.38 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.006 0.431 . . . . 74.109999999999999 111.41 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -92.26 -50.65 5.55 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.251 -0.431 . . . . 63.030000000000001 111.844 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -177.57 -173.02 0.39 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.329 -0.396 . . . . 72.340000000000003 110.901 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.55 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -140.42 159.87 41.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.89 0.376 . . . . 63.32 111.366 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.537 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt85 -139.42 109.54 6.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.473 0.309 . . . . 61.340000000000003 111.432 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 108.05 17.81 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.617 0.722 . . . . 74.239999999999995 111.42 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.71 -27.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.856 -0.611 . . . . 64.109999999999999 112.437 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 111.919 0.34 . . . . 73.219999999999999 111.919 -179.217 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 120.972 0.415 . . . . 72.129999999999995 111.528 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 44' ' ' ILE . 83.5 t -50.69 -54.23 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.174 -0.466 . . . . 65.430000000000007 111.557 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.531 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.2 tttt -53.9 -50.51 66.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 111.613 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 t -59.21 -44.35 92.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.425 -0.352 . . . . 42.439999999999998 111.879 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -63.68 -39.84 95.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.274 0.559 . . . . 74.140000000000001 111.303 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 40' ' ' VAL . 76.4 mt -61.37 -40.33 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.056 0.455 . . . . 74.109999999999999 110.6 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 30.3 mmt -63.54 -34.93 78.87 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.104 -0.498 . . . . 52.32 111.583 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.95 -45.4 86.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.912 0.387 . . . . 54.450000000000003 110.934 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.429 ' O ' ' HD1' ' A' ' 51' ' ' TRP . 30.0 mm-40 -62.53 -52.37 63.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.974 0.416 . . . . 64.129999999999995 111.044 174.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -55.37 -38.42 68.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.106 0.409 . . . . 71.209999999999994 112.106 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.92 -30.92 71.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.471 . . . . 61.229999999999997 111.396 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -76.28 -31.95 58.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.134 -0.485 . . . . 74.340000000000003 111.126 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.429 ' HD1' ' O ' ' A' ' 47' ' ' GLN . 77.7 m95 -99.77 16.55 23.25 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.596 0.591 . . . . 74.140000000000001 112.596 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.81 109.83 1.02 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.836 0.31 . . . . 73.430000000000007 111.836 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.15 15.31 54.22 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.916 -0.659 . . . . 71.340000000000003 114.146 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -78.56 132.88 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 117.318 0.559 . . . . 72.319999999999993 111.951 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -73.84 152.44 40.24 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.201 0.524 . . . . 74.510000000000005 111.907 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 67' ' ' ASP . 72.4 t80 -83.7 148.18 27.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.034 0.445 . . . . 75.25 111.856 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 58.0 ttm-85 -137.69 148.73 45.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.039 -0.528 . . . . 72.239999999999995 110.611 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.02 93.59 8.42 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.973 -0.454 . . . . 74.319999999999993 110.701 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.37 61.32 1.25 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.216 -0.447 . . . . 44.420000000000002 113.361 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -176.37 150.82 10.83 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.16 -0.543 . . . . 73.510000000000005 112.685 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.528 ' HA ' HG13 ' A' ' 66' ' ' ILE . 80.7 p -128.0 99.93 5.69 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.554 0.575 . . . . 72.0 112.554 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 t -170.46 167.54 8.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.41 0.284 . . . . 74.040000000000006 111.439 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -66.35 -22.82 66.27 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.015 0.435 . . . . 71.230000000000004 111.206 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -91.14 21.14 4.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.077 0.465 . . . . 72.310000000000002 111.364 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.534 ' HA3' ' HE ' ' A' ' 57' ' ' ARG . . . 142.88 112.76 0.9 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.223 -0.513 . . . . 64.230000000000004 113.199 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 20.5 tt -137.34 144.79 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 117.067 0.434 . . . . 65.049999999999997 111.558 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.0 p30 -97.89 174.13 6.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.451 0.644 . . . . 62.130000000000003 111.98 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.6 t -58.92 -44.53 91.34 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.925 0.713 . . . . 41.030000000000001 112.925 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.6 p -74.39 -39.05 62.94 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.738 0.304 . . . . 62.350000000000001 110.471 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.63 91.5 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.372 -0.442 . . . . 72.109999999999999 112.928 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.02 -53.23 41.15 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.769 0.318 . . . . 73.129999999999995 111.633 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.96 -48.04 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 111.909 0.337 . . . . 71.420000000000002 111.909 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.581 HE22 ' HG2' ' A' ' 86' ' ' ARG . 13.8 pt20 -59.47 -43.82 93.15 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.15 -0.343 . . . . 72.5 111.463 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.556 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 55.8 mtp180 -64.98 -47.61 76.95 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.12 -0.232 . . . . 71.040000000000006 111.53 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -50.57 -44.39 56.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.966 0.413 . . . . 54.109999999999999 111.777 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 59.0 m-85 -75.66 -44.46 42.37 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.999 0.74 . . . . 73.430000000000007 112.999 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 9.0 ptm180 -62.0 -32.19 72.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.436 -0.79 . . . . 75.129999999999995 111.512 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 33.7 mm-40 -73.24 -72.99 0.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.94 0.4 . . . . 74.129999999999995 111.929 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -87.11 -5.96 58.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.212 0.819 . . . . 73.040000000000006 113.212 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.402 ' HD2' ' HA ' ' A' ' 76' ' ' PHE . 91.0 m-85 -127.41 -7.33 5.8 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 62.219999999999999 112.086 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.84 37.78 79.94 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.228 -0.511 . . . . 75.420000000000002 113.18 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 34.9 tp -104.9 144.38 31.86 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.892 0.377 . . . . 71.140000000000001 111.151 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -95.49 125.96 40.46 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.936 0.398 . . . . 73.409999999999997 111.834 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 73' ' ' GLN . 88.2 mt -135.12 133.47 20.82 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.472 -0.331 . . . . 74.120000000000005 110.929 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.71 155.93 61.85 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.788 2.325 . . . . 61.5 113.275 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.581 ' HG2' HE22 ' A' ' 73' ' ' GLN . 67.2 mtt85 -82.66 48.8 1.37 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.965 0.728 . . . . 63.340000000000003 112.965 -172.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.497 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 20.3 t -169.09 135.54 1.73 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 111.276 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.631 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 25.5 m -53.19 -46.35 68.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.374 -0.376 . . . . 73.150000000000006 111.036 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -39.4 75.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.078 0.466 . . . . 63.520000000000003 111.696 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.497 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 14.5 mm-40 -75.93 -35.57 59.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.996 -0.547 . . . . 71.129999999999995 111.115 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.94 -30.13 70.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.912 0.387 . . . . 70.319999999999993 111.775 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 88' ' ' THR . 20.0 mt-30 -62.72 -21.01 65.47 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.734 0.302 . . . . 74.150000000000006 111.749 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.01 16.42 1.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.667 0.617 . . . . 64.099999999999994 112.667 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptp -142.52 -178.58 5.83 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 122.186 -0.321 . . . . 71.239999999999995 111.067 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.3 50.89 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.13 -0.557 . . . . 63.310000000000002 113.141 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.6 mmtp -127.75 139.17 52.84 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.416 -0.461 . . . . 73.010000000000005 111.952 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.552 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 75.5 p -76.32 127.84 33.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.761 -0.654 . . . . 75.239999999999995 111.905 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.592 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 5.7 m -136.93 157.72 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.307 0.575 . . . . 62.149999999999999 112.532 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 t -109.62 -177.31 3.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.786 -0.643 . . . . 74.049999999999997 112.353 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.647 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 24.3 mmm180 -41.04 -50.28 3.36 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.26 1.208 . . . . 73.239999999999995 114.26 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -84.34 -14.4 49.72 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.566 0.58 . . . . 70.239999999999995 112.566 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.8 m120 -89.75 -12.23 39.94 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.977 0.362 . . . . 75.010000000000005 111.977 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -57.77 131.88 51.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.979 0.733 . . . . 65.510000000000005 112.979 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -111.96 -162.33 0.79 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.788 -0.642 . . . . 74.530000000000001 110.381 171.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.531 HG21 ' HB2' ' A' ' 41' ' ' LYS . 91.7 m -92.9 108.35 19.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.708 0.289 . . . . 74.140000000000001 110.849 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.66 -10.36 7.58 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.598 -0.334 . . . . 74.310000000000002 112.753 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.416 ' OD2' ' HD2' ' A' ' 157' ' ' ARG . 0.8 OUTLIER -60.9 127.05 29.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.115 0.413 . . . . 75.439999999999998 112.115 177.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 39.4 mt -82.87 108.07 15.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.892 0.377 . . . . 51.219999999999999 110.754 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 155' ' ' ALA . 28.4 m -96.27 124.86 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.284 0.564 . . . . 63.310000000000002 111.965 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 73.8 mt -93.96 136.16 34.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.831 -0.622 . . . . 74.299999999999997 112.002 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 96.0 m-85 -124.22 139.99 53.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 64.239999999999995 111.666 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -81.05 98.32 7.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.601 -0.272 . . . . 74.120000000000005 111.141 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 121.145 0.498 . . . . 64.329999999999998 111.743 179.593 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 109.457 -0.572 . . . . 74.099999999999994 109.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 69.0 t60 -84.24 149.32 26.2 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.816 -0.629 . . . . 64.209999999999994 111.277 -172.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 7.6 p -142.6 119.04 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.461 0.648 . . . . 74.519999999999996 111.948 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -114.33 152.85 17.93 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.204 -0.522 . . . . 71.120000000000005 112.854 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.4 mt -88.39 106.92 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 122.51 -0.406 . . . . 73.219999999999999 110.706 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -68.51 116.73 9.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.045 0.45 . . . . 72.209999999999994 111.338 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.1 pt -103.04 -14.44 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.361 0.504 . . . . 35.240000000000002 112.361 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.13 164.67 11.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.11 -0.567 . . . . 70.299999999999997 112.991 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 127' ' ' ASN . 69.1 m-20 61.58 27.35 16.84 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.002 0.401 . . . . 71.299999999999997 111.891 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 126' ' ' ASN . 47.6 m-80 67.12 7.61 5.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.328 0.251 . . . . 75.439999999999998 111.509 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -89.7 144.17 26.2 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.595 0.712 . . . . 60.439999999999998 111.253 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -149.29 138.43 21.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 73.25 111.056 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.92 133.43 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.031 0.443 . . . . 53.439999999999998 110.7 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -157.73 172.2 18.93 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.257 0.551 . . . . 73.439999999999998 111.723 -173.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -105.12 93.04 4.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.0 -0.546 . . . . 71.450000000000003 110.154 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.7 p -67.39 140.04 57.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.952 0.406 . . . . 75.099999999999994 111.531 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -57.6 -30.33 65.22 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.914 0.709 . . . . 63.299999999999997 112.914 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.9 t -102.18 -53.82 2.83 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.564 0.579 . . . . 65.400000000000006 112.564 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 t -81.0 -33.59 33.55 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.601 0.593 . . . . 61.340000000000003 112.601 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.44 -153.09 17.01 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.164 -0.541 . . . . 62.420000000000002 112.635 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.58 106.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.211 0.506 . . . . 73.409999999999997 111.499 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.5 178.21 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.299 0.571 . . . . 72.129999999999995 112.033 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.03 138.17 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.944 -0.571 . . . . 73.430000000000007 109.957 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.4 m -132.06 171.7 13.29 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.312 -0.243 . . . . 74.209999999999994 111.152 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.6 m -127.66 138.24 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.873 0.323 . . . . 72.310000000000002 111.873 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.647 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 66.3 mtt -64.78 -12.18 44.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.97 0.414 . . . . 75.5 111.866 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -66.1 -28.28 68.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.83 0.348 . . . . 75.329999999999998 111.204 173.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.56 125.54 92.04 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.573 -0.285 . . . . 71.25 110.63 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.486 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 82.3 Cg_exo -46.39 -41.88 22.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.968 2.445 . . . . 72.530000000000001 113.723 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -59.63 -41.5 90.61 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.223 0.453 . . . . 74.099999999999994 112.223 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.03 -36.44 19.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.011 0.375 . . . . 74.530000000000001 112.011 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -54.81 -50.93 67.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.074 0.464 . . . . 73.129999999999995 111.612 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 18.4 ptpt -82.35 1.17 38.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.975 0.417 . . . . 71.120000000000005 111.88 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -96.18 -28.69 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.531 0.332 . . . . 74.329999999999998 110.959 176.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -58.51 115.4 2.99 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.179 -0.464 . . . . 73.310000000000002 112.097 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.413 HD22 ' HG2' ' A' ' 154' ' ' GLU . 7.5 t30 -98.07 -62.43 1.25 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.059 -0.519 . . . . 72.340000000000003 111.447 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.413 ' HG2' HD22 ' A' ' 153' ' ' ASN . 13.5 pt-20 -158.44 164.73 35.95 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.231 -0.293 . . . . 74.120000000000005 110.482 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -126.24 149.22 49.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.551 0.215 . . . . 62.229999999999997 111.523 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.552 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 89.5 mtt180 -143.99 112.72 6.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.611 0.243 . . . . 71.340000000000003 110.987 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.592 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -85.4 129.31 34.84 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.16 0.505 . . . . 72.219999999999999 110.84 176.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 84' ' ' LEU . 27.8 m -107.13 7.89 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.895 0.702 . . . . 73.420000000000002 112.895 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.177 0.513 . . . . 73.420000000000002 112.235 -179.895 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.913 0.387 . . . . 64.030000000000001 111.566 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 44' ' ' ILE . 86.6 t -48.66 -46.08 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 72.25 111.215 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 45' ' ' MET . 58.9 tttm -54.89 -46.3 74.79 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.576 0.584 . . . . 74.230000000000004 112.576 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.7 p -60.61 -44.03 96.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.801 0.334 . . . . 72.409999999999997 111.868 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -73.93 -30.03 62.35 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.445 0.535 . . . . 70.549999999999997 112.445 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 40' ' ' VAL . 75.4 mt -63.69 -43.85 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.265 0.555 . . . . 73.230000000000004 110.135 173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 87.4 mmm -66.63 -37.1 84.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.064 -0.516 . . . . 74.319999999999993 110.848 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.06 -43.45 70.25 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.169 0.509 . . . . 74.439999999999998 111.475 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.43 ' NE2' HE22 ' A' ' 79' ' ' GLN . 5.3 tp-100 -69.8 -54.51 13.26 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.273 -0.421 . . . . 75.140000000000001 110.617 174.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.432 ' OH ' ' NZ ' ' A' ' 52' ' ' LYS . 16.4 t80 -49.01 -39.68 27.78 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.088 0.773 . . . . 74.0 113.088 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.45 -33.81 55.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.115 0.484 . . . . 71.120000000000005 111.884 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.79 -23.41 55.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.038 -0.528 . . . . 63.32 112.413 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 138' ' ' VAL . 82.8 m95 -97.2 -0.31 47.01 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.587 0.588 . . . . 72.140000000000001 112.587 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.432 ' NZ ' ' OH ' ' A' ' 48' ' ' TYR . 29.5 mtpp -64.85 95.37 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.992 0.425 . . . . 71.510000000000005 111.269 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.81 -12.47 7.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.444 -0.407 . . . . 73.540000000000006 112.725 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.6 t -74.18 124.9 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 50.43 111.187 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -86.2 160.64 19.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.563 0.697 . . . . 74.409999999999997 112.39 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 47.3 t80 -74.72 127.51 33.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.412 -0.813 . . . . 63.030000000000001 112.125 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -136.93 121.53 18.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.712 0.291 . . . . 74.430000000000007 111.599 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.86 121.63 22.91 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.201 0.445 . . . . 62.420000000000002 112.201 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.4 50.82 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.946 -0.645 . . . . 53.299999999999997 113.689 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -151.7 135.63 5.13 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.09 -0.576 . . . . 61.240000000000002 112.438 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.521 ' HA ' HG13 ' A' ' 66' ' ' ILE . 29.0 p -125.44 98.98 5.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.315 0.579 . . . . 53.219999999999999 111.691 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.1 t -159.84 161.88 34.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.065 -0.516 . . . . 71.430000000000007 110.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -67.88 -3.36 9.49 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.061 0.458 . . . . 71.120000000000005 111.738 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -92.55 -19.37 22.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.983 0.421 . . . . 74.430000000000007 111.269 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 136.52 2.23 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.59 -0.604 . . . . 60.109999999999999 111.59 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.521 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.4 tt -157.45 150.96 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 117.702 0.751 . . . . 62.030000000000001 112.496 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.15 -179.36 4.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.273 0.558 . . . . 70.519999999999996 112.186 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.4 t -58.15 -56.64 19.48 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.593 0.59 . . . . 71.230000000000004 112.593 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 75.2 p -60.46 -36.2 77.68 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.939 0.399 . . . . 74.530000000000001 111.608 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.66 85.09 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.039 -0.528 . . . . 74.010000000000005 113.17 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.73 -50.92 70.48 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.587 -0.361 . . . . 74.450000000000003 111.72 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.509 ' HA ' HD11 ' A' ' 122' ' ' ILE . 11.0 p -65.14 -43.79 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 111.987 0.366 . . . . 73.329999999999998 111.987 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.578 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 21.1 pt20 -62.18 -38.93 90.96 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.162 -0.336 . . . . 64.239999999999995 111.592 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 74' ' ' ARG . 14.4 mtp180 -67.12 -55.54 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.715 0.293 . . . . 71.519999999999996 111.579 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.4 m -47.46 -42.35 22.42 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.284 0.475 . . . . 74.409999999999997 112.284 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 49.9 m-85 -75.02 -41.55 59.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.717 0.636 . . . . 70.239999999999995 112.717 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 13.7 ptm180 -76.92 -26.68 54.37 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.812 -0.555 . . . . 62.009999999999998 112.355 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.0 -37.67 16.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.122 0.415 . . . . 55.420000000000002 112.122 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.43 HE22 ' NE2' ' A' ' 47' ' ' GLN . 19.2 mp0 -93.48 -48.43 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.9 0.704 . . . . 71.420000000000002 112.9 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 58.4 m-85 -101.55 -5.58 24.97 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.42 0.526 . . . . 63.340000000000003 112.42 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.59 13.62 74.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.089 -0.577 . . . . 73.349999999999994 113.066 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -90.82 111.51 22.94 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.671 -0.311 . . . . 71.230000000000004 110.674 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.48 95.85 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.177 0.513 . . . . 70.349999999999994 112.149 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 91.4 mt -82.69 143.6 47.3 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 110.195 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.45 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 43.9 Cg_endo -67.45 -172.67 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.53 2.153 . . . . 73.049999999999997 113.522 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.409 ' H ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -95.62 -33.09 12.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.864 0.69 . . . . 73.219999999999999 112.864 -172.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.512 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 19.9 m -96.43 141.74 29.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.69 0.255 . . . . 74.319999999999993 111.69 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 59.8 m -52.13 -50.35 61.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.905 0.335 . . . . 75.150000000000006 111.905 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.467 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 24.9 m-85 -54.11 -44.0 70.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.534 0.207 . . . . 64.109999999999999 111.437 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.512 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 45.3 mt-10 -58.91 -47.5 84.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.552 . . . . 62.43 110.87 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -63.37 -30.71 71.79 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.147 -0.479 . . . . 73.019999999999996 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.7 mt-30 -71.34 -21.05 62.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.465 -0.334 . . . . 75.400000000000006 111.495 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 89' ' ' TYR . 41.6 mt-10 -79.48 -5.23 54.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.852 0.358 . . . . 74.340000000000003 111.132 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.45 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 75.0 mtp -106.28 131.83 53.04 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.368 -0.378 . . . . 52.340000000000003 110.936 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.24 134.78 1.07 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.465 -0.397 . . . . 73.030000000000001 113.715 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 96' ' ' LYS . 70.3 mmtt -88.31 162.53 16.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.587 . . . . 65.319999999999993 112.025 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 29.6 m -75.38 155.19 36.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.208 1.188 . . . . 42.420000000000002 114.208 -167.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 155' ' ' ALA . 0.9 OUTLIER -144.04 149.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.017 -0.992 . . . . 70.349999999999994 110.864 171.369 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 t -100.57 -173.49 2.42 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.367 -0.379 . . . . 64.329999999999998 111.355 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.461 HH11 ' HE2' ' A' ' 152' ' ' TYR . 1.1 mpp_? -59.87 -38.56 82.53 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.978 1.103 . . . . 73.019999999999996 113.978 -169.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.9 p -79.86 -5.68 55.96 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.744 -0.598 . . . . 51.32 111.67 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -116.73 11.11 14.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.843 0.312 . . . . 62.409999999999997 111.843 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 78.1 mt -72.44 129.56 38.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.109 0.48 . . . . 65.140000000000001 111.588 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.402 HH21 HG11 ' A' ' 98' ' ' VAL . 41.3 mtm180 -138.8 172.23 13.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.02 0.528 . . . . 73.340000000000003 111.08 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.3 m -64.94 114.93 4.88 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.184 0.516 . . . . 71.230000000000004 111.969 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.86 -3.36 24.36 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.296 -0.478 . . . . 72.120000000000005 113.696 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -79.99 134.16 36.22 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.304 0.573 . . . . 70.140000000000001 111.125 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 77.3 mt -89.36 119.37 29.77 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.477 -0.328 . . . . 63.219999999999999 111.482 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 155' ' ' ALA . 12.5 m -95.62 129.24 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.978 0.418 . . . . 70.430000000000007 111.721 -177.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.61 140.7 33.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.308 -0.405 . . . . 45.439999999999998 111.58 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.41 140.09 51.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.794 0.33 . . . . 73.150000000000006 111.407 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -86.72 90.13 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.917 0.389 . . . . 75.340000000000003 110.229 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 112.372 0.508 . . . . 44.240000000000002 112.372 -173.898 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.44 ' O ' HG21 ' A' ' 88' ' ' THR . 2.7 mpt_? . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 121.232 0.539 . . . . 64.450000000000003 110.552 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -92.63 143.01 26.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.919 -0.582 . . . . 73.329999999999998 110.613 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.93 137.58 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.263 0.554 . . . . 63.299999999999997 112.346 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.26 20.65 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.044 -0.525 . . . . 72.25 112.874 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.509 HD11 ' HA ' ' A' ' 72' ' ' VAL . 47.0 mt -90.27 109.42 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.801 0.3 . . . . 74.329999999999998 111.038 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.545 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 63.8 t80 -75.46 113.78 13.27 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.954 0.407 . . . . 63.130000000000003 111.358 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.44 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 27.7 pt -95.51 -32.96 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.107 0.41 . . . . 65.519999999999996 112.107 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.38 165.36 11.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.187 -0.53 . . . . 53.130000000000003 113.2 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.407 ' O ' ' HG3' ' A' ' 128' ' ' GLN . 14.6 t-20 59.39 42.49 17.89 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.219 0.533 . . . . 74.25 110.788 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.545 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 4.2 p30 51.53 17.18 0.52 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.066 0.947 . . . . 62.340000000000003 112.725 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 126' ' ' ASN . 77.5 mt-30 -108.56 145.51 34.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.371 0.605 . . . . 72.219999999999999 111.702 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.525 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 8.0 p90 -148.97 150.43 32.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.648 -0.706 . . . . 74.310000000000002 111.659 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.49 140.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.014 0.435 . . . . 75.310000000000002 111.326 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -161.72 -166.37 1.46 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.474 -0.33 . . . . 71.150000000000006 111.236 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.96 106.46 8.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.76 0.314 . . . . 63.119999999999997 111.615 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.6 m -81.89 155.19 25.44 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.892 0.377 . . . . 71.129999999999995 111.987 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 67.8 p -52.84 -46.56 67.84 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.216 1.191 . . . . 63.439999999999998 114.216 -172.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -100.56 -44.74 5.75 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.904 -0.497 . . . . 72.299999999999997 112.07 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.0 m -65.77 -38.71 89.8 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.938 0.718 . . . . 53.409999999999997 112.938 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.66 -146.4 18.25 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.937 -0.649 . . . . 53.399999999999999 112.212 -173.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 51' ' ' TRP . 61.0 t -69.38 111.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 117.201 0.5 . . . . 61.32 111.67 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.2 pt -141.16 -179.98 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.165 0.507 . . . . 74.239999999999995 111.663 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.47 137.08 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.192 -0.458 . . . . 72.299999999999997 110.42 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.5 m -130.44 159.08 38.13 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.938 0.399 . . . . 74.319999999999993 111.68 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.6 m -115.2 148.4 39.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.366 -0.379 . . . . 61.240000000000002 111.586 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.511 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 91.8 mmm -67.54 -22.53 65.41 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.14 0.495 . . . . 65.200000000000003 110.863 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.33 -20.6 66.13 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.098 -0.501 . . . . 71.040000000000006 111.615 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -67.1 132.25 93.64 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.546 0.212 . . . . 72.439999999999998 110.96 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.592 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 14.1 Cg_endo -54.49 -48.79 19.53 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.747 2.298 . . . . 72.109999999999999 113.299 -174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -56.54 -48.47 77.21 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.129 0.418 . . . . 75.099999999999994 112.129 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.9 -40.07 61.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 111.424 -174.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -53.56 -55.95 21.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.162 -0.472 . . . . 62.340000000000003 111.834 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.608 ' HG3' ' HD2' ' A' ' 151' ' ' ARG . 19.1 ptpt -74.06 -28.74 61.54 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.803 0.668 . . . . 55.520000000000003 112.803 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.608 ' HD2' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -86.89 -7.5 58.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.478 0.547 . . . . 74.400000000000006 112.478 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.461 ' HE2' HH11 ' A' ' 100' ' ' ARG . 63.3 t80 -60.0 121.44 11.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.114 0.483 . . . . 75.129999999999995 111.778 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -94.65 -69.59 0.75 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.851 -0.613 . . . . 71.510000000000005 111.234 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.65 144.15 7.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.507 -0.315 . . . . 64.329999999999998 111.627 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -99.82 162.88 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.417 -0.177 . . . . 70.540000000000006 111.172 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -141.81 141.46 33.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.037 0.446 . . . . 73.310000000000002 111.899 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 157' ' ' ARG . 0.5 OUTLIER -97.45 95.29 7.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.29 0.567 . . . . 75.209999999999994 111.677 178.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.78 -15.18 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.004 -0.544 . . . . 65.430000000000007 112.175 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.479 HD23 HD22 ' A' ' 82' ' ' LEU . 96.0 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.683 0.278 . . . . 70.230000000000004 111.371 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.139 0.495 . . . . 63.409999999999997 110.938 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 44' ' ' ILE . 60.0 t -52.13 -46.64 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.751 -0.659 . . . . 73.230000000000004 112.087 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -59.01 -44.51 91.7 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.942 0.401 . . . . 71.209999999999994 111.086 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.5 m -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.466 -0.334 . . . . 73.340000000000003 111.287 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -65.37 -38.82 91.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 71.049999999999997 112.309 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 40' ' ' VAL . 81.6 mt -64.29 -52.61 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.077 0.465 . . . . 64.409999999999997 111.23 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.415 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 28.9 mmt -63.6 -27.73 69.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.967 0.413 . . . . 52.119999999999997 111.219 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -59.52 -48.4 81.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.917 -0.583 . . . . 63.020000000000003 111.284 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -76.64 -36.27 57.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 54.43 111.106 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.532 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 27.2 t80 -53.58 -37.65 63.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.765 0.317 . . . . 74.340000000000003 110.651 174.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . . . -53.34 -25.35 14.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.206 0.447 . . . . 54.109999999999999 112.206 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -86.4 -38.05 17.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.135 0.493 . . . . 72.540000000000006 111.124 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -88.07 -2.63 58.72 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.924 0.713 . . . . 74.409999999999997 112.924 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 98.6 mttt -53.0 106.07 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.552 0.575 . . . . 74.099999999999994 112.552 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.14 -8.25 25.06 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.982 -0.628 . . . . 74.219999999999999 114.386 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.66 123.22 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 117.49 0.645 . . . . 62.299999999999997 111.031 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.97 169.69 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.424 0.63 . . . . 61.5 112.568 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -83.93 128.42 34.53 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.808 -0.633 . . . . 71.239999999999995 111.679 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -136.87 118.61 15.05 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.53 -0.305 . . . . 70.340000000000003 111.024 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.0 mp -74.3 102.59 4.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.999 0.37 . . . . 71.510000000000005 111.999 -173.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.28 33.7 31.4 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.068 -0.587 . . . . 64.239999999999995 113.241 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.15 102.93 0.27 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.905 -0.478 . . . . 50.210000000000001 111.905 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.511 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 p -94.81 100.84 12.66 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.504 0.557 . . . . 64.140000000000001 112.504 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -158.93 173.09 17.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.161 -0.472 . . . . 62.200000000000003 111.791 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -74.75 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.431 . . . . 74.239999999999995 111.32 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 3.1 mptp? -90.98 0.73 57.46 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.205 -0.452 . . . . 62.409999999999997 111.001 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.11 145.99 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.059 -0.417 . . . . 71.430000000000007 112.059 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.511 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.5 tt -165.02 148.09 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 117.551 0.676 . . . . 62.310000000000002 112.001 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.84 0.352 . . . . 70.129999999999995 111.473 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 25.0 p -59.94 -47.66 84.87 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.285 0.476 . . . . 71.450000000000003 112.285 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.3 m -63.97 -41.5 97.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.976 0.417 . . . . 65.230000000000004 111.225 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.81 -40.27 95.52 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.973 -0.632 . . . . 62.409999999999997 112.605 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -60.24 -54.24 48.19 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.976 0.362 . . . . 74.040000000000006 111.976 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.66 -38.04 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.058 0.456 . . . . 61.329999999999998 111.038 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -53.79 -57.78 9.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.293 0.568 . . . . 64.120000000000005 111.642 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 18.5 mmt180 -64.8 -48.1 75.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.951 -0.568 . . . . 65.040000000000006 111.844 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 m -52.68 -51.1 61.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.093 0.473 . . . . 65.310000000000002 111.865 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 35.3 m-85 -70.05 -38.66 75.87 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.773 0.657 . . . . 75.319999999999993 112.773 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 4.7 ptm180 -69.24 -33.71 73.69 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.89 -0.507 . . . . 73.319999999999993 111.542 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.12 -36.85 64.23 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 111.902 0.334 . . . . 72.409999999999997 111.902 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -97.48 -58.4 2.01 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.578 0.585 . . . . 52.109999999999999 112.578 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.33 -1.74 53.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.421 0.526 . . . . 74.540000000000006 112.421 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.68 22.43 76.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.182 -0.533 . . . . 72.010000000000005 112.889 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -100.34 113.02 25.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 75.219999999999999 111.192 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.994 0.426 . . . . 72.219999999999999 111.575 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.01 153.83 37.75 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.325 -0.398 . . . . 61.310000000000002 111.361 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.86 168.21 19.31 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.443 2.096 . . . . 53.229999999999997 113.208 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -81.32 3.58 23.69 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.559 0.577 . . . . 62.130000000000003 112.559 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 30.8 t -122.17 133.44 54.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.343 0.498 . . . . 73.400000000000006 112.343 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 2.5 m -56.21 -45.21 79.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.854 -0.612 . . . . 75.310000000000002 111.026 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.6 -44.31 85.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.571 -0.741 . . . . 72.329999999999998 111.438 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 19.2 mm-40 -70.52 -33.99 71.79 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.153 0.501 . . . . 75.420000000000002 111.214 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -66.29 -20.36 66.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.528 -0.305 . . . . 65.420000000000002 111.74 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 88' ' ' THR . 22.9 mt-30 -72.08 -22.53 61.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.983 0.42 . . . . 71.129999999999995 111.819 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -87.46 -2.66 58.77 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.342 -0.39 . . . . 71.219999999999999 111.484 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.2 mmm -97.25 -75.83 0.53 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.865 0.364 . . . . 63.5 111.561 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.65 151.87 48.48 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.369 -0.443 . . . . 75.510000000000005 113.634 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 29.8 mmtp -89.29 153.94 20.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.998 0.427 . . . . 73.109999999999999 111.533 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.9 p -85.61 152.86 22.8 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.223 0.823 . . . . 75.510000000000005 113.223 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.513 HG13 ' NE ' ' A' ' 157' ' ' ARG . 1.1 m -152.25 171.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.861 -0.609 . . . . 74.519999999999996 112.161 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.2 t -116.26 -178.63 3.46 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.727 -0.67 . . . . 50.210000000000001 111.053 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.439 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -55.74 -46.09 77.88 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.287 0.477 . . . . 74.430000000000007 112.287 -177.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -69.48 -3.3 14.0 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.22 0.452 . . . . 70.430000000000007 112.22 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.493 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 5.6 m120 -116.08 -7.5 11.89 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.948 -0.47 . . . . 72.040000000000006 111.96 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.27 135.06 57.62 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.897 0.703 . . . . 71.25 112.897 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -115.42 -152.02 0.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.491 -0.777 . . . . 61.109999999999999 109.855 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.9 m -102.83 105.02 15.34 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.791 -0.568 . . . . 74.430000000000007 111.505 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 122.91 -3.78 9.87 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.842 -0.694 . . . . 32.509999999999998 114.604 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.86 134.24 56.89 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.373 0.586 . . . . 75.549999999999997 111.759 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.4 mt -85.38 113.19 21.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.026 0.441 . . . . 63.420000000000002 111.26 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' A' ' 155' ' ' ALA . 19.2 m -95.4 134.78 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.031 0.443 . . . . 74.530000000000001 111.438 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 87.8 mt -104.62 138.57 40.75 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.245 0.461 . . . . 72.340000000000003 112.245 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 56.2 m-85 -123.4 141.28 52.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.933 -0.576 . . . . 75.019999999999996 111.505 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 48.2 mtt180 -82.87 82.01 8.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.956 0.408 . . . . 73.340000000000003 110.027 173.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 112.002 0.371 . . . . 74.200000000000003 112.002 -173.49 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.028 0.442 . . . . 71.439999999999998 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 52.5 t60 -95.94 154.64 17.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.342 -0.39 . . . . 74.510000000000005 110.555 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.406 ' HB ' HG23 ' A' ' 88' ' ' THR . 14.9 p -134.57 142.94 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.172 0.51 . . . . 74.120000000000005 112.308 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.38 160.89 26.93 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.979 -0.555 . . . . 43.450000000000003 112.625 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -97.01 109.65 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.532 -0.393 . . . . 75.319999999999993 111.32 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -68.03 108.65 3.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.928 0.394 . . . . 74.25 111.231 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 pt -109.43 -32.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.458 0.54 . . . . 51.140000000000001 112.458 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.51 -175.72 14.13 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.201 -0.523 . . . . 73.150000000000006 113.038 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -43.02 -58.0 2.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.858 0.688 . . . . 72.450000000000003 112.858 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 142' ' ' SER . 4.9 m-20 -122.11 -10.35 8.58 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.17 -0.331 . . . . 72.329999999999998 111.525 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.36 137.17 33.56 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.348 0.594 . . . . 75.049999999999997 112.459 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.69 142.57 27.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.594 -0.73 . . . . 62.350000000000001 110.965 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -97.41 136.33 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.869 0.366 . . . . 71.030000000000001 111.251 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -165.19 168.69 16.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 73.0 111.181 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.86 91.25 7.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.145 0.498 . . . . 65.530000000000001 110.515 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.8 p -65.14 146.02 55.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.868 -0.606 . . . . 34.420000000000002 112.086 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.2 p -64.48 -25.13 67.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.147 0.499 . . . . 62.539999999999999 111.303 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -73.17 -70.59 0.35 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.089 -0.505 . . . . 54.140000000000001 112.276 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.0 m -102.83 -35.75 8.51 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.124 0.416 . . . . 70.120000000000005 112.124 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.63 -141.29 13.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.078 -0.582 . . . . 54.43 112.567 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.9 92.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.321 0.582 . . . . 74.540000000000006 111.948 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.7 pt -136.88 -176.69 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.059 -0.519 . . . . 74.120000000000005 111.024 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.28 116.36 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.543 -0.299 . . . . 54.299999999999997 110.656 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.2 m -104.3 -177.99 3.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.767 0.318 . . . . 74.109999999999999 110.758 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.3 m -143.59 145.27 32.38 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.154 0.502 . . . . 65.439999999999998 112.342 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.81 -27.57 69.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.687 0.625 . . . . 65.439999999999998 112.687 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -72.85 -3.63 26.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.929 0.344 . . . . 63.210000000000001 111.929 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -74.8 122.25 87.07 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 110.423 -0.214 . . . . 72.329999999999998 110.423 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.14 -39.36 11.58 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.418 2.745 . . . . 64.019999999999996 114.421 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.488 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 85.7 t80 -61.72 -51.46 68.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.862 0.363 . . . . 75.019999999999996 111.28 176.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -76.84 -27.97 55.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.434 -0.348 . . . . 75.319999999999993 111.203 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.91 -34.56 74.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.203 -0.453 . . . . 51.329999999999998 111.234 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -102.6 0.99 34.19 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.362 -0.381 . . . . 55.539999999999999 111.521 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -103.41 -30.64 10.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 111.905 0.335 . . . . 74.349999999999994 111.905 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 70.6 t80 -56.64 135.28 54.96 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.886 0.374 . . . . 74.409999999999997 111.498 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -123.0 -51.33 1.9 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.932 0.345 . . . . 73.319999999999993 111.932 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.69 -179.04 7.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.079 0.4 . . . . 71.310000000000002 112.079 -173.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -144.73 149.47 35.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.516 -0.311 . . . . 74.439999999999998 111.374 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.6 mtm-85 -137.46 118.2 14.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.68 0.252 . . . . 74.439999999999998 111.68 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.513 ' NE ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.21 109.42 11.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.138 0.494 . . . . 72.430000000000007 110.981 174.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.457 ' HB ' HD21 ' A' ' 82' ' ' LEU . 16.8 m -84.13 -29.73 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.14 0.495 . . . . 54.340000000000003 111.201 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 CA--C 1.535 0.383 0 CA-C-N 116.267 -0.424 . . . . 75.150000000000006 110.177 174.33 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.468 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 12.2 t70 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 110.272 -0.27 . . . . 73.329999999999998 110.272 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.1 t -56.21 -53.87 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.831 0.348 . . . . 52.340000000000003 111.411 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.7 tttt -61.4 -43.19 99.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.307 -0.406 . . . . 61.130000000000003 111.238 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.4 m -57.17 -42.73 81.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.099 -0.5 . . . . 41.020000000000003 111.331 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -72.01 -42.36 66.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.259 0.466 . . . . 60.310000000000002 112.259 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 40' ' ' VAL . 78.9 mt -58.35 -48.69 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 64.519999999999996 110.897 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 92.7 mmm -63.88 -36.23 83.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.039 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.35 -43.62 83.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.912 -0.585 . . . . 73.319999999999993 111.37 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -71.24 -45.61 62.87 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.998 0.428 . . . . 72.230000000000004 111.145 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -54.44 -41.22 69.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.445 -0.343 . . . . 74.239999999999995 111.831 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.82 -20.85 9.52 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.321 0.489 . . . . 74.109999999999999 112.321 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.1 -25.54 17.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.087 0.47 . . . . 73.040000000000006 111.47 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.411 ' O ' ' HB ' ' A' ' 138' ' ' VAL . 81.4 m95 -105.14 3.27 30.09 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.101 0.778 . . . . 73.319999999999993 113.101 -175.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -54.84 101.71 0.05 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.844 0.354 . . . . 74.340000000000003 111.916 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.45 21.4 22.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.015 -0.612 . . . . 64.340000000000003 114.412 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.7 t -80.5 132.05 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 117.851 0.826 . . . . 73.329999999999998 110.992 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -63.27 163.3 10.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.938 0.718 . . . . 74.430000000000007 112.938 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 48.9 t80 -92.94 140.17 29.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.096 -0.502 . . . . 63.399999999999999 111.602 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -137.08 139.47 41.31 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.869 0.366 . . . . 65.450000000000003 110.969 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.7 mp -74.72 97.4 3.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 70.510000000000005 112.193 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 67' ' ' ASP . . . 78.43 6.76 88.05 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.051 -0.522 . . . . 65.299999999999997 114.329 174.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.77 77.85 0.3 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 117.497 0.648 . . . . 70.430000000000007 113.128 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.532 ' H ' ' NH2' ' A' ' 86' ' ' ARG . 48.3 t -68.41 107.69 2.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.396 0.887 . . . . 73.030000000000001 113.396 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.8 t -166.14 172.58 11.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.724 0.409 . . . . 73.040000000000006 111.576 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -65.01 -21.35 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.953 -0.467 . . . . 75.230000000000004 111.572 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.01 9.25 20.18 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.392 0.615 . . . . 71.040000000000006 111.021 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.52 136.05 3.08 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.863 -0.895 . . . . 73.109999999999999 110.863 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 71' ' ' PHE . 19.7 tt -144.58 146.4 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.232 1.016 . . . . 65.129999999999995 112.828 -175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 59' ' ' GLY . 5.4 p-10 -93.12 160.04 15.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.005 -0.543 . . . . 74.530000000000001 111.502 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 28.2 p -57.36 -54.46 46.6 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.841 0.353 . . . . 54.530000000000001 111.553 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 8.2 p -58.95 -42.86 90.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.193 -0.458 . . . . 52.229999999999997 111.18 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . -57.63 -33.84 68.31 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.322 -0.399 . . . . 63.439999999999998 113.654 176.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.582 ' HA ' HD11 ' A' ' 66' ' ' ILE . 74.6 t80 -72.04 -48.46 44.32 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.48 -0.423 . . . . 74.109999999999999 111.612 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.58 HG13 HE22 ' A' ' 91' ' ' GLN . 7.1 p -63.1 -44.18 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.576 -0.284 . . . . 72.129999999999995 111.443 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.1 pp0? -61.14 -44.85 96.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.036 -0.415 . . . . 54.439999999999998 111.336 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -57.62 -50.5 72.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.041 0.386 . . . . 64.549999999999997 112.041 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.4 m -53.43 -45.83 69.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.833 0.349 . . . . 74.400000000000006 111.816 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 65.8 m-85 -72.86 -38.39 67.06 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.061 0.763 . . . . 72.530000000000001 113.061 -177.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -76.88 -42.77 38.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.572 -0.705 . . . . 74.450000000000003 112.287 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -73.43 -26.49 60.97 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.274 0.472 . . . . 44.340000000000003 112.274 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -96.0 -61.25 1.48 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.843 0.354 . . . . 74.219999999999999 111.866 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 76' ' ' PHE . 63.9 m-85 -90.08 -28.5 18.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.42 0.526 . . . . 75.540000000000006 112.42 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.1 27.29 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.191 -0.528 . . . . 65.519999999999996 112.512 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 37.4 tp -83.15 160.09 21.92 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.311 0.577 . . . . 74.310000000000002 111.865 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.63 114.57 27.1 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.058 0.456 . . . . 73.439999999999998 111.895 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.77 145.01 41.15 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 122.274 -0.267 . . . . 74.040000000000006 111.033 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.595 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 63.1 Cg_endo -85.73 -171.47 0.9 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.979 2.453 . . . . 74.019999999999996 113.881 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.532 ' NH2' ' H ' ' A' ' 61' ' ' SER . 11.0 mmm180 -88.44 -19.43 26.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.473 0.546 . . . . 74.209999999999994 112.473 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -106.31 126.63 52.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.756 0.65 . . . . 74.109999999999999 112.756 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 44.1 m -52.0 -41.8 62.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.89 -0.595 . . . . 74.340000000000003 111.665 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.407 ' OH ' ' HD3' ' A' ' 118' ' ' ARG . 89.0 m-85 -54.76 -32.53 60.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.85 -0.614 . . . . 73.129999999999995 112.306 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.08 -38.61 31.38 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.18 0.514 . . . . 75.019999999999996 110.961 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.595 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 44.9 mt-30 -61.85 -33.64 74.55 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.192 -0.458 . . . . 64.409999999999997 111.595 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.51 ' HG2' HD11 ' A' ' 110' ' ' LEU . 18.7 mt-30 -52.01 -37.72 54.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.241 0.543 . . . . 44.240000000000002 111.596 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -90.48 -9.81 45.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.015 -0.539 . . . . 74.219999999999999 112.126 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.503 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 81.1 mtp -87.25 -37.18 17.45 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.872 0.367 . . . . 53.130000000000003 111.374 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.76 150.93 21.41 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.946 -0.645 . . . . 64.409999999999997 113.388 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 31.2 mmmt -70.88 141.32 51.22 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.161 0.505 . . . . 72.450000000000003 112.007 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 m -77.47 127.54 32.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.656 -0.702 . . . . 75.400000000000006 112.106 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 7.1 m -145.5 164.65 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.382 0.61 . . . . 71.010000000000005 112.417 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 t -116.7 -177.71 3.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.689 -0.687 . . . . 73.0 110.776 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.512 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -56.14 -36.69 68.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.455 0.539 . . . . 74.400000000000006 112.455 -175.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.0 p -64.88 -29.14 70.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.03 0.443 . . . . 74.420000000000002 112.141 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -100.68 -6.89 24.46 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.173 0.805 . . . . 75.209999999999994 113.173 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.14 131.05 48.77 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.419 0.896 . . . . 74.109999999999999 113.419 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -125.07 175.79 7.12 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.743 -0.662 . . . . 62.539999999999999 110.33 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 41' ' ' LYS . 62.9 m -68.44 111.35 4.63 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.98 -0.45 . . . . 64.109999999999999 111.1 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.33 -12.93 7.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.388 -0.434 . . . . 72.200000000000003 112.711 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.18 130.45 43.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.022 0.439 . . . . 75.519999999999996 111.581 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.8 mt -87.95 112.32 22.43 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.95 0.405 . . . . 71.230000000000004 110.56 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -96.65 128.1 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.375 0.607 . . . . 52.219999999999999 111.577 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.51 HD11 ' HG2' ' A' ' 92' ' ' GLN . 79.3 mt -98.84 143.44 29.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 111.917 -175.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -131.14 132.19 44.61 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.39 -0.368 . . . . 74.310000000000002 111.266 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -81.22 84.79 6.49 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.242 0.544 . . . . 74.120000000000005 110.666 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 CA-C-N 115.873 -0.603 . . . . 54.149999999999999 112.138 -173.405 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.407 ' HD3' ' OH ' ' A' ' 89' ' ' TYR . 9.7 mpt_? . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 64.239999999999995 110.469 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -87.78 151.63 22.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.005 -0.543 . . . . 72.140000000000001 110.236 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.5 139.07 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.092 0.472 . . . . 72.120000000000005 112.242 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 131' ' ' HIS . . . -132.15 149.85 19.49 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 116.177 -0.465 . . . . 55.100000000000001 112.525 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 72' ' ' VAL . 43.6 mt -89.39 106.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 122.476 -0.426 . . . . 74.200000000000003 111.031 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.67 115.05 5.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.387 -0.37 . . . . 73.129999999999995 111.314 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.1 pt -103.04 -33.75 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.893 0.701 . . . . 71.209999999999994 112.893 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.45 123.24 0.83 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 119.777 -1.201 . . . . 41.520000000000003 115.139 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.69 -78.25 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.24 1.016 . . . . 71.319999999999993 111.696 171.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 142' ' ' SER . 53.8 m-80 -133.57 -7.4 2.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.449 -0.342 . . . . 73.200000000000003 111.342 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -86.68 140.42 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.285 0.564 . . . . 70.209999999999994 112.287 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -151.41 140.68 21.36 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.524 -0.762 . . . . 71.219999999999999 111.041 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.44 137.44 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.994 0.426 . . . . 45.409999999999997 111.394 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 133' ' ' SER . 5.0 p80 -162.9 162.21 26.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.988 0.366 . . . . 64.540000000000006 111.988 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -88.23 92.06 9.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.951 0.405 . . . . 41.520000000000003 110.391 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 131' ' ' HIS . 37.5 t -86.78 126.39 34.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.424 -0.353 . . . . 72.120000000000005 111.886 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -59.3 -17.76 31.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.44 0.533 . . . . 72.099999999999994 112.44 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.1 p -65.95 -41.3 91.45 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.91 0.386 . . . . 53.25 111.503 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.1 m -138.79 -39.22 0.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.048 0.388 . . . . 61.130000000000003 112.048 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.48 24.62 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.792 -0.523 . . . . 50.210000000000001 111.792 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 57.5 t -65.72 103.01 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.179 0.49 . . . . 61.43 111.237 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.72 169.84 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.106 -0.497 . . . . 71.150000000000006 111.399 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.48 114.55 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.591 -0.277 . . . . 75.420000000000002 110.687 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.5 m -104.57 178.56 4.52 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.965 0.412 . . . . 74.209999999999994 111.054 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 66.4 m -141.65 140.43 33.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.006 0.431 . . . . 75.540000000000006 112.106 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.02 -6.01 7.67 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.366 0.506 . . . . 54.5 112.366 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -73.0 -19.68 61.16 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 70.209999999999994 110.628 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.77 134.05 69.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.051 -0.522 . . . . 72.030000000000001 110.768 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.541 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 78.4 Cg_exo -51.25 -46.21 32.55 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.757 2.305 . . . . 71.200000000000003 113.489 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.79 -45.42 86.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.197 0.443 . . . . 74.310000000000002 112.197 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -80.33 -34.46 36.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.984 0.421 . . . . 64.5 111.641 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -60.5 -54.59 43.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.114 -0.493 . . . . 63.140000000000001 112.066 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 51.7 pttt -86.06 -14.78 43.33 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.173 0.805 . . . . 74.239999999999995 113.173 -174.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -92.95 -4.59 52.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.0 -0.438 . . . . 73.340000000000003 111.702 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.512 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 77.0 t80 -55.2 135.62 49.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.582 . . . . 62.549999999999997 112.234 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -104.81 -71.0 0.75 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.907 -0.588 . . . . 74.439999999999998 111.258 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.493 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.6 pt-20 -163.45 -174.11 3.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.17 -0.468 . . . . 73.019999999999996 111.057 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -142.11 137.63 31.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.611 0.597 . . . . 54.240000000000002 112.611 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 14.0 mmt180 -137.45 114.79 10.99 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.955 -0.566 . . . . 75.519999999999996 110.325 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.51 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -95.07 122.6 37.9 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.086 -1.009 . . . . 72.109999999999999 111.687 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.48 1.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.669 -0.696 . . . . 63.32 112.766 -176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 112.165 0.432 . . . . 63.149999999999999 112.165 -179.533 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 110.302 -0.258 . . . . 74.299999999999997 110.302 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 44' ' ' ILE . 46.6 t -56.5 -57.08 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.561 -0.291 . . . . 74.420000000000002 111.545 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 85.1 tttt -55.7 -42.31 75.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.901 0.381 . . . . 71.310000000000002 111.475 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -58.89 -43.66 91.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.218 -0.446 . . . . 62.049999999999997 111.583 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -74.29 -33.28 63.19 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.19 0.441 . . . . 65.049999999999997 112.19 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 40' ' ' VAL . 87.5 mt -60.06 -50.25 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.156 0.503 . . . . 73.400000000000006 110.649 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 mmt -67.83 -34.01 75.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 71.420000000000002 111.136 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -55.41 -43.65 75.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.262 -0.426 . . . . 73.409999999999997 110.93 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 60.7 tp60 -78.87 -35.92 43.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.539 -0.3 . . . . 73.329999999999998 111.322 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.35 -32.77 39.89 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.82 0.343 . . . . 74.030000000000001 111.564 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.73 -34.44 52.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.358 -0.383 . . . . 33.229999999999997 111.812 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -19.8 42.24 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.38 0.511 . . . . 72.439999999999998 112.38 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.512 ' CZ3' ' HA ' ' A' ' 63' ' ' LYS . 99.3 m95 -100.91 -4.33 27.92 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.281 0.845 . . . . 73.230000000000004 113.281 -174.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -65.18 127.57 32.23 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.877 -0.514 . . . . 75.319999999999993 111.272 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.27 -1.47 67.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.312 -0.47 . . . . 71.340000000000003 113.785 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.3 134.1 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 117.299 0.55 . . . . 52.409999999999997 111.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -83.56 161.07 21.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.403 0.52 . . . . 65.349999999999994 112.403 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -78.4 116.34 18.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.88 -0.6 . . . . 75.400000000000006 111.404 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -127.25 97.48 4.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.166 0.508 . . . . 70.439999999999998 110.638 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 40.7 tp -70.85 104.94 3.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.095 -0.502 . . . . 71.019999999999996 111.648 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.17 -63.61 0.56 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.362 -0.447 . . . . 74.530000000000001 112.781 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.92 99.35 2.11 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.221 -0.514 . . . . 60.229999999999997 112.532 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.548 ' HA ' HG13 ' A' ' 66' ' ' ILE . 76.4 p -84.09 105.9 15.32 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.068 0.395 . . . . 74.319999999999993 112.068 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -156.89 163.21 39.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.129 0.49 . . . . 62.229999999999997 112.167 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 39.2 ttmt -67.04 -11.76 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.272 0.558 . . . . 72.540000000000006 111.502 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.504 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -94.95 11.46 31.77 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.221 0.534 . . . . 75.109999999999999 110.748 177.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.5 123.25 1.57 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.159 -0.776 . . . . 63.409999999999997 111.159 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.8 tt -155.72 152.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 117.953 0.876 . . . . 72.319999999999993 112.706 -171.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -93.21 179.31 5.46 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.994 0.426 . . . . 71.349999999999994 111.509 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.53 -54.35 41.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.554 0.576 . . . . 52.310000000000002 112.554 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.5 p -62.13 -34.39 76.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.108 0.48 . . . . 62.420000000000002 111.71 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.67 -44.19 72.17 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.832 -0.699 . . . . 71.439999999999998 112.292 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -56.96 -52.31 65.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.866 0.365 . . . . 73.420000000000002 111.851 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.545 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.8 p -59.82 -41.92 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 50.340000000000003 111.386 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 5.7 tt0 -55.24 -54.82 38.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.363 0.601 . . . . 71.329999999999998 111.169 174.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -56.33 -54.38 46.17 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.44 -0.8 . . . . 74.239999999999995 111.73 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.457 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 66.1 m -52.87 -48.06 67.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.054 0.39 . . . . 71.129999999999995 112.054 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 38.3 m-85 -70.18 -35.23 73.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.983 0.735 . . . . 74.040000000000006 112.983 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -80.31 -33.52 37.5 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.722 -0.611 . . . . 74.129999999999995 111.806 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -72.64 -33.61 66.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.978 0.418 . . . . 72.400000000000006 111.53 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -102.35 -56.7 2.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.803 0.668 . . . . 71.299999999999997 112.803 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.54 -3.59 54.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.403 0.52 . . . . 73.400000000000006 112.403 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.49 22.79 66.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.429 -0.415 . . . . 74.510000000000005 113.012 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.511 HD22 HD23 ' A' ' 159' ' ' LEU . 46.4 tp -86.94 130.21 34.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.196 0.522 . . . . 74.310000000000002 111.97 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.67 101.38 10.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 111.496 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 73' ' ' GLN . 83.9 mt -111.99 139.83 22.78 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.292 . . . . 62.5 111.242 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.61 148.92 54.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.351 2.034 . . . . 54.530000000000001 112.751 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -83.37 65.22 8.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.352 0.596 . . . . 74.040000000000006 110.177 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 13.2 t -171.0 120.24 0.52 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.688 -0.687 . . . . 74.549999999999997 111.029 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.57 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 53.5 m -52.06 -41.62 62.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.946 0.403 . . . . 73.219999999999999 111.001 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CZ ' ' HD3' ' A' ' 118' ' ' ARG . 83.7 m-85 -60.83 -46.53 90.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.181 -0.463 . . . . 70.450000000000003 111.322 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 94' ' ' MET . 16.5 mm-40 -64.99 -37.66 88.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.934 0.397 . . . . 74.019999999999996 111.322 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 87' ' ' SER . 95.2 mt-30 -67.07 -36.12 81.33 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.027 0.38 . . . . 74.329999999999998 112.027 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 88' ' ' THR . 23.6 mt-30 -52.89 -55.15 25.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.307 0.575 . . . . 74.230000000000004 111.545 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.08 0.9 17.12 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.598 0.592 . . . . 72.209999999999994 112.598 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 88.0 mmm -91.88 -13.43 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.682 0.277 . . . . 70.150000000000006 111.369 173.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -135.52 156.1 22.55 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.077 -0.583 . . . . 55.340000000000003 113.535 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 34.1 mmtp -94.37 152.84 18.32 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.482 -0.422 . . . . 71.239999999999995 111.367 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 79.3 p -84.44 157.26 21.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.149 0.796 . . . . 34.119999999999997 113.149 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.34 158.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 115.28 -0.873 . . . . 73.140000000000001 111.536 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.6 t -94.41 178.27 5.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.168 0.433 . . . . 73.430000000000007 112.168 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -51.3 -54.91 21.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.854 0.687 . . . . 71.409999999999997 112.854 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -74.17 -8.25 55.53 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.606 0.595 . . . . 72.439999999999998 112.606 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -107.45 3.67 25.38 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.205 0.446 . . . . 64.129999999999995 112.205 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.06 122.93 16.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.797 0.332 . . . . 73.340000000000003 111.843 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -105.72 154.36 20.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.372 -0.376 . . . . 74.140000000000001 110.602 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.3 m -66.35 119.52 11.71 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.916 -0.49 . . . . 75.530000000000001 110.855 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.47 -11.18 23.8 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.361 -0.447 . . . . 74.209999999999994 112.626 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.57 138.41 53.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.228 0.537 . . . . 74.510000000000005 111.412 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.449 HD22 HG21 ' A' ' 72' ' ' VAL . 23.5 mt -86.62 117.04 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.8 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -95.23 118.87 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.433 0.635 . . . . 72.140000000000001 111.418 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 70.1 mt -93.1 127.02 38.48 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.613 -0.721 . . . . 72.019999999999996 111.867 -177.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.67 133.58 55.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.328 -0.396 . . . . 73.420000000000002 111.126 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -75.87 92.06 3.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.904 0.383 . . . . 64.430000000000007 110.832 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 112.21 0.448 . . . . 63.450000000000003 112.21 -175.783 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 8.2 mpt_? . . . . . 0 N--CA 1.468 0.425 0 CA-C-O 121.009 0.433 . . . . 75.450000000000003 111.223 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 82.9 t60 -102.4 151.89 21.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.474 -0.33 . . . . 72.329999999999998 110.213 174.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.71 137.77 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.149 0.499 . . . . 50.119999999999997 112.279 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.18 159.29 23.97 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.082 -0.508 . . . . 73.329999999999998 112.598 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.545 HD11 ' HA ' ' A' ' 72' ' ' VAL . 45.0 mt -92.22 106.57 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.536 -0.391 . . . . 75.329999999999998 111.418 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -65.74 120.79 13.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.818 0.342 . . . . 64.439999999999998 111.32 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.512 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.9 pt -102.98 -37.61 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.348 0.499 . . . . 64.329999999999998 112.348 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.27 142.05 4.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.381 -0.914 . . . . 34.420000000000002 114.086 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.52 -79.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.453 0.701 . . . . 70.530000000000001 111.822 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 143' ' ' MET . 7.8 p30 -150.8 9.08 0.59 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.134 -0.484 . . . . 75.319999999999993 110.92 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -89.28 143.01 27.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 111.22 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.459 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 19.1 p90 -153.92 145.15 22.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 64.530000000000001 111.325 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.13 129.95 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.188 0.518 . . . . 75.299999999999997 110.86 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -150.65 -178.52 6.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.349 -0.387 . . . . 73.040000000000006 111.394 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -110.73 99.6 8.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.986 0.422 . . . . 61.420000000000002 111.482 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.9 t -66.25 136.23 55.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.126 -0.488 . . . . 74.409999999999997 111.452 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -57.28 -25.73 59.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.237 0.458 . . . . 73.349999999999994 112.237 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.8 t -99.56 -60.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.14 0.422 . . . . 41.140000000000001 112.14 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.8 m -73.32 -52.82 12.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.587 0.588 . . . . 53.350000000000001 112.587 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 -146.9 16.61 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.489 -0.386 . . . . 73.299999999999997 112.279 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.75 106.58 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 117.373 0.587 . . . . 72.120000000000005 112.001 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -140.24 174.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 120.988 0.423 . . . . 62.140000000000001 111.568 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.5 mt -105.41 123.26 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.526 -0.306 . . . . 73.239999999999995 111.213 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -116.37 173.58 6.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.658 0.266 . . . . 45.109999999999999 111.287 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 127' ' ' ASN . 67.6 m -137.82 139.48 39.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.554 0.576 . . . . 75.109999999999999 112.554 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 67.7 mtm -78.65 8.74 4.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.954 0.724 . . . . 64.120000000000005 112.954 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 142' ' ' SER . 10.4 p30 -78.6 -21.13 48.99 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.62 -0.675 . . . . 75.030000000000001 109.685 166.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.54 126.01 92.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.626 -0.716 . . . . 53.439999999999998 110.423 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 86.8 Cg_exo -43.7 -48.46 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.134 2.556 . . . . 72.310000000000002 114.298 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.555 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.6 t80 -57.4 -48.74 78.28 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.865 0.32 . . . . 75.329999999999998 111.865 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -73.97 -39.48 63.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.021 0.439 . . . . 60.109999999999999 111.405 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -55.0 -44.33 74.4 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.847 -0.615 . . . . 63.109999999999999 112.159 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.7 ptpt -91.21 -19.65 22.81 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.444 0.535 . . . . 71.120000000000005 112.444 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -83.21 -16.84 44.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.074 -0.391 . . . . 63.32 111.33 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -58.73 111.9 1.44 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.054 0.455 . . . . 74.299999999999997 111.898 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.429 HD22 ' HG2' ' A' ' 154' ' ' GLU . 7.5 t30 -85.85 -58.5 2.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.37 -0.377 . . . . 61.450000000000003 110.794 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.429 ' HG2' HD22 ' A' ' 153' ' ' ASN . 12.0 pt-20 -166.46 152.14 8.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.798 0.332 . . . . 74.0 111.211 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -105.57 145.16 31.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.521 -0.309 . . . . 51.240000000000002 110.637 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 63.5 mtt180 -134.59 118.82 17.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.893 0.377 . . . . 71.200000000000003 111.42 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.551 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -80.8 125.69 30.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.094 0.473 . . . . 75.430000000000007 111.473 -178.271 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.21 -10.49 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.364 -0.38 . . . . 53.119999999999997 112.012 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.511 HD23 HD22 ' A' ' 82' ' ' LEU . 91.1 mt . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.936 0.398 . . . . 72.409999999999997 111.545 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 24.7 m-20 . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.542 0.211 . . . . 73.230000000000004 110.522 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.7 t -50.07 -50.93 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.286 . . . . 72.209999999999994 111.34 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.8 tttt -55.26 -44.6 75.74 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.814 0.34 . . . . 64.310000000000002 111.578 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 35.3 t -59.74 -39.96 86.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.931 0.396 . . . . 73.319999999999993 111.011 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.56 ' HA ' ' HE ' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -67.39 -42.05 83.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.349 -0.387 . . . . 74.209999999999994 111.826 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 40' ' ' VAL . 48.7 mt -64.31 -45.13 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.006 0.431 . . . . 63.229999999999997 111.089 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 29.9 mmt -65.76 -36.31 83.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.902 0.382 . . . . 54.329999999999998 110.871 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -47.72 74.29 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.209999999999994 110.958 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.522 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 8.0 tp60 -66.04 -47.86 72.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.947 -0.57 . . . . 72.209999999999994 110.894 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.519 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 17.0 t80 -55.8 -32.66 63.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.141 -0.481 . . . . 75.329999999999998 111.382 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.41 -33.07 58.65 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.049 0.452 . . . . 65.409999999999997 111.632 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.32 -20.96 31.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.231 0.456 . . . . 73.430000000000007 112.231 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -113.75 17.84 17.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.693 0.627 . . . . 74.409999999999997 112.693 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.1 mtmt -62.68 110.41 1.71 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.144 0.497 . . . . 73.439999999999998 112.33 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 21.77 41.84 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.407 0.523 . . . . 51.310000000000002 114.407 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.95 118.67 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 117.577 0.689 . . . . 71.439999999999998 110.967 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -71.73 163.64 27.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.742 0.645 . . . . 71.430000000000007 112.742 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 50.2 t80 -77.85 126.65 31.18 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.701 . . . . 75.420000000000002 111.833 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -138.39 103.08 4.8 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.056 -0.52 . . . . 63.140000000000001 110.156 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 tp -72.04 132.28 44.03 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.96 0.409 . . . . 74.420000000000002 111.716 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 -44.2 3.22 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.203 -0.522 . . . . 73.230000000000004 113.175 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.75 60.54 2.41 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 122.509 -0.407 . . . . 73.409999999999997 112.749 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.43 ' HB2' HG13 ' A' ' 66' ' ' ILE . 99.1 p -67.26 113.62 5.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.053 0.454 . . . . 42.149999999999999 112.161 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.418 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 2.6 t -164.74 171.57 14.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.991 -0.55 . . . . 74.299999999999997 110.89 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -69.96 -14.4 62.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.658 -0.651 . . . . 64.109999999999999 111.32 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.67 2.38 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.948 0.404 . . . . 64.310000000000002 110.958 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.23 121.37 0.97 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.178 -0.769 . . . . 63.310000000000002 111.178 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.5 tt -149.54 158.6 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 74.519999999999996 112.421 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.93 174.39 6.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.039 0.447 . . . . 71.530000000000001 111.621 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.8 p -65.09 -53.29 47.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.576 0.584 . . . . 71.019999999999996 112.576 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 12.2 p -59.04 -39.62 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.978 0.362 . . . . 54.130000000000003 111.978 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.98 -37.91 92.44 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.021 -0.609 . . . . 72.409999999999997 112.821 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -63.17 -53.97 44.91 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.641 0.258 . . . . 45.350000000000001 111.367 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.53 -43.93 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 112.249 0.463 . . . . 74.219999999999999 112.249 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.8 -37.04 80.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.924 0.392 . . . . 72.540000000000006 110.912 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 84.1 mtt85 -69.53 -50.05 48.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.993 0.368 . . . . 60.25 111.993 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -52.71 -48.16 66.81 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.096 0.474 . . . . 63.32 111.582 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.576 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.8 m-85 -69.72 -36.38 75.83 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.698 . . . . 63.329999999999998 112.886 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 6.4 ptm180 -68.42 -32.06 71.84 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.949 -0.469 . . . . 71.319999999999993 111.201 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.521 ' HG3' HE22 ' A' ' 47' ' ' GLN . 27.2 mm-40 -74.47 -62.18 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.166 0.508 . . . . 72.450000000000003 111.225 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.522 ' OE1' ' HB2' ' A' ' 47' ' ' GLN . 3.0 mp0 -72.1 -44.76 62.71 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.758 0.651 . . . . 74.140000000000001 112.758 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -110.81 -3.6 15.65 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.066 0.765 . . . . 72.129999999999995 113.066 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 22.44 68.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.824 -0.703 . . . . 60.350000000000001 113.068 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.1 tp -95.47 121.52 37.24 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 75.140000000000001 111.31 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.59 110.34 22.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.952 0.406 . . . . 63.340000000000003 111.769 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.9 mt -97.29 152.71 38.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.472 -0.331 . . . . 73.200000000000003 111.221 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.5 175.67 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.433 2.089 . . . . 63.140000000000001 112.963 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 86' ' ' ARG . 34.6 mmt-85 -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.873 1.064 . . . . 73.129999999999995 113.873 -167.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 84.4 p -130.6 147.05 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.806 -0.559 . . . . 70.450000000000003 111.882 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.602 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.4 m -53.32 -40.13 64.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.271 -0.422 . . . . 73.329999999999998 111.274 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -49.65 -43.49 46.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.022 -0.535 . . . . 71.430000000000007 111.104 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.62 -40.96 32.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.769 -0.65 . . . . 73.439999999999998 111.355 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 87' ' ' SER . 91.6 mt-30 -57.58 -31.16 65.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.197 0.443 . . . . 73.040000000000006 112.197 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' A' ' 88' ' ' THR . 37.7 mt-30 -58.45 -33.58 69.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.0 0.37 . . . . 74.299999999999997 112.0 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.92 -25.24 62.67 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.932 0.345 . . . . 74.409999999999997 111.932 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 92.4 mmm -69.32 -43.82 72.95 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.552 0.575 . . . . 72.230000000000004 112.552 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -102.42 160.28 17.46 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.803 -0.713 . . . . 53.439999999999998 114.305 -172.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 75.1 mmtt -91.26 147.31 23.14 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.807 0.337 . . . . 71.140000000000001 111.524 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 41.0 m -76.01 150.72 37.34 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.343 0.868 . . . . 74.129999999999995 113.343 -172.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.5 137.95 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.677 -0.692 . . . . 72.230000000000004 111.739 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.7 t -80.13 176.21 9.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.957 -0.565 . . . . 71.129999999999995 111.789 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.443 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -54.49 -50.31 68.07 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.754 0.65 . . . . 74.319999999999993 112.754 -175.33 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -70.11 -14.91 62.87 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.23 0.456 . . . . 65.450000000000003 112.23 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -102.31 4.52 39.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.302 0.482 . . . . 71.420000000000002 112.302 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.19 138.74 49.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.961 0.41 . . . . 60.210000000000001 111.591 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -134.08 174.48 10.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.948 0.404 . . . . 62.450000000000003 110.852 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.402 HG21 ' HB2' ' A' ' 41' ' ' LYS . 27.6 m -71.7 103.72 3.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.692 0.282 . . . . 63.329999999999998 111.39 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 133.13 -12.99 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.282 -0.485 . . . . 53.130000000000003 113.467 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 157' ' ' ARG . 7.4 m-20 -71.15 147.31 48.51 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.237 0.542 . . . . 64.329999999999998 111.599 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 mt -94.28 123.11 37.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.347 -0.388 . . . . 62.340000000000003 110.769 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 m -96.35 116.06 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.251 0.548 . . . . 70.319999999999993 111.245 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.2 mt -92.41 121.85 34.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.593 -0.731 . . . . 71.010000000000005 111.4 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -114.3 166.41 11.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.598 0.713 . . . . 71.430000000000007 112.188 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 68.1 mtp180 -103.8 109.79 21.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.28 -0.873 . . . . 73.209999999999994 109.474 172.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.596 0 O-C-N 122.126 -0.359 . . . . 63.450000000000003 111.599 -172.412 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.118 0.485 . . . . 74.340000000000003 111.526 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -113.32 156.21 23.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.076 -0.511 . . . . 71.129999999999995 110.096 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.88 137.94 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.387 0.613 . . . . 61.310000000000002 112.254 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.77 155.91 21.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.747 -0.66 . . . . 64.140000000000001 112.205 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.4 mt -92.37 110.32 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.32 -0.518 . . . . 73.409999999999997 110.972 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.447 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 61.1 t80 -73.77 114.89 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.048 0.451 . . . . 75.019999999999996 111.9 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 pt -95.56 -32.61 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.404 -0.362 . . . . 74.540000000000006 111.801 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 148.11 159.73 8.6 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.9 -0.667 . . . . 73.510000000000005 113.654 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 53.96 46.81 24.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.988 0.515 . . . . 73.230000000000004 112.267 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 142' ' ' SER . 44.2 m-80 67.18 -1.11 1.55 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.446 0.536 . . . . 72.549999999999997 112.446 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -90.22 141.99 28.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.353 0.597 . . . . 74.200000000000003 112.127 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -155.42 146.59 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.438 -0.801 . . . . 71.319999999999993 111.271 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.43 133.86 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.936 0.398 . . . . 62.549999999999997 111.089 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 9.3 p80 -158.72 165.28 34.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.513 -0.312 . . . . 64.540000000000006 111.404 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.35 95.75 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.038 0.447 . . . . 53.310000000000002 111.407 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 32.7 t -70.19 142.37 52.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.327 -0.397 . . . . 63.140000000000001 111.719 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -53.28 -41.37 65.5 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.658 0.614 . . . . 71.319999999999993 112.658 -176.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.1 t -108.16 -44.21 4.21 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.842 0.353 . . . . 72.329999999999998 111.802 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.1 m -76.57 -19.14 58.21 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.824 0.675 . . . . 52.409999999999997 112.824 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.73 -164.61 45.1 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.065 -0.588 . . . . 70.439999999999998 113.497 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 60.4 t -65.06 96.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.308 0.575 . . . . 75.430000000000007 111.192 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.8 pt -129.19 174.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.564 . . . . 62.25 111.648 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.1 mt -107.84 104.34 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.108 -0.496 . . . . 74.519999999999996 110.575 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.5 m -96.91 -173.39 2.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.807 0.337 . . . . 61.32 111.099 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 19.7 m -148.19 135.8 20.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.995 0.369 . . . . 73.109999999999999 111.995 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 59.3 mtm -74.46 5.19 4.93 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.015 0.376 . . . . 54.100000000000001 112.015 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -85.18 -6.96 59.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.02 0.438 . . . . 62.329999999999998 110.175 170.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -78.5 137.12 59.45 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.285 171.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.83 -46.44 32.15 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.328 2.019 . . . . 64.120000000000005 113.259 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.44 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 80.3 t80 -60.88 -47.7 85.17 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.809 0.3 . . . . 64.150000000000006 111.809 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -71.75 -37.07 70.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.915 0.388 . . . . 70.030000000000001 111.333 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.46 -42.99 93.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.076 0.465 . . . . 62.140000000000001 111.582 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -88.09 1.74 53.59 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.051 0.389 . . . . 70.209999999999994 112.051 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 2.6 mpt_? -109.04 -16.87 14.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.555 0.206 . . . . 75.409999999999997 111.555 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.443 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 53.3 t80 -57.57 109.71 0.75 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.059 0.456 . . . . 61.329999999999998 111.548 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.429 HD22 ' HG2' ' A' ' 154' ' ' GLU . 6.0 t30 -85.65 -55.01 4.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.136 0.493 . . . . 74.209999999999994 110.331 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.429 ' HG2' HD22 ' A' ' 153' ' ' ASN . 14.1 pt-20 -173.24 169.65 4.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.938 -0.574 . . . . 63.43 110.42 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.62 146.68 47.23 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.229 -0.295 . . . . 72.310000000000002 111.311 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 91.3 mtt180 -142.69 135.05 27.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.932 0.396 . . . . 71.420000000000002 111.997 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.48 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -95.56 117.0 29.62 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.172 0.51 . . . . 74.219999999999999 111.255 176.43 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.72 0.65 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.95 -0.568 . . . . 62.039999999999999 112.041 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.532 HD23 HD22 ' A' ' 82' ' ' LEU . 79.1 mt . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 112.693 0.627 . . . . 63.009999999999998 112.693 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 120.678 0.275 . . . . 74.420000000000002 110.565 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.67 -48.09 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.149 0.5 . . . . 75.439999999999998 111.463 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.504 ' HB2' HG21 ' A' ' 105' ' ' THR . 88.3 tttt -55.02 -46.93 75.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.791 -0.641 . . . . 72.209999999999994 111.593 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t -58.61 -45.18 89.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.842 0.312 . . . . 50.420000000000002 111.842 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 43' ' ' ARG . 8.6 mmm180 -62.67 -39.08 92.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.868 0.366 . . . . 74.120000000000005 111.314 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.35 -46.74 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.922 0.391 . . . . 72.219999999999999 111.35 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 94.3 mmm -62.23 -37.93 87.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.912 0.387 . . . . 73.329999999999998 111.158 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.1 -45.27 93.52 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 72.299999999999997 110.796 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.725 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 59.0 tp60 -62.01 -46.77 87.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.156 -0.474 . . . . 65.019999999999996 111.132 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 20.0 t80 -58.16 -37.95 75.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.427 -0.351 . . . . 73.109999999999999 111.208 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.95 -32.65 47.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.027 0.442 . . . . 64.519999999999996 111.596 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.63 -42.06 61.96 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.001 0.429 . . . . 53.130000000000003 111.348 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.08 4.65 52.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.767 0.654 . . . . 63.140000000000001 112.767 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 50.5 mttm -54.32 112.15 0.93 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.724 0.297 . . . . 63.409999999999997 111.328 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.07 55.15 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.09 -0.576 . . . . 61.420000000000002 114.401 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.66 137.39 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.818 0.809 . . . . 75.200000000000003 111.462 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -76.04 166.89 22.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.128 0.489 . . . . 75.319999999999993 111.724 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -91.32 140.05 30.15 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.481 0.658 . . . . 75.129999999999995 112.567 -173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 65.8 ttt180 -131.57 176.87 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.611 -0.722 . . . . 73.400000000000006 109.944 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.407 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 91.4 mt -129.43 94.94 3.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.983 0.42 . . . . 55.020000000000003 111.407 175.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.38 55.01 2.68 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.362 -0.447 . . . . 24.440000000000001 113.357 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.441 ' HA3' ' NH1' ' A' ' 57' ' ' ARG . . . -177.51 104.47 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.928 -0.653 . . . . 72.510000000000005 113.474 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.8 p -78.64 115.05 18.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.935 0.398 . . . . 61.32 111.901 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -169.97 160.85 8.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.449 -0.342 . . . . 74.019999999999996 111.335 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.34 -6.99 44.21 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 65.040000000000006 111.002 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.58 -10.71 59.37 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.519999999999996 110.919 172.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.97 141.72 3.21 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.322 -0.399 . . . . 40.329999999999998 112.561 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.5 tp -141.31 143.44 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 122.446 -0.443 . . . . 71.409999999999997 111.65 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -93.91 166.48 12.15 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.259 0.552 . . . . 73.430000000000007 112.421 177.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 29.9 t -51.74 -54.34 29.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.615 -0.72 . . . . 62.240000000000002 112.319 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.1 p -67.6 -44.98 76.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.505 -0.316 . . . . 61.409999999999997 111.249 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.78 -40.02 56.13 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.435 -0.412 . . . . 75.209999999999994 113.767 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -61.09 -57.78 11.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.591 -0.358 . . . . 70.439999999999998 111.532 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.485 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.1 p -59.59 -36.49 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.917 0.389 . . . . 55.109999999999999 111.24 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.548 ' HA ' HD12 ' A' ' 84' ' ' LEU . 20.3 mt-30 -55.67 -61.17 2.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.385 -0.37 . . . . 65.329999999999998 111.673 175.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -60.02 -35.46 75.14 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.129 0.418 . . . . 73.230000000000004 112.129 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.725 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 99.7 m -56.12 -54.87 39.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 73.120000000000005 111.84 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.8 m-85 -75.03 -31.22 61.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.238 0.829 . . . . 71.530000000000001 113.238 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -76.05 -43.93 41.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.571 0.582 . . . . 74.549999999999997 112.571 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.04 -33.42 59.61 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.596 0.591 . . . . 72.099999999999994 112.596 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -87.28 -56.41 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.417 0.525 . . . . 64.150000000000006 112.417 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.08 -15.71 18.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.691 0.626 . . . . 73.349999999999994 112.691 -173.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.96 47.74 11.03 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.817 -0.706 . . . . 64.099999999999994 112.6 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 51.1 tp -104.86 137.71 42.22 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.14 0.495 . . . . 64.420000000000002 111.791 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.31 115.84 24.1 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.28 0.562 . . . . 62.219999999999999 111.438 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 73' ' ' GLN . 93.5 mt -127.37 151.41 74.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 122.137 -0.352 . . . . 71.150000000000006 111.625 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.98 -154.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.142 2.561 . . . . 52.409999999999997 112.902 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -110.06 -25.97 9.94 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.915 0.709 . . . . 74.430000000000007 112.915 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -120.72 148.66 43.66 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.828 -0.545 . . . . 52.299999999999997 112.305 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.441 HG23 ' HB ' ' A' ' 120' ' ' VAL . 26.2 m -52.54 -46.17 66.65 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.95 -0.568 . . . . 74.209999999999994 111.904 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -52.14 -32.35 35.22 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.075 -0.511 . . . . 73.349999999999994 111.545 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.22 -37.41 28.64 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.978 -0.556 . . . . 70.400000000000006 111.033 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.449 ' NE2' ' HG3' ' A' ' 73' ' ' GLN . 85.8 mt-30 -61.61 -32.61 72.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.238 -0.437 . . . . 64.040000000000006 111.384 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 88' ' ' THR . 17.1 mt-30 -52.71 -41.63 64.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.164 0.506 . . . . 74.319999999999993 111.547 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -77.73 -11.4 59.87 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.333 0.494 . . . . 75.540000000000006 112.333 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.4 mmm -80.91 -4.66 55.68 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.431 0.53 . . . . 62.119999999999997 112.431 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.472 ' O ' ' HD2' ' A' ' 156' ' ' ARG . . . -151.8 163.25 29.99 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.86 -0.686 . . . . 31.440000000000001 113.091 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 92.1 mttt -86.21 172.27 10.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 60.439999999999998 111.793 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 77.9 p -95.59 141.43 29.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.843 -0.617 . . . . 61.219999999999999 112.624 -171.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 5.1 m -131.98 158.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.796 -0.638 . . . . 32.549999999999997 111.282 175.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.8 t -100.13 176.55 5.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.376 -0.375 . . . . 61.530000000000001 111.833 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -47.53 -48.24 27.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.097 0.475 . . . . 74.420000000000002 112.176 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.2 m -69.11 -28.53 66.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.244 -0.434 . . . . 72.549999999999997 111.88 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.515 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 13.4 m120 -87.06 -13.86 43.13 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.112 0.412 . . . . 71.439999999999998 112.112 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -51.95 128.01 22.93 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.863 0.363 . . . . 62.549999999999997 111.688 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 102' ' ' ASN . 50.7 mtp85 -129.01 173.18 10.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.224 -0.444 . . . . 70.099999999999994 111.571 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.504 HG21 ' HB2' ' A' ' 41' ' ' LYS . 36.7 m -69.49 122.28 18.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.279 -0.418 . . . . 72.400000000000006 111.631 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.27 11.34 52.4 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.241 -0.504 . . . . 75.129999999999995 113.177 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.422 ' OD1' ' HB1' ' A' ' 155' ' ' ALA . 9.5 t70 -84.44 152.84 23.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.824 0.345 . . . . 65.510000000000005 110.875 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 72' ' ' VAL . 44.0 mt -96.37 103.51 15.42 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.973 0.416 . . . . 74.340000000000003 110.66 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -95.56 122.88 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.492 0.663 . . . . 73.120000000000005 111.376 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.516 HD12 ' HG3' ' A' ' 154' ' ' GLU . 72.1 mt -96.73 120.37 36.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.463 -0.789 . . . . 63.439999999999998 111.735 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -114.15 152.24 31.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.386 0.612 . . . . 75.040000000000006 111.749 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -91.2 106.57 18.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.653 -0.703 . . . . 75.329999999999998 111.09 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.967 0.413 . . . . 74.420000000000002 111.955 -178.725 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.944 0.402 . . . . 74.349999999999994 110.479 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -98.17 141.11 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.18 -0.463 . . . . 75.439999999999998 110.392 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 88' ' ' THR . 14.9 p -119.48 139.8 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 63.130000000000003 111.999 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 151.79 19.79 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.981 -0.554 . . . . 23.34 112.151 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.485 HD11 ' HA ' ' A' ' 72' ' ' VAL . 48.5 mt -88.22 107.62 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.51 -0.406 . . . . 62.340000000000003 110.827 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.22 105.71 1.16 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.77 0.319 . . . . 64.239999999999995 110.914 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.7 pt -91.47 -26.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.476 0.547 . . . . 55.530000000000001 112.476 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 160.94 122.17 0.62 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.154 -1.022 . . . . 65.510000000000005 114.193 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 45.99 81.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.88 0.872 . . . . 70.239999999999995 112.9 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 68.21 -19.17 0.15 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.728 1.01 . . . . 35.229999999999997 113.728 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.57 141.45 29.01 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.163 0.506 . . . . 74.519999999999996 111.851 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.04 150.8 27.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.983 -0.553 . . . . 54.109999999999999 111.222 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.67 138.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.869 0.366 . . . . 71.219999999999999 111.159 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -157.25 173.58 16.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.226 0.536 . . . . 72.420000000000002 111.734 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -103.65 122.92 46.02 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.078 -0.51 . . . . 75.109999999999999 110.978 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -114.53 159.62 20.18 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.008 0.432 . . . . 65.530000000000001 111.644 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -53.17 -65.82 0.49 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.767 1.025 . . . . 44.100000000000001 113.767 -171.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.8 t -87.06 -36.47 18.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.987 0.422 . . . . 72.120000000000005 112.028 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 m -77.88 -8.97 58.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.745 0.646 . . . . 70.310000000000002 112.745 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.78 -93.93 0.96 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.856 -0.687 . . . . 73.319999999999993 112.855 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 17.7 t -133.73 113.41 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.468 -0.43 . . . . 74.140000000000001 111.024 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.6 pt -138.24 173.58 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.84 0.681 . . . . 75.230000000000004 112.84 -173.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.5 127.13 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.639 -0.709 . . . . 72.200000000000003 110.388 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 m -119.06 178.18 4.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.981 0.419 . . . . 34.350000000000001 111.202 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.4 m -144.45 139.23 28.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.841 0.353 . . . . 71.319999999999993 111.627 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 75.5 mtm -69.13 3.68 2.0 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.72 0.295 . . . . 71.120000000000005 111.768 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -72.24 -28.8 63.38 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.323 0.582 . . . . 62.32 109.861 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.412 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 37.1 mt-10 -71.61 127.79 90.58 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.737 -0.665 . . . . 74.409999999999997 110.474 176.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 6.2 Cg_endo -47.88 -41.35 32.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.117 2.545 . . . . 52.530000000000001 113.833 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 90.9 t80 -53.6 -53.75 47.35 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.969 0.414 . . . . 73.230000000000004 111.546 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.412 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 88.5 m95 -75.95 -35.35 59.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 65.099999999999994 111.073 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -56.09 -32.63 64.32 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.028 -0.533 . . . . 63.020000000000003 112.129 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 0.4 OUTLIER -97.41 -9.07 28.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.46 0.541 . . . . 74.140000000000001 112.46 -178.266 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 30.6 mmt180 -103.79 -3.02 25.47 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.998 0.74 . . . . 74.439999999999998 112.998 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.43 107.32 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.96 0.409 . . . . 72.25 111.186 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.37 -66.56 0.89 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.25 0.548 . . . . 54.200000000000003 110.346 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.516 ' HG3' HD12 ' A' ' 110' ' ' LEU . 14.2 pt-20 -160.86 -175.65 5.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 64.510000000000005 110.383 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -140.22 157.21 45.95 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.616 0.246 . . . . 63.439999999999998 111.507 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 15.3 mmt180 -139.55 109.54 6.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.933 0.346 . . . . 74.030000000000001 111.933 -174.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -88.94 104.24 16.77 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.785 0.802 . . . . 74.329999999999998 111.1 177.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 113.101 0.778 . . . . 64.430000000000007 113.101 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 112.351 0.5 . . . . 74.420000000000002 112.351 -176.274 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 120.662 0.268 . . . . 73.230000000000004 111.399 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.7 t -51.62 -47.94 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.958 0.409 . . . . 72.310000000000002 111.187 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -56.5 -48.54 76.96 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.083 -0.508 . . . . 61.439999999999998 111.722 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -69.05 -32.85 72.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.632 -0.258 . . . . 73.019999999999996 111.674 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -66.26 -43.68 85.79 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.846 0.355 . . . . 73.340000000000003 111.238 177.244 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 40' ' ' VAL . 64.4 mt -65.02 -37.33 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.752 0.311 . . . . 74.120000000000005 110.759 176.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.5 mmt -64.44 -43.66 93.59 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.915 0.388 . . . . 64.200000000000003 111.368 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.0 -42.03 89.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.229 -0.441 . . . . 71.219999999999999 111.111 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -51.16 60.07 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.085 0.469 . . . . 64.109999999999999 110.036 175.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.5 -34.56 58.52 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.031 -0.532 . . . . 72.150000000000006 111.47 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.51 -33.08 53.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.861 0.362 . . . . 62.549999999999997 111.722 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -31.73 62.95 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.1 0.407 . . . . 73.329999999999998 112.1 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -106.07 12.88 29.85 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.644 0.609 . . . . 71.510000000000005 112.644 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -58.91 95.85 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.121 0.415 . . . . 41.119999999999997 112.121 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.47 27.3 10.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.088 -0.577 . . . . 74.129999999999995 113.898 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.5 t -77.67 127.09 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 122.25 -0.559 . . . . 74.230000000000004 110.796 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HD2' HH11 ' A' ' 55' ' ' ARG . 7.0 ptp180 -62.77 160.81 13.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.341 0.591 . . . . 74.540000000000006 112.281 -177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 39.8 t80 -84.83 123.26 30.26 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.141 -0.481 . . . . 75.319999999999993 111.97 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -136.97 130.38 31.43 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.423 -0.353 . . . . 72.120000000000005 110.531 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 58' ' ' LEU . 4.5 mp -80.96 112.74 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.615 0.245 . . . . 71.430000000000007 111.434 -175.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.53 3.47 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.035 -0.602 . . . . 61.109999999999999 114.151 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.21 72.57 0.58 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.957 -0.64 . . . . 74.430000000000007 112.778 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 t -69.72 100.81 1.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.301 0.482 . . . . 71.5 112.301 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 t -152.69 166.5 31.97 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.926 -0.579 . . . . 73.109999999999999 111.305 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.46 -6.49 36.26 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.441 . . . . 61.520000000000003 112.192 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.23 12.54 33.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.18 0.514 . . . . 52.130000000000003 111.006 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 55' ' ' ARG . . . 157.42 126.9 0.93 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.937 -0.574 . . . . 64.129999999999995 112.253 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 18.5 tt -158.59 154.54 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 117.545 0.672 . . . . 70.400000000000006 111.854 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.0 178.19 4.63 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.243 0.544 . . . . 75.140000000000001 112.299 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 12.3 t -58.17 -52.78 64.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.799 -0.637 . . . . 64.230000000000004 112.677 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 t -69.31 -43.32 74.0 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.214 0.53 . . . . 54.340000000000003 110.676 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.43 75.05 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.835 -0.621 . . . . 33.409999999999997 113.157 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -68.5 -48.88 63.28 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 122.395 -0.473 . . . . 74.510000000000005 112.147 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' A' ' 122' ' ' ILE . 12.1 p -61.88 -43.77 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 111.808 0.299 . . . . 70.120000000000005 111.808 -177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 20.6 pt20 -63.93 -37.72 88.44 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.165 -0.335 . . . . 75.530000000000001 111.484 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 36.0 mmt180 -59.8 -65.92 0.6 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.747 0.308 . . . . 73.349999999999994 111.315 173.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.9 m -44.52 -46.14 9.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.919 0.711 . . . . 75.120000000000005 112.919 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 39.5 m-85 -68.06 -43.22 79.14 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.729 0.64 . . . . 65.030000000000001 112.729 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 8.6 ptp180 -71.91 -30.25 65.17 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.594 -0.691 . . . . 73.230000000000004 111.559 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 mm-40 -68.33 -50.67 51.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 73.430000000000007 111.377 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -87.94 -61.55 1.69 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.451 0.537 . . . . 72.230000000000004 112.451 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.438 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 67.0 m-85 -92.67 -3.19 55.31 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.547 0.573 . . . . 53.530000000000001 112.547 -171.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.49 23.56 72.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.982 -0.627 . . . . 33.420000000000002 112.817 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 38.0 tp -95.12 115.82 27.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.895 0.378 . . . . 74.120000000000005 110.899 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.83 103.87 16.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.211 0.529 . . . . 73.299999999999997 112.179 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.93 146.93 37.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.898 -0.592 . . . . 72.420000000000002 110.521 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.2 172.39 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.546 2.164 . . . . 72.409999999999997 113.641 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -67.8 -48.58 65.88 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.159 0.8 . . . . 73.420000000000002 113.159 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -108.48 144.16 36.48 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.865 -0.522 . . . . 74.400000000000006 112.013 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 32.8 p -46.04 -43.61 14.59 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.827 0.677 . . . . 65.109999999999999 112.827 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.487 ' HA ' HE21 ' A' ' 92' ' ' GLN . 59.2 m-85 -54.08 -35.66 62.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.109 0.48 . . . . 71.239999999999995 111.342 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.76 -38.96 62.08 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.671 -0.695 . . . . 74.209999999999994 110.733 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -63.12 -31.22 72.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.668 -0.696 . . . . 64.319999999999993 111.55 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 89' ' ' TYR . 32.5 mt-30 -59.84 -34.87 73.66 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.143 0.497 . . . . 74.099999999999994 110.83 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 8.56 8.88 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.127 -0.488 . . . . 74.519999999999996 112.044 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.6 mmm -97.9 -68.17 0.81 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.928 0.394 . . . . 74.109999999999999 111.635 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.47 164.52 34.76 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.078 -0.582 . . . . 35.100000000000001 113.485 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HB2' ' NH1' ' A' ' 157' ' ' ARG . 14.3 mmmm -91.12 150.99 21.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 111.551 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 78.2 p -76.47 115.67 16.44 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.878 0.696 . . . . 52.049999999999997 112.878 -174.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 10.2 m -104.12 152.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.879 -0.601 . . . . 71.150000000000006 111.152 173.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.0 t -97.65 -176.98 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.185 -0.322 . . . . 54.5 110.826 175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 100' ' ' ARG . 1.4 mpp_? -59.82 -35.47 74.78 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.336 0.495 . . . . 73.140000000000001 112.336 -175.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.2 m -75.69 -12.5 60.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.946 0.35 . . . . 62.100000000000001 111.946 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.621 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.2 m120 -103.86 -5.06 22.73 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.204 0.446 . . . . 71.540000000000006 112.204 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.09 125.93 24.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.344 0.498 . . . . 75.340000000000003 112.344 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -141.79 134.69 28.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.639 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.0 m -38.67 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.964 0.727 . . . . 43.450000000000003 112.964 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.515 ' HA3' HD12 ' A' ' 159' ' ' LEU . . . 135.51 -0.01 3.38 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.034 -0.603 . . . . 72.420000000000002 114.054 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 4.1 p30 -90.04 158.98 17.08 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 117.706 0.753 . . . . 72.120000000000005 111.436 176.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.7 mt -104.76 120.79 42.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 73.319999999999993 111.165 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 m -94.75 112.98 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.583 0.706 . . . . 50.43 111.443 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.21 119.51 31.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.641 -0.709 . . . . 65.219999999999999 111.681 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HZ ' ' SD ' ' A' ' 143' ' ' MET . 92.2 m-85 -109.4 153.5 23.89 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.415 0.626 . . . . 75.329999999999998 111.922 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -88.39 113.85 24.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.707 -0.679 . . . . 53.32 109.352 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.372 0 O-C-N 122.095 -0.378 . . . . 42.310000000000002 111.868 -171.654 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.637 0.256 . . . . 73.540000000000006 111.631 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -99.6 124.27 44.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.88 -0.415 . . . . 73.420000000000002 109.88 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.412 HG12 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -110.18 145.04 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.659 0.614 . . . . 74.409999999999997 112.659 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.87 148.73 19.16 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.948 -0.569 . . . . 72.099999999999994 112.147 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 72' ' ' VAL . 42.4 mt -89.86 106.6 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.168 0.484 . . . . 74.510000000000005 111.183 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 61.3 t80 -71.29 111.34 6.55 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.233 0.54 . . . . 75.109999999999999 111.622 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.7 pt -95.57 -16.81 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.251 -0.431 . . . . 54.32 111.874 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.21 164.62 11.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.111 -0.566 . . . . 64.340000000000003 112.998 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 58.08 32.6 22.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.818 0.342 . . . . 73.329999999999998 111.863 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 142' ' ' SER . 41.2 m-80 65.55 11.29 7.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.367 0.506 . . . . 64.120000000000005 112.367 -177.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -100.34 143.63 30.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.104 0.478 . . . . 73.230000000000004 111.232 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.72 151.96 31.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.901 -0.59 . . . . 71.239999999999995 111.553 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -103.21 141.99 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.244 -0.434 . . . . 72.109999999999999 110.949 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.39 -170.73 3.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.844 0.354 . . . . 73.019999999999996 111.072 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -132.98 108.26 8.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.53 -0.304 . . . . 72.239999999999995 111.017 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.6 p -91.42 155.26 18.59 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.071 0.462 . . . . 61.009999999999998 111.32 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.4 p -66.66 -2.38 4.84 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.632 0.605 . . . . 52.420000000000002 112.632 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.9 t -97.46 -67.47 0.85 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.053 0.39 . . . . 61.439999999999998 112.053 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.4 m -104.72 -6.41 20.39 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.688 0.625 . . . . 54.109999999999999 112.688 -175.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 132' ' ' ALA . . . 84.28 -133.45 11.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.521 -0.847 . . . . 72.099999999999994 112.614 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.06 108.72 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.216 0.45 . . . . 71.129999999999995 112.216 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.8 pt -143.43 179.19 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.228 0.537 . . . . 75.430000000000007 112.155 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.0 mm -106.81 149.9 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 116.176 -0.465 . . . . 73.530000000000001 110.917 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.1 m -148.97 172.19 15.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.77 0.319 . . . . 72.310000000000002 111.421 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.463 ' HB2' ' HG3' ' A' ' 145' ' ' GLU . 50.6 m -129.31 142.91 50.7 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.289 0.566 . . . . 54.140000000000001 112.376 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.438 ' SD ' ' HZ ' ' A' ' 111' ' ' PHE . 86.3 mmm -59.84 -27.11 66.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.717 -0.674 . . . . 54.329999999999998 112.539 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -85.96 3.65 41.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.593 0.59 . . . . 63.140000000000001 112.593 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 142' ' ' SER . 58.7 mt-10 -81.36 125.97 77.65 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 122.236 -0.29 . . . . 70.549999999999997 110.309 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -38.15 -50.11 2.18 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.946 3.098 . . . . 51.210000000000001 115.232 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.38 -43.04 97.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.009 0.374 . . . . 63.229999999999997 112.009 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.406 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 83.5 m95 -81.35 -42.39 20.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.187 0.518 . . . . 75.340000000000003 111.07 -176.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -54.17 -55.55 26.74 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.609 -0.723 . . . . 74.010000000000005 112.751 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -80.33 -11.69 59.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.059 0.392 . . . . 75.019999999999996 112.059 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -99.83 -2.21 35.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.176 0.436 . . . . 74.230000000000004 112.176 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -58.29 126.49 27.77 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.148 0.499 . . . . 65.340000000000003 111.73 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.406 HD22 ' HG2' ' A' ' 154' ' ' GLU . 5.7 t30 -101.8 -59.5 1.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.482 -0.326 . . . . 65.340000000000003 110.991 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG2' HD22 ' A' ' 153' ' ' ASN . 12.8 pt-20 -169.22 145.62 3.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.487 -0.324 . . . . 61.25 111.456 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -100.43 146.68 26.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.675 -0.239 . . . . 71.219999999999999 110.404 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.481 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 45.5 mtp85 -142.62 115.71 8.86 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.25 -0.281 . . . . 75.120000000000005 110.969 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -81.43 122.23 27.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.213 0.53 . . . . 73.040000000000006 111.976 -176.061 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.96 -20.14 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.561 0.578 . . . . 54.140000000000001 112.561 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.515 HD12 ' HA3' ' A' ' 106' ' ' GLY . 43.8 mt . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.213 0.53 . . . . 71.329999999999998 111.917 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 120.488 0.185 . . . . 71.439999999999998 110.511 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.33 -45.54 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.0 0.429 . . . . 74.0 111.203 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 76.0 tttt -53.38 -50.79 64.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.065 -0.516 . . . . 63.009999999999998 111.46 175.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.5 t -59.36 -44.0 92.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.356 -0.384 . . . . 64.200000000000003 111.59 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -57.17 -53.93 52.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.029 0.442 . . . . 74.239999999999995 110.871 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.02 -39.28 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.98 0.419 . . . . 70.200000000000003 111.791 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 31.1 mmt -66.24 -28.23 68.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.876 0.324 . . . . 74.040000000000006 111.876 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -63.62 -46.63 84.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.18 0.514 . . . . 72.230000000000004 110.044 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.6 tp60 -63.89 -44.97 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.718 -0.673 . . . . 63.43 110.385 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.17 -42.09 76.52 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.999 -0.546 . . . . 64.400000000000006 111.333 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.98 -33.22 66.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.034 0.445 . . . . 74.230000000000004 111.617 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -81.96 -26.09 34.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.21 0.529 . . . . 71.319999999999993 111.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -108.25 20.66 18.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.814 0.672 . . . . 63.119999999999997 112.814 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -59.42 101.56 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.901 0.704 . . . . 71.25 112.901 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.43 38.86 16.36 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.69 -0.687 . . . . 74.219999999999999 114.66 174.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.15 144.19 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 117.547 0.674 . . . . 74.239999999999995 111.081 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -56.54 142.77 38.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.545 0.338 . . . . 73.549999999999997 111.752 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 20.1 t80 -83.64 116.64 22.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.922 -0.399 . . . . 61.119999999999997 109.922 172.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -122.34 105.86 10.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.388 . . . . 61.119999999999997 110.49 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.86 116.86 12.74 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.934 0.397 . . . . 51.130000000000003 110.481 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 26.29 35.9 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.967 -0.635 . . . . 72.150000000000006 113.052 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.02 106.71 0.29 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.334 -0.46 . . . . 64.099999999999994 112.409 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.516 ' HA ' HG13 ' A' ' 66' ' ' ILE . 64.6 p -97.32 112.41 24.24 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.486 0.55 . . . . 64.530000000000001 112.486 -175.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.4 t -171.76 172.91 4.73 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.913 0.387 . . . . 74.519999999999996 111.651 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.64 -14.97 61.71 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 122.04 -0.412 . . . . 75.340000000000003 111.502 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -83.03 4.54 25.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.074 0.464 . . . . 74.439999999999998 110.602 172.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.64 132.47 2.61 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.603 -0.599 . . . . 75.120000000000005 111.603 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.516 HG13 ' HA ' ' A' ' 61' ' ' SER . 21.0 tt -151.22 153.09 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 117.391 0.595 . . . . 63.299999999999997 111.912 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -91.9 177.24 6.24 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.326 0.584 . . . . 72.200000000000003 111.985 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 32.4 t -62.09 -48.31 80.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.545 0.572 . . . . 71.430000000000007 112.545 -176.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 88' ' ' THR . 17.7 p -78.11 -27.58 48.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.918 0.389 . . . . 53.420000000000002 111.742 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.12 98.98 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.116 -0.564 . . . . 74.0 112.634 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -59.92 -50.66 72.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.928 0.344 . . . . 74.420000000000002 111.928 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.541 ' HA ' HD11 ' A' ' 122' ' ' ILE . 6.1 p -59.74 -52.82 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.294 0.479 . . . . 71.140000000000001 112.294 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.511 ' HG2' ' HA ' ' A' ' 86' ' ' ARG . 4.4 pp0? -65.99 -26.71 67.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.15 0.426 . . . . 65.519999999999996 112.15 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.545 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.3 mtp180 -69.31 -53.92 17.23 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.137 -0.352 . . . . 71.219999999999999 111.068 171.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -46.4 -49.61 17.75 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.257 0.551 . . . . 74.200000000000003 111.792 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 67.2 m-85 -68.44 -39.2 81.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.746 0.647 . . . . 65.239999999999995 112.746 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.545 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 11.8 ptp180 -76.75 -25.62 53.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.641 -0.662 . . . . 61.219999999999999 112.159 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.25 -28.27 34.84 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.979 0.362 . . . . 74.140000000000001 111.979 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 85.6 mt-30 -109.05 -61.44 1.62 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.587 0.588 . . . . 74.120000000000005 112.587 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -83.81 -11.67 56.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.928 0.344 . . . . 72.019999999999996 111.928 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.9 71.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.346 -0.454 . . . . 44.420000000000002 113.173 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.4 tp -73.37 123.3 23.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 74.530000000000001 111.53 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -74.29 85.17 1.93 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.401 0.62 . . . . 73.120000000000005 112.434 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.7 mt -106.28 135.2 19.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 122.126 -0.359 . . . . 64.409999999999997 111.215 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.619 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 58.7 Cg_endo -71.27 156.87 58.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.774 2.316 . . . . 75.200000000000003 113.111 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -57.0 -43.35 81.65 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.811 1.041 . . . . 75.209999999999994 113.811 -174.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.419 ' N ' ' HG2' ' A' ' 86' ' ' ARG . 73.9 m -102.61 152.4 21.23 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.841 1.052 . . . . 64.230000000000004 113.841 -170.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 69' ' ' SER . 51.4 p -51.45 -58.91 4.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.971 -1.013 . . . . 52.210000000000001 112.969 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -47.24 -35.56 7.85 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.004 -0.543 . . . . 64.340000000000003 112.287 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.66 -42.59 28.23 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.052 -0.522 . . . . 74.040000000000006 111.162 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.16 -22.15 65.65 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.938 0.399 . . . . 72.0 111.461 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.461 ' HG2' HD11 ' A' ' 110' ' ' LEU . 76.6 mt-30 -66.44 -34.46 77.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 112.171 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -84.22 -10.84 57.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.457 0.539 . . . . 52.340000000000003 112.457 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.619 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 62.4 mtp -94.78 -70.18 0.72 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.589 0.233 . . . . 75.319999999999993 111.525 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.4 130.31 28.99 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.388 -0.91 . . . . 73.430000000000007 112.277 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -85.27 143.57 28.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.406 0.622 . . . . 62.109999999999999 112.363 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 18.4 m -64.84 144.29 57.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.883 -1.053 . . . . 45.420000000000002 113.354 -170.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.428 HG22 ' HD3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -132.44 163.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.838 -0.619 . . . . 73.299999999999997 111.516 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.7 t -116.57 171.68 7.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.402 -0.363 . . . . 72.140000000000001 111.132 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -43.98 -57.64 3.23 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.217 1.191 . . . . 71.340000000000003 114.217 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -69.39 -9.25 52.67 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.981 0.734 . . . . 63.329999999999998 112.981 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -114.97 5.06 14.92 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.502 0.556 . . . . 62.399999999999999 112.502 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.35 133.04 55.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.77 0.319 . . . . 64.129999999999995 111.757 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 104' ' ' ARG . 54.2 mtt180 -108.28 169.44 8.63 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.436 0.636 . . . . 63.130000000000003 112.247 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.7 m -79.85 118.43 21.62 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.192 -0.458 . . . . 75.540000000000006 110.524 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 18.93 33.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.046 -0.597 . . . . 72.25 112.004 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -77.51 159.71 29.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.922 0.489 . . . . 73.530000000000001 110.291 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.0 mt -114.06 109.27 18.18 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.64 -0.663 . . . . 60.329999999999998 111.826 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.59 126.19 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.408 0.623 . . . . 64.510000000000005 111.913 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.461 HD11 ' HG2' ' A' ' 92' ' ' GLN . 83.0 mt -97.97 138.96 34.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.744 -0.662 . . . . 41.439999999999998 111.649 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -124.48 137.99 54.38 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.216 0.532 . . . . 73.230000000000004 111.929 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 33.6 mtp85 -72.56 84.01 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.976 -0.556 . . . . 74.129999999999995 110.533 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 112.381 0.512 . . . . 45.109999999999999 112.381 -174.604 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 111.864 0.32 . . . . 74.030000000000001 111.864 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -115.64 149.22 38.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.413 -0.358 . . . . 72.439999999999998 110.178 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.61 135.34 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.154 0.502 . . . . 71.420000000000002 112.147 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -123.3 148.57 16.79 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.21 -0.519 . . . . 72.129999999999995 113.226 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.541 HD11 ' HA ' ' A' ' 72' ' ' VAL . 40.2 mt -82.47 107.51 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.796 0.332 . . . . 72.230000000000004 110.797 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 2.0 t80 -70.7 104.35 2.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.119 -0.491 . . . . 73.239999999999995 111.616 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.428 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 38.2 pt -102.18 -17.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.743 0.645 . . . . 71.319999999999993 112.743 -176.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.69 -170.31 16.35 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.524 -0.846 . . . . 44.450000000000003 113.9 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -58.31 -32.77 68.78 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.68 0.392 . . . . 73.019999999999996 111.884 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -137.52 -26.46 0.98 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.226 -0.443 . . . . 74.239999999999995 112.153 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -85.26 140.87 30.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.03 0.752 . . . . 74.310000000000002 113.03 -175.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.401 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 22.1 p90 -148.38 142.95 26.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.461 -0.79 . . . . 72.120000000000005 110.982 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.82 137.2 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.975 0.416 . . . . 75.200000000000003 111.558 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -155.92 163.55 39.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.989 0.424 . . . . 64.109999999999999 111.74 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -94.54 97.85 10.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.019 0.438 . . . . 61.420000000000002 110.832 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 80.9 p -81.7 142.06 33.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.175 0.512 . . . . 72.340000000000003 111.714 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.0 t -69.24 -7.04 33.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.233 -0.44 . . . . 72.439999999999998 112.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.3 p -101.52 -59.74 1.65 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.842 0.353 . . . . 40.329999999999998 111.834 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.481 ' HB2' HD13 ' A' ' 139' ' ' ILE . 68.6 m -109.5 13.79 23.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.399 0.518 . . . . 53.240000000000002 112.399 -175.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.65 -152.5 52.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.0 -0.619 . . . . 60.329999999999998 112.883 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 53.6 t -64.74 106.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.458 -0.436 . . . . 64.019999999999996 111.764 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 136' ' ' SER . 35.9 pt -136.82 -175.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.101 0.477 . . . . 55.049999999999997 111.703 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.28 129.11 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.428 -0.351 . . . . 72.540000000000006 110.965 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.7 m -118.53 174.44 6.25 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.876 0.37 . . . . 71.200000000000003 111.809 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.8 t -124.53 142.34 51.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.297 0.48 . . . . 75.420000000000002 112.297 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 85.0 mmm -63.39 -17.16 62.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.156 -0.474 . . . . 53.509999999999998 111.284 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -74.0 -18.04 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.324 -0.398 . . . . 71.439999999999998 111.617 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.09 130.22 93.82 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.786 -0.188 . . . . 73.439999999999998 111.118 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.483 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 85.2 Cg_exo -47.93 -51.97 8.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.907 2.404 . . . . 65.030000000000001 114.059 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 94.4 t80 -58.42 -47.07 85.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.784 0.326 . . . . 64.209999999999994 111.718 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -72.3 -40.14 67.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.784 0.326 . . . . 63.240000000000002 111.591 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.13 -52.64 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.003 0.43 . . . . 72.420000000000002 111.925 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.0 ptpt -78.12 -14.84 59.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.889 0.376 . . . . 72.209999999999994 111.988 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.567 ' HA ' ' HE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -91.83 -12.07 34.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.19 -0.318 . . . . 71.349999999999994 111.789 175.661 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.47 105.57 0.16 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.319 0.581 . . . . 74.430000000000007 111.176 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -90.46 -51.56 5.35 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.993 -0.548 . . . . 74.109999999999999 111.54 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -172.76 147.39 1.74 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.865 0.364 . . . . 75.329999999999998 111.204 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -103.01 161.62 13.61 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.356 -0.215 . . . . 52.329999999999998 110.659 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.8 mtm-85 -146.84 113.01 5.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.829 0.347 . . . . 73.409999999999997 111.806 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.428 ' HD3' HG22 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.76 96.89 4.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.289 0.566 . . . . 55.310000000000002 111.361 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.4 m -77.21 -29.79 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.953 -0.467 . . . . 65.439999999999998 111.62 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.613 -0.267 . . . . 72.439999999999998 110.427 174.995 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.869 0.366 . . . . 73.230000000000004 111.215 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 44' ' ' ILE . 88.9 t -61.84 -49.58 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.211 -0.45 . . . . 75.019999999999996 111.815 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.535 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 87.2 tttt -57.3 -44.88 84.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.34 -0.391 . . . . 75.030000000000001 111.496 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -60.1 -45.18 93.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.264 -0.425 . . . . 74.299999999999997 111.536 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mmm-85 -61.19 -43.57 98.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.073 0.463 . . . . 75.319999999999993 111.111 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 40' ' ' VAL . 73.1 mt -63.09 -47.79 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.021 0.439 . . . . 72.510000000000005 111.372 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 29.7 mmt -62.86 -29.4 70.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.394 -0.366 . . . . 75.230000000000004 111.522 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.43 -38.84 81.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.651 0.262 . . . . 72.319999999999993 111.166 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.4 ' HB2' HE21 ' A' ' 79' ' ' GLN . 63.6 tp60 -77.54 -31.82 53.54 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.575 0.226 . . . . 60.219999999999999 111.506 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -53.45 -37.53 62.71 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.82 0.343 . . . . 74.340000000000003 111.286 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -24.31 64.47 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.127 0.417 . . . . 61.020000000000003 112.127 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -47.12 24.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.085 0.469 . . . . 72.409999999999997 111.513 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -85.55 16.01 4.17 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.073 0.768 . . . . 75.329999999999998 113.073 -172.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' NZ ' ' HB3' ' A' ' 52' ' ' LYS . 2.8 mmmp? -68.87 118.33 11.68 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.141 -0.349 . . . . 75.340000000000003 110.952 176.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.64 46.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.302 -0.475 . . . . 62.43 113.494 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.83 128.94 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.062 0.458 . . . . 74.239999999999995 111.729 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -88.19 179.31 6.4 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.912 -0.586 . . . . 75.140000000000001 111.599 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -91.66 133.02 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.091 0.472 . . . . 75.209999999999994 111.208 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -134.23 113.54 12.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.11 -0.496 . . . . 71.439999999999998 110.192 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.1 mp -57.93 115.2 2.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.924 0.393 . . . . 74.230000000000004 111.717 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.39 19.67 74.61 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.122 -0.49 . . . . 54.100000000000001 113.665 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.94 143.98 17.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.458 -0.401 . . . . 65.329999999999998 112.886 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 66' ' ' ILE . 62.0 p -126.76 99.53 5.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.451 -0.441 . . . . 61.329999999999998 111.21 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 t -174.99 165.62 3.49 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.807 0.337 . . . . 71.510000000000005 111.635 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -74.38 -9.85 59.0 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.107 0.479 . . . . 75.400000000000006 110.909 176.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.11 -1.51 56.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.112 -0.494 . . . . 70.329999999999998 111.281 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.34 124.11 1.57 Allowed Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.248 -0.433 . . . . 74.239999999999995 112.053 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.5 tt -134.03 149.62 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.21 -0.583 . . . . 53.200000000000003 111.922 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.65 160.75 26.22 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.958 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.541 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 29.4 p -58.86 -53.6 56.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.152 0.501 . . . . 75.310000000000002 110.895 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.428 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 87.6 p -63.8 -33.78 76.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.235 0.541 . . . . 63.409999999999997 110.822 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 73' ' ' GLN . . . -67.76 -31.6 76.22 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.817 -0.629 . . . . 74.0 112.954 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -66.13 -47.25 74.7 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.501 -0.411 . . . . 75.109999999999999 111.342 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 HG12 ' A' ' 122' ' ' ILE . 11.2 p -67.9 -40.02 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 111.977 0.362 . . . . 74.239999999999995 111.977 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 1.9 pt20 -58.69 -41.91 87.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.062 0.458 . . . . 75.230000000000004 110.427 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.66 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 11.5 mmm180 -66.64 -67.0 0.48 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.248 -0.433 . . . . 70.129999999999995 110.929 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 m -40.75 -46.65 2.7 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.441 0.534 . . . . 72.099999999999994 112.441 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 14.0 m-30 -68.88 -39.39 79.82 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.432 0.53 . . . . 71.200000000000003 112.432 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 10.9 ptm180 -79.68 -19.29 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.701 -0.624 . . . . 71.239999999999995 111.846 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.7 mm-40 -72.28 -47.68 48.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.464 0.649 . . . . 62.049999999999997 110.162 175.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 47' ' ' GLN . 82.3 mm-40 -95.12 -53.38 3.83 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.59 -0.732 . . . . 74.209999999999994 112.791 -174.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -93.78 -23.76 18.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.278 0.474 . . . . 74.430000000000007 112.278 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.71 36.32 22.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.053 -0.594 . . . . 74.150000000000006 112.973 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 40.4 tp -95.19 119.22 33.32 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.76 0.314 . . . . 75.25 111.23 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.54 84.19 7.16 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.22 0.452 . . . . 70.0 112.22 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.67 145.63 30.74 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.5 -0.318 . . . . 73.230000000000004 111.301 176.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 150.11 62.41 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.721 2.28 . . . . 74.439999999999998 112.837 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.82 42.44 0.79 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.214 0.53 . . . . 51.539999999999999 112.205 -176.591 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.5 m -153.16 117.67 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.116 -0.365 . . . . 53.119999999999997 111.034 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 17.2 m -48.46 -44.36 35.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.506 0.558 . . . . 32.140000000000001 112.506 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -54.98 -46.42 75.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.76 0.314 . . . . 70.129999999999995 111.751 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -62.78 -42.77 99.85 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.429 0.633 . . . . 75.230000000000004 110.534 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -62.9 -30.55 71.62 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.875 -0.602 . . . . 74.409999999999997 111.755 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 88' ' ' THR . 26.1 mt-30 -63.03 -16.08 58.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.815 0.34 . . . . 72.109999999999999 111.692 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.81 -3.47 26.3 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.77 0.319 . . . . 60.310000000000002 111.438 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.3 mmm -95.18 -13.33 25.08 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.885 0.698 . . . . 72.319999999999993 112.885 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -141.58 154.97 25.05 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.858 -0.687 . . . . 72.239999999999995 113.725 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -96.11 153.35 17.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.04 0.448 . . . . 75.109999999999999 111.495 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 92.9 p -77.69 157.26 30.21 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.937 1.088 . . . . 60.350000000000001 113.937 -170.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.42 147.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 114.893 -1.049 . . . . 54.43 110.202 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -83.29 164.28 20.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 111.309 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -49.08 -29.89 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.858 0.688 . . . . 72.420000000000002 112.858 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -82.7 -23.19 34.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.887 0.699 . . . . 72.439999999999998 112.887 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -103.5 20.6 17.58 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.496 0.554 . . . . 74.400000000000006 112.496 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.0 mt -69.84 126.09 28.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.025 0.441 . . . . 63.229999999999997 111.918 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -101.72 -164.6 1.11 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.061 0.457 . . . . 64.239999999999995 111.132 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 41' ' ' LYS . 58.7 m -97.44 109.06 21.89 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.426 -0.352 . . . . 73.430000000000007 110.83 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.54 25.33 6.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.404 -0.427 . . . . 72.219999999999999 113.687 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -94.47 146.28 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.444 -0.445 . . . . 72.230000000000004 111.302 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.412 ' CD2' HG21 ' A' ' 72' ' ' VAL . 47.1 mt -78.03 108.4 11.27 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.369 -0.378 . . . . 74.340000000000003 111.788 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.6 m -96.81 112.48 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.452 0.644 . . . . 70.230000000000004 111.433 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.37 120.64 28.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.649 -0.705 . . . . 74.430000000000007 111.956 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 88.9 m-85 -112.6 157.81 20.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.31 0.576 . . . . 70.219999999999999 111.766 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.564 ' HB2' ' HG3' ' A' ' 151' ' ' ARG . 19.6 mtp180 -90.45 103.52 16.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.048 -0.524 . . . . 73.349999999999994 110.832 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . . . . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 63.200000000000003 111.791 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 . . . . . 0 CA--C 1.536 0.421 0 CA-C-O 120.965 0.412 . . . . 65.439999999999998 110.613 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 59.6 t60 -92.93 148.71 21.78 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.277 -0.42 . . . . 74.219999999999999 111.283 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.93 128.98 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.226 0.536 . . . . 74.540000000000006 111.281 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.72 154.44 16.5 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.208 -0.52 . . . . 70.129999999999995 112.93 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 72' ' ' VAL . 49.5 mt -89.65 102.66 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 122.549 -0.383 . . . . 62.509999999999998 110.584 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 37.2 t80 -73.7 105.24 4.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 75.409999999999997 111.762 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.535 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.0 pt -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.954 0.407 . . . . 61.100000000000001 111.735 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.97 178.71 19.17 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.501 -0.38 . . . . 60.450000000000003 113.032 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 62.67 21.36 12.67 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.689 0.28 . . . . 75.239999999999995 111.139 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 142' ' ' SER . 0.9 OUTLIER 65.12 12.54 8.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.93 0.395 . . . . 65.510000000000005 111.503 -171.288 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -103.81 145.24 30.39 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.376 0.608 . . . . 72.25 111.235 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 10.5 p90 -150.07 140.73 22.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.953 -0.567 . . . . 70.420000000000002 111.39 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.75 133.12 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.965 0.412 . . . . 64.400000000000006 110.718 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.43 ' HD1' ' HE2' ' A' ' 119' ' ' HIS . 7.3 p80 -157.04 154.72 30.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.199 0.523 . . . . 73.109999999999999 111.88 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -84.41 91.04 7.71 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.952 0.406 . . . . 75.409999999999997 110.155 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -67.47 146.04 54.38 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.108 0.48 . . . . 73.329999999999998 111.628 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.6 p -49.55 -47.91 48.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.606 -0.725 . . . . 71.099999999999994 112.855 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.0 m -98.9 -51.07 3.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.683 0.623 . . . . 71.400000000000006 112.683 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.6 m -80.75 -15.14 57.25 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.259 0.837 . . . . 65.310000000000002 113.259 -170.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.61 -154.93 30.18 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.01 -0.614 . . . . 64.409999999999997 113.036 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.38 102.68 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.864 0.364 . . . . 75.120000000000005 111.958 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.9 pt -140.13 178.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.093 0.473 . . . . 71.230000000000004 111.773 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.19 134.93 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.418 -0.355 . . . . 74.430000000000007 110.76 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.402 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . 49.9 m -128.47 172.56 11.02 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 122.267 -0.271 . . . . 73.340000000000003 111.538 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 65.5 m -125.43 141.42 52.07 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.056 0.391 . . . . 54.039999999999999 112.056 -177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.3 mtt -67.4 -15.06 63.47 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.372 0.508 . . . . 73.109999999999999 112.372 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.965 0.412 . . . . 71.450000000000003 111.241 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.403 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 29.8 mm-40 -71.79 135.59 83.19 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.548 -0.296 . . . . 72.120000000000005 110.734 175.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.27 -48.03 21.68 Favored 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 122.91 2.406 . . . . 54.329999999999998 113.672 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 78.9 t80 -59.39 -50.85 72.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.833 0.349 . . . . 71.299999999999997 111.562 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.403 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 75.8 m95 -71.84 -36.92 70.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.576 -0.284 . . . . 64.219999999999999 111.701 -172.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -53.32 -54.87 30.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.08 0.467 . . . . 75.019999999999996 111.777 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -80.82 -18.86 46.11 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.94 0.348 . . . . 75.239999999999995 111.94 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.564 ' HG3' ' HB2' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -84.68 -15.36 45.56 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.958 -0.464 . . . . 72.519999999999996 111.884 177.531 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -61.26 92.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.296 0.569 . . . . 73.540000000000006 110.301 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -79.08 -46.01 18.93 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.966 -0.561 . . . . 74.329999999999998 111.379 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -172.9 163.58 4.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.979 -0.555 . . . . 62.020000000000003 110.978 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -128.15 149.3 50.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.766 -0.197 . . . . 65.329999999999998 110.718 176.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 95' ' ' GLY . 50.8 mtt180 -138.61 125.92 21.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.184 0.516 . . . . 63.509999999999998 112.016 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.71 120.67 27.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.034 -0.53 . . . . 75.129999999999995 111.242 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.55 -19.53 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.732 0.641 . . . . 70.439999999999998 112.732 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 82' ' ' LEU . 91.7 mt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.129 0.49 . . . . 73.200000000000003 112.079 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 41' ' ' LYS . 30.9 t70 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.732 0.301 . . . . 72.5 110.888 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.2 -48.38 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.406 -0.361 . . . . 74.25 111.531 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.9 tttt -60.04 -44.03 94.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.342 -0.39 . . . . 74.420000000000002 111.372 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.7 t -53.19 -49.79 65.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.181 0.437 . . . . 75.340000000000003 112.181 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -63.5 -44.2 95.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.964 0.412 . . . . 73.540000000000006 111.572 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.49 HD13 HG21 ' A' ' 122' ' ' ILE . 67.5 mt -64.36 -36.88 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.957 0.408 . . . . 64.420000000000002 111.365 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 96.0 mmm -65.74 -37.29 85.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.912 0.387 . . . . 72.439999999999998 110.715 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.75 -37.17 78.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.252 0.549 . . . . 54.210000000000001 110.198 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.559 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 7.6 tp60 -62.74 -53.65 51.13 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.013 -0.54 . . . . 54.039999999999999 110.451 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -51.1 -39.44 56.15 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.053 -0.521 . . . . 74.510000000000005 111.293 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.93 71.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.366 . . . . 74.010000000000005 111.685 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.02 -26.91 61.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 75.299999999999997 111.47 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -107.01 11.78 29.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.064 0.764 . . . . 75.519999999999996 113.064 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.78 128.43 35.88 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.959 -0.463 . . . . 64.420000000000002 111.325 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.05 -18.13 58.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.254 -0.498 . . . . 75.409999999999997 113.665 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.58 131.63 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.42 . . . . 74.230000000000004 111.837 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 55' ' ' ARG . 44.5 mtp180 -82.3 178.39 8.27 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.228 0.455 . . . . 65.239999999999995 112.228 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -85.39 121.46 28.15 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.896 0.379 . . . . 64.530000000000001 111.661 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -137.57 115.46 11.5 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 74.510000000000005 110.65 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 21.7 tp -72.87 116.85 13.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.004 0.43 . . . . 72.340000000000003 112.102 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.91 -53.25 3.97 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.369 -0.443 . . . . 61.119999999999997 113.339 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.92 71.48 0.93 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.114 -0.565 . . . . 61.219999999999999 113.236 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.2 p -69.6 106.97 3.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.252 0.549 . . . . 74.0 112.132 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 t -160.94 172.46 16.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.906 -0.588 . . . . 73.019999999999996 111.026 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.5 -14.11 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.911 0.386 . . . . 74.420000000000002 111.433 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.73 -16.28 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.887 0.375 . . . . 61.219999999999999 110.903 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.22 144.38 4.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.157 -0.474 . . . . 54.310000000000002 112.222 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.6 tt -155.58 148.21 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 117.444 0.622 . . . . 71.310000000000002 111.506 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 6.4 p-10 -96.08 -171.37 2.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.185 0.517 . . . . 72.400000000000006 112.063 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 24.4 p -70.97 -50.16 37.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.073 -0.512 . . . . 71.109999999999999 112.023 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 50.5 p -66.76 -40.95 88.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.818 0.342 . . . . 71.420000000000002 110.836 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.29 -40.73 99.4 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.333 -0.461 . . . . 64.150000000000006 113.093 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -65.32 -55.99 15.14 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.666 0.269 . . . . 54.32 111.553 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.06 -42.23 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.915 0.388 . . . . 63.409999999999997 111.054 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.8 tt0 -52.86 -61.28 2.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 75.25 111.719 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 74' ' ' ARG . 52.8 mtt180 -56.96 -46.53 82.07 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.544 -0.298 . . . . 75.420000000000002 111.783 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.2 m -49.85 -50.18 46.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.272 0.471 . . . . 71.140000000000001 112.272 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 85.0 m-85 -80.4 -42.46 22.75 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.849 0.685 . . . . 45.240000000000002 112.849 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 14.7 ptm180 -66.66 -33.56 75.93 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.94 -0.475 . . . . 75.329999999999998 111.996 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 5.0 mm-40 -86.71 -45.93 10.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.961 0.356 . . . . 64.430000000000007 111.961 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 29.8 mt-30 -83.26 -51.7 7.22 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.613 0.597 . . . . 75.239999999999995 112.613 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -97.15 -6.17 35.51 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.391 0.515 . . . . 71.25 112.391 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.03 43.64 98.88 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.032 -0.604 . . . . 71.310000000000002 112.663 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 52.7 tp -108.89 138.85 44.58 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 73.150000000000006 111.742 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.6 118.06 12.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.551 0.575 . . . . 75.299999999999997 112.551 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 158' ' ' VAL . 60.5 mt -136.72 134.78 19.59 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.83 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.518 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 81.3 Cg_endo -77.35 173.7 13.89 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.726 2.284 . . . . 63.210000000000001 113.409 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -95.55 16.03 18.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 73.230000000000004 112.985 -173.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.0 m -143.06 127.88 18.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.652 0.263 . . . . 63.5 111.675 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 69' ' ' SER . 26.9 m -51.28 -37.33 46.78 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.073 0.463 . . . . 72.420000000000002 111.75 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.485 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 72.9 m-85 -57.86 -32.02 67.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.089 -0.505 . . . . 74.109999999999999 111.631 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -83.1 -38.58 22.27 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.385 0.612 . . . . 70.530000000000001 110.456 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.86 -25.46 67.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.052 -0.522 . . . . 73.329999999999998 111.845 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 26.5 pt20 -78.28 -15.51 58.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.443 0.534 . . . . 64.409999999999997 112.443 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -110.99 -21.61 11.92 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.797 0.665 . . . . 70.349999999999994 112.797 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.518 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 25.5 ptm -75.03 -15.95 60.62 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.912 0.708 . . . . 72.129999999999995 112.912 -176.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.63 170.19 13.36 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.048 -0.596 . . . . 71.439999999999998 113.642 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 74.2 mmtt -90.87 133.59 35.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.186 0.517 . . . . 72.209999999999994 111.772 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -78.38 132.7 37.48 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.512 -0.767 . . . . 52.509999999999998 112.797 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.563 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 2.4 m -134.15 161.6 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.971 0.508 . . . . 73.430000000000007 111.488 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -116.95 -175.68 2.83 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.835 -0.62 . . . . 63.020000000000003 112.068 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.545 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 25.8 mmm180 -40.54 -61.49 0.92 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 75.430000000000007 113.855 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -69.03 -16.93 63.83 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.999 0.74 . . . . 54.219999999999999 112.999 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -94.12 -13.8 26.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.518 0.562 . . . . 73.25 112.518 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.22 148.89 43.33 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.439 0.903 . . . . 71.530000000000001 113.439 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -133.25 -163.01 1.3 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.062 -0.972 . . . . 65.019999999999996 109.917 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 41' ' ' LYS . 36.0 m -86.52 108.42 18.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.883 -0.511 . . . . 73.319999999999993 110.907 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.54 -13.48 6.92 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.952 -0.642 . . . . 62.340000000000003 113.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 120.98 13.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.338 0.569 . . . . 41.340000000000003 111.362 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 35.8 mt -76.49 110.98 11.48 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.302 -0.408 . . . . 60.210000000000001 111.282 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 155' ' ' ALA . 27.7 m -95.36 139.98 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.046 0.45 . . . . 72.239999999999995 112.081 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.446 ' HG ' HH12 ' A' ' 156' ' ' ARG . 96.4 mt -106.56 134.76 49.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.15 -0.477 . . . . 72.430000000000007 111.879 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.58 133.92 52.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 72.230000000000004 110.459 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 112' ' ' ARG . 24.5 mtp180 -74.1 91.47 2.09 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.186 0.517 . . . . 73.219999999999999 110.397 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.715 0.635 . . . . 64.439999999999998 112.715 -170.014 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 10.4 mpt_? . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.835 0.35 . . . . 72.530000000000001 110.536 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -105.09 141.68 36.23 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.465 -0.334 . . . . 74.329999999999998 110.799 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.17 137.78 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.199 0.523 . . . . 55.32 111.92 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.28 159.84 23.95 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 116.054 -0.521 . . . . 73.140000000000001 112.635 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.49 HG21 HD13 ' A' ' 44' ' ' ILE . 56.8 mt -93.33 110.3 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 122.603 -0.351 . . . . 72.430000000000007 110.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -69.32 115.7 8.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.928 0.394 . . . . 75.140000000000001 111.611 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.9 pt -106.58 14.27 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.12 0.415 . . . . 71.439999999999998 112.12 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.57 162.62 33.95 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.309 -0.472 . . . . 70.540000000000006 114.071 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 59.07 35.56 23.91 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.831 0.452 . . . . 54.439999999999998 111.996 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 142' ' ' SER . 48.4 m-80 62.18 14.49 6.7 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.126 0.417 . . . . 65.25 112.126 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -103.35 145.7 29.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.111 0.482 . . . . 72.010000000000005 111.139 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.03 139.87 19.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.115 -0.493 . . . . 75.420000000000002 111.844 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.49 133.62 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.091 0.472 . . . . 62.119999999999997 110.977 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -163.67 168.71 19.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.299 -0.41 . . . . 74.010000000000005 111.184 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.13 93.4 8.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.009 0.433 . . . . 71.049999999999997 110.814 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.1 t -79.54 130.39 35.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.309 -0.405 . . . . 73.120000000000005 111.993 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.8 p -63.36 -11.85 25.74 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.063 -0.517 . . . . 62.340000000000003 112.359 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 m -79.72 -32.39 41.23 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.976 0.362 . . . . 52.439999999999998 111.976 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.4 t -139.65 -48.45 0.47 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.04 0.448 . . . . 73.450000000000003 112.069 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.1 -148.28 19.95 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.713 -0.555 . . . . 74.439999999999998 111.713 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.2 99.5 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 117.321 0.561 . . . . 64.409999999999997 111.175 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 41.0 pt -138.23 -177.54 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.118 0.485 . . . . 73.420000000000002 111.824 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.79 129.03 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.251 -0.431 . . . . 72.400000000000006 110.565 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.5 m -119.8 172.94 7.35 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.942 0.401 . . . . 63.32 111.599 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 47.2 m -128.78 144.83 51.26 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.993 0.425 . . . . 54.43 112.085 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.545 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 65.8 mtt -75.2 0.87 14.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.675 0.62 . . . . 50.119999999999997 112.675 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.95 -11.86 49.32 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.936 -0.477 . . . . 65.319999999999993 111.287 173.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.46 130.6 92.04 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.486 -0.325 . . . . 75.030000000000001 110.699 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.34 -31.02 75.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.876 2.384 . . . . 43.450000000000003 113.442 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.19 -45.0 62.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.705 0.288 . . . . 71.400000000000006 111.74 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -83.79 -37.54 22.45 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.183 0.438 . . . . 72.230000000000004 112.183 -174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -53.51 -51.41 62.91 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.43 0.53 . . . . 73.239999999999995 112.43 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.22 -7.86 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.955 0.354 . . . . 71.099999999999994 111.955 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -95.94 -10.87 27.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.119 0.414 . . . . 72.010000000000005 112.119 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.86 114.63 2.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.946 0.403 . . . . 74.150000000000006 111.474 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -96.26 -55.5 2.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.296 -0.411 . . . . 74.420000000000002 111.255 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -168.74 -179.69 3.87 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.871 0.367 . . . . 74.439999999999998 111.398 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.586 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -140.33 160.4 40.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.28 -0.418 . . . . 74.299999999999997 111.162 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.4 mtm-85 -144.33 121.22 11.31 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.321 -0.237 . . . . 73.340000000000003 111.584 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.563 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -94.08 98.92 11.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.755 0.788 . . . . 75.019999999999996 111.242 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.542 HG21 HD21 ' A' ' 84' ' ' LEU . 15.9 m -83.18 -1.01 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.515 -0.766 . . . . 63.43 112.592 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.495 HD23 HD22 ' A' ' 82' ' ' LEU . 90.9 mt . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.866 0.365 . . . . 64.329999999999998 111.974 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.301 0.572 . . . . 74.329999999999998 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.75 -38.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.854 -0.612 . . . . 71.200000000000003 112.117 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.498 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.7 tttt -63.08 -55.31 26.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.638 0.606 . . . . 60.409999999999997 112.638 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 t -57.41 -42.99 83.38 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.95 0.352 . . . . 61.32 111.95 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -59.14 -45.19 91.59 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.022 0.439 . . . . 64.319999999999993 111.446 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.56 HD13 HG21 ' A' ' 122' ' ' ILE . 86.8 mt -69.17 -44.54 80.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.828 0.347 . . . . 72.200000000000003 111.722 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 28.1 mmt -61.56 -32.04 72.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.889 0.376 . . . . 74.150000000000006 111.051 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.09 -53.12 61.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.995 -0.548 . . . . 73.209999999999994 110.765 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.576 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 51.6 tp60 -65.25 -36.33 83.79 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.02 -0.536 . . . . 72.0 111.812 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.484 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 34.0 t80 -55.21 -39.68 69.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.868 0.366 . . . . 63.539999999999999 111.273 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . . . -59.37 -18.4 38.19 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.454 0.538 . . . . 71.129999999999995 112.454 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -92.5 -22.63 19.46 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.058 0.456 . . . . 71.439999999999998 111.776 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.473 ' CZ2' ' HG2' ' A' ' 63' ' ' LYS . 35.5 m95 -113.56 13.0 18.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.06 0.763 . . . . 72.140000000000001 113.06 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.6 mtmt -63.57 105.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.229 0.538 . . . . 50.109999999999999 112.027 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.96 19.33 9.14 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.94 -0.648 . . . . 71.409999999999997 114.375 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.32 130.3 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.619 0.709 . . . . 51.119999999999997 110.738 174.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 55' ' ' ARG . 16.5 ptt180 -79.46 163.27 24.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.408 0.521 . . . . 73.25 112.408 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -81.25 125.48 30.37 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.174 0.511 . . . . 74.5 112.242 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.431 HH11 HG22 ' A' ' 62' ' ' THR . 53.0 ttt180 -137.0 111.47 8.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.794 -0.639 . . . . 75.239999999999995 110.263 176.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.591 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 1.1 pt? -92.82 113.06 25.23 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.324 0.583 . . . . 72.219999999999999 112.026 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.08 -7.26 27.17 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.848 -0.615 . . . . 52.32 113.267 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.01 110.8 0.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.455 -0.403 . . . . 45.210000000000001 112.314 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.52 ' HA ' HG13 ' A' ' 66' ' ' ILE . 48.8 m -92.09 104.23 16.64 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.557 0.577 . . . . 63.210000000000001 112.557 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.431 HG22 HH11 ' A' ' 57' ' ' ARG . 2.9 t -151.87 157.18 41.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 73.200000000000003 111.222 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HG2' ' CZ2' ' A' ' 51' ' ' TRP . 43.8 mtpt -65.69 -15.86 63.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 73.319999999999993 111.708 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -92.41 11.12 27.21 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.061 0.458 . . . . 71.099999999999994 111.015 178.415 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.44 116.39 0.67 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.747 -0.541 . . . . 51.340000000000003 111.747 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.52 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.9 tt -150.19 151.85 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 117.263 0.531 . . . . 53.219999999999999 111.882 -173.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -91.05 177.48 6.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.284 0.564 . . . . 71.239999999999995 112.084 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.444 ' O ' HG12 ' A' ' 72' ' ' VAL . 23.0 p -61.31 -43.9 98.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.1 -0.5 . . . . 72.239999999999995 111.749 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.482 ' HB2' ' OG1' ' A' ' 88' ' ' THR . 40.3 t -61.13 -46.29 91.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.156 0.503 . . . . 72.329999999999998 111.221 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.562 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -60.67 -45.85 95.59 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.045 -0.598 . . . . 70.430000000000007 112.797 177.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.22 -53.7 55.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.804 0.335 . . . . 63.439999999999998 111.902 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.538 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.7 p -59.76 -40.41 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.934 0.397 . . . . 64.310000000000002 110.676 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.501 ' HA ' HD12 ' A' ' 84' ' ' LEU . 20.3 tt0 -55.62 -48.64 74.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.153 -0.476 . . . . 73.319999999999993 111.406 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.576 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 15.7 mmm180 -60.75 -49.03 79.12 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.937 0.347 . . . . 53.32 111.937 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.576 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 86.6 m -57.81 -54.19 49.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.049 0.452 . . . . 70.030000000000001 112.045 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 68.7 m-85 -64.11 -33.96 76.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.494 0.553 . . . . 65.129999999999995 112.494 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.7 -29.18 58.89 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.019 -0.425 . . . . 75.420000000000002 111.679 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 78.6 mm-40 -71.18 -64.08 0.98 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.105 0.479 . . . . 73.109999999999999 111.417 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.401 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 18.4 mp0 -72.5 -59.42 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.81 0.67 . . . . 73.129999999999995 112.81 -177.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -88.78 -12.87 40.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.524 0.565 . . . . 74.420000000000002 112.524 -173.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.03 31.2 77.27 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.793 -0.718 . . . . 25.399999999999999 112.492 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 56.4 tp -90.8 132.34 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.675 0.39 . . . . 74.430000000000007 111.236 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.83 131.07 35.95 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.199 0.523 . . . . 74.109999999999999 112.117 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 73' ' ' GLN . 95.0 mt -136.0 150.96 72.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.224 -0.443 . . . . 73.209999999999994 111.079 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.09 156.92 55.22 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.551 2.167 . . . . 54.439999999999998 112.927 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.46 6.19 10.89 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.728 0.64 . . . . 75.019999999999996 112.728 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.3 m -131.25 129.11 41.17 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.663 0.268 . . . . 73.409999999999997 111.642 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.547 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 89.0 m -54.74 -43.38 72.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.897 0.379 . . . . 74.120000000000005 111.357 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -51.51 -32.39 27.53 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.729 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.15 -40.77 14.31 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.328 -0.397 . . . . 71.340000000000003 111.393 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -56.41 -30.2 62.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.885 0.374 . . . . 52.329999999999998 111.411 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 88' ' ' THR . 21.7 mt-30 -52.94 -38.45 61.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.057 -0.52 . . . . 63.43 111.93 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.41 22.97 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.111 0.411 . . . . 75.430000000000007 112.111 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.0 mmm -98.31 -35.43 10.33 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.085 0.772 . . . . 64.150000000000006 113.085 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.0 -175.89 14.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.641 -0.79 . . . . 63.049999999999997 114.755 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.0 mmmt -86.21 149.03 25.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.687 0.395 . . . . 73.530000000000001 111.875 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -90.28 153.22 20.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.343 0.592 . . . . 72.400000000000006 112.563 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.99 159.76 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.676 -0.693 . . . . 74.109999999999999 111.502 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.4 t -87.66 157.76 19.02 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.286 -0.415 . . . . 65.099999999999994 111.514 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -52.18 -32.68 37.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.191 0.52 . . . . 72.109999999999999 111.413 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.5 p -74.57 -28.88 61.12 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.579 0.585 . . . . 44.140000000000001 112.579 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -96.05 -0.85 49.88 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.867 0.691 . . . . 74.439999999999998 112.867 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.94 123.49 17.23 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.599 0.592 . . . . 74.299999999999997 112.599 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -128.05 -178.84 4.69 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.012 -0.54 . . . . 72.109999999999999 110.771 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.498 HG21 ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -64.33 108.11 1.52 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.819 0.342 . . . . 71.519999999999996 111.893 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.73 -18.61 5.11 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.905 -0.664 . . . . 74.430000000000007 113.452 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 66.8 m-20 -74.15 129.73 38.39 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.047 0.451 . . . . 73.329999999999998 111.331 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.26 115.77 23.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.679 0.276 . . . . 72.230000000000004 110.595 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 155' ' ' ALA . 16.5 m -95.67 128.58 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.143 0.497 . . . . 74.129999999999995 111.908 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.4 mt -97.67 129.19 44.76 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.937 -0.574 . . . . 74.209999999999994 111.714 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.11 140.31 49.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.536 0.684 . . . . 75.219999999999999 112.376 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 112' ' ' ARG . 41.6 mtp180 -83.95 100.35 10.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.459 -0.791 . . . . 62.210000000000001 110.932 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 120.847 0.356 . . . . 64.019999999999996 111.85 -178.761 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.123 0.487 . . . . 60.140000000000001 111.761 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -98.51 148.06 24.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.057 -0.52 . . . . 75.120000000000005 110.643 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.5 141.9 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.069 0.461 . . . . 75.120000000000005 111.969 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.62 155.59 21.84 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.322 -0.466 . . . . 44.240000000000002 112.556 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 44' ' ' ILE . 20.1 mt -95.25 106.26 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.482 -0.422 . . . . 73.400000000000006 111.018 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 33.8 t80 -64.43 113.49 3.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.329 . . . . 65.230000000000004 111.186 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.41 -27.47 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.303 0.483 . . . . 74.010000000000005 112.303 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.33 144.95 4.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.441 -0.885 . . . . 64.209999999999994 114.23 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.21 53.37 12.54 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.107 0.563 . . . . 55.340000000000003 112.393 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 142' ' ' SER . 40.6 m-80 66.93 -4.98 0.72 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.173 0.805 . . . . 73.140000000000001 113.173 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.497 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 25.1 mt-30 -87.45 143.73 27.08 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.26 0.553 . . . . 74.450000000000003 111.061 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.582 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 25.2 p90 -156.32 148.95 23.75 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.77 -0.65 . . . . 74.129999999999995 111.519 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 137.54 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.104 -0.498 . . . . 72.310000000000002 110.835 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -166.45 162.29 16.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.114 0.483 . . . . 65.340000000000003 111.85 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -88.78 86.99 7.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.111 0.482 . . . . 75.409999999999997 110.309 172.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.2 t -58.22 134.71 56.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.783 -0.644 . . . . 74.200000000000003 112.498 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.9 p -57.18 -35.67 69.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.109 0.481 . . . . 60.119999999999997 111.82 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.7 t -85.94 -50.74 6.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.715 0.635 . . . . 62.43 112.715 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.8 m -98.9 -34.63 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.202 0.816 . . . . 61.119999999999997 113.202 -173.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.61 -158.67 14.4 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.05 -0.595 . . . . 71.439999999999998 112.369 -172.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 99.2 t -63.08 102.5 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.318 0.58 . . . . 72.0 111.793 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.76 -178.81 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.817 -0.629 . . . . 70.230000000000004 111.642 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.42 109.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.167 -0.469 . . . . 62.43 110.9 172.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 92.7 p -107.88 -171.46 1.87 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.584 0.23 . . . . 64.230000000000004 110.818 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.641 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 43.9 m -146.86 136.54 23.06 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.339 0.496 . . . . 63.210000000000001 112.339 -174.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.582 ' HG3' ' CE1' ' A' ' 129' ' ' PHE . 72.9 mtm -78.21 3.93 13.98 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.334 0.864 . . . . 54.009999999999998 113.334 -177.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' A' ' 142' ' ' SER . 1.0 OUTLIER -83.2 -12.85 56.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.867 0.365 . . . . 75.030000000000001 110.544 170.154 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -71.54 136.93 83.37 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 116.532 -0.304 . . . . 64.209999999999994 110.427 169.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -52.98 -43.0 60.44 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.722 2.281 . . . . 65.120000000000005 113.522 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 80.5 t80 -59.45 -47.66 84.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.705 0.288 . . . . 73.420000000000002 111.689 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 151' ' ' ARG . 95.6 m95 -78.89 -33.62 45.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.835 0.35 . . . . 75.140000000000001 111.623 -176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -56.81 -38.43 72.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.257 -0.429 . . . . 74.329999999999998 111.382 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -93.52 -12.32 29.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.788 0.328 . . . . 71.329999999999998 111.801 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -79.32 -32.48 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.836 0.35 . . . . 72.549999999999997 111.079 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -58.04 126.59 28.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.845 -0.616 . . . . 73.019999999999996 112.405 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -101.38 -63.9 1.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.177 0.513 . . . . 65.019999999999996 110.344 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.27 172.46 18.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 71.439999999999998 110.032 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.473 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -131.23 145.63 52.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.999 0.428 . . . . 63.450000000000003 111.934 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 97.1 mtt180 -140.6 124.96 17.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.332 -0.395 . . . . 74.209999999999994 110.8 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -98.29 137.19 37.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.325 0.583 . . . . 63.539999999999999 111.767 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.2 m -104.83 14.29 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.661 -0.7 . . . . 71.430000000000007 112.753 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 112.439 0.533 . . . . 73.239999999999995 112.439 -177.737 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 120.745 0.307 . . . . 51.219999999999999 111.384 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.9 t -51.22 -44.59 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.162 -0.472 . . . . 55.340000000000003 111.582 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.49 -37.76 79.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.431 -0.349 . . . . 64.120000000000005 111.62 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.8 m -64.14 -10.87 25.46 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.235 0.457 . . . . 63.130000000000003 112.235 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.53 ' HA ' ' HE ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -101.01 -49.1 4.22 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.023 0.44 . . . . 74.530000000000001 110.512 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.2 mt -52.41 -43.98 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.117 0.484 . . . . 74.5 111.027 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.543 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 31.1 mmt -71.07 -22.49 62.11 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.223 -0.444 . . . . 65.329999999999998 111.801 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.78 -46.47 78.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.69 0.281 . . . . 63.530000000000001 110.673 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.02 -42.23 69.84 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.707 0.289 . . . . 73.129999999999995 110.938 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.584 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 36.6 t80 -50.44 -36.68 34.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.638 0.256 . . . . 73.439999999999998 111.183 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.24 80.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.451 -0.341 . . . . 75.430000000000007 111.665 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.1 -29.66 60.67 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.831 0.348 . . . . 73.299999999999997 111.713 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -92.09 5.9 48.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.163 0.431 . . . . 73.109999999999999 112.163 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 23.6 mmmt -58.69 101.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.483 . . . . 73.150000000000006 111.915 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.34 -0.45 37.56 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.049 -0.596 . . . . 64.549999999999997 113.949 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.5 134.54 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 117.319 0.559 . . . . 73.400000000000006 111.323 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -85.58 171.67 11.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.481 0.658 . . . . 71.219999999999999 112.427 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -102.18 137.81 39.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.732 -0.667 . . . . 72.5 110.666 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -132.63 121.83 23.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.01 0.433 . . . . 74.409999999999997 111.676 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.67 103.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 61.530000000000001 111.275 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.57 28.96 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.184 -0.532 . . . . 75.409999999999997 113.401 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 134.71 7.61 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.394 -0.432 . . . . 72.129999999999995 112.503 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.552 ' HA ' HD12 ' A' ' 66' ' ' ILE . 11.7 m -125.01 98.28 5.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.255 0.527 . . . . 64.219999999999999 111.4 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 t 177.99 172.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.867 0.365 . . . . 73.129999999999995 111.659 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -66.68 -18.6 65.45 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.881 0.372 . . . . 72.409999999999997 111.719 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 3.3 mptp? -78.64 -11.79 59.99 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.107 0.479 . . . . 71.329999999999998 110.883 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.92 111.21 0.25 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.595 -0.602 . . . . 72.129999999999995 111.595 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 61' ' ' SER . 11.2 tp -112.2 154.33 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.999 0.399 . . . . 72.450000000000003 111.658 -173.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.26 178.7 4.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.984 0.421 . . . . 63.329999999999998 111.15 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.8 p -60.27 -52.9 63.29 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.309 -0.405 . . . . 54.329999999999998 112.013 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -69.42 -36.7 76.95 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.956 0.408 . . . . 74.209999999999994 111.129 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.496 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -58.68 -48.95 82.1 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.941 -0.572 . . . . 73.299999999999997 113.774 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.69 -56.16 25.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.184 0.492 . . . . 63.100000000000001 111.912 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.555 ' HA ' HD11 ' A' ' 122' ' ' ILE . 10.8 p -60.02 -39.41 80.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.872 0.368 . . . . 60.130000000000003 111.266 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.581 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 tt0 -56.68 -57.18 13.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.166 -0.47 . . . . 50.520000000000003 111.39 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 25.2 mmt180 -55.28 -49.46 72.02 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.904 0.383 . . . . 74.099999999999994 111.24 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.9 m -49.72 -61.96 1.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.013 -0.54 . . . . 73.049999999999997 112.452 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 69.5 m-85 -68.09 -37.38 81.15 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.202 0.815 . . . . 71.230000000000004 113.202 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -71.36 -36.72 71.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.879 -0.513 . . . . 64.200000000000003 112.172 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -78.08 -23.89 47.82 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.092 -0.38 . . . . 75.299999999999997 111.774 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -92.32 -70.31 0.7 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.178 0.513 . . . . 71.019999999999996 112.127 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -89.96 -9.78 47.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.043 -0.526 . . . . 63.340000000000003 112.042 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.51 77.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.918 -0.658 . . . . 62.539999999999999 112.33 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.8 tp -73.55 111.38 8.63 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.037 0.446 . . . . 72.120000000000005 110.533 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.35 78.59 4.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.437 0.637 . . . . 72.25 112.558 -173.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 83.8 mt -77.13 143.32 69.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.064 -0.516 . . . . 71.329999999999998 111.571 176.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.527 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 89.9 Cg_endo -79.73 -179.43 5.32 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.019 2.479 . . . . 74.209999999999994 113.505 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -11.63 43.12 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.277 0.843 . . . . 73.230000000000004 113.277 -173.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.457 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 39.1 t -115.62 137.56 51.95 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.897 -0.502 . . . . 74.329999999999998 111.851 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 6.2 m -56.87 -39.59 74.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.134 0.492 . . . . 74.439999999999998 111.476 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -64.08 -33.72 76.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.327 -0.397 . . . . 74.439999999999998 111.781 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 87' ' ' SER . 43.0 mt-10 -68.21 -38.34 81.81 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.274 0.559 . . . . 73.209999999999994 110.627 175.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.527 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 84.1 mt-30 -64.93 -30.58 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.697 -0.683 . . . . 53.32 110.912 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.4 mt-30 -64.98 -8.74 17.11 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.652 0.612 . . . . 72.400000000000006 112.652 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -99.16 -1.89 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.52 0.563 . . . . 54.219999999999999 112.52 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.2 ptp -114.04 154.95 26.8 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.062 -0.399 . . . . 74.409999999999997 110.863 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.27 177.22 29.63 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.777 -0.725 . . . . 72.340000000000003 112.756 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -118.46 149.75 40.74 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.325 -0.515 . . . . 75.230000000000004 111.611 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 89.0 p -76.91 154.53 33.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.237 0.829 . . . . 75.239999999999995 113.237 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 1.5 m -145.44 150.16 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.235 -0.893 . . . . 73.019999999999996 111.63 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.5 t -95.79 -179.52 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.884 0.373 . . . . 44.140000000000001 111.571 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -51.52 -44.09 62.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.317 0.488 . . . . 73.25 112.317 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.5 t -83.51 10.12 9.7 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.246 -0.434 . . . . 62.43 112.06 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.3 m120 -120.45 -8.55 9.57 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.126 -0.359 . . . . 53.020000000000003 111.832 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.64 144.19 57.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.101 0.778 . . . . 62.43 113.101 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -130.28 -156.44 0.76 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.717 -0.674 . . . . 71.409999999999997 110.599 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.9 m -101.14 126.97 47.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.548 -0.296 . . . . 74.510000000000005 110.325 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.06 -4.07 31.74 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.08 -0.581 . . . . 65.140000000000001 113.291 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 123' ' ' TYR . 2.2 m-20 -75.84 142.09 42.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.054 0.454 . . . . 64.219999999999999 111.128 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.43 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.535 -0.302 . . . . 63.25 110.331 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.22 126.46 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.473 0.654 . . . . 65.230000000000004 111.508 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.723 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 77.4 mt -105.71 115.1 29.66 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.488 -0.778 . . . . 71.430000000000007 111.823 -173.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -107.07 151.61 25.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.179 -0.464 . . . . 72.200000000000003 111.245 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.591 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 93.4 mtt180 -87.6 101.28 13.49 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.445 -0.343 . . . . 64.430000000000007 111.022 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.506 0 O-C-N 122.173 -0.329 . . . . 72.430000000000007 111.516 -178.317 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.723 ' HD2' ' HB3' ' A' ' 110' ' ' LEU . 2.1 tpp180 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.886 0.374 . . . . 73.519999999999996 111.004 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -118.05 124.92 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.147 -0.316 . . . . 74.099999999999994 110.147 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.82 138.58 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.24 0.459 . . . . 72.230000000000004 112.24 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -127.9 147.56 17.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.261 -0.427 . . . . 74.25 112.56 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 72' ' ' VAL . 40.3 mt -87.46 108.58 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.519 -0.4 . . . . 63.32 110.917 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.519 ' HD1' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -66.28 109.82 2.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.048 0.452 . . . . 72.5 111.901 -175.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.4 pt -105.23 11.49 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.01 0.434 . . . . 54.240000000000002 111.605 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.42 37.94 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.294 -0.412 . . . . 64.510000000000005 112.581 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -67.62 -16.21 64.05 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.281 0.475 . . . . 71.430000000000007 112.281 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.496 ' HA ' ' OH ' ' A' ' 123' ' ' TYR . 9.9 p30 -150.96 -13.42 0.22 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.668 0.618 . . . . 72.099999999999994 112.668 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.3 143.44 26.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.331 0.586 . . . . 63.039999999999999 111.869 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.519 ' HB3' ' HD1' ' A' ' 123' ' ' TYR . 27.6 p90 -153.1 146.46 24.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.647 -0.706 . . . . 65.109999999999999 111.462 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.7 p -99.19 136.84 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.055 0.455 . . . . 65.409999999999997 111.062 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -156.09 -166.28 2.14 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.246 -0.434 . . . . 73.409999999999997 110.736 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.4 114.41 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.707 0.289 . . . . 63.399999999999999 111.696 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 67.5 m -91.06 145.97 24.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.852 0.358 . . . . 72.319999999999993 111.272 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p -50.55 -48.91 57.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.58 0.955 . . . . 63.240000000000002 113.58 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.7 p -106.83 19.54 20.33 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.773 0.657 . . . . 60.310000000000002 112.773 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 133' ' ' SER . 67.6 m -133.05 -23.5 1.96 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.321 0.489 . . . . 74.549999999999997 112.321 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.29 -151.94 31.95 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.966 -0.635 . . . . 64.230000000000004 112.705 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.432 HG12 ' HE1' ' A' ' 48' ' ' TYR . 47.0 t -75.63 111.77 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.947 0.403 . . . . 45.039999999999999 111.993 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.523 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -140.36 -178.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 120.962 0.41 . . . . 63.539999999999999 111.491 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.41 143.13 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.738 0.304 . . . . 72.340000000000003 110.783 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.8 t -138.43 179.47 6.44 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.806 0.336 . . . . 74.140000000000001 111.657 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 69.7 m -137.7 138.71 39.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.341 -0.39 . . . . 70.040000000000006 111.258 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 27.0 mtm -69.97 -9.67 55.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.426 0.528 . . . . 75.010000000000005 112.426 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -78.52 -9.44 59.34 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.092 -0.38 . . . . 72.049999999999997 111.38 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.92 136.18 82.65 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 110.167 -0.309 . . . . 73.400000000000006 110.167 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -49.98 -45.85 30.75 Favored 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 123.029 2.486 . . . . 72.530000000000001 114.157 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.532 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 56.3 t80 -65.11 -44.14 89.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.912 0.387 . . . . 75.140000000000001 111.757 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -77.53 -35.56 53.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.832 0.308 . . . . 75.340000000000003 111.832 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -53.72 -38.98 64.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.237 0.542 . . . . 73.310000000000002 111.565 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -92.59 0.47 57.43 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.525 0.565 . . . . 72.310000000000002 112.525 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 112' ' ' ARG . 33.4 mmt180 -100.83 -17.94 16.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.109 0.411 . . . . 70.019999999999996 112.109 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.41 130.07 44.65 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.373 0.508 . . . . 74.430000000000007 112.373 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -112.89 -54.66 2.6 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 72.5 111.102 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -165.86 167.46 16.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.425 -0.352 . . . . 74.329999999999998 110.914 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -133.91 145.41 49.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.165 0.186 . . . . 51.399999999999999 110.864 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 57.5 mtt180 -141.0 121.14 13.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.743 0.306 . . . . 61.240000000000002 111.422 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.511 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -85.06 121.94 28.55 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.409 0.623 . . . . 72.420000000000002 110.864 175.537 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.48 4.91 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.026 -0.534 . . . . 65.140000000000001 112.329 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 120.874 0.368 . . . . 60.420000000000002 111.315 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 111.435 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -55.31 -48.71 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.581 0.585 . . . . 65.230000000000004 112.581 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.1 tttt -61.86 -56.95 14.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.863 0.32 . . . . 72.530000000000001 111.863 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.411 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 56.6 m -59.83 -38.83 83.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.597 0.237 . . . . 61.229999999999997 111.563 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -52.9 -52.05 59.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.331 0.586 . . . . 71.109999999999999 111.2 176.412 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 122' ' ' ILE . 72.8 mt -69.16 -42.8 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.829 -0.623 . . . . 72.109999999999999 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.7 mmt -62.66 -37.28 85.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.022 0.439 . . . . 63.219999999999999 111.328 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.87 -46.05 92.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.317 -0.401 . . . . 71.040000000000006 110.605 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -68.02 -36.82 80.6 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.399 -0.364 . . . . 64.120000000000005 111.523 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 50.4 t80 -54.07 -39.39 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.831 0.308 . . . . 74.25 111.831 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.36 -23.24 9.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 74.420000000000002 112.234 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.65 -44.41 11.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.12 0.486 . . . . 61.030000000000001 111.024 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -80.92 -2.27 46.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.139 0.792 . . . . 74.120000000000005 113.139 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 54.2 mtmt -50.04 117.75 2.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.678 0.621 . . . . 73.439999999999998 112.678 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.41 -6.35 77.95 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 114.75 0.66 . . . . 72.340000000000003 114.75 172.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.0 t -59.72 130.21 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 117.827 0.814 . . . . 73.25 111.599 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.02 171.15 13.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.094 -0.503 . . . . 64.299999999999997 112.315 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 32.3 t80 -98.28 123.01 42.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.236 0.458 . . . . 72.010000000000005 112.236 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -138.17 133.08 32.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.653 0.381 . . . . 72.510000000000005 110.623 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 5.3 mp -84.0 121.25 27.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.058 0.392 . . . . 73.219999999999999 112.058 -175.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.43 -50.82 3.87 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.03 -0.605 . . . . 74.049999999999997 113.006 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.21 60.19 1.86 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.342 -0.456 . . . . 43.219999999999999 112.305 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.3 m -67.61 103.47 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.814 0.446 . . . . 64.140000000000001 111.919 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.6 t -158.74 172.87 17.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.128 0.49 . . . . 73.549999999999997 111.909 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.39 -1.1 14.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.616 0.599 . . . . 61.119999999999997 112.616 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -105.17 10.84 33.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 74.430000000000007 110.803 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.87 118.55 0.91 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.714 -0.554 . . . . 61.130000000000003 111.714 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.2 tt -147.6 147.5 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.775 0.788 . . . . 51.009999999999998 112.331 -175.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.2 p-10 -92.44 176.22 6.55 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.168 0.509 . . . . 73.129999999999995 112.37 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.433 ' SG ' ' N ' ' A' ' 69' ' ' SER . 26.1 p -59.02 -59.88 4.77 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.893 -0.594 . . . . 53.340000000000003 111.643 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.433 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 16.7 p -62.61 -37.3 85.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.267 -0.424 . . . . 70.450000000000003 111.362 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.65 -43.29 99.18 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.346 -0.454 . . . . 73.219999999999999 113.286 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -61.26 -52.69 63.66 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 122.57 -0.371 . . . . 62.549999999999997 111.774 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.538 ' HA ' HD11 ' A' ' 122' ' ' ILE . 4.9 p -61.42 -49.27 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 112.252 0.464 . . . . 72.25 112.252 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -60.8 -33.9 73.69 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.092 -0.38 . . . . 60.549999999999997 111.791 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.51 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 78.2 mtt-85 -72.0 -52.11 18.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.086 -0.384 . . . . 70.340000000000003 111.497 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -49.66 -40.69 40.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.99 0.424 . . . . 61.119999999999997 111.892 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.555 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 47.0 m-85 -73.47 -40.91 63.79 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.582 0.586 . . . . 65.219999999999999 112.582 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.51 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 12.1 ptp180 -70.43 -24.73 62.96 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.757 -0.589 . . . . 71.129999999999995 111.223 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 20.6 mm-40 -69.48 -62.07 1.53 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.266 0.555 . . . . 74.349999999999994 111.345 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HB3' ' HG2' ' A' ' 43' ' ' ARG . 85.9 mm-40 -88.26 -32.17 18.64 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.555 0.946 . . . . 75.439999999999998 113.555 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.25 -13.05 13.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 64.109999999999999 112.357 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.99 17.61 77.17 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.867 -0.682 . . . . 41.020000000000003 112.814 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.5 tp -83.63 115.06 21.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.919 0.39 . . . . 61.240000000000002 111.147 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.94 96.68 8.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.843 0.354 . . . . 42.200000000000003 111.377 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 97.2 mt -98.64 142.37 24.48 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.459 -0.337 . . . . 64.310000000000002 110.889 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.23 163.79 9.59 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.84 2.36 . . . . 72.430000000000007 113.31 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 3.5 mpt_? -78.81 -25.27 44.21 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.689 0.626 . . . . 73.430000000000007 112.689 -173.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.433 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 36.3 t -98.95 140.22 33.43 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.375 0.509 . . . . 72.230000000000004 112.375 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 92.8 m -55.05 -42.52 72.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.844 -0.616 . . . . 71.439999999999998 111.321 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.38 -44.75 95.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.97 -0.559 . . . . 73.150000000000006 111.33 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 40.2 mm-40 -64.44 -36.73 85.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.08 0.467 . . . . 71.140000000000001 110.649 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.92 -27.42 66.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.18 -0.464 . . . . 71.150000000000006 111.617 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.544 ' HA ' ' NE ' ' A' ' 156' ' ' ARG . 28.4 mt-30 -59.94 -49.58 77.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 71.120000000000005 110.838 175.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.93 -6.21 43.71 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.06 -0.518 . . . . 71.209999999999994 112.247 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mmm -110.72 21.46 16.51 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.875 0.369 . . . . 75.120000000000005 111.95 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.38 133.66 5.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.275 -0.488 . . . . 53.219999999999999 112.272 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.552 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 43.6 mmtm -88.43 140.92 28.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.162 0.506 . . . . 61.509999999999998 112.085 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 t -74.71 136.98 41.81 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.631 0.974 . . . . 53.530000000000001 113.631 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.25 139.6 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.521 -0.763 . . . . 74.200000000000003 110.656 172.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.1 t -92.72 -179.98 5.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.533 0.568 . . . . 73.109999999999999 112.533 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -41.23 -53.72 3.11 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.125 1.157 . . . . 64.239999999999995 114.125 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -82.72 -14.5 54.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.515 0.561 . . . . 74.430000000000007 112.515 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -99.07 6.85 46.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.543 0.571 . . . . 51.520000000000003 112.543 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.28 138.36 58.51 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.785 0.326 . . . . 73.430000000000007 111.542 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -145.5 134.21 22.26 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.579 -0.282 . . . . 60.119999999999997 111.118 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.506 HG21 ' HB2' ' A' ' 41' ' ' LYS . 83.4 m -44.69 102.0 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.047 0.451 . . . . 71.400000000000006 111.792 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.09 -8.12 3.23 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.964 -0.562 . . . . 52.0 113.178 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 3.4 p30 -88.12 160.25 17.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.467 0.651 . . . . 72.200000000000003 111.603 176.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 mt -106.34 117.43 34.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 75.040000000000006 110.709 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 155' ' ' ALA . 12.2 m -94.15 119.18 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.425 0.631 . . . . 71.439999999999998 111.553 -175.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.464 HD11 ' HG2' ' A' ' 92' ' ' GLN . 95.6 mt -91.21 132.0 36.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.642 -0.708 . . . . 63.32 111.436 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -122.16 134.11 54.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.408 -0.36 . . . . 75.540000000000006 110.993 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.436 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 80.2 mtp180 -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.673 -0.491 . . . . 74.439999999999998 109.673 174.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 121.074 0.464 . . . . 74.340000000000003 111.633 -175.22 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 120.917 0.389 . . . . 60.5 111.383 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -127.52 160.46 31.45 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.322 -0.399 . . . . 75.349999999999994 110.107 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.83 141.18 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.148 0.499 . . . . 55.299999999999997 112.317 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.66 160.76 24.62 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.108 -0.497 . . . . 63.5 112.437 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 72' ' ' VAL . 34.1 mt -94.62 112.27 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.464 -0.433 . . . . 74.439999999999998 111.084 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.12 113.65 4.1 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.762 0.315 . . . . 73.430000000000007 111.64 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.461 ' HA ' HG23 ' A' ' 105' ' ' THR . 31.2 pt -98.64 -20.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.201 0.445 . . . . 74.549999999999997 112.201 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.95 148.04 5.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.931 -0.652 . . . . 42.509999999999998 113.782 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 58.47 40.02 24.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.277 0.473 . . . . 74.439999999999998 112.277 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 68.6 3.59 3.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.859 -0.61 . . . . 72.340000000000003 112.397 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.565 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 84.0 mt-30 -90.14 147.53 23.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.039 0.447 . . . . 72.510000000000005 110.759 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -155.35 151.76 28.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 71.310000000000002 111.979 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.34 135.91 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.071 -0.513 . . . . 75.140000000000001 110.448 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.91 173.33 16.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.034 0.445 . . . . 75.310000000000002 111.746 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -102.03 96.81 7.27 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.005 -0.543 . . . . 63.439999999999998 110.909 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.4 t -68.69 135.47 51.39 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.063 -0.517 . . . . 63.210000000000001 111.84 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.6 p -65.22 -20.66 66.54 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 75.129999999999995 111.56 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.9 m -97.07 -52.4 3.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.416 -0.356 . . . . 55.43 111.913 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.441 ' HB2' HD13 ' A' ' 139' ' ' ILE . 49.8 m -101.48 -16.45 16.81 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.073 0.768 . . . . 62.32 113.073 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.1 -154.27 24.3 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.853 -0.689 . . . . 72.430000000000007 112.884 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.37 104.39 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.019 0.438 . . . . 60.119999999999997 111.999 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 136' ' ' SER . 41.6 pt -140.77 178.48 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.113 0.482 . . . . 62.140000000000001 111.704 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.7 mm -101.15 141.83 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.467 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -144.56 165.4 28.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.773 0.321 . . . . 75.530000000000001 110.541 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.565 ' OG ' ' HG2' ' A' ' 128' ' ' GLN . 15.8 m -138.48 142.88 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.975 0.361 . . . . 73.420000000000002 111.975 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.2 mtm -72.57 -3.09 22.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.369 0.604 . . . . 62.420000000000002 110.626 171.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.98 -16.29 61.08 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.864 -0.607 . . . . 75.349999999999994 110.089 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 19.5 mm-40 -85.76 135.01 38.45 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.784 -0.644 . . . . 64.409999999999997 110.317 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -48.92 -44.87 30.77 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.183 2.589 . . . . 55.130000000000003 114.303 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 50.5 t80 -64.56 -44.16 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.946 -0.471 . . . . 73.430000000000007 111.759 -177.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -77.47 -32.75 54.54 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.184 0.516 . . . . 64.109999999999999 111.392 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -56.2 -48.71 75.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.401 0.68 . . . . 65.340000000000003 112.232 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -84.36 -13.92 50.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.853 0.686 . . . . 63.229999999999997 112.853 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 17.2 mmm180 -100.3 -3.39 31.43 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.72 0.637 . . . . 72.129999999999995 112.72 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -54.11 123.03 11.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.094 0.405 . . . . 60.009999999999998 112.094 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 7.0 t30 -98.4 -66.61 0.89 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.382 -0.372 . . . . 72.450000000000003 111.248 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.435 ' HG2' HD22 ' A' ' 153' ' ' ASN . 8.7 pt-20 -164.48 144.71 7.76 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.603 0.24 . . . . 63.219999999999999 110.829 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -102.57 146.49 28.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.781 0.324 . . . . 62.329999999999998 111.357 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.544 ' NE ' ' HA ' ' A' ' 92' ' ' GLN . 11.8 mtm-85 -136.89 111.37 8.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.607 0.225 . . . . 62.450000000000003 111.607 -176.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -75.02 124.99 27.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.04 0.448 . . . . 63.539999999999999 111.143 176.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.23 -19.51 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.037 -0.529 . . . . 74.299999999999997 112.105 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 121.148 0.499 . . . . 73.099999999999994 111.718 177.996 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 111.644 0.239 . . . . 53.240000000000002 111.644 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -64.96 149.92 48.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.921 0.391 . . . . 61.329999999999998 111.808 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.2 t -68.29 82.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.309 0.576 . . . . 53.520000000000003 110.356 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 36.8 t70 -75.12 136.58 41.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.016 -0.538 . . . . 63.439999999999998 111.961 -176.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.2 t -58.71 -61.86 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.723 -0.671 . . . . 50.109999999999999 111.713 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.67 -40.36 79.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.828 0.347 . . . . 72.120000000000005 111.195 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 28.4 t -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.274 -0.421 . . . . 64.299999999999997 111.673 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -35.35 77.91 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.879 0.326 . . . . 74.040000000000006 111.879 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 40' ' ' VAL . 74.7 mt -62.4 -48.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.034 0.445 . . . . 53.409999999999997 111.017 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.7 mmt -67.22 -37.34 83.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.943 0.401 . . . . 63.329999999999998 110.85 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -56.97 -45.24 83.03 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.931 -0.577 . . . . 75.219999999999999 110.624 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.798 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 55.0 tp60 -66.66 -46.25 76.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.294 0.569 . . . . 51.439999999999998 111.271 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 18.3 t80 -56.41 -34.85 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.824 -0.625 . . . . 75.030000000000001 111.221 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.76 12.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.38 0.511 . . . . 73.420000000000002 112.38 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.89 -26.25 21.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.958 0.408 . . . . 62.299999999999997 111.557 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -111.36 12.3 21.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.999 0.74 . . . . 74.510000000000005 112.999 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 10.0 mtmp? -61.95 103.36 0.35 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.074 -0.391 . . . . 74.310000000000002 111.64 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.14 -0.89 26.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.807 -0.711 . . . . 54.119999999999997 114.231 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.03 138.44 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 117.484 0.642 . . . . 54.119999999999997 111.225 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.82 162.44 26.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.145 0.498 . . . . 74.219999999999999 112.229 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 51.7 t80 -84.05 118.41 24.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.053 -0.521 . . . . 74.319999999999993 112.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -137.99 123.61 19.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.661 -0.245 . . . . 62.439999999999998 111.309 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.53 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 97.0 mt -70.78 116.49 11.15 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.481 0.549 . . . . 74.109999999999999 112.481 -177.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.36 3.59 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.304 -0.474 . . . . 61.140000000000001 114.065 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.27 67.88 1.79 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.26 -0.495 . . . . 72.150000000000006 113.248 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -69.48 108.65 3.86 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.406 0.521 . . . . 75.230000000000004 112.406 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -166.61 175.38 8.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.123 -0.489 . . . . 73.010000000000005 110.793 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -67.68 -8.26 33.63 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.252 0.464 . . . . 71.200000000000003 112.252 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 64' ' ' LYS . 3.9 mppt? -97.08 7.94 45.57 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.018 0.437 . . . . 63.329999999999998 111.215 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.0 134.63 2.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.359 -0.382 . . . . 63.329999999999998 112.604 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.3 tt -154.53 144.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.427 -0.455 . . . . 70.209999999999994 110.59 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.53 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.5 p-10 -96.99 -174.51 2.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.302 0.572 . . . . 72.510000000000005 112.35 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.7 p -62.68 -50.72 70.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.939 -0.573 . . . . 62.240000000000002 111.488 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 72' ' ' VAL . 49.1 m -69.09 -35.85 76.94 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.367 -0.379 . . . . 64.430000000000007 111.318 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.04 -44.6 97.55 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.112 -0.565 . . . . 70.209999999999994 112.726 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -66.02 -50.75 63.14 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.54 -0.388 . . . . 71.439999999999998 111.702 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 69' ' ' SER . 11.9 p -61.43 -37.49 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.927 0.394 . . . . 74.019999999999996 110.844 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -54.47 -59.34 4.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.1 0.476 . . . . 73.019999999999996 110.693 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.549 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 9.4 mmm180 -52.24 -55.68 19.66 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.847 -0.615 . . . . 72.150000000000006 111.824 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.798 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 72.3 m -48.74 -56.25 9.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.401 0.519 . . . . 73.219999999999999 112.401 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 41.7 m-85 -74.94 -34.89 62.16 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.013 0.746 . . . . 74.25 113.013 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 ptm180 -66.42 -39.67 89.08 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.422 0.527 . . . . 74.409999999999997 112.422 -175.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 15.6 pt-20 -102.34 -23.39 13.97 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.075 0.769 . . . . 65.519999999999996 113.075 -174.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.468 ' HG3' ' HB2' ' A' ' 47' ' ' GLN . 84.4 mm-40 -87.31 -63.06 1.36 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.984 -0.448 . . . . 62.229999999999997 111.589 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.72 -18.16 30.1 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.004 0.372 . . . . 71.540000000000006 112.004 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 45.14 28.7 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.062 -0.59 . . . . 64.310000000000002 112.592 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 44.4 tp -105.99 136.9 44.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.901 0.381 . . . . 61.420000000000002 111.277 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.83 88.78 4.04 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.818 0.342 . . . . 74.319999999999993 111.645 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.42 138.16 19.46 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.94 0.348 . . . . 62.130000000000003 111.94 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HD2' ' OE1' ' A' ' 91' ' ' GLN . 73.4 Cg_endo -74.25 -161.54 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.412 2.741 . . . . 65.329999999999998 113.717 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -102.01 -31.99 10.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.479 1.289 . . . . 71.430000000000007 114.479 -172.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -114.17 148.72 36.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.879 0.696 . . . . 74.540000000000006 112.879 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.2 m -54.38 -42.73 70.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.832 -0.622 . . . . 70.109999999999999 112.478 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -57.37 -29.89 64.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 73.430000000000007 111.488 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.84 -43.67 17.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.075 0.464 . . . . 62.25 110.382 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.463 ' OE1' ' HD2' ' A' ' 85' ' ' PRO . 20.3 mm-40 -54.25 -47.09 72.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.857 -0.61 . . . . 74.329999999999998 112.046 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -61.7 -23.46 66.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.217 0.451 . . . . 63.520000000000003 112.217 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -92.11 2.11 56.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.971 -0.456 . . . . 74.209999999999994 111.972 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 94.3 mmm -85.63 -14.69 44.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.953 0.406 . . . . 60.130000000000003 111.111 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.42 152.54 23.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.154 -0.546 . . . . 52.119999999999997 113.174 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -83.01 150.82 26.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.923 0.392 . . . . 72.340000000000003 111.555 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 86.8 p -76.6 158.43 31.13 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.995 0.739 . . . . 72.340000000000003 112.995 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.404 HG13 ' NE ' ' A' ' 157' ' ' ARG . 1.5 m -145.41 174.06 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.682 -0.69 . . . . 52.350000000000001 111.779 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -111.53 179.67 3.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.783 -0.644 . . . . 75.109999999999999 111.489 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.534 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 32.6 mmt180 -50.09 -32.98 17.08 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.295 0.48 . . . . 72.299999999999997 112.295 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.9 p -77.1 -29.93 55.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.615 0.598 . . . . 73.530000000000001 112.615 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -109.52 20.42 18.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.483 0.549 . . . . 74.140000000000001 112.483 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.52 135.18 57.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.07 0.462 . . . . 60.219999999999999 111.098 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -108.81 148.6 30.31 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.185 -0.322 . . . . 75.510000000000005 111.438 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.427 ' O ' HG11 ' A' ' 40' ' ' VAL . 63.6 m -68.95 110.76 4.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.847 -0.533 . . . . 72.109999999999999 110.078 173.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.07 15.47 30.68 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.419 -0.419 . . . . 72.5 112.266 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.403 ' OD1' ' HB1' ' A' ' 155' ' ' ALA . 9.0 t70 -76.33 152.43 36.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.729 0.411 . . . . 71.400000000000006 110.71 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.4 mt -99.86 108.35 20.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.296 0.569 . . . . 71.329999999999998 111.344 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.16 123.98 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.328 0.585 . . . . 63.350000000000001 111.628 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.9 mt -90.93 135.37 33.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.625 -0.716 . . . . 61.140000000000001 111.945 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 91.0 m-85 -120.22 141.89 49.52 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.166 0.508 . . . . 73.120000000000005 111.962 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -72.48 96.58 1.94 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.709 -0.678 . . . . 75.409999999999997 110.856 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -126.9 106.9 9.63 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.744 0.307 . . . . 62.210000000000001 111.44 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.37 -28.9 51.86 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 114.034 0.374 . . . . 54.240000000000002 114.034 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -61.09 -32.97 72.63 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.285 0.476 . . . . 72.109999999999999 112.285 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.3 p -130.25 -0.72 4.56 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.091 0.404 . . . . 62.130000000000003 112.091 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.2 -57.02 3.65 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.296 -0.478 . . . . 41.399999999999999 112.257 -174.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.7 mmt-85 -126.65 117.64 23.16 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.898 0.38 . . . . 73.420000000000002 111.537 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 44.5 t60 -102.21 151.5 22.14 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.398 -0.593 . . . . 51.409999999999997 109.398 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.51 137.67 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.258 0.466 . . . . 75.549999999999997 112.258 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 153.34 20.33 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 116.066 -0.516 . . . . 64.109999999999999 112.525 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 72' ' ' VAL . 48.1 mt -88.15 103.44 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.975 0.417 . . . . 55.450000000000003 111.132 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -64.09 116.39 5.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.08 -0.509 . . . . 74.349999999999994 111.654 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.7 pt -102.76 -28.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.639 0.607 . . . . 55.43 112.639 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.65 135.37 1.93 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 119.863 -1.161 . . . . 41.100000000000001 114.973 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 65.0 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.071 0.948 . . . . 51.439999999999998 111.403 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -141.34 -3.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.879 -0.601 . . . . 74.200000000000003 111.493 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -93.29 143.9 25.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.32 0.581 . . . . 74.510000000000005 111.574 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 18.0 p90 -152.61 145.81 24.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.47 -0.786 . . . . 62.5 111.008 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.34 133.83 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 64.049999999999997 110.903 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.49 178.64 8.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.107 0.479 . . . . 75.530000000000001 111.215 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -97.93 110.44 23.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.24 -0.437 . . . . 62.210000000000001 111.187 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 70.3 m -86.08 140.83 29.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.838 0.351 . . . . 71.129999999999995 111.165 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.4 p -47.43 -53.72 13.28 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.453 0.908 . . . . 65.409999999999997 113.453 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 p -90.29 -71.25 0.63 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.537 0.569 . . . . 64.209999999999994 112.537 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 54.2 m -58.71 -26.72 64.17 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.916 0.71 . . . . 54.140000000000001 112.916 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.54 -160.15 18.27 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.895 -0.669 . . . . 45.219999999999999 113.219 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 19.3 t -66.98 109.07 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.03 0.443 . . . . 62.439999999999998 111.909 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.9 pt -138.37 179.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.999 0.428 . . . . 52.149999999999999 111.754 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.22 110.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 110.599 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.451 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . 55.7 m -101.86 172.84 6.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.904 0.383 . . . . 44.030000000000001 111.738 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 138.99 49.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.13 0.49 . . . . 62.420000000000002 111.908 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.534 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 65.0 mtt -69.69 -8.17 45.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.389 -0.369 . . . . 71.230000000000004 111.899 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -77.01 -19.43 57.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.978 0.418 . . . . 55.450000000000003 110.612 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.25 124.48 90.88 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.287 -0.415 . . . . 64.540000000000006 110.267 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -48.69 -38.5 37.04 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.352 2.701 . . . . 65.049999999999997 114.028 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.443 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 52.3 t80 -63.18 -45.92 89.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.924 0.392 . . . . 53.43 111.394 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.535 ' HA ' ' HB2' ' A' ' 151' ' ' ARG . 83.8 m95 -80.79 -28.46 36.33 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.055 0.455 . . . . 72.200000000000003 111.392 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.9 -41.82 98.35 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.967 -0.561 . . . . 71.400000000000006 111.58 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -83.82 -21.38 32.11 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.096 0.474 . . . . 63.420000000000002 111.361 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 148' ' ' TRP . 0.8 OUTLIER -72.16 -39.09 68.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.341 -0.39 . . . . 62.32 111.612 177.402 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.98 104.45 0.14 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.16 0.505 . . . . 63.399999999999999 112.18 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.19 -52.02 5.45 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.925 -0.58 . . . . 74.430000000000007 110.873 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -167.08 171.47 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.251 -0.432 . . . . 74.230000000000004 111.284 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -121.15 154.74 35.81 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.642 -0.254 . . . . 72.120000000000005 110.872 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 79.3 mtt180 -147.93 119.18 7.79 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.076 0.465 . . . . 73.349999999999994 111.742 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.467 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -86.66 109.29 19.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.042 0.448 . . . . 75.5 111.877 -177.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.09 -13.98 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.869 0.366 . . . . 73.430000000000007 111.736 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.69 130.6 34.52 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.443 -0.344 . . . . 73.319999999999993 111.205 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.9 t -77.5 112.26 14.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.918 0.389 . . . . 65.340000000000003 110.903 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -66.81 -28.93 68.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.836 0.35 . . . . 71.510000000000005 111.625 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.1 m -88.97 138.91 30.98 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.893 0.378 . . . . 61.020000000000003 111.467 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 163' ' ' LEU . 1.9 pt? -134.28 154.96 51.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.913 0.387 . . . . 62.049999999999997 111.043 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.684 -0.674 . . . . 74.310000000000002 112.065 -177.132 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.644 ' N ' ' SD ' ' A' ' 36' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.666 0.27 . . . . 72.400000000000006 110.753 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.92 101.7 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.956 0.407 . . . . 74.299999999999997 111.233 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.74 99.48 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.358 -0.383 . . . . 74.099999999999994 111.087 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -80.89 134.6 35.77 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.071 0.462 . . . . 73.200000000000003 111.851 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 44' ' ' ILE . 64.8 t -55.54 -51.88 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.109 -0.496 . . . . 75.099999999999994 110.823 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.7 tttt -57.22 -42.26 81.03 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.866 -0.606 . . . . 74.310000000000002 111.757 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.1 t -58.38 -45.44 88.31 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.886 0.374 . . . . 51.109999999999999 111.891 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.423 ' HD3' ' OE1' ' A' ' 79' ' ' GLN . 3.2 mmp_? -66.05 -44.26 85.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 73.439999999999998 111.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.2 mt -57.97 -41.36 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.038 0.447 . . . . 73.209999999999994 111.13 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 30.7 mmt -67.08 -31.51 72.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 70.540000000000006 111.58 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.77 -41.75 96.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.87 0.367 . . . . 73.120000000000005 110.916 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HG2' HE21 ' A' ' 79' ' ' GLN . 71.2 mm-40 -68.37 -55.19 12.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.436 -0.347 . . . . 72.0 111.096 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.481 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 28.9 t80 -48.25 -47.06 36.22 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.235 0.457 . . . . 75.329999999999998 112.235 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.62 -32.39 63.09 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.241 0.543 . . . . 71.319999999999993 111.715 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.88 -29.97 35.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.063 -0.517 . . . . 51.350000000000001 111.018 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.46 ' HZ2' HH11 ' A' ' 74' ' ' ARG . 73.9 m95 -96.52 3.17 52.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.103 0.779 . . . . 71.510000000000005 113.103 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 30.7 mtpp -61.45 122.89 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.991 -0.443 . . . . 74.409999999999997 110.797 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.93 -8.3 55.83 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.301 -0.476 . . . . 65.329999999999998 113.299 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -77.07 123.46 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.231 -0.57 . . . . 73.140000000000001 111.519 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -74.75 159.79 31.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 72.030000000000001 112.009 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -79.52 130.12 35.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 110.949 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 57' ' ' ARG . 38.9 ttt180 -136.88 115.15 11.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.915 0.388 . . . . 75.329999999999998 112.023 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.86 123.87 24.26 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.046 0.45 . . . . 74.120000000000005 112.04 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.51 7.41 84.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.281 -0.418 . . . . 63.43 114.083 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.34 143.68 15.17 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.975 -0.631 . . . . 71.120000000000005 113.295 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.518 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 t -125.37 100.58 6.56 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.059 0.457 . . . . 72.340000000000003 111.171 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.1 t -170.81 167.95 7.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.274 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -73.96 -13.09 60.83 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.279 0.561 . . . . 51.450000000000003 111.212 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -76.26 -15.63 59.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.245 0.545 . . . . 75.040000000000006 110.55 173.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.33 135.86 1.91 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.847 -0.615 . . . . 40.32 112.024 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.518 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -151.63 154.11 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.985 0.393 . . . . 74.519999999999996 111.343 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -91.7 176.32 6.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.318 0.58 . . . . 75.420000000000002 111.953 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.8 t -59.11 -51.98 67.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.469 0.544 . . . . 71.25 112.469 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.6 t -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.279 0.561 . . . . 73.129999999999995 111.16 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 74' ' ' ARG . . . -64.24 -41.58 98.23 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.859 -0.61 . . . . 72.450000000000003 113.002 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.5 -51.01 70.41 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.445 -0.444 . . . . 61.310000000000002 111.795 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 11.9 p -62.2 -45.3 99.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.66 -0.245 . . . . 54.340000000000003 111.615 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 18.6 pt20 -61.24 -40.02 92.48 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.048 -0.407 . . . . 63.32 111.804 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 10.4 mtp-105 -67.85 -45.04 75.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.817 0.342 . . . . 74.329999999999998 111.327 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.7 m -51.98 -46.76 64.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.012 0.434 . . . . 54.100000000000001 111.778 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.0 m-85 -73.78 -42.17 61.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.018 0.747 . . . . 64.299999999999997 113.018 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 13.3 ptm180 -66.45 -34.27 77.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.048 -0.408 . . . . 73.230000000000004 112.065 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -81.16 -39.31 25.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.156 0.428 . . . . 75.349999999999994 112.156 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.442 HE21 ' HG2' ' A' ' 47' ' ' GLN . 77.6 mm-40 -86.96 -63.21 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.449 0.537 . . . . 42.530000000000001 112.449 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -90.57 -7.41 52.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.024 0.379 . . . . 74.010000000000005 112.024 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.07 10.15 84.08 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.135 -0.555 . . . . 65.209999999999994 112.519 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 39.0 tp -83.5 112.48 20.01 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.126 0.489 . . . . 73.349999999999994 110.737 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -86.0 92.36 8.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 71.200000000000003 111.456 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 93.3 mt -81.11 145.91 57.53 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.788 0.328 . . . . 73.099999999999994 111.159 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.56 -173.17 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.648 2.232 . . . . 73.439999999999998 113.7 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -94.98 -34.39 12.38 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.494 0.553 . . . . 75.439999999999998 112.494 -170.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.477 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 66.3 m -96.01 136.5 36.37 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.259 -0.276 . . . . 70.140000000000001 111.09 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 87.5 m -56.58 -39.51 73.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.844 0.313 . . . . 65.540000000000006 111.844 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -55.45 -45.88 76.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.909 0.385 . . . . 73.230000000000004 111.212 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 49.6 mt-10 -59.63 -38.48 81.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.008 0.432 . . . . 73.409999999999997 110.604 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -67.81 -35.59 78.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.251 -0.431 . . . . 61.219999999999999 111.185 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.4 mt-30 -62.14 -37.58 85.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.378 0.609 . . . . 52.0 110.612 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.98 12.83 10.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.603 -0.726 . . . . 72.200000000000003 112.557 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 90.4 mmm -84.9 -62.6 1.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.893 0.331 . . . . 52.509999999999998 111.893 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.29 -174.57 21.19 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.254 -0.498 . . . . 62.130000000000003 113.942 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.98 159.69 21.18 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.069 0.462 . . . . 74.400000000000006 111.837 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 61.7 p -91.37 150.59 21.21 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.379 0.609 . . . . 74.540000000000006 112.342 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.78 169.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.698 -0.683 . . . . 74.519999999999996 111.416 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -117.16 -179.68 3.78 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.19 -0.459 . . . . 72.319999999999993 111.468 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -47.1 -58.42 4.05 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.919 1.081 . . . . 72.510000000000005 113.919 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.6 m -73.47 -4.73 35.55 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.225 0.454 . . . . 65.340000000000003 112.225 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -99.06 -11.72 21.21 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.891 0.377 . . . . 74.099999999999994 111.28 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.3 114.28 6.63 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.511 0.56 . . . . 70.519999999999996 112.511 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -112.17 -160.91 0.73 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 110.843 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.0 m -82.41 114.84 21.13 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.183 -0.323 . . . . 72.430000000000007 110.984 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.02 -18.69 10.37 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.066 -0.588 . . . . 71.049999999999997 113.098 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.95 130.79 44.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.068 0.461 . . . . 74.109999999999999 111.529 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.55 114.25 24.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.376 -0.375 . . . . 72.540000000000006 110.672 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.27 124.8 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.492 0.663 . . . . 70.219999999999999 111.604 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.8 mt -97.64 126.35 42.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.5 -0.773 . . . . 72.319999999999993 111.776 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -117.41 160.84 20.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.037 0.446 . . . . 71.140000000000001 111.293 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.45 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 63.0 mtt85 -91.83 122.2 34.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.14 0.495 . . . . 73.0 111.279 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.87 163.04 17.49 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.113 -0.494 . . . . 73.409999999999997 111.142 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.34 -67.92 1.54 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.959 -0.639 . . . . 65.019999999999996 113.35 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.1 t -58.73 -52.23 66.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.136 0.421 . . . . 72.120000000000005 112.136 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 77.6 p -85.92 -23.42 27.0 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.666 0.617 . . . . 71.209999999999994 112.666 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.33 -48.17 3.76 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.901 -0.666 . . . . 61.350000000000001 112.598 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -118.08 134.97 54.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.944 0.402 . . . . 70.519999999999996 111.192 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.55 148.81 50.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.187 -0.46 . . . . 63.509999999999998 109.9 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.466 HG12 ' SG ' ' A' ' 68' ' ' CYS . 9.2 p -135.76 138.93 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.335 0.588 . . . . 73.010000000000005 112.334 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -129.05 144.84 15.74 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.869 -0.605 . . . . 72.150000000000006 112.608 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.8 mt -90.23 107.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.634 -0.333 . . . . 73.310000000000002 111.491 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER -64.35 117.6 7.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.597 0.359 . . . . 71.519999999999996 111.422 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.3 pt -102.13 -32.88 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.362 0.504 . . . . 74.140000000000001 112.362 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.35 133.38 2.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.092 -1.051 . . . . 63.030000000000001 114.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 60.45 -80.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.593 0.757 . . . . 62.149999999999999 112.366 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.45 ' HA ' ' OH ' ' A' ' 123' ' ' TYR . 82.4 m-20 -141.57 1.63 1.56 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.177 0.436 . . . . 71.040000000000006 112.177 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -102.38 146.21 28.39 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.365 0.602 . . . . 62.299999999999997 112.051 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.7 p90 -150.73 148.98 29.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.377 -0.829 . . . . 72.230000000000004 111.657 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.87 138.34 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.916 0.389 . . . . 71.040000000000006 111.152 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -163.78 161.65 23.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.995 0.426 . . . . 63.509999999999998 111.847 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -91.2 96.7 10.71 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.207 0.527 . . . . 74.400000000000006 110.641 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.1 p -77.77 150.85 34.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.897 -0.592 . . . . 71.420000000000002 112.569 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.9 p -81.19 8.97 7.59 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.991 -0.55 . . . . 74.230000000000004 111.561 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 t -109.7 -46.55 3.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.855 0.317 . . . . 43.100000000000001 111.855 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.5 t -124.85 -30.16 3.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.385 0.513 . . . . 63.210000000000001 112.385 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.87 -147.65 18.42 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.278 -0.487 . . . . 72.209999999999994 112.005 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.21 101.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 117.141 0.471 . . . . 64.219999999999999 111.626 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.6 pt -136.96 176.6 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 61.310000000000002 112.173 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.12 120.97 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.004 -0.544 . . . . 55.140000000000001 110.846 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.8 p -122.62 178.27 5.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.937 0.399 . . . . 65.310000000000002 111.287 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 t -127.99 153.67 46.47 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.107 0.41 . . . . 65.510000000000005 112.107 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 25.0 mmt -60.07 -20.42 57.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.228 -0.442 . . . . 54.310000000000002 111.348 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.14 -24.3 66.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.287 -0.415 . . . . 65.099999999999994 111.636 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.509 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 29.0 mm-40 -71.47 133.68 84.88 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 120.833 0.349 . . . . 73.530000000000001 111.663 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.47 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 93.3 Cg_exo -45.15 -52.85 5.96 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.592 2.861 . . . . 72.049999999999997 115.11 -173.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.1 t80 -61.38 -43.6 98.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.824 0.345 . . . . 75.25 111.777 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.509 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 73.9 m95 -76.13 -38.77 56.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.043 0.449 . . . . 72.25 111.041 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.88 -45.66 71.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.828 -0.624 . . . . 42.509999999999998 112.064 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.5 ptpt -98.38 6.1 47.58 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.798 0.666 . . . . 73.439999999999998 112.798 -175.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 2.5 mpt_? -116.66 7.57 13.59 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 122.193 -0.317 . . . . 70.510000000000005 111.658 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -60.54 104.27 0.32 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.032 0.444 . . . . 71.409999999999997 111.162 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.463 HD22 ' HG2' ' A' ' 154' ' ' GLU . 8.5 t30 -82.15 -49.01 10.63 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.316 -0.402 . . . . 73.030000000000001 111.072 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.463 ' HG2' HD22 ' A' ' 153' ' ' ASN . 11.1 pt-20 177.3 -166.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.124 0.57 . . . . 60.530000000000001 109.875 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -146.69 146.66 30.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.38 0.511 . . . . 51.399999999999999 112.38 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt180 -137.04 126.35 24.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.365 0.666 . . . . 73.299999999999997 110.318 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.404 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -107.37 111.92 24.48 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.439 -0.788 . . . . 74.140000000000001 110.605 175.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.3 m -89.46 -16.74 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.252 -0.885 . . . . 62.130000000000003 112.692 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.428 HD23 HD22 ' A' ' 82' ' ' LEU . 90.6 mt -69.75 153.57 43.18 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.226 0.536 . . . . 70.109999999999999 111.866 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.4 m -82.74 120.0 25.05 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.158 -0.473 . . . . 74.549999999999997 110.361 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -60.99 94.31 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.727 0.299 . . . . 54.210000000000001 110.253 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.1 m -64.84 132.44 49.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.46 -0.336 . . . . 72.329999999999998 111.604 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 163' ' ' LEU . 2.3 mm? -98.13 -168.74 1.7 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 110.174 -0.306 . . . . 71.239999999999995 110.174 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.779 -0.629 . . . . 70.430000000000007 111.202 175.265 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.853 0.359 . . . . 64.049999999999997 111.19 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -153.99 133.35 12.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.047 0.451 . . . . 71.450000000000003 111.364 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.9 t -76.51 118.18 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.172 -0.467 . . . . 45.039999999999999 111.623 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 15.0 t70 -99.11 122.29 42.13 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.602 0.239 . . . . 72.150000000000006 110.672 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.73 -57.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.347 0.499 . . . . 73.340000000000003 112.347 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.24 -44.15 95.47 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.666 0.27 . . . . 75.230000000000004 111.651 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 40.3 t -55.13 -47.85 74.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.886 0.374 . . . . 62.149999999999999 111.903 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 39' ' ' ASP . 11.0 mmm180 -59.9 -47.67 84.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.076 0.465 . . . . 65.0 111.289 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 122' ' ' ILE . 72.5 mt -61.67 -44.85 99.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.167 -0.469 . . . . 55.539999999999999 111.571 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 18.7 mmt -64.15 -29.08 70.22 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.917 0.389 . . . . 71.25 111.403 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.72 -47.76 82.2 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.223 0.535 . . . . 61.409999999999997 110.53 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 50' ' ' ASP . 25.6 tp60 -66.13 -35.12 79.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 60.210000000000001 111.374 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -54.15 -37.22 64.17 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.463 -0.335 . . . . 73.430000000000007 111.542 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.71 -20.6 57.44 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.336 0.495 . . . . 64.450000000000003 112.336 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.558 ' HB3' HE21 ' A' ' 47' ' ' GLN . 34.9 t70 -90.92 -21.15 21.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.973 0.509 . . . . 70.530000000000001 111.521 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -122.81 30.51 6.4 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.161 -0.472 . . . . 73.239999999999995 111.949 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -57.82 -1.45 0.11 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.273 1.582 . . . . 72.239999999999995 115.273 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.54 49.14 0.11 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.246 -0.978 . . . . 72.219999999999999 113.64 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -92.19 137.24 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.784 0.326 . . . . 74.530000000000001 111.004 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -74.34 158.38 34.08 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.021 0.748 . . . . 75.120000000000005 113.021 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -73.09 119.09 16.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.914 -0.585 . . . . 54.420000000000002 111.513 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -137.66 119.14 14.83 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.989 0.423 . . . . 72.310000000000002 111.783 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.11 118.8 10.38 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.248 0.462 . . . . 75.239999999999995 112.248 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.58 -54.33 4.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.187 -0.53 . . . . 62.119999999999997 113.657 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.84 98.47 0.55 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.094 -0.574 . . . . 60.340000000000003 112.246 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.4 p -97.22 119.41 35.68 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 71.530000000000001 111.625 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -176.52 176.97 1.5 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.043 0.537 . . . . 73.299999999999997 110.978 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -16.45 63.7 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.973 -0.454 . . . . 71.239999999999995 110.943 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -85.72 2.75 44.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.295 -0.411 . . . . 61.310000000000002 110.987 175.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.12 142.75 3.62 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.468 -0.396 . . . . 44.210000000000001 112.746 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.1 tt -165.49 138.28 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.941 0.37 . . . . 73.109999999999999 111.105 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.11 171.47 8.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.798 -0.564 . . . . 74.239999999999995 111.319 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 21.0 p -54.52 -39.72 67.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.695 0.628 . . . . 70.519999999999996 112.695 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.432 ' HB2' ' OG1' ' A' ' 88' ' ' THR . 23.9 t -67.47 -47.01 71.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.803 0.335 . . . . 51.119999999999997 111.417 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.5 -36.22 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.01 -0.614 . . . . 73.140000000000001 112.898 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.87 -56.09 20.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.785 0.326 . . . . 74.439999999999998 111.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.408 HG21 HD22 ' A' ' 108' ' ' LEU . 12.9 p -61.32 -38.15 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.757 0.313 . . . . 74.239999999999995 111.536 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 36.5 tt0 -54.0 -58.11 8.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.286 0.565 . . . . 74.219999999999999 111.28 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -60.2 -51.85 67.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.948 -0.569 . . . . 72.409999999999997 111.913 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 78.1 m -48.37 -53.63 16.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.389 0.514 . . . . 60.310000000000002 112.389 -176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 45.9 m-85 -68.52 -37.95 80.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.787 0.662 . . . . 73.010000000000005 112.787 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.5 -21.26 45.54 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.889 -0.507 . . . . 72.150000000000006 112.174 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -86.45 -55.09 4.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.925 0.393 . . . . 71.030000000000001 111.492 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.409 ' CD ' ' HB2' ' A' ' 47' ' ' GLN . 1.9 mp0 -67.97 -51.38 48.1 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.336 0.495 . . . . 73.209999999999994 112.336 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -100.52 -36.89 9.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.023 0.44 . . . . 74.420000000000002 112.113 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.55 6.21 41.42 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.714 -0.554 . . . . 44.039999999999999 111.714 -172.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.503 HD22 HD23 ' A' ' 159' ' ' LEU . 29.0 tp -79.4 110.75 14.99 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.081 0.467 . . . . 73.409999999999997 110.669 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -84.3 112.08 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 75.5 111.943 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 84.3 mt -100.92 154.93 36.86 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.915 -0.584 . . . . 75.549999999999997 111.312 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.01 -179.02 1.2 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.45 2.1 . . . . 65.349999999999994 113.592 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -39.86 14.9 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.567 0.58 . . . . 71.209999999999994 112.567 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.7 m -110.59 141.87 43.19 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.143 0.423 . . . . 74.010000000000005 112.143 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.522 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 48.7 m -49.3 -39.06 29.66 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.311 -0.404 . . . . 75.319999999999993 111.8 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -52.98 -47.08 68.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.234 -0.439 . . . . 71.109999999999999 110.989 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -65.22 -36.74 85.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.406 0.622 . . . . 72.219999999999999 110.697 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.96 -28.47 68.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.777 -0.647 . . . . 50.409999999999997 111.49 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 88' ' ' THR . 95.8 mt-30 -68.79 -6.58 27.52 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.007 0.373 . . . . 71.430000000000007 112.007 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -98.06 -10.28 24.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.825 0.676 . . . . 70.129999999999995 112.825 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.45 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 25.7 ptm -124.62 162.39 24.2 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.399 0.518 . . . . 54.399999999999999 112.399 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 160.51 36.48 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.319 -0.467 . . . . 74.109999999999999 114.247 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 68.3 mmtt -84.48 125.66 32.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.135 0.493 . . . . 75.430000000000007 111.638 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 64.6 p -81.21 111.98 18.12 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.648 -0.706 . . . . 75.340000000000003 112.841 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.427 HG23 ' HB3' ' A' ' 155' ' ' ALA . 2.8 m -106.2 157.58 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.808 -0.633 . . . . 73.439999999999998 111.964 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.448 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 84.0 p -99.59 -179.8 4.31 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.994 -0.548 . . . . 62.100000000000001 111.823 -177.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -53.23 -41.45 65.42 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.988 0.366 . . . . 71.209999999999994 111.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -77.28 -24.76 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 111.985 0.365 . . . . 72.430000000000007 111.985 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.62 -8.1 57.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.194 0.442 . . . . 72.319999999999993 112.194 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 99' ' ' SER . 85.3 mt -63.2 133.25 53.99 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.509 0.559 . . . . 74.019999999999996 112.509 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.411 ' O ' ' HD1' ' A' ' 123' ' ' TYR . 51.8 mtt180 -137.49 -122.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.466 -0.334 . . . . 74.420000000000002 110.352 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -106.12 127.04 52.92 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.692 -0.63 . . . . 53.530000000000001 112.134 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.16 13.31 36.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.298 -0.477 . . . . 75.439999999999998 114.178 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' A' ' 123' ' ' TYR . 1.6 m-20 -81.44 120.09 24.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 122.571 -0.37 . . . . 62.399999999999999 111.5 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.408 HD22 HG21 ' A' ' 72' ' ' VAL . 27.7 mt -76.62 104.04 6.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.972 0.415 . . . . 75.129999999999995 110.195 173.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 155' ' ' ALA . 27.5 m -95.53 118.8 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.512 0.672 . . . . 72.310000000000002 111.995 -173.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.484 HD13 ' HG2' ' A' ' 92' ' ' GLN . 74.7 mt -93.93 117.6 30.32 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.46 -0.791 . . . . 72.219999999999999 112.312 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 77.8 m-85 -107.91 133.36 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 73.230000000000004 110.331 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.628 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 78.4 mtt-85 -82.6 110.44 17.68 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.637 -0.505 . . . . 72.140000000000001 109.637 174.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.14 156.15 18.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.93 0.395 . . . . 70.340000000000003 111.664 -173.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.92 -95.2 0.33 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.211 -0.518 . . . . 65.239999999999995 112.03 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -116.81 -59.79 1.92 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.242 0.544 . . . . 73.319999999999993 109.78 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.456 ' HA ' ' HB3' ' A' ' 112' ' ' ARG . 8.2 p -145.47 45.44 1.3 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.667 -0.697 . . . . 60.310000000000002 110.883 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.72 -127.72 0.77 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.309 -0.472 . . . . 65.239999999999995 112.994 176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 118' ' ' ARG . 3.5 ppt_? -148.27 149.77 32.47 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 122.066 -0.667 . . . . 73.349999999999994 112.533 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 68.4 t60 -165.67 149.69 8.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.732 -0.667 . . . . 64.310000000000002 109.471 170.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 7.8 p -142.38 137.18 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.288 0.566 . . . . 62.549999999999997 111.969 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 109' ' ' VAL . . . -130.06 154.35 20.5 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.046 -0.597 . . . . 73.400000000000006 112.845 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 44' ' ' ILE . 47.4 mt -92.3 100.33 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 73.319999999999993 110.572 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 37.4 t80 -71.15 117.68 12.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.141 -0.481 . . . . 71.450000000000003 111.15 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.9 pt -99.08 -30.24 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.16 0.43 . . . . 73.510000000000005 112.16 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.27 163.31 9.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.159 -0.543 . . . . 61.210000000000001 113.202 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 56.76 39.86 29.41 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.674 0.39 . . . . 72.239999999999995 111.909 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.637 ' N ' HD22 ' A' ' 127' ' ' ASN . 0.7 OUTLIER 67.92 4.69 4.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.808 0.443 . . . . 75.400000000000006 111.846 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 141' ' ' SER . 99.1 mt-30 -97.4 140.48 31.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.385 0.612 . . . . 73.450000000000003 112.158 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.456 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.5 p90 -146.54 137.58 24.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.739 . . . . 70.109999999999999 111.215 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.08 126.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.058 0.456 . . . . 70.540000000000006 110.765 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -155.32 150.14 26.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.925 0.393 . . . . 75.040000000000006 111.813 -174.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.81 91.42 4.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.176 0.512 . . . . 74.519999999999996 110.183 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.4 p -78.23 143.94 36.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.815 -0.629 . . . . 74.239999999999995 112.234 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.4 t -77.27 -4.97 47.59 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.383 0.611 . . . . 61.240000000000002 111.369 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -87.94 -35.68 17.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.067 -0.515 . . . . 72.420000000000002 111.729 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 m -138.42 -51.78 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.235 0.54 . . . . 62.039999999999999 111.808 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.86 -153.22 24.52 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.642 -0.708 . . . . 52.140000000000001 111.708 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.23 96.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 117.411 0.605 . . . . 72.409999999999997 111.114 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.28 168.47 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.302 -0.408 . . . . 74.329999999999998 111.744 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.12 109.41 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.25 -0.432 . . . . 73.420000000000002 110.666 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 128' ' ' GLN . 48.5 m -107.21 173.81 6.16 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.065 0.395 . . . . 73.099999999999994 112.065 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 29.1 t -119.95 141.16 49.89 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.688 0.625 . . . . 75.299999999999997 112.688 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.5 mtt -76.62 -0.55 23.79 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.859 0.689 . . . . 74.439999999999998 112.859 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -84.95 -10.94 56.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.065 0.459 . . . . 62.210000000000001 110.829 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -76.47 132.91 71.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 110.799 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.11 -49.4 14.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.224 2.616 . . . . 64.329999999999998 114.554 -172.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.567 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 91.9 t80 -61.55 -48.05 82.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.941 0.4 . . . . 61.530000000000001 111.194 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -72.83 -34.94 67.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.782 0.325 . . . . 74.219999999999999 111.665 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.69 -47.58 84.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.898 0.38 . . . . 72.200000000000003 111.319 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -73.24 -32.14 64.54 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.979 0.363 . . . . 75.140000000000001 111.979 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.628 ' HD3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mmp_? -76.82 -23.41 52.77 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.008 -0.433 . . . . 73.319999999999993 111.443 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -61.18 108.27 0.88 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.051 0.453 . . . . 73.310000000000002 111.841 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -91.35 -69.1 0.75 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.305 0.574 . . . . 75.230000000000004 111.171 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG3' HD12 ' A' ' 110' ' ' LEU . 10.9 pt-20 -148.49 153.14 38.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.977 -0.556 . . . . 71.310000000000002 110.782 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -115.48 149.83 37.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.75 -0.204 . . . . 51.140000000000001 110.539 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mtt180 -137.6 122.99 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.365 0.603 . . . . 54.539999999999999 112.437 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 157' ' ' ARG . 2.9 mtp180 -87.91 108.64 19.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.798 -0.637 . . . . 64.109999999999999 110.67 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.0 m -99.31 0.76 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.686 -0.688 . . . . 72.530000000000001 112.546 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.503 HD23 HD22 ' A' ' 82' ' ' LEU . 80.0 mt -67.36 99.36 0.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.106 0.479 . . . . 75.430000000000007 112.21 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.5 t -89.69 -174.53 4.34 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.019 -0.537 . . . . 72.099999999999994 110.53 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -142.11 105.54 4.65 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.155 0.502 . . . . 72.219999999999999 111.682 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 m -82.68 -169.77 2.64 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.95 -0.568 . . . . 72.129999999999995 110.843 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 164' ' ' GLU . 4.8 tt -72.35 132.62 44.21 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 110.156 -0.313 . . . . 64.519999999999996 110.156 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.513 ' N ' HD23 ' A' ' 163' ' ' LEU . 76.9 mm-40 . . . . . 0 C--O 1.252 1.207 0 N-CA-C 113.26 0.837 . . . . 72.409999999999997 113.26 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.633 0.254 . . . . 63.32 111.307 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -70.86 96.27 1.25 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.827 0.346 . . . . 53.049999999999997 110.408 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.38 97.15 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.964 0.411 . . . . 73.200000000000003 111.275 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -58.04 105.34 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.187 -0.461 . . . . 72.420000000000002 111.523 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 44' ' ' ILE . 94.1 t -48.74 -41.35 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.486 0.66 . . . . 55.020000000000003 110.322 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 45' ' ' MET . 88.2 tttt -56.48 -45.36 80.97 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.257 -0.883 . . . . 74.120000000000005 112.132 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.9 p -65.02 -37.78 88.73 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 122.228 -0.295 . . . . 72.219999999999999 111.536 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -70.9 -38.03 73.01 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 75.349999999999994 111.175 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 40' ' ' VAL . 86.2 mt -62.52 -46.08 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.127 0.489 . . . . 63.310000000000002 110.805 174.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 95.8 mmm -67.7 -29.74 69.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.347 -0.388 . . . . 54.310000000000002 111.282 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.46 -44.81 89.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.052 0.453 . . . . 64.049999999999997 110.196 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -65.3 -46.93 78.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.528 -0.76 . . . . 73.420000000000002 111.229 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -53.63 -39.22 64.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 112.136 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.22 68.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.861 0.362 . . . . 53.329999999999998 111.849 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -79.21 -33.79 43.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.248 0.547 . . . . 73.120000000000005 111.081 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.516 ' HZ2' ' NH1' ' A' ' 74' ' ' ARG . 84.9 m95 -99.13 22.75 9.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.438 0.533 . . . . 73.040000000000006 112.438 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.07 120.3 11.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.064 0.459 . . . . 73.239999999999995 112.032 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.03 20.43 75.85 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 114.472 0.549 . . . . 61.310000000000002 114.472 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.3 t -83.6 131.2 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 117.595 0.698 . . . . 74.450000000000003 111.003 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.31 163.46 26.44 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.298 0.571 . . . . 51.240000000000002 112.509 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 134' ' ' THR . 49.9 t80 -89.52 141.59 28.44 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.514 0.673 . . . . 75.329999999999998 112.437 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.624 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 57.2 ttt180 -129.58 131.28 46.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.573 -0.739 . . . . 73.430000000000007 110.462 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.7 mp -76.22 93.54 3.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.969 0.414 . . . . 60.43 111.374 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 71.71 1.29 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.28 -0.486 . . . . 71.349999999999994 113.285 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' ' 57' ' ' ARG . . . 172.92 139.83 2.97 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.893 -0.67 . . . . 25.23 113.186 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.577 ' HB2' ' HD2' ' A' ' 74' ' ' ARG . 84.7 p -110.65 101.17 9.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.601 0.593 . . . . 70.209999999999994 112.601 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -153.22 151.78 30.46 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.12 -0.491 . . . . 73.329999999999998 111.137 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.46 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 32.3 ttmt -70.34 -5.56 28.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.05 0.453 . . . . 72.319999999999993 111.827 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -106.29 15.22 26.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.975 0.417 . . . . 74.200000000000003 111.265 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.75 108.11 0.27 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 112.164 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.493 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -138.48 151.76 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 117.342 0.571 . . . . 71.310000000000002 111.894 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.624 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 6.2 p-10 -95.11 -179.13 4.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.185 0.517 . . . . 71.010000000000005 112.238 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.29 -55.76 22.05 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.003 -0.544 . . . . 45.109999999999999 111.954 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 81.5 p -66.21 -29.17 69.38 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.826 0.346 . . . . 62.530000000000001 110.864 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 74' ' ' ARG . . . -66.1 -44.63 90.9 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.094 -0.503 . . . . 72.099999999999994 112.801 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.07 -51.83 66.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.0 0.428 . . . . 75.409999999999997 111.268 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.45 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.0 p -62.47 -44.46 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 112.173 0.434 . . . . 42.140000000000001 112.173 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.542 ' HG3' ' N ' ' A' ' 74' ' ' ARG . 2.3 pt20 -59.57 -49.98 75.67 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.94 -0.475 . . . . 71.219999999999999 111.443 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.577 ' HD2' ' HB2' ' A' ' 61' ' ' SER . 10.0 mtp-105 -60.13 -41.61 93.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.991 0.424 . . . . 74.319999999999993 111.135 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.4 m -54.53 -52.23 62.68 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.103 -0.499 . . . . 74.129999999999995 111.489 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.6 m-85 -72.27 -37.83 68.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.502 0.556 . . . . 75.239999999999995 112.502 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.493 ' HG3' ' HA ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.77 -20.02 58.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.473 0.546 . . . . 64.329999999999998 112.473 -177.13 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -97.1 -49.93 4.8 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.166 -0.334 . . . . 73.019999999999996 111.509 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -71.55 -44.93 63.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.112 0.412 . . . . 63.329999999999998 112.112 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.11 -12.75 14.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.677 0.621 . . . . 72.200000000000003 112.677 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 32.32 62.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.127 -0.559 . . . . 53.130000000000003 113.33 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 57.9 tp -92.81 127.21 38.24 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.617 -0.343 . . . . 72.420000000000002 111.596 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.23 79.97 2.35 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.906 0.706 . . . . 73.510000000000005 112.906 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.439 HD21 HG21 ' A' ' 158' ' ' VAL . 64.3 mt -95.82 142.56 24.75 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 121.913 -0.492 . . . . 70.540000000000006 111.777 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.679 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 87.9 Cg_endo -82.1 -174.07 1.98 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.174 2.583 . . . . 63.130000000000003 113.391 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.571 ' HD2' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -105.6 20.64 18.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.44 0.904 . . . . 75.450000000000003 113.44 -169.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.1 m -141.29 132.65 26.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.938 0.399 . . . . 73.030000000000001 111.535 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 34.8 m -51.74 -43.87 63.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.239 -0.437 . . . . 41.240000000000002 111.929 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -58.43 -17.04 17.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.43 0.53 . . . . 63.049999999999997 112.43 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 94' ' ' MET . 35.5 mt-10 -92.35 -53.22 4.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.102 0.477 . . . . 70.120000000000005 110.484 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.641 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 80.6 mt-30 -54.6 -45.97 73.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.964 -0.562 . . . . 64.319999999999993 112.341 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 88' ' ' THR . 18.4 pt20 -53.59 -33.91 56.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.49 0.552 . . . . 61.520000000000003 112.49 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.38 10.9 29.49 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.047 0.758 . . . . 60.200000000000003 113.047 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.679 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 77.6 mtp -79.38 -29.95 42.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.043 0.449 . . . . 75.329999999999998 111.018 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.74 -133.27 6.84 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.37 -0.443 . . . . 74.400000000000006 112.674 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -127.19 174.03 9.25 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.549 -0.383 . . . . 65.319999999999993 111.547 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.6 p -106.81 161.53 14.6 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 112.221 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.413 HG23 ' CB ' ' A' ' 155' ' ' ALA . 0.0 OUTLIER -148.2 160.13 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.604 -0.725 . . . . 73.310000000000002 111.662 177.027 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 t -95.92 173.22 7.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.976 -0.556 . . . . 73.430000000000007 111.441 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -51.19 -33.08 25.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.413 0.894 . . . . 75.209999999999994 113.413 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.8 m -82.71 -22.43 34.48 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.811 0.671 . . . . 70.25 112.811 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -96.53 14.71 23.76 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.349 0.5 . . . . 74.299999999999997 112.349 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.37 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.96 0.355 . . . . 71.25 111.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -124.68 -174.63 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.152 0.501 . . . . 72.540000000000006 111.014 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.3 m -76.19 107.22 8.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.255 -0.43 . . . . 72.5 111.173 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.78 -19.64 6.54 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.253 -0.499 . . . . 65.319999999999993 112.885 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.3 134.43 51.56 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.396 0.617 . . . . 64.239999999999995 111.693 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.0 mt -91.58 120.14 32.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.087 -0.506 . . . . 44.109999999999999 111.069 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.3 m -96.21 134.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.899 0.38 . . . . 72.329999999999998 111.564 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.34 125.9 51.57 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.921 0.391 . . . . 61.399999999999999 111.964 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 151' ' ' ARG . 90.6 m-85 -114.95 136.76 52.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.292 -0.413 . . . . 70.230000000000004 111.019 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 57.4 mtp180 -79.02 77.82 5.48 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.227 0.537 . . . . 73.340000000000003 110.903 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.91 123.36 36.11 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.051 -0.522 . . . . 64.129999999999995 112.173 -173.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.29 -25.22 66.39 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 121.113 -0.565 . . . . 74.319999999999993 113.945 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.6 m -82.03 -8.13 59.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.38 0.511 . . . . 72.530000000000001 112.38 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.7 p -141.02 -59.12 0.5 Allowed 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.376 0.608 . . . . 63.229999999999997 112.071 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 130.47 -98.82 0.42 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.151 -0.779 . . . . 65.329999999999998 111.151 -175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -94.7 90.8 6.23 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.072 0.463 . . . . 62.43 110.31 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -84.04 118.9 24.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 110.683 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 10.9 p -105.07 136.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.287 0.565 . . . . 72.409999999999997 112.408 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.18 148.02 19.19 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.995 -0.548 . . . . 75.310000000000002 112.689 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 72' ' ' VAL . 37.1 mt -87.68 110.22 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.492 -0.416 . . . . 72.129999999999995 111.029 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 20.8 t80 -68.13 109.39 3.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.767 0.317 . . . . 74.109999999999999 111.173 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.11 -32.48 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.072 0.397 . . . . 73.349999999999994 112.072 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 149.25 132.94 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.705 -0.76 . . . . 45.329999999999998 113.757 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 t30 55.34 78.33 0.19 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.746 0.647 . . . . 74.540000000000006 112.746 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 70.2 -41.04 0.48 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.777 1.029 . . . . 72.510000000000005 113.777 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -81.03 146.15 30.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.612 0.72 . . . . 74.120000000000005 112.64 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.85 154.65 35.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.349 -0.841 . . . . 73.129999999999995 111.153 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 139.49 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.888 0.375 . . . . 73.25 111.3 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -160.53 177.04 10.93 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.019 0.437 . . . . 72.209999999999994 111.733 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.93 103.47 10.64 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 111.393 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 70.8 m -81.38 149.38 28.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.871 0.367 . . . . 70.420000000000002 111.439 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.433 ' HA ' ' CG ' ' A' ' 56' ' ' TYR . 71.3 p -56.05 -43.77 78.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.98 0.733 . . . . 74.439999999999998 112.98 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.4 m -100.18 -42.07 6.85 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.13 0.418 . . . . 71.409999999999997 112.13 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 133' ' ' SER . 55.0 m -76.63 -25.71 54.14 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.825 0.676 . . . . 51.020000000000003 112.825 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.68 32.8 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.024 -0.608 . . . . 72.099999999999994 112.841 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.47 102.57 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.967 0.413 . . . . 74.129999999999995 111.666 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 136' ' ' SER . 47.1 pt -135.99 179.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.582 0.706 . . . . 70.319999999999993 112.541 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.66 135.81 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.507 -0.769 . . . . 65.420000000000002 110.785 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -132.12 176.1 8.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.441 0.163 . . . . 73.409999999999997 110.903 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.2 t -137.31 145.37 43.36 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.786 0.662 . . . . 74.230000000000004 112.786 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.49 -20.3 66.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.924 0.712 . . . . 71.340000000000003 112.924 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -75.82 -18.67 59.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.717 0.294 . . . . 71.329999999999998 111.694 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.4 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 35.7 mt-10 -68.47 130.66 91.98 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 116.668 -0.242 . . . . 75.140000000000001 111.061 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.86 -46.6 26.92 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.338 2.692 . . . . 71.409999999999997 113.838 -173.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -61.14 -46.31 91.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.709 0.29 . . . . 74.5 111.659 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.4 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 96.1 m95 -73.71 -39.74 64.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.904 0.383 . . . . 74.310000000000002 111.029 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.74 -44.83 70.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 75.209999999999994 111.629 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -78.63 -32.34 47.33 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.8 0.296 . . . . 63.329999999999998 111.8 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 20.0 mmt180 -70.11 -18.89 63.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.89 0.33 . . . . 71.010000000000005 111.89 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.15 111.57 0.99 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.33 0.586 . . . . 73.430000000000007 111.972 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.576 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -89.17 -57.0 3.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 70.0 110.08 177.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -171.87 176.75 3.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 73.510000000000005 110.523 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.413 ' CB ' HG23 ' A' ' 98' ' ' VAL . . . -125.67 153.93 43.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.234 0.54 . . . . 71.439999999999998 111.729 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -140.88 167.01 23.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.947 -0.569 . . . . 74.420000000000002 110.141 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.8 136.06 13.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.127 0.489 . . . . 71.329999999999998 111.287 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.439 HG21 HD21 ' A' ' 84' ' ' LEU . 13.4 m -104.15 3.85 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.785 -0.643 . . . . 72.120000000000005 112.314 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.21 156.96 18.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.911 0.386 . . . . 63.420000000000002 111.629 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.9 t -122.93 178.96 4.82 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.442 -0.345 . . . . 72.329999999999998 110.864 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -118.33 124.15 47.07 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.039 0.447 . . . . 75.510000000000005 112.076 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.9 m -78.81 142.56 36.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.05 -0.523 . . . . 44.450000000000003 110.984 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.443 ' N ' HD22 ' A' ' 163' ' ' LEU . 2.9 mm? -93.92 171.11 9.06 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.756 0.312 . . . . 74.409999999999997 110.904 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.266 -0.874 . . . . 71.310000000000002 112.263 -178.667 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.743 0.306 . . . . 65.420000000000002 111.16 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -67.23 89.08 0.19 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.124 0.488 . . . . 73.200000000000003 111.267 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -72.78 82.21 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.304 0.573 . . . . 65.219999999999999 111.039 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.71 132.36 35.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.031 -0.531 . . . . 71.409999999999997 110.859 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.9 t -55.14 -62.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.307 -0.406 . . . . 72.219999999999999 111.818 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.583 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 86.7 tttt -53.58 -45.86 70.11 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 74.239999999999995 111.66 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.1 m -63.78 -39.29 93.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.058 -0.519 . . . . 74.049999999999997 112.204 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -35.53 75.3 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.814 0.301 . . . . 71.319999999999993 111.814 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 40' ' ' VAL . 63.8 mt -64.61 -44.2 96.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.053 0.454 . . . . 73.150000000000006 110.567 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.9 mmt -64.24 -35.7 81.66 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.028 0.442 . . . . 65.329999999999998 110.892 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.72 -36.85 74.94 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.959 -0.564 . . . . 74.439999999999998 111.184 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' NE2' ' HE1' ' A' ' 51' ' ' TRP . 7.7 tp60 -76.04 -44.31 39.76 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.293 0.568 . . . . 74.439999999999998 111.216 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -55.37 -40.63 71.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.274 -0.421 . . . . 64.319999999999993 111.627 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.54 -21.57 65.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.032 0.382 . . . . 74.230000000000004 112.032 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -84.52 -42.75 15.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.061 0.457 . . . . 72.519999999999996 111.579 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.469 ' HE1' ' NE2' ' A' ' 47' ' ' GLN . 64.9 m95 -82.45 -50.42 8.88 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.43 -0.35 . . . . 64.319999999999993 111.708 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HB3' ' HE3' ' A' ' 52' ' ' LYS . 21.2 mmmt 46.46 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.446 1.276 . . . . 75.439999999999998 114.446 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.11 38.36 96.0 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.301 0.88 . . . . 72.340000000000003 115.301 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.62 131.33 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.635 0.717 . . . . 71.120000000000005 110.291 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.34 155.4 28.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.935 0.717 . . . . 72.530000000000001 112.935 -174.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -67.83 119.94 13.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.705 -0.68 . . . . 71.150000000000006 111.837 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 57' ' ' ARG . 20.6 ttm-85 -137.08 123.75 21.08 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.463 0.305 . . . . 74.450000000000003 110.721 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.3 mp -69.97 113.94 7.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.079 0.466 . . . . 71.140000000000001 112.162 -175.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.26 -56.23 5.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 114.137 0.415 . . . . 51.409999999999997 114.137 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.7 82.34 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.224 -0.513 . . . . 72.310000000000002 113.226 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.497 ' OG ' ' HD2' ' A' ' 74' ' ' ARG . 83.8 p -76.61 110.58 11.3 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.096 0.474 . . . . 73.549999999999997 111.841 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -167.47 173.51 8.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.04 0.448 . . . . 63.420000000000002 111.524 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -69.41 -7.0 33.72 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.112 0.482 . . . . 54.509999999999998 111.42 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -93.42 8.23 41.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.113 0.482 . . . . 61.210000000000001 110.934 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.411 ' HA3' ' HE ' ' A' ' 57' ' ' ARG . . . 143.1 144.1 4.23 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.175 -0.466 . . . . 63.109999999999999 112.687 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 tt -163.52 135.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.582 -0.364 . . . . 74.340000000000003 110.844 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -85.42 177.03 7.92 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.351 0.596 . . . . 75.120000000000005 112.406 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' ' 120' ' ' VAL . 27.5 t -52.6 -57.24 10.64 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.694 -0.685 . . . . 71.310000000000002 111.933 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -65.53 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.161 0.505 . . . . 74.409999999999997 110.954 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.16 -45.78 95.84 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.946 -0.57 . . . . 65.230000000000004 113.107 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.34 -48.92 73.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.521 -0.4 . . . . 73.299999999999997 111.743 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.55 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.3 p -60.34 -50.48 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.11 0.411 . . . . 64.5 112.11 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.739 HE22 ' HG2' ' A' ' 86' ' ' ARG . 3.3 pt20 -57.98 -40.95 81.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.093 0.473 . . . . 53.119999999999997 111.269 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.651 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.9 mtp180 -71.75 -48.63 45.57 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.725 -0.39 . . . . 72.329999999999998 111.868 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.9 m -46.35 -46.3 18.21 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.039 0.447 . . . . 62.130000000000003 111.611 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.646 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 55.0 m-85 -67.81 -44.32 77.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.655 0.613 . . . . 75.010000000000005 112.655 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.651 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 1.2 ptm180 -73.53 -43.19 60.56 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.757 -0.589 . . . . 75.530000000000001 112.284 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 58.2 mm-40 -60.79 -37.73 82.92 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.922 0.392 . . . . 72.510000000000005 111.06 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -94.9 -69.34 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.196 0.443 . . . . 64.409999999999997 112.196 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -81.14 -22.06 39.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.792 0.664 . . . . 65.450000000000003 112.792 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.51 40.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.908 -0.663 . . . . 72.209999999999994 112.407 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.3 tp -103.24 117.35 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.698 -0.295 . . . . 74.540000000000006 110.864 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 129.59 39.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.184 0.438 . . . . 73.239999999999995 112.184 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.3 mt -121.58 159.93 48.47 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.232 -0.44 . . . . 62.399999999999999 110.73 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.16 160.87 48.15 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.639 2.226 . . . . 73.109999999999999 113.581 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.739 ' HG2' HE22 ' A' ' 73' ' ' GLN . 61.8 mtt-85 -88.44 24.86 1.81 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.402 0.89 . . . . 73.340000000000003 113.402 -169.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -154.91 142.9 20.12 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.838 -0.539 . . . . 72.430000000000007 112.183 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 118' ' ' ARG . 37.9 p -51.96 -50.05 62.01 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.127 -0.488 . . . . 70.099999999999994 111.598 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -53.27 -37.63 62.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.578 -0.737 . . . . 53.310000000000002 111.359 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.7 -44.56 63.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 65.340000000000003 110.756 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.02 -20.98 66.36 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.03 -0.532 . . . . 75.5 112.028 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 88' ' ' THR . 98.6 mt-30 -56.46 -28.04 58.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.963 0.411 . . . . 74.340000000000003 111.477 174.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -89.95 -19.46 24.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.216 -0.447 . . . . 75.299999999999997 111.737 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.2 mmm -76.1 140.36 41.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.956 0.408 . . . . 73.409999999999997 111.847 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.77 -166.87 46.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.173 -0.537 . . . . 43.340000000000003 113.454 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -110.34 148.1 32.62 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.296 0.569 . . . . 63.420000000000002 111.865 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.7 p -79.5 133.55 36.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.409 -0.814 . . . . 63.329999999999998 112.11 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.578 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 3.8 m -146.07 167.31 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.93 0.715 . . . . 74.099999999999994 112.93 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.2 t -116.83 -171.43 2.02 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.374 -0.83 . . . . 74.129999999999995 110.985 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 -49.91 -56.47 10.41 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.058 0.762 . . . . 73.129999999999995 113.058 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 m -65.79 -11.72 48.36 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.734 0.642 . . . . 72.349999999999994 112.734 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.576 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.6 m120 -106.7 -4.31 19.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.073 0.398 . . . . 72.329999999999998 112.073 -174.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.88 147.38 50.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.985 0.735 . . . . 31.52 112.985 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -118.12 -159.01 0.73 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.654 -0.703 . . . . 72.200000000000003 109.297 173.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.8 m -102.01 102.75 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.03 -0.419 . . . . 72.109999999999999 110.662 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.06 6.94 5.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.214 -0.517 . . . . 35.229999999999997 113.649 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.12 134.69 44.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.261 0.553 . . . . 51.409999999999997 112.086 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.46 HD22 HG21 ' A' ' 72' ' ' VAL . 37.9 mt -79.59 110.7 15.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.913 -0.585 . . . . 61.520000000000003 110.044 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.44 118.91 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.261 0.553 . . . . 73.019999999999996 111.744 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.4 mt -90.28 123.83 34.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.743 -0.662 . . . . 75.329999999999998 111.593 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.66 140.99 45.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.182 0.515 . . . . 64.219999999999999 111.483 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.593 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 77.1 mtp180 -92.44 97.89 11.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.906 -0.588 . . . . 75.209999999999994 111.031 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.86 122.58 34.52 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.18 0.514 . . . . 72.099999999999994 111.391 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.52 -84.49 0.06 OUTLIER Glycine 0 CA--C 1.527 0.789 0 CA-C-N 116.099 -0.5 . . . . 55.219999999999999 112.43 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.0 m -165.23 -42.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.953 0.501 . . . . 74.400000000000006 110.604 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 p -100.7 5.39 43.71 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.311 0.485 . . . . 64.140000000000001 112.311 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -102.49 107.55 3.15 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.12 -0.562 . . . . 64.219999999999999 113.718 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.475 ' O ' HG21 ' A' ' 88' ' ' THR . 0.7 OUTLIER -90.53 111.29 22.52 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.474 -0.427 . . . . 72.400000000000006 110.632 173.223 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -115.5 149.89 37.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.245 -0.434 . . . . 74.109999999999999 110.556 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -134.84 146.17 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.203 0.525 . . . . 72.140000000000001 112.389 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.4 155.99 22.18 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.333 -0.46 . . . . 74.109999999999999 112.676 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 72' ' ' VAL . 47.8 mt -90.87 103.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.423 -0.457 . . . . 72.099999999999994 111.16 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t80 -69.47 101.11 1.51 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.241 0.543 . . . . 71.120000000000005 111.405 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.583 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.6 pt -82.15 -21.87 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.93 -0.577 . . . . 55.25 111.711 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.69 170.9 13.11 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 116.281 -0.418 . . . . 34.219999999999999 112.641 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 60.84 27.43 17.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.626 0.37 . . . . 54.329999999999998 111.675 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.1 m120 63.81 23.66 13.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.418 0.287 . . . . 64.200000000000003 111.441 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -114.99 150.05 36.42 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.247 0.546 . . . . 71.420000000000002 111.55 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 13.5 p90 -156.54 148.68 23.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.88 -0.6 . . . . 75.329999999999998 111.992 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.33 141.09 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.793 -0.639 . . . . 73.129999999999995 110.952 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.405 ' CE1' HD11 ' A' ' 139' ' ' ILE . 8.1 p80 -158.96 162.1 36.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.94 0.4 . . . . 75.409999999999997 111.517 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -101.76 93.75 5.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.191 0.519 . . . . 73.109999999999999 110.892 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.63 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 41.1 t -76.78 166.07 23.86 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.169 0.509 . . . . 73.319999999999993 111.692 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.7 p -66.4 -66.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.082 0.467 . . . . 61.439999999999998 112.067 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 83.5 p -89.63 8.66 30.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.293 0.479 . . . . 63.219999999999999 112.293 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 48.5 m -125.84 -29.26 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.736 0.643 . . . . 73.209999999999994 112.736 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.86 -154.56 43.54 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.984 -0.627 . . . . 71.400000000000006 112.986 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.39 95.77 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.167 0.432 . . . . 74.140000000000001 112.167 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -131.23 -178.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.098 0.475 . . . . 72.299999999999997 112.263 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.51 139.44 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 72.109999999999999 111.255 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.8 p -143.87 163.94 31.97 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.748 0.308 . . . . 52.409999999999997 110.822 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.418 ' HB2' ' HG2' ' A' ' 145' ' ' GLU . 45.5 m -113.73 143.87 43.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.907 0.706 . . . . 75.219999999999999 112.907 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 91.4 mmm -58.86 -30.42 67.71 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.906 -0.588 . . . . 73.140000000000001 111.266 174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -68.71 -19.62 64.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 112.164 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 41.4 mm-40 -64.98 113.65 11.87 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 117.027 -0.079 . . . . 74.519999999999996 110.952 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -43.71 -38.54 9.49 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.248 2.632 . . . . 55.299999999999997 113.818 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.641 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 71.7 t80 -57.62 -50.49 72.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.764 0.316 . . . . 72.450000000000003 111.629 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -82.53 -36.31 26.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.015 0.436 . . . . 72.200000000000003 111.455 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.5 -36.97 64.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.862 -0.608 . . . . 73.400000000000006 111.983 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -83.6 -15.21 49.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.886 0.328 . . . . 75.319999999999993 111.886 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 20.6 mmt180 -89.74 -17.15 28.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.993 0.368 . . . . 71.310000000000002 111.993 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.26 116.49 3.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.538 . . . . 72.230000000000004 112.454 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -92.57 -60.8 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.977 -0.556 . . . . 55.210000000000001 110.889 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -173.34 170.73 4.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.38 0.272 . . . . 74.040000000000006 110.503 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -119.98 169.41 10.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.267 0.84 . . . . 53.109999999999999 113.267 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -137.75 113.51 9.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.538 -0.755 . . . . 61.119999999999997 111.838 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.578 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.72 105.98 9.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.934 0.397 . . . . 75.040000000000006 110.55 171.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.44 -0.69 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.738 0.644 . . . . 73.409999999999997 112.738 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 82' ' ' LEU . 81.9 mt -87.56 110.7 20.55 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.917 0.389 . . . . 71.019999999999996 111.913 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 65.5 m -74.26 90.83 2.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.336 -0.393 . . . . 62.039999999999999 111.418 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -67.02 123.63 20.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.29 -0.414 . . . . 61.32 111.998 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 58.0 m -83.62 9.78 10.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.992 0.425 . . . . 72.140000000000001 111.983 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.0 tp -95.57 143.76 26.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.699 0.285 . . . . 62.420000000000002 111.16 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.453 -0.784 . . . . 73.239999999999995 112.005 179.465 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 47.6 ttp . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.639 0.257 . . . . 70.200000000000003 111.676 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -109.39 153.84 23.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.769 0.318 . . . . 71.329999999999998 110.505 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.61 91.6 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.129 0.49 . . . . 55.520000000000003 111.021 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -56.93 97.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.196 -0.456 . . . . 74.200000000000003 111.438 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.1 t -46.53 -49.76 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.22 0.533 . . . . 61.530000000000001 111.118 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 82.9 tttt -54.78 -48.29 72.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.655 -0.702 . . . . 72.239999999999995 112.33 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.2 p -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.935 0.398 . . . . 72.540000000000006 111.766 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.31 -36.89 85.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.473 -0.33 . . . . 70.430000000000007 111.592 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.3 mt -63.07 -36.64 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.959 0.409 . . . . 74.209999999999994 110.641 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 28.8 mmt -70.2 -36.5 74.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.454 -0.339 . . . . 54.140000000000001 111.316 175.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.78 -42.54 99.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.214 0.531 . . . . 73.299999999999997 110.526 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.61 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 56.8 tp60 -64.03 -48.01 77.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.013 -0.54 . . . . 71.319999999999993 110.515 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -53.59 -39.56 64.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.797 -0.638 . . . . 73.409999999999997 111.499 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . . . -54.99 -34.42 63.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.018 0.437 . . . . 43.43 111.843 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.17 -24.46 51.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.088 0.471 . . . . 73.099999999999994 111.459 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -114.84 18.32 16.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.783 0.66 . . . . 75.349999999999994 112.783 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' A' ' 49' ' ' ALA . 10.2 mtmp? -59.09 109.08 0.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.144 0.497 . . . . 52.520000000000003 112.245 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.03 4.53 68.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 114.793 0.677 . . . . 61.030000000000001 114.793 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.49 127.68 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.839 0.82 . . . . 72.329999999999998 110.806 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -71.08 157.51 38.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.97 0.73 . . . . 72.120000000000005 112.97 -176.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -77.2 126.03 30.28 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.347 -0.842 . . . . 74.329999999999998 111.775 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -138.04 110.37 7.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.476 -0.329 . . . . 74.150000000000006 111.68 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.32 121.25 15.88 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.984 0.421 . . . . 74.120000000000005 111.894 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.79 69.34 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.098 -0.572 . . . . 42.420000000000002 113.9 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -138.5 137.86 9.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.33 -0.462 . . . . 63.140000000000001 112.365 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.7 m -125.86 99.49 5.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.001 0.401 . . . . 53.240000000000002 111.541 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 64' ' ' LYS . 4.0 t -177.28 177.69 1.18 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.251 -0.432 . . . . 75.239999999999995 111.115 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -71.17 -11.49 60.97 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.082 0.468 . . . . 62.210000000000001 110.87 178.32 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' HB2' HG23 ' A' ' 62' ' ' THR . 30.2 mmmt -74.81 -11.83 60.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.213 0.53 . . . . 74.200000000000003 110.703 170.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 55' ' ' ARG . . . 145.23 148.11 4.76 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.119 -0.491 . . . . 64.129999999999995 112.75 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 19.8 tt -154.98 144.81 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.861 0.331 . . . . 71.540000000000006 111.436 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.16 179.91 4.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.201 0.524 . . . . 54.229999999999997 112.349 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.7 t -58.82 -61.25 2.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.416 0.525 . . . . 71.120000000000005 112.416 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -59.01 -36.86 75.67 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.974 0.416 . . . . 72.219999999999999 111.533 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.91 95.06 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 121.057 -0.592 . . . . 74.549999999999997 113.219 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.26 -54.73 28.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.895 0.332 . . . . 73.420000000000002 111.895 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG21 HD22 ' A' ' 108' ' ' LEU . 7.4 p -57.0 -41.91 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.956 0.408 . . . . 71.349999999999994 111.216 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -50.85 -62.67 1.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.312 0.577 . . . . 71.319999999999993 111.315 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HA ' ' CG ' ' A' ' 77' ' ' ARG . 10.3 mtp180 -63.66 -34.91 78.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.888 -0.596 . . . . 74.299999999999997 112.457 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.61 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 95.7 m -55.93 -54.58 42.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.083 0.468 . . . . 64.299999999999997 111.555 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.492 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.1 m-85 -65.84 -37.81 87.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.829 0.677 . . . . 73.519999999999996 112.829 -177.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HA ' ' H ' ' A' ' 82' ' ' LEU . 3.0 ptm180 -75.15 -43.46 52.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.773 -0.579 . . . . 72.340000000000003 112.265 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.41 -18.49 64.45 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 122.098 -0.376 . . . . 74.299999999999997 111.756 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -108.39 -68.22 0.92 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.121 0.415 . . . . 75.109999999999999 112.121 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.63 0.45 57.38 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.579 0.585 . . . . 63.119999999999997 112.579 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.64 44.27 98.03 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 61.039999999999999 113.095 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.3 tp -104.68 122.39 45.57 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.087 0.47 . . . . 72.310000000000002 111.785 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.71 96.93 2.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.206 0.527 . . . . 72.120000000000005 112.037 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.52 135.69 21.06 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.153 -0.476 . . . . 64.120000000000005 110.513 173.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.03 -175.62 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.463 2.109 . . . . 74.340000000000003 112.301 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -109.25 6.21 24.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.855 -0.528 . . . . 73.209999999999994 111.663 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.7 m -108.71 128.05 54.52 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.447 -0.342 . . . . 64.209999999999994 110.619 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 118' ' ' ARG . 4.8 m -56.76 -46.52 81.37 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.383 0.512 . . . . 52.240000000000002 112.383 -173.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.578 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 33.3 m-85 -59.69 -36.46 76.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 111.872 0.323 . . . . 74.409999999999997 111.872 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.63 -36.02 60.32 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.974 0.416 . . . . 53.329999999999998 111.471 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.21 -43.87 93.68 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.91 0.386 . . . . 70.230000000000004 111.499 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 17.0 pt20 -62.88 -26.87 68.99 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.965 0.412 . . . . 74.409999999999997 111.392 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -86.19 -10.08 55.37 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.23 0.455 . . . . 65.430000000000007 112.23 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.5 mmm -66.39 -37.51 85.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.162 0.506 . . . . 71.239999999999995 110.86 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.35 166.56 12.2 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 116.0 -0.546 . . . . 55.32 112.11 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -86.96 160.34 18.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.36 -0.494 . . . . 54.399999999999999 111.221 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.537 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 36.5 t -78.62 135.02 37.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.602 0.593 . . . . 74.0 112.602 -174.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.55 HG23 ' HB3' ' A' ' 155' ' ' ALA . 15.5 m -127.89 142.99 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 54.509999999999998 110.633 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.6 t -88.66 177.12 6.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.99 0.424 . . . . 73.310000000000002 111.26 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -49.68 -29.19 6.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.153 0.581 . . . . 62.25 112.142 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m -84.4 -21.14 30.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.884 0.698 . . . . 64.120000000000005 112.884 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.0 m120 -108.16 11.35 27.57 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.002 0.741 . . . . 72.120000000000005 113.002 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.0 151.84 14.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.911 0.708 . . . . 65.109999999999999 112.911 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -140.35 143.78 35.94 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.096 -0.502 . . . . 74.209999999999994 111.18 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.9 m -58.47 96.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.833 0.349 . . . . 61.43 110.948 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 123.62 14.17 3.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.171 -0.538 . . . . 54.310000000000002 113.818 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.24 167.87 13.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.94 0.87 . . . . 72.040000000000006 111.123 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.465 HD22 HG21 ' A' ' 72' ' ' VAL . 47.1 mt -102.85 113.87 27.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.097 -0.501 . . . . 62.450000000000003 110.549 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -94.92 122.66 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.401 0.62 . . . . 74.219999999999999 111.43 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 92' ' ' GLN . 67.0 mt -100.4 124.48 45.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.579 -0.737 . . . . 73.319999999999993 111.785 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -116.02 138.41 51.24 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.205 -0.452 . . . . 74.319999999999993 110.982 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -74.22 94.64 2.5 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.899 0.381 . . . . 73.310000000000002 110.715 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.5 157.36 16.24 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.759 0.314 . . . . 74.519999999999996 111.627 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.58 -43.8 8.99 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.001 -0.619 . . . . 64.219999999999999 112.747 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 53.7 m -83.57 -39.69 20.05 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.329 0.492 . . . . 70.010000000000005 112.329 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 67.8 p -101.51 -10.88 19.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.014 0.746 . . . . 65.430000000000007 113.014 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.46 -76.96 0.62 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.036 -0.602 . . . . 50.43 113.029 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.403 ' O ' HG21 ' A' ' 88' ' ' THR . 13.8 mmm180 -107.57 92.95 4.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.002 0.43 . . . . 74.400000000000006 110.218 176.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -91.17 126.9 36.4 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.196 -0.456 . . . . 70.129999999999995 110.459 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -111.6 132.03 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.529 0.681 . . . . 74.329999999999998 112.288 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -124.45 160.69 19.03 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.58 -0.736 . . . . 74.540000000000006 112.074 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.3 mt -97.04 112.8 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.091 0.446 . . . . 71.150000000000006 111.019 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.476 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 51.7 t80 -75.83 113.71 13.62 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.107 0.48 . . . . 73.140000000000001 111.904 -175.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.402 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.2 pt -99.06 -7.95 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.155 0.428 . . . . 71.349999999999994 112.155 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.68 164.37 13.21 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.111 -0.566 . . . . 72.030000000000001 113.348 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 58.61 31.08 20.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.762 0.425 . . . . 73.310000000000002 112.021 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.476 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 80.1 m-20 67.19 13.16 9.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.987 -0.551 . . . . 42.100000000000001 112.367 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -101.32 144.62 29.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.318 0.58 . . . . 62.439999999999998 111.493 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -152.91 146.38 24.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.77 -0.65 . . . . 62.130000000000003 111.584 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.69 138.76 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.729 0.299 . . . . 64.519999999999996 111.008 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -158.78 175.04 14.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.976 0.417 . . . . 75.120000000000005 111.631 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.21 103.44 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.195 -0.457 . . . . 62.210000000000001 111.045 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 36.9 t -89.17 162.5 15.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.789 0.328 . . . . 72.209999999999994 111.421 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -55.12 -61.55 2.24 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.034 0.753 . . . . 63.549999999999997 113.034 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m -93.69 -36.28 12.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.888 -0.508 . . . . 62.420000000000002 111.453 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 14.4 m -66.97 -29.62 69.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.242 -0.435 . . . . 71.120000000000005 112.118 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.69 34.75 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.97 -0.633 . . . . 61.130000000000003 112.565 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.46 102.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 117.127 0.464 . . . . 74.319999999999993 111.761 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.499 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -139.62 -179.01 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.13 0.49 . . . . 70.209999999999994 111.608 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.17 144.3 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.957 0.408 . . . . 73.129999999999995 110.72 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.7 m -137.08 169.41 17.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.199 -0.313 . . . . 71.129999999999995 111.396 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.2 m -130.52 139.89 50.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.911 0.386 . . . . 74.219999999999999 111.769 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 127' ' ' ASN . 67.1 mtt -65.37 -9.63 26.5 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.439 0.533 . . . . 72.340000000000003 112.439 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.67 -4.89 45.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.949 0.404 . . . . 64.209999999999994 111.452 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.41 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 25.8 mm-40 -83.56 127.08 69.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.244 -0.434 . . . . 73.530000000000001 109.962 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.432 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 84.9 Cg_exo -46.75 -39.0 23.49 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.704 2.269 . . . . 61.240000000000002 113.691 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.545 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 73.6 t80 -60.22 -51.31 70.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.651 0.263 . . . . 74.030000000000001 111.623 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.41 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 86.6 m95 -73.26 -33.35 65.21 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.899 0.38 . . . . 74.540000000000006 111.431 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 143' ' ' MET . 37.9 ttpt -68.54 -39.85 80.96 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.07 0.396 . . . . 75.129999999999995 112.07 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 19.3 ptpt -79.56 -28.13 41.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.738 0.304 . . . . 70.319999999999993 111.812 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 9.6 mmm180 -91.13 -4.88 55.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 111.886 0.328 . . . . 71.129999999999995 111.886 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -59.07 111.59 1.38 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.006 0.431 . . . . 74.109999999999999 111.41 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -92.26 -50.65 5.55 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.251 -0.431 . . . . 63.030000000000001 111.844 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -177.57 -173.02 0.39 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.329 -0.396 . . . . 72.340000000000003 110.901 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.55 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -140.42 159.87 41.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.89 0.376 . . . . 63.32 111.366 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.537 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt85 -139.42 109.54 6.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.473 0.309 . . . . 61.340000000000003 111.432 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 108.05 17.81 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.617 0.722 . . . . 74.239999999999995 111.42 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.71 -27.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.856 -0.611 . . . . 64.109999999999999 112.437 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.2 mt -73.3 109.36 6.76 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 111.919 0.34 . . . . 73.219999999999999 111.919 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.3 t -79.41 141.48 36.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.882 0.373 . . . . 71.519999999999996 111.117 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -80.28 99.29 7.79 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.802 0.334 . . . . 73.519999999999996 110.871 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 27.6 t -99.72 -6.48 27.01 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.792 0.329 . . . . 75.099999999999994 111.887 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 163' ' ' LEU . 6.9 mp -97.91 174.66 6.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.725 0.298 . . . . 72.150000000000006 111.096 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.365 -0.826 . . . . 61.020000000000003 112.291 -179.722 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.49 ' N ' ' SD ' ' A' ' 36' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.076 0.465 . . . . 71.349999999999994 111.5 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -76.3 121.76 23.43 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.352 -0.385 . . . . 71.230000000000004 111.261 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.76 109.93 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.959 0.409 . . . . 75.439999999999998 111.281 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.64 84.41 0.63 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.972 0.415 . . . . 72.129999999999995 111.528 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 44' ' ' ILE . 83.5 t -50.69 -54.23 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.174 -0.466 . . . . 65.430000000000007 111.557 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.531 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.2 tttt -53.9 -50.51 66.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 111.613 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 t -59.21 -44.35 92.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.425 -0.352 . . . . 42.439999999999998 111.879 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -63.68 -39.84 95.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.274 0.559 . . . . 74.140000000000001 111.303 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 40' ' ' VAL . 76.4 mt -61.37 -40.33 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.056 0.455 . . . . 74.109999999999999 110.6 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 30.3 mmt -63.54 -34.93 78.87 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.104 -0.498 . . . . 52.32 111.583 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.95 -45.4 86.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.912 0.387 . . . . 54.450000000000003 110.934 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.429 ' O ' ' HD1' ' A' ' 51' ' ' TRP . 30.0 mm-40 -62.53 -52.37 63.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.974 0.416 . . . . 64.129999999999995 111.044 174.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -55.37 -38.42 68.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.106 0.409 . . . . 71.209999999999994 112.106 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.92 -30.92 71.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.471 . . . . 61.229999999999997 111.396 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -76.28 -31.95 58.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.134 -0.485 . . . . 74.340000000000003 111.126 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.429 ' HD1' ' O ' ' A' ' 47' ' ' GLN . 77.7 m95 -99.77 16.55 23.25 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.596 0.591 . . . . 74.140000000000001 112.596 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.81 109.83 1.02 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.836 0.31 . . . . 73.430000000000007 111.836 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.15 15.31 54.22 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.916 -0.659 . . . . 71.340000000000003 114.146 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -78.56 132.88 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 117.318 0.559 . . . . 72.319999999999993 111.951 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -73.84 152.44 40.24 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.201 0.524 . . . . 74.510000000000005 111.907 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 67' ' ' ASP . 72.4 t80 -83.7 148.18 27.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.034 0.445 . . . . 75.25 111.856 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 58.0 ttm-85 -137.69 148.73 45.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.039 -0.528 . . . . 72.239999999999995 110.611 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.02 93.59 8.42 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.973 -0.454 . . . . 74.319999999999993 110.701 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.37 61.32 1.25 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.216 -0.447 . . . . 44.420000000000002 113.361 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -176.37 150.82 10.83 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.16 -0.543 . . . . 73.510000000000005 112.685 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.528 ' HA ' HG13 ' A' ' 66' ' ' ILE . 80.7 p -128.0 99.93 5.69 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.554 0.575 . . . . 72.0 112.554 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 t -170.46 167.54 8.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.41 0.284 . . . . 74.040000000000006 111.439 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -66.35 -22.82 66.27 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.015 0.435 . . . . 71.230000000000004 111.206 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -91.14 21.14 4.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.077 0.465 . . . . 72.310000000000002 111.364 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.534 ' HA3' ' HE ' ' A' ' 57' ' ' ARG . . . 142.88 112.76 0.9 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.223 -0.513 . . . . 64.230000000000004 113.199 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 20.5 tt -137.34 144.79 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 117.067 0.434 . . . . 65.049999999999997 111.558 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.0 p30 -97.89 174.13 6.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.451 0.644 . . . . 62.130000000000003 111.98 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.6 t -58.92 -44.53 91.34 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.925 0.713 . . . . 41.030000000000001 112.925 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.6 p -74.39 -39.05 62.94 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.738 0.304 . . . . 62.350000000000001 110.471 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.63 91.5 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.372 -0.442 . . . . 72.109999999999999 112.928 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.02 -53.23 41.15 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.769 0.318 . . . . 73.129999999999995 111.633 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.96 -48.04 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 111.909 0.337 . . . . 71.420000000000002 111.909 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.581 HE22 ' HG2' ' A' ' 86' ' ' ARG . 13.8 pt20 -59.47 -43.82 93.15 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.15 -0.343 . . . . 72.5 111.463 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.556 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 55.8 mtp180 -64.98 -47.61 76.95 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.12 -0.232 . . . . 71.040000000000006 111.53 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -50.57 -44.39 56.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.966 0.413 . . . . 54.109999999999999 111.777 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 59.0 m-85 -75.66 -44.46 42.37 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.999 0.74 . . . . 73.430000000000007 112.999 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 9.0 ptm180 -62.0 -32.19 72.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.436 -0.79 . . . . 75.129999999999995 111.512 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 33.7 mm-40 -73.24 -72.99 0.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.94 0.4 . . . . 74.129999999999995 111.929 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -87.11 -5.96 58.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.212 0.819 . . . . 73.040000000000006 113.212 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.402 ' HD2' ' HA ' ' A' ' 76' ' ' PHE . 91.0 m-85 -127.41 -7.33 5.8 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 62.219999999999999 112.086 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.84 37.78 79.94 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.228 -0.511 . . . . 75.420000000000002 113.18 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 34.9 tp -104.9 144.38 31.86 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.892 0.377 . . . . 71.140000000000001 111.151 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -95.49 125.96 40.46 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.936 0.398 . . . . 73.409999999999997 111.834 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 73' ' ' GLN . 88.2 mt -135.12 133.47 20.82 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.472 -0.331 . . . . 74.120000000000005 110.929 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.71 155.93 61.85 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.788 2.325 . . . . 61.5 113.275 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.581 ' HG2' HE22 ' A' ' 73' ' ' GLN . 67.2 mtt85 -82.66 48.8 1.37 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.965 0.728 . . . . 63.340000000000003 112.965 -172.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.497 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 20.3 t -169.09 135.54 1.73 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 111.276 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.631 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 25.5 m -53.19 -46.35 68.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.374 -0.376 . . . . 73.150000000000006 111.036 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -39.4 75.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.078 0.466 . . . . 63.520000000000003 111.696 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.497 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 14.5 mm-40 -75.93 -35.57 59.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.996 -0.547 . . . . 71.129999999999995 111.115 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.94 -30.13 70.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.912 0.387 . . . . 70.319999999999993 111.775 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 88' ' ' THR . 20.0 mt-30 -62.72 -21.01 65.47 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.734 0.302 . . . . 74.150000000000006 111.749 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.01 16.42 1.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.667 0.617 . . . . 64.099999999999994 112.667 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptp -142.52 -178.58 5.83 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 122.186 -0.321 . . . . 71.239999999999995 111.067 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.3 50.89 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.13 -0.557 . . . . 63.310000000000002 113.141 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.6 mmtp -127.75 139.17 52.84 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.416 -0.461 . . . . 73.010000000000005 111.952 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.552 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 75.5 p -76.32 127.84 33.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.761 -0.654 . . . . 75.239999999999995 111.905 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.592 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 5.7 m -136.93 157.72 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.307 0.575 . . . . 62.149999999999999 112.532 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 t -109.62 -177.31 3.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.786 -0.643 . . . . 74.049999999999997 112.353 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.647 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 24.3 mmm180 -41.04 -50.28 3.36 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.26 1.208 . . . . 73.239999999999995 114.26 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -84.34 -14.4 49.72 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.566 0.58 . . . . 70.239999999999995 112.566 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.8 m120 -89.75 -12.23 39.94 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.977 0.362 . . . . 75.010000000000005 111.977 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -57.77 131.88 51.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.979 0.733 . . . . 65.510000000000005 112.979 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -111.96 -162.33 0.79 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.788 -0.642 . . . . 74.530000000000001 110.381 171.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.531 HG21 ' HB2' ' A' ' 41' ' ' LYS . 91.7 m -92.9 108.35 19.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.708 0.289 . . . . 74.140000000000001 110.849 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.66 -10.36 7.58 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.598 -0.334 . . . . 74.310000000000002 112.753 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.416 ' OD2' ' HD2' ' A' ' 157' ' ' ARG . 0.8 OUTLIER -60.9 127.05 29.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.115 0.413 . . . . 75.439999999999998 112.115 177.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 39.4 mt -82.87 108.07 15.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.892 0.377 . . . . 51.219999999999999 110.754 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 155' ' ' ALA . 28.4 m -96.27 124.86 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.284 0.564 . . . . 63.310000000000002 111.965 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 73.8 mt -93.96 136.16 34.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.831 -0.622 . . . . 74.299999999999997 112.002 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 96.0 m-85 -124.22 139.99 53.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 64.239999999999995 111.666 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -81.05 98.32 7.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.601 -0.272 . . . . 74.120000000000005 111.141 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.89 100.11 10.39 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.145 0.498 . . . . 64.329999999999998 111.743 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.01 -88.33 0.48 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.293 -0.479 . . . . 75.099999999999994 113.603 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.3 t -151.81 -59.62 0.16 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.174 0.511 . . . . 72.010000000000005 111.534 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.7 p -84.85 -18.67 34.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.86 -0.609 . . . . 62.229999999999997 111.356 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.99 85.05 0.57 Allowed Glycine 0 CA--C 1.526 0.74 0 CA-C-N 116.005 -0.543 . . . . 55.43 113.962 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -86.16 89.71 7.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.457 -0.572 . . . . 74.099999999999994 109.457 170.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 69.0 t60 -84.24 149.32 26.2 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.816 -0.629 . . . . 64.209999999999994 111.277 -172.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 7.6 p -142.6 119.04 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.461 0.648 . . . . 74.519999999999996 111.948 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -114.33 152.85 17.93 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.204 -0.522 . . . . 71.120000000000005 112.854 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.4 mt -88.39 106.92 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 122.51 -0.406 . . . . 73.219999999999999 110.706 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -68.51 116.73 9.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.045 0.45 . . . . 72.209999999999994 111.338 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.1 pt -103.04 -14.44 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.361 0.504 . . . . 35.240000000000002 112.361 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.13 164.67 11.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.11 -0.567 . . . . 70.299999999999997 112.991 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 127' ' ' ASN . 69.1 m-20 61.58 27.35 16.84 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.002 0.401 . . . . 71.299999999999997 111.891 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 126' ' ' ASN . 47.6 m-80 67.12 7.61 5.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.328 0.251 . . . . 75.439999999999998 111.509 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -89.7 144.17 26.2 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.595 0.712 . . . . 60.439999999999998 111.253 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -149.29 138.43 21.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 73.25 111.056 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.92 133.43 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.031 0.443 . . . . 53.439999999999998 110.7 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -157.73 172.2 18.93 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.257 0.551 . . . . 73.439999999999998 111.723 -173.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -105.12 93.04 4.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.0 -0.546 . . . . 71.450000000000003 110.154 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.7 p -67.39 140.04 57.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.952 0.406 . . . . 75.099999999999994 111.531 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -57.6 -30.33 65.22 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.914 0.709 . . . . 63.299999999999997 112.914 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.9 t -102.18 -53.82 2.83 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.564 0.579 . . . . 65.400000000000006 112.564 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 t -81.0 -33.59 33.55 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.601 0.593 . . . . 61.340000000000003 112.601 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.44 -153.09 17.01 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.164 -0.541 . . . . 62.420000000000002 112.635 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.58 106.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.211 0.506 . . . . 73.409999999999997 111.499 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.5 178.21 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.299 0.571 . . . . 72.129999999999995 112.033 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.03 138.17 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.944 -0.571 . . . . 73.430000000000007 109.957 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.4 m -132.06 171.7 13.29 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.312 -0.243 . . . . 74.209999999999994 111.152 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.6 m -127.66 138.24 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.873 0.323 . . . . 72.310000000000002 111.873 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.647 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 66.3 mtt -64.78 -12.18 44.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.97 0.414 . . . . 75.5 111.866 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -66.1 -28.28 68.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.83 0.348 . . . . 75.329999999999998 111.204 173.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.56 125.54 92.04 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.573 -0.285 . . . . 71.25 110.63 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.486 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 82.3 Cg_exo -46.39 -41.88 22.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.968 2.445 . . . . 72.530000000000001 113.723 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -59.63 -41.5 90.61 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.223 0.453 . . . . 74.099999999999994 112.223 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.03 -36.44 19.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.011 0.375 . . . . 74.530000000000001 112.011 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -54.81 -50.93 67.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.074 0.464 . . . . 73.129999999999995 111.612 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 18.4 ptpt -82.35 1.17 38.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.975 0.417 . . . . 71.120000000000005 111.88 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -96.18 -28.69 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.531 0.332 . . . . 74.329999999999998 110.959 176.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -58.51 115.4 2.99 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.179 -0.464 . . . . 73.310000000000002 112.097 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.413 HD22 ' HG2' ' A' ' 154' ' ' GLU . 7.5 t30 -98.07 -62.43 1.25 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.059 -0.519 . . . . 72.340000000000003 111.447 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.413 ' HG2' HD22 ' A' ' 153' ' ' ASN . 13.5 pt-20 -158.44 164.73 35.95 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.231 -0.293 . . . . 74.120000000000005 110.482 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -126.24 149.22 49.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.551 0.215 . . . . 62.229999999999997 111.523 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.552 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 89.5 mtt180 -143.99 112.72 6.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.611 0.243 . . . . 71.340000000000003 110.987 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.592 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -85.4 129.31 34.84 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.16 0.505 . . . . 72.219999999999999 110.84 176.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 84' ' ' LEU . 27.8 m -107.13 7.89 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.895 0.702 . . . . 73.420000000000002 112.895 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 69.3 mt -68.05 141.73 56.09 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.177 0.513 . . . . 73.420000000000002 112.235 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.0 t -98.43 -61.58 1.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.932 -0.576 . . . . 72.329999999999998 111.894 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -67.89 142.48 56.06 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.83 0.347 . . . . 74.109999999999999 111.824 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.4 t -120.17 173.42 7.12 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.873 0.368 . . . . 71.230000000000004 111.281 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -74.68 149.28 39.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.746 0.307 . . . . 70.239999999999995 111.261 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.624 -0.703 . . . . 55.210000000000001 111.227 179.139 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.466 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 5.4 mmt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 112.058 0.392 . . . . 73.209999999999994 112.058 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -50.8 125.19 12.72 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.361 0.874 . . . . 62.109999999999999 113.361 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.94 93.9 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.022 -0.535 . . . . 74.430000000000007 109.964 169.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.52 105.04 0.58 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.913 0.387 . . . . 64.030000000000001 111.566 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 44' ' ' ILE . 86.6 t -48.66 -46.08 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 72.25 111.215 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 45' ' ' MET . 58.9 tttm -54.89 -46.3 74.79 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.576 0.584 . . . . 74.230000000000004 112.576 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.7 p -60.61 -44.03 96.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.801 0.334 . . . . 72.409999999999997 111.868 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -73.93 -30.03 62.35 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.445 0.535 . . . . 70.549999999999997 112.445 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 40' ' ' VAL . 75.4 mt -63.69 -43.85 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.265 0.555 . . . . 73.230000000000004 110.135 173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 87.4 mmm -66.63 -37.1 84.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.064 -0.516 . . . . 74.319999999999993 110.848 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.06 -43.45 70.25 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.169 0.509 . . . . 74.439999999999998 111.475 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.43 ' NE2' HE22 ' A' ' 79' ' ' GLN . 5.3 tp-100 -69.8 -54.51 13.26 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.273 -0.421 . . . . 75.140000000000001 110.617 174.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.432 ' OH ' ' NZ ' ' A' ' 52' ' ' LYS . 16.4 t80 -49.01 -39.68 27.78 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.088 0.773 . . . . 74.0 113.088 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.45 -33.81 55.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.115 0.484 . . . . 71.120000000000005 111.884 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.79 -23.41 55.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.038 -0.528 . . . . 63.32 112.413 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 138' ' ' VAL . 82.8 m95 -97.2 -0.31 47.01 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.587 0.588 . . . . 72.140000000000001 112.587 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' NZ ' ' OH ' ' A' ' 48' ' ' TYR . 29.5 mtpp -64.85 95.37 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.992 0.425 . . . . 71.510000000000005 111.269 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.81 -12.47 7.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.444 -0.407 . . . . 73.540000000000006 112.725 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.6 t -74.18 124.9 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 50.43 111.187 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -86.2 160.64 19.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.563 0.697 . . . . 74.409999999999997 112.39 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 47.3 t80 -74.72 127.51 33.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.412 -0.813 . . . . 63.030000000000001 112.125 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -136.93 121.53 18.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.712 0.291 . . . . 74.430000000000007 111.599 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.86 121.63 22.91 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.201 0.445 . . . . 62.420000000000002 112.201 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.4 50.82 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.946 -0.645 . . . . 53.299999999999997 113.689 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -151.7 135.63 5.13 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.09 -0.576 . . . . 61.240000000000002 112.438 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.521 ' HA ' HG13 ' A' ' 66' ' ' ILE . 29.0 p -125.44 98.98 5.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.315 0.579 . . . . 53.219999999999999 111.691 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.1 t -159.84 161.88 34.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.065 -0.516 . . . . 71.430000000000007 110.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -67.88 -3.36 9.49 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.061 0.458 . . . . 71.120000000000005 111.738 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -92.55 -19.37 22.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.983 0.421 . . . . 74.430000000000007 111.269 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 136.52 2.23 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.59 -0.604 . . . . 60.109999999999999 111.59 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.521 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.4 tt -157.45 150.96 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 117.702 0.751 . . . . 62.030000000000001 112.496 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.15 -179.36 4.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.273 0.558 . . . . 70.519999999999996 112.186 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.4 t -58.15 -56.64 19.48 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.593 0.59 . . . . 71.230000000000004 112.593 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 75.2 p -60.46 -36.2 77.68 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.939 0.399 . . . . 74.530000000000001 111.608 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.66 85.09 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.039 -0.528 . . . . 74.010000000000005 113.17 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.73 -50.92 70.48 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.587 -0.361 . . . . 74.450000000000003 111.72 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.509 ' HA ' HD11 ' A' ' 122' ' ' ILE . 11.0 p -65.14 -43.79 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 111.987 0.366 . . . . 73.329999999999998 111.987 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.578 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 21.1 pt20 -62.18 -38.93 90.96 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.162 -0.336 . . . . 64.239999999999995 111.592 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 74' ' ' ARG . 14.4 mtp180 -67.12 -55.54 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.715 0.293 . . . . 71.519999999999996 111.579 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.4 m -47.46 -42.35 22.42 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.284 0.475 . . . . 74.409999999999997 112.284 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 49.9 m-85 -75.02 -41.55 59.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.717 0.636 . . . . 70.239999999999995 112.717 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 13.7 ptm180 -76.92 -26.68 54.37 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.812 -0.555 . . . . 62.009999999999998 112.355 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.0 -37.67 16.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.122 0.415 . . . . 55.420000000000002 112.122 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.43 HE22 ' NE2' ' A' ' 47' ' ' GLN . 19.2 mp0 -93.48 -48.43 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.9 0.704 . . . . 71.420000000000002 112.9 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 58.4 m-85 -101.55 -5.58 24.97 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.42 0.526 . . . . 63.340000000000003 112.42 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.59 13.62 74.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.089 -0.577 . . . . 73.349999999999994 113.066 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -90.82 111.51 22.94 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.671 -0.311 . . . . 71.230000000000004 110.674 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.48 95.85 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.177 0.513 . . . . 70.349999999999994 112.149 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 91.4 mt -82.69 143.6 47.3 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 110.195 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.45 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 43.9 Cg_endo -67.45 -172.67 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.53 2.153 . . . . 73.049999999999997 113.522 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.409 ' H ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -95.62 -33.09 12.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.864 0.69 . . . . 73.219999999999999 112.864 -172.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.512 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 19.9 m -96.43 141.74 29.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.69 0.255 . . . . 74.319999999999993 111.69 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 59.8 m -52.13 -50.35 61.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.905 0.335 . . . . 75.150000000000006 111.905 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.467 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 24.9 m-85 -54.11 -44.0 70.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.534 0.207 . . . . 64.109999999999999 111.437 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.512 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 45.3 mt-10 -58.91 -47.5 84.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.552 . . . . 62.43 110.87 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -63.37 -30.71 71.79 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.147 -0.479 . . . . 73.019999999999996 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.7 mt-30 -71.34 -21.05 62.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.465 -0.334 . . . . 75.400000000000006 111.495 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 89' ' ' TYR . 41.6 mt-10 -79.48 -5.23 54.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.852 0.358 . . . . 74.340000000000003 111.132 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.45 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 75.0 mtp -106.28 131.83 53.04 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.368 -0.378 . . . . 52.340000000000003 110.936 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.24 134.78 1.07 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.465 -0.397 . . . . 73.030000000000001 113.715 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 96' ' ' LYS . 70.3 mmtt -88.31 162.53 16.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.587 . . . . 65.319999999999993 112.025 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 29.6 m -75.38 155.19 36.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.208 1.188 . . . . 42.420000000000002 114.208 -167.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 155' ' ' ALA . 0.9 OUTLIER -144.04 149.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.017 -0.992 . . . . 70.349999999999994 110.864 171.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 t -100.57 -173.49 2.42 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.367 -0.379 . . . . 64.329999999999998 111.355 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.461 HH11 ' HE2' ' A' ' 152' ' ' TYR . 1.1 mpp_? -59.87 -38.56 82.53 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.978 1.103 . . . . 73.019999999999996 113.978 -169.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.9 p -79.86 -5.68 55.96 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.744 -0.598 . . . . 51.32 111.67 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -116.73 11.11 14.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.843 0.312 . . . . 62.409999999999997 111.843 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 78.1 mt -72.44 129.56 38.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.109 0.48 . . . . 65.140000000000001 111.588 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.402 HH21 HG11 ' A' ' 98' ' ' VAL . 41.3 mtm180 -138.8 172.23 13.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.02 0.528 . . . . 73.340000000000003 111.08 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.3 m -64.94 114.93 4.88 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.184 0.516 . . . . 71.230000000000004 111.969 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.86 -3.36 24.36 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.296 -0.478 . . . . 72.120000000000005 113.696 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -79.99 134.16 36.22 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.304 0.573 . . . . 70.140000000000001 111.125 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 77.3 mt -89.36 119.37 29.77 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.477 -0.328 . . . . 63.219999999999999 111.482 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 155' ' ' ALA . 12.5 m -95.62 129.24 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.978 0.418 . . . . 70.430000000000007 111.721 -177.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.61 140.7 33.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.308 -0.405 . . . . 45.439999999999998 111.58 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.41 140.09 51.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.794 0.33 . . . . 73.150000000000006 111.407 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -86.72 90.13 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.917 0.389 . . . . 75.340000000000003 110.229 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.36 135.04 48.55 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.372 0.508 . . . . 44.240000000000002 112.372 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.78 26.43 1.69 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 121.467 -0.397 . . . . 74.409999999999997 113.778 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.5 m -132.86 -38.42 0.99 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.933 0.397 . . . . 74.420000000000002 111.216 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.0 p -118.91 1.03 11.47 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.224 0.453 . . . . 60.100000000000001 112.224 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.12 -87.48 0.39 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.084 -0.579 . . . . 75.200000000000003 112.549 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.44 ' O ' HG21 ' A' ' 88' ' ' THR . 2.7 mpt_? -107.56 100.0 9.45 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.232 0.539 . . . . 64.450000000000003 110.552 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -92.63 143.01 26.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.919 -0.582 . . . . 73.329999999999998 110.613 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.93 137.58 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.263 0.554 . . . . 63.299999999999997 112.346 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.26 20.65 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.044 -0.525 . . . . 72.25 112.874 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.509 HD11 ' HA ' ' A' ' 72' ' ' VAL . 47.0 mt -90.27 109.42 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.801 0.3 . . . . 74.329999999999998 111.038 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.545 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 63.8 t80 -75.46 113.78 13.27 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.954 0.407 . . . . 63.130000000000003 111.358 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.44 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 27.7 pt -95.51 -32.96 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.107 0.41 . . . . 65.519999999999996 112.107 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.38 165.36 11.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.187 -0.53 . . . . 53.130000000000003 113.2 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.407 ' O ' ' HG3' ' A' ' 128' ' ' GLN . 14.6 t-20 59.39 42.49 17.89 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.219 0.533 . . . . 74.25 110.788 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.545 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 4.2 p30 51.53 17.18 0.52 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.066 0.947 . . . . 62.340000000000003 112.725 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 126' ' ' ASN . 77.5 mt-30 -108.56 145.51 34.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.371 0.605 . . . . 72.219999999999999 111.702 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.525 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 8.0 p90 -148.97 150.43 32.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.648 -0.706 . . . . 74.310000000000002 111.659 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.49 140.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.014 0.435 . . . . 75.310000000000002 111.326 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -161.72 -166.37 1.46 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.474 -0.33 . . . . 71.150000000000006 111.236 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.96 106.46 8.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.76 0.314 . . . . 63.119999999999997 111.615 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.6 m -81.89 155.19 25.44 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.892 0.377 . . . . 71.129999999999995 111.987 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 67.8 p -52.84 -46.56 67.84 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.216 1.191 . . . . 63.439999999999998 114.216 -172.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -100.56 -44.74 5.75 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.904 -0.497 . . . . 72.299999999999997 112.07 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.0 m -65.77 -38.71 89.8 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.938 0.718 . . . . 53.409999999999997 112.938 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.66 -146.4 18.25 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.937 -0.649 . . . . 53.399999999999999 112.212 -173.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 51' ' ' TRP . 61.0 t -69.38 111.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 117.201 0.5 . . . . 61.32 111.67 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.2 pt -141.16 -179.98 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.165 0.507 . . . . 74.239999999999995 111.663 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.47 137.08 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.192 -0.458 . . . . 72.299999999999997 110.42 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.5 m -130.44 159.08 38.13 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.938 0.399 . . . . 74.319999999999993 111.68 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.6 m -115.2 148.4 39.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.366 -0.379 . . . . 61.240000000000002 111.586 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.511 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 91.8 mmm -67.54 -22.53 65.41 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.14 0.495 . . . . 65.200000000000003 110.863 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.33 -20.6 66.13 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.098 -0.501 . . . . 71.040000000000006 111.615 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -67.1 132.25 93.64 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.546 0.212 . . . . 72.439999999999998 110.96 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.592 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 14.1 Cg_endo -54.49 -48.79 19.53 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.747 2.298 . . . . 72.109999999999999 113.299 -174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -56.54 -48.47 77.21 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.129 0.418 . . . . 75.099999999999994 112.129 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.9 -40.07 61.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 111.424 -174.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -53.56 -55.95 21.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.162 -0.472 . . . . 62.340000000000003 111.834 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.608 ' HG3' ' HD2' ' A' ' 151' ' ' ARG . 19.1 ptpt -74.06 -28.74 61.54 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.803 0.668 . . . . 55.520000000000003 112.803 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.608 ' HD2' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -86.89 -7.5 58.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.478 0.547 . . . . 74.400000000000006 112.478 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.461 ' HE2' HH11 ' A' ' 100' ' ' ARG . 63.3 t80 -60.0 121.44 11.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.114 0.483 . . . . 75.129999999999995 111.778 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -94.65 -69.59 0.75 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.851 -0.613 . . . . 71.510000000000005 111.234 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.65 144.15 7.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.507 -0.315 . . . . 64.329999999999998 111.627 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -99.82 162.88 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.417 -0.177 . . . . 70.540000000000006 111.172 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -141.81 141.46 33.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.037 0.446 . . . . 73.310000000000002 111.899 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 157' ' ' ARG . 0.5 OUTLIER -97.45 95.29 7.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.29 0.567 . . . . 75.209999999999994 111.677 178.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.78 -15.18 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.004 -0.544 . . . . 65.430000000000007 112.175 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.479 HD23 HD22 ' A' ' 82' ' ' LEU . 96.0 mt -94.33 128.33 40.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.683 0.278 . . . . 70.230000000000004 111.371 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.8 t -66.98 86.1 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.058 0.456 . . . . 70.209999999999994 111.164 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.3 ppt_? -160.94 160.34 30.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.054 -0.521 . . . . 71.450000000000003 111.556 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.2 t 65.63 27.57 11.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.261 0.553 . . . . 74.329999999999998 110.867 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.6 mt -133.79 -171.33 2.7 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.785 -0.643 . . . . 74.140000000000001 111.324 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.256 1.405 0 CA-C-O 118.484 -0.77 . . . . 52.439999999999998 112.835 -178.044 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.774 0.321 . . . . 73.340000000000003 110.609 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -129.63 173.48 10.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.16 0.505 . . . . 72.409999999999997 111.649 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.6 t -69.67 108.65 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.084 -0.507 . . . . 71.329999999999998 110.42 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.06 106.78 12.33 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.139 0.495 . . . . 63.409999999999997 110.938 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 44' ' ' ILE . 60.0 t -52.13 -46.64 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.751 -0.659 . . . . 73.230000000000004 112.087 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -59.01 -44.51 91.7 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.942 0.401 . . . . 71.209999999999994 111.086 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.5 m -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.466 -0.334 . . . . 73.340000000000003 111.287 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -65.37 -38.82 91.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 71.049999999999997 112.309 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 40' ' ' VAL . 81.6 mt -64.29 -52.61 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.077 0.465 . . . . 64.409999999999997 111.23 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.415 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 28.9 mmt -63.6 -27.73 69.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.967 0.413 . . . . 52.119999999999997 111.219 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -59.52 -48.4 81.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.917 -0.583 . . . . 63.020000000000003 111.284 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -76.64 -36.27 57.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 54.43 111.106 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.532 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 27.2 t80 -53.58 -37.65 63.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.765 0.317 . . . . 74.340000000000003 110.651 174.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . . . -53.34 -25.35 14.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.206 0.447 . . . . 54.109999999999999 112.206 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -86.4 -38.05 17.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.135 0.493 . . . . 72.540000000000006 111.124 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -88.07 -2.63 58.72 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.924 0.713 . . . . 74.409999999999997 112.924 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 98.6 mttt -53.0 106.07 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.552 0.575 . . . . 74.099999999999994 112.552 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.14 -8.25 25.06 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.982 -0.628 . . . . 74.219999999999999 114.386 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.66 123.22 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 117.49 0.645 . . . . 62.299999999999997 111.031 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.97 169.69 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.424 0.63 . . . . 61.5 112.568 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -83.93 128.42 34.53 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.808 -0.633 . . . . 71.239999999999995 111.679 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -136.87 118.61 15.05 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.53 -0.305 . . . . 70.340000000000003 111.024 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.0 mp -74.3 102.59 4.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.999 0.37 . . . . 71.510000000000005 111.999 -173.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.28 33.7 31.4 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.068 -0.587 . . . . 64.239999999999995 113.241 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.15 102.93 0.27 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.905 -0.478 . . . . 50.210000000000001 111.905 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.511 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 p -94.81 100.84 12.66 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.504 0.557 . . . . 64.140000000000001 112.504 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -158.93 173.09 17.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.161 -0.472 . . . . 62.200000000000003 111.791 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -74.75 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.431 . . . . 74.239999999999995 111.32 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 3.1 mptp? -90.98 0.73 57.46 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.205 -0.452 . . . . 62.409999999999997 111.001 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.11 145.99 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.059 -0.417 . . . . 71.430000000000007 112.059 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.511 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.5 tt -165.02 148.09 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 117.551 0.676 . . . . 62.310000000000002 112.001 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.84 0.352 . . . . 70.129999999999995 111.473 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 25.0 p -59.94 -47.66 84.87 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.285 0.476 . . . . 71.450000000000003 112.285 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.3 m -63.97 -41.5 97.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.976 0.417 . . . . 65.230000000000004 111.225 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.81 -40.27 95.52 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.973 -0.632 . . . . 62.409999999999997 112.605 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -60.24 -54.24 48.19 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.976 0.362 . . . . 74.040000000000006 111.976 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.66 -38.04 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.058 0.456 . . . . 61.329999999999998 111.038 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -53.79 -57.78 9.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.293 0.568 . . . . 64.120000000000005 111.642 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 18.5 mmt180 -64.8 -48.1 75.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.951 -0.568 . . . . 65.040000000000006 111.844 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 m -52.68 -51.1 61.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.093 0.473 . . . . 65.310000000000002 111.865 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 35.3 m-85 -70.05 -38.66 75.87 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.773 0.657 . . . . 75.319999999999993 112.773 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 4.7 ptm180 -69.24 -33.71 73.69 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.89 -0.507 . . . . 73.319999999999993 111.542 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.12 -36.85 64.23 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 111.902 0.334 . . . . 72.409999999999997 111.902 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -97.48 -58.4 2.01 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.578 0.585 . . . . 52.109999999999999 112.578 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.33 -1.74 53.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.421 0.526 . . . . 74.540000000000006 112.421 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.68 22.43 76.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.182 -0.533 . . . . 72.010000000000005 112.889 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -100.34 113.02 25.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 75.219999999999999 111.192 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.994 0.426 . . . . 72.219999999999999 111.575 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.01 153.83 37.75 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.325 -0.398 . . . . 61.310000000000002 111.361 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.86 168.21 19.31 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.443 2.096 . . . . 53.229999999999997 113.208 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -81.32 3.58 23.69 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.559 0.577 . . . . 62.130000000000003 112.559 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 30.8 t -122.17 133.44 54.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.343 0.498 . . . . 73.400000000000006 112.343 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 2.5 m -56.21 -45.21 79.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.854 -0.612 . . . . 75.310000000000002 111.026 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.6 -44.31 85.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.571 -0.741 . . . . 72.329999999999998 111.438 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 19.2 mm-40 -70.52 -33.99 71.79 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.153 0.501 . . . . 75.420000000000002 111.214 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -66.29 -20.36 66.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.528 -0.305 . . . . 65.420000000000002 111.74 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 88' ' ' THR . 22.9 mt-30 -72.08 -22.53 61.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.983 0.42 . . . . 71.129999999999995 111.819 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -87.46 -2.66 58.77 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.342 -0.39 . . . . 71.219999999999999 111.484 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.2 mmm -97.25 -75.83 0.53 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.865 0.364 . . . . 63.5 111.561 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.65 151.87 48.48 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.369 -0.443 . . . . 75.510000000000005 113.634 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 29.8 mmtp -89.29 153.94 20.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.998 0.427 . . . . 73.109999999999999 111.533 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.9 p -85.61 152.86 22.8 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.223 0.823 . . . . 75.510000000000005 113.223 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.513 HG13 ' NE ' ' A' ' 157' ' ' ARG . 1.1 m -152.25 171.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.861 -0.609 . . . . 74.519999999999996 112.161 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.2 t -116.26 -178.63 3.46 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.727 -0.67 . . . . 50.210000000000001 111.053 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.439 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -55.74 -46.09 77.88 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.287 0.477 . . . . 74.430000000000007 112.287 -177.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -69.48 -3.3 14.0 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.22 0.452 . . . . 70.430000000000007 112.22 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.493 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 5.6 m120 -116.08 -7.5 11.89 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.948 -0.47 . . . . 72.040000000000006 111.96 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.27 135.06 57.62 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.897 0.703 . . . . 71.25 112.897 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -115.42 -152.02 0.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.491 -0.777 . . . . 61.109999999999999 109.855 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.9 m -102.83 105.02 15.34 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.791 -0.568 . . . . 74.430000000000007 111.505 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 122.91 -3.78 9.87 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.842 -0.694 . . . . 32.509999999999998 114.604 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.86 134.24 56.89 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.373 0.586 . . . . 75.549999999999997 111.759 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.4 mt -85.38 113.19 21.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.026 0.441 . . . . 63.420000000000002 111.26 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' A' ' 155' ' ' ALA . 19.2 m -95.4 134.78 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.031 0.443 . . . . 74.530000000000001 111.438 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 87.8 mt -104.62 138.57 40.75 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.245 0.461 . . . . 72.340000000000003 112.245 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 56.2 m-85 -123.4 141.28 52.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.933 -0.576 . . . . 75.019999999999996 111.505 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 48.2 mtt180 -82.87 82.01 8.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.956 0.408 . . . . 73.340000000000003 110.027 173.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.22 134.07 35.79 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.002 0.371 . . . . 74.200000000000003 112.002 -173.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.17 50.36 1.96 Allowed Glycine 0 CA--C 1.529 0.941 0 CA-C-N 116.51 -0.314 . . . . 74.319999999999993 113.586 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.1 m -154.62 -57.39 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.277 0.56 . . . . 41.210000000000001 109.769 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.6 p -103.17 -10.76 18.54 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.071 -0.513 . . . . 74.439999999999998 111.829 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.68 -61.01 4.31 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.242 -0.504 . . . . 44.420000000000002 112.798 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -117.08 97.75 6.1 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.028 0.442 . . . . 71.439999999999998 110.598 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 52.5 t60 -95.94 154.64 17.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.342 -0.39 . . . . 74.510000000000005 110.555 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.406 ' HB ' HG23 ' A' ' 88' ' ' THR . 14.9 p -134.57 142.94 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.172 0.51 . . . . 74.120000000000005 112.308 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.38 160.89 26.93 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.979 -0.555 . . . . 43.450000000000003 112.625 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -97.01 109.65 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.532 -0.393 . . . . 75.319999999999993 111.32 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -68.03 108.65 3.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.928 0.394 . . . . 74.25 111.231 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 pt -109.43 -32.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.458 0.54 . . . . 51.140000000000001 112.458 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.51 -175.72 14.13 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.201 -0.523 . . . . 73.150000000000006 113.038 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -43.02 -58.0 2.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.858 0.688 . . . . 72.450000000000003 112.858 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 142' ' ' SER . 4.9 m-20 -122.11 -10.35 8.58 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.17 -0.331 . . . . 72.329999999999998 111.525 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.36 137.17 33.56 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.348 0.594 . . . . 75.049999999999997 112.459 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.69 142.57 27.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.594 -0.73 . . . . 62.350000000000001 110.965 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -97.41 136.33 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.869 0.366 . . . . 71.030000000000001 111.251 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -165.19 168.69 16.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 73.0 111.181 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.86 91.25 7.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.145 0.498 . . . . 65.530000000000001 110.515 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.8 p -65.14 146.02 55.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.868 -0.606 . . . . 34.420000000000002 112.086 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.2 p -64.48 -25.13 67.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.147 0.499 . . . . 62.539999999999999 111.303 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -73.17 -70.59 0.35 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.089 -0.505 . . . . 54.140000000000001 112.276 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.0 m -102.83 -35.75 8.51 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.124 0.416 . . . . 70.120000000000005 112.124 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.63 -141.29 13.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.078 -0.582 . . . . 54.43 112.567 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.9 92.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.321 0.582 . . . . 74.540000000000006 111.948 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.7 pt -136.88 -176.69 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.059 -0.519 . . . . 74.120000000000005 111.024 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.28 116.36 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.543 -0.299 . . . . 54.299999999999997 110.656 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.2 m -104.3 -177.99 3.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.767 0.318 . . . . 74.109999999999999 110.758 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.3 m -143.59 145.27 32.38 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.154 0.502 . . . . 65.439999999999998 112.342 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.81 -27.57 69.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.687 0.625 . . . . 65.439999999999998 112.687 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -72.85 -3.63 26.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.929 0.344 . . . . 63.210000000000001 111.929 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -74.8 122.25 87.07 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 110.423 -0.214 . . . . 72.329999999999998 110.423 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.14 -39.36 11.58 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.418 2.745 . . . . 64.019999999999996 114.421 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.488 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 85.7 t80 -61.72 -51.46 68.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.862 0.363 . . . . 75.019999999999996 111.28 176.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -76.84 -27.97 55.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.434 -0.348 . . . . 75.319999999999993 111.203 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.91 -34.56 74.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.203 -0.453 . . . . 51.329999999999998 111.234 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -102.6 0.99 34.19 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.362 -0.381 . . . . 55.539999999999999 111.521 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -103.41 -30.64 10.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 111.905 0.335 . . . . 74.349999999999994 111.905 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 70.6 t80 -56.64 135.28 54.96 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.886 0.374 . . . . 74.409999999999997 111.498 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -123.0 -51.33 1.9 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.932 0.345 . . . . 73.319999999999993 111.932 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.69 -179.04 7.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.079 0.4 . . . . 71.310000000000002 112.079 -173.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -144.73 149.47 35.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.516 -0.311 . . . . 74.439999999999998 111.374 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.6 mtm-85 -137.46 118.2 14.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.68 0.252 . . . . 74.439999999999998 111.68 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.513 ' NE ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.21 109.42 11.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.138 0.494 . . . . 72.430000000000007 110.981 174.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.457 ' HB ' HD21 ' A' ' 82' ' ' LEU . 16.8 m -84.13 -29.73 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.14 0.495 . . . . 54.340000000000003 111.201 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.48 94.72 5.63 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.267 -0.424 . . . . 75.150000000000006 110.177 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -64.32 117.22 6.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.299 0.481 . . . . 72.040000000000006 112.299 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 161' ' ' ARG . 9.2 tpt180 -138.63 111.74 7.93 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.104 -0.498 . . . . 74.25 110.465 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 58.7 m -110.18 131.04 55.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.05 0.452 . . . . 62.530000000000001 112.124 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 163' ' ' LEU . 2.3 pt? -76.96 -178.01 4.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.332 -0.395 . . . . 63.520000000000003 110.624 173.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.509 -0.758 . . . . 54.219999999999999 112.083 177.732 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 111.276 0.102 . . . . 60.32 111.276 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -42.14 138.35 1.65 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.244 0.831 . . . . 53.219999999999999 113.244 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.95 89.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.513 0.673 . . . . 72.430000000000007 112.192 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.468 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 12.2 t70 -96.02 140.91 30.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.772 -0.649 . . . . 73.329999999999998 110.272 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.1 t -56.21 -53.87 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.831 0.348 . . . . 52.340000000000003 111.411 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.7 tttt -61.4 -43.19 99.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.307 -0.406 . . . . 61.130000000000003 111.238 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.4 m -57.17 -42.73 81.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.099 -0.5 . . . . 41.020000000000003 111.331 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -72.01 -42.36 66.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.259 0.466 . . . . 60.310000000000002 112.259 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 40' ' ' VAL . 78.9 mt -58.35 -48.69 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 64.519999999999996 110.897 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 92.7 mmm -63.88 -36.23 83.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.039 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.35 -43.62 83.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.912 -0.585 . . . . 73.319999999999993 111.37 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -71.24 -45.61 62.87 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.998 0.428 . . . . 72.230000000000004 111.145 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -54.44 -41.22 69.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.445 -0.343 . . . . 74.239999999999995 111.831 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.82 -20.85 9.52 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.321 0.489 . . . . 74.109999999999999 112.321 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.1 -25.54 17.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.087 0.47 . . . . 73.040000000000006 111.47 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.411 ' O ' ' HB ' ' A' ' 138' ' ' VAL . 81.4 m95 -105.14 3.27 30.09 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.101 0.778 . . . . 73.319999999999993 113.101 -175.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -54.84 101.71 0.05 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.844 0.354 . . . . 74.340000000000003 111.916 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.45 21.4 22.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.015 -0.612 . . . . 64.340000000000003 114.412 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.7 t -80.5 132.05 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 117.851 0.826 . . . . 73.329999999999998 110.992 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -63.27 163.3 10.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.938 0.718 . . . . 74.430000000000007 112.938 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 48.9 t80 -92.94 140.17 29.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.096 -0.502 . . . . 63.399999999999999 111.602 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -137.08 139.47 41.31 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.869 0.366 . . . . 65.450000000000003 110.969 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.7 mp -74.72 97.4 3.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 70.510000000000005 112.193 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 67' ' ' ASP . . . 78.43 6.76 88.05 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.051 -0.522 . . . . 65.299999999999997 114.329 174.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.77 77.85 0.3 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 117.497 0.648 . . . . 70.430000000000007 113.128 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.532 ' H ' ' NH2' ' A' ' 86' ' ' ARG . 48.3 t -68.41 107.69 2.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.396 0.887 . . . . 73.030000000000001 113.396 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.8 t -166.14 172.58 11.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.724 0.409 . . . . 73.040000000000006 111.576 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -65.01 -21.35 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.953 -0.467 . . . . 75.230000000000004 111.572 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.01 9.25 20.18 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.392 0.615 . . . . 71.040000000000006 111.021 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.52 136.05 3.08 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.863 -0.895 . . . . 73.109999999999999 110.863 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 71' ' ' PHE . 19.7 tt -144.58 146.4 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.232 1.016 . . . . 65.129999999999995 112.828 -175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 59' ' ' GLY . 5.4 p-10 -93.12 160.04 15.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.005 -0.543 . . . . 74.530000000000001 111.502 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 28.2 p -57.36 -54.46 46.6 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.841 0.353 . . . . 54.530000000000001 111.553 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 8.2 p -58.95 -42.86 90.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.193 -0.458 . . . . 52.229999999999997 111.18 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . -57.63 -33.84 68.31 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.322 -0.399 . . . . 63.439999999999998 113.654 176.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.582 ' HA ' HD11 ' A' ' 66' ' ' ILE . 74.6 t80 -72.04 -48.46 44.32 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.48 -0.423 . . . . 74.109999999999999 111.612 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.58 HG13 HE22 ' A' ' 91' ' ' GLN . 7.1 p -63.1 -44.18 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.576 -0.284 . . . . 72.129999999999995 111.443 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.1 pp0? -61.14 -44.85 96.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.036 -0.415 . . . . 54.439999999999998 111.336 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -57.62 -50.5 72.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.041 0.386 . . . . 64.549999999999997 112.041 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.4 m -53.43 -45.83 69.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.833 0.349 . . . . 74.400000000000006 111.816 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 65.8 m-85 -72.86 -38.39 67.06 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.061 0.763 . . . . 72.530000000000001 113.061 -177.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -76.88 -42.77 38.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.572 -0.705 . . . . 74.450000000000003 112.287 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -73.43 -26.49 60.97 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.274 0.472 . . . . 44.340000000000003 112.274 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -96.0 -61.25 1.48 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.843 0.354 . . . . 74.219999999999999 111.866 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 76' ' ' PHE . 63.9 m-85 -90.08 -28.5 18.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.42 0.526 . . . . 75.540000000000006 112.42 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.1 27.29 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.191 -0.528 . . . . 65.519999999999996 112.512 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 37.4 tp -83.15 160.09 21.92 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.311 0.577 . . . . 74.310000000000002 111.865 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.63 114.57 27.1 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.058 0.456 . . . . 73.439999999999998 111.895 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.77 145.01 41.15 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 122.274 -0.267 . . . . 74.040000000000006 111.033 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.595 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 63.1 Cg_endo -85.73 -171.47 0.9 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.979 2.453 . . . . 74.019999999999996 113.881 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.532 ' NH2' ' H ' ' A' ' 61' ' ' SER . 11.0 mmm180 -88.44 -19.43 26.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.473 0.546 . . . . 74.209999999999994 112.473 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -106.31 126.63 52.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.756 0.65 . . . . 74.109999999999999 112.756 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 44.1 m -52.0 -41.8 62.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.89 -0.595 . . . . 74.340000000000003 111.665 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.407 ' OH ' ' HD3' ' A' ' 118' ' ' ARG . 89.0 m-85 -54.76 -32.53 60.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.85 -0.614 . . . . 73.129999999999995 112.306 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.08 -38.61 31.38 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.18 0.514 . . . . 75.019999999999996 110.961 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.595 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 44.9 mt-30 -61.85 -33.64 74.55 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.192 -0.458 . . . . 64.409999999999997 111.595 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.51 ' HG2' HD11 ' A' ' 110' ' ' LEU . 18.7 mt-30 -52.01 -37.72 54.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.241 0.543 . . . . 44.240000000000002 111.596 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -90.48 -9.81 45.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.015 -0.539 . . . . 74.219999999999999 112.126 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.503 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 81.1 mtp -87.25 -37.18 17.45 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.872 0.367 . . . . 53.130000000000003 111.374 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.76 150.93 21.41 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.946 -0.645 . . . . 64.409999999999997 113.388 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 31.2 mmmt -70.88 141.32 51.22 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.161 0.505 . . . . 72.450000000000003 112.007 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 m -77.47 127.54 32.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.656 -0.702 . . . . 75.400000000000006 112.106 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 7.1 m -145.5 164.65 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.382 0.61 . . . . 71.010000000000005 112.417 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 t -116.7 -177.71 3.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.689 -0.687 . . . . 73.0 110.776 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.512 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -56.14 -36.69 68.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.455 0.539 . . . . 74.400000000000006 112.455 -175.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.0 p -64.88 -29.14 70.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.03 0.443 . . . . 74.420000000000002 112.141 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -100.68 -6.89 24.46 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.173 0.805 . . . . 75.209999999999994 113.173 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.14 131.05 48.77 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.419 0.896 . . . . 74.109999999999999 113.419 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -125.07 175.79 7.12 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.743 -0.662 . . . . 62.539999999999999 110.33 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 41' ' ' LYS . 62.9 m -68.44 111.35 4.63 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.98 -0.45 . . . . 64.109999999999999 111.1 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.33 -12.93 7.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.388 -0.434 . . . . 72.200000000000003 112.711 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.18 130.45 43.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.022 0.439 . . . . 75.519999999999996 111.581 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.8 mt -87.95 112.32 22.43 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.95 0.405 . . . . 71.230000000000004 110.56 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -96.65 128.1 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.375 0.607 . . . . 52.219999999999999 111.577 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.51 HD11 ' HG2' ' A' ' 92' ' ' GLN . 79.3 mt -98.84 143.44 29.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 111.917 -175.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -131.14 132.19 44.61 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.39 -0.368 . . . . 74.310000000000002 111.266 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -81.22 84.79 6.49 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.242 0.544 . . . . 74.120000000000005 110.666 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.03 125.01 47.62 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.873 -0.603 . . . . 54.149999999999999 112.138 -173.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.99 1.27 8.54 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 121.116 -0.564 . . . . 74.310000000000002 113.981 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.8 m -105.61 -23.53 12.75 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 122.476 -0.426 . . . . 73.049999999999997 112.1 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 p -134.37 -1.04 2.9 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.54 0.57 . . . . 50.039999999999999 112.54 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.25 -100.69 1.41 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.117 -0.563 . . . . 52.119999999999997 112.546 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.407 ' HD3' ' OH ' ' A' ' 89' ' ' TYR . 9.7 mpt_? -102.98 94.85 5.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 64.239999999999995 110.469 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -87.78 151.63 22.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.005 -0.543 . . . . 72.140000000000001 110.236 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.5 139.07 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.092 0.472 . . . . 72.120000000000005 112.242 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 131' ' ' HIS . . . -132.15 149.85 19.49 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 116.177 -0.465 . . . . 55.100000000000001 112.525 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 72' ' ' VAL . 43.6 mt -89.39 106.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 122.476 -0.426 . . . . 74.200000000000003 111.031 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.67 115.05 5.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.387 -0.37 . . . . 73.129999999999995 111.314 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.1 pt -103.04 -33.75 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.893 0.701 . . . . 71.209999999999994 112.893 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.45 123.24 0.83 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 119.777 -1.201 . . . . 41.520000000000003 115.139 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.69 -78.25 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.24 1.016 . . . . 71.319999999999993 111.696 171.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 142' ' ' SER . 53.8 m-80 -133.57 -7.4 2.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.449 -0.342 . . . . 73.200000000000003 111.342 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -86.68 140.42 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.285 0.564 . . . . 70.209999999999994 112.287 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -151.41 140.68 21.36 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.524 -0.762 . . . . 71.219999999999999 111.041 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.44 137.44 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.994 0.426 . . . . 45.409999999999997 111.394 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 133' ' ' SER . 5.0 p80 -162.9 162.21 26.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.988 0.366 . . . . 64.540000000000006 111.988 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -88.23 92.06 9.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.951 0.405 . . . . 41.520000000000003 110.391 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 131' ' ' HIS . 37.5 t -86.78 126.39 34.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.424 -0.353 . . . . 72.120000000000005 111.886 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -59.3 -17.76 31.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.44 0.533 . . . . 72.099999999999994 112.44 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.1 p -65.95 -41.3 91.45 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.91 0.386 . . . . 53.25 111.503 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.1 m -138.79 -39.22 0.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.048 0.388 . . . . 61.130000000000003 112.048 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.48 24.62 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.792 -0.523 . . . . 50.210000000000001 111.792 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 57.5 t -65.72 103.01 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.179 0.49 . . . . 61.43 111.237 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.72 169.84 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.106 -0.497 . . . . 71.150000000000006 111.399 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.48 114.55 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.591 -0.277 . . . . 75.420000000000002 110.687 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.5 m -104.57 178.56 4.52 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.965 0.412 . . . . 74.209999999999994 111.054 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 66.4 m -141.65 140.43 33.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.006 0.431 . . . . 75.540000000000006 112.106 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.02 -6.01 7.67 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.366 0.506 . . . . 54.5 112.366 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -73.0 -19.68 61.16 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 70.209999999999994 110.628 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.77 134.05 69.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.051 -0.522 . . . . 72.030000000000001 110.768 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.541 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 78.4 Cg_exo -51.25 -46.21 32.55 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.757 2.305 . . . . 71.200000000000003 113.489 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.79 -45.42 86.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.197 0.443 . . . . 74.310000000000002 112.197 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -80.33 -34.46 36.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.984 0.421 . . . . 64.5 111.641 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -60.5 -54.59 43.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.114 -0.493 . . . . 63.140000000000001 112.066 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 51.7 pttt -86.06 -14.78 43.33 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.173 0.805 . . . . 74.239999999999995 113.173 -174.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -92.95 -4.59 52.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.0 -0.438 . . . . 73.340000000000003 111.702 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.512 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 77.0 t80 -55.2 135.62 49.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.582 . . . . 62.549999999999997 112.234 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -104.81 -71.0 0.75 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.907 -0.588 . . . . 74.439999999999998 111.258 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.493 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.6 pt-20 -163.45 -174.11 3.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.17 -0.468 . . . . 73.019999999999996 111.057 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -142.11 137.63 31.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.611 0.597 . . . . 54.240000000000002 112.611 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 14.0 mmt180 -137.45 114.79 10.99 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.955 -0.566 . . . . 75.519999999999996 110.325 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.51 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -95.07 122.6 37.9 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.086 -1.009 . . . . 72.109999999999999 111.687 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.48 1.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.669 -0.696 . . . . 63.32 112.766 -176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.2 mt -95.2 132.92 39.63 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.165 0.432 . . . . 63.149999999999999 112.165 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.9 m -82.24 102.89 11.45 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.497 -0.319 . . . . 71.239999999999995 110.297 172.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 161' ' ' ARG . 4.9 ppt_? -80.08 148.19 31.12 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.578 0.584 . . . . 52.109999999999999 112.578 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.5 m -94.56 151.75 19.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.161 -0.472 . . . . 62.130000000000003 111.132 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 163' ' ' LEU . 6.3 mp -92.27 -169.15 2.16 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.935 0.398 . . . . 52.340000000000003 110.637 176.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.611 -0.709 . . . . 73.420000000000002 110.944 176.898 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 36' ' ' MET . 3.3 mpp? . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 111.798 0.296 . . . . 72.209999999999994 111.798 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -79.46 141.88 36.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.537 0.208 . . . . 74.219999999999999 111.174 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.2 t -78.67 106.1 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.123 0.487 . . . . 73.329999999999998 111.175 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -116.91 139.55 50.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.928 -0.578 . . . . 74.299999999999997 110.302 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 44' ' ' ILE . 46.6 t -56.5 -57.08 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.561 -0.291 . . . . 74.420000000000002 111.545 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 85.1 tttt -55.7 -42.31 75.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.901 0.381 . . . . 71.310000000000002 111.475 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -58.89 -43.66 91.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.218 -0.446 . . . . 62.049999999999997 111.583 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -74.29 -33.28 63.19 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.19 0.441 . . . . 65.049999999999997 112.19 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 40' ' ' VAL . 87.5 mt -60.06 -50.25 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.156 0.503 . . . . 73.400000000000006 110.649 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 mmt -67.83 -34.01 75.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 71.420000000000002 111.136 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -55.41 -43.65 75.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.262 -0.426 . . . . 73.409999999999997 110.93 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 60.7 tp60 -78.87 -35.92 43.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.539 -0.3 . . . . 73.329999999999998 111.322 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.35 -32.77 39.89 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.82 0.343 . . . . 74.030000000000001 111.564 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.73 -34.44 52.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.358 -0.383 . . . . 33.229999999999997 111.812 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -19.8 42.24 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.38 0.511 . . . . 72.439999999999998 112.38 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.512 ' CZ3' ' HA ' ' A' ' 63' ' ' LYS . 99.3 m95 -100.91 -4.33 27.92 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.281 0.845 . . . . 73.230000000000004 113.281 -174.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -65.18 127.57 32.23 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.877 -0.514 . . . . 75.319999999999993 111.272 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.27 -1.47 67.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.312 -0.47 . . . . 71.340000000000003 113.785 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.3 134.1 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 117.299 0.55 . . . . 52.409999999999997 111.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -83.56 161.07 21.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.403 0.52 . . . . 65.349999999999994 112.403 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -78.4 116.34 18.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.88 -0.6 . . . . 75.400000000000006 111.404 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -127.25 97.48 4.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.166 0.508 . . . . 70.439999999999998 110.638 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 40.7 tp -70.85 104.94 3.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.095 -0.502 . . . . 71.019999999999996 111.648 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.17 -63.61 0.56 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.362 -0.447 . . . . 74.530000000000001 112.781 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.92 99.35 2.11 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.221 -0.514 . . . . 60.229999999999997 112.532 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.548 ' HA ' HG13 ' A' ' 66' ' ' ILE . 76.4 p -84.09 105.9 15.32 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.068 0.395 . . . . 74.319999999999993 112.068 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -156.89 163.21 39.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.129 0.49 . . . . 62.229999999999997 112.167 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 39.2 ttmt -67.04 -11.76 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.272 0.558 . . . . 72.540000000000006 111.502 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.504 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -94.95 11.46 31.77 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.221 0.534 . . . . 75.109999999999999 110.748 177.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.5 123.25 1.57 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.159 -0.776 . . . . 63.409999999999997 111.159 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.8 tt -155.72 152.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 117.953 0.876 . . . . 72.319999999999993 112.706 -171.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -93.21 179.31 5.46 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.994 0.426 . . . . 71.349999999999994 111.509 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.53 -54.35 41.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.554 0.576 . . . . 52.310000000000002 112.554 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.5 p -62.13 -34.39 76.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.108 0.48 . . . . 62.420000000000002 111.71 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.67 -44.19 72.17 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.832 -0.699 . . . . 71.439999999999998 112.292 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -56.96 -52.31 65.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.866 0.365 . . . . 73.420000000000002 111.851 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.545 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.8 p -59.82 -41.92 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 50.340000000000003 111.386 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 5.7 tt0 -55.24 -54.82 38.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.363 0.601 . . . . 71.329999999999998 111.169 174.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -56.33 -54.38 46.17 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.44 -0.8 . . . . 74.239999999999995 111.73 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.457 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 66.1 m -52.87 -48.06 67.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.054 0.39 . . . . 71.129999999999995 112.054 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 38.3 m-85 -70.18 -35.23 73.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.983 0.735 . . . . 74.040000000000006 112.983 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -80.31 -33.52 37.5 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.722 -0.611 . . . . 74.129999999999995 111.806 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -72.64 -33.61 66.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.978 0.418 . . . . 72.400000000000006 111.53 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -102.35 -56.7 2.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.803 0.668 . . . . 71.299999999999997 112.803 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.54 -3.59 54.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.403 0.52 . . . . 73.400000000000006 112.403 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.49 22.79 66.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.429 -0.415 . . . . 74.510000000000005 113.012 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.511 HD22 HD23 ' A' ' 159' ' ' LEU . 46.4 tp -86.94 130.21 34.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.196 0.522 . . . . 74.310000000000002 111.97 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.67 101.38 10.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 111.496 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 73' ' ' GLN . 83.9 mt -111.99 139.83 22.78 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.292 . . . . 62.5 111.242 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.61 148.92 54.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.351 2.034 . . . . 54.530000000000001 112.751 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -83.37 65.22 8.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.352 0.596 . . . . 74.040000000000006 110.177 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 13.2 t -171.0 120.24 0.52 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.688 -0.687 . . . . 74.549999999999997 111.029 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.57 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 53.5 m -52.06 -41.62 62.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.946 0.403 . . . . 73.219999999999999 111.001 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CZ ' ' HD3' ' A' ' 118' ' ' ARG . 83.7 m-85 -60.83 -46.53 90.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.181 -0.463 . . . . 70.450000000000003 111.322 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 94' ' ' MET . 16.5 mm-40 -64.99 -37.66 88.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.934 0.397 . . . . 74.019999999999996 111.322 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 87' ' ' SER . 95.2 mt-30 -67.07 -36.12 81.33 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.027 0.38 . . . . 74.329999999999998 112.027 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 88' ' ' THR . 23.6 mt-30 -52.89 -55.15 25.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.307 0.575 . . . . 74.230000000000004 111.545 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.08 0.9 17.12 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.598 0.592 . . . . 72.209999999999994 112.598 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 88.0 mmm -91.88 -13.43 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.682 0.277 . . . . 70.150000000000006 111.369 173.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -135.52 156.1 22.55 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.077 -0.583 . . . . 55.340000000000003 113.535 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 34.1 mmtp -94.37 152.84 18.32 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.482 -0.422 . . . . 71.239999999999995 111.367 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 79.3 p -84.44 157.26 21.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.149 0.796 . . . . 34.119999999999997 113.149 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.34 158.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 115.28 -0.873 . . . . 73.140000000000001 111.536 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.6 t -94.41 178.27 5.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.168 0.433 . . . . 73.430000000000007 112.168 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -51.3 -54.91 21.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.854 0.687 . . . . 71.409999999999997 112.854 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -74.17 -8.25 55.53 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.606 0.595 . . . . 72.439999999999998 112.606 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -107.45 3.67 25.38 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.205 0.446 . . . . 64.129999999999995 112.205 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.06 122.93 16.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.797 0.332 . . . . 73.340000000000003 111.843 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -105.72 154.36 20.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.372 -0.376 . . . . 74.140000000000001 110.602 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.3 m -66.35 119.52 11.71 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.916 -0.49 . . . . 75.530000000000001 110.855 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.47 -11.18 23.8 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.361 -0.447 . . . . 74.209999999999994 112.626 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.57 138.41 53.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.228 0.537 . . . . 74.510000000000005 111.412 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.449 HD22 HG21 ' A' ' 72' ' ' VAL . 23.5 mt -86.62 117.04 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.8 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -95.23 118.87 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.433 0.635 . . . . 72.140000000000001 111.418 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 70.1 mt -93.1 127.02 38.48 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.613 -0.721 . . . . 72.019999999999996 111.867 -177.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.67 133.58 55.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.328 -0.396 . . . . 73.420000000000002 111.126 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -75.87 92.06 3.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.904 0.383 . . . . 64.430000000000007 110.832 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.23 133.66 37.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.21 0.448 . . . . 63.450000000000003 112.21 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.69 60.34 4.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.385 -0.436 . . . . 34.43 113.455 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.6 t -172.52 -69.52 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.225 0.536 . . . . 72.150000000000006 110.744 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.5 p -81.88 -12.72 58.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.097 0.475 . . . . 63.119999999999997 111.12 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.19 -76.08 2.1 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.375 -0.44 . . . . 52.340000000000003 112.155 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 8.2 mpt_? -110.15 116.51 31.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.009 0.433 . . . . 75.450000000000003 111.223 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 82.9 t60 -102.4 151.89 21.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.474 -0.33 . . . . 72.329999999999998 110.213 174.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.71 137.77 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.149 0.499 . . . . 50.119999999999997 112.279 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.18 159.29 23.97 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.082 -0.508 . . . . 73.329999999999998 112.598 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.545 HD11 ' HA ' ' A' ' 72' ' ' VAL . 45.0 mt -92.22 106.57 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.536 -0.391 . . . . 75.329999999999998 111.418 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -65.74 120.79 13.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.818 0.342 . . . . 64.439999999999998 111.32 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.512 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.9 pt -102.98 -37.61 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.348 0.499 . . . . 64.329999999999998 112.348 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.27 142.05 4.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.381 -0.914 . . . . 34.420000000000002 114.086 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.52 -79.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.453 0.701 . . . . 70.530000000000001 111.822 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 143' ' ' MET . 7.8 p30 -150.8 9.08 0.59 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.134 -0.484 . . . . 75.319999999999993 110.92 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -89.28 143.01 27.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 111.22 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.459 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 19.1 p90 -153.92 145.15 22.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 64.530000000000001 111.325 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.13 129.95 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.188 0.518 . . . . 75.299999999999997 110.86 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -150.65 -178.52 6.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.349 -0.387 . . . . 73.040000000000006 111.394 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -110.73 99.6 8.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.986 0.422 . . . . 61.420000000000002 111.482 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.9 t -66.25 136.23 55.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.126 -0.488 . . . . 74.409999999999997 111.452 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -57.28 -25.73 59.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.237 0.458 . . . . 73.349999999999994 112.237 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.8 t -99.56 -60.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.14 0.422 . . . . 41.140000000000001 112.14 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.8 m -73.32 -52.82 12.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.587 0.588 . . . . 53.350000000000001 112.587 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 -146.9 16.61 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.489 -0.386 . . . . 73.299999999999997 112.279 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.75 106.58 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 117.373 0.587 . . . . 72.120000000000005 112.001 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -140.24 174.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 120.988 0.423 . . . . 62.140000000000001 111.568 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.5 mt -105.41 123.26 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.526 -0.306 . . . . 73.239999999999995 111.213 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -116.37 173.58 6.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.658 0.266 . . . . 45.109999999999999 111.287 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 127' ' ' ASN . 67.6 m -137.82 139.48 39.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.554 0.576 . . . . 75.109999999999999 112.554 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 67.7 mtm -78.65 8.74 4.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.954 0.724 . . . . 64.120000000000005 112.954 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 142' ' ' SER . 10.4 p30 -78.6 -21.13 48.99 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.62 -0.675 . . . . 75.030000000000001 109.685 166.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.54 126.01 92.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.626 -0.716 . . . . 53.439999999999998 110.423 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 86.8 Cg_exo -43.7 -48.46 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.134 2.556 . . . . 72.310000000000002 114.298 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.555 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.6 t80 -57.4 -48.74 78.28 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.865 0.32 . . . . 75.329999999999998 111.865 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -73.97 -39.48 63.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.021 0.439 . . . . 60.109999999999999 111.405 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -55.0 -44.33 74.4 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.847 -0.615 . . . . 63.109999999999999 112.159 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.7 ptpt -91.21 -19.65 22.81 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.444 0.535 . . . . 71.120000000000005 112.444 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -83.21 -16.84 44.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.074 -0.391 . . . . 63.32 111.33 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -58.73 111.9 1.44 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.054 0.455 . . . . 74.299999999999997 111.898 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.429 HD22 ' HG2' ' A' ' 154' ' ' GLU . 7.5 t30 -85.85 -58.5 2.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.37 -0.377 . . . . 61.450000000000003 110.794 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.429 ' HG2' HD22 ' A' ' 153' ' ' ASN . 12.0 pt-20 -166.46 152.14 8.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.798 0.332 . . . . 74.0 111.211 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -105.57 145.16 31.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.521 -0.309 . . . . 51.240000000000002 110.637 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 63.5 mtt180 -134.59 118.82 17.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.893 0.377 . . . . 71.200000000000003 111.42 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.551 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -80.8 125.69 30.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.094 0.473 . . . . 75.430000000000007 111.473 -178.271 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.21 -10.49 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.364 -0.38 . . . . 53.119999999999997 112.012 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.511 HD23 HD22 ' A' ' 82' ' ' LEU . 91.1 mt -84.64 108.74 17.53 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.936 0.398 . . . . 72.409999999999997 111.545 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 55.1 p -75.91 92.55 3.11 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.227 0.537 . . . . 71.530000000000001 111.099 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.566 ' HA ' ' HE ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -106.36 177.38 4.87 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.018 0.437 . . . . 73.319999999999993 112.085 -177.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.7 t -53.08 136.67 35.09 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.752 -0.658 . . . . 64.310000000000002 112.45 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.478 ' N ' HD22 ' A' ' 163' ' ' LEU . 2.9 mm? -81.71 -167.02 1.34 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.051 -0.522 . . . . 74.299999999999997 111.084 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.926 -0.559 . . . . 63.439999999999998 111.876 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 112.664 0.616 . . . . 64.329999999999998 112.664 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -69.65 169.85 11.98 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.074 -0.391 . . . . 65.340000000000003 110.797 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.1 t -92.96 92.07 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.078 0.466 . . . . 52.240000000000002 111.485 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 24.7 m-20 -82.87 112.8 20.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.548 -0.296 . . . . 73.230000000000004 110.522 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.7 t -50.07 -50.93 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.286 . . . . 72.209999999999994 111.34 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.8 tttt -55.26 -44.6 75.74 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.814 0.34 . . . . 64.310000000000002 111.578 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 35.3 t -59.74 -39.96 86.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.931 0.396 . . . . 73.319999999999993 111.011 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.56 ' HA ' ' HE ' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -67.39 -42.05 83.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.349 -0.387 . . . . 74.209999999999994 111.826 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 40' ' ' VAL . 48.7 mt -64.31 -45.13 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.006 0.431 . . . . 63.229999999999997 111.089 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 29.9 mmt -65.76 -36.31 83.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.902 0.382 . . . . 54.329999999999998 110.871 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -47.72 74.29 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.209999999999994 110.958 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.522 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 8.0 tp60 -66.04 -47.86 72.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.947 -0.57 . . . . 72.209999999999994 110.894 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.519 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 17.0 t80 -55.8 -32.66 63.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.141 -0.481 . . . . 75.329999999999998 111.382 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.41 -33.07 58.65 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.049 0.452 . . . . 65.409999999999997 111.632 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.32 -20.96 31.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.231 0.456 . . . . 73.430000000000007 112.231 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -113.75 17.84 17.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.693 0.627 . . . . 74.409999999999997 112.693 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.1 mtmt -62.68 110.41 1.71 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.144 0.497 . . . . 73.439999999999998 112.33 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 21.77 41.84 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.407 0.523 . . . . 51.310000000000002 114.407 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.95 118.67 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 117.577 0.689 . . . . 71.439999999999998 110.967 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -71.73 163.64 27.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.742 0.645 . . . . 71.430000000000007 112.742 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 50.2 t80 -77.85 126.65 31.18 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.701 . . . . 75.420000000000002 111.833 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -138.39 103.08 4.8 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.056 -0.52 . . . . 63.140000000000001 110.156 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 tp -72.04 132.28 44.03 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.96 0.409 . . . . 74.420000000000002 111.716 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 -44.2 3.22 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.203 -0.522 . . . . 73.230000000000004 113.175 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.75 60.54 2.41 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 122.509 -0.407 . . . . 73.409999999999997 112.749 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.43 ' HB2' HG13 ' A' ' 66' ' ' ILE . 99.1 p -67.26 113.62 5.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.053 0.454 . . . . 42.149999999999999 112.161 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.418 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 2.6 t -164.74 171.57 14.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.991 -0.55 . . . . 74.299999999999997 110.89 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -69.96 -14.4 62.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.658 -0.651 . . . . 64.109999999999999 111.32 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.67 2.38 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.948 0.404 . . . . 64.310000000000002 110.958 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.23 121.37 0.97 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.178 -0.769 . . . . 63.310000000000002 111.178 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.5 tt -149.54 158.6 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 74.519999999999996 112.421 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.93 174.39 6.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.039 0.447 . . . . 71.530000000000001 111.621 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.8 p -65.09 -53.29 47.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.576 0.584 . . . . 71.019999999999996 112.576 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 12.2 p -59.04 -39.62 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.978 0.362 . . . . 54.130000000000003 111.978 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.98 -37.91 92.44 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.021 -0.609 . . . . 72.409999999999997 112.821 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -63.17 -53.97 44.91 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.641 0.258 . . . . 45.350000000000001 111.367 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.53 -43.93 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 112.249 0.463 . . . . 74.219999999999999 112.249 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.8 -37.04 80.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.924 0.392 . . . . 72.540000000000006 110.912 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 84.1 mtt85 -69.53 -50.05 48.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.993 0.368 . . . . 60.25 111.993 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -52.71 -48.16 66.81 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.096 0.474 . . . . 63.32 111.582 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.576 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.8 m-85 -69.72 -36.38 75.83 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.698 . . . . 63.329999999999998 112.886 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 6.4 ptm180 -68.42 -32.06 71.84 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.949 -0.469 . . . . 71.319999999999993 111.201 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.521 ' HG3' HE22 ' A' ' 47' ' ' GLN . 27.2 mm-40 -74.47 -62.18 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.166 0.508 . . . . 72.450000000000003 111.225 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.522 ' OE1' ' HB2' ' A' ' 47' ' ' GLN . 3.0 mp0 -72.1 -44.76 62.71 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.758 0.651 . . . . 74.140000000000001 112.758 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -110.81 -3.6 15.65 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.066 0.765 . . . . 72.129999999999995 113.066 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 22.44 68.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.824 -0.703 . . . . 60.350000000000001 113.068 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.1 tp -95.47 121.52 37.24 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 75.140000000000001 111.31 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.59 110.34 22.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.952 0.406 . . . . 63.340000000000003 111.769 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.9 mt -97.29 152.71 38.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.472 -0.331 . . . . 73.200000000000003 111.221 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.5 175.67 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.433 2.089 . . . . 63.140000000000001 112.963 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 86' ' ' ARG . 34.6 mmt-85 -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.873 1.064 . . . . 73.129999999999995 113.873 -167.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 84.4 p -130.6 147.05 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.806 -0.559 . . . . 70.450000000000003 111.882 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.602 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.4 m -53.32 -40.13 64.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.271 -0.422 . . . . 73.329999999999998 111.274 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -49.65 -43.49 46.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.022 -0.535 . . . . 71.430000000000007 111.104 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.62 -40.96 32.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.769 -0.65 . . . . 73.439999999999998 111.355 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 87' ' ' SER . 91.6 mt-30 -57.58 -31.16 65.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.197 0.443 . . . . 73.040000000000006 112.197 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' A' ' 88' ' ' THR . 37.7 mt-30 -58.45 -33.58 69.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.0 0.37 . . . . 74.299999999999997 112.0 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.92 -25.24 62.67 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.932 0.345 . . . . 74.409999999999997 111.932 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 92.4 mmm -69.32 -43.82 72.95 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.552 0.575 . . . . 72.230000000000004 112.552 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -102.42 160.28 17.46 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.803 -0.713 . . . . 53.439999999999998 114.305 -172.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 75.1 mmtt -91.26 147.31 23.14 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.807 0.337 . . . . 71.140000000000001 111.524 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 41.0 m -76.01 150.72 37.34 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.343 0.868 . . . . 74.129999999999995 113.343 -172.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.5 137.95 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.677 -0.692 . . . . 72.230000000000004 111.739 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.7 t -80.13 176.21 9.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.957 -0.565 . . . . 71.129999999999995 111.789 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.443 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -54.49 -50.31 68.07 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.754 0.65 . . . . 74.319999999999993 112.754 -175.33 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -70.11 -14.91 62.87 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.23 0.456 . . . . 65.450000000000003 112.23 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -102.31 4.52 39.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.302 0.482 . . . . 71.420000000000002 112.302 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.19 138.74 49.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.961 0.41 . . . . 60.210000000000001 111.591 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -134.08 174.48 10.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.948 0.404 . . . . 62.450000000000003 110.852 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.402 HG21 ' HB2' ' A' ' 41' ' ' LYS . 27.6 m -71.7 103.72 3.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.692 0.282 . . . . 63.329999999999998 111.39 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 133.13 -12.99 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.282 -0.485 . . . . 53.130000000000003 113.467 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 157' ' ' ARG . 7.4 m-20 -71.15 147.31 48.51 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.237 0.542 . . . . 64.329999999999998 111.599 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 mt -94.28 123.11 37.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.347 -0.388 . . . . 62.340000000000003 110.769 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 m -96.35 116.06 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.251 0.548 . . . . 70.319999999999993 111.245 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.2 mt -92.41 121.85 34.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.593 -0.731 . . . . 71.010000000000005 111.4 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -114.3 166.41 11.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.598 0.713 . . . . 71.430000000000007 112.188 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 68.1 mtp180 -103.8 109.79 21.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.28 -0.873 . . . . 73.209999999999994 109.474 172.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.2 124.38 35.37 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.126 -0.359 . . . . 63.450000000000003 111.599 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.25 -73.7 0.71 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.138 -0.553 . . . . 34.530000000000001 111.906 -173.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.7 m -167.78 -51.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.532 0.733 . . . . 74.120000000000005 110.269 174.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 p -107.68 93.84 4.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.986 0.422 . . . . 74.519999999999996 111.541 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 162.18 140.48 2.89 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.973 -0.632 . . . . 45.329999999999998 113.26 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -96.08 122.63 39.13 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.118 0.485 . . . . 74.340000000000003 111.526 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -113.32 156.21 23.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.076 -0.511 . . . . 71.129999999999995 110.096 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.88 137.94 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.387 0.613 . . . . 61.310000000000002 112.254 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.77 155.91 21.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.747 -0.66 . . . . 64.140000000000001 112.205 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.4 mt -92.37 110.32 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.32 -0.518 . . . . 73.409999999999997 110.972 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.447 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 61.1 t80 -73.77 114.89 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.048 0.451 . . . . 75.019999999999996 111.9 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 pt -95.56 -32.61 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.404 -0.362 . . . . 74.540000000000006 111.801 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 148.11 159.73 8.6 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.9 -0.667 . . . . 73.510000000000005 113.654 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 53.96 46.81 24.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.988 0.515 . . . . 73.230000000000004 112.267 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 142' ' ' SER . 44.2 m-80 67.18 -1.11 1.55 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.446 0.536 . . . . 72.549999999999997 112.446 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -90.22 141.99 28.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.353 0.597 . . . . 74.200000000000003 112.127 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -155.42 146.59 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.438 -0.801 . . . . 71.319999999999993 111.271 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.43 133.86 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.936 0.398 . . . . 62.549999999999997 111.089 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 9.3 p80 -158.72 165.28 34.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.513 -0.312 . . . . 64.540000000000006 111.404 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.35 95.75 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.038 0.447 . . . . 53.310000000000002 111.407 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 32.7 t -70.19 142.37 52.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.327 -0.397 . . . . 63.140000000000001 111.719 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -53.28 -41.37 65.5 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.658 0.614 . . . . 71.319999999999993 112.658 -176.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.1 t -108.16 -44.21 4.21 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.842 0.353 . . . . 72.329999999999998 111.802 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.1 m -76.57 -19.14 58.21 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.824 0.675 . . . . 52.409999999999997 112.824 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.73 -164.61 45.1 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.065 -0.588 . . . . 70.439999999999998 113.497 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 60.4 t -65.06 96.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.308 0.575 . . . . 75.430000000000007 111.192 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.8 pt -129.19 174.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.564 . . . . 62.25 111.648 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.1 mt -107.84 104.34 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.108 -0.496 . . . . 74.519999999999996 110.575 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.5 m -96.91 -173.39 2.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.807 0.337 . . . . 61.32 111.099 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 19.7 m -148.19 135.8 20.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.995 0.369 . . . . 73.109999999999999 111.995 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 59.3 mtm -74.46 5.19 4.93 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.015 0.376 . . . . 54.100000000000001 112.015 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -85.18 -6.96 59.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.02 0.438 . . . . 62.329999999999998 110.175 170.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -78.5 137.12 59.45 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.285 171.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.83 -46.44 32.15 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.328 2.019 . . . . 64.120000000000005 113.259 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.44 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 80.3 t80 -60.88 -47.7 85.17 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.809 0.3 . . . . 64.150000000000006 111.809 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -71.75 -37.07 70.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.915 0.388 . . . . 70.030000000000001 111.333 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.46 -42.99 93.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.076 0.465 . . . . 62.140000000000001 111.582 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -88.09 1.74 53.59 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.051 0.389 . . . . 70.209999999999994 112.051 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 2.6 mpt_? -109.04 -16.87 14.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.555 0.206 . . . . 75.409999999999997 111.555 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.443 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 53.3 t80 -57.57 109.71 0.75 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.059 0.456 . . . . 61.329999999999998 111.548 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.429 HD22 ' HG2' ' A' ' 154' ' ' GLU . 6.0 t30 -85.65 -55.01 4.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.136 0.493 . . . . 74.209999999999994 110.331 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.429 ' HG2' HD22 ' A' ' 153' ' ' ASN . 14.1 pt-20 -173.24 169.65 4.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.938 -0.574 . . . . 63.43 110.42 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.62 146.68 47.23 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.229 -0.295 . . . . 72.310000000000002 111.311 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 91.3 mtt180 -142.69 135.05 27.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.932 0.396 . . . . 71.420000000000002 111.997 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.48 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -95.56 117.0 29.62 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.172 0.51 . . . . 74.219999999999999 111.255 176.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.72 0.65 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.95 -0.568 . . . . 62.039999999999999 112.041 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.532 HD23 HD22 ' A' ' 82' ' ' LEU . 79.1 mt -79.31 109.51 13.73 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.693 0.627 . . . . 63.009999999999998 112.693 -176.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 68.9 m -78.01 78.46 4.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.174 0.512 . . . . 64.420000000000002 109.621 168.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.516 ' HD2' ' O ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -63.78 161.6 14.96 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.365 1.246 . . . . 73.340000000000003 114.365 -170.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 47.6 t -109.09 12.67 25.0 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.537 -0.756 . . . . 54.539999999999999 111.688 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.516 ' O ' ' HD2' ' A' ' 161' ' ' ARG . 2.1 pt? -136.0 -167.05 1.97 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.487 -0.324 . . . . 70.400000000000006 110.739 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.861 -0.59 . . . . 71.230000000000004 111.783 -179.894 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 111.778 0.288 . . . . 71.129999999999995 111.778 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -58.18 126.59 28.13 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.444 0.535 . . . . 60.140000000000001 112.444 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.1 t -96.03 101.13 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.501 -0.318 . . . . 64.150000000000006 111.524 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -89.87 114.08 25.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.678 0.275 . . . . 74.420000000000002 110.565 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.67 -48.09 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.149 0.5 . . . . 75.439999999999998 111.463 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.504 ' HB2' HG21 ' A' ' 105' ' ' THR . 88.3 tttt -55.02 -46.93 75.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.791 -0.641 . . . . 72.209999999999994 111.593 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t -58.61 -45.18 89.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.842 0.312 . . . . 50.420000000000002 111.842 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 43' ' ' ARG . 8.6 mmm180 -62.67 -39.08 92.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.868 0.366 . . . . 74.120000000000005 111.314 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.35 -46.74 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.922 0.391 . . . . 72.219999999999999 111.35 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 94.3 mmm -62.23 -37.93 87.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.912 0.387 . . . . 73.329999999999998 111.158 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.1 -45.27 93.52 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 72.299999999999997 110.796 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.725 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 59.0 tp60 -62.01 -46.77 87.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.156 -0.474 . . . . 65.019999999999996 111.132 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 20.0 t80 -58.16 -37.95 75.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.427 -0.351 . . . . 73.109999999999999 111.208 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.95 -32.65 47.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.027 0.442 . . . . 64.519999999999996 111.596 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.63 -42.06 61.96 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.001 0.429 . . . . 53.130000000000003 111.348 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.08 4.65 52.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.767 0.654 . . . . 63.140000000000001 112.767 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 50.5 mttm -54.32 112.15 0.93 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.724 0.297 . . . . 63.409999999999997 111.328 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.07 55.15 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.09 -0.576 . . . . 61.420000000000002 114.401 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.66 137.39 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.818 0.809 . . . . 75.200000000000003 111.462 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -76.04 166.89 22.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.128 0.489 . . . . 75.319999999999993 111.724 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -91.32 140.05 30.15 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.481 0.658 . . . . 75.129999999999995 112.567 -173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 65.8 ttt180 -131.57 176.87 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.611 -0.722 . . . . 73.400000000000006 109.944 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.407 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 91.4 mt -129.43 94.94 3.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.983 0.42 . . . . 55.020000000000003 111.407 175.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.38 55.01 2.68 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.362 -0.447 . . . . 24.440000000000001 113.357 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.441 ' HA3' ' NH1' ' A' ' 57' ' ' ARG . . . -177.51 104.47 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.928 -0.653 . . . . 72.510000000000005 113.474 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.8 p -78.64 115.05 18.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.935 0.398 . . . . 61.32 111.901 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -169.97 160.85 8.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.449 -0.342 . . . . 74.019999999999996 111.335 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.34 -6.99 44.21 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 65.040000000000006 111.002 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.58 -10.71 59.37 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.519999999999996 110.919 172.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.97 141.72 3.21 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.322 -0.399 . . . . 40.329999999999998 112.561 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.5 tp -141.31 143.44 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 122.446 -0.443 . . . . 71.409999999999997 111.65 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -93.91 166.48 12.15 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.259 0.552 . . . . 73.430000000000007 112.421 177.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 29.9 t -51.74 -54.34 29.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.615 -0.72 . . . . 62.240000000000002 112.319 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.1 p -67.6 -44.98 76.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.505 -0.316 . . . . 61.409999999999997 111.249 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.78 -40.02 56.13 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.435 -0.412 . . . . 75.209999999999994 113.767 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -61.09 -57.78 11.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.591 -0.358 . . . . 70.439999999999998 111.532 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.485 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.1 p -59.59 -36.49 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.917 0.389 . . . . 55.109999999999999 111.24 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.548 ' HA ' HD12 ' A' ' 84' ' ' LEU . 20.3 mt-30 -55.67 -61.17 2.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.385 -0.37 . . . . 65.329999999999998 111.673 175.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -60.02 -35.46 75.14 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.129 0.418 . . . . 73.230000000000004 112.129 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.725 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 99.7 m -56.12 -54.87 39.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 73.120000000000005 111.84 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.8 m-85 -75.03 -31.22 61.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.238 0.829 . . . . 71.530000000000001 113.238 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -76.05 -43.93 41.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.571 0.582 . . . . 74.549999999999997 112.571 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.04 -33.42 59.61 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.596 0.591 . . . . 72.099999999999994 112.596 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -87.28 -56.41 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.417 0.525 . . . . 64.150000000000006 112.417 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.08 -15.71 18.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.691 0.626 . . . . 73.349999999999994 112.691 -173.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.96 47.74 11.03 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.817 -0.706 . . . . 64.099999999999994 112.6 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 51.1 tp -104.86 137.71 42.22 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.14 0.495 . . . . 64.420000000000002 111.791 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.31 115.84 24.1 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.28 0.562 . . . . 62.219999999999999 111.438 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 73' ' ' GLN . 93.5 mt -127.37 151.41 74.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 122.137 -0.352 . . . . 71.150000000000006 111.625 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.98 -154.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.142 2.561 . . . . 52.409999999999997 112.902 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -110.06 -25.97 9.94 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.915 0.709 . . . . 74.430000000000007 112.915 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -120.72 148.66 43.66 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.828 -0.545 . . . . 52.299999999999997 112.305 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.441 HG23 ' HB ' ' A' ' 120' ' ' VAL . 26.2 m -52.54 -46.17 66.65 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.95 -0.568 . . . . 74.209999999999994 111.904 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -52.14 -32.35 35.22 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.075 -0.511 . . . . 73.349999999999994 111.545 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.22 -37.41 28.64 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.978 -0.556 . . . . 70.400000000000006 111.033 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.449 ' NE2' ' HG3' ' A' ' 73' ' ' GLN . 85.8 mt-30 -61.61 -32.61 72.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.238 -0.437 . . . . 64.040000000000006 111.384 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 88' ' ' THR . 17.1 mt-30 -52.71 -41.63 64.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.164 0.506 . . . . 74.319999999999993 111.547 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -77.73 -11.4 59.87 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.333 0.494 . . . . 75.540000000000006 112.333 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.4 mmm -80.91 -4.66 55.68 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.431 0.53 . . . . 62.119999999999997 112.431 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.472 ' O ' ' HD2' ' A' ' 156' ' ' ARG . . . -151.8 163.25 29.99 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.86 -0.686 . . . . 31.440000000000001 113.091 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 92.1 mttt -86.21 172.27 10.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 60.439999999999998 111.793 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 77.9 p -95.59 141.43 29.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.843 -0.617 . . . . 61.219999999999999 112.624 -171.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 5.1 m -131.98 158.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.796 -0.638 . . . . 32.549999999999997 111.282 175.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.8 t -100.13 176.55 5.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.376 -0.375 . . . . 61.530000000000001 111.833 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -47.53 -48.24 27.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.097 0.475 . . . . 74.420000000000002 112.176 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.2 m -69.11 -28.53 66.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.244 -0.434 . . . . 72.549999999999997 111.88 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.515 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 13.4 m120 -87.06 -13.86 43.13 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.112 0.412 . . . . 71.439999999999998 112.112 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -51.95 128.01 22.93 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.863 0.363 . . . . 62.549999999999997 111.688 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 102' ' ' ASN . 50.7 mtp85 -129.01 173.18 10.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.224 -0.444 . . . . 70.099999999999994 111.571 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.504 HG21 ' HB2' ' A' ' 41' ' ' LYS . 36.7 m -69.49 122.28 18.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.279 -0.418 . . . . 72.400000000000006 111.631 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.27 11.34 52.4 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.241 -0.504 . . . . 75.129999999999995 113.177 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' OD1' ' HB1' ' A' ' 155' ' ' ALA . 9.5 t70 -84.44 152.84 23.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.824 0.345 . . . . 65.510000000000005 110.875 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 72' ' ' VAL . 44.0 mt -96.37 103.51 15.42 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.973 0.416 . . . . 74.340000000000003 110.66 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -95.56 122.88 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.492 0.663 . . . . 73.120000000000005 111.376 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.516 HD12 ' HG3' ' A' ' 154' ' ' GLU . 72.1 mt -96.73 120.37 36.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.463 -0.789 . . . . 63.439999999999998 111.735 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -114.15 152.24 31.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.386 0.612 . . . . 75.040000000000006 111.749 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -91.2 106.57 18.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.653 -0.703 . . . . 75.329999999999998 111.09 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -103.48 139.26 39.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.967 0.413 . . . . 74.420000000000002 111.955 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -22.73 74.17 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.034 -0.603 . . . . 63.340000000000003 112.73 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.4 t -86.8 -74.27 0.44 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.859 0.361 . . . . 61.210000000000001 111.532 177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.1 p -73.86 -35.82 64.8 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.961 0.726 . . . . 71.430000000000007 112.961 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.06 -89.16 0.83 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.153 -0.546 . . . . 45.549999999999997 111.941 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -91.26 94.18 9.42 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.5 -0.412 . . . . 74.349999999999994 110.479 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -98.17 141.11 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.18 -0.463 . . . . 75.439999999999998 110.392 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 88' ' ' THR . 14.9 p -119.48 139.8 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 63.130000000000003 111.999 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 151.79 19.79 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.981 -0.554 . . . . 23.34 112.151 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.485 HD11 ' HA ' ' A' ' 72' ' ' VAL . 48.5 mt -88.22 107.62 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.51 -0.406 . . . . 62.340000000000003 110.827 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.22 105.71 1.16 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.77 0.319 . . . . 64.239999999999995 110.914 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.7 pt -91.47 -26.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.476 0.547 . . . . 55.530000000000001 112.476 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 160.94 122.17 0.62 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.154 -1.022 . . . . 65.510000000000005 114.193 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 45.99 81.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.88 0.872 . . . . 70.239999999999995 112.9 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 68.21 -19.17 0.15 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.728 1.01 . . . . 35.229999999999997 113.728 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.57 141.45 29.01 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.163 0.506 . . . . 74.519999999999996 111.851 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.04 150.8 27.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.983 -0.553 . . . . 54.109999999999999 111.222 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.67 138.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.869 0.366 . . . . 71.219999999999999 111.159 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -157.25 173.58 16.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.226 0.536 . . . . 72.420000000000002 111.734 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -103.65 122.92 46.02 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.078 -0.51 . . . . 75.109999999999999 110.978 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -114.53 159.62 20.18 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.008 0.432 . . . . 65.530000000000001 111.644 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -53.17 -65.82 0.49 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.767 1.025 . . . . 44.100000000000001 113.767 -171.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.8 t -87.06 -36.47 18.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.987 0.422 . . . . 72.120000000000005 112.028 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 m -77.88 -8.97 58.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.745 0.646 . . . . 70.310000000000002 112.745 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.78 -93.93 0.96 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.856 -0.687 . . . . 73.319999999999993 112.855 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 17.7 t -133.73 113.41 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.468 -0.43 . . . . 74.140000000000001 111.024 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.6 pt -138.24 173.58 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.84 0.681 . . . . 75.230000000000004 112.84 -173.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.5 127.13 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.639 -0.709 . . . . 72.200000000000003 110.388 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 m -119.06 178.18 4.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.981 0.419 . . . . 34.350000000000001 111.202 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.4 m -144.45 139.23 28.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.841 0.353 . . . . 71.319999999999993 111.627 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 75.5 mtm -69.13 3.68 2.0 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.72 0.295 . . . . 71.120000000000005 111.768 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -72.24 -28.8 63.38 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.323 0.582 . . . . 62.32 109.861 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.412 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 37.1 mt-10 -71.61 127.79 90.58 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.737 -0.665 . . . . 74.409999999999997 110.474 176.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 6.2 Cg_endo -47.88 -41.35 32.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.117 2.545 . . . . 52.530000000000001 113.833 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 90.9 t80 -53.6 -53.75 47.35 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.969 0.414 . . . . 73.230000000000004 111.546 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.412 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 88.5 m95 -75.95 -35.35 59.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 65.099999999999994 111.073 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -56.09 -32.63 64.32 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.028 -0.533 . . . . 63.020000000000003 112.129 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 0.4 OUTLIER -97.41 -9.07 28.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.46 0.541 . . . . 74.140000000000001 112.46 -178.266 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 30.6 mmt180 -103.79 -3.02 25.47 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.998 0.74 . . . . 74.439999999999998 112.998 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.43 107.32 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.96 0.409 . . . . 72.25 111.186 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.37 -66.56 0.89 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.25 0.548 . . . . 54.200000000000003 110.346 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.516 ' HG3' HD12 ' A' ' 110' ' ' LEU . 14.2 pt-20 -160.86 -175.65 5.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 64.510000000000005 110.383 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -140.22 157.21 45.95 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.616 0.246 . . . . 63.439999999999998 111.507 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 15.3 mmt180 -139.55 109.54 6.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.933 0.346 . . . . 74.030000000000001 111.933 -174.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -88.94 104.24 16.77 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.785 0.802 . . . . 74.329999999999998 111.1 177.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 113.101 0.778 . . . . 64.430000000000007 113.101 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.93 128.43 36.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.351 0.5 . . . . 74.420000000000002 112.351 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.5 p -79.0 128.93 33.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.275 -0.421 . . . . 75.230000000000004 111.084 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -76.15 145.39 39.97 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.64 0.607 . . . . 70.310000000000002 112.64 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.9 m -130.13 -168.21 1.93 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.849 -0.614 . . . . 53.530000000000001 109.761 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.3 tp -61.7 110.28 1.46 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.169 -0.332 . . . . 70.129999999999995 110.243 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.712 -0.661 . . . . 75.010000000000005 111.853 -176.579 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.99 0.424 . . . . 74.049999999999997 111.886 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -78.23 128.85 34.34 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.238 -0.289 . . . . 65.129999999999995 110.45 173.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.07 106.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.083 0.468 . . . . 70.310000000000002 111.51 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.11 90.98 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.276 -0.42 . . . . 73.230000000000004 111.399 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.7 t -51.62 -47.94 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.958 0.409 . . . . 72.310000000000002 111.187 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -56.5 -48.54 76.96 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.083 -0.508 . . . . 61.439999999999998 111.722 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -69.05 -32.85 72.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.632 -0.258 . . . . 73.019999999999996 111.674 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -66.26 -43.68 85.79 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.846 0.355 . . . . 73.340000000000003 111.238 177.244 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 40' ' ' VAL . 64.4 mt -65.02 -37.33 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.752 0.311 . . . . 74.120000000000005 110.759 176.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.5 mmt -64.44 -43.66 93.59 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.915 0.388 . . . . 64.200000000000003 111.368 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.0 -42.03 89.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.229 -0.441 . . . . 71.219999999999999 111.111 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -51.16 60.07 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.085 0.469 . . . . 64.109999999999999 110.036 175.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.5 -34.56 58.52 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.031 -0.532 . . . . 72.150000000000006 111.47 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.51 -33.08 53.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.861 0.362 . . . . 62.549999999999997 111.722 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -31.73 62.95 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.1 0.407 . . . . 73.329999999999998 112.1 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -106.07 12.88 29.85 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.644 0.609 . . . . 71.510000000000005 112.644 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -58.91 95.85 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.121 0.415 . . . . 41.119999999999997 112.121 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.47 27.3 10.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.088 -0.577 . . . . 74.129999999999995 113.898 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.5 t -77.67 127.09 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 122.25 -0.559 . . . . 74.230000000000004 110.796 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HD2' HH11 ' A' ' 55' ' ' ARG . 7.0 ptp180 -62.77 160.81 13.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.341 0.591 . . . . 74.540000000000006 112.281 -177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 39.8 t80 -84.83 123.26 30.26 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.141 -0.481 . . . . 75.319999999999993 111.97 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -136.97 130.38 31.43 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.423 -0.353 . . . . 72.120000000000005 110.531 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 58' ' ' LEU . 4.5 mp -80.96 112.74 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.615 0.245 . . . . 71.430000000000007 111.434 -175.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.53 3.47 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.035 -0.602 . . . . 61.109999999999999 114.151 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.21 72.57 0.58 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.957 -0.64 . . . . 74.430000000000007 112.778 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 t -69.72 100.81 1.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.301 0.482 . . . . 71.5 112.301 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 t -152.69 166.5 31.97 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.926 -0.579 . . . . 73.109999999999999 111.305 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.46 -6.49 36.26 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.441 . . . . 61.520000000000003 112.192 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.23 12.54 33.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.18 0.514 . . . . 52.130000000000003 111.006 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 55' ' ' ARG . . . 157.42 126.9 0.93 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.937 -0.574 . . . . 64.129999999999995 112.253 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 18.5 tt -158.59 154.54 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 117.545 0.672 . . . . 70.400000000000006 111.854 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.0 178.19 4.63 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.243 0.544 . . . . 75.140000000000001 112.299 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 12.3 t -58.17 -52.78 64.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.799 -0.637 . . . . 64.230000000000004 112.677 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 t -69.31 -43.32 74.0 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.214 0.53 . . . . 54.340000000000003 110.676 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.43 75.05 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.835 -0.621 . . . . 33.409999999999997 113.157 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -68.5 -48.88 63.28 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 122.395 -0.473 . . . . 74.510000000000005 112.147 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' A' ' 122' ' ' ILE . 12.1 p -61.88 -43.77 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 111.808 0.299 . . . . 70.120000000000005 111.808 -177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 20.6 pt20 -63.93 -37.72 88.44 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.165 -0.335 . . . . 75.530000000000001 111.484 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 36.0 mmt180 -59.8 -65.92 0.6 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.747 0.308 . . . . 73.349999999999994 111.315 173.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.9 m -44.52 -46.14 9.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.919 0.711 . . . . 75.120000000000005 112.919 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 39.5 m-85 -68.06 -43.22 79.14 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.729 0.64 . . . . 65.030000000000001 112.729 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 8.6 ptp180 -71.91 -30.25 65.17 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.594 -0.691 . . . . 73.230000000000004 111.559 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 mm-40 -68.33 -50.67 51.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 73.430000000000007 111.377 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -87.94 -61.55 1.69 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.451 0.537 . . . . 72.230000000000004 112.451 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.438 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 67.0 m-85 -92.67 -3.19 55.31 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.547 0.573 . . . . 53.530000000000001 112.547 -171.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.49 23.56 72.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.982 -0.627 . . . . 33.420000000000002 112.817 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 38.0 tp -95.12 115.82 27.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.895 0.378 . . . . 74.120000000000005 110.899 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.83 103.87 16.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.211 0.529 . . . . 73.299999999999997 112.179 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.93 146.93 37.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.898 -0.592 . . . . 72.420000000000002 110.521 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.2 172.39 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.546 2.164 . . . . 72.409999999999997 113.641 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -67.8 -48.58 65.88 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.159 0.8 . . . . 73.420000000000002 113.159 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -108.48 144.16 36.48 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.865 -0.522 . . . . 74.400000000000006 112.013 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 32.8 p -46.04 -43.61 14.59 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.827 0.677 . . . . 65.109999999999999 112.827 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.487 ' HA ' HE21 ' A' ' 92' ' ' GLN . 59.2 m-85 -54.08 -35.66 62.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.109 0.48 . . . . 71.239999999999995 111.342 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.76 -38.96 62.08 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.671 -0.695 . . . . 74.209999999999994 110.733 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -63.12 -31.22 72.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.668 -0.696 . . . . 64.319999999999993 111.55 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 89' ' ' TYR . 32.5 mt-30 -59.84 -34.87 73.66 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.143 0.497 . . . . 74.099999999999994 110.83 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 8.56 8.88 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.127 -0.488 . . . . 74.519999999999996 112.044 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.6 mmm -97.9 -68.17 0.81 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.928 0.394 . . . . 74.109999999999999 111.635 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.47 164.52 34.76 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.078 -0.582 . . . . 35.100000000000001 113.485 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HB2' ' NH1' ' A' ' 157' ' ' ARG . 14.3 mmmm -91.12 150.99 21.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 111.551 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 78.2 p -76.47 115.67 16.44 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.878 0.696 . . . . 52.049999999999997 112.878 -174.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 10.2 m -104.12 152.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.879 -0.601 . . . . 71.150000000000006 111.152 173.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.0 t -97.65 -176.98 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.185 -0.322 . . . . 54.5 110.826 175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 100' ' ' ARG . 1.4 mpp_? -59.82 -35.47 74.78 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.336 0.495 . . . . 73.140000000000001 112.336 -175.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.2 m -75.69 -12.5 60.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.946 0.35 . . . . 62.100000000000001 111.946 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.621 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.2 m120 -103.86 -5.06 22.73 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.204 0.446 . . . . 71.540000000000006 112.204 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.09 125.93 24.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.344 0.498 . . . . 75.340000000000003 112.344 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -141.79 134.69 28.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.639 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.0 m -38.67 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.964 0.727 . . . . 43.450000000000003 112.964 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.515 ' HA3' HD12 ' A' ' 159' ' ' LEU . . . 135.51 -0.01 3.38 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.034 -0.603 . . . . 72.420000000000002 114.054 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 4.1 p30 -90.04 158.98 17.08 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 117.706 0.753 . . . . 72.120000000000005 111.436 176.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.7 mt -104.76 120.79 42.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 73.319999999999993 111.165 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 m -94.75 112.98 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.583 0.706 . . . . 50.43 111.443 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.21 119.51 31.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.641 -0.709 . . . . 65.219999999999999 111.681 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HZ ' ' SD ' ' A' ' 143' ' ' MET . 92.2 m-85 -109.4 153.5 23.89 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.415 0.626 . . . . 75.329999999999998 111.922 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -88.39 113.85 24.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.707 -0.679 . . . . 53.32 109.352 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.36 168.74 11.65 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 122.095 -0.378 . . . . 42.310000000000002 111.868 -171.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.87 -38.83 46.78 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.351 -0.452 . . . . 75.319999999999993 113.472 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -101.22 165.32 11.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.702 0.287 . . . . 75.400000000000006 110.844 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 p -62.2 103.17 0.36 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.901 0.381 . . . . 75.5 111.953 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.481 ' HA2' ' OH ' ' A' ' 89' ' ' TYR . . . 167.04 163.7 21.35 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.258 -0.496 . . . . 74.010000000000005 113.668 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -98.65 119.85 38.07 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.758 -0.26 . . . . 73.540000000000006 111.631 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -99.6 124.27 44.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.88 -0.415 . . . . 73.420000000000002 109.88 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.412 HG12 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -110.18 145.04 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.659 0.614 . . . . 74.409999999999997 112.659 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.87 148.73 19.16 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.948 -0.569 . . . . 72.099999999999994 112.147 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 72' ' ' VAL . 42.4 mt -89.86 106.6 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.168 0.484 . . . . 74.510000000000005 111.183 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 61.3 t80 -71.29 111.34 6.55 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.233 0.54 . . . . 75.109999999999999 111.622 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.7 pt -95.57 -16.81 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.251 -0.431 . . . . 54.32 111.874 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.21 164.62 11.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.111 -0.566 . . . . 64.340000000000003 112.998 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 58.08 32.6 22.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.818 0.342 . . . . 73.329999999999998 111.863 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 142' ' ' SER . 41.2 m-80 65.55 11.29 7.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.367 0.506 . . . . 64.120000000000005 112.367 -177.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -100.34 143.63 30.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.104 0.478 . . . . 73.230000000000004 111.232 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.72 151.96 31.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.901 -0.59 . . . . 71.239999999999995 111.553 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -103.21 141.99 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.244 -0.434 . . . . 72.109999999999999 110.949 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.39 -170.73 3.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.844 0.354 . . . . 73.019999999999996 111.072 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -132.98 108.26 8.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.53 -0.304 . . . . 72.239999999999995 111.017 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.6 p -91.42 155.26 18.59 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.071 0.462 . . . . 61.009999999999998 111.32 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.4 p -66.66 -2.38 4.84 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.632 0.605 . . . . 52.420000000000002 112.632 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.9 t -97.46 -67.47 0.85 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.053 0.39 . . . . 61.439999999999998 112.053 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.4 m -104.72 -6.41 20.39 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.688 0.625 . . . . 54.109999999999999 112.688 -175.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 132' ' ' ALA . . . 84.28 -133.45 11.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.521 -0.847 . . . . 72.099999999999994 112.614 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.06 108.72 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.216 0.45 . . . . 71.129999999999995 112.216 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.8 pt -143.43 179.19 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.228 0.537 . . . . 75.430000000000007 112.155 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.0 mm -106.81 149.9 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 116.176 -0.465 . . . . 73.530000000000001 110.917 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.1 m -148.97 172.19 15.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.77 0.319 . . . . 72.310000000000002 111.421 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.463 ' HB2' ' HG3' ' A' ' 145' ' ' GLU . 50.6 m -129.31 142.91 50.7 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.289 0.566 . . . . 54.140000000000001 112.376 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.438 ' SD ' ' HZ ' ' A' ' 111' ' ' PHE . 86.3 mmm -59.84 -27.11 66.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.717 -0.674 . . . . 54.329999999999998 112.539 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -85.96 3.65 41.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.593 0.59 . . . . 63.140000000000001 112.593 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 142' ' ' SER . 58.7 mt-10 -81.36 125.97 77.65 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 122.236 -0.29 . . . . 70.549999999999997 110.309 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -38.15 -50.11 2.18 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.946 3.098 . . . . 51.210000000000001 115.232 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.38 -43.04 97.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.009 0.374 . . . . 63.229999999999997 112.009 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.406 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 83.5 m95 -81.35 -42.39 20.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.187 0.518 . . . . 75.340000000000003 111.07 -176.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -54.17 -55.55 26.74 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.609 -0.723 . . . . 74.010000000000005 112.751 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -80.33 -11.69 59.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.059 0.392 . . . . 75.019999999999996 112.059 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -99.83 -2.21 35.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.176 0.436 . . . . 74.230000000000004 112.176 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -58.29 126.49 27.77 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.148 0.499 . . . . 65.340000000000003 111.73 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.406 HD22 ' HG2' ' A' ' 154' ' ' GLU . 5.7 t30 -101.8 -59.5 1.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.482 -0.326 . . . . 65.340000000000003 110.991 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG2' HD22 ' A' ' 153' ' ' ASN . 12.8 pt-20 -169.22 145.62 3.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.487 -0.324 . . . . 61.25 111.456 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -100.43 146.68 26.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.675 -0.239 . . . . 71.219999999999999 110.404 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.481 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 45.5 mtp85 -142.62 115.71 8.86 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.25 -0.281 . . . . 75.120000000000005 110.969 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -81.43 122.23 27.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.213 0.53 . . . . 73.040000000000006 111.976 -176.061 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.96 -20.14 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.561 0.578 . . . . 54.140000000000001 112.561 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.515 HD12 ' HA3' ' A' ' 106' ' ' GLY . 43.8 mt -68.17 104.97 1.94 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.213 0.53 . . . . 71.329999999999998 111.917 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 82.4 p -68.83 -19.46 64.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.803 -0.635 . . . . 54.329999999999998 111.6 176.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -69.81 126.84 30.91 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.437 0.532 . . . . 74.439999999999998 112.437 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 79.2 p -128.62 170.74 12.89 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.871 -0.604 . . . . 53.020000000000003 110.339 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -68.92 178.27 2.27 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.977 0.418 . . . . 74.230000000000004 111.493 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--O 1.254 1.33 0 CA-C-O 118.233 -0.889 . . . . 73.319999999999993 112.59 -177.81 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 55.2 ttm . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.593 0.235 . . . . 71.430000000000007 111.119 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -142.93 160.93 39.41 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.916 0.388 . . . . 63.210000000000001 111.468 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -104.03 105.92 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.141 0.496 . . . . 70.439999999999998 111.86 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -83.04 107.04 15.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.202 -0.454 . . . . 71.439999999999998 110.511 175.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.33 -45.54 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.0 0.429 . . . . 74.0 111.203 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 76.0 tttt -53.38 -50.79 64.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.065 -0.516 . . . . 63.009999999999998 111.46 175.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.5 t -59.36 -44.0 92.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.356 -0.384 . . . . 64.200000000000003 111.59 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -57.17 -53.93 52.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.029 0.442 . . . . 74.239999999999995 110.871 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.02 -39.28 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.98 0.419 . . . . 70.200000000000003 111.791 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 31.1 mmt -66.24 -28.23 68.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.876 0.324 . . . . 74.040000000000006 111.876 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -63.62 -46.63 84.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.18 0.514 . . . . 72.230000000000004 110.044 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.6 tp60 -63.89 -44.97 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.718 -0.673 . . . . 63.43 110.385 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.17 -42.09 76.52 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.999 -0.546 . . . . 64.400000000000006 111.333 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.98 -33.22 66.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.034 0.445 . . . . 74.230000000000004 111.617 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -81.96 -26.09 34.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.21 0.529 . . . . 71.319999999999993 111.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -108.25 20.66 18.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.814 0.672 . . . . 63.119999999999997 112.814 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -59.42 101.56 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.901 0.704 . . . . 71.25 112.901 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.43 38.86 16.36 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.69 -0.687 . . . . 74.219999999999999 114.66 174.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.15 144.19 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 117.547 0.674 . . . . 74.239999999999995 111.081 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -56.54 142.77 38.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.545 0.338 . . . . 73.549999999999997 111.752 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 20.1 t80 -83.64 116.64 22.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.922 -0.399 . . . . 61.119999999999997 109.922 172.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -122.34 105.86 10.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.388 . . . . 61.119999999999997 110.49 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.86 116.86 12.74 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.934 0.397 . . . . 51.130000000000003 110.481 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 26.29 35.9 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.967 -0.635 . . . . 72.150000000000006 113.052 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.02 106.71 0.29 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.334 -0.46 . . . . 64.099999999999994 112.409 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.516 ' HA ' HG13 ' A' ' 66' ' ' ILE . 64.6 p -97.32 112.41 24.24 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.486 0.55 . . . . 64.530000000000001 112.486 -175.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.4 t -171.76 172.91 4.73 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.913 0.387 . . . . 74.519999999999996 111.651 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.64 -14.97 61.71 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 122.04 -0.412 . . . . 75.340000000000003 111.502 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -83.03 4.54 25.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.074 0.464 . . . . 74.439999999999998 110.602 172.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.64 132.47 2.61 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.603 -0.599 . . . . 75.120000000000005 111.603 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.516 HG13 ' HA ' ' A' ' 61' ' ' SER . 21.0 tt -151.22 153.09 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 117.391 0.595 . . . . 63.299999999999997 111.912 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -91.9 177.24 6.24 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.326 0.584 . . . . 72.200000000000003 111.985 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 32.4 t -62.09 -48.31 80.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.545 0.572 . . . . 71.430000000000007 112.545 -176.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 88' ' ' THR . 17.7 p -78.11 -27.58 48.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.918 0.389 . . . . 53.420000000000002 111.742 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.12 98.98 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.116 -0.564 . . . . 74.0 112.634 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -59.92 -50.66 72.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.928 0.344 . . . . 74.420000000000002 111.928 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.541 ' HA ' HD11 ' A' ' 122' ' ' ILE . 6.1 p -59.74 -52.82 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.294 0.479 . . . . 71.140000000000001 112.294 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.511 ' HG2' ' HA ' ' A' ' 86' ' ' ARG . 4.4 pp0? -65.99 -26.71 67.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.15 0.426 . . . . 65.519999999999996 112.15 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.545 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.3 mtp180 -69.31 -53.92 17.23 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.137 -0.352 . . . . 71.219999999999999 111.068 171.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -46.4 -49.61 17.75 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.257 0.551 . . . . 74.200000000000003 111.792 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 67.2 m-85 -68.44 -39.2 81.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.746 0.647 . . . . 65.239999999999995 112.746 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.545 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 11.8 ptp180 -76.75 -25.62 53.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.641 -0.662 . . . . 61.219999999999999 112.159 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.25 -28.27 34.84 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.979 0.362 . . . . 74.140000000000001 111.979 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 85.6 mt-30 -109.05 -61.44 1.62 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.587 0.588 . . . . 74.120000000000005 112.587 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -83.81 -11.67 56.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.928 0.344 . . . . 72.019999999999996 111.928 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.9 71.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.346 -0.454 . . . . 44.420000000000002 113.173 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.4 tp -73.37 123.3 23.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 74.530000000000001 111.53 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -74.29 85.17 1.93 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.401 0.62 . . . . 73.120000000000005 112.434 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.7 mt -106.28 135.2 19.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 122.126 -0.359 . . . . 64.409999999999997 111.215 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.619 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 58.7 Cg_endo -71.27 156.87 58.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.774 2.316 . . . . 75.200000000000003 113.111 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -57.0 -43.35 81.65 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.811 1.041 . . . . 75.209999999999994 113.811 -174.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.419 ' N ' ' HG2' ' A' ' 86' ' ' ARG . 73.9 m -102.61 152.4 21.23 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.841 1.052 . . . . 64.230000000000004 113.841 -170.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 69' ' ' SER . 51.4 p -51.45 -58.91 4.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.971 -1.013 . . . . 52.210000000000001 112.969 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -47.24 -35.56 7.85 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.004 -0.543 . . . . 64.340000000000003 112.287 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.66 -42.59 28.23 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.052 -0.522 . . . . 74.040000000000006 111.162 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.16 -22.15 65.65 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.938 0.399 . . . . 72.0 111.461 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.461 ' HG2' HD11 ' A' ' 110' ' ' LEU . 76.6 mt-30 -66.44 -34.46 77.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 112.171 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -84.22 -10.84 57.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.457 0.539 . . . . 52.340000000000003 112.457 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.619 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 62.4 mtp -94.78 -70.18 0.72 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.589 0.233 . . . . 75.319999999999993 111.525 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.4 130.31 28.99 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.388 -0.91 . . . . 73.430000000000007 112.277 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -85.27 143.57 28.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.406 0.622 . . . . 62.109999999999999 112.363 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 18.4 m -64.84 144.29 57.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.883 -1.053 . . . . 45.420000000000002 113.354 -170.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.428 HG22 ' HD3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -132.44 163.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.838 -0.619 . . . . 73.299999999999997 111.516 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.7 t -116.57 171.68 7.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.402 -0.363 . . . . 72.140000000000001 111.132 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -43.98 -57.64 3.23 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.217 1.191 . . . . 71.340000000000003 114.217 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -69.39 -9.25 52.67 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.981 0.734 . . . . 63.329999999999998 112.981 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -114.97 5.06 14.92 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.502 0.556 . . . . 62.399999999999999 112.502 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.35 133.04 55.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.77 0.319 . . . . 64.129999999999995 111.757 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 104' ' ' ARG . 54.2 mtt180 -108.28 169.44 8.63 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.436 0.636 . . . . 63.130000000000003 112.247 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.7 m -79.85 118.43 21.62 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.192 -0.458 . . . . 75.540000000000006 110.524 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 18.93 33.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.046 -0.597 . . . . 72.25 112.004 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -77.51 159.71 29.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.922 0.489 . . . . 73.530000000000001 110.291 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.0 mt -114.06 109.27 18.18 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.64 -0.663 . . . . 60.329999999999998 111.826 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.59 126.19 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.408 0.623 . . . . 64.510000000000005 111.913 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.461 HD11 ' HG2' ' A' ' 92' ' ' GLN . 83.0 mt -97.97 138.96 34.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.744 -0.662 . . . . 41.439999999999998 111.649 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -124.48 137.99 54.38 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.216 0.532 . . . . 73.230000000000004 111.929 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 33.6 mtp85 -72.56 84.01 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.976 -0.556 . . . . 74.129999999999995 110.533 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.36 139.95 30.11 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.381 0.512 . . . . 45.109999999999999 112.381 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.56 -41.81 83.07 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.781 -0.723 . . . . 53.140000000000001 111.55 173.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 m -78.22 128.35 33.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.377 0.271 . . . . 71.230000000000004 110.857 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 74.3 p 57.81 9.13 0.81 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.647 0.98 . . . . 63.450000000000003 113.647 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.31 -87.01 0.8 Allowed Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.418 0.527 . . . . 41.210000000000001 114.418 174.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -93.59 122.1 35.69 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.291 -0.534 . . . . 74.030000000000001 111.864 -176.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -115.64 149.22 38.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.413 -0.358 . . . . 72.439999999999998 110.178 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.61 135.34 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.154 0.502 . . . . 71.420000000000002 112.147 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -123.3 148.57 16.79 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.21 -0.519 . . . . 72.129999999999995 113.226 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.541 HD11 ' HA ' ' A' ' 72' ' ' VAL . 40.2 mt -82.47 107.51 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.796 0.332 . . . . 72.230000000000004 110.797 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 2.0 t80 -70.7 104.35 2.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.119 -0.491 . . . . 73.239999999999995 111.616 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.428 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 38.2 pt -102.18 -17.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.743 0.645 . . . . 71.319999999999993 112.743 -176.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.69 -170.31 16.35 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.524 -0.846 . . . . 44.450000000000003 113.9 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -58.31 -32.77 68.78 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.68 0.392 . . . . 73.019999999999996 111.884 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -137.52 -26.46 0.98 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.226 -0.443 . . . . 74.239999999999995 112.153 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -85.26 140.87 30.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.03 0.752 . . . . 74.310000000000002 113.03 -175.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.401 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 22.1 p90 -148.38 142.95 26.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.461 -0.79 . . . . 72.120000000000005 110.982 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.82 137.2 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.975 0.416 . . . . 75.200000000000003 111.558 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -155.92 163.55 39.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.989 0.424 . . . . 64.109999999999999 111.74 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -94.54 97.85 10.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.019 0.438 . . . . 61.420000000000002 110.832 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 80.9 p -81.7 142.06 33.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.175 0.512 . . . . 72.340000000000003 111.714 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.0 t -69.24 -7.04 33.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.233 -0.44 . . . . 72.439999999999998 112.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.3 p -101.52 -59.74 1.65 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.842 0.353 . . . . 40.329999999999998 111.834 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.481 ' HB2' HD13 ' A' ' 139' ' ' ILE . 68.6 m -109.5 13.79 23.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.399 0.518 . . . . 53.240000000000002 112.399 -175.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.65 -152.5 52.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.0 -0.619 . . . . 60.329999999999998 112.883 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 53.6 t -64.74 106.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.458 -0.436 . . . . 64.019999999999996 111.764 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 136' ' ' SER . 35.9 pt -136.82 -175.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.101 0.477 . . . . 55.049999999999997 111.703 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.28 129.11 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.428 -0.351 . . . . 72.540000000000006 110.965 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.7 m -118.53 174.44 6.25 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.876 0.37 . . . . 71.200000000000003 111.809 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.8 t -124.53 142.34 51.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.297 0.48 . . . . 75.420000000000002 112.297 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 85.0 mmm -63.39 -17.16 62.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.156 -0.474 . . . . 53.509999999999998 111.284 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -74.0 -18.04 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.324 -0.398 . . . . 71.439999999999998 111.617 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.09 130.22 93.82 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.786 -0.188 . . . . 73.439999999999998 111.118 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.483 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 85.2 Cg_exo -47.93 -51.97 8.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.907 2.404 . . . . 65.030000000000001 114.059 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 94.4 t80 -58.42 -47.07 85.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.784 0.326 . . . . 64.209999999999994 111.718 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -72.3 -40.14 67.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.784 0.326 . . . . 63.240000000000002 111.591 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.13 -52.64 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.003 0.43 . . . . 72.420000000000002 111.925 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.0 ptpt -78.12 -14.84 59.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.889 0.376 . . . . 72.209999999999994 111.988 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.567 ' HA ' ' HE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -91.83 -12.07 34.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.19 -0.318 . . . . 71.349999999999994 111.789 175.661 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.47 105.57 0.16 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.319 0.581 . . . . 74.430000000000007 111.176 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -90.46 -51.56 5.35 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.993 -0.548 . . . . 74.109999999999999 111.54 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -172.76 147.39 1.74 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.865 0.364 . . . . 75.329999999999998 111.204 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -103.01 161.62 13.61 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.356 -0.215 . . . . 52.329999999999998 110.659 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.8 mtm-85 -146.84 113.01 5.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.829 0.347 . . . . 73.409999999999997 111.806 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.428 ' HD3' HG22 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.76 96.89 4.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.289 0.566 . . . . 55.310000000000002 111.361 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.4 m -77.21 -29.79 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.953 -0.467 . . . . 65.439999999999998 111.62 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.26 142.77 35.91 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.613 -0.267 . . . . 72.439999999999998 110.427 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.1 t 66.41 23.25 10.63 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.174 0.511 . . . . 71.200000000000003 111.582 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -67.56 119.72 12.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.099 -0.5 . . . . 74.099999999999994 111.109 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.1 p -66.62 150.2 49.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.889 0.376 . . . . 72.430000000000007 111.36 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 163' ' ' LEU . 7.2 mp -69.87 170.16 11.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.432 0.634 . . . . 63.350000000000001 112.365 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.648 -0.691 . . . . 75.329999999999998 111.627 -178.764 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 112.163 0.431 . . . . 73.219999999999999 112.163 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -154.04 149.99 27.76 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.957 0.408 . . . . 74.109999999999999 111.723 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.91 124.68 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.391 -0.368 . . . . 74.140000000000001 111.259 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -97.06 132.68 42.61 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.869 0.366 . . . . 73.230000000000004 111.215 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 44' ' ' ILE . 88.9 t -61.84 -49.58 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.211 -0.45 . . . . 75.019999999999996 111.815 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.535 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 87.2 tttt -57.3 -44.88 84.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.34 -0.391 . . . . 75.030000000000001 111.496 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -60.1 -45.18 93.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.264 -0.425 . . . . 74.299999999999997 111.536 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mmm-85 -61.19 -43.57 98.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.073 0.463 . . . . 75.319999999999993 111.111 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 40' ' ' VAL . 73.1 mt -63.09 -47.79 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.021 0.439 . . . . 72.510000000000005 111.372 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 29.7 mmt -62.86 -29.4 70.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.394 -0.366 . . . . 75.230000000000004 111.522 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.43 -38.84 81.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.651 0.262 . . . . 72.319999999999993 111.166 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.4 ' HB2' HE21 ' A' ' 79' ' ' GLN . 63.6 tp60 -77.54 -31.82 53.54 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.575 0.226 . . . . 60.219999999999999 111.506 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -53.45 -37.53 62.71 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.82 0.343 . . . . 74.340000000000003 111.286 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -24.31 64.47 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.127 0.417 . . . . 61.020000000000003 112.127 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -47.12 24.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.085 0.469 . . . . 72.409999999999997 111.513 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -85.55 16.01 4.17 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.073 0.768 . . . . 75.329999999999998 113.073 -172.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' NZ ' ' HB3' ' A' ' 52' ' ' LYS . 2.8 mmmp? -68.87 118.33 11.68 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.141 -0.349 . . . . 75.340000000000003 110.952 176.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.64 46.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.302 -0.475 . . . . 62.43 113.494 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.83 128.94 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.062 0.458 . . . . 74.239999999999995 111.729 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -88.19 179.31 6.4 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.912 -0.586 . . . . 75.140000000000001 111.599 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -91.66 133.02 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.091 0.472 . . . . 75.209999999999994 111.208 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -134.23 113.54 12.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.11 -0.496 . . . . 71.439999999999998 110.192 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.1 mp -57.93 115.2 2.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.924 0.393 . . . . 74.230000000000004 111.717 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.39 19.67 74.61 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.122 -0.49 . . . . 54.100000000000001 113.665 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.94 143.98 17.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.458 -0.401 . . . . 65.329999999999998 112.886 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 66' ' ' ILE . 62.0 p -126.76 99.53 5.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.451 -0.441 . . . . 61.329999999999998 111.21 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 t -174.99 165.62 3.49 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.807 0.337 . . . . 71.510000000000005 111.635 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -74.38 -9.85 59.0 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.107 0.479 . . . . 75.400000000000006 110.909 176.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.11 -1.51 56.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.112 -0.494 . . . . 70.329999999999998 111.281 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.34 124.11 1.57 Allowed Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.248 -0.433 . . . . 74.239999999999995 112.053 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.5 tt -134.03 149.62 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.21 -0.583 . . . . 53.200000000000003 111.922 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.65 160.75 26.22 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.958 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.541 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 29.4 p -58.86 -53.6 56.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.152 0.501 . . . . 75.310000000000002 110.895 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.428 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 87.6 p -63.8 -33.78 76.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.235 0.541 . . . . 63.409999999999997 110.822 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 73' ' ' GLN . . . -67.76 -31.6 76.22 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.817 -0.629 . . . . 74.0 112.954 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -66.13 -47.25 74.7 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.501 -0.411 . . . . 75.109999999999999 111.342 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 HG12 ' A' ' 122' ' ' ILE . 11.2 p -67.9 -40.02 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 111.977 0.362 . . . . 74.239999999999995 111.977 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 1.9 pt20 -58.69 -41.91 87.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.062 0.458 . . . . 75.230000000000004 110.427 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.66 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 11.5 mmm180 -66.64 -67.0 0.48 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.248 -0.433 . . . . 70.129999999999995 110.929 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 m -40.75 -46.65 2.7 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.441 0.534 . . . . 72.099999999999994 112.441 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 14.0 m-30 -68.88 -39.39 79.82 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.432 0.53 . . . . 71.200000000000003 112.432 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 10.9 ptm180 -79.68 -19.29 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.701 -0.624 . . . . 71.239999999999995 111.846 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.7 mm-40 -72.28 -47.68 48.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.464 0.649 . . . . 62.049999999999997 110.162 175.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 47' ' ' GLN . 82.3 mm-40 -95.12 -53.38 3.83 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.59 -0.732 . . . . 74.209999999999994 112.791 -174.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -93.78 -23.76 18.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.278 0.474 . . . . 74.430000000000007 112.278 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.71 36.32 22.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.053 -0.594 . . . . 74.150000000000006 112.973 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 40.4 tp -95.19 119.22 33.32 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.76 0.314 . . . . 75.25 111.23 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.54 84.19 7.16 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.22 0.452 . . . . 70.0 112.22 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.67 145.63 30.74 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.5 -0.318 . . . . 73.230000000000004 111.301 176.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 150.11 62.41 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.721 2.28 . . . . 74.439999999999998 112.837 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.82 42.44 0.79 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.214 0.53 . . . . 51.539999999999999 112.205 -176.591 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.5 m -153.16 117.67 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.116 -0.365 . . . . 53.119999999999997 111.034 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 17.2 m -48.46 -44.36 35.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.506 0.558 . . . . 32.140000000000001 112.506 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -54.98 -46.42 75.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.76 0.314 . . . . 70.129999999999995 111.751 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -62.78 -42.77 99.85 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.429 0.633 . . . . 75.230000000000004 110.534 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -62.9 -30.55 71.62 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.875 -0.602 . . . . 74.409999999999997 111.755 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 88' ' ' THR . 26.1 mt-30 -63.03 -16.08 58.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.815 0.34 . . . . 72.109999999999999 111.692 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.81 -3.47 26.3 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.77 0.319 . . . . 60.310000000000002 111.438 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.3 mmm -95.18 -13.33 25.08 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.885 0.698 . . . . 72.319999999999993 112.885 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -141.58 154.97 25.05 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.858 -0.687 . . . . 72.239999999999995 113.725 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -96.11 153.35 17.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.04 0.448 . . . . 75.109999999999999 111.495 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 92.9 p -77.69 157.26 30.21 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.937 1.088 . . . . 60.350000000000001 113.937 -170.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.42 147.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 114.893 -1.049 . . . . 54.43 110.202 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -83.29 164.28 20.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 111.309 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -49.08 -29.89 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.858 0.688 . . . . 72.420000000000002 112.858 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -82.7 -23.19 34.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.887 0.699 . . . . 72.439999999999998 112.887 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -103.5 20.6 17.58 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.496 0.554 . . . . 74.400000000000006 112.496 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.0 mt -69.84 126.09 28.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.025 0.441 . . . . 63.229999999999997 111.918 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -101.72 -164.6 1.11 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.061 0.457 . . . . 64.239999999999995 111.132 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 41' ' ' LYS . 58.7 m -97.44 109.06 21.89 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.426 -0.352 . . . . 73.430000000000007 110.83 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.54 25.33 6.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.404 -0.427 . . . . 72.219999999999999 113.687 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -94.47 146.28 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.444 -0.445 . . . . 72.230000000000004 111.302 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.412 ' CD2' HG21 ' A' ' 72' ' ' VAL . 47.1 mt -78.03 108.4 11.27 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.369 -0.378 . . . . 74.340000000000003 111.788 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.6 m -96.81 112.48 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.452 0.644 . . . . 70.230000000000004 111.433 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.37 120.64 28.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.649 -0.705 . . . . 74.430000000000007 111.956 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 88.9 m-85 -112.6 157.81 20.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.31 0.576 . . . . 70.219999999999999 111.766 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.564 ' HB2' ' HG3' ' A' ' 151' ' ' ARG . 19.6 mtp180 -90.45 103.52 16.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.048 -0.524 . . . . 73.349999999999994 110.832 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . . . -93.84 121.13 34.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 63.200000000000003 111.791 -176.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.28 -71.76 0.61 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.199 -0.455 . . . . 62.450000000000003 113.396 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.7 p -163.58 -64.14 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.89 0.376 . . . . 74.209999999999994 110.875 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.2 p -95.19 -17.03 22.1 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.285 -0.416 . . . . 75.5 112.079 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.66 121.23 24.48 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 114.345 0.498 . . . . 74.030000000000001 114.345 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -91.1 97.53 11.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.965 0.412 . . . . 65.439999999999998 110.613 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 59.6 t60 -92.93 148.71 21.78 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.277 -0.42 . . . . 74.219999999999999 111.283 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.93 128.98 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.226 0.536 . . . . 74.540000000000006 111.281 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.72 154.44 16.5 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.208 -0.52 . . . . 70.129999999999995 112.93 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 72' ' ' VAL . 49.5 mt -89.65 102.66 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 122.549 -0.383 . . . . 62.509999999999998 110.584 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 37.2 t80 -73.7 105.24 4.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 75.409999999999997 111.762 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.535 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.0 pt -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.954 0.407 . . . . 61.100000000000001 111.735 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.97 178.71 19.17 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.501 -0.38 . . . . 60.450000000000003 113.032 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 62.67 21.36 12.67 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.689 0.28 . . . . 75.239999999999995 111.139 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 142' ' ' SER . 0.9 OUTLIER 65.12 12.54 8.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.93 0.395 . . . . 65.510000000000005 111.503 -171.288 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -103.81 145.24 30.39 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.376 0.608 . . . . 72.25 111.235 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 10.5 p90 -150.07 140.73 22.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.953 -0.567 . . . . 70.420000000000002 111.39 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.75 133.12 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.965 0.412 . . . . 64.400000000000006 110.718 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.43 ' HD1' ' HE2' ' A' ' 119' ' ' HIS . 7.3 p80 -157.04 154.72 30.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.199 0.523 . . . . 73.109999999999999 111.88 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -84.41 91.04 7.71 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.952 0.406 . . . . 75.409999999999997 110.155 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -67.47 146.04 54.38 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.108 0.48 . . . . 73.329999999999998 111.628 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.6 p -49.55 -47.91 48.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.606 -0.725 . . . . 71.099999999999994 112.855 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.0 m -98.9 -51.07 3.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.683 0.623 . . . . 71.400000000000006 112.683 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.6 m -80.75 -15.14 57.25 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.259 0.837 . . . . 65.310000000000002 113.259 -170.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.61 -154.93 30.18 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.01 -0.614 . . . . 64.409999999999997 113.036 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.38 102.68 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.864 0.364 . . . . 75.120000000000005 111.958 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.9 pt -140.13 178.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.093 0.473 . . . . 71.230000000000004 111.773 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.19 134.93 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.418 -0.355 . . . . 74.430000000000007 110.76 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.402 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . 49.9 m -128.47 172.56 11.02 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 122.267 -0.271 . . . . 73.340000000000003 111.538 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 65.5 m -125.43 141.42 52.07 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.056 0.391 . . . . 54.039999999999999 112.056 -177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.3 mtt -67.4 -15.06 63.47 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.372 0.508 . . . . 73.109999999999999 112.372 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.965 0.412 . . . . 71.450000000000003 111.241 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.403 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 29.8 mm-40 -71.79 135.59 83.19 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.548 -0.296 . . . . 72.120000000000005 110.734 175.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.27 -48.03 21.68 Favored 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 122.91 2.406 . . . . 54.329999999999998 113.672 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 78.9 t80 -59.39 -50.85 72.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.833 0.349 . . . . 71.299999999999997 111.562 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.403 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 75.8 m95 -71.84 -36.92 70.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.576 -0.284 . . . . 64.219999999999999 111.701 -172.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -53.32 -54.87 30.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.08 0.467 . . . . 75.019999999999996 111.777 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -80.82 -18.86 46.11 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.94 0.348 . . . . 75.239999999999995 111.94 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.564 ' HG3' ' HB2' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -84.68 -15.36 45.56 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.958 -0.464 . . . . 72.519999999999996 111.884 177.531 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -61.26 92.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.296 0.569 . . . . 73.540000000000006 110.301 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -79.08 -46.01 18.93 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.966 -0.561 . . . . 74.329999999999998 111.379 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -172.9 163.58 4.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.979 -0.555 . . . . 62.020000000000003 110.978 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -128.15 149.3 50.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.766 -0.197 . . . . 65.329999999999998 110.718 176.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 95' ' ' GLY . 50.8 mtt180 -138.61 125.92 21.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.184 0.516 . . . . 63.509999999999998 112.016 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.71 120.67 27.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.034 -0.53 . . . . 75.129999999999995 111.242 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.55 -19.53 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.732 0.641 . . . . 70.439999999999998 112.732 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 82' ' ' LEU . 91.7 mt -75.33 144.0 42.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.129 0.49 . . . . 73.200000000000003 112.079 -176.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 87.0 p -74.67 137.64 42.32 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.055 -0.521 . . . . 71.209999999999994 111.647 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.552 ' HD2' ' H ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -88.31 15.19 8.04 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.043 0.449 . . . . 43.420000000000002 111.517 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.0 m -83.18 -171.71 3.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.02 0.438 . . . . 61.310000000000002 112.031 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 pp -83.5 -166.25 1.33 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.802 0.667 . . . . 73.150000000000006 112.802 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 164' ' ' GLU . 2.5 mp0 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 123.501 0.72 . . . . 75.010000000000005 112.912 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 112.083 0.401 . . . . 63.229999999999997 112.083 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -130.93 -176.6 4.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.086 0.47 . . . . 64.340000000000003 111.462 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.3 t -102.44 129.14 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.892 0.377 . . . . 61.229999999999997 111.375 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 41' ' ' LYS . 30.9 t70 -101.36 134.57 44.23 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.463 -0.335 . . . . 72.5 110.888 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.2 -48.38 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.406 -0.361 . . . . 74.25 111.531 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.9 tttt -60.04 -44.03 94.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.342 -0.39 . . . . 74.420000000000002 111.372 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.7 t -53.19 -49.79 65.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.181 0.437 . . . . 75.340000000000003 112.181 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -63.5 -44.2 95.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.964 0.412 . . . . 73.540000000000006 111.572 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.49 HD13 HG21 ' A' ' 122' ' ' ILE . 67.5 mt -64.36 -36.88 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.957 0.408 . . . . 64.420000000000002 111.365 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 96.0 mmm -65.74 -37.29 85.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.912 0.387 . . . . 72.439999999999998 110.715 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.75 -37.17 78.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.252 0.549 . . . . 54.210000000000001 110.198 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.559 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 7.6 tp60 -62.74 -53.65 51.13 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.013 -0.54 . . . . 54.039999999999999 110.451 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -51.1 -39.44 56.15 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.053 -0.521 . . . . 74.510000000000005 111.293 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.93 71.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.366 . . . . 74.010000000000005 111.685 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.02 -26.91 61.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 75.299999999999997 111.47 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -107.01 11.78 29.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.064 0.764 . . . . 75.519999999999996 113.064 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.78 128.43 35.88 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.959 -0.463 . . . . 64.420000000000002 111.325 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.05 -18.13 58.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.254 -0.498 . . . . 75.409999999999997 113.665 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.58 131.63 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.42 . . . . 74.230000000000004 111.837 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 55' ' ' ARG . 44.5 mtp180 -82.3 178.39 8.27 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.228 0.455 . . . . 65.239999999999995 112.228 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -85.39 121.46 28.15 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.896 0.379 . . . . 64.530000000000001 111.661 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -137.57 115.46 11.5 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 74.510000000000005 110.65 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 21.7 tp -72.87 116.85 13.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.004 0.43 . . . . 72.340000000000003 112.102 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.91 -53.25 3.97 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.369 -0.443 . . . . 61.119999999999997 113.339 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.92 71.48 0.93 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.114 -0.565 . . . . 61.219999999999999 113.236 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.2 p -69.6 106.97 3.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.252 0.549 . . . . 74.0 112.132 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 t -160.94 172.46 16.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.906 -0.588 . . . . 73.019999999999996 111.026 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.5 -14.11 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.911 0.386 . . . . 74.420000000000002 111.433 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.73 -16.28 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.887 0.375 . . . . 61.219999999999999 110.903 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.22 144.38 4.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.157 -0.474 . . . . 54.310000000000002 112.222 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.6 tt -155.58 148.21 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 117.444 0.622 . . . . 71.310000000000002 111.506 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 6.4 p-10 -96.08 -171.37 2.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.185 0.517 . . . . 72.400000000000006 112.063 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 24.4 p -70.97 -50.16 37.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.073 -0.512 . . . . 71.109999999999999 112.023 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 50.5 p -66.76 -40.95 88.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.818 0.342 . . . . 71.420000000000002 110.836 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.29 -40.73 99.4 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.333 -0.461 . . . . 64.150000000000006 113.093 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -65.32 -55.99 15.14 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.666 0.269 . . . . 54.32 111.553 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.06 -42.23 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.915 0.388 . . . . 63.409999999999997 111.054 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.8 tt0 -52.86 -61.28 2.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 75.25 111.719 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 74' ' ' ARG . 52.8 mtt180 -56.96 -46.53 82.07 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.544 -0.298 . . . . 75.420000000000002 111.783 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.2 m -49.85 -50.18 46.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.272 0.471 . . . . 71.140000000000001 112.272 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 85.0 m-85 -80.4 -42.46 22.75 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.849 0.685 . . . . 45.240000000000002 112.849 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 14.7 ptm180 -66.66 -33.56 75.93 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.94 -0.475 . . . . 75.329999999999998 111.996 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 5.0 mm-40 -86.71 -45.93 10.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.961 0.356 . . . . 64.430000000000007 111.961 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 29.8 mt-30 -83.26 -51.7 7.22 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.613 0.597 . . . . 75.239999999999995 112.613 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -97.15 -6.17 35.51 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.391 0.515 . . . . 71.25 112.391 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.03 43.64 98.88 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.032 -0.604 . . . . 71.310000000000002 112.663 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 52.7 tp -108.89 138.85 44.58 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 73.150000000000006 111.742 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.6 118.06 12.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.551 0.575 . . . . 75.299999999999997 112.551 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 158' ' ' VAL . 60.5 mt -136.72 134.78 19.59 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.83 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.518 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 81.3 Cg_endo -77.35 173.7 13.89 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.726 2.284 . . . . 63.210000000000001 113.409 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -95.55 16.03 18.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 73.230000000000004 112.985 -173.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.0 m -143.06 127.88 18.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.652 0.263 . . . . 63.5 111.675 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 69' ' ' SER . 26.9 m -51.28 -37.33 46.78 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.073 0.463 . . . . 72.420000000000002 111.75 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.485 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 72.9 m-85 -57.86 -32.02 67.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.089 -0.505 . . . . 74.109999999999999 111.631 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -83.1 -38.58 22.27 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.385 0.612 . . . . 70.530000000000001 110.456 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.86 -25.46 67.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.052 -0.522 . . . . 73.329999999999998 111.845 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 26.5 pt20 -78.28 -15.51 58.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.443 0.534 . . . . 64.409999999999997 112.443 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -110.99 -21.61 11.92 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.797 0.665 . . . . 70.349999999999994 112.797 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.518 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 25.5 ptm -75.03 -15.95 60.62 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.912 0.708 . . . . 72.129999999999995 112.912 -176.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.63 170.19 13.36 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.048 -0.596 . . . . 71.439999999999998 113.642 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 74.2 mmtt -90.87 133.59 35.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.186 0.517 . . . . 72.209999999999994 111.772 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -78.38 132.7 37.48 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.512 -0.767 . . . . 52.509999999999998 112.797 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.563 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 2.4 m -134.15 161.6 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.971 0.508 . . . . 73.430000000000007 111.488 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -116.95 -175.68 2.83 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.835 -0.62 . . . . 63.020000000000003 112.068 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.545 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 25.8 mmm180 -40.54 -61.49 0.92 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 75.430000000000007 113.855 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -69.03 -16.93 63.83 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.999 0.74 . . . . 54.219999999999999 112.999 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -94.12 -13.8 26.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.518 0.562 . . . . 73.25 112.518 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.22 148.89 43.33 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.439 0.903 . . . . 71.530000000000001 113.439 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -133.25 -163.01 1.3 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.062 -0.972 . . . . 65.019999999999996 109.917 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 41' ' ' LYS . 36.0 m -86.52 108.42 18.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.883 -0.511 . . . . 73.319999999999993 110.907 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.54 -13.48 6.92 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.952 -0.642 . . . . 62.340000000000003 113.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 120.98 13.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.338 0.569 . . . . 41.340000000000003 111.362 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 35.8 mt -76.49 110.98 11.48 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.302 -0.408 . . . . 60.210000000000001 111.282 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 155' ' ' ALA . 27.7 m -95.36 139.98 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.046 0.45 . . . . 72.239999999999995 112.081 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.446 ' HG ' HH12 ' A' ' 156' ' ' ARG . 96.4 mt -106.56 134.76 49.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.15 -0.477 . . . . 72.430000000000007 111.879 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.58 133.92 52.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 72.230000000000004 110.459 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 112' ' ' ARG . 24.5 mtp180 -74.1 91.47 2.09 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.186 0.517 . . . . 73.219999999999999 110.397 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.54 133.01 35.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.715 0.635 . . . . 64.439999999999998 112.715 -170.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.19 -25.8 69.96 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.816 -0.629 . . . . 64.099999999999994 113.513 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.7 m -78.74 -53.94 6.61 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.046 0.45 . . . . 64.25 111.666 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.6 p -102.89 -48.81 3.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.253 0.549 . . . . 74.319999999999993 112.451 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 118.97 -82.4 0.34 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.731 -0.548 . . . . 63.140000000000001 111.731 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 10.4 mpt_? -92.91 96.13 9.92 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.582 -0.364 . . . . 72.530000000000001 110.536 173.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -105.09 141.68 36.23 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.465 -0.334 . . . . 74.329999999999998 110.799 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.17 137.78 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.199 0.523 . . . . 55.32 111.92 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.28 159.84 23.95 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 116.054 -0.521 . . . . 73.140000000000001 112.635 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.49 HG21 HD13 ' A' ' 44' ' ' ILE . 56.8 mt -93.33 110.3 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 122.603 -0.351 . . . . 72.430000000000007 110.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -69.32 115.7 8.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.928 0.394 . . . . 75.140000000000001 111.611 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.9 pt -106.58 14.27 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.12 0.415 . . . . 71.439999999999998 112.12 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.57 162.62 33.95 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.309 -0.472 . . . . 70.540000000000006 114.071 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 59.07 35.56 23.91 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.831 0.452 . . . . 54.439999999999998 111.996 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 142' ' ' SER . 48.4 m-80 62.18 14.49 6.7 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.126 0.417 . . . . 65.25 112.126 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -103.35 145.7 29.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.111 0.482 . . . . 72.010000000000005 111.139 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.03 139.87 19.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.115 -0.493 . . . . 75.420000000000002 111.844 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.49 133.62 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.091 0.472 . . . . 62.119999999999997 110.977 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -163.67 168.71 19.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.299 -0.41 . . . . 74.010000000000005 111.184 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.13 93.4 8.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.009 0.433 . . . . 71.049999999999997 110.814 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.1 t -79.54 130.39 35.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.309 -0.405 . . . . 73.120000000000005 111.993 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.8 p -63.36 -11.85 25.74 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.063 -0.517 . . . . 62.340000000000003 112.359 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 m -79.72 -32.39 41.23 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.976 0.362 . . . . 52.439999999999998 111.976 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.4 t -139.65 -48.45 0.47 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.04 0.448 . . . . 73.450000000000003 112.069 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.1 -148.28 19.95 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.713 -0.555 . . . . 74.439999999999998 111.713 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.2 99.5 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 117.321 0.561 . . . . 64.409999999999997 111.175 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 41.0 pt -138.23 -177.54 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.118 0.485 . . . . 73.420000000000002 111.824 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.79 129.03 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.251 -0.431 . . . . 72.400000000000006 110.565 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.5 m -119.8 172.94 7.35 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.942 0.401 . . . . 63.32 111.599 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 47.2 m -128.78 144.83 51.26 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.993 0.425 . . . . 54.43 112.085 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.545 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 65.8 mtt -75.2 0.87 14.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.675 0.62 . . . . 50.119999999999997 112.675 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.95 -11.86 49.32 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.936 -0.477 . . . . 65.319999999999993 111.287 173.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.46 130.6 92.04 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.486 -0.325 . . . . 75.030000000000001 110.699 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.34 -31.02 75.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.876 2.384 . . . . 43.450000000000003 113.442 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.19 -45.0 62.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.705 0.288 . . . . 71.400000000000006 111.74 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -83.79 -37.54 22.45 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.183 0.438 . . . . 72.230000000000004 112.183 -174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -53.51 -51.41 62.91 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.43 0.53 . . . . 73.239999999999995 112.43 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.22 -7.86 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.955 0.354 . . . . 71.099999999999994 111.955 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -95.94 -10.87 27.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.119 0.414 . . . . 72.010000000000005 112.119 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.86 114.63 2.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.946 0.403 . . . . 74.150000000000006 111.474 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -96.26 -55.5 2.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.296 -0.411 . . . . 74.420000000000002 111.255 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -168.74 -179.69 3.87 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.871 0.367 . . . . 74.439999999999998 111.398 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.586 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -140.33 160.4 40.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.28 -0.418 . . . . 74.299999999999997 111.162 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.4 mtm-85 -144.33 121.22 11.31 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.321 -0.237 . . . . 73.340000000000003 111.584 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.563 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -94.08 98.92 11.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.755 0.788 . . . . 75.019999999999996 111.242 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.542 HG21 HD21 ' A' ' 84' ' ' LEU . 15.9 m -83.18 -1.01 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.515 -0.766 . . . . 63.43 112.592 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.495 HD23 HD22 ' A' ' 82' ' ' LEU . 90.9 mt -69.48 166.42 18.85 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.866 0.365 . . . . 64.329999999999998 111.974 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 31.8 t -47.79 135.05 12.44 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.037 -0.529 . . . . 53.109999999999999 111.87 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -64.11 101.91 0.45 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.065 0.459 . . . . 72.319999999999993 111.441 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -85.28 -25.63 27.11 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.029 -0.532 . . . . 50.509999999999998 111.044 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.61 -170.63 1.89 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.81 -0.632 . . . . 60.299999999999997 111.315 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 C--O 1.253 1.245 0 CA-C-N 115.979 -0.555 . . . . 63.439999999999998 110.989 178.426 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 81.4 mtp . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.685 0.279 . . . . 65.319999999999993 111.314 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.13 107.4 4.55 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.197 0.522 . . . . 54.409999999999997 111.648 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.64 112.11 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.211 -0.449 . . . . 74.209999999999994 111.301 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -93.1 150.05 20.79 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.301 0.572 . . . . 74.329999999999998 111.133 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.75 -38.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.854 -0.612 . . . . 71.200000000000003 112.117 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.498 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.7 tttt -63.08 -55.31 26.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.638 0.606 . . . . 60.409999999999997 112.638 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 t -57.41 -42.99 83.38 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.95 0.352 . . . . 61.32 111.95 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -59.14 -45.19 91.59 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.022 0.439 . . . . 64.319999999999993 111.446 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.56 HD13 HG21 ' A' ' 122' ' ' ILE . 86.8 mt -69.17 -44.54 80.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.828 0.347 . . . . 72.200000000000003 111.722 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 28.1 mmt -61.56 -32.04 72.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.889 0.376 . . . . 74.150000000000006 111.051 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.09 -53.12 61.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.995 -0.548 . . . . 73.209999999999994 110.765 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.576 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 51.6 tp60 -65.25 -36.33 83.79 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.02 -0.536 . . . . 72.0 111.812 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.484 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 34.0 t80 -55.21 -39.68 69.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.868 0.366 . . . . 63.539999999999999 111.273 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . . . -59.37 -18.4 38.19 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.454 0.538 . . . . 71.129999999999995 112.454 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -92.5 -22.63 19.46 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.058 0.456 . . . . 71.439999999999998 111.776 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.473 ' CZ2' ' HG2' ' A' ' 63' ' ' LYS . 35.5 m95 -113.56 13.0 18.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.06 0.763 . . . . 72.140000000000001 113.06 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.6 mtmt -63.57 105.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.229 0.538 . . . . 50.109999999999999 112.027 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.96 19.33 9.14 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.94 -0.648 . . . . 71.409999999999997 114.375 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.32 130.3 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.619 0.709 . . . . 51.119999999999997 110.738 174.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 55' ' ' ARG . 16.5 ptt180 -79.46 163.27 24.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.408 0.521 . . . . 73.25 112.408 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -81.25 125.48 30.37 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.174 0.511 . . . . 74.5 112.242 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.431 HH11 HG22 ' A' ' 62' ' ' THR . 53.0 ttt180 -137.0 111.47 8.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.794 -0.639 . . . . 75.239999999999995 110.263 176.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.591 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 1.1 pt? -92.82 113.06 25.23 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.324 0.583 . . . . 72.219999999999999 112.026 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.08 -7.26 27.17 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.848 -0.615 . . . . 52.32 113.267 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.01 110.8 0.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.455 -0.403 . . . . 45.210000000000001 112.314 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.52 ' HA ' HG13 ' A' ' 66' ' ' ILE . 48.8 m -92.09 104.23 16.64 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.557 0.577 . . . . 63.210000000000001 112.557 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.431 HG22 HH11 ' A' ' 57' ' ' ARG . 2.9 t -151.87 157.18 41.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 73.200000000000003 111.222 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HG2' ' CZ2' ' A' ' 51' ' ' TRP . 43.8 mtpt -65.69 -15.86 63.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 73.319999999999993 111.708 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -92.41 11.12 27.21 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.061 0.458 . . . . 71.099999999999994 111.015 178.415 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.44 116.39 0.67 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.747 -0.541 . . . . 51.340000000000003 111.747 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.52 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.9 tt -150.19 151.85 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 117.263 0.531 . . . . 53.219999999999999 111.882 -173.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -91.05 177.48 6.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.284 0.564 . . . . 71.239999999999995 112.084 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.444 ' O ' HG12 ' A' ' 72' ' ' VAL . 23.0 p -61.31 -43.9 98.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.1 -0.5 . . . . 72.239999999999995 111.749 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.482 ' HB2' ' OG1' ' A' ' 88' ' ' THR . 40.3 t -61.13 -46.29 91.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.156 0.503 . . . . 72.329999999999998 111.221 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.562 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -60.67 -45.85 95.59 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.045 -0.598 . . . . 70.430000000000007 112.797 177.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.22 -53.7 55.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.804 0.335 . . . . 63.439999999999998 111.902 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.538 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.7 p -59.76 -40.41 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.934 0.397 . . . . 64.310000000000002 110.676 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.501 ' HA ' HD12 ' A' ' 84' ' ' LEU . 20.3 tt0 -55.62 -48.64 74.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.153 -0.476 . . . . 73.319999999999993 111.406 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.576 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 15.7 mmm180 -60.75 -49.03 79.12 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.937 0.347 . . . . 53.32 111.937 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.576 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 86.6 m -57.81 -54.19 49.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.049 0.452 . . . . 70.030000000000001 112.045 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 68.7 m-85 -64.11 -33.96 76.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.494 0.553 . . . . 65.129999999999995 112.494 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.7 -29.18 58.89 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.019 -0.425 . . . . 75.420000000000002 111.679 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 78.6 mm-40 -71.18 -64.08 0.98 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.105 0.479 . . . . 73.109999999999999 111.417 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.401 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 18.4 mp0 -72.5 -59.42 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.81 0.67 . . . . 73.129999999999995 112.81 -177.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -88.78 -12.87 40.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.524 0.565 . . . . 74.420000000000002 112.524 -173.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.03 31.2 77.27 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.793 -0.718 . . . . 25.399999999999999 112.492 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 56.4 tp -90.8 132.34 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.675 0.39 . . . . 74.430000000000007 111.236 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.83 131.07 35.95 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.199 0.523 . . . . 74.109999999999999 112.117 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 73' ' ' GLN . 95.0 mt -136.0 150.96 72.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.224 -0.443 . . . . 73.209999999999994 111.079 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.09 156.92 55.22 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.551 2.167 . . . . 54.439999999999998 112.927 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.46 6.19 10.89 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.728 0.64 . . . . 75.019999999999996 112.728 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.3 m -131.25 129.11 41.17 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.663 0.268 . . . . 73.409999999999997 111.642 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.547 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 89.0 m -54.74 -43.38 72.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.897 0.379 . . . . 74.120000000000005 111.357 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -51.51 -32.39 27.53 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.729 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.15 -40.77 14.31 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.328 -0.397 . . . . 71.340000000000003 111.393 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -56.41 -30.2 62.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.885 0.374 . . . . 52.329999999999998 111.411 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 88' ' ' THR . 21.7 mt-30 -52.94 -38.45 61.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.057 -0.52 . . . . 63.43 111.93 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.41 22.97 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.111 0.411 . . . . 75.430000000000007 112.111 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.0 mmm -98.31 -35.43 10.33 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.085 0.772 . . . . 64.150000000000006 113.085 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.0 -175.89 14.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.641 -0.79 . . . . 63.049999999999997 114.755 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.0 mmmt -86.21 149.03 25.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.687 0.395 . . . . 73.530000000000001 111.875 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -90.28 153.22 20.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.343 0.592 . . . . 72.400000000000006 112.563 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.99 159.76 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.676 -0.693 . . . . 74.109999999999999 111.502 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.4 t -87.66 157.76 19.02 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.286 -0.415 . . . . 65.099999999999994 111.514 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -52.18 -32.68 37.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.191 0.52 . . . . 72.109999999999999 111.413 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.5 p -74.57 -28.88 61.12 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.579 0.585 . . . . 44.140000000000001 112.579 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -96.05 -0.85 49.88 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.867 0.691 . . . . 74.439999999999998 112.867 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.94 123.49 17.23 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.599 0.592 . . . . 74.299999999999997 112.599 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -128.05 -178.84 4.69 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.012 -0.54 . . . . 72.109999999999999 110.771 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.498 HG21 ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -64.33 108.11 1.52 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.819 0.342 . . . . 71.519999999999996 111.893 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.73 -18.61 5.11 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.905 -0.664 . . . . 74.430000000000007 113.452 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 66.8 m-20 -74.15 129.73 38.39 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.047 0.451 . . . . 73.329999999999998 111.331 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.26 115.77 23.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.679 0.276 . . . . 72.230000000000004 110.595 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 155' ' ' ALA . 16.5 m -95.67 128.58 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.143 0.497 . . . . 74.129999999999995 111.908 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.4 mt -97.67 129.19 44.76 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.937 -0.574 . . . . 74.209999999999994 111.714 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.11 140.31 49.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.536 0.684 . . . . 75.219999999999999 112.376 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 112' ' ' ARG . 41.6 mtp180 -83.95 100.35 10.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.459 -0.791 . . . . 62.210000000000001 110.932 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.32 147.99 27.54 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.847 0.356 . . . . 64.019999999999996 111.85 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 56.53 -99.98 0.1 OUTLIER Glycine 0 CA--C 1.529 0.961 0 CA-C-N 116.265 -0.425 . . . . 53.409999999999997 113.806 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 63.9 m -153.6 -50.76 0.1 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.129 0.49 . . . . 54.32 110.181 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -115.4 79.19 1.25 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.193 0.52 . . . . 71.420000000000002 110.215 172.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.53 119.94 0.91 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.138 -0.553 . . . . 75.219999999999999 113.235 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -97.55 108.45 21.18 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.123 0.487 . . . . 60.140000000000001 111.761 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -98.51 148.06 24.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.057 -0.52 . . . . 75.120000000000005 110.643 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.5 141.9 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.069 0.461 . . . . 75.120000000000005 111.969 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.62 155.59 21.84 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.322 -0.466 . . . . 44.240000000000002 112.556 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 44' ' ' ILE . 20.1 mt -95.25 106.26 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.482 -0.422 . . . . 73.400000000000006 111.018 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 33.8 t80 -64.43 113.49 3.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.329 . . . . 65.230000000000004 111.186 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.41 -27.47 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.303 0.483 . . . . 74.010000000000005 112.303 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.33 144.95 4.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.441 -0.885 . . . . 64.209999999999994 114.23 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.21 53.37 12.54 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.107 0.563 . . . . 55.340000000000003 112.393 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 142' ' ' SER . 40.6 m-80 66.93 -4.98 0.72 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.173 0.805 . . . . 73.140000000000001 113.173 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.497 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 25.1 mt-30 -87.45 143.73 27.08 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.26 0.553 . . . . 74.450000000000003 111.061 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.582 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 25.2 p90 -156.32 148.95 23.75 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.77 -0.65 . . . . 74.129999999999995 111.519 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 137.54 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.104 -0.498 . . . . 72.310000000000002 110.835 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -166.45 162.29 16.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.114 0.483 . . . . 65.340000000000003 111.85 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -88.78 86.99 7.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.111 0.482 . . . . 75.409999999999997 110.309 172.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.2 t -58.22 134.71 56.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.783 -0.644 . . . . 74.200000000000003 112.498 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.9 p -57.18 -35.67 69.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.109 0.481 . . . . 60.119999999999997 111.82 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.7 t -85.94 -50.74 6.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.715 0.635 . . . . 62.43 112.715 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.8 m -98.9 -34.63 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.202 0.816 . . . . 61.119999999999997 113.202 -173.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.61 -158.67 14.4 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.05 -0.595 . . . . 71.439999999999998 112.369 -172.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 99.2 t -63.08 102.5 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.318 0.58 . . . . 72.0 111.793 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.76 -178.81 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.817 -0.629 . . . . 70.230000000000004 111.642 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.42 109.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.167 -0.469 . . . . 62.43 110.9 172.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 92.7 p -107.88 -171.46 1.87 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.584 0.23 . . . . 64.230000000000004 110.818 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.641 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 43.9 m -146.86 136.54 23.06 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.339 0.496 . . . . 63.210000000000001 112.339 -174.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.582 ' HG3' ' CE1' ' A' ' 129' ' ' PHE . 72.9 mtm -78.21 3.93 13.98 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.334 0.864 . . . . 54.009999999999998 113.334 -177.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' A' ' 142' ' ' SER . 1.0 OUTLIER -83.2 -12.85 56.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.867 0.365 . . . . 75.030000000000001 110.544 170.154 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -71.54 136.93 83.37 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 116.532 -0.304 . . . . 64.209999999999994 110.427 169.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -52.98 -43.0 60.44 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.722 2.281 . . . . 65.120000000000005 113.522 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 80.5 t80 -59.45 -47.66 84.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.705 0.288 . . . . 73.420000000000002 111.689 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 151' ' ' ARG . 95.6 m95 -78.89 -33.62 45.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.835 0.35 . . . . 75.140000000000001 111.623 -176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -56.81 -38.43 72.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.257 -0.429 . . . . 74.329999999999998 111.382 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -93.52 -12.32 29.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.788 0.328 . . . . 71.329999999999998 111.801 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -79.32 -32.48 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.836 0.35 . . . . 72.549999999999997 111.079 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -58.04 126.59 28.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.845 -0.616 . . . . 73.019999999999996 112.405 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -101.38 -63.9 1.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.177 0.513 . . . . 65.019999999999996 110.344 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.27 172.46 18.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 71.439999999999998 110.032 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.473 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -131.23 145.63 52.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.999 0.428 . . . . 63.450000000000003 111.934 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 97.1 mtt180 -140.6 124.96 17.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.332 -0.395 . . . . 74.209999999999994 110.8 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -98.29 137.19 37.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.325 0.583 . . . . 63.539999999999999 111.767 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.2 m -104.83 14.29 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.661 -0.7 . . . . 71.430000000000007 112.753 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.42 154.85 19.36 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.439 0.533 . . . . 73.239999999999995 112.439 -177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.5 m -139.91 125.53 19.26 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.911 -0.586 . . . . 75.329999999999998 111.122 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -119.15 -172.62 2.34 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.015 0.376 . . . . 62.329999999999998 112.015 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.2 t -125.7 157.29 37.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.665 -0.243 . . . . 43.109999999999999 110.765 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 163' ' ' LEU . 6.7 mp -91.53 155.22 18.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.945 0.402 . . . . 54.109999999999999 111.792 -176.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.823 -0.608 . . . . 75.540000000000006 111.489 177.956 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.476 ' C ' ' SD ' ' A' ' 36' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.825 0.345 . . . . 72.150000000000006 110.919 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -74.16 127.58 33.31 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.836 0.351 . . . . 61.329999999999998 111.827 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.89 101.87 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.834 0.35 . . . . 63.119999999999997 111.202 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -57.1 122.51 12.56 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.745 0.307 . . . . 51.219999999999999 111.384 175.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.9 t -51.22 -44.59 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.162 -0.472 . . . . 55.340000000000003 111.582 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.49 -37.76 79.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.431 -0.349 . . . . 64.120000000000005 111.62 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.8 m -64.14 -10.87 25.46 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.235 0.457 . . . . 63.130000000000003 112.235 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.53 ' HA ' ' HE ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -101.01 -49.1 4.22 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.023 0.44 . . . . 74.530000000000001 110.512 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.2 mt -52.41 -43.98 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.117 0.484 . . . . 74.5 111.027 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.543 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 31.1 mmt -71.07 -22.49 62.11 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.223 -0.444 . . . . 65.329999999999998 111.801 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.78 -46.47 78.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.69 0.281 . . . . 63.530000000000001 110.673 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.02 -42.23 69.84 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.707 0.289 . . . . 73.129999999999995 110.938 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.584 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 36.6 t80 -50.44 -36.68 34.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.638 0.256 . . . . 73.439999999999998 111.183 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.24 80.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.451 -0.341 . . . . 75.430000000000007 111.665 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.1 -29.66 60.67 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.831 0.348 . . . . 73.299999999999997 111.713 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -92.09 5.9 48.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.163 0.431 . . . . 73.109999999999999 112.163 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 23.6 mmmt -58.69 101.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.483 . . . . 73.150000000000006 111.915 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.34 -0.45 37.56 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.049 -0.596 . . . . 64.549999999999997 113.949 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.5 134.54 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 117.319 0.559 . . . . 73.400000000000006 111.323 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -85.58 171.67 11.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.481 0.658 . . . . 71.219999999999999 112.427 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -102.18 137.81 39.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.732 -0.667 . . . . 72.5 110.666 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -132.63 121.83 23.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.01 0.433 . . . . 74.409999999999997 111.676 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.67 103.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 61.530000000000001 111.275 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.57 28.96 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.184 -0.532 . . . . 75.409999999999997 113.401 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 134.71 7.61 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.394 -0.432 . . . . 72.129999999999995 112.503 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.552 ' HA ' HD12 ' A' ' 66' ' ' ILE . 11.7 m -125.01 98.28 5.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.255 0.527 . . . . 64.219999999999999 111.4 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 t 177.99 172.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.867 0.365 . . . . 73.129999999999995 111.659 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -66.68 -18.6 65.45 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.881 0.372 . . . . 72.409999999999997 111.719 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 3.3 mptp? -78.64 -11.79 59.99 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.107 0.479 . . . . 71.329999999999998 110.883 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.92 111.21 0.25 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.595 -0.602 . . . . 72.129999999999995 111.595 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 61' ' ' SER . 11.2 tp -112.2 154.33 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.999 0.399 . . . . 72.450000000000003 111.658 -173.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.26 178.7 4.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.984 0.421 . . . . 63.329999999999998 111.15 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.8 p -60.27 -52.9 63.29 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.309 -0.405 . . . . 54.329999999999998 112.013 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -69.42 -36.7 76.95 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.956 0.408 . . . . 74.209999999999994 111.129 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.496 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -58.68 -48.95 82.1 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.941 -0.572 . . . . 73.299999999999997 113.774 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.69 -56.16 25.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.184 0.492 . . . . 63.100000000000001 111.912 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.555 ' HA ' HD11 ' A' ' 122' ' ' ILE . 10.8 p -60.02 -39.41 80.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.872 0.368 . . . . 60.130000000000003 111.266 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.581 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 tt0 -56.68 -57.18 13.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.166 -0.47 . . . . 50.520000000000003 111.39 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 25.2 mmt180 -55.28 -49.46 72.02 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.904 0.383 . . . . 74.099999999999994 111.24 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.9 m -49.72 -61.96 1.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.013 -0.54 . . . . 73.049999999999997 112.452 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 69.5 m-85 -68.09 -37.38 81.15 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.202 0.815 . . . . 71.230000000000004 113.202 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -71.36 -36.72 71.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.879 -0.513 . . . . 64.200000000000003 112.172 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -78.08 -23.89 47.82 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.092 -0.38 . . . . 75.299999999999997 111.774 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -92.32 -70.31 0.7 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.178 0.513 . . . . 71.019999999999996 112.127 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -89.96 -9.78 47.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.043 -0.526 . . . . 63.340000000000003 112.042 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.51 77.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.918 -0.658 . . . . 62.539999999999999 112.33 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.8 tp -73.55 111.38 8.63 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.037 0.446 . . . . 72.120000000000005 110.533 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.35 78.59 4.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.437 0.637 . . . . 72.25 112.558 -173.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 83.8 mt -77.13 143.32 69.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.064 -0.516 . . . . 71.329999999999998 111.571 176.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.527 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 89.9 Cg_endo -79.73 -179.43 5.32 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.019 2.479 . . . . 74.209999999999994 113.505 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -11.63 43.12 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.277 0.843 . . . . 73.230000000000004 113.277 -173.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.457 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 39.1 t -115.62 137.56 51.95 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.897 -0.502 . . . . 74.329999999999998 111.851 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 6.2 m -56.87 -39.59 74.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.134 0.492 . . . . 74.439999999999998 111.476 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -64.08 -33.72 76.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.327 -0.397 . . . . 74.439999999999998 111.781 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 87' ' ' SER . 43.0 mt-10 -68.21 -38.34 81.81 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.274 0.559 . . . . 73.209999999999994 110.627 175.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.527 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 84.1 mt-30 -64.93 -30.58 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.697 -0.683 . . . . 53.32 110.912 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.4 mt-30 -64.98 -8.74 17.11 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.652 0.612 . . . . 72.400000000000006 112.652 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -99.16 -1.89 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.52 0.563 . . . . 54.219999999999999 112.52 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.2 ptp -114.04 154.95 26.8 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.062 -0.399 . . . . 74.409999999999997 110.863 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.27 177.22 29.63 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.777 -0.725 . . . . 72.340000000000003 112.756 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -118.46 149.75 40.74 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.325 -0.515 . . . . 75.230000000000004 111.611 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 89.0 p -76.91 154.53 33.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.237 0.829 . . . . 75.239999999999995 113.237 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 1.5 m -145.44 150.16 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.235 -0.893 . . . . 73.019999999999996 111.63 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.5 t -95.79 -179.52 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.884 0.373 . . . . 44.140000000000001 111.571 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -51.52 -44.09 62.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.317 0.488 . . . . 73.25 112.317 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.5 t -83.51 10.12 9.7 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.246 -0.434 . . . . 62.43 112.06 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.3 m120 -120.45 -8.55 9.57 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.126 -0.359 . . . . 53.020000000000003 111.832 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.64 144.19 57.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.101 0.778 . . . . 62.43 113.101 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -130.28 -156.44 0.76 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.717 -0.674 . . . . 71.409999999999997 110.599 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.9 m -101.14 126.97 47.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.548 -0.296 . . . . 74.510000000000005 110.325 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.06 -4.07 31.74 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.08 -0.581 . . . . 65.140000000000001 113.291 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 123' ' ' TYR . 2.2 m-20 -75.84 142.09 42.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.054 0.454 . . . . 64.219999999999999 111.128 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.43 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.535 -0.302 . . . . 63.25 110.331 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.22 126.46 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.473 0.654 . . . . 65.230000000000004 111.508 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.723 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 77.4 mt -105.71 115.1 29.66 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.488 -0.778 . . . . 71.430000000000007 111.823 -173.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -107.07 151.61 25.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.179 -0.464 . . . . 72.200000000000003 111.245 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.591 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 93.4 mtt180 -87.6 101.28 13.49 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.445 -0.343 . . . . 64.430000000000007 111.022 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.57 152.97 18.68 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.173 -0.329 . . . . 72.430000000000007 111.516 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.87 -22.8 58.96 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.122 -0.561 . . . . 24.23 113.71 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.9 t -99.01 -55.52 2.68 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 122.406 -0.467 . . . . 73.409999999999997 112.098 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.4 p -86.85 -3.12 59.03 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.591 0.589 . . . . 74.049999999999997 112.591 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.53 -65.57 2.78 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.033 -0.603 . . . . 62.299999999999997 112.189 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.723 ' HD2' ' HB3' ' A' ' 110' ' ' LEU . 2.1 tpp180 -119.46 128.37 53.94 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.371 -0.488 . . . . 73.519999999999996 111.004 176.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -118.05 124.92 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.147 -0.316 . . . . 74.099999999999994 110.147 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.82 138.58 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.24 0.459 . . . . 72.230000000000004 112.24 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -127.9 147.56 17.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.261 -0.427 . . . . 74.25 112.56 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 72' ' ' VAL . 40.3 mt -87.46 108.58 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.519 -0.4 . . . . 63.32 110.917 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.519 ' HD1' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -66.28 109.82 2.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.048 0.452 . . . . 72.5 111.901 -175.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.4 pt -105.23 11.49 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.01 0.434 . . . . 54.240000000000002 111.605 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.42 37.94 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.294 -0.412 . . . . 64.510000000000005 112.581 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -67.62 -16.21 64.05 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.281 0.475 . . . . 71.430000000000007 112.281 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.496 ' HA ' ' OH ' ' A' ' 123' ' ' TYR . 9.9 p30 -150.96 -13.42 0.22 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.668 0.618 . . . . 72.099999999999994 112.668 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.3 143.44 26.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.331 0.586 . . . . 63.039999999999999 111.869 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.519 ' HB3' ' HD1' ' A' ' 123' ' ' TYR . 27.6 p90 -153.1 146.46 24.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.647 -0.706 . . . . 65.109999999999999 111.462 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.7 p -99.19 136.84 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.055 0.455 . . . . 65.409999999999997 111.062 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -156.09 -166.28 2.14 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.246 -0.434 . . . . 73.409999999999997 110.736 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.4 114.41 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.707 0.289 . . . . 63.399999999999999 111.696 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 67.5 m -91.06 145.97 24.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.852 0.358 . . . . 72.319999999999993 111.272 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p -50.55 -48.91 57.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.58 0.955 . . . . 63.240000000000002 113.58 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.7 p -106.83 19.54 20.33 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.773 0.657 . . . . 60.310000000000002 112.773 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 133' ' ' SER . 67.6 m -133.05 -23.5 1.96 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.321 0.489 . . . . 74.549999999999997 112.321 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.29 -151.94 31.95 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.966 -0.635 . . . . 64.230000000000004 112.705 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.432 HG12 ' HE1' ' A' ' 48' ' ' TYR . 47.0 t -75.63 111.77 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.947 0.403 . . . . 45.039999999999999 111.993 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.523 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -140.36 -178.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 120.962 0.41 . . . . 63.539999999999999 111.491 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.41 143.13 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.738 0.304 . . . . 72.340000000000003 110.783 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.8 t -138.43 179.47 6.44 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.806 0.336 . . . . 74.140000000000001 111.657 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 69.7 m -137.7 138.71 39.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.341 -0.39 . . . . 70.040000000000006 111.258 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 27.0 mtm -69.97 -9.67 55.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.426 0.528 . . . . 75.010000000000005 112.426 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -78.52 -9.44 59.34 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.092 -0.38 . . . . 72.049999999999997 111.38 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.92 136.18 82.65 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 110.167 -0.309 . . . . 73.400000000000006 110.167 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -49.98 -45.85 30.75 Favored 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 123.029 2.486 . . . . 72.530000000000001 114.157 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.532 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 56.3 t80 -65.11 -44.14 89.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.912 0.387 . . . . 75.140000000000001 111.757 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -77.53 -35.56 53.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.832 0.308 . . . . 75.340000000000003 111.832 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -53.72 -38.98 64.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.237 0.542 . . . . 73.310000000000002 111.565 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -92.59 0.47 57.43 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.525 0.565 . . . . 72.310000000000002 112.525 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 112' ' ' ARG . 33.4 mmt180 -100.83 -17.94 16.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.109 0.411 . . . . 70.019999999999996 112.109 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.41 130.07 44.65 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.373 0.508 . . . . 74.430000000000007 112.373 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -112.89 -54.66 2.6 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 72.5 111.102 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -165.86 167.46 16.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.425 -0.352 . . . . 74.329999999999998 110.914 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -133.91 145.41 49.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.165 0.186 . . . . 51.399999999999999 110.864 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 57.5 mtt180 -141.0 121.14 13.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.743 0.306 . . . . 61.240000000000002 111.422 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.511 ' HD3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -85.06 121.94 28.55 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.409 0.623 . . . . 72.420000000000002 110.864 175.537 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.48 4.91 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.026 -0.534 . . . . 65.140000000000001 112.329 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.88 110.99 22.35 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.874 0.368 . . . . 60.420000000000002 111.315 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.5 t -82.38 -174.1 4.96 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.136 0.493 . . . . 51.399999999999999 111.903 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -106.06 123.06 47.41 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.118 0.485 . . . . 75.400000000000006 112.091 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 96.1 p -109.7 133.5 53.06 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.63 -0.507 . . . . 64.400000000000006 109.63 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 163' ' ' LEU . 2.0 pt? -144.35 179.09 7.47 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 122.118 -0.364 . . . . 75.239999999999995 111.847 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.252 1.185 0 N-CA-C 113.064 0.765 . . . . 64.040000000000006 113.064 -177.535 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.815 0.34 . . . . 74.150000000000006 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -99.8 167.18 10.7 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.561 0.219 . . . . 73.230000000000004 110.765 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.43 79.22 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.136 0.493 . . . . 51.399999999999999 110.565 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER -69.44 95.19 0.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 111.435 177.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -55.31 -48.71 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.581 0.585 . . . . 65.230000000000004 112.581 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.1 tttt -61.86 -56.95 14.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.863 0.32 . . . . 72.530000000000001 111.863 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.411 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 56.6 m -59.83 -38.83 83.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.597 0.237 . . . . 61.229999999999997 111.563 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -52.9 -52.05 59.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.331 0.586 . . . . 71.109999999999999 111.2 176.412 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 122' ' ' ILE . 72.8 mt -69.16 -42.8 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.829 -0.623 . . . . 72.109999999999999 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.7 mmt -62.66 -37.28 85.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.022 0.439 . . . . 63.219999999999999 111.328 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.87 -46.05 92.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.317 -0.401 . . . . 71.040000000000006 110.605 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -68.02 -36.82 80.6 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.399 -0.364 . . . . 64.120000000000005 111.523 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 50.4 t80 -54.07 -39.39 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.831 0.308 . . . . 74.25 111.831 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.36 -23.24 9.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 74.420000000000002 112.234 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.65 -44.41 11.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.12 0.486 . . . . 61.030000000000001 111.024 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -80.92 -2.27 46.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.139 0.792 . . . . 74.120000000000005 113.139 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 54.2 mtmt -50.04 117.75 2.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.678 0.621 . . . . 73.439999999999998 112.678 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.41 -6.35 77.95 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 114.75 0.66 . . . . 72.340000000000003 114.75 172.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.0 t -59.72 130.21 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 117.827 0.814 . . . . 73.25 111.599 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.02 171.15 13.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.094 -0.503 . . . . 64.299999999999997 112.315 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 32.3 t80 -98.28 123.01 42.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.236 0.458 . . . . 72.010000000000005 112.236 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -138.17 133.08 32.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.653 0.381 . . . . 72.510000000000005 110.623 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 5.3 mp -84.0 121.25 27.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.058 0.392 . . . . 73.219999999999999 112.058 -175.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.43 -50.82 3.87 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.03 -0.605 . . . . 74.049999999999997 113.006 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.21 60.19 1.86 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.342 -0.456 . . . . 43.219999999999999 112.305 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.3 m -67.61 103.47 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.814 0.446 . . . . 64.140000000000001 111.919 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.6 t -158.74 172.87 17.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.128 0.49 . . . . 73.549999999999997 111.909 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.39 -1.1 14.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.616 0.599 . . . . 61.119999999999997 112.616 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -105.17 10.84 33.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 74.430000000000007 110.803 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.87 118.55 0.91 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.714 -0.554 . . . . 61.130000000000003 111.714 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.2 tt -147.6 147.5 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.775 0.788 . . . . 51.009999999999998 112.331 -175.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.2 p-10 -92.44 176.22 6.55 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.168 0.509 . . . . 73.129999999999995 112.37 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.433 ' SG ' ' N ' ' A' ' 69' ' ' SER . 26.1 p -59.02 -59.88 4.77 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.893 -0.594 . . . . 53.340000000000003 111.643 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.433 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 16.7 p -62.61 -37.3 85.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.267 -0.424 . . . . 70.450000000000003 111.362 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.65 -43.29 99.18 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.346 -0.454 . . . . 73.219999999999999 113.286 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -61.26 -52.69 63.66 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 122.57 -0.371 . . . . 62.549999999999997 111.774 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.538 ' HA ' HD11 ' A' ' 122' ' ' ILE . 4.9 p -61.42 -49.27 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 112.252 0.464 . . . . 72.25 112.252 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -60.8 -33.9 73.69 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.092 -0.38 . . . . 60.549999999999997 111.791 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.51 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 78.2 mtt-85 -72.0 -52.11 18.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.086 -0.384 . . . . 70.340000000000003 111.497 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -49.66 -40.69 40.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.99 0.424 . . . . 61.119999999999997 111.892 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.555 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 47.0 m-85 -73.47 -40.91 63.79 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.582 0.586 . . . . 65.219999999999999 112.582 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.51 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 12.1 ptp180 -70.43 -24.73 62.96 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.757 -0.589 . . . . 71.129999999999995 111.223 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 20.6 mm-40 -69.48 -62.07 1.53 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.266 0.555 . . . . 74.349999999999994 111.345 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HB3' ' HG2' ' A' ' 43' ' ' ARG . 85.9 mm-40 -88.26 -32.17 18.64 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.555 0.946 . . . . 75.439999999999998 113.555 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.25 -13.05 13.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 64.109999999999999 112.357 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.99 17.61 77.17 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.867 -0.682 . . . . 41.020000000000003 112.814 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.5 tp -83.63 115.06 21.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.919 0.39 . . . . 61.240000000000002 111.147 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.94 96.68 8.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.843 0.354 . . . . 42.200000000000003 111.377 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 97.2 mt -98.64 142.37 24.48 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.459 -0.337 . . . . 64.310000000000002 110.889 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.23 163.79 9.59 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.84 2.36 . . . . 72.430000000000007 113.31 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 3.5 mpt_? -78.81 -25.27 44.21 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.689 0.626 . . . . 73.430000000000007 112.689 -173.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.433 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 36.3 t -98.95 140.22 33.43 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.375 0.509 . . . . 72.230000000000004 112.375 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 92.8 m -55.05 -42.52 72.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.844 -0.616 . . . . 71.439999999999998 111.321 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.38 -44.75 95.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.97 -0.559 . . . . 73.150000000000006 111.33 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 40.2 mm-40 -64.44 -36.73 85.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.08 0.467 . . . . 71.140000000000001 110.649 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.92 -27.42 66.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.18 -0.464 . . . . 71.150000000000006 111.617 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.544 ' HA ' ' NE ' ' A' ' 156' ' ' ARG . 28.4 mt-30 -59.94 -49.58 77.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 71.120000000000005 110.838 175.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.93 -6.21 43.71 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.06 -0.518 . . . . 71.209999999999994 112.247 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mmm -110.72 21.46 16.51 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.875 0.369 . . . . 75.120000000000005 111.95 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.38 133.66 5.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.275 -0.488 . . . . 53.219999999999999 112.272 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.552 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 43.6 mmtm -88.43 140.92 28.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.162 0.506 . . . . 61.509999999999998 112.085 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 t -74.71 136.98 41.81 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.631 0.974 . . . . 53.530000000000001 113.631 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.25 139.6 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.521 -0.763 . . . . 74.200000000000003 110.656 172.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.1 t -92.72 -179.98 5.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.533 0.568 . . . . 73.109999999999999 112.533 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -41.23 -53.72 3.11 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.125 1.157 . . . . 64.239999999999995 114.125 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -82.72 -14.5 54.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.515 0.561 . . . . 74.430000000000007 112.515 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -99.07 6.85 46.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.543 0.571 . . . . 51.520000000000003 112.543 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.28 138.36 58.51 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.785 0.326 . . . . 73.430000000000007 111.542 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -145.5 134.21 22.26 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.579 -0.282 . . . . 60.119999999999997 111.118 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.506 HG21 ' HB2' ' A' ' 41' ' ' LYS . 83.4 m -44.69 102.0 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.047 0.451 . . . . 71.400000000000006 111.792 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.09 -8.12 3.23 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.964 -0.562 . . . . 52.0 113.178 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 3.4 p30 -88.12 160.25 17.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.467 0.651 . . . . 72.200000000000003 111.603 176.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 mt -106.34 117.43 34.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 75.040000000000006 110.709 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 155' ' ' ALA . 12.2 m -94.15 119.18 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.425 0.631 . . . . 71.439999999999998 111.553 -175.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.464 HD11 ' HG2' ' A' ' 92' ' ' GLN . 95.6 mt -91.21 132.0 36.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.642 -0.708 . . . . 63.32 111.436 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -122.16 134.11 54.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.408 -0.36 . . . . 75.540000000000006 110.993 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.436 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 80.2 mtp180 -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.673 -0.491 . . . . 74.439999999999998 109.673 174.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.558 ' HB3' ' OG1' ' A' ' 116' ' ' THR . . . -92.2 143.05 26.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.074 0.464 . . . . 74.340000000000003 111.633 -175.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.49 -37.21 73.81 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.171 -0.468 . . . . 61.140000000000001 114.159 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -103.5 7.6 37.82 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.926 0.713 . . . . 60.409999999999997 112.926 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.558 ' OG1' ' HB3' ' A' ' 113' ' ' ALA . 43.5 p -132.7 -24.58 1.95 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.555 0.576 . . . . 72.239999999999995 112.555 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.62 -58.33 4.47 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.07 -0.586 . . . . 71.109999999999999 112.468 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -130.89 122.55 27.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.917 0.389 . . . . 60.5 111.383 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -127.52 160.46 31.45 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.322 -0.399 . . . . 75.349999999999994 110.107 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.83 141.18 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.148 0.499 . . . . 55.299999999999997 112.317 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.66 160.76 24.62 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.108 -0.497 . . . . 63.5 112.437 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 72' ' ' VAL . 34.1 mt -94.62 112.27 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.464 -0.433 . . . . 74.439999999999998 111.084 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.12 113.65 4.1 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.762 0.315 . . . . 73.430000000000007 111.64 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.461 ' HA ' HG23 ' A' ' 105' ' ' THR . 31.2 pt -98.64 -20.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.201 0.445 . . . . 74.549999999999997 112.201 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.95 148.04 5.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.931 -0.652 . . . . 42.509999999999998 113.782 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 58.47 40.02 24.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.277 0.473 . . . . 74.439999999999998 112.277 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 68.6 3.59 3.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.859 -0.61 . . . . 72.340000000000003 112.397 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.565 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 84.0 mt-30 -90.14 147.53 23.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.039 0.447 . . . . 72.510000000000005 110.759 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -155.35 151.76 28.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 71.310000000000002 111.979 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.34 135.91 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.071 -0.513 . . . . 75.140000000000001 110.448 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.91 173.33 16.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.034 0.445 . . . . 75.310000000000002 111.746 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -102.03 96.81 7.27 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.005 -0.543 . . . . 63.439999999999998 110.909 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.4 t -68.69 135.47 51.39 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.063 -0.517 . . . . 63.210000000000001 111.84 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.6 p -65.22 -20.66 66.54 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 75.129999999999995 111.56 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.9 m -97.07 -52.4 3.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.416 -0.356 . . . . 55.43 111.913 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.441 ' HB2' HD13 ' A' ' 139' ' ' ILE . 49.8 m -101.48 -16.45 16.81 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.073 0.768 . . . . 62.32 113.073 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.1 -154.27 24.3 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.853 -0.689 . . . . 72.430000000000007 112.884 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.37 104.39 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.019 0.438 . . . . 60.119999999999997 111.999 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 136' ' ' SER . 41.6 pt -140.77 178.48 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.113 0.482 . . . . 62.140000000000001 111.704 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.7 mm -101.15 141.83 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.467 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -144.56 165.4 28.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.773 0.321 . . . . 75.530000000000001 110.541 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.565 ' OG ' ' HG2' ' A' ' 128' ' ' GLN . 15.8 m -138.48 142.88 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.975 0.361 . . . . 73.420000000000002 111.975 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.2 mtm -72.57 -3.09 22.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.369 0.604 . . . . 62.420000000000002 110.626 171.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.98 -16.29 61.08 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.864 -0.607 . . . . 75.349999999999994 110.089 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 19.5 mm-40 -85.76 135.01 38.45 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.784 -0.644 . . . . 64.409999999999997 110.317 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -48.92 -44.87 30.77 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.183 2.589 . . . . 55.130000000000003 114.303 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 50.5 t80 -64.56 -44.16 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.946 -0.471 . . . . 73.430000000000007 111.759 -177.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -77.47 -32.75 54.54 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.184 0.516 . . . . 64.109999999999999 111.392 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -56.2 -48.71 75.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.401 0.68 . . . . 65.340000000000003 112.232 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -84.36 -13.92 50.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.853 0.686 . . . . 63.229999999999997 112.853 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 17.2 mmm180 -100.3 -3.39 31.43 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.72 0.637 . . . . 72.129999999999995 112.72 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -54.11 123.03 11.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.094 0.405 . . . . 60.009999999999998 112.094 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 7.0 t30 -98.4 -66.61 0.89 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.382 -0.372 . . . . 72.450000000000003 111.248 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.435 ' HG2' HD22 ' A' ' 153' ' ' ASN . 8.7 pt-20 -164.48 144.71 7.76 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.603 0.24 . . . . 63.219999999999999 110.829 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -102.57 146.49 28.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.781 0.324 . . . . 62.329999999999998 111.357 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.544 ' NE ' ' HA ' ' A' ' 92' ' ' GLN . 11.8 mtm-85 -136.89 111.37 8.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.607 0.225 . . . . 62.450000000000003 111.607 -176.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -75.02 124.99 27.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.04 0.448 . . . . 63.539999999999999 111.143 176.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.23 -19.51 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.037 -0.529 . . . . 74.299999999999997 112.105 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.89 149.09 34.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.148 0.499 . . . . 73.099999999999994 111.718 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.8 m -87.39 104.79 16.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.087 -0.506 . . . . 65.430000000000007 112.126 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -93.78 1.26 56.52 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.065 0.46 . . . . 73.239999999999995 110.985 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.3 m -108.23 -168.37 1.36 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.005 -0.543 . . . . 71.099999999999994 110.738 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 164' ' ' GLU . 6.7 tt -62.39 137.23 58.22 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.63 0.252 . . . . 74.129999999999995 110.372 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.524 ' N ' HD23 ' A' ' 163' ' ' LEU . 42.2 mt-10 . . . . . 0 C--O 1.253 1.279 0 CA-C-O 119.145 -0.455 . . . . 70.329999999999998 112.048 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 36.8 t70 . . . . . 0 CA--C 1.535 0.381 0 CA-C-O 121.142 0.496 . . . . 63.44 111.961 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.2 t -58.71 -61.86 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.723 -0.671 . . . . 50.11 111.713 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.67 -40.36 79.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.828 0.347 . . . . 72.12 111.195 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 28.4 t -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.274 -0.421 . . . . 64.3 111.673 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -35.35 77.91 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.879 0.326 . . . . 74.04 111.879 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 40' ' ' VAL . 74.7 mt -62.4 -48.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.034 0.445 . . . . 53.41 111.017 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.7 mmt -67.22 -37.34 83.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.943 0.401 . . . . 63.33 110.85 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -56.97 -45.24 83.03 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.931 -0.577 . . . . 75.22 110.624 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.798 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 55.0 tp60 -66.66 -46.25 76.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.294 0.569 . . . . 51.44 111.271 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 18.3 t80 -56.41 -34.85 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.824 -0.625 . . . . 75.03 111.221 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.76 12.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.38 0.511 . . . . 73.42 112.38 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.89 -26.25 21.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.958 0.408 . . . . 62.3 111.557 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -111.36 12.3 21.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.999 0.74 . . . . 74.51 112.999 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 10.0 mtmp? -61.95 103.36 0.35 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.074 -0.391 . . . . 74.31 111.64 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.14 -0.89 26.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.807 -0.711 . . . . 54.12 114.231 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.03 138.44 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 117.484 0.642 . . . . 54.12 111.225 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.82 162.44 26.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.145 0.498 . . . . 74.22 112.229 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 51.7 t80 -84.05 118.41 24.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.053 -0.521 . . . . 74.32 112.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -137.99 123.61 19.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.661 -0.245 . . . . 62.44 111.309 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.53 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 97.0 mt -70.78 116.49 11.15 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.481 0.549 . . . . 74.11 112.481 -177.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.36 3.59 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.304 -0.474 . . . . 61.14 114.065 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.27 67.88 1.79 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.26 -0.495 . . . . 72.15 113.248 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -69.48 108.65 3.86 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.406 0.521 . . . . 75.23 112.406 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -166.61 175.38 8.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.123 -0.489 . . . . 73.01 110.793 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -67.68 -8.26 33.63 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.252 0.464 . . . . 71.2 112.252 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 64' ' ' LYS . 3.9 mppt? -97.08 7.94 45.57 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.018 0.437 . . . . 63.33 111.215 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.0 134.63 2.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.359 -0.382 . . . . 63.33 112.604 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.3 tt -154.53 144.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.427 -0.455 . . . . 70.21 110.59 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.53 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.5 p-10 -96.99 -174.51 2.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.302 0.572 . . . . 72.51 112.35 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.7 p -62.68 -50.72 70.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.939 -0.573 . . . . 62.24 111.488 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 72' ' ' VAL . 49.1 m -69.09 -35.85 76.94 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.367 -0.379 . . . . 64.43 111.318 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.04 -44.6 97.55 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.112 -0.565 . . . . 70.21 112.726 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -66.02 -50.75 63.14 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.54 -0.388 . . . . 71.44 111.702 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 69' ' ' SER . 11.9 p -61.43 -37.49 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.927 0.394 . . . . 74.02 110.844 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.48 ' NE2' ' HD3' ' A' ' 86' ' ' ARG . 4.0 tt0 -54.47 -59.34 4.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.1 0.476 . . . . 73.02 110.693 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.549 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 9.4 mmm180 -52.24 -55.68 19.66 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.847 -0.615 . . . . 72.15 111.824 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.798 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 72.3 m -48.74 -56.25 9.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.401 0.519 . . . . 73.22 112.401 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 41.7 m-85 -74.94 -34.89 62.16 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.013 0.746 . . . . 74.25 113.013 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 ptm180 -66.42 -39.67 89.08 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.422 0.527 . . . . 74.41 112.422 -175.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 15.6 pt-20 -102.34 -23.39 13.97 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.075 0.769 . . . . 65.52 113.075 -174.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.468 ' HG3' ' HB2' ' A' ' 47' ' ' GLN . 84.4 mm-40 -87.31 -63.06 1.36 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.984 -0.448 . . . . 62.23 111.589 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.72 -18.16 30.1 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.004 0.372 . . . . 71.54 112.004 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 45.14 28.7 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.062 -0.59 . . . . 64.31 112.592 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 44.4 tp -105.99 136.9 44.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.901 0.381 . . . . 61.42 111.277 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.83 88.78 4.04 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.818 0.342 . . . . 74.32 111.645 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.42 138.16 19.46 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.94 0.348 . . . . 62.13 111.94 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HD2' ' OE1' ' A' ' 91' ' ' GLN . 73.4 Cg_endo -74.25 -161.54 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.412 2.741 . . . . 65.33 113.717 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.48 ' HD3' ' NE2' ' A' ' 73' ' ' GLN . 13.6 mmt180 -102.01 -31.99 10.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.479 1.289 . . . . 71.43 114.479 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -114.17 148.72 36.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.879 0.696 . . . . 74.54 112.879 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.2 m -54.38 -42.73 70.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.832 -0.622 . . . . 70.11 112.478 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -57.37 -29.89 64.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 73.43 111.488 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.84 -43.67 17.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.075 0.464 . . . . 62.25 110.382 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.463 ' OE1' ' HD2' ' A' ' 85' ' ' PRO . 20.3 mm-40 -54.25 -47.09 72.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.857 -0.61 . . . . 74.33 112.046 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -61.7 -23.46 66.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.217 0.451 . . . . 63.52 112.217 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -92.11 2.11 56.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.971 -0.456 . . . . 74.21 111.972 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 94.3 mmm -85.63 -14.69 44.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.953 0.406 . . . . 60.13 111.111 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.42 152.54 23.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.154 -0.546 . . . . 52.12 113.174 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -83.01 150.82 26.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.923 0.392 . . . . 72.34 111.555 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 86.8 p -76.6 158.43 31.13 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.995 0.739 . . . . 72.34 112.995 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.404 HG13 ' NE ' ' A' ' 157' ' ' ARG . 1.5 m -145.41 174.06 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.682 -0.69 . . . . 52.35 111.779 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -111.53 179.67 3.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.783 -0.644 . . . . 75.11 111.489 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.534 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 32.6 mmt180 -50.09 -32.98 17.08 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.295 0.48 . . . . 72.3 112.295 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.9 p -77.1 -29.93 55.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.615 0.598 . . . . 73.53 112.615 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -109.52 20.42 18.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.483 0.549 . . . . 74.14 112.483 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.52 135.18 57.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.07 0.462 . . . . 60.22 111.098 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -108.81 148.6 30.31 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.185 -0.322 . . . . 75.51 111.438 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.427 ' O ' HG11 ' A' ' 40' ' ' VAL . 63.6 m -68.95 110.76 4.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.847 -0.533 . . . . 72.11 110.078 173.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.07 15.47 30.68 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.419 -0.419 . . . . 72.5 112.266 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.403 ' OD1' ' HB1' ' A' ' 155' ' ' ALA . 9.0 t70 -76.33 152.43 36.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.729 0.411 . . . . 71.4 110.71 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.4 mt -99.86 108.35 20.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.296 0.569 . . . . 71.33 111.344 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.16 123.98 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.328 0.585 . . . . 63.35 111.628 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.9 mt -90.93 135.37 33.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.625 -0.716 . . . . 61.14 111.945 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 91.0 m-85 -120.22 141.89 49.52 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.166 0.508 . . . . 73.12 111.962 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -72.48 96.58 1.94 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.709 -0.678 . . . . 75.41 110.856 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.744 0.307 . . . . 62.21 111.44 -179.509 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.7 mmt-85 . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 120.898 0.38 . . . . 73.42 111.537 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 44.5 t60 -102.21 151.5 22.14 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.398 -0.593 . . . . 51.41 109.398 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.51 137.67 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.258 0.466 . . . . 75.55 112.258 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 153.34 20.33 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 116.066 -0.516 . . . . 64.11 112.525 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 72' ' ' VAL . 48.1 mt -88.15 103.44 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.975 0.417 . . . . 55.45 111.132 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -64.09 116.39 5.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.08 -0.509 . . . . 74.35 111.654 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.7 pt -102.76 -28.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.639 0.607 . . . . 55.43 112.639 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.65 135.37 1.93 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 119.863 -1.161 . . . . 41.1 114.973 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 65.0 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.071 0.948 . . . . 51.44 111.403 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.586 HD22 ' HB2' ' A' ' 143' ' ' MET . 22.6 m120 -141.34 -3.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.879 -0.601 . . . . 74.2 111.493 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -93.29 143.9 25.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.32 0.581 . . . . 74.51 111.574 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 18.0 p90 -152.61 145.81 24.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.47 -0.786 . . . . 62.5 111.008 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.34 133.83 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 64.05 110.903 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.49 178.64 8.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.107 0.479 . . . . 75.53 111.215 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -97.93 110.44 23.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.24 -0.437 . . . . 62.21 111.187 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 70.3 m -86.08 140.83 29.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.838 0.351 . . . . 71.13 111.165 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.4 p -47.43 -53.72 13.28 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.453 0.908 . . . . 65.41 113.453 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 p -90.29 -71.25 0.63 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.537 0.569 . . . . 64.21 112.537 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 54.2 m -58.71 -26.72 64.17 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.916 0.71 . . . . 54.14 112.916 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.54 -160.15 18.27 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.895 -0.669 . . . . 45.22 113.219 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 19.3 t -66.98 109.07 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.03 0.443 . . . . 62.44 111.909 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.9 pt -138.37 179.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.999 0.428 . . . . 52.15 111.754 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.22 110.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.145 -0.48 . . . . 74.44 110.599 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.451 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . 55.7 m -101.86 172.84 6.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.904 0.383 . . . . 44.03 111.738 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 138.99 49.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.13 0.49 . . . . 62.42 111.908 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.586 ' HB2' HD22 ' A' ' 127' ' ' ASN . 65.0 mtt -69.69 -8.17 45.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.389 -0.369 . . . . 71.23 111.899 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -77.01 -19.43 57.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.978 0.418 . . . . 55.45 110.612 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.25 124.48 90.88 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.287 -0.415 . . . . 64.54 110.267 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -48.69 -38.5 37.04 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.352 2.701 . . . . 65.05 114.028 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.443 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 52.3 t80 -63.18 -45.92 89.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.924 0.392 . . . . 53.43 111.394 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.535 ' HA ' ' HB2' ' A' ' 151' ' ' ARG . 83.8 m95 -80.79 -28.46 36.33 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.055 0.455 . . . . 72.2 111.392 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.9 -41.82 98.35 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.967 -0.561 . . . . 71.4 111.58 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -83.82 -21.38 32.11 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.096 0.474 . . . . 63.42 111.361 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 148' ' ' TRP . 0.8 OUTLIER -72.16 -39.09 68.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.341 -0.39 . . . . 62.32 111.612 177.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.98 104.45 0.14 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.16 0.505 . . . . 63.4 112.18 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.19 -52.02 5.45 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.925 -0.58 . . . . 74.43 110.873 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -167.08 171.47 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.251 -0.432 . . . . 74.23 111.284 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -121.15 154.74 35.81 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.642 -0.254 . . . . 72.12 110.872 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 79.3 mtt180 -147.93 119.18 7.79 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.076 0.465 . . . . 73.35 111.742 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.467 ' H ' ' HD3' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -86.66 109.29 19.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.042 0.448 . . . . 75.5 111.877 -177.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.09 -13.98 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.869 0.366 . . . . 73.43 111.736 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.469 0.52 0 CA-C-N 116.443 -0.344 . . . . 73.32 111.205 177.448 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--O 1.235 0.338 0 CA-C-O 121.071 0.462 . . . . 73.2 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 44' ' ' ILE . 64.8 t -55.54 -51.88 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.823 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.7 tttt -57.22 -42.26 81.03 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.866 -0.606 . . . . 74.31 111.757 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.1 t -58.38 -45.44 88.31 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.886 0.374 . . . . 51.11 111.891 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.423 ' HD3' ' OE1' ' A' ' 79' ' ' GLN . 3.2 mmp_? -66.05 -44.26 85.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 73.44 111.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.2 mt -57.97 -41.36 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.038 0.447 . . . . 73.21 111.13 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 30.7 mmt -67.08 -31.51 72.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 70.54 111.58 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.77 -41.75 96.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.87 0.367 . . . . 73.12 110.916 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HG2' HE21 ' A' ' 79' ' ' GLN . 71.2 mm-40 -68.37 -55.19 12.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.436 -0.347 . . . . 72.0 111.096 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.481 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 28.9 t80 -48.25 -47.06 36.22 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.235 0.457 . . . . 75.33 112.235 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.62 -32.39 63.09 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.241 0.543 . . . . 71.32 111.715 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.88 -29.97 35.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.063 -0.517 . . . . 51.35 111.018 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.46 ' HZ2' HH11 ' A' ' 74' ' ' ARG . 73.9 m95 -96.52 3.17 52.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.103 0.779 . . . . 71.51 113.103 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 30.7 mtpp -61.45 122.89 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.991 -0.443 . . . . 74.41 110.797 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.93 -8.3 55.83 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.301 -0.476 . . . . 65.33 113.299 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -77.07 123.46 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.231 -0.57 . . . . 73.14 111.519 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -74.75 159.79 31.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 72.03 112.009 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -79.52 130.12 35.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.197 -0.456 . . . . 71.41 110.949 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 57' ' ' ARG . 38.9 ttt180 -136.88 115.15 11.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.915 0.388 . . . . 75.33 112.023 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.86 123.87 24.26 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.046 0.45 . . . . 74.12 112.04 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.51 7.41 84.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.281 -0.418 . . . . 63.43 114.083 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.34 143.68 15.17 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.975 -0.631 . . . . 71.12 113.295 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.518 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 t -125.37 100.58 6.56 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.059 0.457 . . . . 72.34 111.171 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.1 t -170.81 167.95 7.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.274 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -73.96 -13.09 60.83 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.279 0.561 . . . . 51.45 111.212 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -76.26 -15.63 59.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.245 0.545 . . . . 75.04 110.55 173.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.33 135.86 1.91 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.847 -0.615 . . . . 40.32 112.024 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.518 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -151.63 154.11 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.985 0.393 . . . . 74.52 111.343 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -91.7 176.32 6.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.318 0.58 . . . . 75.42 111.953 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.8 t -59.11 -51.98 67.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.469 0.544 . . . . 71.25 112.469 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.6 t -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.279 0.561 . . . . 73.13 111.16 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 74' ' ' ARG . . . -64.24 -41.58 98.23 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.859 -0.61 . . . . 72.45 113.002 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.5 -51.01 70.41 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.445 -0.444 . . . . 61.31 111.795 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 11.9 p -62.2 -45.3 99.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.66 -0.245 . . . . 54.34 111.615 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 18.6 pt20 -61.24 -40.02 92.48 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.048 -0.407 . . . . 63.32 111.804 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 10.4 mtp-105 -67.85 -45.04 75.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.817 0.342 . . . . 74.33 111.327 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.7 m -51.98 -46.76 64.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.012 0.434 . . . . 54.1 111.778 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.0 m-85 -73.78 -42.17 61.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.018 0.747 . . . . 64.3 113.018 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 13.3 ptm180 -66.45 -34.27 77.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.048 -0.408 . . . . 73.23 112.065 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -81.16 -39.31 25.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.156 0.428 . . . . 75.35 112.156 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.442 HE21 ' HG2' ' A' ' 47' ' ' GLN . 77.6 mm-40 -86.96 -63.21 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.449 0.537 . . . . 42.53 112.449 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -90.57 -7.41 52.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.024 0.379 . . . . 74.01 112.024 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.07 10.15 84.08 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.135 -0.555 . . . . 65.21 112.519 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 39.0 tp -83.5 112.48 20.01 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.126 0.489 . . . . 73.35 110.737 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -86.0 92.36 8.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 71.2 111.456 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 93.3 mt -81.11 145.91 57.53 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.788 0.328 . . . . 73.1 111.159 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.56 -173.17 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.648 2.232 . . . . 73.44 113.7 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -94.98 -34.39 12.38 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.494 0.553 . . . . 75.44 112.494 -170.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.477 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 66.3 m -96.01 136.5 36.37 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.259 -0.276 . . . . 70.14 111.09 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 87.5 m -56.58 -39.51 73.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.844 0.313 . . . . 65.54 111.844 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -55.45 -45.88 76.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.909 0.385 . . . . 73.23 111.212 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 49.6 mt-10 -59.63 -38.48 81.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.008 0.432 . . . . 73.41 110.604 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -67.81 -35.59 78.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.251 -0.431 . . . . 61.22 111.185 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.4 mt-30 -62.14 -37.58 85.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.378 0.609 . . . . 52.0 110.612 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.98 12.83 10.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.603 -0.726 . . . . 72.2 112.557 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 90.4 mmm -84.9 -62.6 1.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.893 0.331 . . . . 52.51 111.893 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.29 -174.57 21.19 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.254 -0.498 . . . . 62.13 113.942 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.98 159.69 21.18 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.069 0.462 . . . . 74.4 111.837 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 61.7 p -91.37 150.59 21.21 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.379 0.609 . . . . 74.54 112.342 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.78 169.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.698 -0.683 . . . . 74.52 111.416 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -117.16 -179.68 3.78 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.19 -0.459 . . . . 72.32 111.468 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -47.1 -58.42 4.05 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.919 1.081 . . . . 72.51 113.919 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.6 m -73.47 -4.73 35.55 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.225 0.454 . . . . 65.34 112.225 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -99.06 -11.72 21.21 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.891 0.377 . . . . 74.1 111.28 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.3 114.28 6.63 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.511 0.56 . . . . 70.52 112.511 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -112.17 -160.91 0.73 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.206 -0.452 . . . . 73.13 110.843 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.0 m -82.41 114.84 21.13 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.183 -0.323 . . . . 72.43 110.984 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.02 -18.69 10.37 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.066 -0.588 . . . . 71.05 113.098 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.95 130.79 44.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.068 0.461 . . . . 74.11 111.529 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.55 114.25 24.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.376 -0.375 . . . . 72.54 110.672 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.27 124.8 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.492 0.663 . . . . 70.22 111.604 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.8 mt -97.64 126.35 42.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.5 -0.773 . . . . 72.32 111.776 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -117.41 160.84 20.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.037 0.446 . . . . 71.14 111.293 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.45 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 63.0 mtt85 -91.83 122.2 34.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.14 0.495 . . . . 73.0 111.279 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.415 0 CA-C-N 116.113 -0.494 . . . . 73.41 111.142 -179.878 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.944 0.402 . . . . 70.52 111.192 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.55 148.81 50.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.187 -0.46 . . . . 63.51 109.9 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.466 HG12 ' SG ' ' A' ' 68' ' ' CYS . 9.2 p -135.76 138.93 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.335 0.588 . . . . 73.01 112.334 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -129.05 144.84 15.74 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.869 -0.605 . . . . 72.15 112.608 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.8 mt -90.23 107.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.634 -0.333 . . . . 73.31 111.491 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER -64.35 117.6 7.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.597 0.359 . . . . 71.52 111.422 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.3 pt -102.13 -32.88 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.362 0.504 . . . . 74.14 112.362 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.35 133.38 2.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.092 -1.051 . . . . 63.03 114.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 60.45 -80.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.593 0.757 . . . . 62.15 112.366 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.45 ' HA ' ' OH ' ' A' ' 123' ' ' TYR . 82.4 m-20 -141.57 1.63 1.56 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.177 0.436 . . . . 71.04 112.177 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -102.38 146.21 28.39 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.365 0.602 . . . . 62.3 112.051 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.7 p90 -150.73 148.98 29.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.377 -0.829 . . . . 72.23 111.657 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.87 138.34 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.916 0.389 . . . . 71.04 111.152 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -163.78 161.65 23.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.995 0.426 . . . . 63.51 111.847 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -91.2 96.7 10.71 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.207 0.527 . . . . 74.4 110.641 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.1 p -77.77 150.85 34.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.897 -0.592 . . . . 71.42 112.569 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.9 p -81.19 8.97 7.59 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.991 -0.55 . . . . 74.23 111.561 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 t -109.7 -46.55 3.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.855 0.317 . . . . 43.1 111.855 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.5 t -124.85 -30.16 3.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.385 0.513 . . . . 63.21 112.385 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.87 -147.65 18.42 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.278 -0.487 . . . . 72.21 112.005 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.21 101.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 117.141 0.471 . . . . 64.22 111.626 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.6 pt -136.96 176.6 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 61.31 112.173 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.12 120.97 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.004 -0.544 . . . . 55.14 110.846 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.8 p -122.62 178.27 5.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.937 0.399 . . . . 65.31 111.287 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 t -127.99 153.67 46.47 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.107 0.41 . . . . 65.51 112.107 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 25.0 mmt -60.07 -20.42 57.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.228 -0.442 . . . . 54.31 111.348 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.14 -24.3 66.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.287 -0.415 . . . . 65.1 111.636 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.509 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 29.0 mm-40 -71.47 133.68 84.88 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 120.833 0.349 . . . . 73.53 111.663 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.47 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 93.3 Cg_exo -45.15 -52.85 5.96 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.592 2.861 . . . . 72.05 115.11 -173.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.1 t80 -61.38 -43.6 98.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.824 0.345 . . . . 75.25 111.777 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.509 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 73.9 m95 -76.13 -38.77 56.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.043 0.449 . . . . 72.25 111.041 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.88 -45.66 71.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.828 -0.624 . . . . 42.51 112.064 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.5 ptpt -98.38 6.1 47.58 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.798 0.666 . . . . 73.44 112.798 -175.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 2.5 mpt_? -116.66 7.57 13.59 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 122.193 -0.317 . . . . 70.51 111.658 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -60.54 104.27 0.32 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.032 0.444 . . . . 71.41 111.162 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.463 HD22 ' HG2' ' A' ' 154' ' ' GLU . 8.5 t30 -82.15 -49.01 10.63 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.316 -0.402 . . . . 73.03 111.072 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.463 ' HG2' HD22 ' A' ' 153' ' ' ASN . 11.1 pt-20 177.3 -166.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.124 0.57 . . . . 60.53 109.875 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -146.69 146.66 30.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.38 0.511 . . . . 51.4 112.38 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt180 -137.04 126.35 24.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.365 0.666 . . . . 73.3 110.318 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.404 ' H ' ' HD3' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -107.37 111.92 24.48 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.439 -0.788 . . . . 74.14 110.605 175.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.3 m -89.46 -16.74 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.252 -0.885 . . . . 62.13 112.692 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.428 HD23 HD22 ' A' ' 82' ' ' LEU . 90.6 mt . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.226 0.536 . . . . 70.11 111.866 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 15.0 t70 . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 120.602 0.239 . . . . 72.15 110.672 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.73 -57.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.347 0.499 . . . . 73.34 112.347 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.24 -44.15 95.47 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.666 0.27 . . . . 75.23 111.651 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 40.3 t -55.13 -47.85 74.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.886 0.374 . . . . 62.15 111.903 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 39' ' ' ASP . 11.0 mmm180 -59.9 -47.67 84.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.076 0.465 . . . . 65.0 111.289 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 122' ' ' ILE . 72.5 mt -61.67 -44.85 99.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.167 -0.469 . . . . 55.54 111.571 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 18.7 mmt -64.15 -29.08 70.22 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.917 0.389 . . . . 71.25 111.403 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.72 -47.76 82.2 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.223 0.535 . . . . 61.41 110.53 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 50' ' ' ASP . 25.6 tp60 -66.13 -35.12 79.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 60.21 111.374 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -54.15 -37.22 64.17 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.463 -0.335 . . . . 73.43 111.542 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.71 -20.6 57.44 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.336 0.495 . . . . 64.45 112.336 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.558 ' HB3' HE21 ' A' ' 47' ' ' GLN . 34.9 t70 -90.92 -21.15 21.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.973 0.509 . . . . 70.53 111.521 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -122.81 30.51 6.4 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.161 -0.472 . . . . 73.24 111.949 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -57.82 -1.45 0.11 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.273 1.582 . . . . 72.24 115.273 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.54 49.14 0.11 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.246 -0.978 . . . . 72.22 113.64 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -92.19 137.24 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.784 0.326 . . . . 74.53 111.004 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -74.34 158.38 34.08 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.021 0.748 . . . . 75.12 113.021 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -73.09 119.09 16.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.914 -0.585 . . . . 54.42 111.513 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -137.66 119.14 14.83 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.989 0.423 . . . . 72.31 111.783 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.11 118.8 10.38 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.248 0.462 . . . . 75.24 112.248 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.58 -54.33 4.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.187 -0.53 . . . . 62.12 113.657 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.84 98.47 0.55 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.094 -0.574 . . . . 60.34 112.246 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.4 p -97.22 119.41 35.68 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 71.53 111.625 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -176.52 176.97 1.5 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.043 0.537 . . . . 73.3 110.978 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -16.45 63.7 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.973 -0.454 . . . . 71.24 110.943 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -85.72 2.75 44.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.295 -0.411 . . . . 61.31 110.987 175.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.12 142.75 3.62 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.468 -0.396 . . . . 44.21 112.746 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.1 tt -165.49 138.28 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.941 0.37 . . . . 73.11 111.105 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.11 171.47 8.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.798 -0.564 . . . . 74.24 111.319 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 21.0 p -54.52 -39.72 67.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.695 0.628 . . . . 70.52 112.695 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.432 ' HB2' ' OG1' ' A' ' 88' ' ' THR . 23.9 t -67.47 -47.01 71.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.803 0.335 . . . . 51.12 111.417 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.5 -36.22 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.01 -0.614 . . . . 73.14 112.898 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.87 -56.09 20.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.785 0.326 . . . . 74.44 111.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.408 HG21 HD22 ' A' ' 108' ' ' LEU . 12.9 p -61.32 -38.15 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.757 0.313 . . . . 74.24 111.536 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 6.0 tt0 -54.0 -58.11 8.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.286 0.565 . . . . 74.22 111.28 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -60.2 -51.85 67.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.948 -0.569 . . . . 72.41 111.913 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 78.1 m -48.37 -53.63 16.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.389 0.514 . . . . 60.31 112.389 -176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 45.9 m-85 -68.52 -37.95 80.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.787 0.662 . . . . 73.01 112.787 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.5 -21.26 45.54 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.889 -0.507 . . . . 72.15 112.174 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -86.45 -55.09 4.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.925 0.393 . . . . 71.03 111.492 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.409 ' CD ' ' HB2' ' A' ' 47' ' ' GLN . 1.9 mp0 -67.97 -51.38 48.1 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.336 0.495 . . . . 73.21 112.336 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -100.52 -36.89 9.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.023 0.44 . . . . 74.42 112.113 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.55 6.21 41.42 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.714 -0.554 . . . . 44.04 111.714 -172.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.503 HD22 HD23 ' A' ' 159' ' ' LEU . 29.0 tp -79.4 110.75 14.99 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.081 0.467 . . . . 73.41 110.669 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -84.3 112.08 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 75.5 111.943 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 84.3 mt -100.92 154.93 36.86 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.915 -0.584 . . . . 75.55 111.312 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.01 -179.02 1.2 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.45 2.1 . . . . 65.35 113.592 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -39.86 14.9 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.567 0.58 . . . . 71.21 112.567 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.7 m -110.59 141.87 43.19 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.143 0.423 . . . . 74.01 112.143 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.522 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 48.7 m -49.3 -39.06 29.66 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.311 -0.404 . . . . 75.32 111.8 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -52.98 -47.08 68.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.234 -0.439 . . . . 71.11 110.989 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -65.22 -36.74 85.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.406 0.622 . . . . 72.22 110.697 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.96 -28.47 68.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.777 -0.647 . . . . 50.41 111.49 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.0 mt-30 -68.79 -6.58 27.52 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.007 0.373 . . . . 71.43 112.007 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -98.06 -10.28 24.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.825 0.676 . . . . 70.13 112.825 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.45 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 25.7 ptm -124.62 162.39 24.2 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.399 0.518 . . . . 54.4 112.399 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 160.51 36.48 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.319 -0.467 . . . . 74.11 114.247 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 68.3 mmtt -84.48 125.66 32.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.135 0.493 . . . . 75.43 111.638 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 64.6 p -81.21 111.98 18.12 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.648 -0.706 . . . . 75.34 112.841 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.427 HG23 ' HB3' ' A' ' 155' ' ' ALA . 2.8 m -106.2 157.58 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.808 -0.633 . . . . 73.44 111.964 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.448 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 84.0 p -99.59 -179.8 4.31 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.994 -0.548 . . . . 62.1 111.823 -177.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -53.23 -41.45 65.42 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.988 0.366 . . . . 71.21 111.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -77.28 -24.76 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 111.985 0.365 . . . . 72.43 111.985 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.62 -8.1 57.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.194 0.442 . . . . 72.32 112.194 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 99' ' ' SER . 85.3 mt -63.2 133.25 53.99 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.509 0.559 . . . . 74.02 112.509 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.411 ' O ' ' HD1' ' A' ' 123' ' ' TYR . 51.8 mtt180 -137.49 -122.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.466 -0.334 . . . . 74.42 110.352 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -106.12 127.04 52.92 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.692 -0.63 . . . . 53.53 112.134 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.16 13.31 36.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.298 -0.477 . . . . 75.44 114.178 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' A' ' 123' ' ' TYR . 1.6 m-20 -81.44 120.09 24.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 122.571 -0.37 . . . . 62.4 111.5 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.408 HD22 HG21 ' A' ' 72' ' ' VAL . 27.7 mt -76.62 104.04 6.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.972 0.415 . . . . 75.13 110.195 173.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 155' ' ' ALA . 27.5 m -95.53 118.8 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.512 0.672 . . . . 72.31 111.995 -173.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.484 HD13 ' HG2' ' A' ' 92' ' ' GLN . 74.7 mt -93.93 117.6 30.32 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.46 -0.791 . . . . 72.22 112.312 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 77.8 m-85 -107.91 133.36 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 73.23 110.331 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.628 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 78.4 mtt-85 -82.6 110.44 17.68 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.637 -0.505 . . . . 72.14 109.637 174.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.93 0.395 . . . . 70.34 111.664 -173.395 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.522 ' O ' ' HD2' ' A' ' 118' ' ' ARG . 3.5 ppt_? . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 112.533 0.568 . . . . 73.35 112.533 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 68.4 t60 -165.67 149.69 8.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.732 -0.667 . . . . 64.31 109.471 170.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 7.8 p -142.38 137.18 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.288 0.566 . . . . 62.55 111.969 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 109' ' ' VAL . . . -130.06 154.35 20.5 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.046 -0.597 . . . . 73.4 112.845 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 44' ' ' ILE . 47.4 mt -92.3 100.33 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 73.32 110.572 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 37.4 t80 -71.15 117.68 12.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.141 -0.481 . . . . 71.45 111.15 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.9 pt -99.08 -30.24 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.16 0.43 . . . . 73.51 112.16 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.27 163.31 9.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.159 -0.543 . . . . 61.21 113.202 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 56.76 39.86 29.41 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.674 0.39 . . . . 72.24 111.909 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.637 HD22 ' N ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 67.92 4.69 4.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.808 0.443 . . . . 75.4 111.846 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 141' ' ' SER . 25.8 mt-30 -97.4 140.48 31.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.385 0.612 . . . . 73.45 112.158 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.456 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.5 p90 -146.54 137.58 24.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.739 . . . . 70.11 111.215 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.08 126.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.058 0.456 . . . . 70.54 110.765 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -155.32 150.14 26.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.925 0.393 . . . . 75.04 111.813 -174.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.81 91.42 4.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.176 0.512 . . . . 74.52 110.183 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.4 p -78.23 143.94 36.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.815 -0.629 . . . . 74.24 112.234 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.4 t -77.27 -4.97 47.59 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.383 0.611 . . . . 61.24 111.369 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -87.94 -35.68 17.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.067 -0.515 . . . . 72.42 111.729 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 m -138.42 -51.78 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.235 0.54 . . . . 62.04 111.808 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.86 -153.22 24.52 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.642 -0.708 . . . . 52.14 111.708 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.23 96.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 117.411 0.605 . . . . 72.41 111.114 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.28 168.47 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.302 -0.408 . . . . 74.33 111.744 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.12 109.41 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.25 -0.432 . . . . 73.42 110.666 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 128' ' ' GLN . 48.5 m -107.21 173.81 6.16 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.065 0.395 . . . . 73.1 112.065 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 29.1 t -119.95 141.16 49.89 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.688 0.625 . . . . 75.3 112.688 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.5 mtt -76.62 -0.55 23.79 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.859 0.689 . . . . 74.44 112.859 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -84.95 -10.94 56.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.065 0.459 . . . . 62.21 110.829 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -76.47 132.91 71.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.237 -0.438 . . . . 73.44 110.799 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.11 -49.4 14.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.224 2.616 . . . . 64.33 114.554 -172.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.567 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 91.9 t80 -61.55 -48.05 82.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.941 0.4 . . . . 61.53 111.194 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -72.83 -34.94 67.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.782 0.325 . . . . 74.22 111.665 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.69 -47.58 84.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.898 0.38 . . . . 72.2 111.319 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -73.24 -32.14 64.54 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.979 0.363 . . . . 75.14 111.979 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.628 ' HD3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mmp_? -76.82 -23.41 52.77 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.008 -0.433 . . . . 73.32 111.443 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -61.18 108.27 0.88 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.051 0.453 . . . . 73.31 111.841 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -91.35 -69.1 0.75 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.305 0.574 . . . . 75.23 111.171 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG3' HD12 ' A' ' 110' ' ' LEU . 10.9 pt-20 -148.49 153.14 38.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.977 -0.556 . . . . 71.31 110.782 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -115.48 149.83 37.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.75 -0.204 . . . . 51.14 110.539 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mtt180 -137.6 122.99 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.365 0.603 . . . . 54.54 112.437 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 157' ' ' ARG . 2.9 mtp180 -87.91 108.64 19.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.798 -0.637 . . . . 64.11 110.67 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.0 m -99.31 0.76 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.686 -0.688 . . . . 72.53 112.546 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.503 HD23 HD22 ' A' ' 82' ' ' LEU . 80.0 mt . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 121.106 0.479 . . . . 75.43 112.21 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 120.516 0.198 . . . . 72.42 111.523 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 44' ' ' ILE . 94.1 t -48.74 -41.35 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.486 0.66 . . . . 55.02 110.322 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 45' ' ' MET . 88.2 tttt -56.48 -45.36 80.97 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.257 -0.883 . . . . 74.12 112.132 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.9 p -65.02 -37.78 88.73 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 122.228 -0.295 . . . . 72.22 111.536 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -70.9 -38.03 73.01 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 75.35 111.175 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 40' ' ' VAL . 86.2 mt -62.52 -46.08 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.127 0.489 . . . . 63.31 110.805 174.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 95.8 mmm -67.7 -29.74 69.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.347 -0.388 . . . . 54.31 111.282 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.46 -44.81 89.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.052 0.453 . . . . 64.05 110.196 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -65.3 -46.93 78.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.528 -0.76 . . . . 73.42 111.229 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -53.63 -39.22 64.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.221 -0.445 . . . . 73.11 112.136 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.22 68.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.861 0.362 . . . . 53.33 111.849 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -79.21 -33.79 43.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.248 0.547 . . . . 73.12 111.081 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.516 ' HZ2' ' NH1' ' A' ' 74' ' ' ARG . 84.9 m95 -99.13 22.75 9.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.438 0.533 . . . . 73.04 112.438 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.07 120.3 11.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.064 0.459 . . . . 73.24 112.032 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.03 20.43 75.85 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 114.472 0.549 . . . . 61.31 114.472 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.3 t -83.6 131.2 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 117.595 0.698 . . . . 74.45 111.003 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.31 163.46 26.44 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.298 0.571 . . . . 51.24 112.509 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 134' ' ' THR . 49.9 t80 -89.52 141.59 28.44 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.514 0.673 . . . . 75.33 112.437 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.624 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 57.2 ttt180 -129.58 131.28 46.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.573 -0.739 . . . . 73.43 110.462 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 58' ' ' LEU . 6.7 mp -76.22 93.54 3.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.969 0.414 . . . . 60.43 111.374 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 71.71 1.29 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.28 -0.486 . . . . 71.35 113.285 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' ' 57' ' ' ARG . . . 172.92 139.83 2.97 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.893 -0.67 . . . . 25.23 113.186 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.577 ' HB2' ' HD2' ' A' ' 74' ' ' ARG . 84.7 p -110.65 101.17 9.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.601 0.593 . . . . 70.21 112.601 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -153.22 151.78 30.46 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.12 -0.491 . . . . 73.33 111.137 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.46 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 32.3 ttmt -70.34 -5.56 28.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.05 0.453 . . . . 72.32 111.827 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -106.29 15.22 26.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.975 0.417 . . . . 74.2 111.265 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.75 108.11 0.27 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.187 -0.46 . . . . 73.22 112.164 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.493 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -138.48 151.76 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 117.342 0.571 . . . . 71.31 111.894 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.624 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 6.2 p-10 -95.11 -179.13 4.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.185 0.517 . . . . 71.01 112.238 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.29 -55.76 22.05 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.003 -0.544 . . . . 45.11 111.954 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 81.5 p -66.21 -29.17 69.38 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.826 0.346 . . . . 62.53 110.864 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.68 ' HA2' HE21 ' A' ' 73' ' ' GLN . . . -66.1 -44.63 90.9 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.094 -0.503 . . . . 72.1 112.801 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.07 -51.83 66.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.0 0.428 . . . . 75.41 111.268 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.45 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.0 p -62.47 -44.46 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 112.173 0.434 . . . . 42.14 112.173 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.68 HE21 ' HA2' ' A' ' 70' ' ' GLY . 21.3 pt20 -59.57 -49.98 75.67 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.94 -0.475 . . . . 71.22 111.443 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.577 ' HD2' ' HB2' ' A' ' 61' ' ' SER . 10.0 mtp-105 -60.13 -41.61 93.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.991 0.424 . . . . 74.32 111.135 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.4 m -54.53 -52.23 62.68 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.103 -0.499 . . . . 74.13 111.489 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.6 m-85 -72.27 -37.83 68.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.502 0.556 . . . . 75.24 112.502 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.493 ' HG3' ' HA ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.77 -20.02 58.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.473 0.546 . . . . 64.33 112.473 -177.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -97.1 -49.93 4.8 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.166 -0.334 . . . . 73.02 111.509 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -71.55 -44.93 63.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.112 0.412 . . . . 63.33 112.112 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.11 -12.75 14.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.677 0.621 . . . . 72.2 112.677 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 32.32 62.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.127 -0.559 . . . . 53.13 113.33 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 57.9 tp -92.81 127.21 38.24 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.617 -0.343 . . . . 72.42 111.596 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.23 79.97 2.35 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.906 0.706 . . . . 73.51 112.906 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.439 HD21 HG21 ' A' ' 158' ' ' VAL . 64.3 mt -95.82 142.56 24.75 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 121.913 -0.492 . . . . 70.54 111.777 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.679 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 87.9 Cg_endo -82.1 -174.07 1.98 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.174 2.583 . . . . 63.13 113.391 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.571 ' H ' ' HD2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -105.6 20.64 18.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.44 0.904 . . . . 75.45 113.44 -169.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.1 m -141.29 132.65 26.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.938 0.399 . . . . 73.03 111.535 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 34.8 m -51.74 -43.87 63.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.239 -0.437 . . . . 41.24 111.929 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -58.43 -17.04 17.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.43 0.53 . . . . 63.05 112.43 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 94' ' ' MET . 35.5 mt-10 -92.35 -53.22 4.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.102 0.477 . . . . 70.12 110.484 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.641 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 80.6 mt-30 -54.6 -45.97 73.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.964 -0.562 . . . . 64.32 112.341 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 88' ' ' THR . 18.4 pt20 -53.59 -33.91 56.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.49 0.552 . . . . 61.52 112.49 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.38 10.9 29.49 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.047 0.758 . . . . 60.2 113.047 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.679 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 77.6 mtp -79.38 -29.95 42.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.043 0.449 . . . . 75.33 111.018 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.74 -133.27 6.84 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.37 -0.443 . . . . 74.4 112.674 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -127.19 174.03 9.25 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.549 -0.383 . . . . 65.32 111.547 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.6 p -106.81 161.53 14.6 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.312 0.577 . . . . 71.54 112.221 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.413 HG23 ' CB ' ' A' ' 155' ' ' ALA . 0.0 OUTLIER -148.2 160.13 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.604 -0.725 . . . . 73.31 111.662 177.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 t -95.92 173.22 7.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.976 -0.556 . . . . 73.43 111.441 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -51.19 -33.08 25.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.413 0.894 . . . . 75.21 113.413 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.8 m -82.71 -22.43 34.48 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.811 0.671 . . . . 70.25 112.811 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -96.53 14.71 23.76 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.349 0.5 . . . . 74.3 112.349 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.37 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.96 0.355 . . . . 71.25 111.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -124.68 -174.63 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.152 0.501 . . . . 72.54 111.014 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.3 m -76.19 107.22 8.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.255 -0.43 . . . . 72.5 111.173 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.78 -19.64 6.54 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.253 -0.499 . . . . 65.32 112.885 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.3 134.43 51.56 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.396 0.617 . . . . 64.24 111.693 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.0 mt -91.58 120.14 32.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.087 -0.506 . . . . 44.11 111.069 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.3 m -96.21 134.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.899 0.38 . . . . 72.33 111.564 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.34 125.9 51.57 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.921 0.391 . . . . 61.4 111.964 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 151' ' ' ARG . 90.6 m-85 -114.95 136.76 52.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.292 -0.413 . . . . 70.23 111.019 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 57.4 mtp180 -79.02 77.82 5.48 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.227 0.537 . . . . 73.34 110.903 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 CA-C-N 116.051 -0.522 . . . . 64.13 112.173 -173.454 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.072 0.463 . . . . 62.43 110.31 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -84.04 118.9 24.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.188 -0.46 . . . . 72.14 110.683 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 10.9 p -105.07 136.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.287 0.565 . . . . 72.41 112.408 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.18 148.02 19.19 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.995 -0.548 . . . . 75.31 112.689 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 72' ' ' VAL . 37.1 mt -87.68 110.22 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.492 -0.416 . . . . 72.13 111.029 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 20.8 t80 -68.13 109.39 3.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.767 0.317 . . . . 74.11 111.173 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.11 -32.48 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.072 0.397 . . . . 73.35 112.072 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 149.25 132.94 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.705 -0.76 . . . . 45.33 113.757 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 t30 55.34 78.33 0.19 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.746 0.647 . . . . 74.54 112.746 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 70.2 -41.04 0.48 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.777 1.029 . . . . 72.51 113.777 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -81.03 146.15 30.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.612 0.72 . . . . 74.12 112.64 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.85 154.65 35.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.349 -0.841 . . . . 73.13 111.153 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 139.49 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.888 0.375 . . . . 73.25 111.3 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -160.53 177.04 10.93 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.019 0.437 . . . . 72.21 111.733 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.93 103.47 10.64 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.208 -0.451 . . . . 73.41 111.393 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 70.8 m -81.38 149.38 28.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.871 0.367 . . . . 70.42 111.439 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.433 ' HA ' ' CG ' ' A' ' 56' ' ' TYR . 71.3 p -56.05 -43.77 78.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.98 0.733 . . . . 74.44 112.98 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.4 m -100.18 -42.07 6.85 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.13 0.418 . . . . 71.41 112.13 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 133' ' ' SER . 55.0 m -76.63 -25.71 54.14 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.825 0.676 . . . . 51.02 112.825 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.68 32.8 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.024 -0.608 . . . . 72.1 112.841 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.47 102.57 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.967 0.413 . . . . 74.13 111.666 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 136' ' ' SER . 47.1 pt -135.99 179.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.582 0.706 . . . . 70.32 112.541 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.66 135.81 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.507 -0.769 . . . . 65.42 110.785 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -132.12 176.1 8.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.441 0.163 . . . . 73.41 110.903 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.2 t -137.31 145.37 43.36 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.786 0.662 . . . . 74.23 112.786 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.49 -20.3 66.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.924 0.712 . . . . 71.34 112.924 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -75.82 -18.67 59.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.717 0.294 . . . . 71.33 111.694 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.4 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 35.7 mt-10 -68.47 130.66 91.98 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 116.668 -0.242 . . . . 75.14 111.061 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.86 -46.6 26.92 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.338 2.692 . . . . 71.41 113.838 -173.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -61.14 -46.31 91.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.709 0.29 . . . . 74.5 111.659 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.4 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 96.1 m95 -73.71 -39.74 64.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.904 0.383 . . . . 74.31 111.029 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.74 -44.83 70.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 75.21 111.629 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -78.63 -32.34 47.33 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.8 0.296 . . . . 63.33 111.8 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 20.0 mmt180 -70.11 -18.89 63.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.89 0.33 . . . . 71.01 111.89 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.15 111.57 0.99 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.33 0.586 . . . . 73.43 111.972 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.576 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -89.17 -57.0 3.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 70.0 110.08 177.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -171.87 176.75 3.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 73.51 110.523 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.413 ' CB ' HG23 ' A' ' 98' ' ' VAL . . . -125.67 153.93 43.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.234 0.54 . . . . 71.44 111.729 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -140.88 167.01 23.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.947 -0.569 . . . . 74.42 110.141 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.8 136.06 13.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.127 0.489 . . . . 71.33 111.287 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.439 HG21 HD21 ' A' ' 84' ' ' LEU . 13.4 m -104.15 3.85 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.785 -0.643 . . . . 72.12 112.314 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.911 0.386 . . . . 63.42 111.629 179.083 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 120.707 0.289 . . . . 71.41 110.859 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.9 t -55.14 -62.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.307 -0.406 . . . . 72.22 111.818 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.583 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 86.7 tttt -53.58 -45.86 70.11 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 74.24 111.66 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.1 m -63.78 -39.29 93.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.058 -0.519 . . . . 74.05 112.204 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -35.53 75.3 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.814 0.301 . . . . 71.32 111.814 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 40' ' ' VAL . 63.8 mt -64.61 -44.2 96.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.053 0.454 . . . . 73.15 110.567 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.9 mmt -64.24 -35.7 81.66 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.028 0.442 . . . . 65.33 110.892 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.72 -36.85 74.94 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.959 -0.564 . . . . 74.44 111.184 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' NE2' ' HE1' ' A' ' 51' ' ' TRP . 7.7 tp60 -76.04 -44.31 39.76 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.293 0.568 . . . . 74.44 111.216 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -55.37 -40.63 71.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.274 -0.421 . . . . 64.32 111.627 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.54 -21.57 65.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.032 0.382 . . . . 74.23 112.032 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -84.52 -42.75 15.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.061 0.457 . . . . 72.52 111.579 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.469 ' HE1' ' NE2' ' A' ' 47' ' ' GLN . 64.9 m95 -82.45 -50.42 8.88 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.43 -0.35 . . . . 64.32 111.708 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HE3' ' HB3' ' A' ' 52' ' ' LYS . 21.2 mmmt 46.46 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.446 1.276 . . . . 75.44 114.446 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.11 38.36 96.0 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.301 0.88 . . . . 72.34 115.301 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.62 131.33 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.635 0.717 . . . . 71.12 110.291 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.34 155.4 28.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.935 0.717 . . . . 72.53 112.935 -174.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -67.83 119.94 13.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.705 -0.68 . . . . 71.15 111.837 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 57' ' ' ARG . 20.6 ttm-85 -137.08 123.75 21.08 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.463 0.305 . . . . 74.45 110.721 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 58' ' ' LEU . 5.3 mp -69.97 113.94 7.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.079 0.466 . . . . 71.14 112.162 -175.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.26 -56.23 5.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 114.137 0.415 . . . . 51.41 114.137 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.7 82.34 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.224 -0.513 . . . . 72.31 113.226 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.497 ' OG ' ' HD2' ' A' ' 74' ' ' ARG . 83.8 p -76.61 110.58 11.3 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.096 0.474 . . . . 73.55 111.841 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -167.47 173.51 8.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.04 0.448 . . . . 63.42 111.524 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -69.41 -7.0 33.72 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.112 0.482 . . . . 54.51 111.42 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -93.42 8.23 41.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.113 0.482 . . . . 61.21 110.934 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.411 ' HA3' ' HE ' ' A' ' 57' ' ' ARG . . . 143.1 144.1 4.23 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.175 -0.466 . . . . 63.11 112.687 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 tt -163.52 135.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.582 -0.364 . . . . 74.34 110.844 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -85.42 177.03 7.92 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.351 0.596 . . . . 75.12 112.406 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' ' 120' ' ' VAL . 27.5 t -52.6 -57.24 10.64 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.694 -0.685 . . . . 71.31 111.933 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -65.53 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.161 0.505 . . . . 74.41 110.954 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.836 ' HA2' HE21 ' A' ' 73' ' ' GLN . . . -61.16 -45.78 95.84 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.946 -0.57 . . . . 65.23 113.107 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.34 -48.92 73.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.521 -0.4 . . . . 73.3 111.743 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.55 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.3 p -60.34 -50.48 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.11 0.411 . . . . 64.5 112.11 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.836 HE21 ' HA2' ' A' ' 70' ' ' GLY . 28.4 pt20 -57.98 -40.95 81.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.093 0.473 . . . . 53.12 111.269 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.651 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.9 mtp180 -71.75 -48.63 45.57 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.725 -0.39 . . . . 72.33 111.868 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.9 m -46.35 -46.3 18.21 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.039 0.447 . . . . 62.13 111.611 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.646 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 55.0 m-85 -67.81 -44.32 77.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.655 0.613 . . . . 75.01 112.655 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.651 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 1.2 ptm180 -73.53 -43.19 60.56 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.757 -0.589 . . . . 75.53 112.284 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 58.2 mm-40 -60.79 -37.73 82.92 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.922 0.392 . . . . 72.51 111.06 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -94.9 -69.34 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.196 0.443 . . . . 64.41 112.196 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -81.14 -22.06 39.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.792 0.664 . . . . 65.45 112.792 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.51 40.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.908 -0.663 . . . . 72.21 112.407 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.3 tp -103.24 117.35 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.698 -0.295 . . . . 74.54 110.864 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 129.59 39.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.184 0.438 . . . . 73.24 112.184 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.3 mt -121.58 159.93 48.47 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.232 -0.44 . . . . 62.4 110.73 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.16 160.87 48.15 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.639 2.226 . . . . 73.11 113.581 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 86' ' ' ARG . 61.8 mtt-85 -88.44 24.86 1.81 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.402 0.89 . . . . 73.34 113.402 -169.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -154.91 142.9 20.12 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.838 -0.539 . . . . 72.43 112.183 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 118' ' ' ARG . 37.9 p -51.96 -50.05 62.01 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.127 -0.488 . . . . 70.1 111.598 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -53.27 -37.63 62.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.578 -0.737 . . . . 53.31 111.359 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.7 -44.56 63.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 65.34 110.756 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.02 -20.98 66.36 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.03 -0.532 . . . . 75.5 112.028 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.4 mt-30 -56.46 -28.04 58.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.963 0.411 . . . . 74.34 111.477 174.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -89.95 -19.46 24.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.216 -0.447 . . . . 75.3 111.737 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.2 mmm -76.1 140.36 41.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.956 0.408 . . . . 73.41 111.847 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.77 -166.87 46.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.173 -0.537 . . . . 43.34 113.454 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -110.34 148.1 32.62 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.296 0.569 . . . . 63.42 111.865 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.7 p -79.5 133.55 36.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.409 -0.814 . . . . 63.33 112.11 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.578 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 3.8 m -146.07 167.31 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.93 0.715 . . . . 74.1 112.93 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.2 t -116.83 -171.43 2.02 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.374 -0.83 . . . . 74.13 110.985 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 -49.91 -56.47 10.41 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.058 0.762 . . . . 73.13 113.058 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 m -65.79 -11.72 48.36 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.734 0.642 . . . . 72.35 112.734 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.576 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.6 m120 -106.7 -4.31 19.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.073 0.398 . . . . 72.33 112.073 -174.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.88 147.38 50.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.985 0.735 . . . . 31.52 112.985 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -118.12 -159.01 0.73 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.654 -0.703 . . . . 72.2 109.297 173.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.8 m -102.01 102.75 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.03 -0.419 . . . . 72.11 110.662 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.06 6.94 5.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.214 -0.517 . . . . 35.23 113.649 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.12 134.69 44.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.261 0.553 . . . . 51.41 112.086 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.46 HD22 HG21 ' A' ' 72' ' ' VAL . 37.9 mt -79.59 110.7 15.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.913 -0.585 . . . . 61.52 110.044 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.44 118.91 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.261 0.553 . . . . 73.02 111.744 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.4 mt -90.28 123.83 34.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.743 -0.662 . . . . 75.33 111.593 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.66 140.99 45.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.182 0.515 . . . . 64.22 111.483 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.593 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 77.1 mtp180 -92.44 97.89 11.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.906 -0.588 . . . . 75.21 111.031 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.18 0.514 . . . . 72.1 111.391 -176.194 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.475 ' O ' HG21 ' A' ' 88' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.671 0.272 . . . . 72.4 110.632 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -115.5 149.89 37.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.245 -0.434 . . . . 74.11 110.556 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -134.84 146.17 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.203 0.525 . . . . 72.14 112.389 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.4 155.99 22.18 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.333 -0.46 . . . . 74.11 112.676 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 72' ' ' VAL . 47.8 mt -90.87 103.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.423 -0.457 . . . . 72.1 111.16 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t80 -69.47 101.11 1.51 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.241 0.543 . . . . 71.12 111.405 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.583 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.6 pt -82.15 -21.87 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.93 -0.577 . . . . 55.25 111.711 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.69 170.9 13.11 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 116.281 -0.418 . . . . 34.22 112.641 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 60.84 27.43 17.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.626 0.37 . . . . 54.33 111.675 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 63.81 23.66 13.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.418 0.287 . . . . 64.2 111.441 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -114.99 150.05 36.42 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.247 0.546 . . . . 71.42 111.55 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 13.5 p90 -156.54 148.68 23.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.88 -0.6 . . . . 75.33 111.992 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.33 141.09 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.793 -0.639 . . . . 73.13 110.952 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.405 ' CE1' HD11 ' A' ' 139' ' ' ILE . 8.1 p80 -158.96 162.1 36.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.94 0.4 . . . . 75.41 111.517 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -101.76 93.75 5.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.191 0.519 . . . . 73.11 110.892 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.63 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 41.1 t -76.78 166.07 23.86 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.169 0.509 . . . . 73.32 111.692 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.7 p -66.4 -66.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.082 0.467 . . . . 61.44 112.067 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 83.5 p -89.63 8.66 30.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.293 0.479 . . . . 63.22 112.293 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 48.5 m -125.84 -29.26 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.736 0.643 . . . . 73.21 112.736 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.86 -154.56 43.54 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.984 -0.627 . . . . 71.4 112.986 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.39 95.77 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.167 0.432 . . . . 74.14 112.167 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -131.23 -178.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.098 0.475 . . . . 72.3 112.263 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.51 139.44 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 72.11 111.255 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.8 p -143.87 163.94 31.97 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.748 0.308 . . . . 52.41 110.822 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.418 ' HB2' ' HG2' ' A' ' 145' ' ' GLU . 45.5 m -113.73 143.87 43.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.907 0.706 . . . . 75.22 112.907 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 91.4 mmm -58.86 -30.42 67.71 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.906 -0.588 . . . . 73.14 111.266 174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -68.71 -19.62 64.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.146 -0.479 . . . . 70.32 112.164 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 41.4 mm-40 -64.98 113.65 11.87 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 117.027 -0.079 . . . . 74.52 110.952 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -43.71 -38.54 9.49 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.248 2.632 . . . . 55.3 113.818 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.641 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 71.7 t80 -57.62 -50.49 72.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.764 0.316 . . . . 72.45 111.629 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -82.53 -36.31 26.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.015 0.436 . . . . 72.2 111.455 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.5 -36.97 64.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.862 -0.608 . . . . 73.4 111.983 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -83.6 -15.21 49.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.886 0.328 . . . . 75.32 111.886 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 20.6 mmt180 -89.74 -17.15 28.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.993 0.368 . . . . 71.31 111.993 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.26 116.49 3.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.538 . . . . 72.23 112.454 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.473 HD22 ' HG2' ' A' ' 154' ' ' GLU . 18.5 t30 -92.57 -60.8 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.977 -0.556 . . . . 55.21 110.889 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.473 ' HG2' HD22 ' A' ' 153' ' ' ASN . 11.7 pt-20 -173.34 170.73 4.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.38 0.272 . . . . 74.04 110.503 176.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -119.98 169.41 10.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.267 0.84 . . . . 53.11 113.267 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -137.75 113.51 9.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.538 -0.755 . . . . 61.12 111.838 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.578 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.72 105.98 9.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.934 0.397 . . . . 75.04 110.55 171.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.44 -0.69 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.738 0.644 . . . . 73.41 112.738 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 82' ' ' LEU . 81.9 mt . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.917 0.389 . . . . 71.02 111.913 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.72 0.295 . . . . 74.2 111.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.1 t -46.53 -49.76 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.22 0.533 . . . . 61.53 111.118 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 82.9 tttt -54.78 -48.29 72.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.655 -0.702 . . . . 72.24 112.33 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.2 p -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.935 0.398 . . . . 72.54 111.766 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.31 -36.89 85.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.473 -0.33 . . . . 70.43 111.592 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.3 mt -63.07 -36.64 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.959 0.409 . . . . 74.21 110.641 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 28.8 mmt -70.2 -36.5 74.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.454 -0.339 . . . . 54.14 111.316 175.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.78 -42.54 99.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.214 0.531 . . . . 73.3 110.526 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.61 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 56.8 tp60 -64.03 -48.01 77.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.013 -0.54 . . . . 71.32 110.515 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -53.59 -39.56 64.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.797 -0.638 . . . . 73.41 111.499 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . . . -54.99 -34.42 63.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.018 0.437 . . . . 43.43 111.843 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.17 -24.46 51.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.088 0.471 . . . . 73.1 111.459 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -114.84 18.32 16.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.783 0.66 . . . . 75.35 112.783 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' A' ' 49' ' ' ALA . 10.2 mtmp? -59.09 109.08 0.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.144 0.497 . . . . 52.52 112.245 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.03 4.53 68.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 114.793 0.677 . . . . 61.03 114.793 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.49 127.68 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.839 0.82 . . . . 72.33 110.806 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -71.08 157.51 38.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.97 0.73 . . . . 72.12 112.97 -176.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -77.2 126.03 30.28 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.347 -0.842 . . . . 74.33 111.775 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -138.04 110.37 7.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.476 -0.329 . . . . 74.15 111.68 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.32 121.25 15.88 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.984 0.421 . . . . 74.12 111.894 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.79 69.34 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.098 -0.572 . . . . 42.42 113.9 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -138.5 137.86 9.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.33 -0.462 . . . . 63.14 112.365 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.7 m -125.86 99.49 5.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.001 0.401 . . . . 53.24 111.541 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 64' ' ' LYS . 4.0 t -177.28 177.69 1.18 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.251 -0.432 . . . . 75.24 111.115 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -71.17 -11.49 60.97 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.082 0.468 . . . . 62.21 110.87 178.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' HB2' HG23 ' A' ' 62' ' ' THR . 30.2 mmmt -74.81 -11.83 60.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.213 0.53 . . . . 74.2 110.703 170.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 55' ' ' ARG . . . 145.23 148.11 4.76 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.119 -0.491 . . . . 64.13 112.75 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 19.8 tt -154.98 144.81 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.861 0.331 . . . . 71.54 111.436 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.16 179.91 4.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.201 0.524 . . . . 54.23 112.349 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.7 t -58.82 -61.25 2.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.416 0.525 . . . . 71.12 112.416 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -59.01 -36.86 75.67 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.974 0.416 . . . . 72.22 111.533 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.91 95.06 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 121.057 -0.592 . . . . 74.55 113.219 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.26 -54.73 28.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.895 0.332 . . . . 73.42 111.895 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG21 HD22 ' A' ' 108' ' ' LEU . 7.4 p -57.0 -41.91 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.956 0.408 . . . . 71.35 111.216 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -50.85 -62.67 1.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.312 0.577 . . . . 71.32 111.315 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HA ' ' CG ' ' A' ' 77' ' ' ARG . 10.3 mtp180 -63.66 -34.91 78.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.888 -0.596 . . . . 74.3 112.457 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.61 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 95.7 m -55.93 -54.58 42.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.083 0.468 . . . . 64.3 111.555 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.492 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.1 m-85 -65.84 -37.81 87.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.829 0.677 . . . . 73.52 112.829 -177.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HA ' ' H ' ' A' ' 82' ' ' LEU . 3.0 ptm180 -75.15 -43.46 52.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.773 -0.579 . . . . 72.34 112.265 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.41 -18.49 64.45 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 122.098 -0.376 . . . . 74.3 111.756 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -108.39 -68.22 0.92 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.121 0.415 . . . . 75.11 112.121 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.63 0.45 57.38 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.579 0.585 . . . . 63.12 112.579 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.64 44.27 98.03 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 61.04 113.095 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.3 tp -104.68 122.39 45.57 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.087 0.47 . . . . 72.31 111.785 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.71 96.93 2.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.206 0.527 . . . . 72.12 112.037 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.52 135.69 21.06 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.153 -0.476 . . . . 64.12 110.513 173.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.03 -175.62 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.463 2.109 . . . . 74.34 112.301 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -109.25 6.21 24.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.855 -0.528 . . . . 73.21 111.663 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.7 m -108.71 128.05 54.52 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.447 -0.342 . . . . 64.21 110.619 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 118' ' ' ARG . 4.8 m -56.76 -46.52 81.37 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.383 0.512 . . . . 52.24 112.383 -173.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.578 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 33.3 m-85 -59.69 -36.46 76.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 111.872 0.323 . . . . 74.41 111.872 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.63 -36.02 60.32 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.974 0.416 . . . . 53.33 111.471 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.21 -43.87 93.68 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.91 0.386 . . . . 70.23 111.499 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 17.0 pt20 -62.88 -26.87 68.99 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.965 0.412 . . . . 74.41 111.392 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -86.19 -10.08 55.37 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.23 0.455 . . . . 65.43 112.23 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.5 mmm -66.39 -37.51 85.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.162 0.506 . . . . 71.24 110.86 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.35 166.56 12.2 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 116.0 -0.546 . . . . 55.32 112.11 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -86.96 160.34 18.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.36 -0.494 . . . . 54.4 111.221 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.537 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 36.5 t -78.62 135.02 37.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.602 0.593 . . . . 74.0 112.602 -174.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.55 HG23 ' HB3' ' A' ' 155' ' ' ALA . 15.5 m -127.89 142.99 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 54.51 110.633 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.6 t -88.66 177.12 6.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.99 0.424 . . . . 73.31 111.26 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -49.68 -29.19 6.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.153 0.581 . . . . 62.25 112.142 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m -84.4 -21.14 30.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.884 0.698 . . . . 64.12 112.884 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.0 m120 -108.16 11.35 27.57 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.002 0.741 . . . . 72.12 113.002 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.0 151.84 14.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.911 0.708 . . . . 65.11 112.911 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -140.35 143.78 35.94 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.096 -0.502 . . . . 74.21 111.18 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.9 m -58.47 96.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.833 0.349 . . . . 61.43 110.948 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 123.62 14.17 3.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.171 -0.538 . . . . 54.31 113.818 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.24 167.87 13.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.94 0.87 . . . . 72.04 111.123 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.465 HD22 HG21 ' A' ' 72' ' ' VAL . 47.1 mt -102.85 113.87 27.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.097 -0.501 . . . . 62.45 110.549 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -94.92 122.66 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.401 0.62 . . . . 74.22 111.43 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 92' ' ' GLN . 67.0 mt -100.4 124.48 45.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.579 -0.737 . . . . 73.32 111.785 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -116.02 138.41 51.24 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.982 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -74.22 94.64 2.5 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.899 0.381 . . . . 73.31 110.715 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 120.759 0.314 . . . . 74.52 111.627 -178.463 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.403 ' O ' HG21 ' A' ' 88' ' ' THR . 13.8 mmm180 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 121.002 0.43 . . . . 74.4 110.218 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -91.17 126.9 36.4 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.196 -0.456 . . . . 70.13 110.459 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -111.6 132.03 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.529 0.681 . . . . 74.33 112.288 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -124.45 160.69 19.03 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.58 -0.736 . . . . 74.54 112.074 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.3 mt -97.04 112.8 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.091 0.446 . . . . 71.15 111.019 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.476 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 51.7 t80 -75.83 113.71 13.62 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.107 0.48 . . . . 73.14 111.904 -175.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.402 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.2 pt -99.06 -7.95 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.155 0.428 . . . . 71.35 112.155 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.68 164.37 13.21 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.111 -0.566 . . . . 72.03 113.348 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 58.61 31.08 20.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.762 0.425 . . . . 73.31 112.021 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.476 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 80.1 m-20 67.19 13.16 9.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.987 -0.551 . . . . 42.1 112.367 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -101.32 144.62 29.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.318 0.58 . . . . 62.44 111.493 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -152.91 146.38 24.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.77 -0.65 . . . . 62.13 111.584 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.69 138.76 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.729 0.299 . . . . 64.52 111.008 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -158.78 175.04 14.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.976 0.417 . . . . 75.12 111.631 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.21 103.44 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.195 -0.457 . . . . 62.21 111.045 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 36.9 t -89.17 162.5 15.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.789 0.328 . . . . 72.21 111.421 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -55.12 -61.55 2.24 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.034 0.753 . . . . 63.55 113.034 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m -93.69 -36.28 12.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.888 -0.508 . . . . 62.42 111.453 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 14.4 m -66.97 -29.62 69.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.242 -0.435 . . . . 71.12 112.118 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.69 34.75 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.97 -0.633 . . . . 61.13 112.565 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.46 102.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 117.127 0.464 . . . . 74.32 111.761 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.499 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -139.62 -179.01 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.13 0.49 . . . . 70.21 111.608 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.17 144.3 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.957 0.408 . . . . 73.13 110.72 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.7 m -137.08 169.41 17.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.199 -0.313 . . . . 71.13 111.396 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.2 m -130.52 139.89 50.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.911 0.386 . . . . 74.22 111.769 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 127' ' ' ASN . 67.1 mtt -65.37 -9.63 26.5 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.439 0.533 . . . . 72.34 112.439 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.67 -4.89 45.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.949 0.404 . . . . 64.21 111.452 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.41 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 25.8 mm-40 -83.56 127.08 69.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.244 -0.434 . . . . 73.53 109.962 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.432 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 84.9 Cg_exo -46.75 -39.0 23.49 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.704 2.269 . . . . 61.24 113.691 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.545 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 73.6 t80 -60.22 -51.31 70.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.651 0.263 . . . . 74.03 111.623 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.41 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 86.6 m95 -73.26 -33.35 65.21 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.899 0.38 . . . . 74.54 111.431 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 143' ' ' MET . 37.9 ttpt -68.54 -39.85 80.96 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.07 0.396 . . . . 75.13 112.07 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 19.3 ptpt -79.56 -28.13 41.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.738 0.304 . . . . 70.32 111.812 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 9.6 mmm180 -91.13 -4.88 55.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 111.886 0.328 . . . . 71.13 111.886 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -59.07 111.59 1.38 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.006 0.431 . . . . 74.11 111.41 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.407 HD22 ' HG2' ' A' ' 154' ' ' GLU . 6.9 t30 -92.26 -50.65 5.55 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.251 -0.431 . . . . 63.03 111.844 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.407 ' HG2' HD22 ' A' ' 153' ' ' ASN . 14.7 pt-20 -177.57 -173.02 0.39 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.329 -0.396 . . . . 72.34 110.901 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.55 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -140.42 159.87 41.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.89 0.376 . . . . 63.32 111.366 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.537 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt85 -139.42 109.54 6.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.473 0.309 . . . . 61.34 111.432 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 108.05 17.81 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.617 0.722 . . . . 74.24 111.42 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.71 -27.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.856 -0.611 . . . . 64.11 112.437 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 111.919 0.34 . . . . 73.22 111.919 -179.217 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 120.972 0.415 . . . . 72.13 111.528 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 44' ' ' ILE . 83.5 t -50.69 -54.23 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.174 -0.466 . . . . 65.43 111.557 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.531 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.2 tttt -53.9 -50.51 66.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.232 -0.44 . . . . 73.43 111.613 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 t -59.21 -44.35 92.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.425 -0.352 . . . . 42.44 111.879 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -63.68 -39.84 95.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.274 0.559 . . . . 74.14 111.303 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 40' ' ' VAL . 76.4 mt -61.37 -40.33 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.056 0.455 . . . . 74.11 110.6 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 30.3 mmt -63.54 -34.93 78.87 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.104 -0.498 . . . . 52.32 111.583 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.95 -45.4 86.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.912 0.387 . . . . 54.45 110.934 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.429 ' O ' ' HD1' ' A' ' 51' ' ' TRP . 15.7 mm100 -62.53 -52.37 63.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.974 0.416 . . . . 64.13 111.044 174.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -55.37 -38.42 68.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.106 0.409 . . . . 71.21 112.106 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.92 -30.92 71.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.471 . . . . 61.23 111.396 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -76.28 -31.95 58.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.134 -0.485 . . . . 74.34 111.126 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.429 ' HD1' ' O ' ' A' ' 47' ' ' GLN . 77.7 m95 -99.77 16.55 23.25 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.596 0.591 . . . . 74.14 112.596 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.81 109.83 1.02 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.836 0.31 . . . . 73.43 111.836 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.15 15.31 54.22 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.916 -0.659 . . . . 71.34 114.146 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -78.56 132.88 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 117.318 0.559 . . . . 72.32 111.951 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -73.84 152.44 40.24 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.201 0.524 . . . . 74.51 111.907 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 67' ' ' ASP . 72.4 t80 -83.7 148.18 27.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.034 0.445 . . . . 75.25 111.856 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 58.0 ttm-85 -137.69 148.73 45.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.039 -0.528 . . . . 72.24 110.611 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.02 93.59 8.42 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.973 -0.454 . . . . 74.32 110.701 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.37 61.32 1.25 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.216 -0.447 . . . . 44.42 113.361 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -176.37 150.82 10.83 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.16 -0.543 . . . . 73.51 112.685 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.528 ' HA ' HG13 ' A' ' 66' ' ' ILE . 80.7 p -128.0 99.93 5.69 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.554 0.575 . . . . 72.0 112.554 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 t -170.46 167.54 8.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.41 0.284 . . . . 74.04 111.439 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -66.35 -22.82 66.27 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.015 0.435 . . . . 71.23 111.206 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -91.14 21.14 4.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.077 0.465 . . . . 72.31 111.364 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.534 ' HA3' ' HE ' ' A' ' 57' ' ' ARG . . . 142.88 112.76 0.9 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.223 -0.513 . . . . 64.23 113.199 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 20.5 tt -137.34 144.79 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 117.067 0.434 . . . . 65.05 111.558 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.0 p30 -97.89 174.13 6.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.451 0.644 . . . . 62.13 111.98 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.6 t -58.92 -44.53 91.34 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.925 0.713 . . . . 41.03 112.925 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.6 p -74.39 -39.05 62.94 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.738 0.304 . . . . 62.35 110.471 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.63 91.5 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.372 -0.442 . . . . 72.11 112.928 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.02 -53.23 41.15 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.769 0.318 . . . . 73.13 111.633 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.96 -48.04 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 111.909 0.337 . . . . 71.42 111.909 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.581 HE22 ' HG2' ' A' ' 86' ' ' ARG . 13.8 pt20 -59.47 -43.82 93.15 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.15 -0.343 . . . . 72.5 111.463 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.556 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 55.8 mtp180 -64.98 -47.61 76.95 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.12 -0.232 . . . . 71.04 111.53 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -50.57 -44.39 56.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.966 0.413 . . . . 54.11 111.777 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 59.0 m-85 -75.66 -44.46 42.37 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.999 0.74 . . . . 73.43 112.999 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 9.0 ptm180 -62.0 -32.19 72.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.436 -0.79 . . . . 75.13 111.512 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 33.7 mm-40 -73.24 -72.99 0.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.94 0.4 . . . . 74.13 111.929 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -87.11 -5.96 58.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.212 0.819 . . . . 73.04 113.212 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.402 ' HD2' ' HA ' ' A' ' 76' ' ' PHE . 91.0 m-85 -127.41 -7.33 5.8 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 62.22 112.086 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.84 37.78 79.94 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.228 -0.511 . . . . 75.42 113.18 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 34.9 tp -104.9 144.38 31.86 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.892 0.377 . . . . 71.14 111.151 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -95.49 125.96 40.46 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.936 0.398 . . . . 73.41 111.834 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 73' ' ' GLN . 88.2 mt -135.12 133.47 20.82 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.472 -0.331 . . . . 74.12 110.929 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.71 155.93 61.85 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.788 2.325 . . . . 61.5 113.275 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.581 ' HG2' HE22 ' A' ' 73' ' ' GLN . 67.2 mtt85 -82.66 48.8 1.37 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.965 0.728 . . . . 63.34 112.965 -172.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.497 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 20.3 t -169.09 135.54 1.73 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.214 -0.448 . . . . 72.31 111.276 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.631 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 25.5 m -53.19 -46.35 68.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.374 -0.376 . . . . 73.15 111.036 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -39.4 75.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.078 0.466 . . . . 63.52 111.696 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.497 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 14.5 mm-40 -75.93 -35.57 59.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.996 -0.547 . . . . 71.13 111.115 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.94 -30.13 70.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.912 0.387 . . . . 70.32 111.775 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 88' ' ' THR . 20.0 mt-30 -62.72 -21.01 65.47 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.734 0.302 . . . . 74.15 111.749 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.01 16.42 1.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.667 0.617 . . . . 64.1 112.667 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptp -142.52 -178.58 5.83 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 122.186 -0.321 . . . . 71.24 111.067 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.3 50.89 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.13 -0.557 . . . . 63.31 113.141 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.6 mmtp -127.75 139.17 52.84 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.416 -0.461 . . . . 73.01 111.952 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.552 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 75.5 p -76.32 127.84 33.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.761 -0.654 . . . . 75.24 111.905 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.592 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 5.7 m -136.93 157.72 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.307 0.575 . . . . 62.15 112.532 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 t -109.62 -177.31 3.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.786 -0.643 . . . . 74.05 112.353 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.647 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 24.3 mmm180 -41.04 -50.28 3.36 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.26 1.208 . . . . 73.24 114.26 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -84.34 -14.4 49.72 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.566 0.58 . . . . 70.24 112.566 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.8 m120 -89.75 -12.23 39.94 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.977 0.362 . . . . 75.01 111.977 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -57.77 131.88 51.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.979 0.733 . . . . 65.51 112.979 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -111.96 -162.33 0.79 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.788 -0.642 . . . . 74.53 110.381 171.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.531 HG21 ' HB2' ' A' ' 41' ' ' LYS . 91.7 m -92.9 108.35 19.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.708 0.289 . . . . 74.14 110.849 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.66 -10.36 7.58 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.598 -0.334 . . . . 74.31 112.753 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.416 ' OD2' ' HD2' ' A' ' 157' ' ' ARG . 0.8 OUTLIER -60.9 127.05 29.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.115 0.413 . . . . 75.44 112.115 177.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 39.4 mt -82.87 108.07 15.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.892 0.377 . . . . 51.22 110.754 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 155' ' ' ALA . 28.4 m -96.27 124.86 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.284 0.564 . . . . 63.31 111.965 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 73.8 mt -93.96 136.16 34.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.831 -0.622 . . . . 74.3 112.002 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 96.0 m-85 -124.22 139.99 53.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 64.24 111.666 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -81.05 98.32 7.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.601 -0.272 . . . . 74.12 111.141 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 121.145 0.498 . . . . 64.33 111.743 179.593 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 109.457 -0.572 . . . . 74.1 109.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 69.0 t60 -84.24 149.32 26.2 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.816 -0.629 . . . . 64.21 111.277 -172.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 7.6 p -142.6 119.04 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.461 0.648 . . . . 74.52 111.948 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -114.33 152.85 17.93 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.204 -0.522 . . . . 71.12 112.854 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.4 mt -88.39 106.92 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 122.51 -0.406 . . . . 73.22 110.706 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -68.51 116.73 9.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.045 0.45 . . . . 72.21 111.338 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.1 pt -103.04 -14.44 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.361 0.504 . . . . 35.24 112.361 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.13 164.67 11.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.11 -0.567 . . . . 70.3 112.991 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 127' ' ' ASN . 13.4 m120 61.58 27.35 16.84 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.002 0.401 . . . . 71.3 111.891 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 126' ' ' ASN . 47.6 m-80 67.12 7.61 5.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.328 0.251 . . . . 75.44 111.509 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.7 144.17 26.2 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.595 0.712 . . . . 60.44 111.253 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -149.29 138.43 21.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 73.25 111.056 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.92 133.43 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.031 0.443 . . . . 53.44 110.7 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -157.73 172.2 18.93 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.257 0.551 . . . . 73.44 111.723 -173.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -105.12 93.04 4.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.0 -0.546 . . . . 71.45 110.154 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.7 p -67.39 140.04 57.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.952 0.406 . . . . 75.1 111.531 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -57.6 -30.33 65.22 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.914 0.709 . . . . 63.3 112.914 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.9 t -102.18 -53.82 2.83 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.564 0.579 . . . . 65.4 112.564 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 t -81.0 -33.59 33.55 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.601 0.593 . . . . 61.34 112.601 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.44 -153.09 17.01 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.164 -0.541 . . . . 62.42 112.635 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.58 106.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.211 0.506 . . . . 73.41 111.499 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.5 178.21 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.299 0.571 . . . . 72.13 112.033 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.03 138.17 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.944 -0.571 . . . . 73.43 109.957 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.4 m -132.06 171.7 13.29 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.312 -0.243 . . . . 74.21 111.152 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.6 m -127.66 138.24 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.873 0.323 . . . . 72.31 111.873 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.647 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 66.3 mtt -64.78 -12.18 44.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.97 0.414 . . . . 75.5 111.866 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.452 HD22 ' N ' ' A' ' 144' ' ' ASN . 0.9 OUTLIER -66.1 -28.28 68.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.83 0.348 . . . . 75.33 111.204 173.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.56 125.54 92.04 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.573 -0.285 . . . . 71.25 110.63 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.486 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 82.3 Cg_exo -46.39 -41.88 22.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.968 2.445 . . . . 72.53 113.723 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -59.63 -41.5 90.61 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.223 0.453 . . . . 74.1 112.223 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.03 -36.44 19.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.011 0.375 . . . . 74.53 112.011 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -54.81 -50.93 67.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.074 0.464 . . . . 73.13 111.612 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 18.4 ptpt -82.35 1.17 38.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.975 0.417 . . . . 71.12 111.88 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -96.18 -28.69 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.531 0.332 . . . . 74.33 110.959 176.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -58.51 115.4 2.99 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.179 -0.464 . . . . 73.31 112.097 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.413 HD22 ' HG2' ' A' ' 154' ' ' GLU . 7.5 t30 -98.07 -62.43 1.25 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.059 -0.519 . . . . 72.34 111.447 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.413 ' HG2' HD22 ' A' ' 153' ' ' ASN . 13.5 pt-20 -158.44 164.73 35.95 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.231 -0.293 . . . . 74.12 110.482 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -126.24 149.22 49.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.551 0.215 . . . . 62.23 111.523 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.552 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 89.5 mtt180 -143.99 112.72 6.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.611 0.243 . . . . 71.34 110.987 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.592 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -85.4 129.31 34.84 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.16 0.505 . . . . 72.22 110.84 176.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 84' ' ' LEU . 27.8 m -107.13 7.89 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.895 0.702 . . . . 73.42 112.895 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.177 0.513 . . . . 73.42 112.235 -179.895 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.913 0.387 . . . . 64.03 111.566 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 44' ' ' ILE . 86.6 t -48.66 -46.08 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 72.25 111.215 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 45' ' ' MET . 58.9 tttm -54.89 -46.3 74.79 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.576 0.584 . . . . 74.23 112.576 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.7 p -60.61 -44.03 96.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.801 0.334 . . . . 72.41 111.868 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -73.93 -30.03 62.35 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.445 0.535 . . . . 70.55 112.445 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 40' ' ' VAL . 75.4 mt -63.69 -43.85 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.265 0.555 . . . . 73.23 110.135 173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 87.4 mmm -66.63 -37.1 84.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.064 -0.516 . . . . 74.32 110.848 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.06 -43.45 70.25 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.169 0.509 . . . . 74.44 111.475 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.43 ' NE2' HE22 ' A' ' 79' ' ' GLN . 5.3 tp-100 -69.8 -54.51 13.26 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.273 -0.421 . . . . 75.14 110.617 174.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.432 ' OH ' ' NZ ' ' A' ' 52' ' ' LYS . 16.4 t80 -49.01 -39.68 27.78 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.088 0.773 . . . . 74.0 113.088 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.45 -33.81 55.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.115 0.484 . . . . 71.12 111.884 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.79 -23.41 55.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.038 -0.528 . . . . 63.32 112.413 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 138' ' ' VAL . 82.8 m95 -97.2 -0.31 47.01 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.587 0.588 . . . . 72.14 112.587 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.432 ' NZ ' ' OH ' ' A' ' 48' ' ' TYR . 29.5 mtpp -64.85 95.37 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.992 0.425 . . . . 71.51 111.269 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.81 -12.47 7.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.444 -0.407 . . . . 73.54 112.725 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.6 t -74.18 124.9 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 50.43 111.187 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -86.2 160.64 19.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.563 0.697 . . . . 74.41 112.39 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 47.3 t80 -74.72 127.51 33.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.412 -0.813 . . . . 63.03 112.125 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -136.93 121.53 18.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.712 0.291 . . . . 74.43 111.599 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.86 121.63 22.91 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.201 0.445 . . . . 62.42 112.201 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.4 50.82 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.946 -0.645 . . . . 53.3 113.689 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -151.7 135.63 5.13 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.09 -0.576 . . . . 61.24 112.438 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.521 ' HA ' HG13 ' A' ' 66' ' ' ILE . 29.0 p -125.44 98.98 5.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.315 0.579 . . . . 53.22 111.691 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.1 t -159.84 161.88 34.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.065 -0.516 . . . . 71.43 110.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -67.88 -3.36 9.49 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.061 0.458 . . . . 71.12 111.738 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -92.55 -19.37 22.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.983 0.421 . . . . 74.43 111.269 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 136.52 2.23 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.59 -0.604 . . . . 60.11 111.59 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.521 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.4 tt -157.45 150.96 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 117.702 0.751 . . . . 62.03 112.496 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.15 -179.36 4.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.273 0.558 . . . . 70.52 112.186 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.4 t -58.15 -56.64 19.48 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.593 0.59 . . . . 71.23 112.593 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 75.2 p -60.46 -36.2 77.68 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.939 0.399 . . . . 74.53 111.608 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.66 85.09 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.039 -0.528 . . . . 74.01 113.17 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.73 -50.92 70.48 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.587 -0.361 . . . . 74.45 111.72 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.509 ' HA ' HD11 ' A' ' 122' ' ' ILE . 11.0 p -65.14 -43.79 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 111.987 0.366 . . . . 73.33 111.987 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.578 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 21.1 pt20 -62.18 -38.93 90.96 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.162 -0.336 . . . . 64.24 111.592 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 74' ' ' ARG . 14.4 mtp180 -67.12 -55.54 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.715 0.293 . . . . 71.52 111.579 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.4 m -47.46 -42.35 22.42 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.284 0.475 . . . . 74.41 112.284 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 49.9 m-85 -75.02 -41.55 59.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.717 0.636 . . . . 70.24 112.717 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 13.7 ptm180 -76.92 -26.68 54.37 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.812 -0.555 . . . . 62.01 112.355 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.0 -37.67 16.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.122 0.415 . . . . 55.42 112.122 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.43 HE22 ' NE2' ' A' ' 47' ' ' GLN . 19.2 mp0 -93.48 -48.43 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.9 0.704 . . . . 71.42 112.9 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 58.4 m-85 -101.55 -5.58 24.97 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.42 0.526 . . . . 63.34 112.42 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.59 13.62 74.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.089 -0.577 . . . . 73.35 113.066 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -90.82 111.51 22.94 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.671 -0.311 . . . . 71.23 110.674 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.48 95.85 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.177 0.513 . . . . 70.35 112.149 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 91.4 mt -82.69 143.6 47.3 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.1 -0.5 . . . . 74.4 110.195 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.45 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 43.9 Cg_endo -67.45 -172.67 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.53 2.153 . . . . 73.05 113.522 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.409 ' H ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -95.62 -33.09 12.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.864 0.69 . . . . 73.22 112.864 -172.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.512 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 19.9 m -96.43 141.74 29.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.69 0.255 . . . . 74.32 111.69 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 59.8 m -52.13 -50.35 61.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.905 0.335 . . . . 75.15 111.905 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.467 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 24.9 m-85 -54.11 -44.0 70.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.534 0.207 . . . . 64.11 111.437 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.512 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 45.3 mt-10 -58.91 -47.5 84.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.552 . . . . 62.43 110.87 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -63.37 -30.71 71.79 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.147 -0.479 . . . . 73.02 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.7 mt-30 -71.34 -21.05 62.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.465 -0.334 . . . . 75.4 111.495 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 89' ' ' TYR . 41.6 mt-10 -79.48 -5.23 54.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.852 0.358 . . . . 74.34 111.132 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.45 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 75.0 mtp -106.28 131.83 53.04 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.368 -0.378 . . . . 52.34 110.936 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.24 134.78 1.07 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.465 -0.397 . . . . 73.03 113.715 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 96' ' ' LYS . 70.3 mmtt -88.31 162.53 16.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.587 . . . . 65.32 112.025 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 29.6 m -75.38 155.19 36.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.208 1.188 . . . . 42.42 114.208 -167.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 155' ' ' ALA . 0.9 OUTLIER -144.04 149.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.017 -0.992 . . . . 70.35 110.864 171.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 t -100.57 -173.49 2.42 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.367 -0.379 . . . . 64.33 111.355 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.461 HH11 ' HE2' ' A' ' 152' ' ' TYR . 1.1 mpp_? -59.87 -38.56 82.53 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.978 1.103 . . . . 73.02 113.978 -169.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.9 p -79.86 -5.68 55.96 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.744 -0.598 . . . . 51.32 111.67 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -116.73 11.11 14.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.843 0.312 . . . . 62.41 111.843 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 78.1 mt -72.44 129.56 38.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.109 0.48 . . . . 65.14 111.588 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.402 HH21 HG11 ' A' ' 98' ' ' VAL . 41.3 mtm180 -138.8 172.23 13.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.02 0.528 . . . . 73.34 111.08 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.3 m -64.94 114.93 4.88 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.184 0.516 . . . . 71.23 111.969 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.86 -3.36 24.36 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.296 -0.478 . . . . 72.12 113.696 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -79.99 134.16 36.22 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.304 0.573 . . . . 70.14 111.125 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 77.3 mt -89.36 119.37 29.77 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.477 -0.328 . . . . 63.22 111.482 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 155' ' ' ALA . 12.5 m -95.62 129.24 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.978 0.418 . . . . 70.43 111.721 -177.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.61 140.7 33.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.308 -0.405 . . . . 45.44 111.58 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.41 140.09 51.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.794 0.33 . . . . 73.15 111.407 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -86.72 90.13 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.917 0.389 . . . . 75.34 110.229 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 112.372 0.508 . . . . 44.24 112.372 -173.898 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.44 ' O ' HG21 ' A' ' 88' ' ' THR . 2.7 mpt_? . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 121.232 0.539 . . . . 64.45 110.552 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -92.63 143.01 26.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.919 -0.582 . . . . 73.33 110.613 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.93 137.58 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.263 0.554 . . . . 63.3 112.346 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.26 20.65 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.044 -0.525 . . . . 72.25 112.874 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.509 HD11 ' HA ' ' A' ' 72' ' ' VAL . 47.0 mt -90.27 109.42 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.801 0.3 . . . . 74.33 111.038 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.545 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 63.8 t80 -75.46 113.78 13.27 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.954 0.407 . . . . 63.13 111.358 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.44 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 27.7 pt -95.51 -32.96 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.107 0.41 . . . . 65.52 112.107 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.38 165.36 11.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.187 -0.53 . . . . 53.13 113.2 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.407 ' O ' ' HG3' ' A' ' 128' ' ' GLN . 10.0 t30 59.39 42.49 17.89 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.219 0.533 . . . . 74.25 110.788 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.545 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 4.2 p30 51.53 17.18 0.52 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.066 0.947 . . . . 62.34 112.725 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 126' ' ' ASN . 28.0 mt-30 -108.56 145.51 34.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.371 0.605 . . . . 72.22 111.702 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.525 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 8.0 p90 -148.97 150.43 32.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.648 -0.706 . . . . 74.31 111.659 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.49 140.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.014 0.435 . . . . 75.31 111.326 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -161.72 -166.37 1.46 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.474 -0.33 . . . . 71.15 111.236 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.96 106.46 8.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.76 0.314 . . . . 63.12 111.615 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.6 m -81.89 155.19 25.44 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.892 0.377 . . . . 71.13 111.987 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 67.8 p -52.84 -46.56 67.84 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.216 1.191 . . . . 63.44 114.216 -172.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -100.56 -44.74 5.75 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.904 -0.497 . . . . 72.3 112.07 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.0 m -65.77 -38.71 89.8 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.938 0.718 . . . . 53.41 112.938 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.66 -146.4 18.25 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.937 -0.649 . . . . 53.4 112.212 -173.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 51' ' ' TRP . 61.0 t -69.38 111.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 117.201 0.5 . . . . 61.32 111.67 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.2 pt -141.16 -179.98 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.165 0.507 . . . . 74.24 111.663 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.47 137.08 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.192 -0.458 . . . . 72.3 110.42 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.5 m -130.44 159.08 38.13 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.938 0.399 . . . . 74.32 111.68 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.6 m -115.2 148.4 39.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.366 -0.379 . . . . 61.24 111.586 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.511 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 91.8 mmm -67.54 -22.53 65.41 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.14 0.495 . . . . 65.2 110.863 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.33 -20.6 66.13 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.098 -0.501 . . . . 71.04 111.615 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -67.1 132.25 93.64 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.546 0.212 . . . . 72.44 110.96 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.592 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 14.1 Cg_endo -54.49 -48.79 19.53 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.747 2.298 . . . . 72.11 113.299 -174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -56.54 -48.47 77.21 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.129 0.418 . . . . 75.1 112.129 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.9 -40.07 61.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.228 -0.442 . . . . 72.22 111.424 -174.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -53.56 -55.95 21.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.162 -0.472 . . . . 62.34 111.834 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.608 ' HG3' ' HD2' ' A' ' 151' ' ' ARG . 19.1 ptpt -74.06 -28.74 61.54 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.803 0.668 . . . . 55.52 112.803 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.608 ' HD2' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -86.89 -7.5 58.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.478 0.547 . . . . 74.4 112.478 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.461 ' HE2' HH11 ' A' ' 100' ' ' ARG . 63.3 t80 -60.0 121.44 11.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.114 0.483 . . . . 75.13 111.778 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -94.65 -69.59 0.75 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.851 -0.613 . . . . 71.51 111.234 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.65 144.15 7.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.507 -0.315 . . . . 64.33 111.627 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -99.82 162.88 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.417 -0.177 . . . . 70.54 111.172 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -141.81 141.46 33.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.037 0.446 . . . . 73.31 111.899 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 157' ' ' ARG . 0.5 OUTLIER -97.45 95.29 7.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.29 0.567 . . . . 75.21 111.677 178.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.78 -15.18 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.004 -0.544 . . . . 65.43 112.175 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.479 HD23 HD22 ' A' ' 82' ' ' LEU . 96.0 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.683 0.278 . . . . 70.23 111.371 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.139 0.495 . . . . 63.41 110.938 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 44' ' ' ILE . 60.0 t -52.13 -46.64 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.751 -0.659 . . . . 73.23 112.087 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -59.01 -44.51 91.7 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.942 0.401 . . . . 71.21 111.086 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.5 m -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.466 -0.334 . . . . 73.34 111.287 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -65.37 -38.82 91.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 71.05 112.309 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 40' ' ' VAL . 81.6 mt -64.29 -52.61 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.077 0.465 . . . . 64.41 111.23 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.415 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 28.9 mmt -63.6 -27.73 69.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.967 0.413 . . . . 52.12 111.219 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -59.52 -48.4 81.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.917 -0.583 . . . . 63.02 111.284 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -76.64 -36.27 57.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 54.43 111.106 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.532 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 27.2 t80 -53.58 -37.65 63.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.765 0.317 . . . . 74.34 110.651 174.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . . . -53.34 -25.35 14.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.206 0.447 . . . . 54.11 112.206 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -86.4 -38.05 17.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.135 0.493 . . . . 72.54 111.124 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -88.07 -2.63 58.72 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.924 0.713 . . . . 74.41 112.924 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 98.6 mttt -53.0 106.07 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.552 0.575 . . . . 74.1 112.552 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.14 -8.25 25.06 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.982 -0.628 . . . . 74.22 114.386 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.66 123.22 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 117.49 0.645 . . . . 62.3 111.031 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.97 169.69 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.424 0.63 . . . . 61.5 112.568 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -83.93 128.42 34.53 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.808 -0.633 . . . . 71.24 111.679 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -136.87 118.61 15.05 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.53 -0.305 . . . . 70.34 111.024 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 58' ' ' LEU . 5.0 mp -74.3 102.59 4.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.999 0.37 . . . . 71.51 111.999 -173.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.28 33.7 31.4 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.068 -0.587 . . . . 64.24 113.241 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.15 102.93 0.27 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.905 -0.478 . . . . 50.21 111.905 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.511 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 p -94.81 100.84 12.66 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.504 0.557 . . . . 64.14 112.504 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -158.93 173.09 17.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.161 -0.472 . . . . 62.2 111.791 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -74.75 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.431 . . . . 74.24 111.32 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 3.1 mptp? -90.98 0.73 57.46 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.205 -0.452 . . . . 62.41 111.001 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.11 145.99 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.059 -0.417 . . . . 71.43 112.059 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.511 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.5 tt -165.02 148.09 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 117.551 0.676 . . . . 62.31 112.001 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.84 0.352 . . . . 70.13 111.473 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 25.0 p -59.94 -47.66 84.87 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.285 0.476 . . . . 71.45 112.285 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.3 m -63.97 -41.5 97.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.976 0.417 . . . . 65.23 111.225 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.81 -40.27 95.52 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.973 -0.632 . . . . 62.41 112.605 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -60.24 -54.24 48.19 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.976 0.362 . . . . 74.04 111.976 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.66 -38.04 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.058 0.456 . . . . 61.33 111.038 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -53.79 -57.78 9.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.293 0.568 . . . . 64.12 111.642 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 18.5 mmt180 -64.8 -48.1 75.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.951 -0.568 . . . . 65.04 111.844 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 m -52.68 -51.1 61.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.093 0.473 . . . . 65.31 111.865 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 35.3 m-85 -70.05 -38.66 75.87 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.773 0.657 . . . . 75.32 112.773 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 4.7 ptm180 -69.24 -33.71 73.69 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.89 -0.507 . . . . 73.32 111.542 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.12 -36.85 64.23 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 111.902 0.334 . . . . 72.41 111.902 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -97.48 -58.4 2.01 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.578 0.585 . . . . 52.11 112.578 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.33 -1.74 53.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.421 0.526 . . . . 74.54 112.421 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.68 22.43 76.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.182 -0.533 . . . . 72.01 112.889 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -100.34 113.02 25.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 75.22 111.192 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.994 0.426 . . . . 72.22 111.575 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.01 153.83 37.75 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.325 -0.398 . . . . 61.31 111.361 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.86 168.21 19.31 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.443 2.096 . . . . 53.23 113.208 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -81.32 3.58 23.69 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.559 0.577 . . . . 62.13 112.559 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 30.8 t -122.17 133.44 54.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.343 0.498 . . . . 73.4 112.343 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 2.5 m -56.21 -45.21 79.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.854 -0.612 . . . . 75.31 111.026 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.6 -44.31 85.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.571 -0.741 . . . . 72.33 111.438 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 19.2 mm-40 -70.52 -33.99 71.79 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.153 0.501 . . . . 75.42 111.214 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -66.29 -20.36 66.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.528 -0.305 . . . . 65.42 111.74 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 88' ' ' THR . 22.9 mt-30 -72.08 -22.53 61.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.983 0.42 . . . . 71.13 111.819 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -87.46 -2.66 58.77 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.342 -0.39 . . . . 71.22 111.484 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.2 mmm -97.25 -75.83 0.53 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.865 0.364 . . . . 63.5 111.561 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.65 151.87 48.48 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.369 -0.443 . . . . 75.51 113.634 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 29.8 mmtp -89.29 153.94 20.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.998 0.427 . . . . 73.11 111.533 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.9 p -85.61 152.86 22.8 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.223 0.823 . . . . 75.51 113.223 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.513 HG13 ' NE ' ' A' ' 157' ' ' ARG . 1.1 m -152.25 171.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.861 -0.609 . . . . 74.52 112.161 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.2 t -116.26 -178.63 3.46 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.727 -0.67 . . . . 50.21 111.053 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.439 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -55.74 -46.09 77.88 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.287 0.477 . . . . 74.43 112.287 -177.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -69.48 -3.3 14.0 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.22 0.452 . . . . 70.43 112.22 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.493 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 5.6 m120 -116.08 -7.5 11.89 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.948 -0.47 . . . . 72.04 111.96 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.27 135.06 57.62 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.897 0.703 . . . . 71.25 112.897 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -115.42 -152.02 0.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.491 -0.777 . . . . 61.11 109.855 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.9 m -102.83 105.02 15.34 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.791 -0.568 . . . . 74.43 111.505 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 122.91 -3.78 9.87 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.842 -0.694 . . . . 32.51 114.604 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.86 134.24 56.89 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.373 0.586 . . . . 75.55 111.759 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.4 mt -85.38 113.19 21.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.026 0.441 . . . . 63.42 111.26 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' A' ' 155' ' ' ALA . 19.2 m -95.4 134.78 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.031 0.443 . . . . 74.53 111.438 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 87.8 mt -104.62 138.57 40.75 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.245 0.461 . . . . 72.34 112.245 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 56.2 m-85 -123.4 141.28 52.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.933 -0.576 . . . . 75.02 111.505 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 48.2 mtt180 -82.87 82.01 8.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.956 0.408 . . . . 73.34 110.027 173.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 112.002 0.371 . . . . 74.2 112.002 -173.49 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.028 0.442 . . . . 71.44 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 52.5 t60 -95.94 154.64 17.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.342 -0.39 . . . . 74.51 110.555 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.406 ' HB ' HG23 ' A' ' 88' ' ' THR . 14.9 p -134.57 142.94 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.172 0.51 . . . . 74.12 112.308 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.38 160.89 26.93 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.979 -0.555 . . . . 43.45 112.625 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -97.01 109.65 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.532 -0.393 . . . . 75.32 111.32 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -68.03 108.65 3.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.928 0.394 . . . . 74.25 111.231 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 pt -109.43 -32.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.458 0.54 . . . . 51.14 112.458 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.51 -175.72 14.13 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.201 -0.523 . . . . 73.15 113.038 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -43.02 -58.0 2.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.858 0.688 . . . . 72.45 112.858 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -122.11 -10.35 8.58 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.17 -0.331 . . . . 72.33 111.525 174.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -84.36 137.17 33.56 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.348 0.594 . . . . 75.05 112.459 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.69 142.57 27.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.594 -0.73 . . . . 62.35 110.965 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -97.41 136.33 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.869 0.366 . . . . 71.03 111.251 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -165.19 168.69 16.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 73.0 111.181 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.86 91.25 7.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.145 0.498 . . . . 65.53 110.515 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.8 p -65.14 146.02 55.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.868 -0.606 . . . . 34.42 112.086 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.2 p -64.48 -25.13 67.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.147 0.499 . . . . 62.54 111.303 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -73.17 -70.59 0.35 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.089 -0.505 . . . . 54.14 112.276 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.0 m -102.83 -35.75 8.51 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.124 0.416 . . . . 70.12 112.124 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.63 -141.29 13.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.078 -0.582 . . . . 54.43 112.567 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.9 92.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.321 0.582 . . . . 74.54 111.948 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.7 pt -136.88 -176.69 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.059 -0.519 . . . . 74.12 111.024 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.28 116.36 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.543 -0.299 . . . . 54.3 110.656 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.2 m -104.3 -177.99 3.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.767 0.318 . . . . 74.11 110.758 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.3 m -143.59 145.27 32.38 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.154 0.502 . . . . 65.44 112.342 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.81 -27.57 69.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.687 0.625 . . . . 65.44 112.687 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -72.85 -3.63 26.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.929 0.344 . . . . 63.21 111.929 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -74.8 122.25 87.07 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 110.423 -0.214 . . . . 72.33 110.423 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.14 -39.36 11.58 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.418 2.745 . . . . 64.02 114.421 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.488 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 85.7 t80 -61.72 -51.46 68.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.862 0.363 . . . . 75.02 111.28 176.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -76.84 -27.97 55.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.434 -0.348 . . . . 75.32 111.203 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.91 -34.56 74.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.203 -0.453 . . . . 51.33 111.234 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -102.6 0.99 34.19 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.362 -0.381 . . . . 55.54 111.521 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -103.41 -30.64 10.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 111.905 0.335 . . . . 74.35 111.905 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 70.6 t80 -56.64 135.28 54.96 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.886 0.374 . . . . 74.41 111.498 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -123.0 -51.33 1.9 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.932 0.345 . . . . 73.32 111.932 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.69 -179.04 7.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.079 0.4 . . . . 71.31 112.079 -173.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -144.73 149.47 35.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.516 -0.311 . . . . 74.44 111.374 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.6 mtm-85 -137.46 118.2 14.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.68 0.252 . . . . 74.44 111.68 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.513 ' NE ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.21 109.42 11.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.138 0.494 . . . . 72.43 110.981 174.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.457 ' HB ' HD21 ' A' ' 82' ' ' LEU . 16.8 m -84.13 -29.73 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.14 0.495 . . . . 54.34 111.201 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 CA--C 1.535 0.383 0 CA-C-N 116.267 -0.424 . . . . 75.15 110.177 174.33 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.468 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 12.2 t70 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 110.272 -0.27 . . . . 73.33 110.272 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.1 t -56.21 -53.87 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.831 0.348 . . . . 52.34 111.411 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.7 tttt -61.4 -43.19 99.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.307 -0.406 . . . . 61.13 111.238 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.4 m -57.17 -42.73 81.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.099 -0.5 . . . . 41.02 111.331 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -72.01 -42.36 66.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.259 0.466 . . . . 60.31 112.259 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 40' ' ' VAL . 78.9 mt -58.35 -48.69 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 64.52 110.897 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 92.7 mmm -63.88 -36.23 83.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.236 -0.438 . . . . 75.44 111.039 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.35 -43.62 83.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.912 -0.585 . . . . 73.32 111.37 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -71.24 -45.61 62.87 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.998 0.428 . . . . 72.23 111.145 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -54.44 -41.22 69.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.445 -0.343 . . . . 74.24 111.831 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.82 -20.85 9.52 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.321 0.489 . . . . 74.11 112.321 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.1 -25.54 17.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.087 0.47 . . . . 73.04 111.47 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.411 ' O ' ' HB ' ' A' ' 138' ' ' VAL . 81.4 m95 -105.14 3.27 30.09 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.101 0.778 . . . . 73.32 113.101 -175.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -54.84 101.71 0.05 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.844 0.354 . . . . 74.34 111.916 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.45 21.4 22.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.015 -0.612 . . . . 64.34 114.412 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.7 t -80.5 132.05 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 117.851 0.826 . . . . 73.33 110.992 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -63.27 163.3 10.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.938 0.718 . . . . 74.43 112.938 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 48.9 t80 -92.94 140.17 29.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.096 -0.502 . . . . 63.4 111.602 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -137.08 139.47 41.31 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.869 0.366 . . . . 65.45 110.969 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 58' ' ' LEU . 6.7 mp -74.72 97.4 3.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 70.51 112.193 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 67' ' ' ASP . . . 78.43 6.76 88.05 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.051 -0.522 . . . . 65.3 114.329 174.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.77 77.85 0.3 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 117.497 0.648 . . . . 70.43 113.128 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.532 ' H ' ' NH2' ' A' ' 86' ' ' ARG . 48.3 t -68.41 107.69 2.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.396 0.887 . . . . 73.03 113.396 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.8 t -166.14 172.58 11.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.724 0.409 . . . . 73.04 111.576 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -65.01 -21.35 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.953 -0.467 . . . . 75.23 111.572 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.01 9.25 20.18 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.392 0.615 . . . . 71.04 111.021 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.52 136.05 3.08 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.863 -0.895 . . . . 73.11 110.863 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 71' ' ' PHE . 19.7 tt -144.58 146.4 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.232 1.016 . . . . 65.13 112.828 -175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 59' ' ' GLY . 5.4 p-10 -93.12 160.04 15.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.005 -0.543 . . . . 74.53 111.502 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 28.2 p -57.36 -54.46 46.6 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.841 0.353 . . . . 54.53 111.553 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 8.2 p -58.95 -42.86 90.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.193 -0.458 . . . . 52.23 111.18 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . -57.63 -33.84 68.31 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.322 -0.399 . . . . 63.44 113.654 176.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.582 ' HA ' HD11 ' A' ' 66' ' ' ILE . 74.6 t80 -72.04 -48.46 44.32 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.48 -0.423 . . . . 74.11 111.612 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.58 HG13 HE22 ' A' ' 91' ' ' GLN . 7.1 p -63.1 -44.18 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.576 -0.284 . . . . 72.13 111.443 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.1 pp0? -61.14 -44.85 96.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.036 -0.415 . . . . 54.44 111.336 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -57.62 -50.5 72.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.041 0.386 . . . . 64.55 112.041 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.4 m -53.43 -45.83 69.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.833 0.349 . . . . 74.4 111.816 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 65.8 m-85 -72.86 -38.39 67.06 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.061 0.763 . . . . 72.53 113.061 -177.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -76.88 -42.77 38.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.572 -0.705 . . . . 74.45 112.287 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -73.43 -26.49 60.97 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.274 0.472 . . . . 44.34 112.274 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -96.0 -61.25 1.48 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.843 0.354 . . . . 74.22 111.866 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 76' ' ' PHE . 63.9 m-85 -90.08 -28.5 18.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.42 0.526 . . . . 75.54 112.42 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.1 27.29 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.191 -0.528 . . . . 65.52 112.512 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 37.4 tp -83.15 160.09 21.92 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.311 0.577 . . . . 74.31 111.865 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.63 114.57 27.1 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.058 0.456 . . . . 73.44 111.895 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.77 145.01 41.15 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 122.274 -0.267 . . . . 74.04 111.033 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.595 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 63.1 Cg_endo -85.73 -171.47 0.9 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.979 2.453 . . . . 74.02 113.881 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.532 ' NH2' ' H ' ' A' ' 61' ' ' SER . 11.0 mmm180 -88.44 -19.43 26.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.473 0.546 . . . . 74.21 112.473 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -106.31 126.63 52.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.756 0.65 . . . . 74.11 112.756 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 44.1 m -52.0 -41.8 62.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.89 -0.595 . . . . 74.34 111.665 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.407 ' OH ' ' HD3' ' A' ' 118' ' ' ARG . 89.0 m-85 -54.76 -32.53 60.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.85 -0.614 . . . . 73.13 112.306 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.08 -38.61 31.38 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.18 0.514 . . . . 75.02 110.961 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.595 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 44.9 mt-30 -61.85 -33.64 74.55 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.192 -0.458 . . . . 64.41 111.595 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.51 ' HG2' HD11 ' A' ' 110' ' ' LEU . 18.7 mt-30 -52.01 -37.72 54.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.241 0.543 . . . . 44.24 111.596 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -90.48 -9.81 45.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.015 -0.539 . . . . 74.22 112.126 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.503 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 81.1 mtp -87.25 -37.18 17.45 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.872 0.367 . . . . 53.13 111.374 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.76 150.93 21.41 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.946 -0.645 . . . . 64.41 113.388 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 31.2 mmmt -70.88 141.32 51.22 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.161 0.505 . . . . 72.45 112.007 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 m -77.47 127.54 32.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.656 -0.702 . . . . 75.4 112.106 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 7.1 m -145.5 164.65 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.382 0.61 . . . . 71.01 112.417 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 t -116.7 -177.71 3.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.689 -0.687 . . . . 73.0 110.776 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.512 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -56.14 -36.69 68.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.455 0.539 . . . . 74.4 112.455 -175.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.0 p -64.88 -29.14 70.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.03 0.443 . . . . 74.42 112.141 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -100.68 -6.89 24.46 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.173 0.805 . . . . 75.21 113.173 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.14 131.05 48.77 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.419 0.896 . . . . 74.11 113.419 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -125.07 175.79 7.12 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.743 -0.662 . . . . 62.54 110.33 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 41' ' ' LYS . 62.9 m -68.44 111.35 4.63 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.98 -0.45 . . . . 64.11 111.1 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.33 -12.93 7.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.388 -0.434 . . . . 72.2 112.711 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.18 130.45 43.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.022 0.439 . . . . 75.52 111.581 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.8 mt -87.95 112.32 22.43 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.95 0.405 . . . . 71.23 110.56 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -96.65 128.1 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.375 0.607 . . . . 52.22 111.577 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.51 HD11 ' HG2' ' A' ' 92' ' ' GLN . 79.3 mt -98.84 143.44 29.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.872 -0.604 . . . . 71.41 111.917 -175.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -131.14 132.19 44.61 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.39 -0.368 . . . . 74.31 111.266 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -81.22 84.79 6.49 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.242 0.544 . . . . 74.12 110.666 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 CA-C-N 115.873 -0.603 . . . . 54.15 112.138 -173.405 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.407 ' HD3' ' OH ' ' A' ' 89' ' ' TYR . 9.7 mpt_? . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 64.24 110.469 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -87.78 151.63 22.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.005 -0.543 . . . . 72.14 110.236 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.5 139.07 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.092 0.472 . . . . 72.12 112.242 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 131' ' ' HIS . . . -132.15 149.85 19.49 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 116.177 -0.465 . . . . 55.1 112.525 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 72' ' ' VAL . 43.6 mt -89.39 106.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 122.476 -0.426 . . . . 74.2 111.031 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.67 115.05 5.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.387 -0.37 . . . . 73.13 111.314 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.1 pt -103.04 -33.75 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.893 0.701 . . . . 71.21 112.893 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.45 123.24 0.83 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 119.777 -1.201 . . . . 41.52 115.139 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.69 -78.25 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.24 1.016 . . . . 71.32 111.696 171.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 142' ' ' SER . 53.8 m-80 -133.57 -7.4 2.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.449 -0.342 . . . . 73.2 111.342 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -86.68 140.42 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.285 0.564 . . . . 70.21 112.287 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -151.41 140.68 21.36 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.524 -0.762 . . . . 71.22 111.041 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.44 137.44 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.994 0.426 . . . . 45.41 111.394 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 133' ' ' SER . 5.0 p80 -162.9 162.21 26.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.988 0.366 . . . . 64.54 111.988 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -88.23 92.06 9.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.951 0.405 . . . . 41.52 110.391 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 131' ' ' HIS . 37.5 t -86.78 126.39 34.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.424 -0.353 . . . . 72.12 111.886 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -59.3 -17.76 31.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.44 0.533 . . . . 72.1 112.44 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.1 p -65.95 -41.3 91.45 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.91 0.386 . . . . 53.25 111.503 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.1 m -138.79 -39.22 0.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.048 0.388 . . . . 61.13 112.048 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.48 24.62 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.792 -0.523 . . . . 50.21 111.792 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 57.5 t -65.72 103.01 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.179 0.49 . . . . 61.43 111.237 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.72 169.84 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.106 -0.497 . . . . 71.15 111.399 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.48 114.55 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.591 -0.277 . . . . 75.42 110.687 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.5 m -104.57 178.56 4.52 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.965 0.412 . . . . 74.21 111.054 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 66.4 m -141.65 140.43 33.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.006 0.431 . . . . 75.54 112.106 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.02 -6.01 7.67 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.366 0.506 . . . . 54.5 112.366 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -73.0 -19.68 61.16 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 70.21 110.628 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.77 134.05 69.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.051 -0.522 . . . . 72.03 110.768 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.541 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 78.4 Cg_exo -51.25 -46.21 32.55 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.757 2.305 . . . . 71.2 113.489 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.79 -45.42 86.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.197 0.443 . . . . 74.31 112.197 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -80.33 -34.46 36.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.984 0.421 . . . . 64.5 111.641 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -60.5 -54.59 43.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.114 -0.493 . . . . 63.14 112.066 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 51.7 pttt -86.06 -14.78 43.33 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.173 0.805 . . . . 74.24 113.173 -174.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -92.95 -4.59 52.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.0 -0.438 . . . . 73.34 111.702 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.512 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 77.0 t80 -55.2 135.62 49.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.582 . . . . 62.55 112.234 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -104.81 -71.0 0.75 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.907 -0.588 . . . . 74.44 111.258 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.493 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.6 pt-20 -163.45 -174.11 3.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.17 -0.468 . . . . 73.02 111.057 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -142.11 137.63 31.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.611 0.597 . . . . 54.24 112.611 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 14.0 mmt180 -137.45 114.79 10.99 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.955 -0.566 . . . . 75.52 110.325 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.51 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -95.07 122.6 37.9 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.086 -1.009 . . . . 72.11 111.687 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.48 1.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.669 -0.696 . . . . 63.32 112.766 -176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 112.165 0.432 . . . . 63.15 112.165 -179.533 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 110.302 -0.258 . . . . 74.3 110.302 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 44' ' ' ILE . 46.6 t -56.5 -57.08 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.561 -0.291 . . . . 74.42 111.545 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 85.1 tttt -55.7 -42.31 75.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.901 0.381 . . . . 71.31 111.475 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -58.89 -43.66 91.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.218 -0.446 . . . . 62.05 111.583 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -74.29 -33.28 63.19 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.19 0.441 . . . . 65.05 112.19 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 40' ' ' VAL . 87.5 mt -60.06 -50.25 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.156 0.503 . . . . 73.4 110.649 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 mmt -67.83 -34.01 75.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 71.42 111.136 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -55.41 -43.65 75.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.262 -0.426 . . . . 73.41 110.93 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 60.7 tp60 -78.87 -35.92 43.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.539 -0.3 . . . . 73.33 111.322 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.35 -32.77 39.89 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.82 0.343 . . . . 74.03 111.564 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.73 -34.44 52.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.358 -0.383 . . . . 33.23 111.812 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -19.8 42.24 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.38 0.511 . . . . 72.44 112.38 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.512 ' CZ3' ' HA ' ' A' ' 63' ' ' LYS . 99.3 m95 -100.91 -4.33 27.92 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.281 0.845 . . . . 73.23 113.281 -174.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -65.18 127.57 32.23 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.877 -0.514 . . . . 75.32 111.272 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.27 -1.47 67.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.312 -0.47 . . . . 71.34 113.785 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.3 134.1 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 117.299 0.55 . . . . 52.41 111.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -83.56 161.07 21.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.403 0.52 . . . . 65.35 112.403 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -78.4 116.34 18.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.88 -0.6 . . . . 75.4 111.404 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -127.25 97.48 4.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.166 0.508 . . . . 70.44 110.638 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 40.7 tp -70.85 104.94 3.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.095 -0.502 . . . . 71.02 111.648 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.17 -63.61 0.56 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.362 -0.447 . . . . 74.53 112.781 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.92 99.35 2.11 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.221 -0.514 . . . . 60.23 112.532 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.548 ' HA ' HG13 ' A' ' 66' ' ' ILE . 76.4 p -84.09 105.9 15.32 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.068 0.395 . . . . 74.32 112.068 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -156.89 163.21 39.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.129 0.49 . . . . 62.23 112.167 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 39.2 ttmt -67.04 -11.76 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.272 0.558 . . . . 72.54 111.502 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.504 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -94.95 11.46 31.77 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.221 0.534 . . . . 75.11 110.748 177.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.5 123.25 1.57 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.159 -0.776 . . . . 63.41 111.159 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.8 tt -155.72 152.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 117.953 0.876 . . . . 72.32 112.706 -171.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -93.21 179.31 5.46 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.994 0.426 . . . . 71.35 111.509 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.53 -54.35 41.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.554 0.576 . . . . 52.31 112.554 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.5 p -62.13 -34.39 76.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.108 0.48 . . . . 62.42 111.71 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.67 -44.19 72.17 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.832 -0.699 . . . . 71.44 112.292 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -56.96 -52.31 65.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.866 0.365 . . . . 73.42 111.851 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.545 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.8 p -59.82 -41.92 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 50.34 111.386 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 5.7 tt0 -55.24 -54.82 38.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.363 0.601 . . . . 71.33 111.169 174.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -56.33 -54.38 46.17 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.44 -0.8 . . . . 74.24 111.73 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.457 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 66.1 m -52.87 -48.06 67.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.054 0.39 . . . . 71.13 112.054 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 38.3 m-85 -70.18 -35.23 73.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.983 0.735 . . . . 74.04 112.983 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -80.31 -33.52 37.5 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.722 -0.611 . . . . 74.13 111.806 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -72.64 -33.61 66.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.978 0.418 . . . . 72.4 111.53 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -102.35 -56.7 2.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.803 0.668 . . . . 71.3 112.803 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.54 -3.59 54.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.403 0.52 . . . . 73.4 112.403 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.49 22.79 66.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.429 -0.415 . . . . 74.51 113.012 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.511 HD22 HD23 ' A' ' 159' ' ' LEU . 46.4 tp -86.94 130.21 34.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.196 0.522 . . . . 74.31 111.97 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.67 101.38 10.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.171 -0.468 . . . . 74.41 111.496 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 73' ' ' GLN . 83.9 mt -111.99 139.83 22.78 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.292 . . . . 62.5 111.242 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.61 148.92 54.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.351 2.034 . . . . 54.53 112.751 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -83.37 65.22 8.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.352 0.596 . . . . 74.04 110.177 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 13.2 t -171.0 120.24 0.52 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.688 -0.687 . . . . 74.55 111.029 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.57 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 53.5 m -52.06 -41.62 62.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.946 0.403 . . . . 73.22 111.001 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CZ ' ' HD3' ' A' ' 118' ' ' ARG . 83.7 m-85 -60.83 -46.53 90.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.181 -0.463 . . . . 70.45 111.322 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 94' ' ' MET . 16.5 mm-40 -64.99 -37.66 88.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.934 0.397 . . . . 74.02 111.322 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 87' ' ' SER . 95.2 mt-30 -67.07 -36.12 81.33 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.027 0.38 . . . . 74.33 112.027 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 88' ' ' THR . 23.6 mt-30 -52.89 -55.15 25.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.307 0.575 . . . . 74.23 111.545 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.08 0.9 17.12 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.598 0.592 . . . . 72.21 112.598 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 88.0 mmm -91.88 -13.43 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.682 0.277 . . . . 70.15 111.369 173.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -135.52 156.1 22.55 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.077 -0.583 . . . . 55.34 113.535 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 34.1 mmtp -94.37 152.84 18.32 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.482 -0.422 . . . . 71.24 111.367 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 79.3 p -84.44 157.26 21.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.149 0.796 . . . . 34.12 113.149 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.34 158.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 115.28 -0.873 . . . . 73.14 111.536 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.6 t -94.41 178.27 5.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.168 0.433 . . . . 73.43 112.168 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -51.3 -54.91 21.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.854 0.687 . . . . 71.41 112.854 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -74.17 -8.25 55.53 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.606 0.595 . . . . 72.44 112.606 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -107.45 3.67 25.38 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.205 0.446 . . . . 64.13 112.205 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.06 122.93 16.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.797 0.332 . . . . 73.34 111.843 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -105.72 154.36 20.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.372 -0.376 . . . . 74.14 110.602 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.3 m -66.35 119.52 11.71 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.916 -0.49 . . . . 75.53 110.855 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.47 -11.18 23.8 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.361 -0.447 . . . . 74.21 112.626 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.57 138.41 53.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.228 0.537 . . . . 74.51 111.412 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.449 HD22 HG21 ' A' ' 72' ' ' VAL . 23.5 mt -86.62 117.04 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.8 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -95.23 118.87 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.433 0.635 . . . . 72.14 111.418 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 70.1 mt -93.1 127.02 38.48 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.613 -0.721 . . . . 72.02 111.867 -177.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.67 133.58 55.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.328 -0.396 . . . . 73.42 111.126 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -75.87 92.06 3.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.904 0.383 . . . . 64.43 110.832 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 112.21 0.448 . . . . 63.45 112.21 -175.783 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 8.2 mpt_? . . . . . 0 N--CA 1.468 0.425 0 CA-C-O 121.009 0.433 . . . . 75.45 111.223 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 82.9 t60 -102.4 151.89 21.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.474 -0.33 . . . . 72.33 110.213 174.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.71 137.77 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.149 0.499 . . . . 50.12 112.279 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.18 159.29 23.97 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.082 -0.508 . . . . 73.33 112.598 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.545 HD11 ' HA ' ' A' ' 72' ' ' VAL . 45.0 mt -92.22 106.57 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.536 -0.391 . . . . 75.33 111.418 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -65.74 120.79 13.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.818 0.342 . . . . 64.44 111.32 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.512 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.9 pt -102.98 -37.61 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.348 0.499 . . . . 64.33 112.348 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.27 142.05 4.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.381 -0.914 . . . . 34.42 114.086 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.52 -79.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.453 0.701 . . . . 70.53 111.822 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 143' ' ' MET . 7.8 p30 -150.8 9.08 0.59 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.134 -0.484 . . . . 75.32 110.92 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -89.28 143.01 27.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.112 0.482 . . . . 73.44 111.22 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.459 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 19.1 p90 -153.92 145.15 22.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 64.53 111.325 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.13 129.95 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.188 0.518 . . . . 75.3 110.86 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -150.65 -178.52 6.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.349 -0.387 . . . . 73.04 111.394 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -110.73 99.6 8.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.986 0.422 . . . . 61.42 111.482 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.9 t -66.25 136.23 55.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.126 -0.488 . . . . 74.41 111.452 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -57.28 -25.73 59.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.237 0.458 . . . . 73.35 112.237 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.8 t -99.56 -60.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.14 0.422 . . . . 41.14 112.14 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.8 m -73.32 -52.82 12.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.587 0.588 . . . . 53.35 112.587 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 -146.9 16.61 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.489 -0.386 . . . . 73.3 112.279 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.75 106.58 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 117.373 0.587 . . . . 72.12 112.001 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -140.24 174.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 120.988 0.423 . . . . 62.14 111.568 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.5 mt -105.41 123.26 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.526 -0.306 . . . . 73.24 111.213 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -116.37 173.58 6.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.658 0.266 . . . . 45.11 111.287 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 127' ' ' ASN . 67.6 m -137.82 139.48 39.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.554 0.576 . . . . 75.11 112.554 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 67.7 mtm -78.65 8.74 4.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.954 0.724 . . . . 64.12 112.954 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 142' ' ' SER . 10.4 p30 -78.6 -21.13 48.99 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.62 -0.675 . . . . 75.03 109.685 166.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.54 126.01 92.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.626 -0.716 . . . . 53.44 110.423 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 86.8 Cg_exo -43.7 -48.46 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.134 2.556 . . . . 72.31 114.298 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.555 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.6 t80 -57.4 -48.74 78.28 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.865 0.32 . . . . 75.33 111.865 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -73.97 -39.48 63.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.021 0.439 . . . . 60.11 111.405 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -55.0 -44.33 74.4 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.847 -0.615 . . . . 63.11 112.159 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.7 ptpt -91.21 -19.65 22.81 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.444 0.535 . . . . 71.12 112.444 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -83.21 -16.84 44.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.074 -0.391 . . . . 63.32 111.33 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -58.73 111.9 1.44 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.054 0.455 . . . . 74.3 111.898 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.429 HD22 ' HG2' ' A' ' 154' ' ' GLU . 7.5 t30 -85.85 -58.5 2.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.37 -0.377 . . . . 61.45 110.794 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.429 ' HG2' HD22 ' A' ' 153' ' ' ASN . 12.0 pt-20 -166.46 152.14 8.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.798 0.332 . . . . 74.0 111.211 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -105.57 145.16 31.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.521 -0.309 . . . . 51.24 110.637 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 63.5 mtt180 -134.59 118.82 17.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.893 0.377 . . . . 71.2 111.42 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.551 ' H ' ' HD3' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -80.8 125.69 30.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.094 0.473 . . . . 75.43 111.473 -178.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.21 -10.49 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.364 -0.38 . . . . 53.12 112.012 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.511 HD23 HD22 ' A' ' 82' ' ' LEU . 91.1 mt . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.936 0.398 . . . . 72.41 111.545 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 24.7 m-20 . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.542 0.211 . . . . 73.23 110.522 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.7 t -50.07 -50.93 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.286 . . . . 72.21 111.34 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.8 tttt -55.26 -44.6 75.74 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.814 0.34 . . . . 64.31 111.578 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 35.3 t -59.74 -39.96 86.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.931 0.396 . . . . 73.32 111.011 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.56 ' HE ' ' HA ' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -67.39 -42.05 83.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.349 -0.387 . . . . 74.21 111.826 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 40' ' ' VAL . 48.7 mt -64.31 -45.13 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.006 0.431 . . . . 63.23 111.089 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 29.9 mmt -65.76 -36.31 83.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.902 0.382 . . . . 54.33 110.871 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -47.72 74.29 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.21 110.958 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.522 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 8.0 tp60 -66.04 -47.86 72.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.947 -0.57 . . . . 72.21 110.894 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.519 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 17.0 t80 -55.8 -32.66 63.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.141 -0.481 . . . . 75.33 111.382 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.41 -33.07 58.65 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.049 0.452 . . . . 65.41 111.632 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.32 -20.96 31.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.231 0.456 . . . . 73.43 112.231 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -113.75 17.84 17.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.693 0.627 . . . . 74.41 112.693 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.1 mtmt -62.68 110.41 1.71 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.144 0.497 . . . . 73.44 112.33 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 21.77 41.84 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.407 0.523 . . . . 51.31 114.407 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.95 118.67 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 117.577 0.689 . . . . 71.44 110.967 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -71.73 163.64 27.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.742 0.645 . . . . 71.43 112.742 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 50.2 t80 -77.85 126.65 31.18 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.701 . . . . 75.42 111.833 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -138.39 103.08 4.8 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.056 -0.52 . . . . 63.14 110.156 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 tp -72.04 132.28 44.03 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.96 0.409 . . . . 74.42 111.716 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 -44.2 3.22 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.203 -0.522 . . . . 73.23 113.175 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.75 60.54 2.41 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 122.509 -0.407 . . . . 73.41 112.749 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.43 ' HB2' HG13 ' A' ' 66' ' ' ILE . 99.1 p -67.26 113.62 5.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.053 0.454 . . . . 42.15 112.161 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.418 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 2.6 t -164.74 171.57 14.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.991 -0.55 . . . . 74.3 110.89 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -69.96 -14.4 62.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.658 -0.651 . . . . 64.11 111.32 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.67 2.38 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.948 0.404 . . . . 64.31 110.958 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.23 121.37 0.97 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.178 -0.769 . . . . 63.31 111.178 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.5 tt -149.54 158.6 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 74.52 112.421 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.93 174.39 6.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.039 0.447 . . . . 71.53 111.621 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.8 p -65.09 -53.29 47.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.576 0.584 . . . . 71.02 112.576 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 12.2 p -59.04 -39.62 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.978 0.362 . . . . 54.13 111.978 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.98 -37.91 92.44 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.021 -0.609 . . . . 72.41 112.821 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -63.17 -53.97 44.91 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.641 0.258 . . . . 45.35 111.367 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.53 -43.93 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 112.249 0.463 . . . . 74.22 112.249 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.8 -37.04 80.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.924 0.392 . . . . 72.54 110.912 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 84.1 mtt85 -69.53 -50.05 48.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.993 0.368 . . . . 60.25 111.993 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -52.71 -48.16 66.81 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.096 0.474 . . . . 63.32 111.582 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.576 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.8 m-85 -69.72 -36.38 75.83 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.698 . . . . 63.33 112.886 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 6.4 ptm180 -68.42 -32.06 71.84 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.949 -0.469 . . . . 71.32 111.201 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.521 ' HG3' HE22 ' A' ' 47' ' ' GLN . 27.2 mm-40 -74.47 -62.18 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.166 0.508 . . . . 72.45 111.225 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.522 ' OE1' ' HB2' ' A' ' 47' ' ' GLN . 3.0 mp0 -72.1 -44.76 62.71 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.758 0.651 . . . . 74.14 112.758 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -110.81 -3.6 15.65 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.066 0.765 . . . . 72.13 113.066 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 22.44 68.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.824 -0.703 . . . . 60.35 113.068 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.1 tp -95.47 121.52 37.24 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 75.14 111.31 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.59 110.34 22.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.952 0.406 . . . . 63.34 111.769 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.9 mt -97.29 152.71 38.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.472 -0.331 . . . . 73.2 111.221 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.5 175.67 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.433 2.089 . . . . 63.14 112.963 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 86' ' ' ARG . 34.6 mmt-85 -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.873 1.064 . . . . 73.13 113.873 -167.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 84.4 p -130.6 147.05 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.806 -0.559 . . . . 70.45 111.882 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.602 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.4 m -53.32 -40.13 64.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.271 -0.422 . . . . 73.33 111.274 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -49.65 -43.49 46.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.022 -0.535 . . . . 71.43 111.104 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.62 -40.96 32.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.769 -0.65 . . . . 73.44 111.355 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 87' ' ' SER . 91.6 mt-30 -57.58 -31.16 65.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.197 0.443 . . . . 73.04 112.197 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' A' ' 88' ' ' THR . 37.7 mt-30 -58.45 -33.58 69.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.0 0.37 . . . . 74.3 112.0 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.92 -25.24 62.67 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.932 0.345 . . . . 74.41 111.932 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 92.4 mmm -69.32 -43.82 72.95 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.552 0.575 . . . . 72.23 112.552 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -102.42 160.28 17.46 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.803 -0.713 . . . . 53.44 114.305 -172.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 75.1 mmtt -91.26 147.31 23.14 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.807 0.337 . . . . 71.14 111.524 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 41.0 m -76.01 150.72 37.34 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.343 0.868 . . . . 74.13 113.343 -172.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.5 137.95 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.677 -0.692 . . . . 72.23 111.739 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.7 t -80.13 176.21 9.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.957 -0.565 . . . . 71.13 111.789 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.443 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -54.49 -50.31 68.07 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.754 0.65 . . . . 74.32 112.754 -175.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -70.11 -14.91 62.87 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.23 0.456 . . . . 65.45 112.23 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -102.31 4.52 39.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.302 0.482 . . . . 71.42 112.302 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.19 138.74 49.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.961 0.41 . . . . 60.21 111.591 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -134.08 174.48 10.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.948 0.404 . . . . 62.45 110.852 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.402 HG21 ' HB2' ' A' ' 41' ' ' LYS . 27.6 m -71.7 103.72 3.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.692 0.282 . . . . 63.33 111.39 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 133.13 -12.99 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.282 -0.485 . . . . 53.13 113.467 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 157' ' ' ARG . 7.4 m-20 -71.15 147.31 48.51 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.237 0.542 . . . . 64.33 111.599 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 mt -94.28 123.11 37.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.347 -0.388 . . . . 62.34 110.769 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 m -96.35 116.06 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.251 0.548 . . . . 70.32 111.245 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.2 mt -92.41 121.85 34.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.593 -0.731 . . . . 71.01 111.4 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -114.3 166.41 11.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.598 0.713 . . . . 71.43 112.188 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 68.1 mtp180 -103.8 109.79 21.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.28 -0.873 . . . . 73.21 109.474 172.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.596 0 O-C-N 122.126 -0.359 . . . . 63.45 111.599 -172.412 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.118 0.485 . . . . 74.34 111.526 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -113.32 156.21 23.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.076 -0.511 . . . . 71.13 110.096 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.88 137.94 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.387 0.613 . . . . 61.31 112.254 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.77 155.91 21.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.747 -0.66 . . . . 64.14 112.205 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.4 mt -92.37 110.32 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.32 -0.518 . . . . 73.41 110.972 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.447 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 61.1 t80 -73.77 114.89 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.048 0.451 . . . . 75.02 111.9 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 pt -95.56 -32.61 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.404 -0.362 . . . . 74.54 111.801 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 148.11 159.73 8.6 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.9 -0.667 . . . . 73.51 113.654 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 53.96 46.81 24.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.988 0.515 . . . . 73.23 112.267 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 142' ' ' SER . 44.2 m-80 67.18 -1.11 1.55 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.446 0.536 . . . . 72.55 112.446 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.22 141.99 28.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.353 0.597 . . . . 74.2 112.127 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -155.42 146.59 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.438 -0.801 . . . . 71.32 111.271 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.43 133.86 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.936 0.398 . . . . 62.55 111.089 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 9.3 p80 -158.72 165.28 34.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.513 -0.312 . . . . 64.54 111.404 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.35 95.75 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.038 0.447 . . . . 53.31 111.407 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 32.7 t -70.19 142.37 52.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.327 -0.397 . . . . 63.14 111.719 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -53.28 -41.37 65.5 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.658 0.614 . . . . 71.32 112.658 -176.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.1 t -108.16 -44.21 4.21 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.842 0.353 . . . . 72.33 111.802 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.1 m -76.57 -19.14 58.21 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.824 0.675 . . . . 52.41 112.824 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.73 -164.61 45.1 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.065 -0.588 . . . . 70.44 113.497 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 60.4 t -65.06 96.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.308 0.575 . . . . 75.43 111.192 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.8 pt -129.19 174.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.564 . . . . 62.25 111.648 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.1 mt -107.84 104.34 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.108 -0.496 . . . . 74.52 110.575 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.5 m -96.91 -173.39 2.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.807 0.337 . . . . 61.32 111.099 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 19.7 m -148.19 135.8 20.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.995 0.369 . . . . 73.11 111.995 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 59.3 mtm -74.46 5.19 4.93 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.015 0.376 . . . . 54.1 112.015 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -85.18 -6.96 59.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.02 0.438 . . . . 62.33 110.175 170.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -78.5 137.12 59.45 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.285 171.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.83 -46.44 32.15 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.328 2.019 . . . . 64.12 113.259 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.44 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 80.3 t80 -60.88 -47.7 85.17 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.809 0.3 . . . . 64.15 111.809 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -71.75 -37.07 70.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.915 0.388 . . . . 70.03 111.333 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.46 -42.99 93.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.076 0.465 . . . . 62.14 111.582 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -88.09 1.74 53.59 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.051 0.389 . . . . 70.21 112.051 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 2.6 mpt_? -109.04 -16.87 14.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.555 0.206 . . . . 75.41 111.555 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.443 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 53.3 t80 -57.57 109.71 0.75 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.059 0.456 . . . . 61.33 111.548 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.429 HD22 ' HG2' ' A' ' 154' ' ' GLU . 6.0 t30 -85.65 -55.01 4.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.136 0.493 . . . . 74.21 110.331 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.429 ' HG2' HD22 ' A' ' 153' ' ' ASN . 14.1 pt-20 -173.24 169.65 4.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.938 -0.574 . . . . 63.43 110.42 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.62 146.68 47.23 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.229 -0.295 . . . . 72.31 111.311 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 91.3 mtt180 -142.69 135.05 27.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.932 0.396 . . . . 71.42 111.997 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.48 ' H ' ' HD3' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -95.56 117.0 29.62 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.172 0.51 . . . . 74.22 111.255 176.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.72 0.65 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.95 -0.568 . . . . 62.04 112.041 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.532 HD23 HD22 ' A' ' 82' ' ' LEU . 79.1 mt . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 112.693 0.627 . . . . 63.01 112.693 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 120.678 0.275 . . . . 74.42 110.565 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.67 -48.09 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.149 0.5 . . . . 75.44 111.463 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.504 ' HB2' HG21 ' A' ' 105' ' ' THR . 88.3 tttt -55.02 -46.93 75.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.791 -0.641 . . . . 72.21 111.593 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t -58.61 -45.18 89.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.842 0.312 . . . . 50.42 111.842 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 43' ' ' ARG . 8.6 mmm180 -62.67 -39.08 92.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.868 0.366 . . . . 74.12 111.314 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.35 -46.74 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.922 0.391 . . . . 72.22 111.35 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 94.3 mmm -62.23 -37.93 87.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.912 0.387 . . . . 73.33 111.158 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.1 -45.27 93.52 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 72.3 110.796 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.725 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 59.0 tp60 -62.01 -46.77 87.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.156 -0.474 . . . . 65.02 111.132 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 20.0 t80 -58.16 -37.95 75.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.427 -0.351 . . . . 73.11 111.208 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.95 -32.65 47.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.027 0.442 . . . . 64.52 111.596 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.63 -42.06 61.96 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.001 0.429 . . . . 53.13 111.348 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.08 4.65 52.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.767 0.654 . . . . 63.14 112.767 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 50.5 mttm -54.32 112.15 0.93 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.724 0.297 . . . . 63.41 111.328 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.07 55.15 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.09 -0.576 . . . . 61.42 114.401 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.66 137.39 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.818 0.809 . . . . 75.2 111.462 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -76.04 166.89 22.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.128 0.489 . . . . 75.32 111.724 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -91.32 140.05 30.15 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.481 0.658 . . . . 75.13 112.567 -173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 65.8 ttt180 -131.57 176.87 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.611 -0.722 . . . . 73.4 109.944 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.407 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 91.4 mt -129.43 94.94 3.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.983 0.42 . . . . 55.02 111.407 175.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.38 55.01 2.68 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.362 -0.447 . . . . 24.44 113.357 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.441 ' HA3' ' NH1' ' A' ' 57' ' ' ARG . . . -177.51 104.47 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.928 -0.653 . . . . 72.51 113.474 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.8 p -78.64 115.05 18.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.935 0.398 . . . . 61.32 111.901 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -169.97 160.85 8.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.449 -0.342 . . . . 74.02 111.335 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.34 -6.99 44.21 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 65.04 111.002 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.58 -10.71 59.37 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.52 110.919 172.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.97 141.72 3.21 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.322 -0.399 . . . . 40.33 112.561 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.5 tp -141.31 143.44 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 122.446 -0.443 . . . . 71.41 111.65 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -93.91 166.48 12.15 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.259 0.552 . . . . 73.43 112.421 177.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 29.9 t -51.74 -54.34 29.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.615 -0.72 . . . . 62.24 112.319 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.1 p -67.6 -44.98 76.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.505 -0.316 . . . . 61.41 111.249 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.78 -40.02 56.13 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.435 -0.412 . . . . 75.21 113.767 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -61.09 -57.78 11.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.591 -0.358 . . . . 70.44 111.532 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.485 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.1 p -59.59 -36.49 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.917 0.389 . . . . 55.11 111.24 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.548 ' HA ' HD12 ' A' ' 84' ' ' LEU . 20.3 mt-30 -55.67 -61.17 2.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.385 -0.37 . . . . 65.33 111.673 175.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -60.02 -35.46 75.14 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.129 0.418 . . . . 73.23 112.129 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.725 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 99.7 m -56.12 -54.87 39.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 73.12 111.84 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.8 m-85 -75.03 -31.22 61.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.238 0.829 . . . . 71.53 113.238 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -76.05 -43.93 41.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.571 0.582 . . . . 74.55 112.571 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.04 -33.42 59.61 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.596 0.591 . . . . 72.1 112.596 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -87.28 -56.41 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.417 0.525 . . . . 64.15 112.417 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.08 -15.71 18.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.691 0.626 . . . . 73.35 112.691 -173.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.96 47.74 11.03 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.817 -0.706 . . . . 64.1 112.6 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 51.1 tp -104.86 137.71 42.22 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.14 0.495 . . . . 64.42 111.791 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.31 115.84 24.1 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.28 0.562 . . . . 62.22 111.438 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 73' ' ' GLN . 93.5 mt -127.37 151.41 74.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 122.137 -0.352 . . . . 71.15 111.625 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.98 -154.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.142 2.561 . . . . 52.41 112.902 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -110.06 -25.97 9.94 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.915 0.709 . . . . 74.43 112.915 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -120.72 148.66 43.66 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.828 -0.545 . . . . 52.3 112.305 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.441 HG23 ' HB ' ' A' ' 120' ' ' VAL . 26.2 m -52.54 -46.17 66.65 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.95 -0.568 . . . . 74.21 111.904 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -52.14 -32.35 35.22 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.075 -0.511 . . . . 73.35 111.545 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.22 -37.41 28.64 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.978 -0.556 . . . . 70.4 111.033 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.449 ' NE2' ' HG3' ' A' ' 73' ' ' GLN . 85.8 mt-30 -61.61 -32.61 72.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.238 -0.437 . . . . 64.04 111.384 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 88' ' ' THR . 17.1 mt-30 -52.71 -41.63 64.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.164 0.506 . . . . 74.32 111.547 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -77.73 -11.4 59.87 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.333 0.494 . . . . 75.54 112.333 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.4 mmm -80.91 -4.66 55.68 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.431 0.53 . . . . 62.12 112.431 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.472 ' O ' ' HD2' ' A' ' 156' ' ' ARG . . . -151.8 163.25 29.99 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.86 -0.686 . . . . 31.44 113.091 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 92.1 mttt -86.21 172.27 10.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 60.44 111.793 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 77.9 p -95.59 141.43 29.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.843 -0.617 . . . . 61.22 112.624 -171.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 5.1 m -131.98 158.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.796 -0.638 . . . . 32.55 111.282 175.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.8 t -100.13 176.55 5.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.376 -0.375 . . . . 61.53 111.833 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -47.53 -48.24 27.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.097 0.475 . . . . 74.42 112.176 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.2 m -69.11 -28.53 66.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.244 -0.434 . . . . 72.55 111.88 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.515 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 13.4 m120 -87.06 -13.86 43.13 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.112 0.412 . . . . 71.44 112.112 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -51.95 128.01 22.93 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.863 0.363 . . . . 62.55 111.688 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 102' ' ' ASN . 50.7 mtp85 -129.01 173.18 10.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.224 -0.444 . . . . 70.1 111.571 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.504 HG21 ' HB2' ' A' ' 41' ' ' LYS . 36.7 m -69.49 122.28 18.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.279 -0.418 . . . . 72.4 111.631 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.27 11.34 52.4 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.241 -0.504 . . . . 75.13 113.177 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.422 ' OD1' ' HB1' ' A' ' 155' ' ' ALA . 9.5 t70 -84.44 152.84 23.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.824 0.345 . . . . 65.51 110.875 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 72' ' ' VAL . 44.0 mt -96.37 103.51 15.42 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.973 0.416 . . . . 74.34 110.66 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -95.56 122.88 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.492 0.663 . . . . 73.12 111.376 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.516 HD12 ' HG3' ' A' ' 154' ' ' GLU . 72.1 mt -96.73 120.37 36.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.463 -0.789 . . . . 63.44 111.735 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -114.15 152.24 31.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.386 0.612 . . . . 75.04 111.749 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -91.2 106.57 18.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.653 -0.703 . . . . 75.33 111.09 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.967 0.413 . . . . 74.42 111.955 -178.725 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.944 0.402 . . . . 74.35 110.479 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -98.17 141.11 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.18 -0.463 . . . . 75.44 110.392 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 88' ' ' THR . 14.9 p -119.48 139.8 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 63.13 111.999 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 151.79 19.79 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.981 -0.554 . . . . 23.34 112.151 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.485 HD11 ' HA ' ' A' ' 72' ' ' VAL . 48.5 mt -88.22 107.62 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.51 -0.406 . . . . 62.34 110.827 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.22 105.71 1.16 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.77 0.319 . . . . 64.24 110.914 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.7 pt -91.47 -26.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.476 0.547 . . . . 55.53 112.476 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 160.94 122.17 0.62 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.154 -1.022 . . . . 65.51 114.193 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 45.99 81.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.88 0.872 . . . . 70.24 112.9 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.435 HD22 ' HB2' ' A' ' 143' ' ' MET . 18.2 m120 68.21 -19.17 0.15 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.728 1.01 . . . . 35.23 113.728 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -86.57 141.45 29.01 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.163 0.506 . . . . 74.52 111.851 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.04 150.8 27.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.983 -0.553 . . . . 54.11 111.222 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.67 138.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.869 0.366 . . . . 71.22 111.159 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -157.25 173.58 16.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.226 0.536 . . . . 72.42 111.734 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -103.65 122.92 46.02 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.078 -0.51 . . . . 75.11 110.978 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -114.53 159.62 20.18 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.008 0.432 . . . . 65.53 111.644 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -53.17 -65.82 0.49 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.767 1.025 . . . . 44.1 113.767 -171.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.8 t -87.06 -36.47 18.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.987 0.422 . . . . 72.12 112.028 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 m -77.88 -8.97 58.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.745 0.646 . . . . 70.31 112.745 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.78 -93.93 0.96 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.856 -0.687 . . . . 73.32 112.855 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 17.7 t -133.73 113.41 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.468 -0.43 . . . . 74.14 111.024 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.6 pt -138.24 173.58 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.84 0.681 . . . . 75.23 112.84 -173.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.5 127.13 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.639 -0.709 . . . . 72.2 110.388 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 m -119.06 178.18 4.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.981 0.419 . . . . 34.35 111.202 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.4 m -144.45 139.23 28.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.841 0.353 . . . . 71.32 111.627 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.435 ' HB2' HD22 ' A' ' 127' ' ' ASN . 75.5 mtm -69.13 3.68 2.0 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.72 0.295 . . . . 71.12 111.768 175.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -72.24 -28.8 63.38 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.323 0.582 . . . . 62.32 109.861 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.412 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 37.1 mt-10 -71.61 127.79 90.58 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.737 -0.665 . . . . 74.41 110.474 176.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 6.2 Cg_endo -47.88 -41.35 32.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.117 2.545 . . . . 52.53 113.833 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 90.9 t80 -53.6 -53.75 47.35 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.969 0.414 . . . . 73.23 111.546 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.412 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 88.5 m95 -75.95 -35.35 59.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 65.1 111.073 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -56.09 -32.63 64.32 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.028 -0.533 . . . . 63.02 112.129 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 0.4 OUTLIER -97.41 -9.07 28.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.46 0.541 . . . . 74.14 112.46 -178.266 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 30.6 mmt180 -103.79 -3.02 25.47 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.998 0.74 . . . . 74.44 112.998 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.43 107.32 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.96 0.409 . . . . 72.25 111.186 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.37 -66.56 0.89 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.25 0.548 . . . . 54.2 110.346 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.516 ' HG3' HD12 ' A' ' 110' ' ' LEU . 14.2 pt-20 -160.86 -175.65 5.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 64.51 110.383 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -140.22 157.21 45.95 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.616 0.246 . . . . 63.44 111.507 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 15.3 mmt180 -139.55 109.54 6.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.933 0.346 . . . . 74.03 111.933 -174.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -88.94 104.24 16.77 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.785 0.802 . . . . 74.33 111.1 177.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 113.101 0.778 . . . . 64.43 113.101 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 112.351 0.5 . . . . 74.42 112.351 -176.274 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 120.662 0.268 . . . . 73.23 111.399 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.7 t -51.62 -47.94 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.958 0.409 . . . . 72.31 111.187 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -56.5 -48.54 76.96 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.083 -0.508 . . . . 61.44 111.722 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -69.05 -32.85 72.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.632 -0.258 . . . . 73.02 111.674 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -66.26 -43.68 85.79 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.846 0.355 . . . . 73.34 111.238 177.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 40' ' ' VAL . 64.4 mt -65.02 -37.33 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.752 0.311 . . . . 74.12 110.759 176.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.5 mmt -64.44 -43.66 93.59 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.915 0.388 . . . . 64.2 111.368 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.0 -42.03 89.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.229 -0.441 . . . . 71.22 111.111 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -51.16 60.07 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.085 0.469 . . . . 64.11 110.036 175.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.5 -34.56 58.52 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.031 -0.532 . . . . 72.15 111.47 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.51 -33.08 53.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.861 0.362 . . . . 62.55 111.722 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -31.73 62.95 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.1 0.407 . . . . 73.33 112.1 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -106.07 12.88 29.85 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.644 0.609 . . . . 71.51 112.644 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -58.91 95.85 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.121 0.415 . . . . 41.12 112.121 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.47 27.3 10.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.088 -0.577 . . . . 74.13 113.898 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.5 t -77.67 127.09 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 122.25 -0.559 . . . . 74.23 110.796 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 55' ' ' ARG . 7.0 ptp180 -62.77 160.81 13.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.341 0.591 . . . . 74.54 112.281 -177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 39.8 t80 -84.83 123.26 30.26 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.141 -0.481 . . . . 75.32 111.97 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -136.97 130.38 31.43 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.423 -0.353 . . . . 72.12 110.531 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 58' ' ' LEU . 4.5 mp -80.96 112.74 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.615 0.245 . . . . 71.43 111.434 -175.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.53 3.47 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.035 -0.602 . . . . 61.11 114.151 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.21 72.57 0.58 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.957 -0.64 . . . . 74.43 112.778 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 t -69.72 100.81 1.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.301 0.482 . . . . 71.5 112.301 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 t -152.69 166.5 31.97 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.926 -0.579 . . . . 73.11 111.305 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.46 -6.49 36.26 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.441 . . . . 61.52 112.192 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.23 12.54 33.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.18 0.514 . . . . 52.13 111.006 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 55' ' ' ARG . . . 157.42 126.9 0.93 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.937 -0.574 . . . . 64.13 112.253 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 18.5 tt -158.59 154.54 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 117.545 0.672 . . . . 70.4 111.854 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.0 178.19 4.63 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.243 0.544 . . . . 75.14 112.299 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 12.3 t -58.17 -52.78 64.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.799 -0.637 . . . . 64.23 112.677 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 t -69.31 -43.32 74.0 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.214 0.53 . . . . 54.34 110.676 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.43 75.05 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.835 -0.621 . . . . 33.41 113.157 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -68.5 -48.88 63.28 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 122.395 -0.473 . . . . 74.51 112.147 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' A' ' 122' ' ' ILE . 12.1 p -61.88 -43.77 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 111.808 0.299 . . . . 70.12 111.808 -177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 20.6 pt20 -63.93 -37.72 88.44 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.165 -0.335 . . . . 75.53 111.484 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 36.0 mmt180 -59.8 -65.92 0.6 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.747 0.308 . . . . 73.35 111.315 173.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.9 m -44.52 -46.14 9.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.919 0.711 . . . . 75.12 112.919 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 39.5 m-85 -68.06 -43.22 79.14 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.729 0.64 . . . . 65.03 112.729 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 8.6 ptp180 -71.91 -30.25 65.17 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.594 -0.691 . . . . 73.23 111.559 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 mm-40 -68.33 -50.67 51.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 73.43 111.377 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -87.94 -61.55 1.69 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.451 0.537 . . . . 72.23 112.451 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.438 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 67.0 m-85 -92.67 -3.19 55.31 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.547 0.573 . . . . 53.53 112.547 -171.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.49 23.56 72.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.982 -0.627 . . . . 33.42 112.817 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 38.0 tp -95.12 115.82 27.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.895 0.378 . . . . 74.12 110.899 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.83 103.87 16.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.211 0.529 . . . . 73.3 112.179 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.93 146.93 37.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.898 -0.592 . . . . 72.42 110.521 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.2 172.39 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.546 2.164 . . . . 72.41 113.641 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -67.8 -48.58 65.88 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.159 0.8 . . . . 73.42 113.159 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -108.48 144.16 36.48 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.865 -0.522 . . . . 74.4 112.013 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 32.8 p -46.04 -43.61 14.59 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.827 0.677 . . . . 65.11 112.827 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.487 ' HA ' HE21 ' A' ' 92' ' ' GLN . 59.2 m-85 -54.08 -35.66 62.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.109 0.48 . . . . 71.24 111.342 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.76 -38.96 62.08 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.671 -0.695 . . . . 74.21 110.733 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -63.12 -31.22 72.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.668 -0.696 . . . . 64.32 111.55 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 89' ' ' TYR . 32.5 mt-30 -59.84 -34.87 73.66 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.143 0.497 . . . . 74.1 110.83 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 8.56 8.88 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.127 -0.488 . . . . 74.52 112.044 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.6 mmm -97.9 -68.17 0.81 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.928 0.394 . . . . 74.11 111.635 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.47 164.52 34.76 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.078 -0.582 . . . . 35.1 113.485 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HB2' ' NH1' ' A' ' 157' ' ' ARG . 14.3 mmmm -91.12 150.99 21.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 74.24 111.551 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 78.2 p -76.47 115.67 16.44 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.878 0.696 . . . . 52.05 112.878 -174.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 10.2 m -104.12 152.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.879 -0.601 . . . . 71.15 111.152 173.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.0 t -97.65 -176.98 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.185 -0.322 . . . . 54.5 110.826 175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.423 ' N ' ' HD3' ' A' ' 100' ' ' ARG . 1.4 mpp_? -59.82 -35.47 74.78 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.336 0.495 . . . . 73.14 112.336 -175.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.2 m -75.69 -12.5 60.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.946 0.35 . . . . 62.1 111.946 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.621 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.2 m120 -103.86 -5.06 22.73 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.204 0.446 . . . . 71.54 112.204 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.09 125.93 24.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.344 0.498 . . . . 75.34 112.344 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -141.79 134.69 28.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.149 -0.478 . . . . 75.41 110.639 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.0 m -38.67 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.964 0.727 . . . . 43.45 112.964 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.515 ' HA3' HD12 ' A' ' 159' ' ' LEU . . . 135.51 -0.01 3.38 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.034 -0.603 . . . . 72.42 114.054 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 4.1 p30 -90.04 158.98 17.08 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 117.706 0.753 . . . . 72.12 111.436 176.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.7 mt -104.76 120.79 42.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 73.32 111.165 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 m -94.75 112.98 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.583 0.706 . . . . 50.43 111.443 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.21 119.51 31.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.641 -0.709 . . . . 65.22 111.681 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HZ ' ' SD ' ' A' ' 143' ' ' MET . 92.2 m-85 -109.4 153.5 23.89 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.415 0.626 . . . . 75.33 111.922 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -88.39 113.85 24.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.707 -0.679 . . . . 53.32 109.352 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.372 0 O-C-N 122.095 -0.378 . . . . 42.31 111.868 -171.654 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.637 0.256 . . . . 73.54 111.631 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -99.6 124.27 44.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.88 -0.415 . . . . 73.42 109.88 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.412 HG12 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -110.18 145.04 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.659 0.614 . . . . 74.41 112.659 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.87 148.73 19.16 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.948 -0.569 . . . . 72.1 112.147 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 72' ' ' VAL . 42.4 mt -89.86 106.6 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.168 0.484 . . . . 74.51 111.183 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 61.3 t80 -71.29 111.34 6.55 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.233 0.54 . . . . 75.11 111.622 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.7 pt -95.57 -16.81 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.251 -0.431 . . . . 54.32 111.874 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.21 164.62 11.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.111 -0.566 . . . . 64.34 112.998 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.8 m120 58.08 32.6 22.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.818 0.342 . . . . 73.33 111.863 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 142' ' ' SER . 41.2 m-80 65.55 11.29 7.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.367 0.506 . . . . 64.12 112.367 -177.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -100.34 143.63 30.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.104 0.478 . . . . 73.23 111.232 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.72 151.96 31.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.901 -0.59 . . . . 71.24 111.553 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -103.21 141.99 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.244 -0.434 . . . . 72.11 110.949 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.39 -170.73 3.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.844 0.354 . . . . 73.02 111.072 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -132.98 108.26 8.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.53 -0.304 . . . . 72.24 111.017 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.6 p -91.42 155.26 18.59 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.071 0.462 . . . . 61.01 111.32 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.4 p -66.66 -2.38 4.84 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.632 0.605 . . . . 52.42 112.632 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.9 t -97.46 -67.47 0.85 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.053 0.39 . . . . 61.44 112.053 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.4 m -104.72 -6.41 20.39 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.688 0.625 . . . . 54.11 112.688 -175.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 132' ' ' ALA . . . 84.28 -133.45 11.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.521 -0.847 . . . . 72.1 112.614 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.06 108.72 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.216 0.45 . . . . 71.13 112.216 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.8 pt -143.43 179.19 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.228 0.537 . . . . 75.43 112.155 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.0 mm -106.81 149.9 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 116.176 -0.465 . . . . 73.53 110.917 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.1 m -148.97 172.19 15.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.77 0.319 . . . . 72.31 111.421 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.463 ' HB2' ' HG3' ' A' ' 145' ' ' GLU . 50.6 m -129.31 142.91 50.7 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.289 0.566 . . . . 54.14 112.376 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.438 ' SD ' ' HZ ' ' A' ' 111' ' ' PHE . 86.3 mmm -59.84 -27.11 66.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.717 -0.674 . . . . 54.33 112.539 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -85.96 3.65 41.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.593 0.59 . . . . 63.14 112.593 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 142' ' ' SER . 58.7 mt-10 -81.36 125.97 77.65 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 122.236 -0.29 . . . . 70.55 110.309 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -38.15 -50.11 2.18 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.946 3.098 . . . . 51.21 115.232 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.38 -43.04 97.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.009 0.374 . . . . 63.23 112.009 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.406 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 83.5 m95 -81.35 -42.39 20.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.187 0.518 . . . . 75.34 111.07 -176.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -54.17 -55.55 26.74 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.609 -0.723 . . . . 74.01 112.751 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -80.33 -11.69 59.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.059 0.392 . . . . 75.02 112.059 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -99.83 -2.21 35.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.176 0.436 . . . . 74.23 112.176 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -58.29 126.49 27.77 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.148 0.499 . . . . 65.34 111.73 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.406 HD22 ' HG2' ' A' ' 154' ' ' GLU . 5.7 t30 -101.8 -59.5 1.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.482 -0.326 . . . . 65.34 110.991 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG2' HD22 ' A' ' 153' ' ' ASN . 12.8 pt-20 -169.22 145.62 3.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.487 -0.324 . . . . 61.25 111.456 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -100.43 146.68 26.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.675 -0.239 . . . . 71.22 110.404 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.481 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 45.5 mtp85 -142.62 115.71 8.86 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.25 -0.281 . . . . 75.12 110.969 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -81.43 122.23 27.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.213 0.53 . . . . 73.04 111.976 -176.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.96 -20.14 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.561 0.578 . . . . 54.14 112.561 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.515 HD12 ' HA3' ' A' ' 106' ' ' GLY . 43.8 mt . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.213 0.53 . . . . 71.33 111.917 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 120.488 0.185 . . . . 71.44 110.511 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.33 -45.54 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.0 0.429 . . . . 74.0 111.203 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 76.0 tttt -53.38 -50.79 64.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.065 -0.516 . . . . 63.01 111.46 175.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.5 t -59.36 -44.0 92.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.356 -0.384 . . . . 64.2 111.59 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -57.17 -53.93 52.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.029 0.442 . . . . 74.24 110.871 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.02 -39.28 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.98 0.419 . . . . 70.2 111.791 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 31.1 mmt -66.24 -28.23 68.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.876 0.324 . . . . 74.04 111.876 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -63.62 -46.63 84.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.18 0.514 . . . . 72.23 110.044 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.6 tp60 -63.89 -44.97 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.718 -0.673 . . . . 63.43 110.385 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.17 -42.09 76.52 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.999 -0.546 . . . . 64.4 111.333 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.98 -33.22 66.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.034 0.445 . . . . 74.23 111.617 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -81.96 -26.09 34.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.21 0.529 . . . . 71.32 111.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -108.25 20.66 18.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.814 0.672 . . . . 63.12 112.814 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -59.42 101.56 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.901 0.704 . . . . 71.25 112.901 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.43 38.86 16.36 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.69 -0.687 . . . . 74.22 114.66 174.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.15 144.19 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 117.547 0.674 . . . . 74.24 111.081 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -56.54 142.77 38.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.545 0.338 . . . . 73.55 111.752 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 20.1 t80 -83.64 116.64 22.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.922 -0.399 . . . . 61.12 109.922 172.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -122.34 105.86 10.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.388 . . . . 61.12 110.49 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.86 116.86 12.74 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.934 0.397 . . . . 51.13 110.481 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 26.29 35.9 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.967 -0.635 . . . . 72.15 113.052 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.02 106.71 0.29 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.334 -0.46 . . . . 64.1 112.409 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.516 ' HA ' HG13 ' A' ' 66' ' ' ILE . 64.6 p -97.32 112.41 24.24 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.486 0.55 . . . . 64.53 112.486 -175.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.4 t -171.76 172.91 4.73 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.913 0.387 . . . . 74.52 111.651 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.64 -14.97 61.71 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 122.04 -0.412 . . . . 75.34 111.502 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -83.03 4.54 25.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.074 0.464 . . . . 74.44 110.602 172.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.64 132.47 2.61 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.603 -0.599 . . . . 75.12 111.603 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.516 HG13 ' HA ' ' A' ' 61' ' ' SER . 21.0 tt -151.22 153.09 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 117.391 0.595 . . . . 63.3 111.912 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -91.9 177.24 6.24 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.326 0.584 . . . . 72.2 111.985 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 32.4 t -62.09 -48.31 80.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.545 0.572 . . . . 71.43 112.545 -176.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 88' ' ' THR . 17.7 p -78.11 -27.58 48.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.918 0.389 . . . . 53.42 111.742 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.12 98.98 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.116 -0.564 . . . . 74.0 112.634 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -59.92 -50.66 72.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.928 0.344 . . . . 74.42 111.928 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.541 ' HA ' HD11 ' A' ' 122' ' ' ILE . 6.1 p -59.74 -52.82 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.294 0.479 . . . . 71.14 112.294 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.511 ' HG2' ' HA ' ' A' ' 86' ' ' ARG . 4.4 pp0? -65.99 -26.71 67.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.15 0.426 . . . . 65.52 112.15 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.545 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.3 mtp180 -69.31 -53.92 17.23 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.137 -0.352 . . . . 71.22 111.068 171.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -46.4 -49.61 17.75 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.257 0.551 . . . . 74.2 111.792 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 67.2 m-85 -68.44 -39.2 81.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.746 0.647 . . . . 65.24 112.746 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.545 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 11.8 ptp180 -76.75 -25.62 53.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.641 -0.662 . . . . 61.22 112.159 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.25 -28.27 34.84 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.979 0.362 . . . . 74.14 111.979 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 85.6 mt-30 -109.05 -61.44 1.62 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.587 0.588 . . . . 74.12 112.587 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -83.81 -11.67 56.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.928 0.344 . . . . 72.02 111.928 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.9 71.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.346 -0.454 . . . . 44.42 113.173 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.4 tp -73.37 123.3 23.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 74.53 111.53 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -74.29 85.17 1.93 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.401 0.62 . . . . 73.12 112.434 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.7 mt -106.28 135.2 19.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 122.126 -0.359 . . . . 64.41 111.215 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.619 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 58.7 Cg_endo -71.27 156.87 58.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.774 2.316 . . . . 75.2 113.111 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -57.0 -43.35 81.65 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.811 1.041 . . . . 75.21 113.811 -174.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.419 ' N ' ' HG2' ' A' ' 86' ' ' ARG . 73.9 m -102.61 152.4 21.23 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.841 1.052 . . . . 64.23 113.841 -170.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 69' ' ' SER . 51.4 p -51.45 -58.91 4.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.971 -1.013 . . . . 52.21 112.969 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -47.24 -35.56 7.85 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.004 -0.543 . . . . 64.34 112.287 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.66 -42.59 28.23 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.052 -0.522 . . . . 74.04 111.162 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.16 -22.15 65.65 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.938 0.399 . . . . 72.0 111.461 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.461 ' HG2' HD11 ' A' ' 110' ' ' LEU . 27.1 mt-30 -66.44 -34.46 77.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.204 -0.453 . . . . 73.23 112.171 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -84.22 -10.84 57.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.457 0.539 . . . . 52.34 112.457 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.619 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 62.4 mtp -94.78 -70.18 0.72 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.589 0.233 . . . . 75.32 111.525 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.4 130.31 28.99 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.388 -0.91 . . . . 73.43 112.277 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -85.27 143.57 28.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.406 0.622 . . . . 62.11 112.363 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 18.4 m -64.84 144.29 57.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.883 -1.053 . . . . 45.42 113.354 -170.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.428 HG22 ' HD3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -132.44 163.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.838 -0.619 . . . . 73.3 111.516 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.7 t -116.57 171.68 7.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.402 -0.363 . . . . 72.14 111.132 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -43.98 -57.64 3.23 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.217 1.191 . . . . 71.34 114.217 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -69.39 -9.25 52.67 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.981 0.734 . . . . 63.33 112.981 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -114.97 5.06 14.92 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.502 0.556 . . . . 62.4 112.502 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.35 133.04 55.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.77 0.319 . . . . 64.13 111.757 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 104' ' ' ARG . 54.2 mtt180 -108.28 169.44 8.63 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.436 0.636 . . . . 63.13 112.247 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.7 m -79.85 118.43 21.62 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.192 -0.458 . . . . 75.54 110.524 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 18.93 33.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.046 -0.597 . . . . 72.25 112.004 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -77.51 159.71 29.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.922 0.489 . . . . 73.53 110.291 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.0 mt -114.06 109.27 18.18 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.64 -0.663 . . . . 60.33 111.826 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.59 126.19 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.408 0.623 . . . . 64.51 111.913 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.461 HD11 ' HG2' ' A' ' 92' ' ' GLN . 83.0 mt -97.97 138.96 34.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.744 -0.662 . . . . 41.44 111.649 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -124.48 137.99 54.38 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.216 0.532 . . . . 73.23 111.929 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 33.6 mtp85 -72.56 84.01 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.976 -0.556 . . . . 74.13 110.533 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 112.381 0.512 . . . . 45.11 112.381 -174.604 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 111.864 0.32 . . . . 74.03 111.864 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -115.64 149.22 38.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.413 -0.358 . . . . 72.44 110.178 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.61 135.34 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.154 0.502 . . . . 71.42 112.147 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -123.3 148.57 16.79 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.21 -0.519 . . . . 72.13 113.226 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.541 HD11 ' HA ' ' A' ' 72' ' ' VAL . 40.2 mt -82.47 107.51 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.796 0.332 . . . . 72.23 110.797 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 2.0 t80 -70.7 104.35 2.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.119 -0.491 . . . . 73.24 111.616 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.428 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 38.2 pt -102.18 -17.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.743 0.645 . . . . 71.32 112.743 -176.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.69 -170.31 16.35 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.524 -0.846 . . . . 44.45 113.9 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -58.31 -32.77 68.78 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.68 0.392 . . . . 73.02 111.884 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -137.52 -26.46 0.98 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.226 -0.443 . . . . 74.24 112.153 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -85.26 140.87 30.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.03 0.752 . . . . 74.31 113.03 -175.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.401 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 22.1 p90 -148.38 142.95 26.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.461 -0.79 . . . . 72.12 110.982 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.82 137.2 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.975 0.416 . . . . 75.2 111.558 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -155.92 163.55 39.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.989 0.424 . . . . 64.11 111.74 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -94.54 97.85 10.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.019 0.438 . . . . 61.42 110.832 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 80.9 p -81.7 142.06 33.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.175 0.512 . . . . 72.34 111.714 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.0 t -69.24 -7.04 33.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.233 -0.44 . . . . 72.44 112.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.3 p -101.52 -59.74 1.65 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.842 0.353 . . . . 40.33 111.834 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.481 ' HB2' HD13 ' A' ' 139' ' ' ILE . 68.6 m -109.5 13.79 23.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.399 0.518 . . . . 53.24 112.399 -175.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.65 -152.5 52.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.0 -0.619 . . . . 60.33 112.883 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 53.6 t -64.74 106.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.458 -0.436 . . . . 64.02 111.764 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 136' ' ' SER . 35.9 pt -136.82 -175.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.101 0.477 . . . . 55.05 111.703 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.28 129.11 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.428 -0.351 . . . . 72.54 110.965 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.7 m -118.53 174.44 6.25 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.876 0.37 . . . . 71.2 111.809 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.8 t -124.53 142.34 51.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.297 0.48 . . . . 75.42 112.297 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 85.0 mmm -63.39 -17.16 62.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.156 -0.474 . . . . 53.51 111.284 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -74.0 -18.04 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.324 -0.398 . . . . 71.44 111.617 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.09 130.22 93.82 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.786 -0.188 . . . . 73.44 111.118 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.483 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 85.2 Cg_exo -47.93 -51.97 8.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.907 2.404 . . . . 65.03 114.059 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 94.4 t80 -58.42 -47.07 85.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.784 0.326 . . . . 64.21 111.718 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -72.3 -40.14 67.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.784 0.326 . . . . 63.24 111.591 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.13 -52.64 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.003 0.43 . . . . 72.42 111.925 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.0 ptpt -78.12 -14.84 59.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.889 0.376 . . . . 72.21 111.988 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.567 ' HE ' ' HA ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -91.83 -12.07 34.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.19 -0.318 . . . . 71.35 111.789 175.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.47 105.57 0.16 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.319 0.581 . . . . 74.43 111.176 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.406 HD22 ' HG2' ' A' ' 154' ' ' GLU . 8.9 t30 -90.46 -51.56 5.35 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.993 -0.548 . . . . 74.11 111.54 -176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG2' HD22 ' A' ' 153' ' ' ASN . 17.2 pt-20 -172.76 147.39 1.74 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.865 0.364 . . . . 75.33 111.204 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -103.01 161.62 13.61 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.356 -0.215 . . . . 52.33 110.659 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.8 mtm-85 -146.84 113.01 5.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.829 0.347 . . . . 73.41 111.806 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.428 ' HD3' HG22 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.76 96.89 4.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.289 0.566 . . . . 55.31 111.361 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.4 m -77.21 -29.79 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.953 -0.467 . . . . 65.44 111.62 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.613 -0.267 . . . . 72.44 110.427 174.995 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.869 0.366 . . . . 73.23 111.215 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 44' ' ' ILE . 88.9 t -61.84 -49.58 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.211 -0.45 . . . . 75.02 111.815 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.535 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 87.2 tttt -57.3 -44.88 84.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.34 -0.391 . . . . 75.03 111.496 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -60.1 -45.18 93.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.264 -0.425 . . . . 74.3 111.536 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mmm-85 -61.19 -43.57 98.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.073 0.463 . . . . 75.32 111.111 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 40' ' ' VAL . 73.1 mt -63.09 -47.79 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.021 0.439 . . . . 72.51 111.372 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 29.7 mmt -62.86 -29.4 70.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.394 -0.366 . . . . 75.23 111.522 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.43 -38.84 81.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.651 0.262 . . . . 72.32 111.166 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.4 ' HB2' HE21 ' A' ' 79' ' ' GLN . 63.6 tp60 -77.54 -31.82 53.54 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.575 0.226 . . . . 60.22 111.506 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -53.45 -37.53 62.71 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.82 0.343 . . . . 74.34 111.286 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -24.31 64.47 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.127 0.417 . . . . 61.02 112.127 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -47.12 24.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.085 0.469 . . . . 72.41 111.513 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -85.55 16.01 4.17 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.073 0.768 . . . . 75.33 113.073 -172.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HB3' ' NZ ' ' A' ' 52' ' ' LYS . 2.8 mmmp? -68.87 118.33 11.68 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.141 -0.349 . . . . 75.34 110.952 176.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.64 46.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.302 -0.475 . . . . 62.43 113.494 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.83 128.94 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.062 0.458 . . . . 74.24 111.729 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -88.19 179.31 6.4 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.912 -0.586 . . . . 75.14 111.599 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -91.66 133.02 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.091 0.472 . . . . 75.21 111.208 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -134.23 113.54 12.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.11 -0.496 . . . . 71.44 110.192 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 58' ' ' LEU . 7.1 mp -57.93 115.2 2.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.924 0.393 . . . . 74.23 111.717 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.39 19.67 74.61 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.122 -0.49 . . . . 54.1 113.665 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.94 143.98 17.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.458 -0.401 . . . . 65.33 112.886 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 66' ' ' ILE . 62.0 p -126.76 99.53 5.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.451 -0.441 . . . . 61.33 111.21 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 t -174.99 165.62 3.49 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.807 0.337 . . . . 71.51 111.635 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -74.38 -9.85 59.0 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.107 0.479 . . . . 75.4 110.909 176.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.11 -1.51 56.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.112 -0.494 . . . . 70.33 111.281 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.34 124.11 1.57 Allowed Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.248 -0.433 . . . . 74.24 112.053 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.5 tt -134.03 149.62 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.21 -0.583 . . . . 53.2 111.922 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.65 160.75 26.22 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.281 -0.418 . . . . 73.33 110.958 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.541 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 29.4 p -58.86 -53.6 56.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.152 0.501 . . . . 75.31 110.895 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.428 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 87.6 p -63.8 -33.78 76.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.235 0.541 . . . . 63.41 110.822 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 73' ' ' GLN . . . -67.76 -31.6 76.22 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.817 -0.629 . . . . 74.0 112.954 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -66.13 -47.25 74.7 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.501 -0.411 . . . . 75.11 111.342 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 HG12 ' A' ' 122' ' ' ILE . 11.2 p -67.9 -40.02 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 111.977 0.362 . . . . 74.24 111.977 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 22.0 pt20 -58.69 -41.91 87.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.062 0.458 . . . . 75.23 110.427 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.66 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 11.5 mmm180 -66.64 -67.0 0.48 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.248 -0.433 . . . . 70.13 110.929 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 m -40.75 -46.65 2.7 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.441 0.534 . . . . 72.1 112.441 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 14.0 m-30 -68.88 -39.39 79.82 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.432 0.53 . . . . 71.2 112.432 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 10.9 ptm180 -79.68 -19.29 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.701 -0.624 . . . . 71.24 111.846 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.7 mm-40 -72.28 -47.68 48.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.464 0.649 . . . . 62.05 110.162 175.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 47' ' ' GLN . 82.3 mm-40 -95.12 -53.38 3.83 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.59 -0.732 . . . . 74.21 112.791 -174.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -93.78 -23.76 18.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.278 0.474 . . . . 74.43 112.278 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.71 36.32 22.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.053 -0.594 . . . . 74.15 112.973 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 40.4 tp -95.19 119.22 33.32 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.76 0.314 . . . . 75.25 111.23 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.54 84.19 7.16 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.22 0.452 . . . . 70.0 112.22 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.67 145.63 30.74 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.5 -0.318 . . . . 73.23 111.301 176.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 150.11 62.41 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.721 2.28 . . . . 74.44 112.837 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.82 42.44 0.79 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.214 0.53 . . . . 51.54 112.205 -176.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.5 m -153.16 117.67 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.116 -0.365 . . . . 53.12 111.034 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 17.2 m -48.46 -44.36 35.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.506 0.558 . . . . 32.14 112.506 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -54.98 -46.42 75.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.76 0.314 . . . . 70.13 111.751 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -62.78 -42.77 99.85 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.429 0.633 . . . . 75.23 110.534 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -62.9 -30.55 71.62 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.875 -0.602 . . . . 74.41 111.755 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 88' ' ' THR . 26.1 mt-30 -63.03 -16.08 58.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.815 0.34 . . . . 72.11 111.692 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.81 -3.47 26.3 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.77 0.319 . . . . 60.31 111.438 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.3 mmm -95.18 -13.33 25.08 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.885 0.698 . . . . 72.32 112.885 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -141.58 154.97 25.05 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.858 -0.687 . . . . 72.24 113.725 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -96.11 153.35 17.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.04 0.448 . . . . 75.11 111.495 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 92.9 p -77.69 157.26 30.21 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.937 1.088 . . . . 60.35 113.937 -170.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.42 147.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 114.893 -1.049 . . . . 54.43 110.202 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -83.29 164.28 20.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.879 0.371 . . . . 74.11 111.309 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -49.08 -29.89 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.858 0.688 . . . . 72.42 112.858 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -82.7 -23.19 34.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.887 0.699 . . . . 72.44 112.887 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -103.5 20.6 17.58 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.496 0.554 . . . . 74.4 112.496 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.0 mt -69.84 126.09 28.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.025 0.441 . . . . 63.23 111.918 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -101.72 -164.6 1.11 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.061 0.457 . . . . 64.24 111.132 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 41' ' ' LYS . 58.7 m -97.44 109.06 21.89 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.426 -0.352 . . . . 73.43 110.83 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.54 25.33 6.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.404 -0.427 . . . . 72.22 113.687 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -94.47 146.28 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.444 -0.445 . . . . 72.23 111.302 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.412 ' CD2' HG21 ' A' ' 72' ' ' VAL . 47.1 mt -78.03 108.4 11.27 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.369 -0.378 . . . . 74.34 111.788 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.6 m -96.81 112.48 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.452 0.644 . . . . 70.23 111.433 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.37 120.64 28.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.649 -0.705 . . . . 74.43 111.956 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 88.9 m-85 -112.6 157.81 20.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.31 0.576 . . . . 70.22 111.766 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.564 ' HB2' ' HG3' ' A' ' 151' ' ' ARG . 19.6 mtp180 -90.45 103.52 16.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.048 -0.524 . . . . 73.35 110.832 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . . . . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 63.2 111.791 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 . . . . . 0 CA--C 1.536 0.421 0 CA-C-O 120.965 0.412 . . . . 65.44 110.613 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 59.6 t60 -92.93 148.71 21.78 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.277 -0.42 . . . . 74.22 111.283 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.93 128.98 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.226 0.536 . . . . 74.54 111.281 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.72 154.44 16.5 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.208 -0.52 . . . . 70.13 112.93 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 72' ' ' VAL . 49.5 mt -89.65 102.66 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 122.549 -0.383 . . . . 62.51 110.584 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 37.2 t80 -73.7 105.24 4.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 75.41 111.762 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.535 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.0 pt -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.954 0.407 . . . . 61.1 111.735 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.97 178.71 19.17 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.501 -0.38 . . . . 60.45 113.032 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 62.67 21.36 12.67 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.689 0.28 . . . . 75.24 111.139 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 142' ' ' SER . 0.9 OUTLIER 65.12 12.54 8.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.93 0.395 . . . . 65.51 111.503 -171.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -103.81 145.24 30.39 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.376 0.608 . . . . 72.25 111.235 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 10.5 p90 -150.07 140.73 22.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.953 -0.567 . . . . 70.42 111.39 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.75 133.12 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.965 0.412 . . . . 64.4 110.718 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.43 ' HD1' ' HE2' ' A' ' 119' ' ' HIS . 7.3 p80 -157.04 154.72 30.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.199 0.523 . . . . 73.11 111.88 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -84.41 91.04 7.71 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.952 0.406 . . . . 75.41 110.155 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -67.47 146.04 54.38 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.108 0.48 . . . . 73.33 111.628 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.6 p -49.55 -47.91 48.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.606 -0.725 . . . . 71.1 112.855 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.0 m -98.9 -51.07 3.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.683 0.623 . . . . 71.4 112.683 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.6 m -80.75 -15.14 57.25 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.259 0.837 . . . . 65.31 113.259 -170.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.61 -154.93 30.18 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.01 -0.614 . . . . 64.41 113.036 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.38 102.68 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.864 0.364 . . . . 75.12 111.958 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.9 pt -140.13 178.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.093 0.473 . . . . 71.23 111.773 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.19 134.93 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.418 -0.355 . . . . 74.43 110.76 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.402 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . 49.9 m -128.47 172.56 11.02 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 122.267 -0.271 . . . . 73.34 111.538 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 65.5 m -125.43 141.42 52.07 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.056 0.391 . . . . 54.04 112.056 -177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.3 mtt -67.4 -15.06 63.47 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.372 0.508 . . . . 73.11 112.372 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.965 0.412 . . . . 71.45 111.241 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.403 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 29.8 mm-40 -71.79 135.59 83.19 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.548 -0.296 . . . . 72.12 110.734 175.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.27 -48.03 21.68 Favored 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 122.91 2.406 . . . . 54.33 113.672 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 78.9 t80 -59.39 -50.85 72.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.833 0.349 . . . . 71.3 111.562 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.403 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 75.8 m95 -71.84 -36.92 70.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.576 -0.284 . . . . 64.22 111.701 -172.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -53.32 -54.87 30.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.08 0.467 . . . . 75.02 111.777 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -80.82 -18.86 46.11 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.94 0.348 . . . . 75.24 111.94 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.564 ' HG3' ' HB2' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -84.68 -15.36 45.56 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.958 -0.464 . . . . 72.52 111.884 177.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -61.26 92.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.296 0.569 . . . . 73.54 110.301 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -79.08 -46.01 18.93 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.966 -0.561 . . . . 74.33 111.379 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -172.9 163.58 4.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.979 -0.555 . . . . 62.02 110.978 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -128.15 149.3 50.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.766 -0.197 . . . . 65.33 110.718 176.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 95' ' ' GLY . 50.8 mtt180 -138.61 125.92 21.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.184 0.516 . . . . 63.51 112.016 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.71 120.67 27.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.034 -0.53 . . . . 75.13 111.242 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.55 -19.53 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.732 0.641 . . . . 70.44 112.732 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 82' ' ' LEU . 91.7 mt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.129 0.49 . . . . 73.2 112.079 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 41' ' ' LYS . 30.9 t70 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.732 0.301 . . . . 72.5 110.888 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.2 -48.38 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.406 -0.361 . . . . 74.25 111.531 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.9 tttt -60.04 -44.03 94.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.342 -0.39 . . . . 74.42 111.372 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.7 t -53.19 -49.79 65.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.181 0.437 . . . . 75.34 112.181 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -63.5 -44.2 95.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.964 0.412 . . . . 73.54 111.572 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.49 HD13 HG21 ' A' ' 122' ' ' ILE . 67.5 mt -64.36 -36.88 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.957 0.408 . . . . 64.42 111.365 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 96.0 mmm -65.74 -37.29 85.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.912 0.387 . . . . 72.44 110.715 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.75 -37.17 78.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.252 0.549 . . . . 54.21 110.198 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.559 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 7.6 tp60 -62.74 -53.65 51.13 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.013 -0.54 . . . . 54.04 110.451 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -51.1 -39.44 56.15 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.053 -0.521 . . . . 74.51 111.293 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.93 71.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.366 . . . . 74.01 111.685 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.02 -26.91 61.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 75.3 111.47 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -107.01 11.78 29.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.064 0.764 . . . . 75.52 113.064 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.78 128.43 35.88 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.959 -0.463 . . . . 64.42 111.325 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.05 -18.13 58.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.254 -0.498 . . . . 75.41 113.665 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.58 131.63 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.42 . . . . 74.23 111.837 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 55' ' ' ARG . 44.5 mtp180 -82.3 178.39 8.27 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.228 0.455 . . . . 65.24 112.228 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -85.39 121.46 28.15 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.896 0.379 . . . . 64.53 111.661 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -137.57 115.46 11.5 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 74.51 110.65 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 21.7 tp -72.87 116.85 13.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.004 0.43 . . . . 72.34 112.102 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.91 -53.25 3.97 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.369 -0.443 . . . . 61.12 113.339 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.92 71.48 0.93 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.114 -0.565 . . . . 61.22 113.236 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.2 p -69.6 106.97 3.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.252 0.549 . . . . 74.0 112.132 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 t -160.94 172.46 16.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.906 -0.588 . . . . 73.02 111.026 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.5 -14.11 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.911 0.386 . . . . 74.42 111.433 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.73 -16.28 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.887 0.375 . . . . 61.22 110.903 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.22 144.38 4.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.157 -0.474 . . . . 54.31 112.222 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.6 tt -155.58 148.21 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 117.444 0.622 . . . . 71.31 111.506 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 6.4 p-10 -96.08 -171.37 2.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.185 0.517 . . . . 72.4 112.063 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 24.4 p -70.97 -50.16 37.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.073 -0.512 . . . . 71.11 112.023 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 50.5 p -66.76 -40.95 88.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.818 0.342 . . . . 71.42 110.836 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.29 -40.73 99.4 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.333 -0.461 . . . . 64.15 113.093 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -65.32 -55.99 15.14 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.666 0.269 . . . . 54.32 111.553 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.06 -42.23 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.915 0.388 . . . . 63.41 111.054 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.8 tt0 -52.86 -61.28 2.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 75.25 111.719 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 74' ' ' ARG . 52.8 mtt180 -56.96 -46.53 82.07 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.544 -0.298 . . . . 75.42 111.783 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.2 m -49.85 -50.18 46.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.272 0.471 . . . . 71.14 112.272 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 85.0 m-85 -80.4 -42.46 22.75 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.849 0.685 . . . . 45.24 112.849 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 14.7 ptm180 -66.66 -33.56 75.93 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.94 -0.475 . . . . 75.33 111.996 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 5.0 mm-40 -86.71 -45.93 10.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.961 0.356 . . . . 64.43 111.961 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 29.8 mt-30 -83.26 -51.7 7.22 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.613 0.597 . . . . 75.24 112.613 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -97.15 -6.17 35.51 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.391 0.515 . . . . 71.25 112.391 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.03 43.64 98.88 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.032 -0.604 . . . . 71.31 112.663 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 52.7 tp -108.89 138.85 44.58 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 73.15 111.742 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.6 118.06 12.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.551 0.575 . . . . 75.3 112.551 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 158' ' ' VAL . 60.5 mt -136.72 134.78 19.59 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.83 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.518 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 81.3 Cg_endo -77.35 173.7 13.89 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.726 2.284 . . . . 63.21 113.409 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -95.55 16.03 18.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 73.23 112.985 -173.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.0 m -143.06 127.88 18.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.652 0.263 . . . . 63.5 111.675 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 69' ' ' SER . 26.9 m -51.28 -37.33 46.78 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.073 0.463 . . . . 72.42 111.75 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.485 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 72.9 m-85 -57.86 -32.02 67.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.089 -0.505 . . . . 74.11 111.631 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -83.1 -38.58 22.27 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.385 0.612 . . . . 70.53 110.456 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.86 -25.46 67.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.052 -0.522 . . . . 73.33 111.845 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 26.5 pt20 -78.28 -15.51 58.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.443 0.534 . . . . 64.41 112.443 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -110.99 -21.61 11.92 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.797 0.665 . . . . 70.35 112.797 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.518 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 25.5 ptm -75.03 -15.95 60.62 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.912 0.708 . . . . 72.13 112.912 -176.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.63 170.19 13.36 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.048 -0.596 . . . . 71.44 113.642 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 74.2 mmtt -90.87 133.59 35.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.186 0.517 . . . . 72.21 111.772 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -78.38 132.7 37.48 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.512 -0.767 . . . . 52.51 112.797 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.563 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 2.4 m -134.15 161.6 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.971 0.508 . . . . 73.43 111.488 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -116.95 -175.68 2.83 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.835 -0.62 . . . . 63.02 112.068 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.545 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 25.8 mmm180 -40.54 -61.49 0.92 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 75.43 113.855 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -69.03 -16.93 63.83 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.999 0.74 . . . . 54.22 112.999 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -94.12 -13.8 26.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.518 0.562 . . . . 73.25 112.518 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.22 148.89 43.33 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.439 0.903 . . . . 71.53 113.439 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -133.25 -163.01 1.3 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.062 -0.972 . . . . 65.02 109.917 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 41' ' ' LYS . 36.0 m -86.52 108.42 18.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.883 -0.511 . . . . 73.32 110.907 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.54 -13.48 6.92 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.952 -0.642 . . . . 62.34 113.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 120.98 13.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.338 0.569 . . . . 41.34 111.362 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 35.8 mt -76.49 110.98 11.48 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.302 -0.408 . . . . 60.21 111.282 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 155' ' ' ALA . 27.7 m -95.36 139.98 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.046 0.45 . . . . 72.24 112.081 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.446 ' HG ' HH12 ' A' ' 156' ' ' ARG . 96.4 mt -106.56 134.76 49.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.15 -0.477 . . . . 72.43 111.879 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.58 133.92 52.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 72.23 110.459 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 112' ' ' ARG . 24.5 mtp180 -74.1 91.47 2.09 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.186 0.517 . . . . 73.22 110.397 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.715 0.635 . . . . 64.44 112.715 -170.014 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 10.4 mpt_? . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.835 0.35 . . . . 72.53 110.536 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -105.09 141.68 36.23 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.465 -0.334 . . . . 74.33 110.799 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.17 137.78 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.199 0.523 . . . . 55.32 111.92 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.28 159.84 23.95 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 116.054 -0.521 . . . . 73.14 112.635 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.49 HG21 HD13 ' A' ' 44' ' ' ILE . 56.8 mt -93.33 110.3 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 122.603 -0.351 . . . . 72.43 110.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -69.32 115.7 8.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.928 0.394 . . . . 75.14 111.611 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.9 pt -106.58 14.27 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.12 0.415 . . . . 71.44 112.12 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.57 162.62 33.95 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.309 -0.472 . . . . 70.54 114.071 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 59.07 35.56 23.91 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.831 0.452 . . . . 54.44 111.996 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 142' ' ' SER . 48.4 m-80 62.18 14.49 6.7 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.126 0.417 . . . . 65.25 112.126 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -103.35 145.7 29.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.111 0.482 . . . . 72.01 111.139 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.03 139.87 19.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.115 -0.493 . . . . 75.42 111.844 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.49 133.62 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.091 0.472 . . . . 62.12 110.977 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -163.67 168.71 19.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.299 -0.41 . . . . 74.01 111.184 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.13 93.4 8.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.009 0.433 . . . . 71.05 110.814 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.1 t -79.54 130.39 35.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.309 -0.405 . . . . 73.12 111.993 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.8 p -63.36 -11.85 25.74 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.063 -0.517 . . . . 62.34 112.359 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 m -79.72 -32.39 41.23 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.976 0.362 . . . . 52.44 111.976 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.4 t -139.65 -48.45 0.47 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.04 0.448 . . . . 73.45 112.069 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.1 -148.28 19.95 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.713 -0.555 . . . . 74.44 111.713 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.2 99.5 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 117.321 0.561 . . . . 64.41 111.175 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 41.0 pt -138.23 -177.54 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.118 0.485 . . . . 73.42 111.824 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.79 129.03 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.251 -0.431 . . . . 72.4 110.565 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.5 m -119.8 172.94 7.35 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.942 0.401 . . . . 63.32 111.599 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 47.2 m -128.78 144.83 51.26 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.993 0.425 . . . . 54.43 112.085 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.545 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 65.8 mtt -75.2 0.87 14.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.675 0.62 . . . . 50.12 112.675 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -86.95 -11.86 49.32 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.936 -0.477 . . . . 65.32 111.287 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.46 130.6 92.04 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.486 -0.325 . . . . 75.03 110.699 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.34 -31.02 75.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.876 2.384 . . . . 43.45 113.442 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.19 -45.0 62.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.705 0.288 . . . . 71.4 111.74 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -83.79 -37.54 22.45 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.183 0.438 . . . . 72.23 112.183 -174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -53.51 -51.41 62.91 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.43 0.53 . . . . 73.24 112.43 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.22 -7.86 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.955 0.354 . . . . 71.1 111.955 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -95.94 -10.87 27.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.119 0.414 . . . . 72.01 112.119 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.86 114.63 2.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.946 0.403 . . . . 74.15 111.474 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -96.26 -55.5 2.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.296 -0.411 . . . . 74.42 111.255 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -168.74 -179.69 3.87 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.871 0.367 . . . . 74.44 111.398 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.586 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -140.33 160.4 40.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.28 -0.418 . . . . 74.3 111.162 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.4 mtm-85 -144.33 121.22 11.31 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.321 -0.237 . . . . 73.34 111.584 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.563 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -94.08 98.92 11.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.755 0.788 . . . . 75.02 111.242 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.542 HG21 HD21 ' A' ' 84' ' ' LEU . 15.9 m -83.18 -1.01 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.515 -0.766 . . . . 63.43 112.592 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.495 HD23 HD22 ' A' ' 82' ' ' LEU . 90.9 mt . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.866 0.365 . . . . 64.33 111.974 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.301 0.572 . . . . 74.33 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.75 -38.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.854 -0.612 . . . . 71.2 112.117 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.498 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.7 tttt -63.08 -55.31 26.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.638 0.606 . . . . 60.41 112.638 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 t -57.41 -42.99 83.38 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.95 0.352 . . . . 61.32 111.95 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -59.14 -45.19 91.59 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.022 0.439 . . . . 64.32 111.446 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.56 HD13 HG21 ' A' ' 122' ' ' ILE . 86.8 mt -69.17 -44.54 80.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.828 0.347 . . . . 72.2 111.722 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 28.1 mmt -61.56 -32.04 72.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.889 0.376 . . . . 74.15 111.051 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.09 -53.12 61.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.995 -0.548 . . . . 73.21 110.765 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.576 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 51.6 tp60 -65.25 -36.33 83.79 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.02 -0.536 . . . . 72.0 111.812 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.484 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 34.0 t80 -55.21 -39.68 69.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.868 0.366 . . . . 63.54 111.273 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . . . -59.37 -18.4 38.19 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.454 0.538 . . . . 71.13 112.454 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -92.5 -22.63 19.46 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.058 0.456 . . . . 71.44 111.776 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.473 ' CZ2' ' HG2' ' A' ' 63' ' ' LYS . 35.5 m95 -113.56 13.0 18.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.06 0.763 . . . . 72.14 113.06 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.6 mtmt -63.57 105.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.229 0.538 . . . . 50.11 112.027 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.96 19.33 9.14 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.94 -0.648 . . . . 71.41 114.375 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.32 130.3 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.619 0.709 . . . . 51.12 110.738 174.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 55' ' ' ARG . 16.5 ptt180 -79.46 163.27 24.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.408 0.521 . . . . 73.25 112.408 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -81.25 125.48 30.37 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.174 0.511 . . . . 74.5 112.242 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.431 HH11 HG22 ' A' ' 62' ' ' THR . 53.0 ttt180 -137.0 111.47 8.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.794 -0.639 . . . . 75.24 110.263 176.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.591 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 1.1 pt? -92.82 113.06 25.23 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.324 0.583 . . . . 72.22 112.026 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.08 -7.26 27.17 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.848 -0.615 . . . . 52.32 113.267 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.01 110.8 0.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.455 -0.403 . . . . 45.21 112.314 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.52 ' HA ' HG13 ' A' ' 66' ' ' ILE . 48.8 m -92.09 104.23 16.64 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.557 0.577 . . . . 63.21 112.557 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.431 HG22 HH11 ' A' ' 57' ' ' ARG . 2.9 t -151.87 157.18 41.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 73.2 111.222 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HG2' ' CZ2' ' A' ' 51' ' ' TRP . 43.8 mtpt -65.69 -15.86 63.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 73.32 111.708 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -92.41 11.12 27.21 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.061 0.458 . . . . 71.1 111.015 178.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.44 116.39 0.67 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.747 -0.541 . . . . 51.34 111.747 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.52 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.9 tt -150.19 151.85 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 117.263 0.531 . . . . 53.22 111.882 -173.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -91.05 177.48 6.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.284 0.564 . . . . 71.24 112.084 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.444 ' O ' HG12 ' A' ' 72' ' ' VAL . 23.0 p -61.31 -43.9 98.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.1 -0.5 . . . . 72.24 111.749 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.482 ' HB2' ' OG1' ' A' ' 88' ' ' THR . 40.3 t -61.13 -46.29 91.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.156 0.503 . . . . 72.33 111.221 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.562 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -60.67 -45.85 95.59 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.045 -0.598 . . . . 70.43 112.797 177.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.22 -53.7 55.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.804 0.335 . . . . 63.44 111.902 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.538 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.7 p -59.76 -40.41 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.934 0.397 . . . . 64.31 110.676 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.501 ' HA ' HD12 ' A' ' 84' ' ' LEU . 20.3 tt0 -55.62 -48.64 74.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.153 -0.476 . . . . 73.32 111.406 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.576 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 15.7 mmm180 -60.75 -49.03 79.12 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.937 0.347 . . . . 53.32 111.937 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.576 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 86.6 m -57.81 -54.19 49.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.049 0.452 . . . . 70.03 112.045 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 68.7 m-85 -64.11 -33.96 76.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.494 0.553 . . . . 65.13 112.494 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.7 -29.18 58.89 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.019 -0.425 . . . . 75.42 111.679 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 78.6 mm-40 -71.18 -64.08 0.98 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.105 0.479 . . . . 73.11 111.417 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.401 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 18.4 mp0 -72.5 -59.42 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.81 0.67 . . . . 73.13 112.81 -177.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -88.78 -12.87 40.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.524 0.565 . . . . 74.42 112.524 -173.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.03 31.2 77.27 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.793 -0.718 . . . . 25.4 112.492 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 56.4 tp -90.8 132.34 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.675 0.39 . . . . 74.43 111.236 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.83 131.07 35.95 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.199 0.523 . . . . 74.11 112.117 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 73' ' ' GLN . 95.0 mt -136.0 150.96 72.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.224 -0.443 . . . . 73.21 111.079 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.09 156.92 55.22 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.551 2.167 . . . . 54.44 112.927 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.46 6.19 10.89 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.728 0.64 . . . . 75.02 112.728 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.3 m -131.25 129.11 41.17 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.663 0.268 . . . . 73.41 111.642 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.547 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 89.0 m -54.74 -43.38 72.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.897 0.379 . . . . 74.12 111.357 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -51.51 -32.39 27.53 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.94 -0.573 . . . . 72.21 111.729 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.15 -40.77 14.31 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.328 -0.397 . . . . 71.34 111.393 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -56.41 -30.2 62.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.885 0.374 . . . . 52.33 111.411 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 88' ' ' THR . 21.7 mt-30 -52.94 -38.45 61.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.057 -0.52 . . . . 63.43 111.93 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.41 22.97 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.111 0.411 . . . . 75.43 112.111 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.0 mmm -98.31 -35.43 10.33 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.085 0.772 . . . . 64.15 113.085 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.0 -175.89 14.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.641 -0.79 . . . . 63.05 114.755 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.0 mmmt -86.21 149.03 25.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.687 0.395 . . . . 73.53 111.875 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -90.28 153.22 20.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.343 0.592 . . . . 72.4 112.563 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.99 159.76 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.676 -0.693 . . . . 74.11 111.502 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.4 t -87.66 157.76 19.02 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.286 -0.415 . . . . 65.1 111.514 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -52.18 -32.68 37.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.191 0.52 . . . . 72.11 111.413 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.5 p -74.57 -28.88 61.12 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.579 0.585 . . . . 44.14 112.579 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -96.05 -0.85 49.88 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.867 0.691 . . . . 74.44 112.867 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.94 123.49 17.23 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.599 0.592 . . . . 74.3 112.599 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -128.05 -178.84 4.69 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.012 -0.54 . . . . 72.11 110.771 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.498 HG21 ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -64.33 108.11 1.52 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.819 0.342 . . . . 71.52 111.893 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.73 -18.61 5.11 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.905 -0.664 . . . . 74.43 113.452 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 66.8 m-20 -74.15 129.73 38.39 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.047 0.451 . . . . 73.33 111.331 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.26 115.77 23.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.679 0.276 . . . . 72.23 110.595 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 155' ' ' ALA . 16.5 m -95.67 128.58 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.143 0.497 . . . . 74.13 111.908 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.4 mt -97.67 129.19 44.76 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.937 -0.574 . . . . 74.21 111.714 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.11 140.31 49.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.536 0.684 . . . . 75.22 112.376 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 112' ' ' ARG . 41.6 mtp180 -83.95 100.35 10.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.459 -0.791 . . . . 62.21 110.932 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 120.847 0.356 . . . . 64.02 111.85 -178.761 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.123 0.487 . . . . 60.14 111.761 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -98.51 148.06 24.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.057 -0.52 . . . . 75.12 110.643 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.5 141.9 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.069 0.461 . . . . 75.12 111.969 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.62 155.59 21.84 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.322 -0.466 . . . . 44.24 112.556 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 44' ' ' ILE . 20.1 mt -95.25 106.26 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.482 -0.422 . . . . 73.4 111.018 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 33.8 t80 -64.43 113.49 3.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.329 . . . . 65.23 111.186 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.41 -27.47 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.303 0.483 . . . . 74.01 112.303 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.33 144.95 4.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.441 -0.885 . . . . 64.21 114.23 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.21 53.37 12.54 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.107 0.563 . . . . 55.34 112.393 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 142' ' ' SER . 40.6 m-80 66.93 -4.98 0.72 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.173 0.805 . . . . 73.14 113.173 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.497 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 25.1 mt-30 -87.45 143.73 27.08 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.26 0.553 . . . . 74.45 111.061 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.582 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 25.2 p90 -156.32 148.95 23.75 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.77 -0.65 . . . . 74.13 111.519 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 137.54 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.104 -0.498 . . . . 72.31 110.835 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -166.45 162.29 16.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.114 0.483 . . . . 65.34 111.85 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -88.78 86.99 7.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.111 0.482 . . . . 75.41 110.309 172.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.2 t -58.22 134.71 56.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.783 -0.644 . . . . 74.2 112.498 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.9 p -57.18 -35.67 69.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.109 0.481 . . . . 60.12 111.82 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.7 t -85.94 -50.74 6.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.715 0.635 . . . . 62.43 112.715 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.8 m -98.9 -34.63 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.202 0.816 . . . . 61.12 113.202 -173.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.61 -158.67 14.4 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.05 -0.595 . . . . 71.44 112.369 -172.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 99.2 t -63.08 102.5 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.318 0.58 . . . . 72.0 111.793 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.76 -178.81 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.817 -0.629 . . . . 70.23 111.642 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.42 109.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.167 -0.469 . . . . 62.43 110.9 172.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 92.7 p -107.88 -171.46 1.87 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.584 0.23 . . . . 64.23 110.818 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.641 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 43.9 m -146.86 136.54 23.06 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.339 0.496 . . . . 63.21 112.339 -174.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.582 ' HG3' ' CE1' ' A' ' 129' ' ' PHE . 72.9 mtm -78.21 3.93 13.98 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.334 0.864 . . . . 54.01 113.334 -177.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' A' ' 142' ' ' SER . 1.0 OUTLIER -83.2 -12.85 56.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.867 0.365 . . . . 75.03 110.544 170.154 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -71.54 136.93 83.37 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 116.532 -0.304 . . . . 64.21 110.427 169.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -52.98 -43.0 60.44 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.722 2.281 . . . . 65.12 113.522 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 80.5 t80 -59.45 -47.66 84.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.705 0.288 . . . . 73.42 111.689 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 151' ' ' ARG . 95.6 m95 -78.89 -33.62 45.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.835 0.35 . . . . 75.14 111.623 -176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -56.81 -38.43 72.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.257 -0.429 . . . . 74.33 111.382 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -93.52 -12.32 29.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.788 0.328 . . . . 71.33 111.801 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -79.32 -32.48 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.836 0.35 . . . . 72.55 111.079 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -58.04 126.59 28.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.845 -0.616 . . . . 73.02 112.405 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -101.38 -63.9 1.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.177 0.513 . . . . 65.02 110.344 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.27 172.46 18.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 71.44 110.032 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.473 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -131.23 145.63 52.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.999 0.428 . . . . 63.45 111.934 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 97.1 mtt180 -140.6 124.96 17.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.332 -0.395 . . . . 74.21 110.8 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -98.29 137.19 37.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.325 0.583 . . . . 63.54 111.767 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.2 m -104.83 14.29 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.661 -0.7 . . . . 71.43 112.753 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 112.439 0.533 . . . . 73.24 112.439 -177.737 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 120.745 0.307 . . . . 51.22 111.384 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.9 t -51.22 -44.59 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.162 -0.472 . . . . 55.34 111.582 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.49 -37.76 79.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.431 -0.349 . . . . 64.12 111.62 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.8 m -64.14 -10.87 25.46 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.235 0.457 . . . . 63.13 112.235 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -101.01 -49.1 4.22 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.023 0.44 . . . . 74.53 110.512 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.552 ' HA ' HE22 ' A' ' 79' ' ' GLN . 59.2 mt -52.41 -43.98 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.117 0.484 . . . . 74.5 111.027 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.543 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 31.1 mmt -71.07 -22.49 62.11 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.223 -0.444 . . . . 65.33 111.801 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.78 -46.47 78.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.69 0.281 . . . . 63.53 110.673 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.02 -42.23 69.84 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.707 0.289 . . . . 73.13 110.938 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.584 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 36.6 t80 -50.44 -36.68 34.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.638 0.256 . . . . 73.44 111.183 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.24 80.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.451 -0.341 . . . . 75.43 111.665 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.1 -29.66 60.67 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.831 0.348 . . . . 73.3 111.713 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -92.09 5.9 48.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.163 0.431 . . . . 73.11 112.163 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 23.6 mmmt -58.69 101.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.483 . . . . 73.15 111.915 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.34 -0.45 37.56 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.049 -0.596 . . . . 64.55 113.949 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.5 134.54 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 117.319 0.559 . . . . 73.4 111.323 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -85.58 171.67 11.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.481 0.658 . . . . 71.22 112.427 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -102.18 137.81 39.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.732 -0.667 . . . . 72.5 110.666 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -132.63 121.83 23.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.01 0.433 . . . . 74.41 111.676 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.67 103.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 61.53 111.275 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.57 28.96 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.184 -0.532 . . . . 75.41 113.401 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 134.71 7.61 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.394 -0.432 . . . . 72.13 112.503 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.552 ' HA ' HD12 ' A' ' 66' ' ' ILE . 11.7 m -125.01 98.28 5.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.255 0.527 . . . . 64.22 111.4 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 t 177.99 172.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.867 0.365 . . . . 73.13 111.659 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -66.68 -18.6 65.45 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.881 0.372 . . . . 72.41 111.719 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 3.3 mptp? -78.64 -11.79 59.99 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.107 0.479 . . . . 71.33 110.883 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.92 111.21 0.25 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.595 -0.602 . . . . 72.13 111.595 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 61' ' ' SER . 11.2 tp -112.2 154.33 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.999 0.399 . . . . 72.45 111.658 -173.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.26 178.7 4.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.984 0.421 . . . . 63.33 111.15 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.8 p -60.27 -52.9 63.29 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.309 -0.405 . . . . 54.33 112.013 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -69.42 -36.7 76.95 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.956 0.408 . . . . 74.21 111.129 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.496 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -58.68 -48.95 82.1 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.941 -0.572 . . . . 73.3 113.774 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.69 -56.16 25.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.184 0.492 . . . . 63.1 111.912 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.555 ' HA ' HD11 ' A' ' 122' ' ' ILE . 10.8 p -60.02 -39.41 80.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.872 0.368 . . . . 60.13 111.266 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.581 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 tt0 -56.68 -57.18 13.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.166 -0.47 . . . . 50.52 111.39 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 25.2 mmt180 -55.28 -49.46 72.02 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.904 0.383 . . . . 74.1 111.24 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.492 HG23 ' NE2' ' A' ' 79' ' ' GLN . 97.9 m -49.72 -61.96 1.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.013 -0.54 . . . . 73.05 112.452 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 69.5 m-85 -68.09 -37.38 81.15 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.202 0.815 . . . . 71.23 113.202 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -71.36 -36.72 71.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.879 -0.513 . . . . 64.2 112.172 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -78.08 -23.89 47.82 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.092 -0.38 . . . . 75.3 111.774 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.552 HE22 ' HA ' ' A' ' 44' ' ' ILE . 77.1 mt-30 -92.32 -70.31 0.7 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.178 0.513 . . . . 71.02 112.127 178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -89.96 -9.78 47.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.043 -0.526 . . . . 63.34 112.042 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.51 77.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.918 -0.658 . . . . 62.54 112.33 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.8 tp -73.55 111.38 8.63 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.037 0.446 . . . . 72.12 110.533 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.35 78.59 4.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.437 0.637 . . . . 72.25 112.558 -173.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 83.8 mt -77.13 143.32 69.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.064 -0.516 . . . . 71.33 111.571 176.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.527 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 89.9 Cg_endo -79.73 -179.43 5.32 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.019 2.479 . . . . 74.21 113.505 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -11.63 43.12 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.277 0.843 . . . . 73.23 113.277 -173.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.457 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 39.1 t -115.62 137.56 51.95 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.897 -0.502 . . . . 74.33 111.851 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 6.2 m -56.87 -39.59 74.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.134 0.492 . . . . 74.44 111.476 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -64.08 -33.72 76.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.327 -0.397 . . . . 74.44 111.781 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 87' ' ' SER . 43.0 mt-10 -68.21 -38.34 81.81 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.274 0.559 . . . . 73.21 110.627 175.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.527 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 84.1 mt-30 -64.93 -30.58 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.697 -0.683 . . . . 53.32 110.912 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.4 mt-30 -64.98 -8.74 17.11 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.652 0.612 . . . . 72.4 112.652 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -99.16 -1.89 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.52 0.563 . . . . 54.22 112.52 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.2 ptp -114.04 154.95 26.8 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.062 -0.399 . . . . 74.41 110.863 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.27 177.22 29.63 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.777 -0.725 . . . . 72.34 112.756 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -118.46 149.75 40.74 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.325 -0.515 . . . . 75.23 111.611 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 89.0 p -76.91 154.53 33.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.237 0.829 . . . . 75.24 113.237 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 1.5 m -145.44 150.16 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.235 -0.893 . . . . 73.02 111.63 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.5 t -95.79 -179.52 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.884 0.373 . . . . 44.14 111.571 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -51.52 -44.09 62.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.317 0.488 . . . . 73.25 112.317 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.5 t -83.51 10.12 9.7 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.246 -0.434 . . . . 62.43 112.06 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.3 m120 -120.45 -8.55 9.57 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.126 -0.359 . . . . 53.02 111.832 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.64 144.19 57.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.101 0.778 . . . . 62.43 113.101 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -130.28 -156.44 0.76 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.717 -0.674 . . . . 71.41 110.599 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.9 m -101.14 126.97 47.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.548 -0.296 . . . . 74.51 110.325 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.06 -4.07 31.74 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.08 -0.581 . . . . 65.14 113.291 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 123' ' ' TYR . 2.2 m-20 -75.84 142.09 42.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.054 0.454 . . . . 64.22 111.128 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.43 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.535 -0.302 . . . . 63.25 110.331 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.22 126.46 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.473 0.654 . . . . 65.23 111.508 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.723 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 77.4 mt -105.71 115.1 29.66 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.488 -0.778 . . . . 71.43 111.823 -173.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -107.07 151.61 25.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.179 -0.464 . . . . 72.2 111.245 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.591 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 93.4 mtt180 -87.6 101.28 13.49 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.445 -0.343 . . . . 64.43 111.022 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.506 0 O-C-N 122.173 -0.329 . . . . 72.43 111.516 -178.317 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.723 ' HD2' ' HB3' ' A' ' 110' ' ' LEU . 2.1 tpp180 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.886 0.374 . . . . 73.52 111.004 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -118.05 124.92 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.147 -0.316 . . . . 74.1 110.147 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.82 138.58 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.24 0.459 . . . . 72.23 112.24 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -127.9 147.56 17.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.261 -0.427 . . . . 74.25 112.56 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 72' ' ' VAL . 40.3 mt -87.46 108.58 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.519 -0.4 . . . . 63.32 110.917 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.519 ' HD1' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -66.28 109.82 2.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.048 0.452 . . . . 72.5 111.901 -175.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.4 pt -105.23 11.49 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.01 0.434 . . . . 54.24 111.605 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.42 37.94 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.294 -0.412 . . . . 64.51 112.581 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -67.62 -16.21 64.05 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.281 0.475 . . . . 71.43 112.281 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.496 ' HA ' ' OH ' ' A' ' 123' ' ' TYR . 9.9 p30 -150.96 -13.42 0.22 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.668 0.618 . . . . 72.1 112.668 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -89.3 143.44 26.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.331 0.586 . . . . 63.04 111.869 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.519 ' HB3' ' HD1' ' A' ' 123' ' ' TYR . 27.6 p90 -153.1 146.46 24.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.647 -0.706 . . . . 65.11 111.462 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.7 p -99.19 136.84 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.055 0.455 . . . . 65.41 111.062 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -156.09 -166.28 2.14 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.736 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.4 114.41 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.707 0.289 . . . . 63.4 111.696 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 67.5 m -91.06 145.97 24.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.852 0.358 . . . . 72.32 111.272 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p -50.55 -48.91 57.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.58 0.955 . . . . 63.24 113.58 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.7 p -106.83 19.54 20.33 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.773 0.657 . . . . 60.31 112.773 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 133' ' ' SER . 67.6 m -133.05 -23.5 1.96 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.321 0.489 . . . . 74.55 112.321 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.29 -151.94 31.95 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.966 -0.635 . . . . 64.23 112.705 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.432 HG12 ' HE1' ' A' ' 48' ' ' TYR . 47.0 t -75.63 111.77 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.947 0.403 . . . . 45.04 111.993 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.523 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -140.36 -178.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 120.962 0.41 . . . . 63.54 111.491 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.41 143.13 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.738 0.304 . . . . 72.34 110.783 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.8 t -138.43 179.47 6.44 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.806 0.336 . . . . 74.14 111.657 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 69.7 m -137.7 138.71 39.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.341 -0.39 . . . . 70.04 111.258 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 27.0 mtm -69.97 -9.67 55.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.426 0.528 . . . . 75.01 112.426 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -78.52 -9.44 59.34 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.092 -0.38 . . . . 72.05 111.38 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.92 136.18 82.65 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 110.167 -0.309 . . . . 73.4 110.167 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -49.98 -45.85 30.75 Favored 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 123.029 2.486 . . . . 72.53 114.157 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.532 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 56.3 t80 -65.11 -44.14 89.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.912 0.387 . . . . 75.14 111.757 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -77.53 -35.56 53.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.832 0.308 . . . . 75.34 111.832 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -53.72 -38.98 64.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.237 0.542 . . . . 73.31 111.565 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -92.59 0.47 57.43 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.525 0.565 . . . . 72.31 112.525 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 112' ' ' ARG . 33.4 mmt180 -100.83 -17.94 16.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.109 0.411 . . . . 70.02 112.109 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.41 130.07 44.65 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.373 0.508 . . . . 74.43 112.373 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -112.89 -54.66 2.6 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 72.5 111.102 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -165.86 167.46 16.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.425 -0.352 . . . . 74.33 110.914 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -133.91 145.41 49.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.165 0.186 . . . . 51.4 110.864 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 57.5 mtt180 -141.0 121.14 13.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.743 0.306 . . . . 61.24 111.422 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.511 ' H ' ' HD3' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -85.06 121.94 28.55 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.409 0.623 . . . . 72.42 110.864 175.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.48 4.91 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.026 -0.534 . . . . 65.14 112.329 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 120.874 0.368 . . . . 60.42 111.315 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 121.328 0.585 . . . . 71.23 111.435 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -55.31 -48.71 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.581 0.585 . . . . 65.23 112.581 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.1 tttt -61.86 -56.95 14.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.863 0.32 . . . . 72.53 111.863 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.411 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 56.6 m -59.83 -38.83 83.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.597 0.237 . . . . 61.23 111.563 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -52.9 -52.05 59.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.331 0.586 . . . . 71.11 111.2 176.412 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 122' ' ' ILE . 72.8 mt -69.16 -42.8 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.829 -0.623 . . . . 72.11 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.7 mmt -62.66 -37.28 85.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.022 0.439 . . . . 63.22 111.328 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.87 -46.05 92.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.317 -0.401 . . . . 71.04 110.605 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -68.02 -36.82 80.6 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.399 -0.364 . . . . 64.12 111.523 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 50.4 t80 -54.07 -39.39 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.831 0.308 . . . . 74.25 111.831 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.36 -23.24 9.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 74.42 112.234 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.65 -44.41 11.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.12 0.486 . . . . 61.03 111.024 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -80.92 -2.27 46.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.139 0.792 . . . . 74.12 113.139 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 54.2 mtmt -50.04 117.75 2.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.678 0.621 . . . . 73.44 112.678 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.41 -6.35 77.95 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 114.75 0.66 . . . . 72.34 114.75 172.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.0 t -59.72 130.21 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 117.827 0.814 . . . . 73.25 111.599 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.02 171.15 13.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.094 -0.503 . . . . 64.3 112.315 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 32.3 t80 -98.28 123.01 42.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.236 0.458 . . . . 72.01 112.236 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -138.17 133.08 32.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.653 0.381 . . . . 72.51 110.623 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 5.3 mp -84.0 121.25 27.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.058 0.392 . . . . 73.22 112.058 -175.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.43 -50.82 3.87 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.03 -0.605 . . . . 74.05 113.006 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.21 60.19 1.86 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.342 -0.456 . . . . 43.22 112.305 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.3 m -67.61 103.47 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.814 0.446 . . . . 64.14 111.919 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.6 t -158.74 172.87 17.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.128 0.49 . . . . 73.55 111.909 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.39 -1.1 14.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.616 0.599 . . . . 61.12 112.616 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -105.17 10.84 33.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 74.43 110.803 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.87 118.55 0.91 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.714 -0.554 . . . . 61.13 111.714 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.2 tt -147.6 147.5 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.775 0.788 . . . . 51.01 112.331 -175.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.2 p-10 -92.44 176.22 6.55 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.168 0.509 . . . . 73.13 112.37 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.433 ' SG ' ' N ' ' A' ' 69' ' ' SER . 26.1 p -59.02 -59.88 4.77 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.893 -0.594 . . . . 53.34 111.643 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.433 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 16.7 p -62.61 -37.3 85.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.267 -0.424 . . . . 70.45 111.362 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.65 -43.29 99.18 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.346 -0.454 . . . . 73.22 113.286 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -61.26 -52.69 63.66 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 122.57 -0.371 . . . . 62.55 111.774 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.538 ' HA ' HD11 ' A' ' 122' ' ' ILE . 4.9 p -61.42 -49.27 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 112.252 0.464 . . . . 72.25 112.252 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -60.8 -33.9 73.69 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.092 -0.38 . . . . 60.55 111.791 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.51 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 78.2 mtt-85 -72.0 -52.11 18.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.086 -0.384 . . . . 70.34 111.497 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -49.66 -40.69 40.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.99 0.424 . . . . 61.12 111.892 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.555 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 47.0 m-85 -73.47 -40.91 63.79 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.582 0.586 . . . . 65.22 112.582 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.51 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 12.1 ptp180 -70.43 -24.73 62.96 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.757 -0.589 . . . . 71.13 111.223 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 20.6 mm-40 -69.48 -62.07 1.53 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.266 0.555 . . . . 74.35 111.345 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HB3' ' HG2' ' A' ' 43' ' ' ARG . 85.9 mm-40 -88.26 -32.17 18.64 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.555 0.946 . . . . 75.44 113.555 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.25 -13.05 13.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 64.11 112.357 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.99 17.61 77.17 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.867 -0.682 . . . . 41.02 112.814 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.5 tp -83.63 115.06 21.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.919 0.39 . . . . 61.24 111.147 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.94 96.68 8.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.843 0.354 . . . . 42.2 111.377 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 97.2 mt -98.64 142.37 24.48 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.459 -0.337 . . . . 64.31 110.889 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.23 163.79 9.59 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.84 2.36 . . . . 72.43 113.31 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 3.5 mpt_? -78.81 -25.27 44.21 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.689 0.626 . . . . 73.43 112.689 -173.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.433 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 36.3 t -98.95 140.22 33.43 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.375 0.509 . . . . 72.23 112.375 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 92.8 m -55.05 -42.52 72.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.844 -0.616 . . . . 71.44 111.321 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.38 -44.75 95.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.97 -0.559 . . . . 73.15 111.33 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 40.2 mm-40 -64.44 -36.73 85.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.08 0.467 . . . . 71.14 110.649 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.92 -27.42 66.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.18 -0.464 . . . . 71.15 111.617 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.544 ' HA ' ' NE ' ' A' ' 156' ' ' ARG . 28.4 mt-30 -59.94 -49.58 77.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 71.12 110.838 175.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.93 -6.21 43.71 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.06 -0.518 . . . . 71.21 112.247 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mmm -110.72 21.46 16.51 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.875 0.369 . . . . 75.12 111.95 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.38 133.66 5.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.275 -0.488 . . . . 53.22 112.272 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.552 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 43.6 mmtm -88.43 140.92 28.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.162 0.506 . . . . 61.51 112.085 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 t -74.71 136.98 41.81 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.631 0.974 . . . . 53.53 113.631 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.25 139.6 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.521 -0.763 . . . . 74.2 110.656 172.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.1 t -92.72 -179.98 5.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.533 0.568 . . . . 73.11 112.533 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -41.23 -53.72 3.11 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.125 1.157 . . . . 64.24 114.125 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -82.72 -14.5 54.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.515 0.561 . . . . 74.43 112.515 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -99.07 6.85 46.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.543 0.571 . . . . 51.52 112.543 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.28 138.36 58.51 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.785 0.326 . . . . 73.43 111.542 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -145.5 134.21 22.26 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.579 -0.282 . . . . 60.12 111.118 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.506 HG21 ' HB2' ' A' ' 41' ' ' LYS . 83.4 m -44.69 102.0 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.047 0.451 . . . . 71.4 111.792 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.09 -8.12 3.23 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.964 -0.562 . . . . 52.0 113.178 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 3.4 p30 -88.12 160.25 17.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.467 0.651 . . . . 72.2 111.603 176.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 mt -106.34 117.43 34.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 75.04 110.709 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 155' ' ' ALA . 12.2 m -94.15 119.18 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.425 0.631 . . . . 71.44 111.553 -175.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.464 HD11 ' HG2' ' A' ' 92' ' ' GLN . 95.6 mt -91.21 132.0 36.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.642 -0.708 . . . . 63.32 111.436 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -122.16 134.11 54.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.408 -0.36 . . . . 75.54 110.993 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.436 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 80.2 mtp180 -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.673 -0.491 . . . . 74.44 109.673 174.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 121.074 0.464 . . . . 74.34 111.633 -175.22 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 120.917 0.389 . . . . 60.5 111.383 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -127.52 160.46 31.45 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.322 -0.399 . . . . 75.35 110.107 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.83 141.18 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.148 0.499 . . . . 55.3 112.317 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.66 160.76 24.62 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.108 -0.497 . . . . 63.5 112.437 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 72' ' ' VAL . 34.1 mt -94.62 112.27 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.464 -0.433 . . . . 74.44 111.084 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.12 113.65 4.1 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.762 0.315 . . . . 73.43 111.64 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.461 ' HA ' HG23 ' A' ' 105' ' ' THR . 31.2 pt -98.64 -20.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.201 0.445 . . . . 74.55 112.201 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.95 148.04 5.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.931 -0.652 . . . . 42.51 113.782 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.4 m120 58.47 40.02 24.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.277 0.473 . . . . 74.44 112.277 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 68.6 3.59 3.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.859 -0.61 . . . . 72.34 112.397 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.565 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 25.1 mt-30 -90.14 147.53 23.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.039 0.447 . . . . 72.51 110.759 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -155.35 151.76 28.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 71.31 111.979 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.34 135.91 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.071 -0.513 . . . . 75.14 110.448 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.91 173.33 16.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.034 0.445 . . . . 75.31 111.746 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -102.03 96.81 7.27 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.005 -0.543 . . . . 63.44 110.909 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.4 t -68.69 135.47 51.39 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.063 -0.517 . . . . 63.21 111.84 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.6 p -65.22 -20.66 66.54 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 75.13 111.56 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.9 m -97.07 -52.4 3.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.416 -0.356 . . . . 55.43 111.913 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.441 ' HB2' HD13 ' A' ' 139' ' ' ILE . 49.8 m -101.48 -16.45 16.81 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.073 0.768 . . . . 62.32 113.073 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.1 -154.27 24.3 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.853 -0.689 . . . . 72.43 112.884 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.37 104.39 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.019 0.438 . . . . 60.12 111.999 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 136' ' ' SER . 41.6 pt -140.77 178.48 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.113 0.482 . . . . 62.14 111.704 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.7 mm -101.15 141.83 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.467 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -144.56 165.4 28.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.773 0.321 . . . . 75.53 110.541 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.565 ' OG ' ' HG2' ' A' ' 128' ' ' GLN . 15.8 m -138.48 142.88 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.975 0.361 . . . . 73.42 111.975 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.2 mtm -72.57 -3.09 22.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.369 0.604 . . . . 62.42 110.626 171.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.98 -16.29 61.08 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.864 -0.607 . . . . 75.35 110.089 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 19.5 mm-40 -85.76 135.01 38.45 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.784 -0.644 . . . . 64.41 110.317 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -48.92 -44.87 30.77 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.183 2.589 . . . . 55.13 114.303 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 50.5 t80 -64.56 -44.16 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.946 -0.471 . . . . 73.43 111.759 -177.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -77.47 -32.75 54.54 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.184 0.516 . . . . 64.11 111.392 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -56.2 -48.71 75.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.401 0.68 . . . . 65.34 112.232 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -84.36 -13.92 50.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.853 0.686 . . . . 63.23 112.853 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 17.2 mmm180 -100.3 -3.39 31.43 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.72 0.637 . . . . 72.13 112.72 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -54.11 123.03 11.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.094 0.405 . . . . 60.01 112.094 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 7.0 t30 -98.4 -66.61 0.89 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.382 -0.372 . . . . 72.45 111.248 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.435 ' HG2' HD22 ' A' ' 153' ' ' ASN . 8.7 pt-20 -164.48 144.71 7.76 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.603 0.24 . . . . 63.22 110.829 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -102.57 146.49 28.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.781 0.324 . . . . 62.33 111.357 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.544 ' NE ' ' HA ' ' A' ' 92' ' ' GLN . 11.8 mtm-85 -136.89 111.37 8.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.607 0.225 . . . . 62.45 111.607 -176.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -75.02 124.99 27.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.04 0.448 . . . . 63.54 111.143 176.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.23 -19.51 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.037 -0.529 . . . . 74.3 112.105 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 121.148 0.499 . . . . 73.1 111.718 177.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 111.644 0.239 . . . . 53.24 111.644 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -64.96 149.92 48.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.921 0.391 . . . . 61.33 111.808 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.2 t -68.29 82.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.309 0.576 . . . . 53.52 110.356 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 36.8 t70 -75.12 136.58 41.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.016 -0.538 . . . . 63.44 111.961 -176.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.2 t -58.71 -61.86 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.723 -0.671 . . . . 50.11 111.713 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.67 -40.36 79.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.828 0.347 . . . . 72.12 111.195 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 28.4 t -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.274 -0.421 . . . . 64.3 111.673 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -35.35 77.91 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.879 0.326 . . . . 74.04 111.879 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 40' ' ' VAL . 74.7 mt -62.4 -48.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.034 0.445 . . . . 53.41 111.017 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.7 mmt -67.22 -37.34 83.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.943 0.401 . . . . 63.33 110.85 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -56.97 -45.24 83.03 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.931 -0.577 . . . . 75.22 110.624 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.798 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 55.0 tp60 -66.66 -46.25 76.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.294 0.569 . . . . 51.44 111.271 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 18.3 t80 -56.41 -34.85 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.824 -0.625 . . . . 75.03 111.221 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.76 12.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.38 0.511 . . . . 73.42 112.38 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.89 -26.25 21.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.958 0.408 . . . . 62.3 111.557 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -111.36 12.3 21.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.999 0.74 . . . . 74.51 112.999 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 10.0 mtmp? -61.95 103.36 0.35 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.074 -0.391 . . . . 74.31 111.64 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.14 -0.89 26.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.807 -0.711 . . . . 54.12 114.231 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.03 138.44 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 117.484 0.642 . . . . 54.12 111.225 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.82 162.44 26.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.145 0.498 . . . . 74.22 112.229 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 51.7 t80 -84.05 118.41 24.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.053 -0.521 . . . . 74.32 112.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -137.99 123.61 19.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.661 -0.245 . . . . 62.44 111.309 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.53 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 97.0 mt -70.78 116.49 11.15 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.481 0.549 . . . . 74.11 112.481 -177.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.36 3.59 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.304 -0.474 . . . . 61.14 114.065 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.27 67.88 1.79 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.26 -0.495 . . . . 72.15 113.248 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.6 m -69.48 108.65 3.86 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.406 0.521 . . . . 75.23 112.406 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -166.61 175.38 8.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.123 -0.489 . . . . 73.01 110.793 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -67.68 -8.26 33.63 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.252 0.464 . . . . 71.2 112.252 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 64' ' ' LYS . 3.9 mppt? -97.08 7.94 45.57 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.018 0.437 . . . . 63.33 111.215 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.0 134.63 2.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.359 -0.382 . . . . 63.33 112.604 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.3 tt -154.53 144.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.427 -0.455 . . . . 70.21 110.59 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.53 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.5 p-10 -96.99 -174.51 2.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.302 0.572 . . . . 72.51 112.35 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.7 p -62.68 -50.72 70.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.939 -0.573 . . . . 62.24 111.488 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 72' ' ' VAL . 49.1 m -69.09 -35.85 76.94 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.367 -0.379 . . . . 64.43 111.318 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.04 -44.6 97.55 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.112 -0.565 . . . . 70.21 112.726 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -66.02 -50.75 63.14 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.54 -0.388 . . . . 71.44 111.702 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 69' ' ' SER . 11.9 p -61.43 -37.49 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.927 0.394 . . . . 74.02 110.844 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.48 ' NE2' ' HD3' ' A' ' 86' ' ' ARG . 4.0 tt0 -54.47 -59.34 4.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.1 0.476 . . . . 73.02 110.693 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.549 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 9.4 mmm180 -52.24 -55.68 19.66 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.847 -0.615 . . . . 72.15 111.824 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.798 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 72.3 m -48.74 -56.25 9.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.401 0.519 . . . . 73.22 112.401 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 41.7 m-85 -74.94 -34.89 62.16 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.013 0.746 . . . . 74.25 113.013 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 ptm180 -66.42 -39.67 89.08 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.422 0.527 . . . . 74.41 112.422 -175.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 15.6 pt-20 -102.34 -23.39 13.97 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.075 0.769 . . . . 65.52 113.075 -174.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.468 ' HG3' ' HB2' ' A' ' 47' ' ' GLN . 84.4 mm-40 -87.31 -63.06 1.36 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.984 -0.448 . . . . 62.23 111.589 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.72 -18.16 30.1 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.004 0.372 . . . . 71.54 112.004 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 45.14 28.7 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.062 -0.59 . . . . 64.31 112.592 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 44.4 tp -105.99 136.9 44.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.901 0.381 . . . . 61.42 111.277 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.83 88.78 4.04 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.818 0.342 . . . . 74.32 111.645 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.42 138.16 19.46 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.94 0.348 . . . . 62.13 111.94 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HD2' ' OE1' ' A' ' 91' ' ' GLN . 73.4 Cg_endo -74.25 -161.54 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.412 2.741 . . . . 65.33 113.717 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.48 ' HD3' ' NE2' ' A' ' 73' ' ' GLN . 13.6 mmt180 -102.01 -31.99 10.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.479 1.289 . . . . 71.43 114.479 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -114.17 148.72 36.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.879 0.696 . . . . 74.54 112.879 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.2 m -54.38 -42.73 70.71 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.832 -0.622 . . . . 70.11 112.478 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -57.37 -29.89 64.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 73.43 111.488 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.84 -43.67 17.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.075 0.464 . . . . 62.25 110.382 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.463 ' OE1' ' HD2' ' A' ' 85' ' ' PRO . 20.3 mm-40 -54.25 -47.09 72.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.857 -0.61 . . . . 74.33 112.046 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -61.7 -23.46 66.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.217 0.451 . . . . 63.52 112.217 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -92.11 2.11 56.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.971 -0.456 . . . . 74.21 111.972 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 94.3 mmm -85.63 -14.69 44.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.953 0.406 . . . . 60.13 111.111 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.42 152.54 23.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.154 -0.546 . . . . 52.12 113.174 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -83.01 150.82 26.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.923 0.392 . . . . 72.34 111.555 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 86.8 p -76.6 158.43 31.13 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.995 0.739 . . . . 72.34 112.995 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.404 HG13 ' NE ' ' A' ' 157' ' ' ARG . 1.5 m -145.41 174.06 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.682 -0.69 . . . . 52.35 111.779 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -111.53 179.67 3.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.783 -0.644 . . . . 75.11 111.489 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.534 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 32.6 mmt180 -50.09 -32.98 17.08 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.295 0.48 . . . . 72.3 112.295 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.9 p -77.1 -29.93 55.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.615 0.598 . . . . 73.53 112.615 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -109.52 20.42 18.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.483 0.549 . . . . 74.14 112.483 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.52 135.18 57.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.07 0.462 . . . . 60.22 111.098 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -108.81 148.6 30.31 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.185 -0.322 . . . . 75.51 111.438 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.427 ' O ' HG11 ' A' ' 40' ' ' VAL . 63.6 m -68.95 110.76 4.58 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.847 -0.533 . . . . 72.11 110.078 173.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.07 15.47 30.68 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.419 -0.419 . . . . 72.5 112.266 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.403 ' OD1' ' HB1' ' A' ' 155' ' ' ALA . 9.0 t70 -76.33 152.43 36.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.729 0.411 . . . . 71.4 110.71 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.4 mt -99.86 108.35 20.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.296 0.569 . . . . 71.33 111.344 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.16 123.98 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.328 0.585 . . . . 63.35 111.628 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.9 mt -90.93 135.37 33.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.625 -0.716 . . . . 61.14 111.945 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 91.0 m-85 -120.22 141.89 49.52 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.166 0.508 . . . . 73.12 111.962 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -72.48 96.58 1.94 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.709 -0.678 . . . . 75.41 110.856 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -126.9 106.9 9.63 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.744 0.307 . . . . 62.21 111.44 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.37 -28.9 51.86 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 114.034 0.374 . . . . 54.24 114.034 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -61.09 -32.97 72.63 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.285 0.476 . . . . 72.11 112.285 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.3 p -130.25 -0.72 4.56 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.091 0.404 . . . . 62.13 112.091 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.2 -57.02 3.65 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.296 -0.478 . . . . 41.4 112.257 -174.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.7 mmt-85 -126.65 117.64 23.16 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.898 0.38 . . . . 73.42 111.537 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 44.5 t60 -102.21 151.5 22.14 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.398 -0.593 . . . . 51.41 109.398 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.51 137.67 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.258 0.466 . . . . 75.55 112.258 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 153.34 20.33 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 116.066 -0.516 . . . . 64.11 112.525 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 72' ' ' VAL . 48.1 mt -88.15 103.44 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.975 0.417 . . . . 55.45 111.132 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -64.09 116.39 5.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.08 -0.509 . . . . 74.35 111.654 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.7 pt -102.76 -28.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.639 0.607 . . . . 55.43 112.639 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.65 135.37 1.93 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 119.863 -1.161 . . . . 41.1 114.973 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 65.0 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.071 0.948 . . . . 51.44 111.403 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.586 HD22 ' HB2' ' A' ' 143' ' ' MET . 22.6 m120 -141.34 -3.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.879 -0.601 . . . . 74.2 111.493 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -93.29 143.9 25.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.32 0.581 . . . . 74.51 111.574 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 18.0 p90 -152.61 145.81 24.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.47 -0.786 . . . . 62.5 111.008 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.34 133.83 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 64.05 110.903 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.49 178.64 8.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.107 0.479 . . . . 75.53 111.215 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -97.93 110.44 23.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.24 -0.437 . . . . 62.21 111.187 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 70.3 m -86.08 140.83 29.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.838 0.351 . . . . 71.13 111.165 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.4 p -47.43 -53.72 13.28 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.453 0.908 . . . . 65.41 113.453 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 p -90.29 -71.25 0.63 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.537 0.569 . . . . 64.21 112.537 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 54.2 m -58.71 -26.72 64.17 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.916 0.71 . . . . 54.14 112.916 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.54 -160.15 18.27 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.895 -0.669 . . . . 45.22 113.219 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 19.3 t -66.98 109.07 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.03 0.443 . . . . 62.44 111.909 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.9 pt -138.37 179.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.999 0.428 . . . . 52.15 111.754 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.22 110.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.145 -0.48 . . . . 74.44 110.599 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.451 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . 55.7 m -101.86 172.84 6.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.904 0.383 . . . . 44.03 111.738 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 138.99 49.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.13 0.49 . . . . 62.42 111.908 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.586 ' HB2' HD22 ' A' ' 127' ' ' ASN . 65.0 mtt -69.69 -8.17 45.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.389 -0.369 . . . . 71.23 111.899 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -77.01 -19.43 57.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.978 0.418 . . . . 55.45 110.612 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.25 124.48 90.88 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.287 -0.415 . . . . 64.54 110.267 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -48.69 -38.5 37.04 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.352 2.701 . . . . 65.05 114.028 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.443 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 52.3 t80 -63.18 -45.92 89.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.924 0.392 . . . . 53.43 111.394 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.535 ' HA ' ' HB2' ' A' ' 151' ' ' ARG . 83.8 m95 -80.79 -28.46 36.33 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.055 0.455 . . . . 72.2 111.392 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.9 -41.82 98.35 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.967 -0.561 . . . . 71.4 111.58 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -83.82 -21.38 32.11 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.096 0.474 . . . . 63.42 111.361 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 148' ' ' TRP . 0.8 OUTLIER -72.16 -39.09 68.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.341 -0.39 . . . . 62.32 111.612 177.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.98 104.45 0.14 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.16 0.505 . . . . 63.4 112.18 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.19 -52.02 5.45 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.925 -0.58 . . . . 74.43 110.873 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -167.08 171.47 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.251 -0.432 . . . . 74.23 111.284 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -121.15 154.74 35.81 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.642 -0.254 . . . . 72.12 110.872 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 79.3 mtt180 -147.93 119.18 7.79 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.076 0.465 . . . . 73.35 111.742 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.467 ' H ' ' HD3' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -86.66 109.29 19.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.042 0.448 . . . . 75.5 111.877 -177.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.09 -13.98 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.869 0.366 . . . . 73.43 111.736 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.69 130.6 34.52 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.443 -0.344 . . . . 73.32 111.205 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.9 t -77.5 112.26 14.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.918 0.389 . . . . 65.34 110.903 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -66.81 -28.93 68.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.836 0.35 . . . . 71.51 111.625 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.1 m -88.97 138.91 30.98 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.893 0.378 . . . . 61.02 111.467 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 163' ' ' LEU . 1.9 pt? -134.28 154.96 51.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.913 0.387 . . . . 62.05 111.043 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.684 -0.674 . . . . 74.31 112.065 -177.132 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.644 ' N ' ' SD ' ' A' ' 36' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.666 0.27 . . . . 72.4 110.753 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.92 101.7 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.956 0.407 . . . . 74.3 111.233 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.74 99.48 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.358 -0.383 . . . . 74.1 111.087 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -80.89 134.6 35.77 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.071 0.462 . . . . 73.2 111.851 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 44' ' ' ILE . 64.8 t -55.54 -51.88 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.823 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.7 tttt -57.22 -42.26 81.03 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.866 -0.606 . . . . 74.31 111.757 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.1 t -58.38 -45.44 88.31 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.886 0.374 . . . . 51.11 111.891 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.423 ' HD3' ' OE1' ' A' ' 79' ' ' GLN . 3.2 mmp_? -66.05 -44.26 85.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 73.44 111.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.2 mt -57.97 -41.36 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.038 0.447 . . . . 73.21 111.13 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 30.7 mmt -67.08 -31.51 72.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 70.54 111.58 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.77 -41.75 96.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.87 0.367 . . . . 73.12 110.916 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HG2' HE21 ' A' ' 79' ' ' GLN . 71.2 mm-40 -68.37 -55.19 12.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.436 -0.347 . . . . 72.0 111.096 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.481 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 28.9 t80 -48.25 -47.06 36.22 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.235 0.457 . . . . 75.33 112.235 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.62 -32.39 63.09 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.241 0.543 . . . . 71.32 111.715 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.88 -29.97 35.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.063 -0.517 . . . . 51.35 111.018 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.46 ' HZ2' HH11 ' A' ' 74' ' ' ARG . 73.9 m95 -96.52 3.17 52.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.103 0.779 . . . . 71.51 113.103 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 30.7 mtpp -61.45 122.89 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.991 -0.443 . . . . 74.41 110.797 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.93 -8.3 55.83 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.301 -0.476 . . . . 65.33 113.299 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -77.07 123.46 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.231 -0.57 . . . . 73.14 111.519 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -74.75 159.79 31.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 72.03 112.009 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -79.52 130.12 35.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.197 -0.456 . . . . 71.41 110.949 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 57' ' ' ARG . 38.9 ttt180 -136.88 115.15 11.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.915 0.388 . . . . 75.33 112.023 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.86 123.87 24.26 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.046 0.45 . . . . 74.12 112.04 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.51 7.41 84.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.281 -0.418 . . . . 63.43 114.083 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.34 143.68 15.17 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.975 -0.631 . . . . 71.12 113.295 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.518 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 t -125.37 100.58 6.56 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.059 0.457 . . . . 72.34 111.171 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.1 t -170.81 167.95 7.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.274 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -73.96 -13.09 60.83 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.279 0.561 . . . . 51.45 111.212 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -76.26 -15.63 59.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.245 0.545 . . . . 75.04 110.55 173.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.33 135.86 1.91 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.847 -0.615 . . . . 40.32 112.024 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.518 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -151.63 154.11 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.985 0.393 . . . . 74.52 111.343 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -91.7 176.32 6.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.318 0.58 . . . . 75.42 111.953 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.8 t -59.11 -51.98 67.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.469 0.544 . . . . 71.25 112.469 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.6 t -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.279 0.561 . . . . 73.13 111.16 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 74' ' ' ARG . . . -64.24 -41.58 98.23 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.859 -0.61 . . . . 72.45 113.002 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.5 -51.01 70.41 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.445 -0.444 . . . . 61.31 111.795 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 11.9 p -62.2 -45.3 99.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.66 -0.245 . . . . 54.34 111.615 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 18.6 pt20 -61.24 -40.02 92.48 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.048 -0.407 . . . . 63.32 111.804 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 10.4 mtp-105 -67.85 -45.04 75.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.817 0.342 . . . . 74.33 111.327 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.7 m -51.98 -46.76 64.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.012 0.434 . . . . 54.1 111.778 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.0 m-85 -73.78 -42.17 61.39 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.018 0.747 . . . . 64.3 113.018 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 13.3 ptm180 -66.45 -34.27 77.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.048 -0.408 . . . . 73.23 112.065 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -81.16 -39.31 25.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.156 0.428 . . . . 75.35 112.156 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.442 HE21 ' HG2' ' A' ' 47' ' ' GLN . 77.6 mm-40 -86.96 -63.21 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.449 0.537 . . . . 42.53 112.449 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -90.57 -7.41 52.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.024 0.379 . . . . 74.01 112.024 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.07 10.15 84.08 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.135 -0.555 . . . . 65.21 112.519 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 39.0 tp -83.5 112.48 20.01 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.126 0.489 . . . . 73.35 110.737 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -86.0 92.36 8.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 71.2 111.456 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 93.3 mt -81.11 145.91 57.53 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.788 0.328 . . . . 73.1 111.159 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.56 -173.17 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.648 2.232 . . . . 73.44 113.7 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -94.98 -34.39 12.38 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.494 0.553 . . . . 75.44 112.494 -170.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.477 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 66.3 m -96.01 136.5 36.37 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.259 -0.276 . . . . 70.14 111.09 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 87.5 m -56.58 -39.51 73.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.844 0.313 . . . . 65.54 111.844 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -55.45 -45.88 76.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.909 0.385 . . . . 73.23 111.212 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 49.6 mt-10 -59.63 -38.48 81.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.008 0.432 . . . . 73.41 110.604 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -67.81 -35.59 78.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.251 -0.431 . . . . 61.22 111.185 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.4 mt-30 -62.14 -37.58 85.71 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.378 0.609 . . . . 52.0 110.612 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.98 12.83 10.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.603 -0.726 . . . . 72.2 112.557 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 90.4 mmm -84.9 -62.6 1.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.893 0.331 . . . . 52.51 111.893 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.29 -174.57 21.19 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.254 -0.498 . . . . 62.13 113.942 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.98 159.69 21.18 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.069 0.462 . . . . 74.4 111.837 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 61.7 p -91.37 150.59 21.21 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.379 0.609 . . . . 74.54 112.342 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.78 169.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.698 -0.683 . . . . 74.52 111.416 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -117.16 -179.68 3.78 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.19 -0.459 . . . . 72.32 111.468 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -47.1 -58.42 4.05 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.919 1.081 . . . . 72.51 113.919 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.6 m -73.47 -4.73 35.55 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.225 0.454 . . . . 65.34 112.225 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -99.06 -11.72 21.21 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.891 0.377 . . . . 74.1 111.28 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.3 114.28 6.63 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.511 0.56 . . . . 70.52 112.511 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -112.17 -160.91 0.73 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.206 -0.452 . . . . 73.13 110.843 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.0 m -82.41 114.84 21.13 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.183 -0.323 . . . . 72.43 110.984 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.02 -18.69 10.37 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.066 -0.588 . . . . 71.05 113.098 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.95 130.79 44.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.068 0.461 . . . . 74.11 111.529 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.55 114.25 24.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.376 -0.375 . . . . 72.54 110.672 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.27 124.8 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.492 0.663 . . . . 70.22 111.604 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.8 mt -97.64 126.35 42.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.5 -0.773 . . . . 72.32 111.776 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -117.41 160.84 20.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.037 0.446 . . . . 71.14 111.293 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.45 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 63.0 mtt85 -91.83 122.2 34.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.14 0.495 . . . . 73.0 111.279 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -118.87 163.04 17.49 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.113 -0.494 . . . . 73.41 111.142 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.34 -67.92 1.54 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.959 -0.639 . . . . 65.02 113.35 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.1 t -58.73 -52.23 66.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.136 0.421 . . . . 72.12 112.136 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 77.6 p -85.92 -23.42 27.0 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.666 0.617 . . . . 71.21 112.666 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.33 -48.17 3.76 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.901 -0.666 . . . . 61.35 112.598 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -118.08 134.97 54.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.944 0.402 . . . . 70.52 111.192 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.55 148.81 50.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.187 -0.46 . . . . 63.51 109.9 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.466 HG12 ' SG ' ' A' ' 68' ' ' CYS . 9.2 p -135.76 138.93 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.335 0.588 . . . . 73.01 112.334 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -129.05 144.84 15.74 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.869 -0.605 . . . . 72.15 112.608 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.8 mt -90.23 107.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.634 -0.333 . . . . 73.31 111.491 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER -64.35 117.6 7.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.597 0.359 . . . . 71.52 111.422 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.3 pt -102.13 -32.88 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.362 0.504 . . . . 74.14 112.362 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.35 133.38 2.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.092 -1.051 . . . . 63.03 114.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 60.45 -80.08 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.593 0.757 . . . . 62.15 112.366 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.45 ' HA ' ' OH ' ' A' ' 123' ' ' TYR . 82.4 m-20 -141.57 1.63 1.56 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.177 0.436 . . . . 71.04 112.177 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -102.38 146.21 28.39 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.365 0.602 . . . . 62.3 112.051 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.7 p90 -150.73 148.98 29.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.377 -0.829 . . . . 72.23 111.657 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.87 138.34 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.916 0.389 . . . . 71.04 111.152 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -163.78 161.65 23.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.995 0.426 . . . . 63.51 111.847 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -91.2 96.7 10.71 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.207 0.527 . . . . 74.4 110.641 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.1 p -77.77 150.85 34.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.897 -0.592 . . . . 71.42 112.569 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.9 p -81.19 8.97 7.59 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.991 -0.55 . . . . 74.23 111.561 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 t -109.7 -46.55 3.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.855 0.317 . . . . 43.1 111.855 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.5 t -124.85 -30.16 3.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.385 0.513 . . . . 63.21 112.385 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.87 -147.65 18.42 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.278 -0.487 . . . . 72.21 112.005 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.21 101.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 117.141 0.471 . . . . 64.22 111.626 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.6 pt -136.96 176.6 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 61.31 112.173 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.12 120.97 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.004 -0.544 . . . . 55.14 110.846 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.8 p -122.62 178.27 5.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.937 0.399 . . . . 65.31 111.287 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 t -127.99 153.67 46.47 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.107 0.41 . . . . 65.51 112.107 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 25.0 mmt -60.07 -20.42 57.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.228 -0.442 . . . . 54.31 111.348 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.14 -24.3 66.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.287 -0.415 . . . . 65.1 111.636 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.509 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 29.0 mm-40 -71.47 133.68 84.88 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 120.833 0.349 . . . . 73.53 111.663 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.47 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 93.3 Cg_exo -45.15 -52.85 5.96 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.592 2.861 . . . . 72.05 115.11 -173.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.1 t80 -61.38 -43.6 98.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.824 0.345 . . . . 75.25 111.777 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.509 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 73.9 m95 -76.13 -38.77 56.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.043 0.449 . . . . 72.25 111.041 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.88 -45.66 71.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.828 -0.624 . . . . 42.51 112.064 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.5 ptpt -98.38 6.1 47.58 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.798 0.666 . . . . 73.44 112.798 -175.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 2.5 mpt_? -116.66 7.57 13.59 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 122.193 -0.317 . . . . 70.51 111.658 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -60.54 104.27 0.32 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.032 0.444 . . . . 71.41 111.162 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.463 HD22 ' HG2' ' A' ' 154' ' ' GLU . 8.5 t30 -82.15 -49.01 10.63 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.316 -0.402 . . . . 73.03 111.072 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.463 ' HG2' HD22 ' A' ' 153' ' ' ASN . 11.1 pt-20 177.3 -166.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.124 0.57 . . . . 60.53 109.875 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -146.69 146.66 30.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.38 0.511 . . . . 51.4 112.38 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt180 -137.04 126.35 24.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.365 0.666 . . . . 73.3 110.318 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.404 ' H ' ' HD3' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -107.37 111.92 24.48 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.439 -0.788 . . . . 74.14 110.605 175.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.3 m -89.46 -16.74 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.252 -0.885 . . . . 62.13 112.692 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.428 HD23 HD22 ' A' ' 82' ' ' LEU . 90.6 mt -69.75 153.57 43.18 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.226 0.536 . . . . 70.11 111.866 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.4 m -82.74 120.0 25.05 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.158 -0.473 . . . . 74.55 110.361 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -60.99 94.31 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.727 0.299 . . . . 54.21 110.253 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.1 m -64.84 132.44 49.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.46 -0.336 . . . . 72.33 111.604 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 163' ' ' LEU . 2.3 mm? -98.13 -168.74 1.7 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 110.174 -0.306 . . . . 71.24 110.174 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.779 -0.629 . . . . 70.43 111.202 175.265 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.853 0.359 . . . . 64.05 111.19 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -153.99 133.35 12.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.047 0.451 . . . . 71.45 111.364 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.9 t -76.51 118.18 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.172 -0.467 . . . . 45.04 111.623 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 15.0 t70 -99.11 122.29 42.13 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.602 0.239 . . . . 72.15 110.672 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.73 -57.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.347 0.499 . . . . 73.34 112.347 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.24 -44.15 95.47 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.666 0.27 . . . . 75.23 111.651 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 40.3 t -55.13 -47.85 74.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.886 0.374 . . . . 62.15 111.903 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 39' ' ' ASP . 11.0 mmm180 -59.9 -47.67 84.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.076 0.465 . . . . 65.0 111.289 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 122' ' ' ILE . 72.5 mt -61.67 -44.85 99.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.167 -0.469 . . . . 55.54 111.571 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 18.7 mmt -64.15 -29.08 70.22 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.917 0.389 . . . . 71.25 111.403 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.72 -47.76 82.2 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.223 0.535 . . . . 61.41 110.53 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 50' ' ' ASP . 25.6 tp60 -66.13 -35.12 79.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 60.21 111.374 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -54.15 -37.22 64.17 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.463 -0.335 . . . . 73.43 111.542 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.71 -20.6 57.44 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.336 0.495 . . . . 64.45 112.336 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.558 ' HB3' HE21 ' A' ' 47' ' ' GLN . 34.9 t70 -90.92 -21.15 21.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.973 0.509 . . . . 70.53 111.521 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -122.81 30.51 6.4 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.161 -0.472 . . . . 73.24 111.949 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -57.82 -1.45 0.11 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.273 1.582 . . . . 72.24 115.273 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.54 49.14 0.11 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.246 -0.978 . . . . 72.22 113.64 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -92.19 137.24 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.784 0.326 . . . . 74.53 111.004 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -74.34 158.38 34.08 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.021 0.748 . . . . 75.12 113.021 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -73.09 119.09 16.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.914 -0.585 . . . . 54.42 111.513 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -137.66 119.14 14.83 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.989 0.423 . . . . 72.31 111.783 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.11 118.8 10.38 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.248 0.462 . . . . 75.24 112.248 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.58 -54.33 4.6 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.187 -0.53 . . . . 62.12 113.657 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.84 98.47 0.55 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.094 -0.574 . . . . 60.34 112.246 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.4 p -97.22 119.41 35.68 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 71.53 111.625 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -176.52 176.97 1.5 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.043 0.537 . . . . 73.3 110.978 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -16.45 63.7 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.973 -0.454 . . . . 71.24 110.943 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -85.72 2.75 44.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.295 -0.411 . . . . 61.31 110.987 175.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.12 142.75 3.62 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.468 -0.396 . . . . 44.21 112.746 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.1 tt -165.49 138.28 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.941 0.37 . . . . 73.11 111.105 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.11 171.47 8.82 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.798 -0.564 . . . . 74.24 111.319 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 21.0 p -54.52 -39.72 67.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.695 0.628 . . . . 70.52 112.695 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.432 ' HB2' ' OG1' ' A' ' 88' ' ' THR . 23.9 t -67.47 -47.01 71.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.803 0.335 . . . . 51.12 111.417 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.5 -36.22 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.01 -0.614 . . . . 73.14 112.898 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.87 -56.09 20.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.785 0.326 . . . . 74.44 111.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.408 HG21 HD22 ' A' ' 108' ' ' LEU . 12.9 p -61.32 -38.15 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.757 0.313 . . . . 74.24 111.536 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 6.0 tt0 -54.0 -58.11 8.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.286 0.565 . . . . 74.22 111.28 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -60.2 -51.85 67.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.948 -0.569 . . . . 72.41 111.913 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 78.1 m -48.37 -53.63 16.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.389 0.514 . . . . 60.31 112.389 -176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 45.9 m-85 -68.52 -37.95 80.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.787 0.662 . . . . 73.01 112.787 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.5 -21.26 45.54 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.889 -0.507 . . . . 72.15 112.174 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -86.45 -55.09 4.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.925 0.393 . . . . 71.03 111.492 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.409 ' CD ' ' HB2' ' A' ' 47' ' ' GLN . 1.9 mp0 -67.97 -51.38 48.1 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.336 0.495 . . . . 73.21 112.336 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -100.52 -36.89 9.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.023 0.44 . . . . 74.42 112.113 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.55 6.21 41.42 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.714 -0.554 . . . . 44.04 111.714 -172.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.503 HD22 HD23 ' A' ' 159' ' ' LEU . 29.0 tp -79.4 110.75 14.99 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.081 0.467 . . . . 73.41 110.669 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -84.3 112.08 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 75.5 111.943 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 84.3 mt -100.92 154.93 36.86 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.915 -0.584 . . . . 75.55 111.312 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.01 -179.02 1.2 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.45 2.1 . . . . 65.35 113.592 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -39.86 14.9 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.567 0.58 . . . . 71.21 112.567 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.7 m -110.59 141.87 43.19 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.143 0.423 . . . . 74.01 112.143 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.522 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 48.7 m -49.3 -39.06 29.66 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.311 -0.404 . . . . 75.32 111.8 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -52.98 -47.08 68.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.234 -0.439 . . . . 71.11 110.989 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -65.22 -36.74 85.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.406 0.622 . . . . 72.22 110.697 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.96 -28.47 68.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.777 -0.647 . . . . 50.41 111.49 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.0 mt-30 -68.79 -6.58 27.52 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.007 0.373 . . . . 71.43 112.007 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -98.06 -10.28 24.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.825 0.676 . . . . 70.13 112.825 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.45 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 25.7 ptm -124.62 162.39 24.2 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.399 0.518 . . . . 54.4 112.399 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 160.51 36.48 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.319 -0.467 . . . . 74.11 114.247 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 68.3 mmtt -84.48 125.66 32.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.135 0.493 . . . . 75.43 111.638 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 64.6 p -81.21 111.98 18.12 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.648 -0.706 . . . . 75.34 112.841 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.427 HG23 ' HB3' ' A' ' 155' ' ' ALA . 2.8 m -106.2 157.58 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.808 -0.633 . . . . 73.44 111.964 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.448 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 84.0 p -99.59 -179.8 4.31 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.994 -0.548 . . . . 62.1 111.823 -177.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -53.23 -41.45 65.42 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.988 0.366 . . . . 71.21 111.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -77.28 -24.76 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 111.985 0.365 . . . . 72.43 111.985 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.62 -8.1 57.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.194 0.442 . . . . 72.32 112.194 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 99' ' ' SER . 85.3 mt -63.2 133.25 53.99 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.509 0.559 . . . . 74.02 112.509 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.411 ' O ' ' HD1' ' A' ' 123' ' ' TYR . 51.8 mtt180 -137.49 -122.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.466 -0.334 . . . . 74.42 110.352 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -106.12 127.04 52.92 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.692 -0.63 . . . . 53.53 112.134 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.16 13.31 36.75 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.298 -0.477 . . . . 75.44 114.178 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' A' ' 123' ' ' TYR . 1.6 m-20 -81.44 120.09 24.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 122.571 -0.37 . . . . 62.4 111.5 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.408 HD22 HG21 ' A' ' 72' ' ' VAL . 27.7 mt -76.62 104.04 6.92 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.972 0.415 . . . . 75.13 110.195 173.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 155' ' ' ALA . 27.5 m -95.53 118.8 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.512 0.672 . . . . 72.31 111.995 -173.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.484 HD13 ' HG2' ' A' ' 92' ' ' GLN . 74.7 mt -93.93 117.6 30.32 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.46 -0.791 . . . . 72.22 112.312 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 77.8 m-85 -107.91 133.36 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 73.23 110.331 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.628 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 78.4 mtt-85 -82.6 110.44 17.68 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.637 -0.505 . . . . 72.14 109.637 174.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.14 156.15 18.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.93 0.395 . . . . 70.34 111.664 -173.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.92 -95.2 0.33 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.211 -0.518 . . . . 65.24 112.03 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -116.81 -59.79 1.92 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.242 0.544 . . . . 73.32 109.78 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.456 ' HA ' ' HB3' ' A' ' 112' ' ' ARG . 8.2 p -145.47 45.44 1.3 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.667 -0.697 . . . . 60.31 110.883 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.72 -127.72 0.77 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.309 -0.472 . . . . 65.24 112.994 176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.522 ' O ' ' HD2' ' A' ' 118' ' ' ARG . 3.5 ppt_? -148.27 149.77 32.47 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 122.066 -0.667 . . . . 73.35 112.533 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 68.4 t60 -165.67 149.69 8.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.732 -0.667 . . . . 64.31 109.471 170.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 7.8 p -142.38 137.18 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.288 0.566 . . . . 62.55 111.969 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 109' ' ' VAL . . . -130.06 154.35 20.5 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.046 -0.597 . . . . 73.4 112.845 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 44' ' ' ILE . 47.4 mt -92.3 100.33 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 73.32 110.572 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 37.4 t80 -71.15 117.68 12.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.141 -0.481 . . . . 71.45 111.15 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.9 pt -99.08 -30.24 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.16 0.43 . . . . 73.51 112.16 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.27 163.31 9.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.159 -0.543 . . . . 61.21 113.202 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 56.76 39.86 29.41 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.674 0.39 . . . . 72.24 111.909 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.637 HD22 ' N ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 67.92 4.69 4.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.808 0.443 . . . . 75.4 111.846 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 141' ' ' SER . 25.8 mt-30 -97.4 140.48 31.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.385 0.612 . . . . 73.45 112.158 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.456 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 11.5 p90 -146.54 137.58 24.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.739 . . . . 70.11 111.215 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.08 126.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.058 0.456 . . . . 70.54 110.765 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -155.32 150.14 26.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.925 0.393 . . . . 75.04 111.813 -174.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.81 91.42 4.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.176 0.512 . . . . 74.52 110.183 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.4 p -78.23 143.94 36.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.815 -0.629 . . . . 74.24 112.234 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.4 t -77.27 -4.97 47.59 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.383 0.611 . . . . 61.24 111.369 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -87.94 -35.68 17.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.067 -0.515 . . . . 72.42 111.729 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 m -138.42 -51.78 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.235 0.54 . . . . 62.04 111.808 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.86 -153.22 24.52 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.642 -0.708 . . . . 52.14 111.708 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.23 96.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 117.411 0.605 . . . . 72.41 111.114 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.4 pt -133.28 168.47 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.302 -0.408 . . . . 74.33 111.744 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.12 109.41 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.25 -0.432 . . . . 73.42 110.666 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 128' ' ' GLN . 48.5 m -107.21 173.81 6.16 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.065 0.395 . . . . 73.1 112.065 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 29.1 t -119.95 141.16 49.89 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.688 0.625 . . . . 75.3 112.688 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.5 mtt -76.62 -0.55 23.79 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.859 0.689 . . . . 74.44 112.859 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -84.95 -10.94 56.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.065 0.459 . . . . 62.21 110.829 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -76.47 132.91 71.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.237 -0.438 . . . . 73.44 110.799 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.11 -49.4 14.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.224 2.616 . . . . 64.33 114.554 -172.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.567 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 91.9 t80 -61.55 -48.05 82.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.941 0.4 . . . . 61.53 111.194 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -72.83 -34.94 67.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.782 0.325 . . . . 74.22 111.665 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.69 -47.58 84.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.898 0.38 . . . . 72.2 111.319 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -73.24 -32.14 64.54 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.979 0.363 . . . . 75.14 111.979 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.628 ' HD3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mmp_? -76.82 -23.41 52.77 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.008 -0.433 . . . . 73.32 111.443 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -61.18 108.27 0.88 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.051 0.453 . . . . 73.31 111.841 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -91.35 -69.1 0.75 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.305 0.574 . . . . 75.23 111.171 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG3' HD12 ' A' ' 110' ' ' LEU . 10.9 pt-20 -148.49 153.14 38.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.977 -0.556 . . . . 71.31 110.782 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -115.48 149.83 37.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.75 -0.204 . . . . 51.14 110.539 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mtt180 -137.6 122.99 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.365 0.603 . . . . 54.54 112.437 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 157' ' ' ARG . 2.9 mtp180 -87.91 108.64 19.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.798 -0.637 . . . . 64.11 110.67 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.0 m -99.31 0.76 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.686 -0.688 . . . . 72.53 112.546 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.503 HD23 HD22 ' A' ' 82' ' ' LEU . 80.0 mt -67.36 99.36 0.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.106 0.479 . . . . 75.43 112.21 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.5 t -89.69 -174.53 4.34 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.019 -0.537 . . . . 72.1 110.53 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -142.11 105.54 4.65 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.155 0.502 . . . . 72.22 111.682 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 m -82.68 -169.77 2.64 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.95 -0.568 . . . . 72.13 110.843 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 164' ' ' GLU . 4.8 tt -72.35 132.62 44.21 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 110.156 -0.313 . . . . 64.52 110.156 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.513 ' N ' HD23 ' A' ' 163' ' ' LEU . 76.9 mm-40 . . . . . 0 C--O 1.252 1.207 0 N-CA-C 113.26 0.837 . . . . 72.41 113.26 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.633 0.254 . . . . 63.32 111.307 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -70.86 96.27 1.25 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.827 0.346 . . . . 53.05 110.408 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.38 97.15 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.964 0.411 . . . . 73.2 111.275 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -58.04 105.34 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.187 -0.461 . . . . 72.42 111.523 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 44' ' ' ILE . 94.1 t -48.74 -41.35 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.486 0.66 . . . . 55.02 110.322 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 45' ' ' MET . 88.2 tttt -56.48 -45.36 80.97 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.257 -0.883 . . . . 74.12 112.132 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.9 p -65.02 -37.78 88.73 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 122.228 -0.295 . . . . 72.22 111.536 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -70.9 -38.03 73.01 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 75.35 111.175 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 40' ' ' VAL . 86.2 mt -62.52 -46.08 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.127 0.489 . . . . 63.31 110.805 174.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 95.8 mmm -67.7 -29.74 69.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.347 -0.388 . . . . 54.31 111.282 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.46 -44.81 89.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.052 0.453 . . . . 64.05 110.196 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -65.3 -46.93 78.43 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.528 -0.76 . . . . 73.42 111.229 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -53.63 -39.22 64.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.221 -0.445 . . . . 73.11 112.136 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.22 68.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.861 0.362 . . . . 53.33 111.849 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -79.21 -33.79 43.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.248 0.547 . . . . 73.12 111.081 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.516 ' HZ2' ' NH1' ' A' ' 74' ' ' ARG . 84.9 m95 -99.13 22.75 9.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.438 0.533 . . . . 73.04 112.438 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.07 120.3 11.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.064 0.459 . . . . 73.24 112.032 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.03 20.43 75.85 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 114.472 0.549 . . . . 61.31 114.472 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.3 t -83.6 131.2 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 117.595 0.698 . . . . 74.45 111.003 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.31 163.46 26.44 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.298 0.571 . . . . 51.24 112.509 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 134' ' ' THR . 49.9 t80 -89.52 141.59 28.44 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.514 0.673 . . . . 75.33 112.437 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.624 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 57.2 ttt180 -129.58 131.28 46.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.573 -0.739 . . . . 73.43 110.462 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 58' ' ' LEU . 6.7 mp -76.22 93.54 3.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.969 0.414 . . . . 60.43 111.374 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 71.71 1.29 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.28 -0.486 . . . . 71.35 113.285 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' ' 57' ' ' ARG . . . 172.92 139.83 2.97 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.893 -0.67 . . . . 25.23 113.186 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.577 ' HB2' ' HD2' ' A' ' 74' ' ' ARG . 84.7 p -110.65 101.17 9.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.601 0.593 . . . . 70.21 112.601 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -153.22 151.78 30.46 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.12 -0.491 . . . . 73.33 111.137 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.46 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 32.3 ttmt -70.34 -5.56 28.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.05 0.453 . . . . 72.32 111.827 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -106.29 15.22 26.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.975 0.417 . . . . 74.2 111.265 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.75 108.11 0.27 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.187 -0.46 . . . . 73.22 112.164 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.493 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.3 tt -138.48 151.76 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 117.342 0.571 . . . . 71.31 111.894 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.624 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 6.2 p-10 -95.11 -179.13 4.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.185 0.517 . . . . 71.01 112.238 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.29 -55.76 22.05 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.003 -0.544 . . . . 45.11 111.954 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 81.5 p -66.21 -29.17 69.38 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.826 0.346 . . . . 62.53 110.864 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.68 ' HA2' HE21 ' A' ' 73' ' ' GLN . . . -66.1 -44.63 90.9 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.094 -0.503 . . . . 72.1 112.801 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.07 -51.83 66.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.0 0.428 . . . . 75.41 111.268 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.45 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.0 p -62.47 -44.46 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 112.173 0.434 . . . . 42.14 112.173 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.68 HE21 ' HA2' ' A' ' 70' ' ' GLY . 21.3 pt20 -59.57 -49.98 75.67 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.94 -0.475 . . . . 71.22 111.443 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.577 ' HD2' ' HB2' ' A' ' 61' ' ' SER . 10.0 mtp-105 -60.13 -41.61 93.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.991 0.424 . . . . 74.32 111.135 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.4 m -54.53 -52.23 62.68 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.103 -0.499 . . . . 74.13 111.489 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.6 m-85 -72.27 -37.83 68.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.502 0.556 . . . . 75.24 112.502 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.493 ' HG3' ' HA ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.77 -20.02 58.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.473 0.546 . . . . 64.33 112.473 -177.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -97.1 -49.93 4.8 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.166 -0.334 . . . . 73.02 111.509 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -71.55 -44.93 63.67 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.112 0.412 . . . . 63.33 112.112 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.11 -12.75 14.47 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.677 0.621 . . . . 72.2 112.677 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 32.32 62.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.127 -0.559 . . . . 53.13 113.33 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 57.9 tp -92.81 127.21 38.24 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.617 -0.343 . . . . 72.42 111.596 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.23 79.97 2.35 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.906 0.706 . . . . 73.51 112.906 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.439 HD21 HG21 ' A' ' 158' ' ' VAL . 64.3 mt -95.82 142.56 24.75 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 121.913 -0.492 . . . . 70.54 111.777 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.679 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 87.9 Cg_endo -82.1 -174.07 1.98 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.174 2.583 . . . . 63.13 113.391 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.571 ' H ' ' HD2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -105.6 20.64 18.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.44 0.904 . . . . 75.45 113.44 -169.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.1 m -141.29 132.65 26.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.938 0.399 . . . . 73.03 111.535 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 34.8 m -51.74 -43.87 63.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.239 -0.437 . . . . 41.24 111.929 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -58.43 -17.04 17.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.43 0.53 . . . . 63.05 112.43 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 94' ' ' MET . 35.5 mt-10 -92.35 -53.22 4.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.102 0.477 . . . . 70.12 110.484 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.641 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 80.6 mt-30 -54.6 -45.97 73.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.964 -0.562 . . . . 64.32 112.341 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 88' ' ' THR . 18.4 pt20 -53.59 -33.91 56.56 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.49 0.552 . . . . 61.52 112.49 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.38 10.9 29.49 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.047 0.758 . . . . 60.2 113.047 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.679 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 77.6 mtp -79.38 -29.95 42.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.043 0.449 . . . . 75.33 111.018 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -108.74 -133.27 6.84 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.37 -0.443 . . . . 74.4 112.674 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -127.19 174.03 9.25 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.549 -0.383 . . . . 65.32 111.547 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.6 p -106.81 161.53 14.6 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.312 0.577 . . . . 71.54 112.221 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.413 HG23 ' CB ' ' A' ' 155' ' ' ALA . 0.0 OUTLIER -148.2 160.13 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.604 -0.725 . . . . 73.31 111.662 177.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 t -95.92 173.22 7.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.976 -0.556 . . . . 73.43 111.441 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 51.4 tpt85 -51.19 -33.08 25.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.413 0.894 . . . . 75.21 113.413 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.8 m -82.71 -22.43 34.48 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.811 0.671 . . . . 70.25 112.811 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -96.53 14.71 23.76 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.349 0.5 . . . . 74.3 112.349 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.37 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.96 0.355 . . . . 71.25 111.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -124.68 -174.63 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.152 0.501 . . . . 72.54 111.014 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.3 m -76.19 107.22 8.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.255 -0.43 . . . . 72.5 111.173 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.78 -19.64 6.54 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.253 -0.499 . . . . 65.32 112.885 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.3 134.43 51.56 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.396 0.617 . . . . 64.24 111.693 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.0 mt -91.58 120.14 32.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.087 -0.506 . . . . 44.11 111.069 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.3 m -96.21 134.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.899 0.38 . . . . 72.33 111.564 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.34 125.9 51.57 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.921 0.391 . . . . 61.4 111.964 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 151' ' ' ARG . 90.6 m-85 -114.95 136.76 52.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.292 -0.413 . . . . 70.23 111.019 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 57.4 mtp180 -79.02 77.82 5.48 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.227 0.537 . . . . 73.34 110.903 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.91 123.36 36.11 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.051 -0.522 . . . . 64.13 112.173 -173.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.29 -25.22 66.39 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 121.113 -0.565 . . . . 74.32 113.945 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.6 m -82.03 -8.13 59.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.38 0.511 . . . . 72.53 112.38 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.7 p -141.02 -59.12 0.5 Allowed 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.376 0.608 . . . . 63.23 112.071 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 130.47 -98.82 0.42 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.151 -0.779 . . . . 65.33 111.151 -175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -94.7 90.8 6.23 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.072 0.463 . . . . 62.43 110.31 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -84.04 118.9 24.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.188 -0.46 . . . . 72.14 110.683 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 10.9 p -105.07 136.97 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.287 0.565 . . . . 72.41 112.408 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.18 148.02 19.19 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.995 -0.548 . . . . 75.31 112.689 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 72' ' ' VAL . 37.1 mt -87.68 110.22 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.492 -0.416 . . . . 72.13 111.029 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 20.8 t80 -68.13 109.39 3.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.767 0.317 . . . . 74.11 111.173 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.11 -32.48 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.072 0.397 . . . . 73.35 112.072 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 149.25 132.94 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.705 -0.76 . . . . 45.33 113.757 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 t30 55.34 78.33 0.19 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.746 0.647 . . . . 74.54 112.746 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 70.2 -41.04 0.48 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.777 1.029 . . . . 72.51 113.777 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -81.03 146.15 30.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.612 0.72 . . . . 74.12 112.64 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.85 154.65 35.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.349 -0.841 . . . . 73.13 111.153 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 139.49 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.888 0.375 . . . . 73.25 111.3 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -160.53 177.04 10.93 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.019 0.437 . . . . 72.21 111.733 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.93 103.47 10.64 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.208 -0.451 . . . . 73.41 111.393 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 70.8 m -81.38 149.38 28.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.871 0.367 . . . . 70.42 111.439 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.433 ' HA ' ' CG ' ' A' ' 56' ' ' TYR . 71.3 p -56.05 -43.77 78.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.98 0.733 . . . . 74.44 112.98 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.4 m -100.18 -42.07 6.85 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.13 0.418 . . . . 71.41 112.13 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 133' ' ' SER . 55.0 m -76.63 -25.71 54.14 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.825 0.676 . . . . 51.02 112.825 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.68 32.8 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.024 -0.608 . . . . 72.1 112.841 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.47 102.57 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.967 0.413 . . . . 74.13 111.666 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 136' ' ' SER . 47.1 pt -135.99 179.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.582 0.706 . . . . 70.32 112.541 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.66 135.81 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.507 -0.769 . . . . 65.42 110.785 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -132.12 176.1 8.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.441 0.163 . . . . 73.41 110.903 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.2 t -137.31 145.37 43.36 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.786 0.662 . . . . 74.23 112.786 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.49 -20.3 66.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.924 0.712 . . . . 71.34 112.924 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -75.82 -18.67 59.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.717 0.294 . . . . 71.33 111.694 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.4 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 35.7 mt-10 -68.47 130.66 91.98 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 116.668 -0.242 . . . . 75.14 111.061 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.86 -46.6 26.92 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.338 2.692 . . . . 71.41 113.838 -173.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -61.14 -46.31 91.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.709 0.29 . . . . 74.5 111.659 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.4 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 96.1 m95 -73.71 -39.74 64.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.904 0.383 . . . . 74.31 111.029 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.74 -44.83 70.27 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 75.21 111.629 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -78.63 -32.34 47.33 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.8 0.296 . . . . 63.33 111.8 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 20.0 mmt180 -70.11 -18.89 63.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.89 0.33 . . . . 71.01 111.89 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -56.15 111.57 0.99 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.33 0.586 . . . . 73.43 111.972 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.576 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -89.17 -57.0 3.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 70.0 110.08 177.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -171.87 176.75 3.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 73.51 110.523 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.413 ' CB ' HG23 ' A' ' 98' ' ' VAL . . . -125.67 153.93 43.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.234 0.54 . . . . 71.44 111.729 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -140.88 167.01 23.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.947 -0.569 . . . . 74.42 110.141 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.8 136.06 13.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.127 0.489 . . . . 71.33 111.287 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.439 HG21 HD21 ' A' ' 84' ' ' LEU . 13.4 m -104.15 3.85 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.785 -0.643 . . . . 72.12 112.314 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.21 156.96 18.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.911 0.386 . . . . 63.42 111.629 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.9 t -122.93 178.96 4.82 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.442 -0.345 . . . . 72.33 110.864 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -118.33 124.15 47.07 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.039 0.447 . . . . 75.51 112.076 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.9 m -78.81 142.56 36.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.05 -0.523 . . . . 44.45 110.984 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 163' ' ' LEU . 2.9 mm? -93.92 171.11 9.06 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.756 0.312 . . . . 74.41 110.904 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.266 -0.874 . . . . 71.31 112.263 -178.667 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.743 0.306 . . . . 65.42 111.16 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -67.23 89.08 0.19 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.124 0.488 . . . . 73.2 111.267 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -72.78 82.21 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.304 0.573 . . . . 65.22 111.039 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.71 132.36 35.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.031 -0.531 . . . . 71.41 110.859 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.9 t -55.14 -62.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.307 -0.406 . . . . 72.22 111.818 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.583 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 86.7 tttt -53.58 -45.86 70.11 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 74.24 111.66 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.1 m -63.78 -39.29 93.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.058 -0.519 . . . . 74.05 112.204 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -35.53 75.3 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.814 0.301 . . . . 71.32 111.814 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 40' ' ' VAL . 63.8 mt -64.61 -44.2 96.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.053 0.454 . . . . 73.15 110.567 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.9 mmt -64.24 -35.7 81.66 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.028 0.442 . . . . 65.33 110.892 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.72 -36.85 74.94 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.959 -0.564 . . . . 74.44 111.184 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' NE2' ' HE1' ' A' ' 51' ' ' TRP . 7.7 tp60 -76.04 -44.31 39.76 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.293 0.568 . . . . 74.44 111.216 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -55.37 -40.63 71.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.274 -0.421 . . . . 64.32 111.627 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.54 -21.57 65.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.032 0.382 . . . . 74.23 112.032 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -84.52 -42.75 15.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.061 0.457 . . . . 72.52 111.579 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.469 ' HE1' ' NE2' ' A' ' 47' ' ' GLN . 64.9 m95 -82.45 -50.42 8.88 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.43 -0.35 . . . . 64.32 111.708 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HE3' ' HB3' ' A' ' 52' ' ' LYS . 21.2 mmmt 46.46 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.446 1.276 . . . . 75.44 114.446 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.11 38.36 96.0 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.301 0.88 . . . . 72.34 115.301 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.62 131.33 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.635 0.717 . . . . 71.12 110.291 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.34 155.4 28.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.935 0.717 . . . . 72.53 112.935 -174.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -67.83 119.94 13.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.705 -0.68 . . . . 71.15 111.837 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 57' ' ' ARG . 20.6 ttm-85 -137.08 123.75 21.08 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.463 0.305 . . . . 74.45 110.721 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 58' ' ' LEU . 5.3 mp -69.97 113.94 7.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.079 0.466 . . . . 71.14 112.162 -175.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.26 -56.23 5.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 114.137 0.415 . . . . 51.41 114.137 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.7 82.34 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.224 -0.513 . . . . 72.31 113.226 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.497 ' OG ' ' HD2' ' A' ' 74' ' ' ARG . 83.8 p -76.61 110.58 11.3 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.096 0.474 . . . . 73.55 111.841 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -167.47 173.51 8.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.04 0.448 . . . . 63.42 111.524 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -69.41 -7.0 33.72 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.112 0.482 . . . . 54.51 111.42 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -93.42 8.23 41.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.113 0.482 . . . . 61.21 110.934 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.411 ' HA3' ' HE ' ' A' ' 57' ' ' ARG . . . 143.1 144.1 4.23 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.175 -0.466 . . . . 63.11 112.687 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 tt -163.52 135.27 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.582 -0.364 . . . . 74.34 110.844 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -85.42 177.03 7.92 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.351 0.596 . . . . 75.12 112.406 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' ' 120' ' ' VAL . 27.5 t -52.6 -57.24 10.64 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.694 -0.685 . . . . 71.31 111.933 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -65.53 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.161 0.505 . . . . 74.41 110.954 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.836 ' HA2' HE21 ' A' ' 73' ' ' GLN . . . -61.16 -45.78 95.84 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.946 -0.57 . . . . 65.23 113.107 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.34 -48.92 73.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.521 -0.4 . . . . 73.3 111.743 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.55 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.3 p -60.34 -50.48 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.11 0.411 . . . . 64.5 112.11 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.836 HE21 ' HA2' ' A' ' 70' ' ' GLY . 28.4 pt20 -57.98 -40.95 81.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.093 0.473 . . . . 53.12 111.269 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.651 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.9 mtp180 -71.75 -48.63 45.57 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.725 -0.39 . . . . 72.33 111.868 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.9 m -46.35 -46.3 18.21 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.039 0.447 . . . . 62.13 111.611 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.646 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 55.0 m-85 -67.81 -44.32 77.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.655 0.613 . . . . 75.01 112.655 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.651 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 1.2 ptm180 -73.53 -43.19 60.56 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.757 -0.589 . . . . 75.53 112.284 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 58.2 mm-40 -60.79 -37.73 82.92 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.922 0.392 . . . . 72.51 111.06 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -94.9 -69.34 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.196 0.443 . . . . 64.41 112.196 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -81.14 -22.06 39.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.792 0.664 . . . . 65.45 112.792 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.51 40.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.908 -0.663 . . . . 72.21 112.407 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.3 tp -103.24 117.35 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.698 -0.295 . . . . 74.54 110.864 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 129.59 39.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.184 0.438 . . . . 73.24 112.184 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.3 mt -121.58 159.93 48.47 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.232 -0.44 . . . . 62.4 110.73 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.16 160.87 48.15 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.639 2.226 . . . . 73.11 113.581 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 86' ' ' ARG . 61.8 mtt-85 -88.44 24.86 1.81 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.402 0.89 . . . . 73.34 113.402 -169.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -154.91 142.9 20.12 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.838 -0.539 . . . . 72.43 112.183 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 118' ' ' ARG . 37.9 p -51.96 -50.05 62.01 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.127 -0.488 . . . . 70.1 111.598 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -53.27 -37.63 62.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.578 -0.737 . . . . 53.31 111.359 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -71.7 -44.56 63.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 65.34 110.756 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.02 -20.98 66.36 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.03 -0.532 . . . . 75.5 112.028 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 88' ' ' THR . 24.4 mt-30 -56.46 -28.04 58.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.963 0.411 . . . . 74.34 111.477 174.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -89.95 -19.46 24.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.216 -0.447 . . . . 75.3 111.737 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.2 mmm -76.1 140.36 41.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.956 0.408 . . . . 73.41 111.847 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.77 -166.87 46.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.173 -0.537 . . . . 43.34 113.454 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -110.34 148.1 32.62 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.296 0.569 . . . . 63.42 111.865 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.7 p -79.5 133.55 36.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.409 -0.814 . . . . 63.33 112.11 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.578 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 3.8 m -146.07 167.31 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.93 0.715 . . . . 74.1 112.93 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.2 t -116.83 -171.43 2.02 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.374 -0.83 . . . . 74.13 110.985 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 -49.91 -56.47 10.41 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.058 0.762 . . . . 73.13 113.058 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 m -65.79 -11.72 48.36 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.734 0.642 . . . . 72.35 112.734 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.576 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.6 m120 -106.7 -4.31 19.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.073 0.398 . . . . 72.33 112.073 -174.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.88 147.38 50.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.985 0.735 . . . . 31.52 112.985 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -118.12 -159.01 0.73 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.654 -0.703 . . . . 72.2 109.297 173.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.8 m -102.01 102.75 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.03 -0.419 . . . . 72.11 110.662 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.06 6.94 5.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.214 -0.517 . . . . 35.23 113.649 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.12 134.69 44.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.261 0.553 . . . . 51.41 112.086 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.46 HD22 HG21 ' A' ' 72' ' ' VAL . 37.9 mt -79.59 110.7 15.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.913 -0.585 . . . . 61.52 110.044 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.44 118.91 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.261 0.553 . . . . 73.02 111.744 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.4 mt -90.28 123.83 34.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.743 -0.662 . . . . 75.33 111.593 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.66 140.99 45.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.182 0.515 . . . . 64.22 111.483 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.593 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 77.1 mtp180 -92.44 97.89 11.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.906 -0.588 . . . . 75.21 111.031 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.86 122.58 34.52 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.18 0.514 . . . . 72.1 111.391 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.52 -84.49 0.06 OUTLIER Glycine 0 CA--C 1.527 0.789 0 CA-C-N 116.099 -0.5 . . . . 55.22 112.43 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.0 m -165.23 -42.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.953 0.501 . . . . 74.4 110.604 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 p -100.7 5.39 43.71 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.311 0.485 . . . . 64.14 112.311 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -102.49 107.55 3.15 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.12 -0.562 . . . . 64.22 113.718 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.475 ' O ' HG21 ' A' ' 88' ' ' THR . 0.7 OUTLIER -90.53 111.29 22.52 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.474 -0.427 . . . . 72.4 110.632 173.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -115.5 149.89 37.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.245 -0.434 . . . . 74.11 110.556 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -134.84 146.17 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.203 0.525 . . . . 72.14 112.389 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.4 155.99 22.18 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.333 -0.46 . . . . 74.11 112.676 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 72' ' ' VAL . 47.8 mt -90.87 103.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.423 -0.457 . . . . 72.1 111.16 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t80 -69.47 101.11 1.51 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.241 0.543 . . . . 71.12 111.405 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.583 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.6 pt -82.15 -21.87 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.93 -0.577 . . . . 55.25 111.711 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.69 170.9 13.11 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 116.281 -0.418 . . . . 34.22 112.641 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 60.84 27.43 17.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.626 0.37 . . . . 54.33 111.675 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 63.81 23.66 13.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.418 0.287 . . . . 64.2 111.441 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -114.99 150.05 36.42 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.247 0.546 . . . . 71.42 111.55 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 13.5 p90 -156.54 148.68 23.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.88 -0.6 . . . . 75.33 111.992 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.33 141.09 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.793 -0.639 . . . . 73.13 110.952 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.405 ' CE1' HD11 ' A' ' 139' ' ' ILE . 8.1 p80 -158.96 162.1 36.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.94 0.4 . . . . 75.41 111.517 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -101.76 93.75 5.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.191 0.519 . . . . 73.11 110.892 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.63 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 41.1 t -76.78 166.07 23.86 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.169 0.509 . . . . 73.32 111.692 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.7 p -66.4 -66.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.082 0.467 . . . . 61.44 112.067 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 83.5 p -89.63 8.66 30.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.293 0.479 . . . . 63.22 112.293 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 48.5 m -125.84 -29.26 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.736 0.643 . . . . 73.21 112.736 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.86 -154.56 43.54 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.984 -0.627 . . . . 71.4 112.986 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.39 95.77 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.167 0.432 . . . . 74.14 112.167 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -131.23 -178.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.098 0.475 . . . . 72.3 112.263 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.51 139.44 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 72.11 111.255 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.8 p -143.87 163.94 31.97 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.748 0.308 . . . . 52.41 110.822 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.418 ' HB2' ' HG2' ' A' ' 145' ' ' GLU . 45.5 m -113.73 143.87 43.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.907 0.706 . . . . 75.22 112.907 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 91.4 mmm -58.86 -30.42 67.71 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.906 -0.588 . . . . 73.14 111.266 174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -68.71 -19.62 64.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.146 -0.479 . . . . 70.32 112.164 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 41.4 mm-40 -64.98 113.65 11.87 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 117.027 -0.079 . . . . 74.52 110.952 177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -43.71 -38.54 9.49 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.248 2.632 . . . . 55.3 113.818 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.641 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 71.7 t80 -57.62 -50.49 72.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.764 0.316 . . . . 72.45 111.629 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -82.53 -36.31 26.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.015 0.436 . . . . 72.2 111.455 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.5 -36.97 64.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.862 -0.608 . . . . 73.4 111.983 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -83.6 -15.21 49.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.886 0.328 . . . . 75.32 111.886 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 20.6 mmt180 -89.74 -17.15 28.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.993 0.368 . . . . 71.31 111.993 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.26 116.49 3.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.538 . . . . 72.23 112.454 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.473 HD22 ' HG2' ' A' ' 154' ' ' GLU . 18.5 t30 -92.57 -60.8 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.977 -0.556 . . . . 55.21 110.889 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.473 ' HG2' HD22 ' A' ' 153' ' ' ASN . 11.7 pt-20 -173.34 170.73 4.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.38 0.272 . . . . 74.04 110.503 176.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -119.98 169.41 10.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.267 0.84 . . . . 53.11 113.267 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -137.75 113.51 9.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.538 -0.755 . . . . 61.12 111.838 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.578 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.72 105.98 9.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.934 0.397 . . . . 75.04 110.55 171.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.44 -0.69 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.738 0.644 . . . . 73.41 112.738 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 82' ' ' LEU . 81.9 mt -87.56 110.7 20.55 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.917 0.389 . . . . 71.02 111.913 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 65.5 m -74.26 90.83 2.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.336 -0.393 . . . . 62.04 111.418 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -67.02 123.63 20.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.29 -0.414 . . . . 61.32 111.998 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 58.0 m -83.62 9.78 10.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.992 0.425 . . . . 72.14 111.983 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.0 tp -95.57 143.76 26.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.699 0.285 . . . . 62.42 111.16 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.453 -0.784 . . . . 73.24 112.005 179.465 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 47.6 ttp . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.639 0.257 . . . . 70.2 111.676 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -109.39 153.84 23.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.769 0.318 . . . . 71.33 110.505 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.61 91.6 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.129 0.49 . . . . 55.52 111.021 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -56.93 97.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.196 -0.456 . . . . 74.2 111.438 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.1 t -46.53 -49.76 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.22 0.533 . . . . 61.53 111.118 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 82.9 tttt -54.78 -48.29 72.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.655 -0.702 . . . . 72.24 112.33 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.2 p -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.935 0.398 . . . . 72.54 111.766 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.31 -36.89 85.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.473 -0.33 . . . . 70.43 111.592 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 40' ' ' VAL . 77.3 mt -63.07 -36.64 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.959 0.409 . . . . 74.21 110.641 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 28.8 mmt -70.2 -36.5 74.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.454 -0.339 . . . . 54.14 111.316 175.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.78 -42.54 99.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.214 0.531 . . . . 73.3 110.526 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.61 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 56.8 tp60 -64.03 -48.01 77.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.013 -0.54 . . . . 71.32 110.515 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -53.59 -39.56 64.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.797 -0.638 . . . . 73.41 111.499 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . . . -54.99 -34.42 63.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.018 0.437 . . . . 43.43 111.843 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.17 -24.46 51.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.088 0.471 . . . . 73.1 111.459 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -114.84 18.32 16.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.783 0.66 . . . . 75.35 112.783 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' A' ' 49' ' ' ALA . 10.2 mtmp? -59.09 109.08 0.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.144 0.497 . . . . 52.52 112.245 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.03 4.53 68.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 114.793 0.677 . . . . 61.03 114.793 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.49 127.68 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.839 0.82 . . . . 72.33 110.806 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -71.08 157.51 38.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.97 0.73 . . . . 72.12 112.97 -176.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -77.2 126.03 30.28 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.347 -0.842 . . . . 74.33 111.775 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -138.04 110.37 7.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.476 -0.329 . . . . 74.15 111.68 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.32 121.25 15.88 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.984 0.421 . . . . 74.12 111.894 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.79 69.34 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.098 -0.572 . . . . 42.42 113.9 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -138.5 137.86 9.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.33 -0.462 . . . . 63.14 112.365 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.7 m -125.86 99.49 5.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.001 0.401 . . . . 53.24 111.541 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 64' ' ' LYS . 4.0 t -177.28 177.69 1.18 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.251 -0.432 . . . . 75.24 111.115 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -71.17 -11.49 60.97 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.082 0.468 . . . . 62.21 110.87 178.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' HB2' HG23 ' A' ' 62' ' ' THR . 30.2 mmmt -74.81 -11.83 60.24 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.213 0.53 . . . . 74.2 110.703 170.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 55' ' ' ARG . . . 145.23 148.11 4.76 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.119 -0.491 . . . . 64.13 112.75 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 19.8 tt -154.98 144.81 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.861 0.331 . . . . 71.54 111.436 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.16 179.91 4.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.201 0.524 . . . . 54.23 112.349 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.7 t -58.82 -61.25 2.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.416 0.525 . . . . 71.12 112.416 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -59.01 -36.86 75.67 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.974 0.416 . . . . 72.22 111.533 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.91 95.06 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 121.057 -0.592 . . . . 74.55 113.219 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.26 -54.73 28.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.895 0.332 . . . . 73.42 111.895 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG21 HD22 ' A' ' 108' ' ' LEU . 7.4 p -57.0 -41.91 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.956 0.408 . . . . 71.35 111.216 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -50.85 -62.67 1.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.312 0.577 . . . . 71.32 111.315 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HA ' ' CG ' ' A' ' 77' ' ' ARG . 10.3 mtp180 -63.66 -34.91 78.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.888 -0.596 . . . . 74.3 112.457 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.61 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 95.7 m -55.93 -54.58 42.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.083 0.468 . . . . 64.3 111.555 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.492 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 63.1 m-85 -65.84 -37.81 87.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.829 0.677 . . . . 73.52 112.829 -177.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HA ' ' H ' ' A' ' 82' ' ' LEU . 3.0 ptm180 -75.15 -43.46 52.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.773 -0.579 . . . . 72.34 112.265 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.41 -18.49 64.45 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 122.098 -0.376 . . . . 74.3 111.756 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -108.39 -68.22 0.92 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.121 0.415 . . . . 75.11 112.121 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.63 0.45 57.38 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.579 0.585 . . . . 63.12 112.579 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.64 44.27 98.03 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 61.04 113.095 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.3 tp -104.68 122.39 45.57 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.087 0.47 . . . . 72.31 111.785 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.71 96.93 2.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.206 0.527 . . . . 72.12 112.037 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.52 135.69 21.06 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.153 -0.476 . . . . 64.12 110.513 173.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.03 -175.62 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.463 2.109 . . . . 74.34 112.301 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -109.25 6.21 24.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.855 -0.528 . . . . 73.21 111.663 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.7 m -108.71 128.05 54.52 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.447 -0.342 . . . . 64.21 110.619 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 118' ' ' ARG . 4.8 m -56.76 -46.52 81.37 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.383 0.512 . . . . 52.24 112.383 -173.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.578 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 33.3 m-85 -59.69 -36.46 76.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 111.872 0.323 . . . . 74.41 111.872 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.63 -36.02 60.32 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.974 0.416 . . . . 53.33 111.471 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.21 -43.87 93.68 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.91 0.386 . . . . 70.23 111.499 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 17.0 pt20 -62.88 -26.87 68.99 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.965 0.412 . . . . 74.41 111.392 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -86.19 -10.08 55.37 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.23 0.455 . . . . 65.43 112.23 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.5 mmm -66.39 -37.51 85.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.162 0.506 . . . . 71.24 110.86 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.35 166.56 12.2 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 116.0 -0.546 . . . . 55.32 112.11 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -86.96 160.34 18.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.36 -0.494 . . . . 54.4 111.221 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.537 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 36.5 t -78.62 135.02 37.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.602 0.593 . . . . 74.0 112.602 -174.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.55 HG23 ' HB3' ' A' ' 155' ' ' ALA . 15.5 m -127.89 142.99 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 54.51 110.633 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.6 t -88.66 177.12 6.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.99 0.424 . . . . 73.31 111.26 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -49.68 -29.19 6.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.153 0.581 . . . . 62.25 112.142 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m -84.4 -21.14 30.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.884 0.698 . . . . 64.12 112.884 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.0 m120 -108.16 11.35 27.57 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.002 0.741 . . . . 72.12 113.002 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.0 151.84 14.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.911 0.708 . . . . 65.11 112.911 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -140.35 143.78 35.94 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.096 -0.502 . . . . 74.21 111.18 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.9 m -58.47 96.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.833 0.349 . . . . 61.43 110.948 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 123.62 14.17 3.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.171 -0.538 . . . . 54.31 113.818 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.24 167.87 13.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.94 0.87 . . . . 72.04 111.123 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.465 HD22 HG21 ' A' ' 72' ' ' VAL . 47.1 mt -102.85 113.87 27.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.097 -0.501 . . . . 62.45 110.549 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -94.92 122.66 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.401 0.62 . . . . 74.22 111.43 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 92' ' ' GLN . 67.0 mt -100.4 124.48 45.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.579 -0.737 . . . . 73.32 111.785 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -116.02 138.41 51.24 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.982 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -74.22 94.64 2.5 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.899 0.381 . . . . 73.31 110.715 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.5 157.36 16.24 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.759 0.314 . . . . 74.52 111.627 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.58 -43.8 8.99 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.001 -0.619 . . . . 64.22 112.747 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 53.7 m -83.57 -39.69 20.05 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.329 0.492 . . . . 70.01 112.329 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 67.8 p -101.51 -10.88 19.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.014 0.746 . . . . 65.43 113.014 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.46 -76.96 0.62 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.036 -0.602 . . . . 50.43 113.029 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.403 ' O ' HG21 ' A' ' 88' ' ' THR . 13.8 mmm180 -107.57 92.95 4.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.002 0.43 . . . . 74.4 110.218 176.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -91.17 126.9 36.4 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.196 -0.456 . . . . 70.13 110.459 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -111.6 132.03 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.529 0.681 . . . . 74.33 112.288 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -124.45 160.69 19.03 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.58 -0.736 . . . . 74.54 112.074 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.3 mt -97.04 112.8 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.091 0.446 . . . . 71.15 111.019 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.476 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 51.7 t80 -75.83 113.71 13.62 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.107 0.48 . . . . 73.14 111.904 -175.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.402 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.2 pt -99.06 -7.95 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.155 0.428 . . . . 71.35 112.155 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.68 164.37 13.21 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.111 -0.566 . . . . 72.03 113.348 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 58.61 31.08 20.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.762 0.425 . . . . 73.31 112.021 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.476 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 80.1 m-20 67.19 13.16 9.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.987 -0.551 . . . . 42.1 112.367 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -101.32 144.62 29.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.318 0.58 . . . . 62.44 111.493 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -152.91 146.38 24.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.77 -0.65 . . . . 62.13 111.584 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.69 138.76 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.729 0.299 . . . . 64.52 111.008 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -158.78 175.04 14.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.976 0.417 . . . . 75.12 111.631 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.21 103.44 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.195 -0.457 . . . . 62.21 111.045 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 36.9 t -89.17 162.5 15.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.789 0.328 . . . . 72.21 111.421 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -55.12 -61.55 2.24 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.034 0.753 . . . . 63.55 113.034 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.4 m -93.69 -36.28 12.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.888 -0.508 . . . . 62.42 111.453 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 133' ' ' SER . 14.4 m -66.97 -29.62 69.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.242 -0.435 . . . . 71.12 112.118 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.69 34.75 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.97 -0.633 . . . . 61.13 112.565 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.46 102.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 117.127 0.464 . . . . 74.32 111.761 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.499 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -139.62 -179.01 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.13 0.49 . . . . 70.21 111.608 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.17 144.3 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.957 0.408 . . . . 73.13 110.72 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.7 m -137.08 169.41 17.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.199 -0.313 . . . . 71.13 111.396 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.2 m -130.52 139.89 50.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.911 0.386 . . . . 74.22 111.769 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 127' ' ' ASN . 67.1 mtt -65.37 -9.63 26.5 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.439 0.533 . . . . 72.34 112.439 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.67 -4.89 45.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.949 0.404 . . . . 64.21 111.452 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.41 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 25.8 mm-40 -83.56 127.08 69.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.244 -0.434 . . . . 73.53 109.962 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.432 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 84.9 Cg_exo -46.75 -39.0 23.49 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.704 2.269 . . . . 61.24 113.691 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.545 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 73.6 t80 -60.22 -51.31 70.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.651 0.263 . . . . 74.03 111.623 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.41 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 86.6 m95 -73.26 -33.35 65.21 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.899 0.38 . . . . 74.54 111.431 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 143' ' ' MET . 37.9 ttpt -68.54 -39.85 80.96 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.07 0.396 . . . . 75.13 112.07 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 19.3 ptpt -79.56 -28.13 41.22 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.738 0.304 . . . . 70.32 111.812 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 9.6 mmm180 -91.13 -4.88 55.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 111.886 0.328 . . . . 71.13 111.886 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -59.07 111.59 1.38 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.006 0.431 . . . . 74.11 111.41 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.407 HD22 ' HG2' ' A' ' 154' ' ' GLU . 6.9 t30 -92.26 -50.65 5.55 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.251 -0.431 . . . . 63.03 111.844 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.407 ' HG2' HD22 ' A' ' 153' ' ' ASN . 14.7 pt-20 -177.57 -173.02 0.39 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.329 -0.396 . . . . 72.34 110.901 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.55 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -140.42 159.87 41.25 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.89 0.376 . . . . 63.32 111.366 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.537 ' HD3' ' HA ' ' A' ' 97' ' ' SER . 16.2 mmt85 -139.42 109.54 6.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.473 0.309 . . . . 61.34 111.432 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 108.05 17.81 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.617 0.722 . . . . 74.24 111.42 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.71 -27.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.856 -0.611 . . . . 64.11 112.437 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.2 mt -73.3 109.36 6.76 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 111.919 0.34 . . . . 73.22 111.919 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.3 t -79.41 141.48 36.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.882 0.373 . . . . 71.52 111.117 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -80.28 99.29 7.79 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.802 0.334 . . . . 73.52 110.871 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 27.6 t -99.72 -6.48 27.01 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.792 0.329 . . . . 75.1 111.887 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 163' ' ' LEU . 6.9 mp -97.91 174.66 6.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.725 0.298 . . . . 72.15 111.096 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.365 -0.826 . . . . 61.02 112.291 -179.722 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.49 ' N ' ' SD ' ' A' ' 36' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.076 0.465 . . . . 71.35 111.5 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -76.3 121.76 23.43 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.352 -0.385 . . . . 71.23 111.261 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.76 109.93 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.959 0.409 . . . . 75.44 111.281 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.64 84.41 0.63 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.972 0.415 . . . . 72.13 111.528 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 44' ' ' ILE . 83.5 t -50.69 -54.23 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.174 -0.466 . . . . 65.43 111.557 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.531 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.2 tttt -53.9 -50.51 66.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.232 -0.44 . . . . 73.43 111.613 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 t -59.21 -44.35 92.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.425 -0.352 . . . . 42.44 111.879 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -63.68 -39.84 95.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.274 0.559 . . . . 74.14 111.303 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 40' ' ' VAL . 76.4 mt -61.37 -40.33 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.056 0.455 . . . . 74.11 110.6 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 30.3 mmt -63.54 -34.93 78.87 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.104 -0.498 . . . . 52.32 111.583 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.95 -45.4 86.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.912 0.387 . . . . 54.45 110.934 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.429 ' O ' ' HD1' ' A' ' 51' ' ' TRP . 15.7 mm100 -62.53 -52.37 63.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.974 0.416 . . . . 64.13 111.044 174.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -55.37 -38.42 68.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.106 0.409 . . . . 71.21 112.106 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.92 -30.92 71.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.471 . . . . 61.23 111.396 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -76.28 -31.95 58.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.134 -0.485 . . . . 74.34 111.126 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.429 ' HD1' ' O ' ' A' ' 47' ' ' GLN . 77.7 m95 -99.77 16.55 23.25 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.596 0.591 . . . . 74.14 112.596 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.81 109.83 1.02 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.836 0.31 . . . . 73.43 111.836 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.15 15.31 54.22 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.916 -0.659 . . . . 71.34 114.146 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -78.56 132.88 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 117.318 0.559 . . . . 72.32 111.951 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -73.84 152.44 40.24 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.201 0.524 . . . . 74.51 111.907 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 67' ' ' ASP . 72.4 t80 -83.7 148.18 27.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.034 0.445 . . . . 75.25 111.856 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 58.0 ttm-85 -137.69 148.73 45.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.039 -0.528 . . . . 72.24 110.611 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.02 93.59 8.42 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.973 -0.454 . . . . 74.32 110.701 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.37 61.32 1.25 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.216 -0.447 . . . . 44.42 113.361 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -176.37 150.82 10.83 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.16 -0.543 . . . . 73.51 112.685 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.528 ' HA ' HG13 ' A' ' 66' ' ' ILE . 80.7 p -128.0 99.93 5.69 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.554 0.575 . . . . 72.0 112.554 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 t -170.46 167.54 8.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.41 0.284 . . . . 74.04 111.439 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -66.35 -22.82 66.27 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.015 0.435 . . . . 71.23 111.206 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -91.14 21.14 4.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.077 0.465 . . . . 72.31 111.364 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.534 ' HA3' ' HE ' ' A' ' 57' ' ' ARG . . . 142.88 112.76 0.9 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.223 -0.513 . . . . 64.23 113.199 177.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 20.5 tt -137.34 144.79 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 117.067 0.434 . . . . 65.05 111.558 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.0 p30 -97.89 174.13 6.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.451 0.644 . . . . 62.13 111.98 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 44.6 t -58.92 -44.53 91.34 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.925 0.713 . . . . 41.03 112.925 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.6 p -74.39 -39.05 62.94 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.738 0.304 . . . . 62.35 110.471 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.63 91.5 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.372 -0.442 . . . . 72.11 112.928 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.02 -53.23 41.15 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.769 0.318 . . . . 73.13 111.633 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.96 -48.04 90.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 111.909 0.337 . . . . 71.42 111.909 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.581 HE22 ' HG2' ' A' ' 86' ' ' ARG . 13.8 pt20 -59.47 -43.82 93.15 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.15 -0.343 . . . . 72.5 111.463 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.556 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 55.8 mtp180 -64.98 -47.61 76.95 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.12 -0.232 . . . . 71.04 111.53 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -50.57 -44.39 56.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.966 0.413 . . . . 54.11 111.777 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 59.0 m-85 -75.66 -44.46 42.37 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.999 0.74 . . . . 73.43 112.999 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 9.0 ptm180 -62.0 -32.19 72.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.436 -0.79 . . . . 75.13 111.512 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 33.7 mm-40 -73.24 -72.99 0.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.94 0.4 . . . . 74.13 111.929 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -87.11 -5.96 58.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.212 0.819 . . . . 73.04 113.212 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.402 ' HD2' ' HA ' ' A' ' 76' ' ' PHE . 91.0 m-85 -127.41 -7.33 5.8 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 62.22 112.086 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.84 37.78 79.94 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.228 -0.511 . . . . 75.42 113.18 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 34.9 tp -104.9 144.38 31.86 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.892 0.377 . . . . 71.14 111.151 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -95.49 125.96 40.46 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.936 0.398 . . . . 73.41 111.834 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 73' ' ' GLN . 88.2 mt -135.12 133.47 20.82 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.472 -0.331 . . . . 74.12 110.929 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.71 155.93 61.85 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.788 2.325 . . . . 61.5 113.275 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.581 ' HG2' HE22 ' A' ' 73' ' ' GLN . 67.2 mtt85 -82.66 48.8 1.37 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.965 0.728 . . . . 63.34 112.965 -172.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.497 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 20.3 t -169.09 135.54 1.73 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.214 -0.448 . . . . 72.31 111.276 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.631 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 25.5 m -53.19 -46.35 68.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.374 -0.376 . . . . 73.15 111.036 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -39.4 75.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.078 0.466 . . . . 63.52 111.696 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.497 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 14.5 mm-40 -75.93 -35.57 59.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.996 -0.547 . . . . 71.13 111.115 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.94 -30.13 70.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.912 0.387 . . . . 70.32 111.775 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 88' ' ' THR . 20.0 mt-30 -62.72 -21.01 65.47 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.734 0.302 . . . . 74.15 111.749 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.01 16.42 1.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.667 0.617 . . . . 64.1 112.667 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptp -142.52 -178.58 5.83 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 122.186 -0.321 . . . . 71.24 111.067 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.3 50.89 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.13 -0.557 . . . . 63.31 113.141 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.6 mmtp -127.75 139.17 52.84 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.416 -0.461 . . . . 73.01 111.952 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.552 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 75.5 p -76.32 127.84 33.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.761 -0.654 . . . . 75.24 111.905 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.592 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 5.7 m -136.93 157.72 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.307 0.575 . . . . 62.15 112.532 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 t -109.62 -177.31 3.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.786 -0.643 . . . . 74.05 112.353 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.647 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 24.3 mmm180 -41.04 -50.28 3.36 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.26 1.208 . . . . 73.24 114.26 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -84.34 -14.4 49.72 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.566 0.58 . . . . 70.24 112.566 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 12.8 m120 -89.75 -12.23 39.94 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.977 0.362 . . . . 75.01 111.977 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -57.77 131.88 51.66 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.979 0.733 . . . . 65.51 112.979 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -111.96 -162.33 0.79 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.788 -0.642 . . . . 74.53 110.381 171.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.531 HG21 ' HB2' ' A' ' 41' ' ' LYS . 91.7 m -92.9 108.35 19.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.708 0.289 . . . . 74.14 110.849 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.66 -10.36 7.58 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.598 -0.334 . . . . 74.31 112.753 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.416 ' OD2' ' HD2' ' A' ' 157' ' ' ARG . 0.8 OUTLIER -60.9 127.05 29.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.115 0.413 . . . . 75.44 112.115 177.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 39.4 mt -82.87 108.07 15.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.892 0.377 . . . . 51.22 110.754 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 155' ' ' ALA . 28.4 m -96.27 124.86 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.284 0.564 . . . . 63.31 111.965 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 73.8 mt -93.96 136.16 34.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.831 -0.622 . . . . 74.3 112.002 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 96.0 m-85 -124.22 139.99 53.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 64.24 111.666 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -81.05 98.32 7.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.601 -0.272 . . . . 74.12 111.141 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.89 100.11 10.39 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.145 0.498 . . . . 64.33 111.743 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.01 -88.33 0.48 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.293 -0.479 . . . . 75.1 113.603 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.3 t -151.81 -59.62 0.16 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.174 0.511 . . . . 72.01 111.534 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.7 p -84.85 -18.67 34.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.86 -0.609 . . . . 62.23 111.356 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.99 85.05 0.57 Allowed Glycine 0 CA--C 1.526 0.74 0 CA-C-N 116.005 -0.543 . . . . 55.43 113.962 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -86.16 89.71 7.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.457 -0.572 . . . . 74.1 109.457 170.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 69.0 t60 -84.24 149.32 26.2 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.816 -0.629 . . . . 64.21 111.277 -172.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 7.6 p -142.6 119.04 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.461 0.648 . . . . 74.52 111.948 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -114.33 152.85 17.93 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.204 -0.522 . . . . 71.12 112.854 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.4 mt -88.39 106.92 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 122.51 -0.406 . . . . 73.22 110.706 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -68.51 116.73 9.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.045 0.45 . . . . 72.21 111.338 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.1 pt -103.04 -14.44 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.361 0.504 . . . . 35.24 112.361 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.13 164.67 11.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.11 -0.567 . . . . 70.3 112.991 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 127' ' ' ASN . 13.4 m120 61.58 27.35 16.84 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.002 0.401 . . . . 71.3 111.891 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 126' ' ' ASN . 47.6 m-80 67.12 7.61 5.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.328 0.251 . . . . 75.44 111.509 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.7 144.17 26.2 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.595 0.712 . . . . 60.44 111.253 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -149.29 138.43 21.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 73.25 111.056 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.92 133.43 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.031 0.443 . . . . 53.44 110.7 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -157.73 172.2 18.93 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.257 0.551 . . . . 73.44 111.723 -173.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -105.12 93.04 4.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.0 -0.546 . . . . 71.45 110.154 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.7 p -67.39 140.04 57.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.952 0.406 . . . . 75.1 111.531 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -57.6 -30.33 65.22 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.914 0.709 . . . . 63.3 112.914 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.9 t -102.18 -53.82 2.83 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.564 0.579 . . . . 65.4 112.564 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 t -81.0 -33.59 33.55 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.601 0.593 . . . . 61.34 112.601 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.44 -153.09 17.01 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.164 -0.541 . . . . 62.42 112.635 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.58 106.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.211 0.506 . . . . 73.41 111.499 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.5 178.21 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.299 0.571 . . . . 72.13 112.033 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.03 138.17 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.944 -0.571 . . . . 73.43 109.957 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.4 m -132.06 171.7 13.29 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.312 -0.243 . . . . 74.21 111.152 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.6 m -127.66 138.24 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.873 0.323 . . . . 72.31 111.873 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.647 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 66.3 mtt -64.78 -12.18 44.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.97 0.414 . . . . 75.5 111.866 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.452 HD22 ' N ' ' A' ' 144' ' ' ASN . 0.9 OUTLIER -66.1 -28.28 68.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.83 0.348 . . . . 75.33 111.204 173.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.56 125.54 92.04 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.573 -0.285 . . . . 71.25 110.63 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.486 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 82.3 Cg_exo -46.39 -41.88 22.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.968 2.445 . . . . 72.53 113.723 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -59.63 -41.5 90.61 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.223 0.453 . . . . 74.1 112.223 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.03 -36.44 19.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.011 0.375 . . . . 74.53 112.011 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -54.81 -50.93 67.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.074 0.464 . . . . 73.13 111.612 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 18.4 ptpt -82.35 1.17 38.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.975 0.417 . . . . 71.12 111.88 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -96.18 -28.69 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.531 0.332 . . . . 74.33 110.959 176.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -58.51 115.4 2.99 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.179 -0.464 . . . . 73.31 112.097 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.413 HD22 ' HG2' ' A' ' 154' ' ' GLU . 7.5 t30 -98.07 -62.43 1.25 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.059 -0.519 . . . . 72.34 111.447 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.413 ' HG2' HD22 ' A' ' 153' ' ' ASN . 13.5 pt-20 -158.44 164.73 35.95 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.231 -0.293 . . . . 74.12 110.482 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -126.24 149.22 49.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.551 0.215 . . . . 62.23 111.523 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.552 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 89.5 mtt180 -143.99 112.72 6.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.611 0.243 . . . . 71.34 110.987 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.592 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -85.4 129.31 34.84 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.16 0.505 . . . . 72.22 110.84 176.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 84' ' ' LEU . 27.8 m -107.13 7.89 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.895 0.702 . . . . 73.42 112.895 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 69.3 mt -68.05 141.73 56.09 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.177 0.513 . . . . 73.42 112.235 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.0 t -98.43 -61.58 1.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.932 -0.576 . . . . 72.33 111.894 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -67.89 142.48 56.06 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.83 0.347 . . . . 74.11 111.824 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.4 t -120.17 173.42 7.12 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.873 0.368 . . . . 71.23 111.281 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -74.68 149.28 39.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.746 0.307 . . . . 70.24 111.261 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.624 -0.703 . . . . 55.21 111.227 179.139 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.466 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 5.4 mmt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 112.058 0.392 . . . . 73.21 112.058 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -50.8 125.19 12.72 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.361 0.874 . . . . 62.11 113.361 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.94 93.9 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.022 -0.535 . . . . 74.43 109.964 169.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.52 105.04 0.58 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.913 0.387 . . . . 64.03 111.566 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 44' ' ' ILE . 86.6 t -48.66 -46.08 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 72.25 111.215 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 45' ' ' MET . 58.9 tttm -54.89 -46.3 74.79 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.576 0.584 . . . . 74.23 112.576 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.7 p -60.61 -44.03 96.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.801 0.334 . . . . 72.41 111.868 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -73.93 -30.03 62.35 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.445 0.535 . . . . 70.55 112.445 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 40' ' ' VAL . 75.4 mt -63.69 -43.85 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.265 0.555 . . . . 73.23 110.135 173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 87.4 mmm -66.63 -37.1 84.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.064 -0.516 . . . . 74.32 110.848 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.06 -43.45 70.25 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.169 0.509 . . . . 74.44 111.475 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.43 ' NE2' HE22 ' A' ' 79' ' ' GLN . 5.3 tp-100 -69.8 -54.51 13.26 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.273 -0.421 . . . . 75.14 110.617 174.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.432 ' OH ' ' NZ ' ' A' ' 52' ' ' LYS . 16.4 t80 -49.01 -39.68 27.78 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.088 0.773 . . . . 74.0 113.088 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.45 -33.81 55.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.115 0.484 . . . . 71.12 111.884 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.79 -23.41 55.88 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.038 -0.528 . . . . 63.32 112.413 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 138' ' ' VAL . 82.8 m95 -97.2 -0.31 47.01 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.587 0.588 . . . . 72.14 112.587 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' NZ ' ' OH ' ' A' ' 48' ' ' TYR . 29.5 mtpp -64.85 95.37 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.992 0.425 . . . . 71.51 111.269 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.81 -12.47 7.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.444 -0.407 . . . . 73.54 112.725 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.6 t -74.18 124.9 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 50.43 111.187 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -86.2 160.64 19.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.563 0.697 . . . . 74.41 112.39 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 47.3 t80 -74.72 127.51 33.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.412 -0.813 . . . . 63.03 112.125 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -136.93 121.53 18.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.712 0.291 . . . . 74.43 111.599 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.86 121.63 22.91 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.201 0.445 . . . . 62.42 112.201 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.4 50.82 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.946 -0.645 . . . . 53.3 113.689 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' ILE . . . -151.7 135.63 5.13 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.09 -0.576 . . . . 61.24 112.438 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.521 ' HA ' HG13 ' A' ' 66' ' ' ILE . 29.0 p -125.44 98.98 5.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.315 0.579 . . . . 53.22 111.691 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.1 t -159.84 161.88 34.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.065 -0.516 . . . . 71.43 110.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -67.88 -3.36 9.49 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.061 0.458 . . . . 71.12 111.738 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -92.55 -19.37 22.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.983 0.421 . . . . 74.43 111.269 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 136.52 2.23 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.59 -0.604 . . . . 60.11 111.59 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.521 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.4 tt -157.45 150.96 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 117.702 0.751 . . . . 62.03 112.496 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.15 -179.36 4.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.273 0.558 . . . . 70.52 112.186 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.4 t -58.15 -56.64 19.48 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.593 0.59 . . . . 71.23 112.593 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 75.2 p -60.46 -36.2 77.68 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.939 0.399 . . . . 74.53 111.608 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.66 85.09 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.039 -0.528 . . . . 74.01 113.17 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.73 -50.92 70.48 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.587 -0.361 . . . . 74.45 111.72 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.509 ' HA ' HD11 ' A' ' 122' ' ' ILE . 11.0 p -65.14 -43.79 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 111.987 0.366 . . . . 73.33 111.987 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.578 ' HA ' ' HB2' ' A' ' 84' ' ' LEU . 21.1 pt20 -62.18 -38.93 90.96 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.162 -0.336 . . . . 64.24 111.592 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 74' ' ' ARG . 14.4 mtp180 -67.12 -55.54 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.715 0.293 . . . . 71.52 111.579 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.4 m -47.46 -42.35 22.42 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.284 0.475 . . . . 74.41 112.284 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 49.9 m-85 -75.02 -41.55 59.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.717 0.636 . . . . 70.24 112.717 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 13.7 ptm180 -76.92 -26.68 54.37 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.812 -0.555 . . . . 62.01 112.355 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.0 -37.67 16.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.122 0.415 . . . . 55.42 112.122 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.43 HE22 ' NE2' ' A' ' 47' ' ' GLN . 19.2 mp0 -93.48 -48.43 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.9 0.704 . . . . 71.42 112.9 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 58.4 m-85 -101.55 -5.58 24.97 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.42 0.526 . . . . 63.34 112.42 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.59 13.62 74.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.089 -0.577 . . . . 73.35 113.066 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -90.82 111.51 22.94 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.671 -0.311 . . . . 71.23 110.674 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.48 95.85 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.177 0.513 . . . . 70.35 112.149 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 91.4 mt -82.69 143.6 47.3 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.1 -0.5 . . . . 74.4 110.195 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.45 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 43.9 Cg_endo -67.45 -172.67 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.53 2.153 . . . . 73.05 113.522 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.409 ' H ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -95.62 -33.09 12.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.864 0.69 . . . . 73.22 112.864 -172.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.512 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 19.9 m -96.43 141.74 29.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.69 0.255 . . . . 74.32 111.69 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 59.8 m -52.13 -50.35 61.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.905 0.335 . . . . 75.15 111.905 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.467 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 24.9 m-85 -54.11 -44.0 70.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.534 0.207 . . . . 64.11 111.437 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.512 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 45.3 mt-10 -58.91 -47.5 84.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.552 . . . . 62.43 110.87 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -63.37 -30.71 71.79 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.147 -0.479 . . . . 73.02 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.7 mt-30 -71.34 -21.05 62.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.465 -0.334 . . . . 75.4 111.495 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 89' ' ' TYR . 41.6 mt-10 -79.48 -5.23 54.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.852 0.358 . . . . 74.34 111.132 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.45 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 75.0 mtp -106.28 131.83 53.04 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.368 -0.378 . . . . 52.34 110.936 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.24 134.78 1.07 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.465 -0.397 . . . . 73.03 113.715 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 96' ' ' LYS . 70.3 mmtt -88.31 162.53 16.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.587 . . . . 65.32 112.025 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 29.6 m -75.38 155.19 36.69 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.208 1.188 . . . . 42.42 114.208 -167.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 155' ' ' ALA . 0.9 OUTLIER -144.04 149.39 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.017 -0.992 . . . . 70.35 110.864 171.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 t -100.57 -173.49 2.42 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.367 -0.379 . . . . 64.33 111.355 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.461 HH11 ' HE2' ' A' ' 152' ' ' TYR . 1.1 mpp_? -59.87 -38.56 82.53 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.978 1.103 . . . . 73.02 113.978 -169.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.9 p -79.86 -5.68 55.96 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.744 -0.598 . . . . 51.32 111.67 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -116.73 11.11 14.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.843 0.312 . . . . 62.41 111.843 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 78.1 mt -72.44 129.56 38.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.109 0.48 . . . . 65.14 111.588 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.402 HH21 HG11 ' A' ' 98' ' ' VAL . 41.3 mtm180 -138.8 172.23 13.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.02 0.528 . . . . 73.34 111.08 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.3 m -64.94 114.93 4.88 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.184 0.516 . . . . 71.23 111.969 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.86 -3.36 24.36 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.296 -0.478 . . . . 72.12 113.696 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -79.99 134.16 36.22 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.304 0.573 . . . . 70.14 111.125 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 77.3 mt -89.36 119.37 29.77 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.477 -0.328 . . . . 63.22 111.482 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 155' ' ' ALA . 12.5 m -95.62 129.24 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.978 0.418 . . . . 70.43 111.721 -177.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.61 140.7 33.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.308 -0.405 . . . . 45.44 111.58 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.41 140.09 51.45 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.794 0.33 . . . . 73.15 111.407 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -86.72 90.13 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.917 0.389 . . . . 75.34 110.229 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.36 135.04 48.55 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.372 0.508 . . . . 44.24 112.372 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.78 26.43 1.69 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 121.467 -0.397 . . . . 74.41 113.778 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.5 m -132.86 -38.42 0.99 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.933 0.397 . . . . 74.42 111.216 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.0 p -118.91 1.03 11.47 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.224 0.453 . . . . 60.1 112.224 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.12 -87.48 0.39 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.084 -0.579 . . . . 75.2 112.549 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.44 ' O ' HG21 ' A' ' 88' ' ' THR . 2.7 mpt_? -107.56 100.0 9.45 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.232 0.539 . . . . 64.45 110.552 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -92.63 143.01 26.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.919 -0.582 . . . . 73.33 110.613 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.93 137.58 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.263 0.554 . . . . 63.3 112.346 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.26 20.65 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.044 -0.525 . . . . 72.25 112.874 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.509 HD11 ' HA ' ' A' ' 72' ' ' VAL . 47.0 mt -90.27 109.42 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.801 0.3 . . . . 74.33 111.038 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.545 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 63.8 t80 -75.46 113.78 13.27 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.954 0.407 . . . . 63.13 111.358 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.44 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 27.7 pt -95.51 -32.96 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.107 0.41 . . . . 65.52 112.107 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.38 165.36 11.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.187 -0.53 . . . . 53.13 113.2 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.407 ' O ' ' HG3' ' A' ' 128' ' ' GLN . 10.0 t30 59.39 42.49 17.89 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.219 0.533 . . . . 74.25 110.788 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.545 ' HA ' ' HE1' ' A' ' 123' ' ' TYR . 4.2 p30 51.53 17.18 0.52 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.066 0.947 . . . . 62.34 112.725 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 126' ' ' ASN . 28.0 mt-30 -108.56 145.51 34.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.371 0.605 . . . . 72.22 111.702 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.525 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 8.0 p90 -148.97 150.43 32.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.648 -0.706 . . . . 74.31 111.659 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.49 140.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.014 0.435 . . . . 75.31 111.326 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -161.72 -166.37 1.46 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.474 -0.33 . . . . 71.15 111.236 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.96 106.46 8.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.76 0.314 . . . . 63.12 111.615 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.6 m -81.89 155.19 25.44 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.892 0.377 . . . . 71.13 111.987 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 67.8 p -52.84 -46.56 67.84 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.216 1.191 . . . . 63.44 114.216 -172.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -100.56 -44.74 5.75 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.904 -0.497 . . . . 72.3 112.07 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.0 m -65.77 -38.71 89.8 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.938 0.718 . . . . 53.41 112.938 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 91.66 -146.4 18.25 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.937 -0.649 . . . . 53.4 112.212 -173.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 51' ' ' TRP . 61.0 t -69.38 111.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 117.201 0.5 . . . . 61.32 111.67 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.2 pt -141.16 -179.98 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.165 0.507 . . . . 74.24 111.663 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.47 137.08 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.192 -0.458 . . . . 72.3 110.42 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.5 m -130.44 159.08 38.13 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.938 0.399 . . . . 74.32 111.68 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.6 m -115.2 148.4 39.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.366 -0.379 . . . . 61.24 111.586 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.511 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 91.8 mmm -67.54 -22.53 65.41 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.14 0.495 . . . . 65.2 110.863 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.33 -20.6 66.13 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.098 -0.501 . . . . 71.04 111.615 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -67.1 132.25 93.64 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.546 0.212 . . . . 72.44 110.96 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.592 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 14.1 Cg_endo -54.49 -48.79 19.53 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.747 2.298 . . . . 72.11 113.299 -174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -56.54 -48.47 77.21 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.129 0.418 . . . . 75.1 112.129 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.9 -40.07 61.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.228 -0.442 . . . . 72.22 111.424 -174.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -53.56 -55.95 21.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.162 -0.472 . . . . 62.34 111.834 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.608 ' HG3' ' HD2' ' A' ' 151' ' ' ARG . 19.1 ptpt -74.06 -28.74 61.54 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.803 0.668 . . . . 55.52 112.803 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.608 ' HD2' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -86.89 -7.5 58.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.478 0.547 . . . . 74.4 112.478 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.461 ' HE2' HH11 ' A' ' 100' ' ' ARG . 63.3 t80 -60.0 121.44 11.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.114 0.483 . . . . 75.13 111.778 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -94.65 -69.59 0.75 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.851 -0.613 . . . . 71.51 111.234 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.65 144.15 7.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.507 -0.315 . . . . 64.33 111.627 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -99.82 162.88 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.417 -0.177 . . . . 70.54 111.172 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -141.81 141.46 33.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.037 0.446 . . . . 73.31 111.899 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 157' ' ' ARG . 0.5 OUTLIER -97.45 95.29 7.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.29 0.567 . . . . 75.21 111.677 178.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.78 -15.18 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.004 -0.544 . . . . 65.43 112.175 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.479 HD23 HD22 ' A' ' 82' ' ' LEU . 96.0 mt -94.33 128.33 40.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.683 0.278 . . . . 70.23 111.371 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.8 t -66.98 86.1 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.058 0.456 . . . . 70.21 111.164 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.3 ppt_? -160.94 160.34 30.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.054 -0.521 . . . . 71.45 111.556 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.2 t 65.63 27.57 11.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.261 0.553 . . . . 74.33 110.867 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.6 mt -133.79 -171.33 2.7 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.785 -0.643 . . . . 74.14 111.324 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.256 1.405 0 CA-C-O 118.484 -0.77 . . . . 52.44 112.835 -178.044 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.774 0.321 . . . . 73.34 110.609 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -129.63 173.48 10.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.16 0.505 . . . . 72.41 111.649 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.6 t -69.67 108.65 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.084 -0.507 . . . . 71.33 110.42 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.06 106.78 12.33 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.139 0.495 . . . . 63.41 110.938 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 44' ' ' ILE . 60.0 t -52.13 -46.64 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.751 -0.659 . . . . 73.23 112.087 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -59.01 -44.51 91.7 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.942 0.401 . . . . 71.21 111.086 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.5 m -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.466 -0.334 . . . . 73.34 111.287 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -65.37 -38.82 91.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 71.05 112.309 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 40' ' ' VAL . 81.6 mt -64.29 -52.61 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.077 0.465 . . . . 64.41 111.23 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.415 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 28.9 mmt -63.6 -27.73 69.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.967 0.413 . . . . 52.12 111.219 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -59.52 -48.4 81.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.917 -0.583 . . . . 63.02 111.284 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -76.64 -36.27 57.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.808 0.337 . . . . 54.43 111.106 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.532 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 27.2 t80 -53.58 -37.65 63.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.765 0.317 . . . . 74.34 110.651 174.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . . . -53.34 -25.35 14.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.206 0.447 . . . . 54.11 112.206 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -86.4 -38.05 17.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.135 0.493 . . . . 72.54 111.124 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -88.07 -2.63 58.72 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.924 0.713 . . . . 74.41 112.924 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 98.6 mttt -53.0 106.07 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.552 0.575 . . . . 74.1 112.552 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.14 -8.25 25.06 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.982 -0.628 . . . . 74.22 114.386 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.66 123.22 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 117.49 0.645 . . . . 62.3 111.031 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.97 169.69 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.424 0.63 . . . . 61.5 112.568 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -83.93 128.42 34.53 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.808 -0.633 . . . . 71.24 111.679 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -136.87 118.61 15.05 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.53 -0.305 . . . . 70.34 111.024 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 58' ' ' LEU . 5.0 mp -74.3 102.59 4.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.999 0.37 . . . . 71.51 111.999 -173.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.28 33.7 31.4 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.068 -0.587 . . . . 64.24 113.241 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.15 102.93 0.27 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.905 -0.478 . . . . 50.21 111.905 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.511 ' HA ' HG13 ' A' ' 66' ' ' ILE . 47.2 p -94.81 100.84 12.66 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.504 0.557 . . . . 64.14 112.504 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -158.93 173.09 17.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.161 -0.472 . . . . 62.2 111.791 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -74.75 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.431 . . . . 74.24 111.32 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 3.1 mptp? -90.98 0.73 57.46 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.205 -0.452 . . . . 62.41 111.001 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.11 145.99 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.059 -0.417 . . . . 71.43 112.059 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.511 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.5 tt -165.02 148.09 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 117.551 0.676 . . . . 62.31 112.001 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.84 0.352 . . . . 70.13 111.473 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 25.0 p -59.94 -47.66 84.87 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.285 0.476 . . . . 71.45 112.285 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.3 m -63.97 -41.5 97.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.976 0.417 . . . . 65.23 111.225 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.81 -40.27 95.52 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.973 -0.632 . . . . 62.41 112.605 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -60.24 -54.24 48.19 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.976 0.362 . . . . 74.04 111.976 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.66 -38.04 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.058 0.456 . . . . 61.33 111.038 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -53.79 -57.78 9.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.293 0.568 . . . . 64.12 111.642 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 18.5 mmt180 -64.8 -48.1 75.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.951 -0.568 . . . . 65.04 111.844 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 m -52.68 -51.1 61.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.093 0.473 . . . . 65.31 111.865 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 35.3 m-85 -70.05 -38.66 75.87 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.773 0.657 . . . . 75.32 112.773 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 4.7 ptm180 -69.24 -33.71 73.69 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.89 -0.507 . . . . 73.32 111.542 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.12 -36.85 64.23 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 111.902 0.334 . . . . 72.41 111.902 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -97.48 -58.4 2.01 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.578 0.585 . . . . 52.11 112.578 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.33 -1.74 53.34 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.421 0.526 . . . . 74.54 112.421 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.68 22.43 76.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.182 -0.533 . . . . 72.01 112.889 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 23.9 tp -100.34 113.02 25.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 75.22 111.192 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.994 0.426 . . . . 72.22 111.575 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.01 153.83 37.75 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.325 -0.398 . . . . 61.31 111.361 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.86 168.21 19.31 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.443 2.096 . . . . 53.23 113.208 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -81.32 3.58 23.69 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.559 0.577 . . . . 62.13 112.559 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 30.8 t -122.17 133.44 54.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.343 0.498 . . . . 73.4 112.343 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 2.5 m -56.21 -45.21 79.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.854 -0.612 . . . . 75.31 111.026 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.6 -44.31 85.35 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.571 -0.741 . . . . 72.33 111.438 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 19.2 mm-40 -70.52 -33.99 71.79 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.153 0.501 . . . . 75.42 111.214 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -66.29 -20.36 66.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.528 -0.305 . . . . 65.42 111.74 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 88' ' ' THR . 22.9 mt-30 -72.08 -22.53 61.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.983 0.42 . . . . 71.13 111.819 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -87.46 -2.66 58.77 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.342 -0.39 . . . . 71.22 111.484 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.2 mmm -97.25 -75.83 0.53 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.865 0.364 . . . . 63.5 111.561 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.65 151.87 48.48 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.369 -0.443 . . . . 75.51 113.634 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 29.8 mmtp -89.29 153.94 20.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.998 0.427 . . . . 73.11 111.533 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 80.9 p -85.61 152.86 22.8 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.223 0.823 . . . . 75.51 113.223 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.513 HG13 ' NE ' ' A' ' 157' ' ' ARG . 1.1 m -152.25 171.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.861 -0.609 . . . . 74.52 112.161 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.2 t -116.26 -178.63 3.46 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.727 -0.67 . . . . 50.21 111.053 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.439 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -55.74 -46.09 77.88 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.287 0.477 . . . . 74.43 112.287 -177.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -69.48 -3.3 14.0 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.22 0.452 . . . . 70.43 112.22 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.493 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 5.6 m120 -116.08 -7.5 11.89 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.948 -0.47 . . . . 72.04 111.96 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.27 135.06 57.62 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.897 0.703 . . . . 71.25 112.897 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -115.42 -152.02 0.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.491 -0.777 . . . . 61.11 109.855 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.9 m -102.83 105.02 15.34 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.791 -0.568 . . . . 74.43 111.505 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 122.91 -3.78 9.87 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.842 -0.694 . . . . 32.51 114.604 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.86 134.24 56.89 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.373 0.586 . . . . 75.55 111.759 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.4 mt -85.38 113.19 21.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.026 0.441 . . . . 63.42 111.26 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' A' ' 155' ' ' ALA . 19.2 m -95.4 134.78 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.031 0.443 . . . . 74.53 111.438 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 87.8 mt -104.62 138.57 40.75 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.245 0.461 . . . . 72.34 112.245 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 119' ' ' HIS . 56.2 m-85 -123.4 141.28 52.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.933 -0.576 . . . . 75.02 111.505 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 48.2 mtt180 -82.87 82.01 8.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.956 0.408 . . . . 73.34 110.027 173.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.22 134.07 35.79 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.002 0.371 . . . . 74.2 112.002 -173.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.17 50.36 1.96 Allowed Glycine 0 CA--C 1.529 0.941 0 CA-C-N 116.51 -0.314 . . . . 74.32 113.586 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.1 m -154.62 -57.39 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.277 0.56 . . . . 41.21 109.769 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.6 p -103.17 -10.76 18.54 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.071 -0.513 . . . . 74.44 111.829 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.68 -61.01 4.31 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.242 -0.504 . . . . 44.42 112.798 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -117.08 97.75 6.1 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.028 0.442 . . . . 71.44 110.598 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 52.5 t60 -95.94 154.64 17.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.342 -0.39 . . . . 74.51 110.555 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.406 ' HB ' HG23 ' A' ' 88' ' ' THR . 14.9 p -134.57 142.94 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.172 0.51 . . . . 74.12 112.308 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.38 160.89 26.93 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.979 -0.555 . . . . 43.45 112.625 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -97.01 109.65 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.532 -0.393 . . . . 75.32 111.32 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -68.03 108.65 3.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.928 0.394 . . . . 74.25 111.231 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.4 pt -109.43 -32.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.458 0.54 . . . . 51.14 112.458 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.51 -175.72 14.13 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.201 -0.523 . . . . 73.15 113.038 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -43.02 -58.0 2.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.858 0.688 . . . . 72.45 112.858 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -122.11 -10.35 8.58 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.17 -0.331 . . . . 72.33 111.525 174.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -84.36 137.17 33.56 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.348 0.594 . . . . 75.05 112.459 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.69 142.57 27.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.594 -0.73 . . . . 62.35 110.965 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -97.41 136.33 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.869 0.366 . . . . 71.03 111.251 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -165.19 168.69 16.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 73.0 111.181 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.86 91.25 7.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.145 0.498 . . . . 65.53 110.515 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 99.8 p -65.14 146.02 55.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.868 -0.606 . . . . 34.42 112.086 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.2 p -64.48 -25.13 67.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.147 0.499 . . . . 62.54 111.303 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -73.17 -70.59 0.35 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.089 -0.505 . . . . 54.14 112.276 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.0 m -102.83 -35.75 8.51 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.124 0.416 . . . . 70.12 112.124 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.63 -141.29 13.5 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.078 -0.582 . . . . 54.43 112.567 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.9 92.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.321 0.582 . . . . 74.54 111.948 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.7 pt -136.88 -176.69 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.059 -0.519 . . . . 74.12 111.024 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.28 116.36 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.543 -0.299 . . . . 54.3 110.656 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.2 m -104.3 -177.99 3.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.767 0.318 . . . . 74.11 110.758 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 50.3 m -143.59 145.27 32.38 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.154 0.502 . . . . 65.44 112.342 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.81 -27.57 69.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.687 0.625 . . . . 65.44 112.687 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -72.85 -3.63 26.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.929 0.344 . . . . 63.21 111.929 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -74.8 122.25 87.07 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 110.423 -0.214 . . . . 72.33 110.423 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.14 -39.36 11.58 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.418 2.745 . . . . 64.02 114.421 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.488 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 85.7 t80 -61.72 -51.46 68.29 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.862 0.363 . . . . 75.02 111.28 176.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -76.84 -27.97 55.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.434 -0.348 . . . . 75.32 111.203 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.91 -34.56 74.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.203 -0.453 . . . . 51.33 111.234 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -102.6 0.99 34.19 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.362 -0.381 . . . . 55.54 111.521 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -103.41 -30.64 10.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 111.905 0.335 . . . . 74.35 111.905 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 70.6 t80 -56.64 135.28 54.96 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.886 0.374 . . . . 74.41 111.498 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -123.0 -51.33 1.9 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.932 0.345 . . . . 73.32 111.932 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.69 -179.04 7.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.079 0.4 . . . . 71.31 112.079 -173.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -144.73 149.47 35.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.516 -0.311 . . . . 74.44 111.374 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.6 mtm-85 -137.46 118.2 14.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.68 0.252 . . . . 74.44 111.68 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.513 ' NE ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -77.21 109.42 11.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.138 0.494 . . . . 72.43 110.981 174.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.457 ' HB ' HD21 ' A' ' 82' ' ' LEU . 16.8 m -84.13 -29.73 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.14 0.495 . . . . 54.34 111.201 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.48 94.72 5.63 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.267 -0.424 . . . . 75.15 110.177 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -64.32 117.22 6.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.299 0.481 . . . . 72.04 112.299 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 161' ' ' ARG . 9.2 tpt180 -138.63 111.74 7.93 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.104 -0.498 . . . . 74.25 110.465 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 58.7 m -110.18 131.04 55.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.05 0.452 . . . . 62.53 112.124 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.444 ' H ' HD23 ' A' ' 163' ' ' LEU . 2.3 pt? -76.96 -178.01 4.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.332 -0.395 . . . . 63.52 110.624 173.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.509 -0.758 . . . . 54.22 112.083 177.732 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 111.276 0.102 . . . . 60.32 111.276 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -42.14 138.35 1.65 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.244 0.831 . . . . 53.22 113.244 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.95 89.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.513 0.673 . . . . 72.43 112.192 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.468 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 12.2 t70 -96.02 140.91 30.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.772 -0.649 . . . . 73.33 110.272 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 44' ' ' ILE . 56.1 t -56.21 -53.87 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.831 0.348 . . . . 52.34 111.411 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.7 tttt -61.4 -43.19 99.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.307 -0.406 . . . . 61.13 111.238 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.4 m -57.17 -42.73 81.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.099 -0.5 . . . . 41.02 111.331 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -72.01 -42.36 66.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.259 0.466 . . . . 60.31 112.259 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 40' ' ' VAL . 78.9 mt -58.35 -48.69 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 64.52 110.897 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 92.7 mmm -63.88 -36.23 83.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.236 -0.438 . . . . 75.44 111.039 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.35 -43.62 83.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.912 -0.585 . . . . 73.32 111.37 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -71.24 -45.61 62.87 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.998 0.428 . . . . 72.23 111.145 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -54.44 -41.22 69.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.445 -0.343 . . . . 74.24 111.831 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.82 -20.85 9.52 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.321 0.489 . . . . 74.11 112.321 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.1 -25.54 17.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.087 0.47 . . . . 73.04 111.47 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.411 ' O ' ' HB ' ' A' ' 138' ' ' VAL . 81.4 m95 -105.14 3.27 30.09 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.101 0.778 . . . . 73.32 113.101 -175.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -54.84 101.71 0.05 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.844 0.354 . . . . 74.34 111.916 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.45 21.4 22.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.015 -0.612 . . . . 64.34 114.412 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.7 t -80.5 132.05 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 117.851 0.826 . . . . 73.33 110.992 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -63.27 163.3 10.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.938 0.718 . . . . 74.43 112.938 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 48.9 t80 -92.94 140.17 29.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.096 -0.502 . . . . 63.4 111.602 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -137.08 139.47 41.31 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.869 0.366 . . . . 65.45 110.969 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 58' ' ' LEU . 6.7 mp -74.72 97.4 3.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 70.51 112.193 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 67' ' ' ASP . . . 78.43 6.76 88.05 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.051 -0.522 . . . . 65.3 114.329 174.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.77 77.85 0.3 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 117.497 0.648 . . . . 70.43 113.128 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.532 ' H ' ' NH2' ' A' ' 86' ' ' ARG . 48.3 t -68.41 107.69 2.97 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.396 0.887 . . . . 73.03 113.396 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.8 t -166.14 172.58 11.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.724 0.409 . . . . 73.04 111.576 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -65.01 -21.35 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.953 -0.467 . . . . 75.23 111.572 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.01 9.25 20.18 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.392 0.615 . . . . 71.04 111.021 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.52 136.05 3.08 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.863 -0.895 . . . . 73.11 110.863 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 71' ' ' PHE . 19.7 tt -144.58 146.4 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.232 1.016 . . . . 65.13 112.828 -175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 59' ' ' GLY . 5.4 p-10 -93.12 160.04 15.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.005 -0.543 . . . . 74.53 111.502 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 28.2 p -57.36 -54.46 46.6 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.841 0.353 . . . . 54.53 111.553 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 8.2 p -58.95 -42.86 90.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.193 -0.458 . . . . 52.23 111.18 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . -57.63 -33.84 68.31 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.322 -0.399 . . . . 63.44 113.654 176.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.582 ' HA ' HD11 ' A' ' 66' ' ' ILE . 74.6 t80 -72.04 -48.46 44.32 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.48 -0.423 . . . . 74.11 111.612 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.58 HG13 HE22 ' A' ' 91' ' ' GLN . 7.1 p -63.1 -44.18 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.576 -0.284 . . . . 72.13 111.443 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 1.1 pp0? -61.14 -44.85 96.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.036 -0.415 . . . . 54.44 111.336 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -57.62 -50.5 72.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.041 0.386 . . . . 64.55 112.041 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.4 m -53.43 -45.83 69.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.833 0.349 . . . . 74.4 111.816 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 65.8 m-85 -72.86 -38.39 67.06 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.061 0.763 . . . . 72.53 113.061 -177.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -76.88 -42.77 38.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.572 -0.705 . . . . 74.45 112.287 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -73.43 -26.49 60.97 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.274 0.472 . . . . 44.34 112.274 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -96.0 -61.25 1.48 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.843 0.354 . . . . 74.22 111.866 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 76' ' ' PHE . 63.9 m-85 -90.08 -28.5 18.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.42 0.526 . . . . 75.54 112.42 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.1 27.29 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.191 -0.528 . . . . 65.52 112.512 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 37.4 tp -83.15 160.09 21.92 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.311 0.577 . . . . 74.31 111.865 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.63 114.57 27.1 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.058 0.456 . . . . 73.44 111.895 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.77 145.01 41.15 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 122.274 -0.267 . . . . 74.04 111.033 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.595 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 63.1 Cg_endo -85.73 -171.47 0.9 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.979 2.453 . . . . 74.02 113.881 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.532 ' NH2' ' H ' ' A' ' 61' ' ' SER . 11.0 mmm180 -88.44 -19.43 26.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.473 0.546 . . . . 74.21 112.473 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -106.31 126.63 52.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.756 0.65 . . . . 74.11 112.756 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 44.1 m -52.0 -41.8 62.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.89 -0.595 . . . . 74.34 111.665 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.407 ' OH ' ' HD3' ' A' ' 118' ' ' ARG . 89.0 m-85 -54.76 -32.53 60.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.85 -0.614 . . . . 73.13 112.306 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.08 -38.61 31.38 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.18 0.514 . . . . 75.02 110.961 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.595 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 44.9 mt-30 -61.85 -33.64 74.55 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.192 -0.458 . . . . 64.41 111.595 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.51 ' HG2' HD11 ' A' ' 110' ' ' LEU . 18.7 mt-30 -52.01 -37.72 54.34 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.241 0.543 . . . . 44.24 111.596 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -90.48 -9.81 45.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.015 -0.539 . . . . 74.22 112.126 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.503 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 81.1 mtp -87.25 -37.18 17.45 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.872 0.367 . . . . 53.13 111.374 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.76 150.93 21.41 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.946 -0.645 . . . . 64.41 113.388 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 31.2 mmmt -70.88 141.32 51.22 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.161 0.505 . . . . 72.45 112.007 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 m -77.47 127.54 32.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.656 -0.702 . . . . 75.4 112.106 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 7.1 m -145.5 164.65 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.382 0.61 . . . . 71.01 112.417 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 t -116.7 -177.71 3.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.689 -0.687 . . . . 73.0 110.776 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.512 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -56.14 -36.69 68.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.455 0.539 . . . . 74.4 112.455 -175.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.0 p -64.88 -29.14 70.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.03 0.443 . . . . 74.42 112.141 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -100.68 -6.89 24.46 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.173 0.805 . . . . 75.21 113.173 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.14 131.05 48.77 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.419 0.896 . . . . 74.11 113.419 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -125.07 175.79 7.12 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.743 -0.662 . . . . 62.54 110.33 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 41' ' ' LYS . 62.9 m -68.44 111.35 4.63 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.98 -0.45 . . . . 64.11 111.1 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 125.33 -12.93 7.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.388 -0.434 . . . . 72.2 112.711 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.18 130.45 43.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.022 0.439 . . . . 75.52 111.581 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.8 mt -87.95 112.32 22.43 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.95 0.405 . . . . 71.23 110.56 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.6 m -96.65 128.1 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.375 0.607 . . . . 52.22 111.577 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.51 HD11 ' HG2' ' A' ' 92' ' ' GLN . 79.3 mt -98.84 143.44 29.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.872 -0.604 . . . . 71.41 111.917 -175.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -131.14 132.19 44.61 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.39 -0.368 . . . . 74.31 111.266 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -81.22 84.79 6.49 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.242 0.544 . . . . 74.12 110.666 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.03 125.01 47.62 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.873 -0.603 . . . . 54.15 112.138 -173.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.99 1.27 8.54 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 121.116 -0.564 . . . . 74.31 113.981 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.8 m -105.61 -23.53 12.75 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 122.476 -0.426 . . . . 73.05 112.1 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.7 p -134.37 -1.04 2.9 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.54 0.57 . . . . 50.04 112.54 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.25 -100.69 1.41 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.117 -0.563 . . . . 52.12 112.546 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.407 ' HD3' ' OH ' ' A' ' 89' ' ' TYR . 9.7 mpt_? -102.98 94.85 5.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 64.24 110.469 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -87.78 151.63 22.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.005 -0.543 . . . . 72.14 110.236 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.5 139.07 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.092 0.472 . . . . 72.12 112.242 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 131' ' ' HIS . . . -132.15 149.85 19.49 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 116.177 -0.465 . . . . 55.1 112.525 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 72' ' ' VAL . 43.6 mt -89.39 106.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 122.476 -0.426 . . . . 74.2 111.031 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.67 115.05 5.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.387 -0.37 . . . . 73.13 111.314 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.1 pt -103.04 -33.75 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.893 0.701 . . . . 71.21 112.893 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.45 123.24 0.83 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 119.777 -1.201 . . . . 41.52 115.139 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.69 -78.25 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.24 1.016 . . . . 71.32 111.696 171.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 142' ' ' SER . 53.8 m-80 -133.57 -7.4 2.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.449 -0.342 . . . . 73.2 111.342 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -86.68 140.42 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.285 0.564 . . . . 70.21 112.287 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -151.41 140.68 21.36 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.524 -0.762 . . . . 71.22 111.041 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.44 137.44 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.994 0.426 . . . . 45.41 111.394 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 133' ' ' SER . 5.0 p80 -162.9 162.21 26.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.988 0.366 . . . . 64.54 111.988 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -88.23 92.06 9.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.951 0.405 . . . . 41.52 110.391 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 131' ' ' HIS . 37.5 t -86.78 126.39 34.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.424 -0.353 . . . . 72.12 111.886 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -59.3 -17.76 31.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.44 0.533 . . . . 72.1 112.44 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.1 p -65.95 -41.3 91.45 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.91 0.386 . . . . 53.25 111.503 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.1 m -138.79 -39.22 0.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.048 0.388 . . . . 61.13 112.048 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.3 -155.48 24.62 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.792 -0.523 . . . . 50.21 111.792 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 57.5 t -65.72 103.01 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 117.179 0.49 . . . . 61.43 111.237 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.72 169.84 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.106 -0.497 . . . . 71.15 111.399 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.48 114.55 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.591 -0.277 . . . . 75.42 110.687 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.5 m -104.57 178.56 4.52 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.965 0.412 . . . . 74.21 111.054 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 66.4 m -141.65 140.43 33.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.006 0.431 . . . . 75.54 112.106 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.02 -6.01 7.67 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.366 0.506 . . . . 54.5 112.366 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -73.0 -19.68 61.16 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 70.21 110.628 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.77 134.05 69.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.051 -0.522 . . . . 72.03 110.768 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.541 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 78.4 Cg_exo -51.25 -46.21 32.55 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.757 2.305 . . . . 71.2 113.489 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.79 -45.42 86.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.197 0.443 . . . . 74.31 112.197 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -80.33 -34.46 36.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.984 0.421 . . . . 64.5 111.641 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -60.5 -54.59 43.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.114 -0.493 . . . . 63.14 112.066 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 51.7 pttt -86.06 -14.78 43.33 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.173 0.805 . . . . 74.24 113.173 -174.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -92.95 -4.59 52.46 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.0 -0.438 . . . . 73.34 111.702 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.512 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 77.0 t80 -55.2 135.62 49.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.582 . . . . 62.55 112.234 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -104.81 -71.0 0.75 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.907 -0.588 . . . . 74.44 111.258 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.493 ' HG3' HD12 ' A' ' 110' ' ' LEU . 9.6 pt-20 -163.45 -174.11 3.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.17 -0.468 . . . . 73.02 111.057 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -142.11 137.63 31.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.611 0.597 . . . . 54.24 112.611 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 14.0 mmt180 -137.45 114.79 10.99 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.955 -0.566 . . . . 75.52 110.325 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.51 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -95.07 122.6 37.9 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.086 -1.009 . . . . 72.11 111.687 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.48 1.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.669 -0.696 . . . . 63.32 112.766 -176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.2 mt -95.2 132.92 39.63 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.165 0.432 . . . . 63.15 112.165 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.9 m -82.24 102.89 11.45 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.497 -0.319 . . . . 71.24 110.297 172.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.466 ' O ' ' HD2' ' A' ' 161' ' ' ARG . 4.9 ppt_? -80.08 148.19 31.12 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.578 0.584 . . . . 52.11 112.578 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.5 m -94.56 151.75 19.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.161 -0.472 . . . . 62.13 111.132 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 163' ' ' LEU . 6.3 mp -92.27 -169.15 2.16 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.935 0.398 . . . . 52.34 110.637 176.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.611 -0.709 . . . . 73.42 110.944 176.898 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 36' ' ' MET . 3.3 mpp? . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 111.798 0.296 . . . . 72.21 111.798 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -79.46 141.88 36.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.537 0.208 . . . . 74.22 111.174 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.2 t -78.67 106.1 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.123 0.487 . . . . 73.33 111.175 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -116.91 139.55 50.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.928 -0.578 . . . . 74.3 110.302 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 44' ' ' ILE . 46.6 t -56.5 -57.08 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.561 -0.291 . . . . 74.42 111.545 -176.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 85.1 tttt -55.7 -42.31 75.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.901 0.381 . . . . 71.31 111.475 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -58.89 -43.66 91.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.218 -0.446 . . . . 62.05 111.583 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -74.29 -33.28 63.19 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.19 0.441 . . . . 65.05 112.19 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 40' ' ' VAL . 87.5 mt -60.06 -50.25 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.156 0.503 . . . . 73.4 110.649 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 mmt -67.83 -34.01 75.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.093 -0.503 . . . . 71.42 111.136 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -55.41 -43.65 75.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.262 -0.426 . . . . 73.41 110.93 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 60.7 tp60 -78.87 -35.92 43.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.539 -0.3 . . . . 73.33 111.322 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -52.35 -32.77 39.89 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.82 0.343 . . . . 74.03 111.564 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.73 -34.44 52.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.358 -0.383 . . . . 33.23 111.812 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -19.8 42.24 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.38 0.511 . . . . 72.44 112.38 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.512 ' CZ3' ' HA ' ' A' ' 63' ' ' LYS . 99.3 m95 -100.91 -4.33 27.92 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.281 0.845 . . . . 73.23 113.281 -174.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -65.18 127.57 32.23 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.877 -0.514 . . . . 75.32 111.272 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.27 -1.47 67.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.312 -0.47 . . . . 71.34 113.785 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.3 134.1 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 117.299 0.55 . . . . 52.41 111.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -83.56 161.07 21.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.403 0.52 . . . . 65.35 112.403 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -78.4 116.34 18.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.88 -0.6 . . . . 75.4 111.404 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -127.25 97.48 4.93 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.166 0.508 . . . . 70.44 110.638 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 40.7 tp -70.85 104.94 3.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.095 -0.502 . . . . 71.02 111.648 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.17 -63.61 0.56 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.362 -0.447 . . . . 74.53 112.781 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.92 99.35 2.11 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.221 -0.514 . . . . 60.23 112.532 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.548 ' HA ' HG13 ' A' ' 66' ' ' ILE . 76.4 p -84.09 105.9 15.32 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.068 0.395 . . . . 74.32 112.068 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -156.89 163.21 39.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.129 0.49 . . . . 62.23 112.167 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HA ' ' CZ3' ' A' ' 51' ' ' TRP . 39.2 ttmt -67.04 -11.76 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.272 0.558 . . . . 72.54 111.502 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.504 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -94.95 11.46 31.77 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.221 0.534 . . . . 75.11 110.748 177.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.5 123.25 1.57 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.159 -0.776 . . . . 63.41 111.159 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 61' ' ' SER . 20.8 tt -155.72 152.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 117.953 0.876 . . . . 72.32 112.706 -171.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -93.21 179.31 5.46 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.994 0.426 . . . . 71.35 111.509 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.53 -54.35 41.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.554 0.576 . . . . 52.31 112.554 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.5 p -62.13 -34.39 76.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.108 0.48 . . . . 62.42 111.71 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.67 -44.19 72.17 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.832 -0.699 . . . . 71.44 112.292 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -56.96 -52.31 65.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.866 0.365 . . . . 73.42 111.851 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.545 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.8 p -59.82 -41.92 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 50.34 111.386 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 5.7 tt0 -55.24 -54.82 38.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.363 0.601 . . . . 71.33 111.169 174.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -56.33 -54.38 46.17 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.44 -0.8 . . . . 74.24 111.73 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.457 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 66.1 m -52.87 -48.06 67.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.054 0.39 . . . . 71.13 112.054 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 38.3 m-85 -70.18 -35.23 73.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.983 0.735 . . . . 74.04 112.983 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -80.31 -33.52 37.5 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.722 -0.611 . . . . 74.13 111.806 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -72.64 -33.61 66.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.978 0.418 . . . . 72.4 111.53 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -102.35 -56.7 2.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.803 0.668 . . . . 71.3 112.803 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.54 -3.59 54.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.403 0.52 . . . . 73.4 112.403 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.49 22.79 66.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.429 -0.415 . . . . 74.51 113.012 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.511 HD22 HD23 ' A' ' 159' ' ' LEU . 46.4 tp -86.94 130.21 34.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.196 0.522 . . . . 74.31 111.97 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.67 101.38 10.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.171 -0.468 . . . . 74.41 111.496 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 73' ' ' GLN . 83.9 mt -111.99 139.83 22.78 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.292 . . . . 62.5 111.242 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.61 148.92 54.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.351 2.034 . . . . 54.53 112.751 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -83.37 65.22 8.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.352 0.596 . . . . 74.04 110.177 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 13.2 t -171.0 120.24 0.52 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.688 -0.687 . . . . 74.55 111.029 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.57 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 53.5 m -52.06 -41.62 62.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.946 0.403 . . . . 73.22 111.001 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CZ ' ' HD3' ' A' ' 118' ' ' ARG . 83.7 m-85 -60.83 -46.53 90.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.181 -0.463 . . . . 70.45 111.322 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 94' ' ' MET . 16.5 mm-40 -64.99 -37.66 88.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.934 0.397 . . . . 74.02 111.322 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 87' ' ' SER . 95.2 mt-30 -67.07 -36.12 81.33 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.027 0.38 . . . . 74.33 112.027 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 88' ' ' THR . 23.6 mt-30 -52.89 -55.15 25.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.307 0.575 . . . . 74.23 111.545 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.08 0.9 17.12 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.598 0.592 . . . . 72.21 112.598 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 88.0 mmm -91.88 -13.43 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.682 0.277 . . . . 70.15 111.369 173.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -135.52 156.1 22.55 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.077 -0.583 . . . . 55.34 113.535 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 34.1 mmtp -94.37 152.84 18.32 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.482 -0.422 . . . . 71.24 111.367 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 79.3 p -84.44 157.26 21.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.149 0.796 . . . . 34.12 113.149 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.34 158.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 115.28 -0.873 . . . . 73.14 111.536 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.6 t -94.41 178.27 5.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.168 0.433 . . . . 73.43 112.168 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -51.3 -54.91 21.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.854 0.687 . . . . 71.41 112.854 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -74.17 -8.25 55.53 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.606 0.595 . . . . 72.44 112.606 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -107.45 3.67 25.38 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.205 0.446 . . . . 64.13 112.205 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.06 122.93 16.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.797 0.332 . . . . 73.34 111.843 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -105.72 154.36 20.58 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.372 -0.376 . . . . 74.14 110.602 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.3 m -66.35 119.52 11.71 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.916 -0.49 . . . . 75.53 110.855 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.47 -11.18 23.8 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.361 -0.447 . . . . 74.21 112.626 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.57 138.41 53.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.228 0.537 . . . . 74.51 111.412 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.449 HD22 HG21 ' A' ' 72' ' ' VAL . 23.5 mt -86.62 117.04 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.8 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -95.23 118.87 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.433 0.635 . . . . 72.14 111.418 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 70.1 mt -93.1 127.02 38.48 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.613 -0.721 . . . . 72.02 111.867 -177.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.67 133.58 55.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.328 -0.396 . . . . 73.42 111.126 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -75.87 92.06 3.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.904 0.383 . . . . 64.43 110.832 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.23 133.66 37.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.21 0.448 . . . . 63.45 112.21 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.69 60.34 4.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.385 -0.436 . . . . 34.43 113.455 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.6 t -172.52 -69.52 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.225 0.536 . . . . 72.15 110.744 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.5 p -81.88 -12.72 58.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.097 0.475 . . . . 63.12 111.12 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.19 -76.08 2.1 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.375 -0.44 . . . . 52.34 112.155 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 8.2 mpt_? -110.15 116.51 31.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.009 0.433 . . . . 75.45 111.223 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 82.9 t60 -102.4 151.89 21.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.474 -0.33 . . . . 72.33 110.213 174.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.71 137.77 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.149 0.499 . . . . 50.12 112.279 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.18 159.29 23.97 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.082 -0.508 . . . . 73.33 112.598 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.545 HD11 ' HA ' ' A' ' 72' ' ' VAL . 45.0 mt -92.22 106.57 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.536 -0.391 . . . . 75.33 111.418 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -65.74 120.79 13.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.818 0.342 . . . . 64.44 111.32 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.512 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 33.9 pt -102.98 -37.61 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.348 0.499 . . . . 64.33 112.348 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.27 142.05 4.77 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.381 -0.914 . . . . 34.42 114.086 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.52 -79.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.453 0.701 . . . . 70.53 111.822 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 143' ' ' MET . 7.8 p30 -150.8 9.08 0.59 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.134 -0.484 . . . . 75.32 110.92 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -89.28 143.01 27.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.112 0.482 . . . . 73.44 111.22 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.459 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 19.1 p90 -153.92 145.15 22.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 64.53 111.325 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.13 129.95 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.188 0.518 . . . . 75.3 110.86 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -150.65 -178.52 6.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.349 -0.387 . . . . 73.04 111.394 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -110.73 99.6 8.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.986 0.422 . . . . 61.42 111.482 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.9 t -66.25 136.23 55.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.126 -0.488 . . . . 74.41 111.452 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -57.28 -25.73 59.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.237 0.458 . . . . 73.35 112.237 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.8 t -99.56 -60.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.14 0.422 . . . . 41.14 112.14 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.8 m -73.32 -52.82 12.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.587 0.588 . . . . 53.35 112.587 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 -146.9 16.61 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.489 -0.386 . . . . 73.3 112.279 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.75 106.58 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 117.373 0.587 . . . . 72.12 112.001 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -140.24 174.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 120.988 0.423 . . . . 62.14 111.568 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 63.5 mt -105.41 123.26 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.526 -0.306 . . . . 73.24 111.213 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -116.37 173.58 6.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.658 0.266 . . . . 45.11 111.287 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 127' ' ' ASN . 67.6 m -137.82 139.48 39.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.554 0.576 . . . . 75.11 112.554 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 67.7 mtm -78.65 8.74 4.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.954 0.724 . . . . 64.12 112.954 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 142' ' ' SER . 10.4 p30 -78.6 -21.13 48.99 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.62 -0.675 . . . . 75.03 109.685 166.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.54 126.01 92.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.626 -0.716 . . . . 53.44 110.423 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 86.8 Cg_exo -43.7 -48.46 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.134 2.556 . . . . 72.31 114.298 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.555 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 82.6 t80 -57.4 -48.74 78.28 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.865 0.32 . . . . 75.33 111.865 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -73.97 -39.48 63.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.021 0.439 . . . . 60.11 111.405 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -55.0 -44.33 74.4 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.847 -0.615 . . . . 63.11 112.159 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.7 ptpt -91.21 -19.65 22.81 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.444 0.535 . . . . 71.12 112.444 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -83.21 -16.84 44.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.074 -0.391 . . . . 63.32 111.33 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -58.73 111.9 1.44 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.054 0.455 . . . . 74.3 111.898 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.429 HD22 ' HG2' ' A' ' 154' ' ' GLU . 7.5 t30 -85.85 -58.5 2.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.37 -0.377 . . . . 61.45 110.794 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.429 ' HG2' HD22 ' A' ' 153' ' ' ASN . 12.0 pt-20 -166.46 152.14 8.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.798 0.332 . . . . 74.0 111.211 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -105.57 145.16 31.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.521 -0.309 . . . . 51.24 110.637 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 63.5 mtt180 -134.59 118.82 17.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.893 0.377 . . . . 71.2 111.42 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.551 ' H ' ' HD3' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -80.8 125.69 30.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.094 0.473 . . . . 75.43 111.473 -178.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.21 -10.49 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.364 -0.38 . . . . 53.12 112.012 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.511 HD23 HD22 ' A' ' 82' ' ' LEU . 91.1 mt -84.64 108.74 17.53 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.936 0.398 . . . . 72.41 111.545 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 55.1 p -75.91 92.55 3.11 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.227 0.537 . . . . 71.53 111.099 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.566 ' HA ' ' HE ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -106.36 177.38 4.87 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.018 0.437 . . . . 73.32 112.085 -177.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.7 t -53.08 136.67 35.09 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.752 -0.658 . . . . 64.31 112.45 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.478 HD22 ' N ' ' A' ' 163' ' ' LEU . 2.9 mm? -81.71 -167.02 1.34 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.051 -0.522 . . . . 74.3 111.084 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.926 -0.559 . . . . 63.44 111.876 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 112.664 0.616 . . . . 64.33 112.664 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -69.65 169.85 11.98 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.074 -0.391 . . . . 65.34 110.797 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.1 t -92.96 92.07 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.078 0.466 . . . . 52.24 111.485 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 24.7 m-20 -82.87 112.8 20.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.548 -0.296 . . . . 73.23 110.522 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 44' ' ' ILE . 90.7 t -50.07 -50.93 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.286 . . . . 72.21 111.34 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' HB2' HG21 ' A' ' 105' ' ' THR . 87.8 tttt -55.26 -44.6 75.74 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.814 0.34 . . . . 64.31 111.578 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 35.3 t -59.74 -39.96 86.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.931 0.396 . . . . 73.32 111.011 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.56 ' HE ' ' HA ' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -67.39 -42.05 83.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.349 -0.387 . . . . 74.21 111.826 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 40' ' ' VAL . 48.7 mt -64.31 -45.13 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.006 0.431 . . . . 63.23 111.089 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 29.9 mmt -65.76 -36.31 83.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.902 0.382 . . . . 54.33 110.871 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -47.72 74.29 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.973 -0.558 . . . . 74.21 110.958 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.522 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 8.0 tp60 -66.04 -47.86 72.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.947 -0.57 . . . . 72.21 110.894 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.519 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 17.0 t80 -55.8 -32.66 63.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.141 -0.481 . . . . 75.33 111.382 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.41 -33.07 58.65 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.049 0.452 . . . . 65.41 111.632 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.32 -20.96 31.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.231 0.456 . . . . 73.43 112.231 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -113.75 17.84 17.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.693 0.627 . . . . 74.41 112.693 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.1 mtmt -62.68 110.41 1.71 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.144 0.497 . . . . 73.44 112.33 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 21.77 41.84 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.407 0.523 . . . . 51.31 114.407 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.95 118.67 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 117.577 0.689 . . . . 71.44 110.967 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -71.73 163.64 27.42 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.742 0.645 . . . . 71.43 112.742 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 50.2 t80 -77.85 126.65 31.18 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.701 . . . . 75.42 111.833 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -138.39 103.08 4.8 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.056 -0.52 . . . . 63.14 110.156 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 tp -72.04 132.28 44.03 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.96 0.409 . . . . 74.42 111.716 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 -44.2 3.22 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.203 -0.522 . . . . 73.23 113.175 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.75 60.54 2.41 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 122.509 -0.407 . . . . 73.41 112.749 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.43 ' HB2' HG13 ' A' ' 66' ' ' ILE . 99.1 p -67.26 113.62 5.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.053 0.454 . . . . 42.15 112.161 -173.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.418 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 2.6 t -164.74 171.57 14.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.991 -0.55 . . . . 74.3 110.89 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -69.96 -14.4 62.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.658 -0.651 . . . . 64.11 111.32 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.67 2.38 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.948 0.404 . . . . 64.31 110.958 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.23 121.37 0.97 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.178 -0.769 . . . . 63.31 111.178 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 19.5 tt -149.54 158.6 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 74.52 112.421 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.93 174.39 6.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.039 0.447 . . . . 71.53 111.621 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 19.8 p -65.09 -53.29 47.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.576 0.584 . . . . 71.02 112.576 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 12.2 p -59.04 -39.62 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.978 0.362 . . . . 54.13 111.978 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.98 -37.91 92.44 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.021 -0.609 . . . . 72.41 112.821 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -63.17 -53.97 44.91 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.641 0.258 . . . . 45.35 111.367 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.53 -43.93 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 112.249 0.463 . . . . 74.22 112.249 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.8 -37.04 80.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.924 0.392 . . . . 72.54 110.912 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 84.1 mtt85 -69.53 -50.05 48.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.993 0.368 . . . . 60.25 111.993 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -52.71 -48.16 66.81 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.096 0.474 . . . . 63.32 111.582 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.576 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.8 m-85 -69.72 -36.38 75.83 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.698 . . . . 63.33 112.886 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 6.4 ptm180 -68.42 -32.06 71.84 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.949 -0.469 . . . . 71.32 111.201 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.521 ' HG3' HE22 ' A' ' 47' ' ' GLN . 27.2 mm-40 -74.47 -62.18 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.166 0.508 . . . . 72.45 111.225 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.522 ' OE1' ' HB2' ' A' ' 47' ' ' GLN . 3.0 mp0 -72.1 -44.76 62.71 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.758 0.651 . . . . 74.14 112.758 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -110.81 -3.6 15.65 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.066 0.765 . . . . 72.13 113.066 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 22.44 68.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.824 -0.703 . . . . 60.35 113.068 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 50.1 tp -95.47 121.52 37.24 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 75.14 111.31 -177.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.59 110.34 22.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.952 0.406 . . . . 63.34 111.769 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.9 mt -97.29 152.71 38.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.472 -0.331 . . . . 73.2 111.221 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.5 175.67 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.433 2.089 . . . . 63.14 112.963 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 86' ' ' ARG . 34.6 mmt-85 -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.873 1.064 . . . . 73.13 113.873 -167.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 91' ' ' GLN . 84.4 p -130.6 147.05 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.806 -0.559 . . . . 70.45 111.882 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.602 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.4 m -53.32 -40.13 64.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.271 -0.422 . . . . 73.33 111.274 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -49.65 -43.49 46.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.022 -0.535 . . . . 71.43 111.104 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.62 -40.96 32.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.769 -0.65 . . . . 73.44 111.355 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 87' ' ' SER . 91.6 mt-30 -57.58 -31.16 65.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.197 0.443 . . . . 73.04 112.197 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' A' ' 88' ' ' THR . 37.7 mt-30 -58.45 -33.58 69.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.0 0.37 . . . . 74.3 112.0 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.92 -25.24 62.67 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.932 0.345 . . . . 74.41 111.932 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 92.4 mmm -69.32 -43.82 72.95 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.552 0.575 . . . . 72.23 112.552 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -102.42 160.28 17.46 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.803 -0.713 . . . . 53.44 114.305 -172.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 75.1 mmtt -91.26 147.31 23.14 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.807 0.337 . . . . 71.14 111.524 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 41.0 m -76.01 150.72 37.34 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.343 0.868 . . . . 74.13 113.343 -172.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.5 137.95 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.677 -0.692 . . . . 72.23 111.739 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.7 t -80.13 176.21 9.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.957 -0.565 . . . . 71.13 111.789 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.443 ' HD2' ' CE2' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -54.49 -50.31 68.07 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.754 0.65 . . . . 74.32 112.754 -175.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -70.11 -14.91 62.87 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.23 0.456 . . . . 65.45 112.23 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -102.31 4.52 39.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.302 0.482 . . . . 71.42 112.302 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.19 138.74 49.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.961 0.41 . . . . 60.21 111.591 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -134.08 174.48 10.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.948 0.404 . . . . 62.45 110.852 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.402 HG21 ' HB2' ' A' ' 41' ' ' LYS . 27.6 m -71.7 103.72 3.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.692 0.282 . . . . 63.33 111.39 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 133.13 -12.99 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.282 -0.485 . . . . 53.13 113.467 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 157' ' ' ARG . 7.4 m-20 -71.15 147.31 48.51 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.237 0.542 . . . . 64.33 111.599 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 mt -94.28 123.11 37.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.347 -0.388 . . . . 62.34 110.769 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 m -96.35 116.06 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.251 0.548 . . . . 70.32 111.245 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.2 mt -92.41 121.85 34.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.593 -0.731 . . . . 71.01 111.4 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -114.3 166.41 11.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.598 0.713 . . . . 71.43 112.188 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 68.1 mtp180 -103.8 109.79 21.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.28 -0.873 . . . . 73.21 109.474 172.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.2 124.38 35.37 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.126 -0.359 . . . . 63.45 111.599 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.25 -73.7 0.71 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.138 -0.553 . . . . 34.53 111.906 -173.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.7 m -167.78 -51.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.532 0.733 . . . . 74.12 110.269 174.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 p -107.68 93.84 4.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.986 0.422 . . . . 74.52 111.541 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 162.18 140.48 2.89 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.973 -0.632 . . . . 45.33 113.26 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -96.08 122.63 39.13 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.118 0.485 . . . . 74.34 111.526 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -113.32 156.21 23.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.076 -0.511 . . . . 71.13 110.096 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.88 137.94 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.387 0.613 . . . . 61.31 112.254 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.77 155.91 21.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.747 -0.66 . . . . 64.14 112.205 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.4 mt -92.37 110.32 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.32 -0.518 . . . . 73.41 110.972 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.447 ' HE1' ' HA ' ' A' ' 127' ' ' ASN . 61.1 t80 -73.77 114.89 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.048 0.451 . . . . 75.02 111.9 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 pt -95.56 -32.61 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.404 -0.362 . . . . 74.54 111.801 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 148.11 159.73 8.6 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.9 -0.667 . . . . 73.51 113.654 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 53.96 46.81 24.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.988 0.515 . . . . 73.23 112.267 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 142' ' ' SER . 44.2 m-80 67.18 -1.11 1.55 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.446 0.536 . . . . 72.55 112.446 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.22 141.99 28.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.353 0.597 . . . . 74.2 112.127 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -155.42 146.59 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.438 -0.801 . . . . 71.32 111.271 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.43 133.86 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.936 0.398 . . . . 62.55 111.089 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 9.3 p80 -158.72 165.28 34.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.513 -0.312 . . . . 64.54 111.404 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.35 95.75 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.038 0.447 . . . . 53.31 111.407 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 32.7 t -70.19 142.37 52.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.327 -0.397 . . . . 63.14 111.719 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.9 p -53.28 -41.37 65.5 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.658 0.614 . . . . 71.32 112.658 -176.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.1 t -108.16 -44.21 4.21 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.842 0.353 . . . . 72.33 111.802 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.1 m -76.57 -19.14 58.21 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.824 0.675 . . . . 52.41 112.824 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.73 -164.61 45.1 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.065 -0.588 . . . . 70.44 113.497 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 60.4 t -65.06 96.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.308 0.575 . . . . 75.43 111.192 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.8 pt -129.19 174.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.564 . . . . 62.25 111.648 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.1 mt -107.84 104.34 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.108 -0.496 . . . . 74.52 110.575 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.5 m -96.91 -173.39 2.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.807 0.337 . . . . 61.32 111.099 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 19.7 m -148.19 135.8 20.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.995 0.369 . . . . 73.11 111.995 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 59.3 mtm -74.46 5.19 4.93 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.015 0.376 . . . . 54.1 112.015 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -85.18 -6.96 59.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.02 0.438 . . . . 62.33 110.175 170.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -78.5 137.12 59.45 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.285 171.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.83 -46.44 32.15 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.328 2.019 . . . . 64.12 113.259 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.44 ' O ' ' HD3' ' A' ' 151' ' ' ARG . 80.3 t80 -60.88 -47.7 85.17 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.809 0.3 . . . . 64.15 111.809 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -71.75 -37.07 70.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.915 0.388 . . . . 70.03 111.333 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.46 -42.99 93.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.076 0.465 . . . . 62.14 111.582 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -88.09 1.74 53.59 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.051 0.389 . . . . 70.21 112.051 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 2.6 mpt_? -109.04 -16.87 14.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.555 0.206 . . . . 75.41 111.555 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.443 ' CE2' ' HD2' ' A' ' 100' ' ' ARG . 53.3 t80 -57.57 109.71 0.75 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.059 0.456 . . . . 61.33 111.548 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.429 HD22 ' HG2' ' A' ' 154' ' ' GLU . 6.0 t30 -85.65 -55.01 4.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.136 0.493 . . . . 74.21 110.331 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.429 ' HG2' HD22 ' A' ' 153' ' ' ASN . 14.1 pt-20 -173.24 169.65 4.47 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.938 -0.574 . . . . 63.43 110.42 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.62 146.68 47.23 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.229 -0.295 . . . . 72.31 111.311 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 91.3 mtt180 -142.69 135.05 27.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.932 0.396 . . . . 71.42 111.997 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.48 ' H ' ' HD3' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -95.56 117.0 29.62 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.172 0.51 . . . . 74.22 111.255 176.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.72 0.65 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.95 -0.568 . . . . 62.04 112.041 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.532 HD23 HD22 ' A' ' 82' ' ' LEU . 79.1 mt -79.31 109.51 13.73 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.693 0.627 . . . . 63.01 112.693 -176.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 68.9 m -78.01 78.46 4.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.174 0.512 . . . . 64.42 109.621 168.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.516 ' HD2' ' O ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -63.78 161.6 14.96 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.365 1.246 . . . . 73.34 114.365 -170.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 47.6 t -109.09 12.67 25.0 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.537 -0.756 . . . . 54.54 111.688 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.516 ' O ' ' HD2' ' A' ' 161' ' ' ARG . 2.1 pt? -136.0 -167.05 1.97 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.487 -0.324 . . . . 70.4 110.739 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.861 -0.59 . . . . 71.23 111.783 -179.894 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 111.778 0.288 . . . . 71.13 111.778 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -58.18 126.59 28.13 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.444 0.535 . . . . 60.14 112.444 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.1 t -96.03 101.13 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.501 -0.318 . . . . 64.15 111.524 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -89.87 114.08 25.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.678 0.275 . . . . 74.42 110.565 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.67 -48.09 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.149 0.5 . . . . 75.44 111.463 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.504 ' HB2' HG21 ' A' ' 105' ' ' THR . 88.3 tttt -55.02 -46.93 75.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.791 -0.641 . . . . 72.21 111.593 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.9 t -58.61 -45.18 89.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.842 0.312 . . . . 50.42 111.842 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 43' ' ' ARG . 8.6 mmm180 -62.67 -39.08 92.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.868 0.366 . . . . 74.12 111.314 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.35 -46.74 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.922 0.391 . . . . 72.22 111.35 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 94.3 mmm -62.23 -37.93 87.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.912 0.387 . . . . 73.33 111.158 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.1 -45.27 93.52 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.976 0.417 . . . . 72.3 110.796 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.725 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 59.0 tp60 -62.01 -46.77 87.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.156 -0.474 . . . . 65.02 111.132 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 20.0 t80 -58.16 -37.95 75.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.427 -0.351 . . . . 73.11 111.208 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.95 -32.65 47.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.027 0.442 . . . . 64.52 111.596 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.63 -42.06 61.96 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.001 0.429 . . . . 53.13 111.348 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.08 4.65 52.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.767 0.654 . . . . 63.14 112.767 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 50.5 mttm -54.32 112.15 0.93 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.724 0.297 . . . . 63.41 111.328 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.07 55.15 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.09 -0.576 . . . . 61.42 114.401 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.66 137.39 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.818 0.809 . . . . 75.2 111.462 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -76.04 166.89 22.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.128 0.489 . . . . 75.32 111.724 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -91.32 140.05 30.15 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.481 0.658 . . . . 75.13 112.567 -173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 65.8 ttt180 -131.57 176.87 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.611 -0.722 . . . . 73.4 109.944 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.407 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 91.4 mt -129.43 94.94 3.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.983 0.42 . . . . 55.02 111.407 175.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.38 55.01 2.68 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.362 -0.447 . . . . 24.44 113.357 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.441 ' HA3' ' NH1' ' A' ' 57' ' ' ARG . . . -177.51 104.47 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.928 -0.653 . . . . 72.51 113.474 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.8 p -78.64 115.05 18.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.935 0.398 . . . . 61.32 111.901 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -169.97 160.85 8.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.449 -0.342 . . . . 74.02 111.335 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.34 -6.99 44.21 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 65.04 111.002 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.58 -10.71 59.37 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.52 110.919 172.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.97 141.72 3.21 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.322 -0.399 . . . . 40.33 112.561 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.5 tp -141.31 143.44 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 122.446 -0.443 . . . . 71.41 111.65 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -93.91 166.48 12.15 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.259 0.552 . . . . 73.43 112.421 177.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 29.9 t -51.74 -54.34 29.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.615 -0.72 . . . . 62.24 112.319 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.1 p -67.6 -44.98 76.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.505 -0.316 . . . . 61.41 111.249 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -52.78 -40.02 56.13 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.435 -0.412 . . . . 75.21 113.767 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -61.09 -57.78 11.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.591 -0.358 . . . . 70.44 111.532 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.485 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.1 p -59.59 -36.49 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.917 0.389 . . . . 55.11 111.24 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.548 ' HA ' HD12 ' A' ' 84' ' ' LEU . 20.3 mt-30 -55.67 -61.17 2.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.385 -0.37 . . . . 65.33 111.673 175.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -60.02 -35.46 75.14 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.129 0.418 . . . . 73.23 112.129 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.725 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 99.7 m -56.12 -54.87 39.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 73.12 111.84 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 72.8 m-85 -75.03 -31.22 61.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.238 0.829 . . . . 71.53 113.238 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -76.05 -43.93 41.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.571 0.582 . . . . 74.55 112.571 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.04 -33.42 59.61 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.596 0.591 . . . . 72.1 112.596 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -87.28 -56.41 3.38 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.417 0.525 . . . . 64.15 112.417 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.08 -15.71 18.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.691 0.626 . . . . 73.35 112.691 -173.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.96 47.74 11.03 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.817 -0.706 . . . . 64.1 112.6 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 51.1 tp -104.86 137.71 42.22 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.14 0.495 . . . . 64.42 111.791 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.31 115.84 24.1 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.28 0.562 . . . . 62.22 111.438 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 73' ' ' GLN . 93.5 mt -127.37 151.41 74.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 122.137 -0.352 . . . . 71.15 111.625 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.98 -154.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.142 2.561 . . . . 52.41 112.902 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -110.06 -25.97 9.94 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.915 0.709 . . . . 74.43 112.915 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -120.72 148.66 43.66 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.828 -0.545 . . . . 52.3 112.305 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.441 HG23 ' HB ' ' A' ' 120' ' ' VAL . 26.2 m -52.54 -46.17 66.65 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.95 -0.568 . . . . 74.21 111.904 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -52.14 -32.35 35.22 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.075 -0.511 . . . . 73.35 111.545 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.22 -37.41 28.64 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.978 -0.556 . . . . 70.4 111.033 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.449 ' NE2' ' HG3' ' A' ' 73' ' ' GLN . 85.8 mt-30 -61.61 -32.61 72.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.238 -0.437 . . . . 64.04 111.384 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 88' ' ' THR . 17.1 mt-30 -52.71 -41.63 64.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.164 0.506 . . . . 74.32 111.547 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -77.73 -11.4 59.87 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.333 0.494 . . . . 75.54 112.333 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.4 mmm -80.91 -4.66 55.68 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.431 0.53 . . . . 62.12 112.431 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.472 ' O ' ' HD2' ' A' ' 156' ' ' ARG . . . -151.8 163.25 29.99 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.86 -0.686 . . . . 31.44 113.091 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 92.1 mttt -86.21 172.27 10.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 60.44 111.793 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 77.9 p -95.59 141.43 29.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.843 -0.617 . . . . 61.22 112.624 -171.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 5.1 m -131.98 158.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.796 -0.638 . . . . 32.55 111.282 175.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.8 t -100.13 176.55 5.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.376 -0.375 . . . . 61.53 111.833 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -47.53 -48.24 27.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.097 0.475 . . . . 74.42 112.176 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.2 m -69.11 -28.53 66.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.244 -0.434 . . . . 72.55 111.88 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.515 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 13.4 m120 -87.06 -13.86 43.13 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.112 0.412 . . . . 71.44 112.112 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -51.95 128.01 22.93 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.863 0.363 . . . . 62.55 111.688 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 102' ' ' ASN . 50.7 mtp85 -129.01 173.18 10.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.224 -0.444 . . . . 70.1 111.571 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.504 HG21 ' HB2' ' A' ' 41' ' ' LYS . 36.7 m -69.49 122.28 18.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.279 -0.418 . . . . 72.4 111.631 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.27 11.34 52.4 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.241 -0.504 . . . . 75.13 113.177 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' OD1' ' HB1' ' A' ' 155' ' ' ALA . 9.5 t70 -84.44 152.84 23.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.824 0.345 . . . . 65.51 110.875 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 72' ' ' VAL . 44.0 mt -96.37 103.51 15.42 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.973 0.416 . . . . 74.34 110.66 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -95.56 122.88 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.492 0.663 . . . . 73.12 111.376 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.516 HD12 ' HG3' ' A' ' 154' ' ' GLU . 72.1 mt -96.73 120.37 36.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.463 -0.789 . . . . 63.44 111.735 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -114.15 152.24 31.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.386 0.612 . . . . 75.04 111.749 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -91.2 106.57 18.6 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.653 -0.703 . . . . 75.33 111.09 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -103.48 139.26 39.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.967 0.413 . . . . 74.42 111.955 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -22.73 74.17 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.034 -0.603 . . . . 63.34 112.73 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.4 t -86.8 -74.27 0.44 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.859 0.361 . . . . 61.21 111.532 177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.1 p -73.86 -35.82 64.8 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.961 0.726 . . . . 71.43 112.961 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.06 -89.16 0.83 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.153 -0.546 . . . . 45.55 111.941 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -91.26 94.18 9.42 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.5 -0.412 . . . . 74.35 110.479 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -98.17 141.11 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.18 -0.463 . . . . 75.44 110.392 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 88' ' ' THR . 14.9 p -119.48 139.8 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 63.13 111.999 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.23 151.79 19.79 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.981 -0.554 . . . . 23.34 112.151 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.485 HD11 ' HA ' ' A' ' 72' ' ' VAL . 48.5 mt -88.22 107.62 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.51 -0.406 . . . . 62.34 110.827 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.22 105.71 1.16 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.77 0.319 . . . . 64.24 110.914 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.7 pt -91.47 -26.59 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.476 0.547 . . . . 55.53 112.476 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 160.94 122.17 0.62 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.154 -1.022 . . . . 65.51 114.193 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 45.99 81.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.88 0.872 . . . . 70.24 112.9 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.435 HD22 ' HB2' ' A' ' 143' ' ' MET . 18.2 m120 68.21 -19.17 0.15 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.728 1.01 . . . . 35.23 113.728 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -86.57 141.45 29.01 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.163 0.506 . . . . 74.52 111.851 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.04 150.8 27.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.983 -0.553 . . . . 54.11 111.222 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.67 138.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.869 0.366 . . . . 71.22 111.159 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -157.25 173.58 16.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.226 0.536 . . . . 72.42 111.734 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -103.65 122.92 46.02 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.078 -0.51 . . . . 75.11 110.978 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -114.53 159.62 20.18 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.008 0.432 . . . . 65.53 111.644 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.8 p -53.17 -65.82 0.49 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.767 1.025 . . . . 44.1 113.767 -171.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.8 t -87.06 -36.47 18.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.987 0.422 . . . . 72.12 112.028 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 m -77.88 -8.97 58.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.745 0.646 . . . . 70.31 112.745 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.78 -93.93 0.96 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.856 -0.687 . . . . 73.32 112.855 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 17.7 t -133.73 113.41 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.468 -0.43 . . . . 74.14 111.024 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.6 pt -138.24 173.58 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.84 0.681 . . . . 75.23 112.84 -173.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.5 127.13 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.639 -0.709 . . . . 72.2 110.388 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 m -119.06 178.18 4.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.981 0.419 . . . . 34.35 111.202 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.4 m -144.45 139.23 28.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.841 0.353 . . . . 71.32 111.627 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.435 ' HB2' HD22 ' A' ' 127' ' ' ASN . 75.5 mtm -69.13 3.68 2.0 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.72 0.295 . . . . 71.12 111.768 175.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -72.24 -28.8 63.38 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.323 0.582 . . . . 62.32 109.861 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.412 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 37.1 mt-10 -71.61 127.79 90.58 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.737 -0.665 . . . . 74.41 110.474 176.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 6.2 Cg_endo -47.88 -41.35 32.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.117 2.545 . . . . 52.53 113.833 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 90.9 t80 -53.6 -53.75 47.35 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.969 0.414 . . . . 73.23 111.546 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.412 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 88.5 m95 -75.95 -35.35 59.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 65.1 111.073 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -56.09 -32.63 64.32 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.028 -0.533 . . . . 63.02 112.129 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 0.4 OUTLIER -97.41 -9.07 28.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.46 0.541 . . . . 74.14 112.46 -178.266 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 30.6 mmt180 -103.79 -3.02 25.47 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.998 0.74 . . . . 74.44 112.998 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.43 107.32 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.96 0.409 . . . . 72.25 111.186 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.37 -66.56 0.89 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.25 0.548 . . . . 54.2 110.346 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.516 ' HG3' HD12 ' A' ' 110' ' ' LEU . 14.2 pt-20 -160.86 -175.65 5.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 64.51 110.383 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' A' ' 98' ' ' VAL . . . -140.22 157.21 45.95 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.616 0.246 . . . . 63.44 111.507 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 15.3 mmt180 -139.55 109.54 6.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.933 0.346 . . . . 74.03 111.933 -174.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -88.94 104.24 16.77 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.785 0.802 . . . . 74.33 111.1 177.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 113.101 0.778 . . . . 64.43 113.101 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.93 128.43 36.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.351 0.5 . . . . 74.42 112.351 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.5 p -79.0 128.93 33.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.275 -0.421 . . . . 75.23 111.084 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -76.15 145.39 39.97 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.64 0.607 . . . . 70.31 112.64 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.9 m -130.13 -168.21 1.93 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.849 -0.614 . . . . 53.53 109.761 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.3 tp -61.7 110.28 1.46 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.169 -0.332 . . . . 70.13 110.243 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.712 -0.661 . . . . 75.01 111.853 -176.579 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.99 0.424 . . . . 74.05 111.886 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -78.23 128.85 34.34 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.238 -0.289 . . . . 65.13 110.45 173.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.07 106.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.083 0.468 . . . . 70.31 111.51 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.11 90.98 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.276 -0.42 . . . . 73.23 111.399 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 44' ' ' ILE . 65.7 t -51.62 -47.94 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.958 0.409 . . . . 72.31 111.187 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -56.5 -48.54 76.96 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.083 -0.508 . . . . 61.44 111.722 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -69.05 -32.85 72.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.632 -0.258 . . . . 73.02 111.674 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -66.26 -43.68 85.79 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.846 0.355 . . . . 73.34 111.238 177.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 40' ' ' VAL . 64.4 mt -65.02 -37.33 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.752 0.311 . . . . 74.12 110.759 176.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.5 mmt -64.44 -43.66 93.59 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.915 0.388 . . . . 64.2 111.368 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.0 -42.03 89.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.229 -0.441 . . . . 71.22 111.111 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -51.16 60.07 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.085 0.469 . . . . 64.11 110.036 175.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.5 -34.56 58.52 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.031 -0.532 . . . . 72.15 111.47 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.51 -33.08 53.15 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.861 0.362 . . . . 62.55 111.722 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -31.73 62.95 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.1 0.407 . . . . 73.33 112.1 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -106.07 12.88 29.85 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.644 0.609 . . . . 71.51 112.644 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -58.91 95.85 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.121 0.415 . . . . 41.12 112.121 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.47 27.3 10.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.088 -0.577 . . . . 74.13 113.898 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.5 t -77.67 127.09 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 122.25 -0.559 . . . . 74.23 110.796 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 55' ' ' ARG . 7.0 ptp180 -62.77 160.81 13.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.341 0.591 . . . . 74.54 112.281 -177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 39.8 t80 -84.83 123.26 30.26 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.141 -0.481 . . . . 75.32 111.97 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -136.97 130.38 31.43 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.423 -0.353 . . . . 72.12 110.531 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 58' ' ' LEU . 4.5 mp -80.96 112.74 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.615 0.245 . . . . 71.43 111.434 -175.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.53 3.47 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.035 -0.602 . . . . 61.11 114.151 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.21 72.57 0.58 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.957 -0.64 . . . . 74.43 112.778 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 t -69.72 100.81 1.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.301 0.482 . . . . 71.5 112.301 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 t -152.69 166.5 31.97 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.926 -0.579 . . . . 73.11 111.305 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.46 -6.49 36.26 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.441 . . . . 61.52 112.192 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.23 12.54 33.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.18 0.514 . . . . 52.13 111.006 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 55' ' ' ARG . . . 157.42 126.9 0.93 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.937 -0.574 . . . . 64.13 112.253 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 18.5 tt -158.59 154.54 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 117.545 0.672 . . . . 70.4 111.854 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.0 178.19 4.63 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.243 0.544 . . . . 75.14 112.299 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 12.3 t -58.17 -52.78 64.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.799 -0.637 . . . . 64.23 112.677 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.7 t -69.31 -43.32 74.0 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.214 0.53 . . . . 54.34 110.676 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.19 -33.43 75.05 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.835 -0.621 . . . . 33.41 113.157 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -68.5 -48.88 63.28 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 122.395 -0.473 . . . . 74.51 112.147 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' A' ' 122' ' ' ILE . 12.1 p -61.88 -43.77 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 111.808 0.299 . . . . 70.12 111.808 -177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 20.6 pt20 -63.93 -37.72 88.44 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.165 -0.335 . . . . 75.53 111.484 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 36.0 mmt180 -59.8 -65.92 0.6 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.747 0.308 . . . . 73.35 111.315 173.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.9 m -44.52 -46.14 9.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.919 0.711 . . . . 75.12 112.919 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 39.5 m-85 -68.06 -43.22 79.14 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.729 0.64 . . . . 65.03 112.729 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 8.6 ptp180 -71.91 -30.25 65.17 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.594 -0.691 . . . . 73.23 111.559 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.5 mm-40 -68.33 -50.67 51.71 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.946 0.403 . . . . 73.43 111.377 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -87.94 -61.55 1.69 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.451 0.537 . . . . 72.23 112.451 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.438 ' CZ ' HG13 ' A' ' 40' ' ' VAL . 67.0 m-85 -92.67 -3.19 55.31 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.547 0.573 . . . . 53.53 112.547 -171.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.49 23.56 72.02 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.982 -0.627 . . . . 33.42 112.817 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 38.0 tp -95.12 115.82 27.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.895 0.378 . . . . 74.12 110.899 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.83 103.87 16.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.211 0.529 . . . . 73.3 112.179 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.93 146.93 37.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.898 -0.592 . . . . 72.42 110.521 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.2 172.39 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.546 2.164 . . . . 72.41 113.641 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -67.8 -48.58 65.88 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.159 0.8 . . . . 73.42 113.159 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -108.48 144.16 36.48 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.865 -0.522 . . . . 74.4 112.013 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 32.8 p -46.04 -43.61 14.59 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.827 0.677 . . . . 65.11 112.827 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.487 ' HA ' HE21 ' A' ' 92' ' ' GLN . 59.2 m-85 -54.08 -35.66 62.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.109 0.48 . . . . 71.24 111.342 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.76 -38.96 62.08 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.671 -0.695 . . . . 74.21 110.733 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -63.12 -31.22 72.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.668 -0.696 . . . . 64.32 111.55 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 89' ' ' TYR . 32.5 mt-30 -59.84 -34.87 73.66 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.143 0.497 . . . . 74.1 110.83 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 8.56 8.88 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.127 -0.488 . . . . 74.52 112.044 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 93.6 mmm -97.9 -68.17 0.81 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.928 0.394 . . . . 74.11 111.635 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.47 164.52 34.76 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.078 -0.582 . . . . 35.1 113.485 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HB2' ' NH1' ' A' ' 157' ' ' ARG . 14.3 mmmm -91.12 150.99 21.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 74.24 111.551 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 78.2 p -76.47 115.67 16.44 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.878 0.696 . . . . 52.05 112.878 -174.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 10.2 m -104.12 152.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.879 -0.601 . . . . 71.15 111.152 173.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.0 t -97.65 -176.98 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.185 -0.322 . . . . 54.5 110.826 175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.423 ' N ' ' HD3' ' A' ' 100' ' ' ARG . 1.4 mpp_? -59.82 -35.47 74.78 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.336 0.495 . . . . 73.14 112.336 -175.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.2 m -75.69 -12.5 60.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.946 0.35 . . . . 62.1 111.946 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.621 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.2 m120 -103.86 -5.06 22.73 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.204 0.446 . . . . 71.54 112.204 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.09 125.93 24.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.344 0.498 . . . . 75.34 112.344 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -141.79 134.69 28.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.149 -0.478 . . . . 75.41 110.639 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.0 m -38.67 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.964 0.727 . . . . 43.45 112.964 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.515 ' HA3' HD12 ' A' ' 159' ' ' LEU . . . 135.51 -0.01 3.38 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.034 -0.603 . . . . 72.42 114.054 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 4.1 p30 -90.04 158.98 17.08 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 117.706 0.753 . . . . 72.12 111.436 176.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.7 mt -104.76 120.79 42.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 73.32 111.165 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 m -94.75 112.98 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.583 0.706 . . . . 50.43 111.443 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.21 119.51 31.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.641 -0.709 . . . . 65.22 111.681 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HZ ' ' SD ' ' A' ' 143' ' ' MET . 92.2 m-85 -109.4 153.5 23.89 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.415 0.626 . . . . 75.33 111.922 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -88.39 113.85 24.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.707 -0.679 . . . . 53.32 109.352 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.36 168.74 11.65 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 122.095 -0.378 . . . . 42.31 111.868 -171.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.87 -38.83 46.78 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.351 -0.452 . . . . 75.32 113.472 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -101.22 165.32 11.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.702 0.287 . . . . 75.4 110.844 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 p -62.2 103.17 0.36 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.901 0.381 . . . . 75.5 111.953 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.481 ' HA2' ' OH ' ' A' ' 89' ' ' TYR . . . 167.04 163.7 21.35 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.258 -0.496 . . . . 74.01 113.668 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -98.65 119.85 38.07 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.758 -0.26 . . . . 73.54 111.631 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -99.6 124.27 44.64 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.88 -0.415 . . . . 73.42 109.88 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.412 HG12 ' SG ' ' A' ' 68' ' ' CYS . 14.9 p -110.18 145.04 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.659 0.614 . . . . 74.41 112.659 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.87 148.73 19.16 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.948 -0.569 . . . . 72.1 112.147 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 72' ' ' VAL . 42.4 mt -89.86 106.6 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.168 0.484 . . . . 74.51 111.183 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 61.3 t80 -71.29 111.34 6.55 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.233 0.54 . . . . 75.11 111.622 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.7 pt -95.57 -16.81 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.251 -0.431 . . . . 54.32 111.874 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.21 164.62 11.72 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.111 -0.566 . . . . 64.34 112.998 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.8 m120 58.08 32.6 22.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.818 0.342 . . . . 73.33 111.863 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 142' ' ' SER . 41.2 m-80 65.55 11.29 7.33 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.367 0.506 . . . . 64.12 112.367 -177.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -100.34 143.63 30.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.104 0.478 . . . . 73.23 111.232 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 24.9 p90 -152.72 151.96 31.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.901 -0.59 . . . . 71.24 111.553 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -103.21 141.99 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.244 -0.434 . . . . 72.11 110.949 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.39 -170.73 3.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.844 0.354 . . . . 73.02 111.072 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -132.98 108.26 8.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.53 -0.304 . . . . 72.24 111.017 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.6 p -91.42 155.26 18.59 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.071 0.462 . . . . 61.01 111.32 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.4 p -66.66 -2.38 4.84 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.632 0.605 . . . . 52.42 112.632 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.9 t -97.46 -67.47 0.85 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.053 0.39 . . . . 61.44 112.053 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.4 m -104.72 -6.41 20.39 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.688 0.625 . . . . 54.11 112.688 -175.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 132' ' ' ALA . . . 84.28 -133.45 11.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.521 -0.847 . . . . 72.1 112.614 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.06 108.72 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.216 0.45 . . . . 71.13 112.216 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.8 pt -143.43 179.19 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.228 0.537 . . . . 75.43 112.155 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.0 mm -106.81 149.9 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 116.176 -0.465 . . . . 73.53 110.917 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.1 m -148.97 172.19 15.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.77 0.319 . . . . 72.31 111.421 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.463 ' HB2' ' HG3' ' A' ' 145' ' ' GLU . 50.6 m -129.31 142.91 50.7 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.289 0.566 . . . . 54.14 112.376 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.438 ' SD ' ' HZ ' ' A' ' 111' ' ' PHE . 86.3 mmm -59.84 -27.11 66.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.717 -0.674 . . . . 54.33 112.539 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -85.96 3.65 41.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.593 0.59 . . . . 63.14 112.593 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 142' ' ' SER . 58.7 mt-10 -81.36 125.97 77.65 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 122.236 -0.29 . . . . 70.55 110.309 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -38.15 -50.11 2.18 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.946 3.098 . . . . 51.21 115.232 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.38 -43.04 97.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.009 0.374 . . . . 63.23 112.009 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.406 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 83.5 m95 -81.35 -42.39 20.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.187 0.518 . . . . 75.34 111.07 -176.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -54.17 -55.55 26.74 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.609 -0.723 . . . . 74.01 112.751 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -80.33 -11.69 59.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.059 0.392 . . . . 75.02 112.059 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -99.83 -2.21 35.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.176 0.436 . . . . 74.23 112.176 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -58.29 126.49 27.77 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.148 0.499 . . . . 65.34 111.73 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.406 HD22 ' HG2' ' A' ' 154' ' ' GLU . 5.7 t30 -101.8 -59.5 1.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.482 -0.326 . . . . 65.34 110.991 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG2' HD22 ' A' ' 153' ' ' ASN . 12.8 pt-20 -169.22 145.62 3.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.487 -0.324 . . . . 61.25 111.456 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -100.43 146.68 26.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.675 -0.239 . . . . 71.22 110.404 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.481 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 45.5 mtp85 -142.62 115.71 8.86 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.25 -0.281 . . . . 75.12 110.969 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -81.43 122.23 27.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.213 0.53 . . . . 73.04 111.976 -176.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.96 -20.14 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.561 0.578 . . . . 54.14 112.561 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.515 HD12 ' HA3' ' A' ' 106' ' ' GLY . 43.8 mt -68.17 104.97 1.94 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.213 0.53 . . . . 71.33 111.917 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 82.4 p -68.83 -19.46 64.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.803 -0.635 . . . . 54.33 111.6 176.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -69.81 126.84 30.91 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.437 0.532 . . . . 74.44 112.437 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 79.2 p -128.62 170.74 12.89 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.871 -0.604 . . . . 53.02 110.339 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -68.92 178.27 2.27 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.977 0.418 . . . . 74.23 111.493 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--O 1.254 1.33 0 CA-C-O 118.233 -0.889 . . . . 73.32 112.59 -177.81 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 55.2 ttm . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.593 0.235 . . . . 71.43 111.119 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -142.93 160.93 39.41 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.916 0.388 . . . . 63.21 111.468 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -104.03 105.92 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.141 0.496 . . . . 70.44 111.86 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -83.04 107.04 15.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.202 -0.454 . . . . 71.44 110.511 175.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.33 -45.54 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.0 0.429 . . . . 74.0 111.203 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 76.0 tttt -53.38 -50.79 64.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.065 -0.516 . . . . 63.01 111.46 175.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.5 t -59.36 -44.0 92.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.356 -0.384 . . . . 64.2 111.59 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -57.17 -53.93 52.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.029 0.442 . . . . 74.24 110.871 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.02 -39.28 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.98 0.419 . . . . 70.2 111.791 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 31.1 mmt -66.24 -28.23 68.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.876 0.324 . . . . 74.04 111.876 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -63.62 -46.63 84.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.18 0.514 . . . . 72.23 110.044 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.6 tp60 -63.89 -44.97 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.718 -0.673 . . . . 63.43 110.385 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.17 -42.09 76.52 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.999 -0.546 . . . . 64.4 111.333 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.98 -33.22 66.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.034 0.445 . . . . 74.23 111.617 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -81.96 -26.09 34.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.21 0.529 . . . . 71.32 111.197 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -108.25 20.66 18.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.814 0.672 . . . . 63.12 112.814 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -59.42 101.56 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.901 0.704 . . . . 71.25 112.901 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.43 38.86 16.36 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.69 -0.687 . . . . 74.22 114.66 174.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.15 144.19 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 117.547 0.674 . . . . 74.24 111.081 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -56.54 142.77 38.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.545 0.338 . . . . 73.55 111.752 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 20.1 t80 -83.64 116.64 22.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.922 -0.399 . . . . 61.12 109.922 172.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -122.34 105.86 10.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.388 . . . . 61.12 110.49 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.86 116.86 12.74 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.934 0.397 . . . . 51.13 110.481 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.64 26.29 35.9 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.967 -0.635 . . . . 72.15 113.052 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.02 106.71 0.29 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.334 -0.46 . . . . 64.1 112.409 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.516 ' HA ' HG13 ' A' ' 66' ' ' ILE . 64.6 p -97.32 112.41 24.24 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.486 0.55 . . . . 64.53 112.486 -175.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.4 t -171.76 172.91 4.73 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.913 0.387 . . . . 74.52 111.651 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.64 -14.97 61.71 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 122.04 -0.412 . . . . 75.34 111.502 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -83.03 4.54 25.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.074 0.464 . . . . 74.44 110.602 172.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.64 132.47 2.61 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.603 -0.599 . . . . 75.12 111.603 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.516 HG13 ' HA ' ' A' ' 61' ' ' SER . 21.0 tt -151.22 153.09 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 117.391 0.595 . . . . 63.3 111.912 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -91.9 177.24 6.24 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.326 0.584 . . . . 72.2 111.985 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 32.4 t -62.09 -48.31 80.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.545 0.572 . . . . 71.43 112.545 -176.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 88' ' ' THR . 17.7 p -78.11 -27.58 48.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.918 0.389 . . . . 53.42 111.742 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.12 98.98 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.116 -0.564 . . . . 74.0 112.634 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -59.92 -50.66 72.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.928 0.344 . . . . 74.42 111.928 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.541 ' HA ' HD11 ' A' ' 122' ' ' ILE . 6.1 p -59.74 -52.82 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.294 0.479 . . . . 71.14 112.294 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.511 ' HG2' ' HA ' ' A' ' 86' ' ' ARG . 4.4 pp0? -65.99 -26.71 67.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.15 0.426 . . . . 65.52 112.15 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.545 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 7.3 mtp180 -69.31 -53.92 17.23 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.137 -0.352 . . . . 71.22 111.068 171.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -46.4 -49.61 17.75 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.257 0.551 . . . . 74.2 111.792 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 67.2 m-85 -68.44 -39.2 81.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.746 0.647 . . . . 65.24 112.746 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.545 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 11.8 ptp180 -76.75 -25.62 53.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.641 -0.662 . . . . 61.22 112.159 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.25 -28.27 34.84 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.979 0.362 . . . . 74.14 111.979 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 85.6 mt-30 -109.05 -61.44 1.62 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.587 0.588 . . . . 74.12 112.587 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -83.81 -11.67 56.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.928 0.344 . . . . 72.02 111.928 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.9 71.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.346 -0.454 . . . . 44.42 113.173 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.4 tp -73.37 123.3 23.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 74.53 111.53 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -74.29 85.17 1.93 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.401 0.62 . . . . 73.12 112.434 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.7 mt -106.28 135.2 19.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 122.126 -0.359 . . . . 64.41 111.215 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.619 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 58.7 Cg_endo -71.27 156.87 58.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.774 2.316 . . . . 75.2 113.111 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -57.0 -43.35 81.65 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.811 1.041 . . . . 75.21 113.811 -174.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.419 ' N ' ' HG2' ' A' ' 86' ' ' ARG . 73.9 m -102.61 152.4 21.23 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.841 1.052 . . . . 64.23 113.841 -170.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 69' ' ' SER . 51.4 p -51.45 -58.91 4.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.971 -1.013 . . . . 52.21 112.969 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -47.24 -35.56 7.85 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.004 -0.543 . . . . 64.34 112.287 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.66 -42.59 28.23 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.052 -0.522 . . . . 74.04 111.162 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.16 -22.15 65.65 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.938 0.399 . . . . 72.0 111.461 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.461 ' HG2' HD11 ' A' ' 110' ' ' LEU . 27.1 mt-30 -66.44 -34.46 77.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.204 -0.453 . . . . 73.23 112.171 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -84.22 -10.84 57.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.457 0.539 . . . . 52.34 112.457 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.619 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 62.4 mtp -94.78 -70.18 0.72 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.589 0.233 . . . . 75.32 111.525 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.4 130.31 28.99 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.388 -0.91 . . . . 73.43 112.277 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -85.27 143.57 28.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.406 0.622 . . . . 62.11 112.363 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 18.4 m -64.84 144.29 57.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.883 -1.053 . . . . 45.42 113.354 -170.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.428 HG22 ' HD3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -132.44 163.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.838 -0.619 . . . . 73.3 111.516 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.7 t -116.57 171.68 7.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.402 -0.363 . . . . 72.14 111.132 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -43.98 -57.64 3.23 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.217 1.191 . . . . 71.34 114.217 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -69.39 -9.25 52.67 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.981 0.734 . . . . 63.33 112.981 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -114.97 5.06 14.92 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.502 0.556 . . . . 62.4 112.502 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.35 133.04 55.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.77 0.319 . . . . 64.13 111.757 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 104' ' ' ARG . 54.2 mtt180 -108.28 169.44 8.63 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.436 0.636 . . . . 63.13 112.247 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.7 m -79.85 118.43 21.62 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.192 -0.458 . . . . 75.54 110.524 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 18.93 33.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.046 -0.597 . . . . 72.25 112.004 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -77.51 159.71 29.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.922 0.489 . . . . 73.53 110.291 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.0 mt -114.06 109.27 18.18 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.64 -0.663 . . . . 60.33 111.826 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -95.59 126.19 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.408 0.623 . . . . 64.51 111.913 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.461 HD11 ' HG2' ' A' ' 92' ' ' GLN . 83.0 mt -97.97 138.96 34.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.744 -0.662 . . . . 41.44 111.649 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -124.48 137.99 54.38 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.216 0.532 . . . . 73.23 111.929 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 33.6 mtp85 -72.56 84.01 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.976 -0.556 . . . . 74.13 110.533 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.36 139.95 30.11 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.381 0.512 . . . . 45.11 112.381 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.56 -41.81 83.07 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.781 -0.723 . . . . 53.14 111.55 173.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 m -78.22 128.35 33.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.377 0.271 . . . . 71.23 110.857 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 74.3 p 57.81 9.13 0.81 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.647 0.98 . . . . 63.45 113.647 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.31 -87.01 0.8 Allowed Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.418 0.527 . . . . 41.21 114.418 174.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -93.59 122.1 35.69 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.291 -0.534 . . . . 74.03 111.864 -176.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -115.64 149.22 38.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.413 -0.358 . . . . 72.44 110.178 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.61 135.34 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.154 0.502 . . . . 71.42 112.147 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -123.3 148.57 16.79 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.21 -0.519 . . . . 72.13 113.226 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.541 HD11 ' HA ' ' A' ' 72' ' ' VAL . 40.2 mt -82.47 107.51 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.796 0.332 . . . . 72.23 110.797 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 2.0 t80 -70.7 104.35 2.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.119 -0.491 . . . . 73.24 111.616 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.428 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 38.2 pt -102.18 -17.19 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.743 0.645 . . . . 71.32 112.743 -176.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.69 -170.31 16.35 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.524 -0.846 . . . . 44.45 113.9 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -58.31 -32.77 68.78 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.68 0.392 . . . . 73.02 111.884 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -137.52 -26.46 0.98 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.226 -0.443 . . . . 74.24 112.153 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -85.26 140.87 30.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.03 0.752 . . . . 74.31 113.03 -175.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.401 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 22.1 p90 -148.38 142.95 26.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.461 -0.79 . . . . 72.12 110.982 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.82 137.2 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.975 0.416 . . . . 75.2 111.558 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -155.92 163.55 39.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.989 0.424 . . . . 64.11 111.74 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -94.54 97.85 10.43 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.019 0.438 . . . . 61.42 110.832 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 80.9 p -81.7 142.06 33.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.175 0.512 . . . . 72.34 111.714 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.0 t -69.24 -7.04 33.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.233 -0.44 . . . . 72.44 112.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.3 p -101.52 -59.74 1.65 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.842 0.353 . . . . 40.33 111.834 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.481 ' HB2' HD13 ' A' ' 139' ' ' ILE . 68.6 m -109.5 13.79 23.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.399 0.518 . . . . 53.24 112.399 -175.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.65 -152.5 52.39 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.0 -0.619 . . . . 60.33 112.883 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 53.6 t -64.74 106.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.458 -0.436 . . . . 64.02 111.764 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 136' ' ' SER . 35.9 pt -136.82 -175.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.101 0.477 . . . . 55.05 111.703 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.28 129.11 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.428 -0.351 . . . . 72.54 110.965 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.7 m -118.53 174.44 6.25 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.876 0.37 . . . . 71.2 111.809 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.8 t -124.53 142.34 51.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.297 0.48 . . . . 75.42 112.297 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 85.0 mmm -63.39 -17.16 62.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.156 -0.474 . . . . 53.51 111.284 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -74.0 -18.04 60.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.324 -0.398 . . . . 71.44 111.617 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.09 130.22 93.82 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.786 -0.188 . . . . 73.44 111.118 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.483 ' O ' ' HG2' ' A' ' 150' ' ' LYS . 85.2 Cg_exo -47.93 -51.97 8.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.907 2.404 . . . . 65.03 114.059 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 94.4 t80 -58.42 -47.07 85.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.784 0.326 . . . . 64.21 111.718 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -72.3 -40.14 67.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.784 0.326 . . . . 63.24 111.591 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.13 -52.64 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.003 0.43 . . . . 72.42 111.925 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 146' ' ' PRO . 17.0 ptpt -78.12 -14.84 59.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.889 0.376 . . . . 72.21 111.988 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.567 ' HE ' ' HA ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -91.83 -12.07 34.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.19 -0.318 . . . . 71.35 111.789 175.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -54.47 105.57 0.16 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.319 0.581 . . . . 74.43 111.176 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.406 HD22 ' HG2' ' A' ' 154' ' ' GLU . 8.9 t30 -90.46 -51.56 5.35 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.993 -0.548 . . . . 74.11 111.54 -176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG2' HD22 ' A' ' 153' ' ' ASN . 17.2 pt-20 -172.76 147.39 1.74 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.865 0.364 . . . . 75.33 111.204 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -103.01 161.62 13.61 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.356 -0.215 . . . . 52.33 110.659 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.8 mtm-85 -146.84 113.01 5.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.829 0.347 . . . . 73.41 111.806 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.428 ' HD3' HG22 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.76 96.89 4.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.289 0.566 . . . . 55.31 111.361 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.4 m -77.21 -29.79 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.953 -0.467 . . . . 65.44 111.62 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.26 142.77 35.91 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.613 -0.267 . . . . 72.44 110.427 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.1 t 66.41 23.25 10.63 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.174 0.511 . . . . 71.2 111.582 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -67.56 119.72 12.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.099 -0.5 . . . . 74.1 111.109 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.1 p -66.62 150.2 49.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.889 0.376 . . . . 72.43 111.36 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 163' ' ' LEU . 7.2 mp -69.87 170.16 11.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.432 0.634 . . . . 63.35 112.365 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.648 -0.691 . . . . 75.33 111.627 -178.764 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 112.163 0.431 . . . . 73.22 112.163 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -154.04 149.99 27.76 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.957 0.408 . . . . 74.11 111.723 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.91 124.68 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.391 -0.368 . . . . 74.14 111.259 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -97.06 132.68 42.61 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.869 0.366 . . . . 73.23 111.215 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 44' ' ' ILE . 88.9 t -61.84 -49.58 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.211 -0.45 . . . . 75.02 111.815 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.535 ' HG3' ' HB ' ' A' ' 124' ' ' ILE . 87.2 tttt -57.3 -44.88 84.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.34 -0.391 . . . . 75.03 111.496 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -60.1 -45.18 93.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.264 -0.425 . . . . 74.3 111.536 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mmm-85 -61.19 -43.57 98.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.073 0.463 . . . . 75.32 111.111 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 40' ' ' VAL . 73.1 mt -63.09 -47.79 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.021 0.439 . . . . 72.51 111.372 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 29.7 mmt -62.86 -29.4 70.72 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.394 -0.366 . . . . 75.23 111.522 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.43 -38.84 81.57 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.651 0.262 . . . . 72.32 111.166 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.4 ' HB2' HE21 ' A' ' 79' ' ' GLN . 63.6 tp60 -77.54 -31.82 53.54 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.575 0.226 . . . . 60.22 111.506 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -53.45 -37.53 62.71 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.82 0.343 . . . . 74.34 111.286 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -24.31 64.47 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.127 0.417 . . . . 61.02 112.127 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -47.12 24.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.085 0.469 . . . . 72.41 111.513 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -85.55 16.01 4.17 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.073 0.768 . . . . 75.33 113.073 -172.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HB3' ' NZ ' ' A' ' 52' ' ' LYS . 2.8 mmmp? -68.87 118.33 11.68 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.141 -0.349 . . . . 75.34 110.952 176.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.64 46.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.302 -0.475 . . . . 62.43 113.494 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.83 128.94 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.062 0.458 . . . . 74.24 111.729 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -88.19 179.31 6.4 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.912 -0.586 . . . . 75.14 111.599 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -91.66 133.02 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.091 0.472 . . . . 75.21 111.208 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -134.23 113.54 12.09 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.11 -0.496 . . . . 71.44 110.192 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 58' ' ' LEU . 7.1 mp -57.93 115.2 2.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.924 0.393 . . . . 74.23 111.717 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.39 19.67 74.61 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.122 -0.49 . . . . 54.1 113.665 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.94 143.98 17.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 121.458 -0.401 . . . . 65.33 112.886 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 66' ' ' ILE . 62.0 p -126.76 99.53 5.8 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.451 -0.441 . . . . 61.33 111.21 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 t -174.99 165.62 3.49 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.807 0.337 . . . . 71.51 111.635 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -74.38 -9.85 59.0 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.107 0.479 . . . . 75.4 110.909 176.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.11 -1.51 56.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.112 -0.494 . . . . 70.33 111.281 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.34 124.11 1.57 Allowed Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.248 -0.433 . . . . 74.24 112.053 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.5 tt -134.03 149.62 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.21 -0.583 . . . . 53.2 111.922 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.65 160.75 26.22 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.281 -0.418 . . . . 73.33 110.958 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.541 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 29.4 p -58.86 -53.6 56.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.152 0.501 . . . . 75.31 110.895 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.428 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 87.6 p -63.8 -33.78 76.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.235 0.541 . . . . 63.41 110.822 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 73' ' ' GLN . . . -67.76 -31.6 76.22 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.817 -0.629 . . . . 74.0 112.954 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -66.13 -47.25 74.7 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.501 -0.411 . . . . 75.11 111.342 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 HG12 ' A' ' 122' ' ' ILE . 11.2 p -67.9 -40.02 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 111.977 0.362 . . . . 74.24 111.977 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 22.0 pt20 -58.69 -41.91 87.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.062 0.458 . . . . 75.23 110.427 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.66 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 11.5 mmm180 -66.64 -67.0 0.48 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.248 -0.433 . . . . 70.13 110.929 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 m -40.75 -46.65 2.7 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.441 0.534 . . . . 72.1 112.441 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 14.0 m-30 -68.88 -39.39 79.82 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.432 0.53 . . . . 71.2 112.432 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 10.9 ptm180 -79.68 -19.29 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.701 -0.624 . . . . 71.24 111.846 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 8.7 mm-40 -72.28 -47.68 48.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.464 0.649 . . . . 62.05 110.162 175.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 47' ' ' GLN . 82.3 mm-40 -95.12 -53.38 3.83 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.59 -0.732 . . . . 74.21 112.791 -174.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -93.78 -23.76 18.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.278 0.474 . . . . 74.43 112.278 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.71 36.32 22.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.053 -0.594 . . . . 74.15 112.973 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 40.4 tp -95.19 119.22 33.32 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.76 0.314 . . . . 75.25 111.23 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.54 84.19 7.16 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.22 0.452 . . . . 70.0 112.22 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.67 145.63 30.74 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.5 -0.318 . . . . 73.23 111.301 176.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 150.11 62.41 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.721 2.28 . . . . 74.44 112.837 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.82 42.44 0.79 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.214 0.53 . . . . 51.54 112.205 -176.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.5 m -153.16 117.67 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.116 -0.365 . . . . 53.12 111.034 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 17.2 m -48.46 -44.36 35.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.506 0.558 . . . . 32.14 112.506 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -54.98 -46.42 75.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.76 0.314 . . . . 70.13 111.751 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -62.78 -42.77 99.85 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.429 0.633 . . . . 75.23 110.534 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -62.9 -30.55 71.62 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.875 -0.602 . . . . 74.41 111.755 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 88' ' ' THR . 26.1 mt-30 -63.03 -16.08 58.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.815 0.34 . . . . 72.11 111.692 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.81 -3.47 26.3 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.77 0.319 . . . . 60.31 111.438 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.3 mmm -95.18 -13.33 25.08 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.885 0.698 . . . . 72.32 112.885 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 156' ' ' ARG . . . -141.58 154.97 25.05 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.858 -0.687 . . . . 72.24 113.725 -177.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -96.11 153.35 17.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.04 0.448 . . . . 75.11 111.495 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 155' ' ' ALA . 92.9 p -77.69 157.26 30.21 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.937 1.088 . . . . 60.35 113.937 -170.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.42 147.7 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 114.893 -1.049 . . . . 54.43 110.202 171.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -83.29 164.28 20.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.879 0.371 . . . . 74.11 111.309 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -49.08 -29.89 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.858 0.688 . . . . 72.42 112.858 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -82.7 -23.19 34.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.887 0.699 . . . . 72.44 112.887 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -103.5 20.6 17.58 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.496 0.554 . . . . 74.4 112.496 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.0 mt -69.84 126.09 28.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.025 0.441 . . . . 63.23 111.918 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -101.72 -164.6 1.11 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.061 0.457 . . . . 64.24 111.132 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 41' ' ' LYS . 58.7 m -97.44 109.06 21.89 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.426 -0.352 . . . . 73.43 110.83 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.54 25.33 6.05 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.404 -0.427 . . . . 72.22 113.687 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -94.47 146.28 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.444 -0.445 . . . . 72.23 111.302 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.412 ' CD2' HG21 ' A' ' 72' ' ' VAL . 47.1 mt -78.03 108.4 11.27 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.369 -0.378 . . . . 74.34 111.788 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.6 m -96.81 112.48 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.452 0.644 . . . . 70.23 111.433 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.37 120.64 28.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.649 -0.705 . . . . 74.43 111.956 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 88.9 m-85 -112.6 157.81 20.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.31 0.576 . . . . 70.22 111.766 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.564 ' HB2' ' HG3' ' A' ' 151' ' ' ARG . 19.6 mtp180 -90.45 103.52 16.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.048 -0.524 . . . . 73.35 110.832 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . . . -93.84 121.13 34.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 63.2 111.791 -176.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.28 -71.76 0.61 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.199 -0.455 . . . . 62.45 113.396 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.7 p -163.58 -64.14 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.89 0.376 . . . . 74.21 110.875 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.2 p -95.19 -17.03 22.1 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.285 -0.416 . . . . 75.5 112.079 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.66 121.23 24.48 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 114.345 0.498 . . . . 74.03 114.345 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -91.1 97.53 11.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.965 0.412 . . . . 65.44 110.613 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 59.6 t60 -92.93 148.71 21.78 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.277 -0.42 . . . . 74.22 111.283 -176.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.93 128.98 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.226 0.536 . . . . 74.54 111.281 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.72 154.44 16.5 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.208 -0.52 . . . . 70.13 112.93 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 72' ' ' VAL . 49.5 mt -89.65 102.66 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 122.549 -0.383 . . . . 62.51 110.584 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 37.2 t80 -73.7 105.24 4.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 75.41 111.762 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.535 ' HB ' ' HG3' ' A' ' 41' ' ' LYS . 28.0 pt -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.954 0.407 . . . . 61.1 111.735 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.97 178.71 19.17 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.501 -0.38 . . . . 60.45 113.032 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 62.67 21.36 12.67 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.689 0.28 . . . . 75.24 111.139 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 142' ' ' SER . 0.9 OUTLIER 65.12 12.54 8.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.93 0.395 . . . . 65.51 111.503 -171.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -103.81 145.24 30.39 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.376 0.608 . . . . 72.25 111.235 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 123' ' ' TYR . 10.5 p90 -150.07 140.73 22.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.953 -0.567 . . . . 70.42 111.39 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.75 133.12 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.965 0.412 . . . . 64.4 110.718 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.43 ' HD1' ' HE2' ' A' ' 119' ' ' HIS . 7.3 p80 -157.04 154.72 30.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.199 0.523 . . . . 73.11 111.88 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -84.41 91.04 7.71 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.952 0.406 . . . . 75.41 110.155 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -67.47 146.04 54.38 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.108 0.48 . . . . 73.33 111.628 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.6 p -49.55 -47.91 48.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.606 -0.725 . . . . 71.1 112.855 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.0 m -98.9 -51.07 3.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.683 0.623 . . . . 71.4 112.683 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.6 m -80.75 -15.14 57.25 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.259 0.837 . . . . 65.31 113.259 -170.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.61 -154.93 30.18 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.01 -0.614 . . . . 64.41 113.036 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.38 102.68 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.864 0.364 . . . . 75.12 111.958 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.9 pt -140.13 178.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.093 0.473 . . . . 71.23 111.773 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.19 134.93 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.418 -0.355 . . . . 74.43 110.76 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.402 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . 49.9 m -128.47 172.56 11.02 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 122.267 -0.271 . . . . 73.34 111.538 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 65.5 m -125.43 141.42 52.07 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.056 0.391 . . . . 54.04 112.056 -177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.3 mtt -67.4 -15.06 63.47 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.372 0.508 . . . . 73.11 112.372 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -72.14 -13.97 61.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.965 0.412 . . . . 71.45 111.241 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.403 ' HB2' ' HD1' ' A' ' 148' ' ' TRP . 29.8 mm-40 -71.79 135.59 83.19 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.548 -0.296 . . . . 72.12 110.734 175.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.27 -48.03 21.68 Favored 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 122.91 2.406 . . . . 54.33 113.672 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 78.9 t80 -59.39 -50.85 72.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.833 0.349 . . . . 71.3 111.562 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.403 ' HD1' ' HB2' ' A' ' 145' ' ' GLU . 75.8 m95 -71.84 -36.92 70.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.576 -0.284 . . . . 64.22 111.701 -172.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -53.32 -54.87 30.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.08 0.467 . . . . 75.02 111.777 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -80.82 -18.86 46.11 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.94 0.348 . . . . 75.24 111.94 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.564 ' HG3' ' HB2' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -84.68 -15.36 45.56 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.958 -0.464 . . . . 72.52 111.884 177.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -61.26 92.76 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.296 0.569 . . . . 73.54 110.301 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -79.08 -46.01 18.93 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.966 -0.561 . . . . 74.33 111.379 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -172.9 163.58 4.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.979 -0.555 . . . . 62.02 110.978 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -128.15 149.3 50.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.766 -0.197 . . . . 65.33 110.718 176.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 95' ' ' GLY . 50.8 mtt180 -138.61 125.92 21.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.184 0.516 . . . . 63.51 112.016 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.71 120.67 27.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.034 -0.53 . . . . 75.13 111.242 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.55 -19.53 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.732 0.641 . . . . 70.44 112.732 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 82' ' ' LEU . 91.7 mt -75.33 144.0 42.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.129 0.49 . . . . 73.2 112.079 -176.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 87.0 p -74.67 137.64 42.32 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.055 -0.521 . . . . 71.21 111.647 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.552 ' H ' ' HD2' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -88.31 15.19 8.04 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.043 0.449 . . . . 43.42 111.517 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.0 m -83.18 -171.71 3.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.02 0.438 . . . . 61.31 112.031 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 pp -83.5 -166.25 1.33 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.802 0.667 . . . . 73.15 112.802 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 164' ' ' GLU . 2.5 mp0 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 123.501 0.72 . . . . 75.01 112.912 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 112.083 0.401 . . . . 63.23 112.083 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -130.93 -176.6 4.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.086 0.47 . . . . 64.34 111.462 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.3 t -102.44 129.14 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.892 0.377 . . . . 61.23 111.375 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 41' ' ' LYS . 30.9 t70 -101.36 134.57 44.23 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.463 -0.335 . . . . 72.5 110.888 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.2 -48.38 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.406 -0.361 . . . . 74.25 111.531 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 45' ' ' MET . 87.9 tttt -60.04 -44.03 94.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.342 -0.39 . . . . 74.42 111.372 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.7 t -53.19 -49.79 65.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.181 0.437 . . . . 75.34 112.181 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -63.5 -44.2 95.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.964 0.412 . . . . 73.54 111.572 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.49 HD13 HG21 ' A' ' 122' ' ' ILE . 67.5 mt -64.36 -36.88 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.957 0.408 . . . . 64.42 111.365 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 96.0 mmm -65.74 -37.29 85.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.912 0.387 . . . . 72.44 110.715 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.75 -37.17 78.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.252 0.549 . . . . 54.21 110.198 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.559 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 7.6 tp60 -62.74 -53.65 51.13 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.013 -0.54 . . . . 54.04 110.451 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -51.1 -39.44 56.15 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.053 -0.521 . . . . 74.51 111.293 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.93 71.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.366 . . . . 74.01 111.685 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.02 -26.91 61.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 75.3 111.47 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -107.01 11.78 29.38 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.064 0.764 . . . . 75.52 113.064 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.78 128.43 35.88 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.959 -0.463 . . . . 64.42 111.325 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.05 -18.13 58.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.254 -0.498 . . . . 75.41 113.665 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.58 131.63 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.42 . . . . 74.23 111.837 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 55' ' ' ARG . 44.5 mtp180 -82.3 178.39 8.27 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.228 0.455 . . . . 65.24 112.228 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -85.39 121.46 28.15 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.896 0.379 . . . . 64.53 111.661 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -137.57 115.46 11.5 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 74.51 110.65 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 21.7 tp -72.87 116.85 13.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.004 0.43 . . . . 72.34 112.102 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.91 -53.25 3.97 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.369 -0.443 . . . . 61.12 113.339 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.92 71.48 0.93 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.114 -0.565 . . . . 61.22 113.236 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.2 p -69.6 106.97 3.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.252 0.549 . . . . 74.0 112.132 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 t -160.94 172.46 16.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.906 -0.588 . . . . 73.02 111.026 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.5 -14.11 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.911 0.386 . . . . 74.42 111.433 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.73 -16.28 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.887 0.375 . . . . 61.22 110.903 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.22 144.38 4.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.157 -0.474 . . . . 54.31 112.222 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.6 tt -155.58 148.21 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 117.444 0.622 . . . . 71.31 111.506 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 6.4 p-10 -96.08 -171.37 2.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.185 0.517 . . . . 72.4 112.063 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 24.4 p -70.97 -50.16 37.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.073 -0.512 . . . . 71.11 112.023 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' OG1' ' A' ' 88' ' ' THR . 50.5 p -66.76 -40.95 88.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.818 0.342 . . . . 71.42 110.836 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.29 -40.73 99.4 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.333 -0.461 . . . . 64.15 113.093 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -65.32 -55.99 15.14 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.666 0.269 . . . . 54.32 111.553 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.06 -42.23 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.915 0.388 . . . . 63.41 111.054 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.8 tt0 -52.86 -61.28 2.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 75.25 111.719 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 74' ' ' ARG . 52.8 mtt180 -56.96 -46.53 82.07 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.544 -0.298 . . . . 75.42 111.783 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.2 m -49.85 -50.18 46.41 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.272 0.471 . . . . 71.14 112.272 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 85.0 m-85 -80.4 -42.46 22.75 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.849 0.685 . . . . 45.24 112.849 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 14.7 ptm180 -66.66 -33.56 75.93 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.94 -0.475 . . . . 75.33 111.996 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 5.0 mm-40 -86.71 -45.93 10.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.961 0.356 . . . . 64.43 111.961 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 29.8 mt-30 -83.26 -51.7 7.22 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.613 0.597 . . . . 75.24 112.613 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -97.15 -6.17 35.51 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.391 0.515 . . . . 71.25 112.391 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.03 43.64 98.88 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.032 -0.604 . . . . 71.31 112.663 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 52.7 tp -108.89 138.85 44.58 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.762 0.315 . . . . 73.15 111.742 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.6 118.06 12.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.551 0.575 . . . . 75.3 112.551 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 158' ' ' VAL . 60.5 mt -136.72 134.78 19.59 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.83 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.518 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 81.3 Cg_endo -77.35 173.7 13.89 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.726 2.284 . . . . 63.21 113.409 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -95.55 16.03 18.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.985 0.735 . . . . 73.23 112.985 -173.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.0 m -143.06 127.88 18.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.652 0.263 . . . . 63.5 111.675 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 69' ' ' SER . 26.9 m -51.28 -37.33 46.78 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.073 0.463 . . . . 72.42 111.75 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.485 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 72.9 m-85 -57.86 -32.02 67.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.089 -0.505 . . . . 74.11 111.631 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -83.1 -38.58 22.27 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.385 0.612 . . . . 70.53 110.456 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.86 -25.46 67.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.052 -0.522 . . . . 73.33 111.845 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 26.5 pt20 -78.28 -15.51 58.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.443 0.534 . . . . 64.41 112.443 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -110.99 -21.61 11.92 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.797 0.665 . . . . 70.35 112.797 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.518 ' SD ' ' HD3' ' A' ' 85' ' ' PRO . 25.5 ptm -75.03 -15.95 60.62 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.912 0.708 . . . . 72.13 112.912 -176.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.63 170.19 13.36 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.048 -0.596 . . . . 71.44 113.642 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 74.2 mmtt -90.87 133.59 35.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.186 0.517 . . . . 72.21 111.772 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -78.38 132.7 37.48 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.512 -0.767 . . . . 52.51 112.797 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.563 HG11 ' CZ ' ' A' ' 157' ' ' ARG . 2.4 m -134.15 161.6 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.971 0.508 . . . . 73.43 111.488 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -116.95 -175.68 2.83 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.835 -0.62 . . . . 63.02 112.068 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.545 ' NH1' ' SD ' ' A' ' 143' ' ' MET . 25.8 mmm180 -40.54 -61.49 0.92 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 75.43 113.855 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -69.03 -16.93 63.83 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.999 0.74 . . . . 54.22 112.999 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -94.12 -13.8 26.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.518 0.562 . . . . 73.25 112.518 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.22 148.89 43.33 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.439 0.903 . . . . 71.53 113.439 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -133.25 -163.01 1.3 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.062 -0.972 . . . . 65.02 109.917 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 41' ' ' LYS . 36.0 m -86.52 108.42 18.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.883 -0.511 . . . . 73.32 110.907 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 126.54 -13.48 6.92 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.952 -0.642 . . . . 62.34 113.77 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 120.98 13.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.338 0.569 . . . . 41.34 111.362 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 155' ' ' ALA . 35.8 mt -76.49 110.98 11.48 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.302 -0.408 . . . . 60.21 111.282 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 155' ' ' ALA . 27.7 m -95.36 139.98 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.046 0.45 . . . . 72.24 112.081 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.446 ' HG ' HH12 ' A' ' 156' ' ' ARG . 96.4 mt -106.56 134.76 49.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.15 -0.477 . . . . 72.43 111.879 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.58 133.92 52.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 72.23 110.459 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 112' ' ' ARG . 24.5 mtp180 -74.1 91.47 2.09 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.186 0.517 . . . . 73.22 110.397 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.54 133.01 35.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.715 0.635 . . . . 64.44 112.715 -170.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.19 -25.8 69.96 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.816 -0.629 . . . . 64.1 113.513 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.7 m -78.74 -53.94 6.61 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.046 0.45 . . . . 64.25 111.666 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.6 p -102.89 -48.81 3.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.253 0.549 . . . . 74.32 112.451 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 118.97 -82.4 0.34 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.731 -0.548 . . . . 63.14 111.731 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 10.4 mpt_? -92.91 96.13 9.92 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.582 -0.364 . . . . 72.53 110.536 173.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -105.09 141.68 36.23 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.465 -0.334 . . . . 74.33 110.799 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.17 137.78 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.199 0.523 . . . . 55.32 111.92 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.28 159.84 23.95 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 116.054 -0.521 . . . . 73.14 112.635 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.49 HG21 HD13 ' A' ' 44' ' ' ILE . 56.8 mt -93.33 110.3 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 122.603 -0.351 . . . . 72.43 110.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -69.32 115.7 8.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.928 0.394 . . . . 75.14 111.611 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.9 pt -106.58 14.27 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.12 0.415 . . . . 71.44 112.12 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.57 162.62 33.95 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.309 -0.472 . . . . 70.54 114.071 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 59.07 35.56 23.91 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.831 0.452 . . . . 54.44 111.996 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 142' ' ' SER . 48.4 m-80 62.18 14.49 6.7 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.126 0.417 . . . . 65.25 112.126 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -103.35 145.7 29.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.111 0.482 . . . . 72.01 111.139 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.03 139.87 19.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.115 -0.493 . . . . 75.42 111.844 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.49 133.62 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.091 0.472 . . . . 62.12 110.977 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -163.67 168.71 19.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.299 -0.41 . . . . 74.01 111.184 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.13 93.4 8.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.009 0.433 . . . . 71.05 110.814 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.1 t -79.54 130.39 35.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.309 -0.405 . . . . 73.12 111.993 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.8 p -63.36 -11.85 25.74 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.063 -0.517 . . . . 62.34 112.359 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.3 m -79.72 -32.39 41.23 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.976 0.362 . . . . 52.44 111.976 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.4 t -139.65 -48.45 0.47 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.04 0.448 . . . . 73.45 112.069 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.1 -148.28 19.95 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.713 -0.555 . . . . 74.44 111.713 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.2 99.5 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 117.321 0.561 . . . . 64.41 111.175 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 41.0 pt -138.23 -177.54 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.118 0.485 . . . . 73.42 111.824 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.79 129.03 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.251 -0.431 . . . . 72.4 110.565 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.5 m -119.8 172.94 7.35 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.942 0.401 . . . . 63.32 111.599 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 47.2 m -128.78 144.83 51.26 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.993 0.425 . . . . 54.43 112.085 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.545 ' SD ' ' NH1' ' A' ' 100' ' ' ARG . 65.8 mtt -75.2 0.87 14.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.675 0.62 . . . . 50.12 112.675 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -86.95 -11.86 49.32 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.936 -0.477 . . . . 65.32 111.287 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.46 130.6 92.04 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.486 -0.325 . . . . 75.03 110.699 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.34 -31.02 75.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.876 2.384 . . . . 43.45 113.442 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.19 -45.0 62.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.705 0.288 . . . . 71.4 111.74 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -83.79 -37.54 22.45 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.183 0.438 . . . . 72.23 112.183 -174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -53.51 -51.41 62.91 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.43 0.53 . . . . 73.24 112.43 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.22 -7.86 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.955 0.354 . . . . 71.1 111.955 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -95.94 -10.87 27.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.119 0.414 . . . . 72.01 112.119 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.86 114.63 2.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.946 0.403 . . . . 74.15 111.474 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -96.26 -55.5 2.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.296 -0.411 . . . . 74.42 111.255 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -168.74 -179.69 3.87 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.871 0.367 . . . . 74.44 111.398 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.586 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -140.33 160.4 40.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.28 -0.418 . . . . 74.3 111.162 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 17.4 mtm-85 -144.33 121.22 11.31 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.321 -0.237 . . . . 73.34 111.584 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.563 ' CZ ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -94.08 98.92 11.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.755 0.788 . . . . 75.02 111.242 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.542 HG21 HD21 ' A' ' 84' ' ' LEU . 15.9 m -83.18 -1.01 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.515 -0.766 . . . . 63.43 112.592 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.495 HD23 HD22 ' A' ' 82' ' ' LEU . 90.9 mt -69.48 166.42 18.85 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.866 0.365 . . . . 64.33 111.974 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 31.8 t -47.79 135.05 12.44 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.037 -0.529 . . . . 53.11 111.87 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -64.11 101.91 0.45 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.065 0.459 . . . . 72.32 111.441 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -85.28 -25.63 27.11 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.029 -0.532 . . . . 50.51 111.044 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.61 -170.63 1.89 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.81 -0.632 . . . . 60.3 111.315 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 C--O 1.253 1.245 0 CA-C-N 115.979 -0.555 . . . . 63.44 110.989 178.426 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 81.4 mtp . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.685 0.279 . . . . 65.32 111.314 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -144.13 107.4 4.55 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.197 0.522 . . . . 54.41 111.648 175.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.64 112.11 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.211 -0.449 . . . . 74.21 111.301 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -93.1 150.05 20.79 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.301 0.572 . . . . 74.33 111.133 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.75 -38.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.854 -0.612 . . . . 71.2 112.117 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.498 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.7 tttt -63.08 -55.31 26.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.638 0.606 . . . . 60.41 112.638 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 t -57.41 -42.99 83.38 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.95 0.352 . . . . 61.32 111.95 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -59.14 -45.19 91.59 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.022 0.439 . . . . 64.32 111.446 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.56 HD13 HG21 ' A' ' 122' ' ' ILE . 86.8 mt -69.17 -44.54 80.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.828 0.347 . . . . 72.2 111.722 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 28.1 mmt -61.56 -32.04 72.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.889 0.376 . . . . 74.15 111.051 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.09 -53.12 61.49 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.995 -0.548 . . . . 73.21 110.765 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.576 ' HG2' ' HA ' ' A' ' 75' ' ' THR . 51.6 tp60 -65.25 -36.33 83.79 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.02 -0.536 . . . . 72.0 111.812 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.484 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 34.0 t80 -55.21 -39.68 69.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.868 0.366 . . . . 63.54 111.273 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . . . -59.37 -18.4 38.19 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.454 0.538 . . . . 71.13 112.454 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -92.5 -22.63 19.46 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.058 0.456 . . . . 71.44 111.776 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.473 ' CZ2' ' HG2' ' A' ' 63' ' ' LYS . 35.5 m95 -113.56 13.0 18.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.06 0.763 . . . . 72.14 113.06 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 55.6 mtmt -63.57 105.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.229 0.538 . . . . 50.11 112.027 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.96 19.33 9.14 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.94 -0.648 . . . . 71.41 114.375 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.32 130.3 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.619 0.709 . . . . 51.12 110.738 174.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 55' ' ' ARG . 16.5 ptt180 -79.46 163.27 24.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.408 0.521 . . . . 73.25 112.408 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -81.25 125.48 30.37 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.174 0.511 . . . . 74.5 112.242 -174.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.431 HH11 HG22 ' A' ' 62' ' ' THR . 53.0 ttt180 -137.0 111.47 8.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.794 -0.639 . . . . 75.24 110.263 176.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.591 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 1.1 pt? -92.82 113.06 25.23 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.324 0.583 . . . . 72.22 112.026 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.08 -7.26 27.17 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.848 -0.615 . . . . 52.32 113.267 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.01 110.8 0.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.455 -0.403 . . . . 45.21 112.314 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.52 ' HA ' HG13 ' A' ' 66' ' ' ILE . 48.8 m -92.09 104.23 16.64 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.557 0.577 . . . . 63.21 112.557 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.431 HG22 HH11 ' A' ' 57' ' ' ARG . 2.9 t -151.87 157.18 41.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 73.2 111.222 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HG2' ' CZ2' ' A' ' 51' ' ' TRP . 43.8 mtpt -65.69 -15.86 63.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 73.32 111.708 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -92.41 11.12 27.21 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.061 0.458 . . . . 71.1 111.015 178.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.44 116.39 0.67 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.747 -0.541 . . . . 51.34 111.747 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.52 HG13 ' HA ' ' A' ' 61' ' ' SER . 19.9 tt -150.19 151.85 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 117.263 0.531 . . . . 53.22 111.882 -173.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 2.7 p30 -91.05 177.48 6.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.284 0.564 . . . . 71.24 112.084 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.444 ' O ' HG12 ' A' ' 72' ' ' VAL . 23.0 p -61.31 -43.9 98.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.1 -0.5 . . . . 72.24 111.749 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.482 ' HB2' ' OG1' ' A' ' 88' ' ' THR . 40.3 t -61.13 -46.29 91.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.156 0.503 . . . . 72.33 111.221 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.562 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -60.67 -45.85 95.59 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.045 -0.598 . . . . 70.43 112.797 177.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.22 -53.7 55.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.804 0.335 . . . . 63.44 111.902 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.538 ' HA ' HD11 ' A' ' 122' ' ' ILE . 7.7 p -59.76 -40.41 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.934 0.397 . . . . 64.31 110.676 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.501 ' HA ' HD12 ' A' ' 84' ' ' LEU . 20.3 tt0 -55.62 -48.64 74.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.153 -0.476 . . . . 73.32 111.406 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.576 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 15.7 mmm180 -60.75 -49.03 79.12 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.937 0.347 . . . . 53.32 111.937 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.576 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . 86.6 m -57.81 -54.19 49.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.049 0.452 . . . . 70.03 112.045 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 68.7 m-85 -64.11 -33.96 76.97 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.494 0.553 . . . . 65.13 112.494 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -75.7 -29.18 58.89 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.019 -0.425 . . . . 75.42 111.679 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 78.6 mm-40 -71.18 -64.08 0.98 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.105 0.479 . . . . 73.11 111.417 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.401 ' NE2' ' HB2' ' A' ' 47' ' ' GLN . 18.4 mp0 -72.5 -59.42 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.81 0.67 . . . . 73.13 112.81 -177.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -88.78 -12.87 40.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.524 0.565 . . . . 74.42 112.524 -173.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.03 31.2 77.27 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.793 -0.718 . . . . 25.4 112.492 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 56.4 tp -90.8 132.34 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.675 0.39 . . . . 74.43 111.236 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.83 131.07 35.95 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.199 0.523 . . . . 74.11 112.117 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 73' ' ' GLN . 95.0 mt -136.0 150.96 72.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.224 -0.443 . . . . 73.21 111.079 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.09 156.92 55.22 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.551 2.167 . . . . 54.44 112.927 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.46 6.19 10.89 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.728 0.64 . . . . 75.02 112.728 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.3 m -131.25 129.11 41.17 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.663 0.268 . . . . 73.41 111.642 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.547 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 89.0 m -54.74 -43.38 72.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.897 0.379 . . . . 74.12 111.357 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -51.51 -32.39 27.53 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.94 -0.573 . . . . 72.21 111.729 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.15 -40.77 14.31 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.328 -0.397 . . . . 71.34 111.393 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -56.41 -30.2 62.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.885 0.374 . . . . 52.33 111.411 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 88' ' ' THR . 21.7 mt-30 -52.94 -38.45 61.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.057 -0.52 . . . . 63.43 111.93 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.41 22.97 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.111 0.411 . . . . 75.43 112.111 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 96.0 mmm -98.31 -35.43 10.33 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.085 0.772 . . . . 64.15 113.085 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.0 -175.89 14.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.641 -0.79 . . . . 63.05 114.755 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 156' ' ' ARG . 32.0 mmmt -86.21 149.03 25.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.687 0.395 . . . . 73.53 111.875 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -90.28 153.22 20.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.343 0.592 . . . . 72.4 112.563 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.99 159.76 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.676 -0.693 . . . . 74.11 111.502 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.4 t -87.66 157.76 19.02 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.286 -0.415 . . . . 65.1 111.514 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -52.18 -32.68 37.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.191 0.52 . . . . 72.11 111.413 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.5 p -74.57 -28.88 61.12 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.579 0.585 . . . . 44.14 112.579 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -96.05 -0.85 49.88 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.867 0.691 . . . . 74.44 112.867 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.94 123.49 17.23 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.599 0.592 . . . . 74.3 112.599 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -128.05 -178.84 4.69 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.012 -0.54 . . . . 72.11 110.771 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.498 HG21 ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -64.33 108.11 1.52 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.819 0.342 . . . . 71.52 111.893 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.73 -18.61 5.11 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.905 -0.664 . . . . 74.43 113.452 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 66.8 m-20 -74.15 129.73 38.39 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.047 0.451 . . . . 73.33 111.331 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.26 115.77 23.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.679 0.276 . . . . 72.23 110.595 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 155' ' ' ALA . 16.5 m -95.67 128.58 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.143 0.497 . . . . 74.13 111.908 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.4 mt -97.67 129.19 44.76 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.937 -0.574 . . . . 74.21 111.714 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.11 140.31 49.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.536 0.684 . . . . 75.22 112.376 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 112' ' ' ARG . 41.6 mtp180 -83.95 100.35 10.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.459 -0.791 . . . . 62.21 110.932 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.32 147.99 27.54 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.847 0.356 . . . . 64.02 111.85 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 56.53 -99.98 0.1 OUTLIER Glycine 0 CA--C 1.529 0.961 0 CA-C-N 116.265 -0.425 . . . . 53.41 113.806 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 63.9 m -153.6 -50.76 0.1 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.129 0.49 . . . . 54.32 110.181 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -115.4 79.19 1.25 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.193 0.52 . . . . 71.42 110.215 172.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.53 119.94 0.91 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.138 -0.553 . . . . 75.22 113.235 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -97.55 108.45 21.18 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.123 0.487 . . . . 60.14 111.761 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -98.51 148.06 24.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.057 -0.52 . . . . 75.12 110.643 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.5 141.9 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.069 0.461 . . . . 75.12 111.969 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.62 155.59 21.84 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.322 -0.466 . . . . 44.24 112.556 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 44' ' ' ILE . 20.1 mt -95.25 106.26 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.482 -0.422 . . . . 73.4 111.018 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . 33.8 t80 -64.43 113.49 3.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.329 . . . . 65.23 111.186 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.41 -27.47 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.303 0.483 . . . . 74.01 112.303 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.33 144.95 4.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.441 -0.885 . . . . 64.21 114.23 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.21 53.37 12.54 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.107 0.563 . . . . 55.34 112.393 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 142' ' ' SER . 40.6 m-80 66.93 -4.98 0.72 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.173 0.805 . . . . 73.14 113.173 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.497 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 25.1 mt-30 -87.45 143.73 27.08 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.26 0.553 . . . . 74.45 111.061 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.582 ' CE1' ' HG3' ' A' ' 143' ' ' MET . 25.2 p90 -156.32 148.95 23.75 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.77 -0.65 . . . . 74.13 111.519 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.37 137.54 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.104 -0.498 . . . . 72.31 110.835 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -166.45 162.29 16.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.114 0.483 . . . . 65.34 111.85 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -88.78 86.99 7.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.111 0.482 . . . . 75.41 110.309 172.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.2 t -58.22 134.71 56.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.783 -0.644 . . . . 74.2 112.498 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.9 p -57.18 -35.67 69.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.109 0.481 . . . . 60.12 111.82 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.7 t -85.94 -50.74 6.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.715 0.635 . . . . 62.43 112.715 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.8 m -98.9 -34.63 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.202 0.816 . . . . 61.12 113.202 -173.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.61 -158.67 14.4 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.05 -0.595 . . . . 71.44 112.369 -172.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 99.2 t -63.08 102.5 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.318 0.58 . . . . 72.0 111.793 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.76 -178.81 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.817 -0.629 . . . . 70.23 111.642 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.42 109.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.167 -0.469 . . . . 62.43 110.9 172.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 92.7 p -107.88 -171.46 1.87 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.584 0.23 . . . . 64.23 110.818 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.641 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 43.9 m -146.86 136.54 23.06 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.339 0.496 . . . . 63.21 112.339 -174.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.582 ' HG3' ' CE1' ' A' ' 129' ' ' PHE . 72.9 mtm -78.21 3.93 13.98 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.334 0.864 . . . . 54.01 113.334 -177.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' A' ' 142' ' ' SER . 1.0 OUTLIER -83.2 -12.85 56.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.867 0.365 . . . . 75.03 110.544 170.154 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -71.54 136.93 83.37 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 116.532 -0.304 . . . . 64.21 110.427 169.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -52.98 -43.0 60.44 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.722 2.281 . . . . 65.12 113.522 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 80.5 t80 -59.45 -47.66 84.64 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.705 0.288 . . . . 73.42 111.689 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 151' ' ' ARG . 95.6 m95 -78.89 -33.62 45.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.835 0.35 . . . . 75.14 111.623 -176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -56.81 -38.43 72.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.257 -0.429 . . . . 74.33 111.382 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -93.52 -12.32 29.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.788 0.328 . . . . 71.33 111.801 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -79.32 -32.48 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.836 0.35 . . . . 72.55 111.079 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -58.04 126.59 28.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.845 -0.616 . . . . 73.02 112.405 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -101.38 -63.9 1.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.177 0.513 . . . . 65.02 110.344 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.27 172.46 18.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 71.44 110.032 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.473 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -131.23 145.63 52.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.999 0.428 . . . . 63.45 111.934 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' LYS . 97.1 mtt180 -140.6 124.96 17.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.332 -0.395 . . . . 74.21 110.8 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -98.29 137.19 37.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.325 0.583 . . . . 63.54 111.767 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.2 m -104.83 14.29 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.661 -0.7 . . . . 71.43 112.753 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.42 154.85 19.36 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.439 0.533 . . . . 73.24 112.439 -177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.5 m -139.91 125.53 19.26 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.911 -0.586 . . . . 75.33 111.122 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -119.15 -172.62 2.34 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.015 0.376 . . . . 62.33 112.015 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.2 t -125.7 157.29 37.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.665 -0.243 . . . . 43.11 110.765 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 163' ' ' LEU . 6.7 mp -91.53 155.22 18.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.945 0.402 . . . . 54.11 111.792 -176.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.823 -0.608 . . . . 75.54 111.489 177.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.476 ' SD ' ' C ' ' A' ' 36' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.825 0.345 . . . . 72.15 110.919 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -74.16 127.58 33.31 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.836 0.351 . . . . 61.33 111.827 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.89 101.87 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.834 0.35 . . . . 63.12 111.202 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -57.1 122.51 12.56 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.745 0.307 . . . . 51.22 111.384 175.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.9 t -51.22 -44.59 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.162 -0.472 . . . . 55.34 111.582 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.49 -37.76 79.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.431 -0.349 . . . . 64.12 111.62 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.8 m -64.14 -10.87 25.46 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.235 0.457 . . . . 63.13 112.235 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 43' ' ' ARG . 1.5 mmp_? -101.01 -49.1 4.22 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.023 0.44 . . . . 74.53 110.512 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.552 ' HA ' HE22 ' A' ' 79' ' ' GLN . 59.2 mt -52.41 -43.98 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.117 0.484 . . . . 74.5 111.027 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.543 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 31.1 mmt -71.07 -22.49 62.11 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.223 -0.444 . . . . 65.33 111.801 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.78 -46.47 78.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.69 0.281 . . . . 63.53 110.673 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.02 -42.23 69.84 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.707 0.289 . . . . 73.13 110.938 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.584 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 36.6 t80 -50.44 -36.68 34.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.638 0.256 . . . . 73.44 111.183 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.24 80.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.451 -0.341 . . . . 75.43 111.665 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.1 -29.66 60.67 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.831 0.348 . . . . 73.3 111.713 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -92.09 5.9 48.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.163 0.431 . . . . 73.11 112.163 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 23.6 mmmt -58.69 101.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.483 . . . . 73.15 111.915 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.34 -0.45 37.56 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.049 -0.596 . . . . 64.55 113.949 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.5 134.54 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 117.319 0.559 . . . . 73.4 111.323 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -85.58 171.67 11.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.481 0.658 . . . . 71.22 112.427 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -102.18 137.81 39.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.732 -0.667 . . . . 72.5 110.666 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -132.63 121.83 23.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.01 0.433 . . . . 74.41 111.676 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.67 103.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 61.53 111.275 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.57 28.96 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.184 -0.532 . . . . 75.41 113.401 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 134.71 7.61 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.394 -0.432 . . . . 72.13 112.503 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.552 ' HA ' HD12 ' A' ' 66' ' ' ILE . 11.7 m -125.01 98.28 5.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.255 0.527 . . . . 64.22 111.4 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 t 177.99 172.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.867 0.365 . . . . 73.13 111.659 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -66.68 -18.6 65.45 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.881 0.372 . . . . 72.41 111.719 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 3.3 mptp? -78.64 -11.79 59.99 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.107 0.479 . . . . 71.33 110.883 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.92 111.21 0.25 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.595 -0.602 . . . . 72.13 111.595 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 61' ' ' SER . 11.2 tp -112.2 154.33 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.999 0.399 . . . . 72.45 111.658 -173.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.26 178.7 4.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.984 0.421 . . . . 63.33 111.15 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.8 p -60.27 -52.9 63.29 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.309 -0.405 . . . . 54.33 112.013 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -69.42 -36.7 76.95 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.956 0.408 . . . . 74.21 111.129 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.496 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -58.68 -48.95 82.1 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.941 -0.572 . . . . 73.3 113.774 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.69 -56.16 25.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.184 0.492 . . . . 63.1 111.912 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.555 ' HA ' HD11 ' A' ' 122' ' ' ILE . 10.8 p -60.02 -39.41 80.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.872 0.368 . . . . 60.13 111.266 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.581 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 7.4 tt0 -56.68 -57.18 13.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.166 -0.47 . . . . 50.52 111.39 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 25.2 mmt180 -55.28 -49.46 72.02 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.904 0.383 . . . . 74.1 111.24 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.492 HG23 ' NE2' ' A' ' 79' ' ' GLN . 97.9 m -49.72 -61.96 1.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.013 -0.54 . . . . 73.05 112.452 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 69.5 m-85 -68.09 -37.38 81.15 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.202 0.815 . . . . 71.23 113.202 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 73' ' ' GLN . 12.5 ptm180 -71.36 -36.72 71.57 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.879 -0.513 . . . . 64.2 112.172 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -78.08 -23.89 47.82 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.092 -0.38 . . . . 75.3 111.774 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.552 HE22 ' HA ' ' A' ' 44' ' ' ILE . 77.1 mt-30 -92.32 -70.31 0.7 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.178 0.513 . . . . 71.02 112.127 178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -89.96 -9.78 47.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.043 -0.526 . . . . 63.34 112.042 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.51 77.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.918 -0.658 . . . . 62.54 112.33 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 27.8 tp -73.55 111.38 8.63 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.037 0.446 . . . . 72.12 110.533 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.35 78.59 4.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.437 0.637 . . . . 72.25 112.558 -173.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 73' ' ' GLN . 83.8 mt -77.13 143.32 69.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.064 -0.516 . . . . 71.33 111.571 176.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.527 ' HD2' ' HG2' ' A' ' 91' ' ' GLN . 89.9 Cg_endo -79.73 -179.43 5.32 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.019 2.479 . . . . 74.21 113.505 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -11.63 43.12 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.277 0.843 . . . . 73.23 113.277 -173.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.457 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 39.1 t -115.62 137.56 51.95 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.897 -0.502 . . . . 74.33 111.851 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 6.2 m -56.87 -39.59 74.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.134 0.492 . . . . 74.44 111.476 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -64.08 -33.72 76.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.327 -0.397 . . . . 74.44 111.781 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 87' ' ' SER . 43.0 mt-10 -68.21 -38.34 81.81 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.274 0.559 . . . . 73.21 110.627 175.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.527 ' HG2' ' HD2' ' A' ' 85' ' ' PRO . 84.1 mt-30 -64.93 -30.58 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.697 -0.683 . . . . 53.32 110.912 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 88' ' ' THR . 25.4 mt-30 -64.98 -8.74 17.11 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.652 0.612 . . . . 72.4 112.652 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -99.16 -1.89 38.24 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.52 0.563 . . . . 54.22 112.52 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.2 ptp -114.04 154.95 26.8 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.062 -0.399 . . . . 74.41 110.863 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.27 177.22 29.63 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.777 -0.725 . . . . 72.34 112.756 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -118.46 149.75 40.74 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.325 -0.515 . . . . 75.23 111.611 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 156' ' ' ARG . 89.0 p -76.91 154.53 33.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.237 0.829 . . . . 75.24 113.237 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 1.5 m -145.44 150.16 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.235 -0.893 . . . . 73.02 111.63 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.5 t -95.79 -179.52 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.884 0.373 . . . . 44.14 111.571 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -51.52 -44.09 62.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.317 0.488 . . . . 73.25 112.317 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.5 t -83.51 10.12 9.7 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.246 -0.434 . . . . 62.43 112.06 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 8.3 m120 -120.45 -8.55 9.57 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.126 -0.359 . . . . 53.02 111.832 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.64 144.19 57.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.101 0.778 . . . . 62.43 113.101 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -130.28 -156.44 0.76 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.717 -0.674 . . . . 71.41 110.599 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.9 m -101.14 126.97 47.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.548 -0.296 . . . . 74.51 110.325 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.06 -4.07 31.74 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.08 -0.581 . . . . 65.14 113.291 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 123' ' ' TYR . 2.2 m-20 -75.84 142.09 42.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.054 0.454 . . . . 64.22 111.128 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.43 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.535 -0.302 . . . . 63.25 110.331 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.22 126.46 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.473 0.654 . . . . 65.23 111.508 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.723 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 77.4 mt -105.71 115.1 29.66 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.488 -0.778 . . . . 71.43 111.823 -173.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -107.07 151.61 25.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.179 -0.464 . . . . 72.2 111.245 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.591 ' O ' ' HD2' ' A' ' 151' ' ' ARG . 93.4 mtt180 -87.6 101.28 13.49 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.445 -0.343 . . . . 64.43 111.022 176.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.57 152.97 18.68 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.173 -0.329 . . . . 72.43 111.516 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.87 -22.8 58.96 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.122 -0.561 . . . . 24.23 113.71 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.9 t -99.01 -55.52 2.68 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 122.406 -0.467 . . . . 73.41 112.098 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.4 p -86.85 -3.12 59.03 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.591 0.589 . . . . 74.05 112.591 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.53 -65.57 2.78 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.033 -0.603 . . . . 62.3 112.189 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.723 ' HD2' ' HB3' ' A' ' 110' ' ' LEU . 2.1 tpp180 -119.46 128.37 53.94 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.371 -0.488 . . . . 73.52 111.004 176.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -118.05 124.92 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.147 -0.316 . . . . 74.1 110.147 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.82 138.58 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.24 0.459 . . . . 72.23 112.24 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -127.9 147.56 17.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.261 -0.427 . . . . 74.25 112.56 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 72' ' ' VAL . 40.3 mt -87.46 108.58 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.519 -0.4 . . . . 63.32 110.917 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.519 ' HD1' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -66.28 109.82 2.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.048 0.452 . . . . 72.5 111.901 -175.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.4 pt -105.23 11.49 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.01 0.434 . . . . 54.24 111.605 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.06 -172.42 37.94 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 116.294 -0.412 . . . . 64.51 112.581 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -67.62 -16.21 64.05 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.281 0.475 . . . . 71.43 112.281 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.496 ' HA ' ' OH ' ' A' ' 123' ' ' TYR . 9.9 p30 -150.96 -13.42 0.22 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.668 0.618 . . . . 72.1 112.668 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -89.3 143.44 26.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.331 0.586 . . . . 63.04 111.869 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.519 ' HB3' ' HD1' ' A' ' 123' ' ' TYR . 27.6 p90 -153.1 146.46 24.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.647 -0.706 . . . . 65.11 111.462 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.7 p -99.19 136.84 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.055 0.455 . . . . 65.41 111.062 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -156.09 -166.28 2.14 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.736 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.4 114.41 13.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.707 0.289 . . . . 63.4 111.696 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 67.5 m -91.06 145.97 24.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.852 0.358 . . . . 72.32 111.272 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 66.2 p -50.55 -48.91 57.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.58 0.955 . . . . 63.24 113.58 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.7 p -106.83 19.54 20.33 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.773 0.657 . . . . 60.31 112.773 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 133' ' ' SER . 67.6 m -133.05 -23.5 1.96 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.321 0.489 . . . . 74.55 112.321 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.29 -151.94 31.95 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.966 -0.635 . . . . 64.23 112.705 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.432 HG12 ' HE1' ' A' ' 48' ' ' TYR . 47.0 t -75.63 111.77 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.947 0.403 . . . . 45.04 111.993 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.523 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -140.36 -178.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 120.962 0.41 . . . . 63.54 111.491 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.41 143.13 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.738 0.304 . . . . 72.34 110.783 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.8 t -138.43 179.47 6.44 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.806 0.336 . . . . 74.14 111.657 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 127' ' ' ASN . 69.7 m -137.7 138.71 39.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.341 -0.39 . . . . 70.04 111.258 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 27.0 mtm -69.97 -9.67 55.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.426 0.528 . . . . 75.01 112.426 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -78.52 -9.44 59.34 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.092 -0.38 . . . . 72.05 111.38 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.92 136.18 82.65 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 110.167 -0.309 . . . . 73.4 110.167 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -49.98 -45.85 30.75 Favored 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 123.029 2.486 . . . . 72.53 114.157 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.532 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 56.3 t80 -65.11 -44.14 89.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.912 0.387 . . . . 75.14 111.757 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -77.53 -35.56 53.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.832 0.308 . . . . 75.34 111.832 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -53.72 -38.98 64.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.237 0.542 . . . . 73.31 111.565 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -92.59 0.47 57.43 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.525 0.565 . . . . 72.31 112.525 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 112' ' ' ARG . 33.4 mmt180 -100.83 -17.94 16.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.109 0.411 . . . . 70.02 112.109 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.41 130.07 44.65 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.373 0.508 . . . . 74.43 112.373 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -112.89 -54.66 2.6 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 72.5 111.102 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -165.86 167.46 16.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.425 -0.352 . . . . 74.33 110.914 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' SER . . . -133.91 145.41 49.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.165 0.186 . . . . 51.4 110.864 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' A' ' 97' ' ' SER . 57.5 mtt180 -141.0 121.14 13.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.743 0.306 . . . . 61.24 111.422 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.511 ' H ' ' HD3' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -85.06 121.94 28.55 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.409 0.623 . . . . 72.42 110.864 175.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.48 4.91 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.026 -0.534 . . . . 65.14 112.329 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.88 110.99 22.35 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.874 0.368 . . . . 60.42 111.315 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.5 t -82.38 -174.1 4.96 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.136 0.493 . . . . 51.4 111.903 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -106.06 123.06 47.41 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.118 0.485 . . . . 75.4 112.091 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 96.1 p -109.7 133.5 53.06 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.63 -0.507 . . . . 64.4 109.63 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 163' ' ' LEU . 2.0 pt? -144.35 179.09 7.47 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 122.118 -0.364 . . . . 75.24 111.847 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.252 1.185 0 N-CA-C 113.064 0.765 . . . . 64.04 113.064 -177.535 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.815 0.34 . . . . 74.15 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.442 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -99.8 167.18 10.7 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.561 0.219 . . . . 73.23 110.765 177.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.43 79.22 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.136 0.493 . . . . 51.4 110.565 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER -69.44 95.19 0.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.328 0.585 . . . . 71.23 111.435 177.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -55.31 -48.71 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.581 0.585 . . . . 65.23 112.581 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HB2' HG21 ' A' ' 105' ' ' THR . 84.1 tttt -61.86 -56.95 14.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.863 0.32 . . . . 72.53 111.863 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.411 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 56.6 m -59.83 -38.83 83.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.597 0.237 . . . . 61.23 111.563 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -52.9 -52.05 59.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.331 0.586 . . . . 71.11 111.2 176.412 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 122' ' ' ILE . 72.8 mt -69.16 -42.8 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.829 -0.623 . . . . 72.11 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.7 mmt -62.66 -37.28 85.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.022 0.439 . . . . 63.22 111.328 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.87 -46.05 92.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.317 -0.401 . . . . 71.04 110.605 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -68.02 -36.82 80.6 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.399 -0.364 . . . . 64.12 111.523 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 50.4 t80 -54.07 -39.39 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 111.831 0.308 . . . . 74.25 111.831 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.36 -23.24 9.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 74.42 112.234 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.65 -44.41 11.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.12 0.486 . . . . 61.03 111.024 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -80.92 -2.27 46.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.139 0.792 . . . . 74.12 113.139 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 54.2 mtmt -50.04 117.75 2.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.678 0.621 . . . . 73.44 112.678 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.41 -6.35 77.95 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 114.75 0.66 . . . . 72.34 114.75 172.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.0 t -59.72 130.21 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 117.827 0.814 . . . . 73.25 111.599 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.02 171.15 13.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.094 -0.503 . . . . 64.3 112.315 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 32.3 t80 -98.28 123.01 42.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.236 0.458 . . . . 72.01 112.236 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -138.17 133.08 32.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.653 0.381 . . . . 72.51 110.623 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 5.3 mp -84.0 121.25 27.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.058 0.392 . . . . 73.22 112.058 -175.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.43 -50.82 3.87 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.03 -0.605 . . . . 74.05 113.006 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.21 60.19 1.86 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.342 -0.456 . . . . 43.22 112.305 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.3 m -67.61 103.47 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.814 0.446 . . . . 64.14 111.919 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.6 t -158.74 172.87 17.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.128 0.49 . . . . 73.55 111.909 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.39 -1.1 14.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.616 0.599 . . . . 61.12 112.616 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -105.17 10.84 33.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 74.43 110.803 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.87 118.55 0.91 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.714 -0.554 . . . . 61.13 111.714 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.2 tt -147.6 147.5 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.775 0.788 . . . . 51.01 112.331 -175.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 7.2 p-10 -92.44 176.22 6.55 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.168 0.509 . . . . 73.13 112.37 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.433 ' SG ' ' N ' ' A' ' 69' ' ' SER . 26.1 p -59.02 -59.88 4.77 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.893 -0.594 . . . . 53.34 111.643 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.433 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 16.7 p -62.61 -37.3 85.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.267 -0.424 . . . . 70.45 111.362 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.65 -43.29 99.18 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.346 -0.454 . . . . 73.22 113.286 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -61.26 -52.69 63.66 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 122.57 -0.371 . . . . 62.55 111.774 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.538 ' HA ' HD11 ' A' ' 122' ' ' ILE . 4.9 p -61.42 -49.27 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 112.252 0.464 . . . . 72.25 112.252 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -60.8 -33.9 73.69 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.092 -0.38 . . . . 60.55 111.791 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.51 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 78.2 mtt-85 -72.0 -52.11 18.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.086 -0.384 . . . . 70.34 111.497 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -49.66 -40.69 40.57 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.99 0.424 . . . . 61.12 111.892 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.555 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 47.0 m-85 -73.47 -40.91 63.79 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.582 0.586 . . . . 65.22 112.582 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.51 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 12.1 ptp180 -70.43 -24.73 62.96 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.757 -0.589 . . . . 71.13 111.223 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 20.6 mm-40 -69.48 -62.07 1.53 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.266 0.555 . . . . 74.35 111.345 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HB3' ' HG2' ' A' ' 43' ' ' ARG . 85.9 mm-40 -88.26 -32.17 18.64 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.555 0.946 . . . . 75.44 113.555 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -112.25 -13.05 13.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 64.11 112.357 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.99 17.61 77.17 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.867 -0.682 . . . . 41.02 112.814 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 49.5 tp -83.63 115.06 21.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.919 0.39 . . . . 61.24 111.147 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.94 96.68 8.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.843 0.354 . . . . 42.2 111.377 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 97.2 mt -98.64 142.37 24.48 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.459 -0.337 . . . . 64.31 110.889 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.23 163.79 9.59 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.84 2.36 . . . . 72.43 113.31 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 3.5 mpt_? -78.81 -25.27 44.21 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.689 0.626 . . . . 73.43 112.689 -173.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.433 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 36.3 t -98.95 140.22 33.43 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.375 0.509 . . . . 72.23 112.375 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 92.8 m -55.05 -42.52 72.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.844 -0.616 . . . . 71.44 111.321 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.38 -44.75 95.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.97 -0.559 . . . . 73.15 111.33 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 40.2 mm-40 -64.44 -36.73 85.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.08 0.467 . . . . 71.14 110.649 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.92 -27.42 66.61 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.18 -0.464 . . . . 71.15 111.617 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.544 ' HA ' ' NE ' ' A' ' 156' ' ' ARG . 28.4 mt-30 -59.94 -49.58 77.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 71.12 110.838 175.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.93 -6.21 43.71 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.06 -0.518 . . . . 71.21 112.247 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mmm -110.72 21.46 16.51 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.875 0.369 . . . . 75.12 111.95 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -142.38 133.66 5.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.275 -0.488 . . . . 53.22 112.272 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.552 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 43.6 mmtm -88.43 140.92 28.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.162 0.506 . . . . 61.51 112.085 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 t -74.71 136.98 41.81 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.631 0.974 . . . . 53.53 113.631 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.25 139.6 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.521 -0.763 . . . . 74.2 110.656 172.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.1 t -92.72 -179.98 5.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.533 0.568 . . . . 73.11 112.533 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -41.23 -53.72 3.11 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.125 1.157 . . . . 64.24 114.125 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -82.72 -14.5 54.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.515 0.561 . . . . 74.43 112.515 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -99.07 6.85 46.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.543 0.571 . . . . 51.52 112.543 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.28 138.36 58.51 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.785 0.326 . . . . 73.43 111.542 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -145.5 134.21 22.26 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.579 -0.282 . . . . 60.12 111.118 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.506 HG21 ' HB2' ' A' ' 41' ' ' LYS . 83.4 m -44.69 102.0 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.047 0.451 . . . . 71.4 111.792 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.09 -8.12 3.23 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.964 -0.562 . . . . 52.0 113.178 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 157' ' ' ARG . 3.4 p30 -88.12 160.25 17.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.467 0.651 . . . . 72.2 111.603 176.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 mt -106.34 117.43 34.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 75.04 110.709 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 155' ' ' ALA . 12.2 m -94.15 119.18 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.425 0.631 . . . . 71.44 111.553 -175.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.464 HD11 ' HG2' ' A' ' 92' ' ' GLN . 95.6 mt -91.21 132.0 36.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.642 -0.708 . . . . 63.32 111.436 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -122.16 134.11 54.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.408 -0.36 . . . . 75.54 110.993 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.436 ' HG3' ' HB2' ' A' ' 153' ' ' ASN . 80.2 mtp180 -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.673 -0.491 . . . . 74.44 109.673 174.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.558 ' HB3' ' OG1' ' A' ' 116' ' ' THR . . . -92.2 143.05 26.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.074 0.464 . . . . 74.34 111.633 -175.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.49 -37.21 73.81 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.171 -0.468 . . . . 61.14 114.159 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -103.5 7.6 37.82 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.926 0.713 . . . . 60.41 112.926 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.558 ' OG1' ' HB3' ' A' ' 113' ' ' ALA . 43.5 p -132.7 -24.58 1.95 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.555 0.576 . . . . 72.24 112.555 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.62 -58.33 4.47 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.07 -0.586 . . . . 71.11 112.468 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -130.89 122.55 27.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.917 0.389 . . . . 60.5 111.383 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -127.52 160.46 31.45 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.322 -0.399 . . . . 75.35 110.107 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.83 141.18 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.148 0.499 . . . . 55.3 112.317 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.66 160.76 24.62 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.108 -0.497 . . . . 63.5 112.437 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 72' ' ' VAL . 34.1 mt -94.62 112.27 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.464 -0.433 . . . . 74.44 111.084 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.12 113.65 4.1 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.762 0.315 . . . . 73.43 111.64 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.461 ' HA ' HG23 ' A' ' 105' ' ' THR . 31.2 pt -98.64 -20.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.201 0.445 . . . . 74.55 112.201 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.95 148.04 5.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.931 -0.652 . . . . 42.51 113.782 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.4 m120 58.47 40.02 24.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.277 0.473 . . . . 74.44 112.277 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 68.6 3.59 3.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.859 -0.61 . . . . 72.34 112.397 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.565 ' HG2' ' OG ' ' A' ' 142' ' ' SER . 25.1 mt-30 -90.14 147.53 23.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.039 0.447 . . . . 72.51 110.759 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -155.35 151.76 28.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 71.31 111.979 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.34 135.91 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.071 -0.513 . . . . 75.14 110.448 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.91 173.33 16.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.034 0.445 . . . . 75.31 111.746 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 68' ' ' CYS . . . -102.03 96.81 7.27 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.005 -0.543 . . . . 63.44 110.909 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.4 t -68.69 135.47 51.39 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.063 -0.517 . . . . 63.21 111.84 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.6 p -65.22 -20.66 66.54 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 75.13 111.56 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.9 m -97.07 -52.4 3.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.416 -0.356 . . . . 55.43 111.913 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.441 ' HB2' HD13 ' A' ' 139' ' ' ILE . 49.8 m -101.48 -16.45 16.81 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.073 0.768 . . . . 62.32 113.073 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.1 -154.27 24.3 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.853 -0.689 . . . . 72.43 112.884 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.37 104.39 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.019 0.438 . . . . 60.12 111.999 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 136' ' ' SER . 41.6 pt -140.77 178.48 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.113 0.482 . . . . 62.14 111.704 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.7 mm -101.15 141.83 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.467 173.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -144.56 165.4 28.11 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.773 0.321 . . . . 75.53 110.541 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.565 ' OG ' ' HG2' ' A' ' 128' ' ' GLN . 15.8 m -138.48 142.88 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.975 0.361 . . . . 73.42 111.975 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.2 mtm -72.57 -3.09 22.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.369 0.604 . . . . 62.42 110.626 171.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.98 -16.29 61.08 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.864 -0.607 . . . . 75.35 110.089 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 19.5 mm-40 -85.76 135.01 38.45 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.784 -0.644 . . . . 64.41 110.317 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -48.92 -44.87 30.77 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.183 2.589 . . . . 55.13 114.303 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 50.5 t80 -64.56 -44.16 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.946 -0.471 . . . . 73.43 111.759 -177.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -77.47 -32.75 54.54 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.184 0.516 . . . . 64.11 111.392 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -56.2 -48.71 75.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.401 0.68 . . . . 65.34 112.232 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -84.36 -13.92 50.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.853 0.686 . . . . 63.23 112.853 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 17.2 mmm180 -100.3 -3.39 31.43 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.72 0.637 . . . . 72.13 112.72 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -54.11 123.03 11.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.094 0.405 . . . . 60.01 112.094 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 112' ' ' ARG . 7.0 t30 -98.4 -66.61 0.89 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.382 -0.372 . . . . 72.45 111.248 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.435 ' HG2' HD22 ' A' ' 153' ' ' ASN . 8.7 pt-20 -164.48 144.71 7.76 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.603 0.24 . . . . 63.22 110.829 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 109' ' ' VAL . . . -102.57 146.49 28.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.781 0.324 . . . . 62.33 111.357 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.544 ' NE ' ' HA ' ' A' ' 92' ' ' GLN . 11.8 mtm-85 -136.89 111.37 8.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.607 0.225 . . . . 62.45 111.607 -176.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -75.02 124.99 27.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.04 0.448 . . . . 63.54 111.143 176.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.5 m -103.23 -19.51 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.037 -0.529 . . . . 74.3 112.105 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.89 149.09 34.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.148 0.499 . . . . 73.1 111.718 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.8 m -87.39 104.79 16.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.087 -0.506 . . . . 65.43 112.126 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -93.78 1.26 56.52 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.065 0.46 . . . . 73.24 110.985 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.3 m -108.23 -168.37 1.36 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.005 -0.543 . . . . 71.1 110.738 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 164' ' ' GLU . 6.7 tt -62.39 137.23 58.22 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.63 0.252 . . . . 74.13 110.372 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.524 ' N ' HD23 ' A' ' 163' ' ' LEU . 42.2 mt-10 . . . . . 0 C--O 1.253 1.279 0 CA-C-O 119.145 -0.455 . . . . 70.33 112.048 -176.927 . . . . . . . . 1 1 . 1 stop_ save_